Clustering O 0 0.02055135741829872
of O 0 0.005812853574752808
missense O 0 0.056653089821338654
mutations O 0 0.005028273444622755
in O 0 0.0025066696107387543
the O 0 0.08527946472167969
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999337196350098
telangiectasia I-Disease 1 0.9999713897705078
gene O 0 0.0031474989373236895
in O 0 0.0014430484734475613
a O 0 0.003181181149557233
sporadic B-Disease 1 0.8389579653739929
T I-Disease 1 0.9997861981391907
- I-Disease 1 0.9894474744796753
cell I-Disease 0 0.48284053802490234
leukaemia I-Disease 1 0.9997685551643372
. O 0 0.010147328488528728

Ataxia B-Disease 1 0.9999940395355225
- I-Disease 1 0.9993176460266113
telangiectasia I-Disease 1 0.9999806880950928
( O 0 0.2991412878036499
A B-Disease 1 0.9587083458900452
- I-Disease 1 0.9989847540855408
T I-Disease 1 0.9976370334625244
) O 0 0.0009440337307751179
is O 0 0.0007222941494546831
a O 0 0.0014921351103112102
recessive B-Disease 1 0.990462601184845
multi I-Disease 1 0.999935507774353
- I-Disease 1 0.9999598264694214
system I-Disease 1 0.9692251682281494
disorder I-Disease 1 0.9999849796295166
caused O 1 0.8107425570487976
by O 0 0.0010807731887325644
mutations O 0 0.001329102204181254
in O 0 0.0005371379083953798
the O 0 0.0007137691136449575
ATM O 0 0.0020921113900840282
gene O 0 0.000887692382093519
at O 0 0.000977177289314568
11q22 O 0 0.0130606759339571
- O 0 0.011744698509573936
q23 O 0 0.09568345546722412
( O 0 0.002562369219958782
ref O 0 0.00911669060587883
. O 0 0.001631881226785481
3 O 0 0.0033774953335523605
) O 0 0.0038858605548739433
. O 0 0.006157343741506338

The O 0 0.008090007118880749
risk O 0 0.20139679312705994
of O 0 0.39569878578186035
cancer B-Disease 1 0.9999988079071045
, O 0 0.28411754965782166
especially O 0 0.3266146779060364
lymphoid B-Disease 1 0.9999827146530151
neoplasias I-Disease 1 0.9940363168716431
, O 0 0.0013035578886047006
is O 0 0.0010256289970129728
substantially O 0 0.00206632143817842
elevated O 0 0.24088050425052643
in O 0 0.0014521891716867685
A B-Disease 1 0.9983123540878296
- I-Disease 1 0.9999874830245972
T I-Disease 1 0.9999887943267822
patients O 1 0.7181251645088196
and O 0 0.000749060942325741
has O 0 0.0008005300769582391
long O 0 0.0012268929276615381
been O 0 0.0009243956301361322
associated O 0 0.0016248656902462244
with O 0 0.002734025474637747
chromosomal O 1 0.9988258481025696
instability O 1 0.9995720982551575
. O 0 0.014052371494472027

By O 0 0.00822724960744381
analysing O 0 0.12109038978815079
tumour B-Disease 1 0.9997861981391907
DNA O 0 0.003646457800641656
from O 0 0.0016485441010445356
patients O 0 0.00634954497218132
with O 0 0.001239176606759429
sporadic B-Disease 0 0.1436748057603836
T I-Disease 1 0.9956165552139282
- I-Disease 1 0.7259800434112549
cell I-Disease 0 0.08310069888830185
prolymphocytic I-Disease 1 0.9959717392921448
leukaemia I-Disease 1 0.9999960660934448
( O 1 0.524061918258667
T B-Disease 1 0.9975814819335938
- I-Disease 1 0.7907208204269409
PLL I-Disease 1 0.9945172667503357
) O 0 0.0011589123168960214
, O 0 0.0008252598927356303
a O 0 0.0010896754683926702
rare O 0 0.0021197611931711435
clonal B-Disease 0 0.16340698301792145
malignancy I-Disease 1 0.8956234455108643
with O 0 0.0007538135396316648
similarities O 0 0.001148712239228189
to O 0 0.0006202085060067475
a O 0 0.0015222765505313873
mature B-Disease 0 0.18427160382270813
T I-Disease 1 0.9967666864395142
- I-Disease 1 0.8635106682777405
cell I-Disease 0 0.13538460433483124
leukaemia I-Disease 1 0.9997995495796204
seen O 0 0.0012960784370079637
in O 0 0.0009153421851806343
A B-Disease 1 0.9283591508865356
- I-Disease 1 0.9992557168006897
T I-Disease 1 0.9958618879318237
, O 0 0.000504076830111444
we O 0 0.00035388057585805655
demonstrate O 0 0.000629042973741889
a O 0 0.0004739444120787084
high O 0 0.0008147287298925221
frequency O 0 0.0007675267988815904
of O 0 0.0008884480921551585
ATM O 0 0.003889793995767832
mutations O 0 0.002415988827124238
in O 0 0.0022798823192715645
T B-Disease 1 0.9587705731391907
- I-Disease 0 0.4494929611682892
PLL I-Disease 1 0.9835811853408813
. O 0 0.010303986258804798

In O 0 0.005844178143888712
marked O 0 0.005813826806843281
contrast O 0 0.0032589733600616455
to O 0 0.0011972049251198769
the O 0 0.0012877953704446554
ATM O 0 0.0038049714639782906
mutation O 0 0.0016582095995545387
pattern O 0 0.001548046013340354
in O 0 0.0008223828044719994
A B-Disease 1 0.8328030109405518
- I-Disease 1 0.9935964345932007
T I-Disease 1 0.9256845712661743
, O 0 0.0005568223423324525
the O 0 0.0004990118322893977
most O 0 0.00045163105824030936
frequent O 0 0.001029627281241119
nucleotide O 0 0.0013484969967976213
changes O 0 0.000699098571203649
in O 0 0.000937166390940547
this O 0 0.0016189326997846365
leukaemia B-Disease 1 0.968752920627594
were O 0 0.003947837743908167
missense O 0 0.03457598015666008
mutations O 0 0.013021274469792843
. O 0 0.010300212539732456

These O 0 0.003732818178832531
clustered O 0 0.005524044390767813
in O 0 0.0018791803158819675
the O 0 0.0013745686737820506
region O 0 0.0015534532722085714
corresponding O 0 0.0013199439272284508
to O 0 0.0006735726492479444
the O 0 0.0008273578714579344
kinase O 0 0.001854458823800087
domain O 0 0.0008255169959738851
, O 0 0.00042473216308280826
which O 0 0.00039168892544694245
is O 0 0.0004435231676325202
highly O 0 0.0007047712570056319
conserved O 0 0.0009902267483994365
in O 0 0.000706083548720926
ATM O 0 0.004198557697236538
- O 0 0.002348676323890686
related O 0 0.0009192686411552131
proteins O 0 0.0010169695597141981
in O 0 0.0009807607857510448
mouse O 0 0.0026344889774918556
, O 0 0.0014363436494022608
yeast O 0 0.004649920389056206
and O 0 0.0031455543357878923
Drosophila O 0 0.015188191086053848
. O 0 0.008472362533211708

The O 0 0.006723120342940092
resulting O 0 0.007800373714417219
amino O 0 0.006535207852721214
- O 0 0.08967917412519455
acid O 0 0.004242860712110996
substitutions O 0 0.0024797911755740643
are O 0 0.0007879587356001139
predicted O 0 0.001738519174978137
to O 0 0.000816201267298311
interfere O 0 0.0018261540681123734
with O 0 0.001299688476137817
ATP O 0 0.00907836388796568
binding O 0 0.0025591417215764523
or O 0 0.002251127501949668
substrate O 0 0.0065872869454324245
recognition O 0 0.008354347199201584
. O 0 0.008769834414124489

Two O 0 0.003977032378315926
of O 0 0.0037016035057604313
seventeen O 0 0.03882693871855736
mutated O 1 0.921968936920166
T B-Disease 1 0.9875165224075317
- I-Disease 0 0.29314419627189636
PLL I-Disease 1 0.8155781030654907
samples O 0 0.0016674234066158533
had O 0 0.0011030056048184633
a O 0 0.0010654234793037176
previously O 0 0.0015945368213579059
reported O 0 0.003926171455532312
A B-Disease 1 0.5739527940750122
- I-Disease 1 0.9902282953262329
T I-Disease 1 0.9968305230140686
allele O 0 0.02040042169392109
. O 0 0.009070968255400658

In O 0 0.004949119407683611
contrast O 0 0.003969816491007805
, O 0 0.0019144188845530152
no O 0 0.00132302928250283
mutations O 0 0.0015162526397034526
were O 0 0.0006415548850782216
detected O 0 0.0012523402692750096
in O 0 0.0006153243011794984
the O 0 0.0007945547113195062
p53 O 0 0.0025724531151354313
gene O 0 0.0009952075779438019
, O 0 0.0005927921156398952
suggesting O 0 0.0012113065458834171
that O 0 0.0006082524196244776
this O 0 0.0010899510234594345
tumour B-Disease 1 0.9998013377189636
suppressor O 0 0.13745255768299103
is O 0 0.0008567958138883114
not O 0 0.0005737645551562309
frequently O 0 0.0011151842772960663
altered O 0 0.001980446046218276
in O 0 0.001449962262995541
this O 0 0.0027098464779555798
leukaemia B-Disease 1 0.998504638671875
. O 0 0.009944124147295952

Occasional O 0 0.01671602390706539
missense O 0 0.024448039010167122
mutations O 0 0.0052156164310872555
in O 0 0.0019816614221781492
ATM O 0 0.003925671800971031
were O 0 0.0008974693482741714
also O 0 0.000789891229942441
found O 0 0.000730396481230855
in O 0 0.0008628728101029992
tumour B-Disease 1 0.9984166622161865
DNA O 0 0.001101178815588355
from O 0 0.0005884233978576958
patients O 0 0.002549306722357869
with O 0 0.0006654962198808789
B B-Disease 1 0.5250623822212219
- I-Disease 0 0.48183995485305786
cell I-Disease 0 0.04238342493772507
non I-Disease 1 0.6723242402076721
- I-Disease 1 0.999627947807312
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999039173126221
( O 0 0.005832073278725147
B B-Disease 0 0.055158983916044235
- I-Disease 0 0.005147218704223633
NHL I-Disease 0 0.0025551854632794857
) O 0 0.0007430390105582774
and O 0 0.0006609609699808061
a O 0 0.0014086350565776229
B B-Disease 0 0.017607664689421654
- I-Disease 0 0.010427289642393589
NHL I-Disease 0 0.007694241590797901
cell O 0 0.005392083432525396
line O 0 0.007671651430428028
. O 0 0.008854282088577747

The O 0 0.004433991853147745
evidence O 0 0.002703763311728835
of O 0 0.0015781186521053314
a O 0 0.0013010615948587656
significant O 0 0.0010214019566774368
proportion O 0 0.001491399365477264
of O 0 0.0012571237748488784
loss O 1 0.9066231846809387
- O 1 0.8440645337104797
of O 0 0.04420964792370796
- O 1 0.9192068576812744
function O 0 0.0012877536937594414
mutations O 0 0.0008252232801169157
and O 0 0.0003941748582292348
a O 0 0.0005521824932657182
complete O 0 0.0007970018195919693
absence O 0 0.0012160855112597346
of O 0 0.0005815011099912226
the O 0 0.0007191079203039408
normal O 0 0.0009074588888324797
copy O 0 0.0008616166305728257
of O 0 0.0005412862519733608
ATM O 0 0.001526813954114914
in O 0 0.00045086684986017644
the O 0 0.0005256767617538571
majority O 0 0.0007026336388662457
of O 0 0.0013331882655620575
mutated O 1 0.7979733347892761
tumours B-Disease 1 0.9998230338096619
establishes O 1 0.6937465071678162
somatic O 0 0.24273210763931274
inactivation O 0 0.06083376705646515
of O 0 0.0008516085799783468
this O 0 0.0006365860463120043
gene O 0 0.0007820071186870337
in O 0 0.0005570071516558528
the O 0 0.0008972871582955122
pathogenesis O 1 0.8359594941139221
of O 0 0.004259258043020964
sporadic B-Disease 1 0.989175021648407
T I-Disease 1 0.9998966455459595
- I-Disease 1 0.9251340627670288
PLL I-Disease 1 0.990727424621582
and O 0 0.0009848370682448149
suggests O 0 0.0014066509902477264
that O 0 0.000748512102290988
ATM O 0 0.003104973351582885
acts O 0 0.0017724267672747374
as O 0 0.0019753093365579844
a O 0 0.007701584603637457
tumour B-Disease 1 0.9999743700027466
suppressor O 1 0.9557511806488037
. O 0 0.011724603362381458

As O 0 0.005072018131613731
constitutional O 0 0.004448345862329006
DNA O 0 0.002896885620430112
was O 0 0.0018294280162081122
not O 0 0.0006994874565862119
available O 0 0.0005932782078161836
, O 0 0.0007573355687782168
a O 0 0.001199871301651001
putative O 0 0.013491586782038212
hereditary O 1 0.9678400158882141
predisposition O 1 0.9982158541679382
to O 0 0.013887866400182247
T B-Disease 1 0.9997199177742004
- I-Disease 1 0.9616748690605164
PLL I-Disease 1 0.9859697818756104
will O 0 0.0014488021843135357
require O 0 0.0015638481127098203
further O 0 0.0019348410423845053
investigation O 0 0.004931860137730837
. O 0 0.0040986016392707825
. O 0 0.007748465519398451

Myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999998807907104
protein O 0 0.48074427247047424
kinase O 0 0.03426419198513031
is O 0 0.0014729320537298918
involved O 0 0.0009945039637386799
in O 0 0.0006065931520424783
the O 0 0.0008647943614050746
modulation O 0 0.00209511024877429
of O 0 0.0011737144086509943
the O 0 0.008000352419912815
Ca2 O 1 0.9920599460601807
+ O 0 0.27725544571876526
homeostasis O 0 0.4501524865627289
in O 0 0.003991568926721811
skeletal O 1 0.9996323585510254
muscle O 1 0.9923607707023621
cells O 0 0.013101139105856419
. O 0 0.009263075888156891

Myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9999599456787109
DM B-Disease 1 1.0
) O 0 0.009838788770139217
, O 0 0.0014452780596911907
the O 0 0.0015609085094183683
most O 0 0.0026842718943953514
prevalent O 1 0.9985628724098206
muscular B-Disease 1 0.9999992847442627
disorder I-Disease 1 0.9999979734420776
in O 0 0.061719588935375214
adults O 0 0.11365681141614914
, O 0 0.0010375609854236245
is O 0 0.000754801498260349
caused O 0 0.0020843250676989555
by O 0 0.000713622139301151
( O 0 0.0018460557330399752
CTG O 1 0.8105087280273438
) O 0 0.0010495196329429746
n O 0 0.0016392237739637494
- O 0 0.0017551054479554296
repeat O 0 0.0014924370916560292
expansion O 0 0.0010936111211776733
in O 0 0.0005754930898547173
a O 0 0.0007793134427629411
gene O 0 0.0009029688080772758
encoding O 0 0.0012188229011371732
a O 0 0.0012419895501807332
protein O 0 0.0019423990743234754
kinase O 0 0.004083938430994749
( O 0 0.0026191032957285643
DM B-Disease 1 0.9929694533348083
protein O 0 0.0024984884075820446
kinase O 0 0.0031151538714766502
; O 0 0.0012239586794748902
DMPK O 0 0.009261260740458965
) O 0 0.0010307058691978455
and O 0 0.0007443430367857218
involves O 0 0.0016573065659031272
changes O 0 0.00115540053229779
in O 0 0.001683610025793314
cytoarchitecture O 0 0.27947574853897095
and O 0 0.004175600595772266
ion O 0 0.23578859865665436
homeostasis O 1 0.596968948841095
. O 0 0.01158648356795311

To O 0 0.0038445189129561186
obtain O 0 0.003383522853255272
clues O 0 0.0032078747171908617
to O 0 0.0010973676107823849
the O 0 0.0011226765345782042
normal O 0 0.001185069209896028
biological O 0 0.0012640776112675667
role O 0 0.0010754986433312297
of O 0 0.0010054102167487144
DMPK O 1 0.9207009673118591
in O 0 0.0011668818769976497
cellular O 0 0.008088861592113972
ion O 0 0.03909813612699509
homeostasis O 0 0.05921245738863945
, O 0 0.0006833174265921116
we O 0 0.000493242812808603
have O 0 0.00038946926360949874
compared O 0 0.0007593462942168117
the O 0 0.0007986344280652702
resting O 0 0.030254116281867027
[ O 0 0.009363061748445034
Ca2 O 0 0.040673840790987015
+ O 0 0.0028027815278619528
] O 0 0.0015143170021474361
i O 0 0.0008140155696310103
, O 0 0.0004989506560377777
the O 0 0.0005251566763035953
amplitude O 0 0.0010272287763655186
and O 0 0.0005218907026574016
shape O 0 0.0012627857504412532
of O 0 0.0016573367174714804
depolarization O 1 0.9995212554931641
- O 1 0.999403715133667
induced O 1 0.9996960163116455
Ca2 O 1 0.8942586779594421
+ O 0 0.004432978108525276
transients O 0 0.0027895562816411257
, O 0 0.0005978120025247335
and O 0 0.00040695175994187593
the O 0 0.0005342442891560495
content O 0 0.0006560354377143085
of O 0 0.0008944754372350872
ATP O 0 0.4792667627334595
- O 0 0.06353383511304855
driven O 0 0.0034234197810292244
ion O 0 0.005313422530889511
pumps O 0 0.004907913040369749
in O 0 0.0011065918952226639
cultured O 0 0.06921625137329102
skeletal O 1 0.963676929473877
muscle O 0 0.09596209228038788
cells O 0 0.0008949583861976862
of O 0 0.0007583650876767933
wild O 0 0.0020478873047977686
- O 0 0.010703543201088905
type O 0 0.002014359226450324
and O 0 0.0010454809525981545
DMPK O 1 0.9710104465484619
[ O 0 0.053515538573265076
- O 1 0.6737632751464844
/ O 1 0.7056609392166138
- O 0 0.19987063109874725
] O 0 0.009020522236824036
knockout O 0 0.02264331467449665
mice O 0 0.013635885901749134
. O 0 0.008820592425763607

In O 0 0.00568559393286705
vitro O 0 0.013626019470393658
- O 0 0.07803870737552643
differentiated O 0 0.12197417765855789
DMPK O 1 0.9955247640609741
[ O 0 0.19635343551635742
- O 1 0.8550199866294861
/ O 1 0.9180883169174194
- O 0 0.22432854771614075
] O 0 0.002829557517543435
myotubes O 0 0.003749055555090308
exhibit O 0 0.0013525278773158789
a O 0 0.0009307097061537206
higher O 0 0.0012972336262464523
resting O 0 0.20701651275157928
[ O 0 0.024583088234066963
Ca2 O 0 0.11215467005968094
+ O 0 0.0025754524394869804
] O 0 0.0015262194210663438
i O 0 0.0008443486294709146
than O 0 0.0004681115970015526
do O 0 0.0005991156795062125
wild O 0 0.0014323089271783829
- O 0 0.0051905205473303795
type O 0 0.0021359212696552277
myotubes O 0 0.0071708159521222115
because O 0 0.0005707762902602553
of O 0 0.0005376559565775096
an O 0 0.0005740782362408936
altered O 0 0.0008077421807684004
open O 0 0.0006870846264064312
probability O 0 0.0008025671122595668
of O 0 0.0008755422895774245
voltage O 0 0.003288197098299861
- O 0 0.04566984996199608
dependent O 0 0.004334071651101112
l O 0 0.4571099877357483
- O 0 0.13546890020370483
type O 0 0.03344682231545448
Ca2 O 0 0.12691360712051392
+ O 0 0.006271925754845142
and O 0 0.002869131974875927
Na O 0 0.474734902381897
+ O 0 0.011086653918027878
channels O 0 0.009021904319524765
. O 0 0.009519251994788647

The O 0 0.009437305852770805
mutant O 0 0.08140596747398376
myotubes O 1 0.5880563855171204
exhibit O 0 0.005893445108085871
smaller O 0 0.0022703788708895445
and O 0 0.001761946128681302
slower O 0 0.004419758450239897
Ca2 O 0 0.009514927864074707
+ O 0 0.002738716546446085
responses O 0 0.0013600675156340003
upon O 0 0.001146191731095314
triggering O 0 0.0027325802948325872
by O 0 0.0012083665933459997
acetylcholine O 0 0.006499073468148708
or O 0 0.0015139246825128794
high O 0 0.004281165078282356
external O 0 0.00918356142938137
K O 0 0.06946207582950592
+ O 0 0.014187484048306942
. O 0 0.008149929344654083

In O 0 0.004580919165164232
addition O 0 0.0031311127822846174
, O 0 0.0017003905959427357
we O 0 0.0008255205466412008
observed O 0 0.0009416950051672757
that O 0 0.0005663310876116157
these O 0 0.0007293677190318704
Ca2 O 0 0.030729515478014946
+ O 0 0.004197148606181145
transients O 0 0.004489164333790541
partially O 0 0.0016365849878638983
result O 0 0.0007997348438948393
from O 0 0.0006522039766423404
an O 0 0.0006762158591300249
influx O 0 0.0020117221865803003
of O 0 0.0012174677103757858
extracellular O 0 0.00651251757517457
Ca2 O 0 0.009391259402036667
+ O 0 0.002310605952516198
through O 0 0.001099775661714375
the O 0 0.0021383841522037983
l O 1 0.5988118648529053
- O 0 0.13464964926242828
type O 0 0.029731150716543198
Ca2 O 0 0.0629315972328186
+ O 0 0.01243465393781662
channel O 0 0.01317580509930849
. O 0 0.01182608027011156

Neither O 0 0.009078827686607838
the O 0 0.0033242660574615
content O 0 0.0024512140080332756
nor O 0 0.001994285499677062
the O 0 0.0013760790461674333
activity O 0 0.0016882946947589517
of O 0 0.002519672503694892
Na O 1 0.9998582601547241
+ O 1 0.5123280882835388
/ O 0 0.2518748641014099
K O 0 0.01587936468422413
+ O 0 0.008175581693649292
ATPase O 0 0.015157269313931465
and O 0 0.0036935375537723303
sarcoplasmic O 1 0.9959825277328491
reticulum O 1 0.9963191747665405
Ca2 O 1 0.9630419611930847
+ O 0 0.111882783472538
- O 0 0.032712869346141815
ATPase O 0 0.01638147421181202
are O 0 0.0017301462357863784
affected O 0 0.003255832241848111
by O 0 0.0033819503150880337
DMPK O 0 0.40581879019737244
absence O 0 0.019357072189450264
. O 0 0.010781596414744854

In O 0 0.005134464707225561
conclusion O 0 0.004751642234623432
, O 0 0.0019436641596257687
our O 0 0.0013045382220298052
data O 0 0.00110331189353019
suggest O 0 0.001242288970388472
that O 0 0.0007457549218088388
DMPK O 0 0.01733744889497757
is O 0 0.0007706008618697524
involved O 0 0.0006790587212890387
in O 0 0.0006748320301994681
modulating O 0 0.002329100389033556
the O 0 0.0007314643007703125
initial O 0 0.0010603575501590967
events O 0 0.0008142568403854966
of O 0 0.0010277212131768465
excitation O 0 0.06210506707429886
- O 1 0.7675215005874634
contraction O 1 0.9003399610519409
coupling O 0 0.07349339872598648
in O 0 0.00331369461491704
skeletal O 1 0.998595654964447
muscle O 1 0.8673432469367981
. O 0 0.004368502646684647
. O 0 0.007261141203343868

Constitutional O 0 0.061125241219997406
RB1 O 1 0.9998279809951782
- O 1 0.6971883773803711
gene O 0 0.0070993853732943535
mutations O 0 0.004211120307445526
in O 0 0.0020253441762179136
patients O 0 0.34450581669807434
with O 0 0.003138143802061677
isolated O 1 0.5480939745903015
unilateral B-Disease 1 0.9015916585922241
retinoblastoma I-Disease 1 0.9996806383132935
. O 0 0.01339913159608841

In O 0 0.005021335557103157
most O 0 0.003630423452705145
patients O 0 0.05965563654899597
with O 0 0.002115589799359441
isolated O 0 0.25665128231048584
unilateral B-Disease 1 0.9667596220970154
retinoblastoma I-Disease 1 0.9999904632568359
, O 0 0.2763623297214508
tumor B-Disease 1 0.9997425675392151
development O 0 0.00569459144026041
is O 0 0.0012766423169523478
initiated O 0 0.0034838130231946707
by O 0 0.001104308757930994
somatic O 0 0.0044949729926884174
inactivation O 0 0.006001552566885948
of O 0 0.0013313662493601441
both O 0 0.0012756360229104757
alleles O 0 0.003006148850545287
of O 0 0.002229816047474742
the O 0 0.007586569990962744
RB1 O 1 0.998755931854248
gene O 0 0.010757395066320896
. O 0 0.00847096461802721

However O 0 0.004774488043040037
, O 0 0.00200079707428813
some O 0 0.001056793611496687
of O 0 0.0010976409539580345
these O 0 0.000985658960416913
patients O 0 0.281249076128006
can O 0 0.0016273589571937919
transmit O 0 0.012565426528453827
retinoblastoma B-Disease 1 0.9806217551231384
predisposition O 1 0.5902407169342041
to O 0 0.0022714484948664904
their O 0 0.0028258655220270157
offspring O 0 0.0116834482178092
. O 0 0.007951854728162289

To O 0 0.003198186168447137
determine O 0 0.002230097306892276
the O 0 0.001357749104499817
frequency O 0 0.0010480846976861358
and O 0 0.0006257002241909504
nature O 0 0.0007989974692463875
of O 0 0.0009789043106138706
constitutional O 0 0.012223409488797188
RB1 O 1 0.9999535083770752
- O 1 0.543592631816864
gene O 0 0.0014743611682206392
mutations O 0 0.0011188436765223742
in O 0 0.000664714549202472
patients O 0 0.013709676451981068
with O 0 0.0007134946645237505
isolated O 0 0.009239143691956997
unilateral B-Disease 0 0.048216428607702255
retinoblastoma I-Disease 1 0.8879088759422302
, O 0 0.000664275954477489
we O 0 0.0005519823171198368
analyzed O 0 0.0010391154792159796
DNA O 0 0.0011971119092777371
from O 0 0.001065568532794714
peripheral O 0 0.2479037046432495
blood O 0 0.013844097964465618
and O 0 0.0019163258839398623
from O 0 0.0053164600394666195
tumor B-Disease 1 0.9999024868011475
tissue O 1 0.9204072952270508
. O 0 0.010819346643984318

The O 0 0.004963676445186138
analysis O 0 0.0029475747141987085
of O 0 0.002506265416741371
tumors B-Disease 1 0.6000510454177856
from O 0 0.0011947574093937874
54 O 0 0.002670231042429805
( O 0 0.0013036682503297925
71 O 0 0.0018023914890363812
% O 0 0.0007454333826899529
) O 0 0.0005783923552371562
of O 0 0.000594991841353476
76 O 0 0.0023316836450248957
informative O 0 0.0022417926229536533
patients O 0 0.0024942043237388134
showed O 0 0.0015374120557680726
loss O 0 0.0017064843559637666
of O 0 0.001442569773644209
constitutional O 0 0.007114247884601355
heterozygosity O 1 0.9994367957115173
( O 0 0.13122352957725525
LOH O 1 0.9999662637710571
) O 0 0.003983036149293184
at O 0 0.004774753004312515
intragenic O 0 0.07273158431053162
loci O 0 0.023879891261458397
. O 0 0.010669726878404617

Three O 0 0.00618242472410202
of O 0 0.0053586154244840145
13 O 0 0.009602131322026253
uninformative O 1 0.976929247379303
patients O 1 0.5215426683425903
had O 0 0.006731642875820398
constitutional O 0 0.013261801563203335
deletions O 0 0.15741586685180664
. O 0 0.012035996653139591

For O 0 0.004771036095917225
39 O 0 0.005189466755837202
randomly O 0 0.0032617878168821335
selected O 0 0.002843930386006832
tumors B-Disease 1 0.6050700545310974
, O 0 0.0017136111855506897
SSCP O 1 0.8724558353424072
, O 0 0.002700888318940997
hetero O 1 0.9943575263023376
- O 0 0.14620119333267212
duplex O 0 0.05629071220755577
analysis O 0 0.0009292025351896882
, O 0 0.0006167301908135414
sequencing O 0 0.0011499226093292236
, O 0 0.0005650477833114564
and O 0 0.0005754297017119825
Southern O 0 0.0010685628512874246
blot O 0 0.0029406726825982332
analysis O 0 0.0008508875034749508
were O 0 0.0006597142200917006
used O 0 0.0008486583246849477
to O 0 0.0013692843494936824
identify O 0 0.0037970661651343107
mutations O 0 0.006951299030333757
. O 0 0.006694337353110313

Mutations O 0 0.00895609799772501
were O 0 0.002907866844907403
detected O 0 0.0027448770124465227
in O 0 0.0012386185117065907
21 O 0 0.0017930074827745557
( O 0 0.00133716210257262
91 O 0 0.002330922754481435
% O 0 0.001111296471208334
) O 0 0.0009752937476150692
of O 0 0.001420829095877707
23 O 0 0.007157760672271252
tumors B-Disease 1 0.9953256845474243
with O 0 0.010904491879045963
LOH O 1 0.9999874830245972
. O 0 0.015405373647809029

In O 0 0.004798798356205225
6 O 0 0.004589717835187912
( O 0 0.002129211090505123
38 O 0 0.0019889192190021276
% O 0 0.001000281423330307
) O 0 0.0006893835379742086
of O 0 0.0007906070677563548
16 O 0 0.0025446764193475246
tumors B-Disease 1 0.9956284761428833
without O 0 0.0021136831492185593
LOH O 1 0.9999908208847046
, O 0 0.0010582548566162586
one O 0 0.0007106963894329965
mutation O 0 0.0011849886504933238
was O 0 0.0008610597578808665
detected O 0 0.0008220493327826262
, O 0 0.00038211862556636333
and O 0 0.00030289252754300833
in O 0 0.00034150658757425845
9 O 0 0.0006843346054665744
( O 0 0.0005535938544198871
56 O 0 0.0007599769160151482
% O 0 0.0005043361452408135
) O 0 0.0004015734884887934
of O 0 0.00045655519352294505
the O 0 0.001215741503983736
tumors B-Disease 1 0.9979428648948669
without O 0 0.00197037891484797
LOH O 1 0.9999886751174927
, O 0 0.0012239022180438042
both O 0 0.001072436454705894
mutations O 0 0.0018785702995955944
were O 0 0.0014762085629627109
found O 0 0.0032017177436500788
. O 0 0.006016314495354891

Thus O 0 0.005026307888329029
, O 0 0.0022196306381374598
a O 0 0.0015229798154905438
total O 0 0.0012576441513374448
of O 0 0.0010855161817744374
45 O 0 0.0012292905012145638
mutations O 0 0.00110429129563272
were O 0 0.000526136253029108
identified O 0 0.0009385634330101311
in O 0 0.000998317264020443
tumors B-Disease 1 0.818061351776123
of O 0 0.0031016936991363764
36 O 0 0.027689078822731972
patients O 1 0.8265304565429688
. O 0 0.006747986655682325

Thirty O 0 0.011228137649595737
- O 0 0.006610675249248743
nine O 0 0.002371672773733735
of O 0 0.0013444588985294104
the O 0 0.001361639704555273
mutations O 0 0.0018354362109676003
- O 0 0.002056167693808675
including O 0 0.0006328831659629941
34 O 0 0.0010220094118267298
small O 0 0.0005601403536275029
mutations O 0 0.0007565048872493207
, O 0 0.00047759589506313205
2 O 0 0.0007273954106494784
large O 0 0.0006805257871747017
structural O 0 0.01105212327092886
alterations O 0 0.0021746226120740175
, O 0 0.0006329561583697796
and O 0 0.0007703181472606957
hypermethylation O 1 0.7957954406738281
in O 0 0.0012118604499846697
3 O 0 0.006536075379699469
tumors O 1 0.9923127293586731
- O 0 0.003930265083909035
were O 0 0.0005843942635692656
not O 0 0.0004721052246168256
detected O 0 0.0010214712237939239
in O 0 0.0007815008284524083
the O 0 0.0014051286270841956
corresponding O 0 0.005764582194387913
peripheral O 1 0.9612491726875305
blood O 0 0.1571977734565735
DNA O 0 0.010092506185173988
. O 0 0.00810049008578062

In O 0 0.004114856477826834
6 O 0 0.0037730950862169266
( O 0 0.0018504858016967773
17 O 0 0.0012943785404786468
% O 0 0.0008689822861924767
) O 0 0.0005412392783910036
of O 0 0.000506056472659111
the O 0 0.0007073797169141471
36 O 0 0.001267668092623353
patients O 0 0.005103724543005228
, O 0 0.0004952865419909358
a O 0 0.000678860058542341
mutation O 0 0.001118816900998354
was O 0 0.0007707748445682228
detected O 0 0.0007385541102848947
in O 0 0.00033400015672668815
constitutional O 0 0.0006581220659427345
DNA O 0 0.0005990040954202414
, O 0 0.0003649870050139725
and O 0 0.000339085963787511
1 O 0 0.0005560318240895867
of O 0 0.00038680111174471676
these O 0 0.00032793518039397895
mutations O 0 0.0007390014943666756
is O 0 0.0004237708344589919
known O 0 0.0006158769829198718
to O 0 0.0005739663611166179
be O 0 0.0006537245935760438
associated O 0 0.0014788226690143347
with O 0 0.0019722997676581144
reduced O 0 0.008368827402591705
expressivity O 1 0.5498253703117371
. O 0 0.01129862666130066

The O 0 0.00587635301053524
presence O 0 0.003373189829289913
of O 0 0.001891390304081142
a O 0 0.002059083664789796
constitutional O 0 0.009594008326530457
mutation O 0 0.020436150953173637
was O 0 0.0015098323347046971
not O 0 0.00042060186387971044
associated O 0 0.0005380027578212321
with O 0 0.0004922550870105624
an O 0 0.0006699882796965539
early O 0 0.0014080260880291462
age O 0 0.00299025047570467
at O 0 0.0039616357535123825
treatment O 1 0.5240779519081116
. O 0 0.0077921925112605095

In O 0 0.005892040673643351
1 O 0 0.008375530131161213
patient O 1 0.5062614679336548
, O 0 0.0032738426234573126
somatic O 0 0.4842183589935303
mosaicism O 1 0.9420909881591797
was O 0 0.002400123979896307
demonstrated O 0 0.0015823857393115759
by O 0 0.0006968244560994208
molecular O 0 0.0010361148742958903
analysis O 0 0.0008815007167868316
of O 0 0.0008494738140143454
DNA O 0 0.0014501342084258795
and O 0 0.001093520550057292
RNA O 0 0.003958344459533691
from O 0 0.002626959467306733
peripheral O 1 0.5818154811859131
blood O 0 0.029331671074032784
. O 0 0.009589391760528088

In O 0 0.00502788694575429
2 O 0 0.004957596771419048
patients O 0 0.005620851181447506
without O 0 0.0012600624468177557
a O 0 0.0018028762424364686
detectable O 0 0.4059497117996216
mutation O 0 0.023143447935581207
in O 0 0.0021542564500123262
peripheral O 1 0.9978376030921936
blood O 1 0.8212072253227234
, O 0 0.002036032034084201
mosaicism O 1 0.8597980737686157
was O 0 0.0013448928948491812
suggested O 0 0.0008410371956415474
because O 0 0.00041321522439830005
1 O 0 0.0006268327706493437
of O 0 0.0006320970715023577
the O 0 0.0019931127317249775
patients O 1 0.9880716800689697
showed O 1 0.9631065726280212
multifocal O 1 0.9999997615814209
tumors B-Disease 1 0.9999674558639526
and O 0 0.0014293526764959097
the O 0 0.0013889385154470801
other O 0 0.0009556094300933182
later O 0 0.002210276434198022
developed O 0 0.0067357090301811695
bilateral B-Disease 0 0.11489668488502502
retinoblastoma I-Disease 1 0.9972992539405823
. O 0 0.012889591045677662

In O 0 0.005408179480582476
conclusion O 0 0.005331206135451794
, O 0 0.0022291364148259163
our O 0 0.0018795727519318461
results O 0 0.0014365967363119125
emphasize O 0 0.0019984254613518715
that O 0 0.0008331025019288063
the O 0 0.0012297588400542736
manifestation O 1 0.6275166273117065
and O 0 0.00164820346981287
transmissibility O 1 0.9837151169776917
of O 0 0.007560621947050095
retinoblastoma B-Disease 1 0.9928522706031799
depend O 0 0.0009699764777906239
on O 0 0.0005086850724183023
the O 0 0.0005369270220398903
nature O 0 0.0006982483901083469
of O 0 0.00048546670586802065
the O 0 0.0005942267016507685
first O 0 0.0006641740910708904
mutation O 0 0.0009081803145818412
, O 0 0.00036846473813056946
its O 0 0.0003024764300789684
time O 0 0.0003357298264745623
in O 0 0.0003479424922261387
development O 0 0.0005842145765200257
, O 0 0.00041910141590051353
and O 0 0.0003597354516386986
the O 0 0.0004447250976227224
number O 0 0.00038926175329834223
and O 0 0.00038460377254523337
types O 0 0.0006168037070892751
of O 0 0.0008217443246394396
cells O 0 0.0012157896999269724
that O 0 0.0006212462321855128
are O 0 0.0007524713291786611
affected O 0 0.002242541639134288
. O 0 0.0021025943569839
. O 0 0.005078499671071768

Hereditary B-Disease 1 0.999980092048645
deficiency I-Disease 1 0.9999966621398926
of I-Disease 0 0.32125869393348694
the I-Disease 1 0.6064241528511047
fifth I-Disease 1 0.9966073036193848
component I-Disease 1 0.7946338057518005
of I-Disease 0 0.10451100766658783
complement I-Disease 0 0.11437327414751053
in O 0 0.003941645845770836
man O 0 0.015655988827347755
. O 0 0.007879837416112423

I O 0 0.0670660063624382
. O 0 0.03634246066212654

Clinical O 1 0.6071104407310486
, O 0 0.006890169810503721
immunochemical O 1 0.7118129730224609
, O 0 0.003265811363235116
and O 0 0.002549526048824191
family O 0 0.004876833874732256
studies O 0 0.006802819203585386
. O 0 0.008416542783379555

The O 0 0.0056171538308262825
first O 0 0.003193357028067112
recognized O 0 0.0033829007297754288
human O 0 0.007346257567405701
kindred O 1 0.9990828037261963
with O 0 0.27594131231307983
hereditary B-Disease 1 0.9999996423721313
deficiency I-Disease 1 1.0
of I-Disease 1 0.941528856754303
the I-Disease 1 0.9075520634651184
fifth I-Disease 1 0.9990764856338501
component I-Disease 1 0.7886401414871216
of I-Disease 0 0.07896441966295242
complement I-Disease 1 0.9027140140533447
( O 0 0.13373097777366638
C5 O 1 0.8873352408409119
) O 0 0.0016276590758934617
is O 0 0.001952854567207396
described O 0 0.005887266248464584
. O 0 0.006148805841803551

The O 0 0.0068782600574195385
proband O 0 0.016517091542482376
, O 0 0.001959683606401086
a O 0 0.0016444673528894782
20 O 0 0.0014928585151210427
- O 0 0.0030464197043329477
year O 0 0.001255164504982531
- O 0 0.023337244987487793
old O 0 0.033564936369657516
black O 0 0.25102585554122925
female O 1 0.9017511606216431
with O 1 0.9950039982795715
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9940035939216614
age O 1 0.9842535257339478
11 O 0 0.407207727432251
, O 0 0.07721812278032303
lacked O 1 0.9937716126441956
serum O 1 0.9999527931213379
hemolytic O 1 0.9999971389770508
complement O 0 0.012947075068950653
activity O 0 0.001716857310384512
, O 0 0.0011227428913116455
even O 0 0.001516456250101328
during O 0 0.003994735889136791
remission O 1 0.9424517750740051
. O 0 0.00865849107503891

C5 O 1 0.9764838814735413
was O 0 0.024284005165100098
undetectable O 1 0.9018625020980835
in O 0 0.0033938048873096704
her O 0 0.012879815883934498
serum O 1 0.8320890665054321
by O 0 0.002086079213768244
both O 0 0.0028476067818701267
immunodiffusion O 1 0.9911389946937561
and O 0 0.020723802968859673
hemolytic O 1 0.9999951124191284
assays O 0 0.3139208257198334
. O 0 0.013690830208361149

Other O 0 0.004135751165449619
complement O 0 0.004662650171667337
components O 0 0.002325075212866068
were O 0 0.0011637088609859347
normal O 0 0.001597700989805162
during O 0 0.0022594849579036236
remission O 1 0.9982314705848694
of O 1 0.7753798365592957
lupus O 1 1.0
, O 0 0.07528603821992874
but O 0 0.0020755622535943985
C1 O 1 0.9998714923858643
, O 0 0.0017612675437703729
C4 O 1 0.8351069688796997
, O 0 0.0017032129690051079
C2 O 1 0.978921115398407
, O 0 0.0010755560360848904
and O 0 0.0015302466927096248
C3 O 1 0.9672257900238037
levels O 0 0.004820649977773428
fell O 0 0.013988937251269817
during O 0 0.009256722405552864
exacerbations O 1 0.9975491166114807
. O 0 0.012087817303836346

A O 0 0.008679337799549103
younger O 0 0.007525175344198942
half O 0 0.0038189610932022333
- O 0 0.2003093808889389
sister O 0 0.0452914722263813
, O 0 0.0011104615405201912
who O 0 0.0014227931387722492
had O 0 0.002347988309338689
no O 0 0.004941784776747227
underlying O 1 0.999036431312561
disease O 1 0.9999948740005493
, O 0 0.007616368122398853
was O 0 0.021763969212770462
also O 0 0.001036904868669808
found O 0 0.0011706443037837744
to O 0 0.0016269711777567863
lack O 0 0.007504288572818041
immunochemically O 1 0.9689105749130249
detectable O 1 0.7452313899993896
C5 O 1 0.7498190999031067
. O 0 0.010760999284684658

By O 0 0.011719600297510624
hemolytic O 1 0.9999591112136841
assay O 0 0.04219646006822586
, O 0 0.002554649254307151
she O 0 0.002089638030156493
exhibited O 0 0.002958951983600855
1 O 0 0.001714028650894761
- O 0 0.0018059475114569068
2 O 0 0.0008455180795863271
% O 0 0.0005429288721643388
of O 0 0.000527413038071245
the O 0 0.0009068378712981939
normal O 0 0.002377340802922845
serum O 1 0.8572548031806946
C5 O 0 0.11591837555170059
level O 0 0.0010998127982020378
and O 0 0.0007915410096757114
normal O 0 0.0012404178269207478
concentrations O 0 0.0016670598415657878
of O 0 0.001095482730306685
other O 0 0.0012611870188266039
complement O 0 0.004715492017567158
components O 0 0.0061467234045267105
. O 0 0.00740343052893877

C5 O 1 0.6775603294372559
levels O 0 0.005114258266985416
of O 0 0.0018717232160270214
other O 0 0.0008363444358110428
family O 0 0.001221180660650134
members O 0 0.00065782101592049
were O 0 0.00045832691830582917
either O 0 0.0005204768967814744
normal O 0 0.0006486105266958475
or O 0 0.0004023421788588166
approximately O 0 0.000681755889672786
half O 0 0.000826511939521879
- O 0 0.0017300160834565759
normal O 0 0.0008898659725673497
, O 0 0.0007187150768004358
consistent O 0 0.0014197112759575248
with O 0 0.001026388956233859
autosomal O 0 0.1645098328590393
codominant O 1 0.5365381836891174
inheritance O 0 0.007236636709421873
of O 0 0.002614712342619896
the O 0 0.05007962882518768
gene O 0 0.4394766390323639
determining O 1 0.8164770603179932
C5 B-Disease 1 0.9999809265136719
deficiency I-Disease 1 0.9999982118606567
. O 0 0.01591399870812893

Normal O 0 0.09105623513460159
hemolytic O 1 0.9999446868896484
titers O 1 0.8744946122169495
were O 0 0.002804636023938656
restored O 0 0.0036330341827124357
to O 0 0.001087798154912889
both O 0 0.0012771806214004755
homozygous O 0 0.2605254650115967
C5 B-Disease 1 0.9999743700027466
- I-Disease 1 0.9984549283981323
deficient I-Disease 1 0.9999253749847412
( O 0 0.03128368407487869
C5D B-Disease 1 0.9988006353378296
) O 0 0.0015170462429523468
sera O 0 0.01490087527781725
by O 0 0.0008164960308931768
addition O 0 0.0010517816990613937
of O 0 0.0015267505077645183
highly O 0 0.00692781712859869
purified O 0 0.45298436284065247
human O 0 0.011810812167823315
C5 O 1 0.853413462638855
. O 0 0.01097725797444582

In O 0 0.0070077795535326
specific O 0 0.004947020672261715
C5 O 1 0.9526516199111938
titrations O 0 0.2779923677444458
, O 0 0.0019241312984377146
however O 0 0.0012216478353366256
, O 0 0.0007733285310678184
it O 0 0.0005615290720015764
was O 0 0.0007891223067417741
noted O 0 0.0007045073434710503
that O 0 0.00033199344761669636
when O 0 0.0004550086450763047
limited O 0 0.000495469372253865
amounts O 0 0.000607489375397563
of O 0 0.0007917945040389895
C5 O 0 0.1125432625412941
were O 0 0.0006385919405147433
assayed O 0 0.002054475713521242
in O 0 0.0006176508613862097
the O 0 0.0006334585486911237
presence O 0 0.0007898287149146199
of O 0 0.000777063483837992
low O 0 0.0021111893001943827
dilutions O 0 0.03712007775902748
of O 0 0.001379981404170394
either O 0 0.001893702195957303
C5D B-Disease 1 0.9993788003921509
serum O 1 0.549618124961853
, O 0 0.0010132711613550782
curving O 0 0.0023748904932290316
rather O 0 0.0008850886370055377
than O 0 0.0006351721240207553
linear O 0 0.001914108986966312
dose O 0 0.024383025243878365
- O 0 0.0023755626752972603
response O 0 0.001207556575536728
plots O 0 0.0013009760295972228
were O 0 0.0006952894036658108
consistently O 0 0.0014242524048313498
obtained O 0 0.0011700172908604145
, O 0 0.0011905221035704017
suggesting O 0 0.0024142013862729073
some O 0 0.0017551957862451673
inhibitory O 0 0.007899032905697823
effect O 0 0.005990962963551283
. O 0 0.007894313894212246

Further O 0 0.00674216914921999
studies O 0 0.0040824743919074535
suggested O 0 0.003392003709450364
that O 0 0.0016266993479803205
low O 0 0.0031493217684328556
dilutions O 0 0.16484634578227997
of O 0 0.007797790691256523
C5D B-Disease 1 0.9999891519546509
serum O 1 0.9924374222755432
contain O 0 0.001858277479186654
a O 0 0.0014022185932844877
factor O 0 0.0019596433266997337
( O 0 0.0006922612083144486
or O 0 0.00043437143904156983
factors O 0 0.0005880079697817564
) O 0 0.00045516531099565327
interfering O 0 0.0007644682191312313
at O 0 0.0005237928708083928
some O 0 0.0003756960213650018
step O 0 0.0008417178178206086
in O 0 0.0006675380864180624
the O 0 0.0013521673390641809
hemolytic O 1 0.9999579191207886
assay O 0 0.026405775919556618
of O 0 0.0027082720771431923
C5 O 1 0.8666079640388489
, O 0 0.0008319811313413084
rather O 0 0.0007706111646257341
than O 0 0.0006533723790198565
a O 0 0.001599145238287747
true O 0 0.005217887926846743
C5 O 1 0.9814272522926331
inhibitor O 1 0.8275232315063477
or O 0 0.005175286903977394
inactivator O 0 0.20869822800159454
. O 0 0.011513162404298782

Of O 0 0.006646116264164448
clinical O 0 0.03476337343454361
interest O 0 0.002148442203179002
are O 0 0.0008578687557019293
( O 0 0.0009918470168486238
a O 0 0.0008149166242219508
) O 0 0.0006456197006627917
the O 0 0.0005799684440717101
documentation O 0 0.002272333949804306
of O 0 0.06946896761655807
membranous O 1 0.9999997615814209
glomerulonephritis B-Disease 1 1.0
, O 1 0.9901296496391296
vasculitis B-Disease 1 1.0
, O 1 0.8569356203079224
and O 1 0.6231610774993896
arthritis B-Disease 1 1.0
in O 0 0.016597464680671692
an O 0 0.0029356214217841625
individual O 0 0.0029380186460912228
lacking O 1 0.7706247568130493
C5 O 1 0.9917348623275757
( O 0 0.000953568029217422
and O 0 0.00046904137707315385
its O 0 0.0005254912539385259
biologic O 0 0.005873123649507761
functions O 0 0.0006228213896974921
) O 0 0.0005110420752316713
, O 0 0.0004117927164770663
and O 0 0.00041339057497680187
( O 0 0.0007379857124760747
b O 0 0.0010999721707776189
) O 0 0.0004860389744862914
a O 0 0.0005302734207361937
remarkable O 0 0.0023719007149338722
propensity O 0 0.30190563201904297
to O 0 0.0012135045835748315
bacterial B-Disease 1 0.9992470741271973
infections I-Disease 1 0.9998983144760132
in O 0 0.0009604147053323686
the O 0 0.0011492015328258276
proband O 0 0.2736121416091919
, O 0 0.0005963813746348023
even O 0 0.000436564238043502
during O 0 0.0005600489675998688
periods O 0 0.000878575025126338
of O 0 0.0008294932194985449
low O 0 0.006893968675285578
- O 0 0.07589191943407059
dose O 0 0.03272290527820587
or O 0 0.0013683588476851583
alternate O 0 0.0034536365419626236
- O 0 0.0711563229560852
day O 0 0.008134081959724426
corticosteroid O 1 0.9986624717712402
therapy O 1 0.8674683570861816
. O 0 0.010474298149347305

Other O 0 0.003807754023000598
observations O 0 0.0044500757940113544
indicate O 0 0.002551110228523612
that O 0 0.0011124123120680451
the O 0 0.001477216836065054
C5D B-Disease 1 0.6433296799659729
state O 0 0.0010864142095670104
is O 0 0.0007998766377568245
compatible O 0 0.0012959837913513184
with O 0 0.0006405345047824085
normal O 0 0.0014611919177696109
coagulation O 0 0.02948594279587269
function O 0 0.0008417534991167486
and O 0 0.0005616176640614867
the O 0 0.0007242132560350001
capacity O 0 0.0012276798952370882
to O 0 0.0009204482776112854
mount O 0 0.01534721627831459
a O 0 0.009553599171340466
neutrophilic O 1 0.9999773502349854
leukocytosis O 1 0.999971866607666
during O 1 0.8715774416923523
pyogenic B-Disease 1 0.9999823570251465
infection I-Disease 1 0.999910831451416
. O 0 0.005872624926269054
. O 0 0.009573468007147312

Susceptibility O 1 0.9846287965774536
to O 0 0.0807056799530983
ankylosing B-Disease 1 0.9999998807907104
spondylitis I-Disease 1 1.0
in O 0 0.14280274510383606
twins O 1 0.8386629819869995
: O 0 0.0017104814760386944
the O 0 0.001022293814457953
role O 0 0.0013265887973830104
of O 0 0.0012875316897407174
genes O 0 0.0026271671522408724
, O 0 0.0020973242353647947
HLA O 1 0.9992879033088684
, O 0 0.0011989048216491938
and O 0 0.0011526966700330377
the O 0 0.0021032048389315605
environment O 0 0.006573033053427935
. O 0 0.007196219637989998

OBJECTIVE O 0 0.012092038057744503
To O 0 0.0025231014005839825
determine O 0 0.0021786121651530266
the O 0 0.0014755296288058162
relative O 0 0.0020677221473306417
effects O 0 0.0021384921856224537
of O 0 0.001047142082825303
genetic O 0 0.0033704559318721294
and O 0 0.0008445803541690111
environmental O 0 0.002912108786404133
factors O 0 0.001658217515796423
in O 0 0.001892350148409605
susceptibility O 1 0.9848396182060242
to O 0 0.029618317261338234
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.954953134059906
AS B-Disease 0 0.34150028228759766
) O 0 0.005639730952680111
. O 0 0.00682005425915122

METHODS O 0 0.011464932933449745
Twins O 0 0.010518420487642288
with O 0 0.0017632481176406145
AS B-Disease 0 0.0016033188439905643
were O 0 0.0007746893679723144
identified O 0 0.0009732562466524541
from O 0 0.0006795846857130527
the O 0 0.000991332926787436
Royal O 0 0.07751534134149551
National O 1 0.9621286392211914
Hospital O 1 0.9999974966049194
for O 1 0.9941260814666748
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9904491305351257
. O 0 0.016821112483739853

Clinical O 0 0.36723843216896057
and O 0 0.005078075919300318
radiographic O 1 0.7033041715621948
examinations O 0 0.01606828160583973
were O 0 0.0014355547027662396
performed O 0 0.0017715918365865946
to O 0 0.0008801527437753975
establish O 0 0.003398452652618289
diagnoses O 1 0.99595707654953
, O 0 0.006023524794727564
and O 0 0.08466728776693344
disease O 1 0.9999969005584717
severity O 1 0.9993543028831482
was O 0 0.19748538732528687
assessed O 0 0.0024341377429664135
using O 0 0.0005976759130135179
a O 0 0.0008309270488098264
combination O 0 0.00140103860758245
of O 0 0.001161135034635663
validated O 0 0.004596229642629623
scoring O 0 0.0036454289220273495
systems O 0 0.006254564039409161
. O 0 0.006981971208006144

HLA O 1 0.9949454665184021
typing O 0 0.024047842249274254
for O 0 0.007673528511077166
HLA O 1 0.9999194145202637
- O 1 0.6351606845855713
B27 O 1 0.6403952240943909
, O 0 0.004742772318422794
HLA O 1 0.9997406601905823
- O 0 0.2301611602306366
B60 O 0 0.13949339091777802
, O 0 0.0016626256983727217
and O 0 0.0023262216709554195
HLA O 1 0.9999817609786987
- O 1 0.9703410267829895
DR1 O 1 0.9965853691101074
was O 0 0.002812005812302232
performed O 0 0.0012263532262295485
by O 0 0.0007875484880059958
polymerase O 0 0.0025572997983545065
chain O 0 0.0013956092298030853
reaction O 0 0.0009640711941756308
with O 0 0.0005302766803652048
sequence O 0 0.000980196287855506
- O 0 0.0013356703566387296
specific O 0 0.0007568615255877376
primers O 0 0.0027993349358439445
, O 0 0.0009100595489144325
and O 0 0.0009750192402862012
zygosity O 0 0.007545529864728451
was O 0 0.002729854080826044
assessed O 0 0.003597107483074069
using O 0 0.0036451672203838825
microsatellite O 0 0.024704867973923683
markers O 0 0.015394658781588078
. O 0 0.009265605360269547

Genetic O 0 0.010766381397843361
and O 0 0.0030528013594448566
environmental O 0 0.003435936290770769
variance O 0 0.002397039905190468
components O 0 0.0015139406314119697
were O 0 0.0007739979773759842
assessed O 0 0.0013711346546187997
with O 0 0.0006405540625564754
the O 0 0.0008451414760202169
program O 0 0.0013986375415697694
Mx O 0 0.006936282850801945
, O 0 0.0005962788127362728
using O 0 0.0004752738168463111
data O 0 0.00046981143532320857
from O 0 0.00038413621950894594
this O 0 0.00035327990190126
and O 0 0.00039703879156149924
previous O 0 0.0007295106188394129
studies O 0 0.0008690411341376603
of O 0 0.0011758096516132355
twins O 0 0.020629603415727615
with O 0 0.0021858944091945887
AS B-Disease 0 0.018387222662568092
. O 0 0.0069843255914747715

RESULTS O 0 0.005580598022788763
Six O 0 0.002411764580756426
of O 0 0.0021907081827521324
8 O 0 0.003616363974288106
monozygotic O 1 0.6179071068763733
( O 0 0.006133983377367258
MZ O 1 0.9995026588439941
) O 0 0.0014339657500386238
twin O 0 0.0031795790418982506
pairs O 0 0.001444766647182405
were O 0 0.0011290922993794084
disease O 1 0.9956865310668945
concordant O 0 0.4079976975917816
, O 0 0.0009484675829298794
compared O 0 0.0008601167937740684
with O 0 0.0004673311486840248
4 O 0 0.0007347366772592068
of O 0 0.0006468958454206586
15 O 0 0.0010876598535105586
B27 O 0 0.005390139762312174
- O 0 0.002636950695887208
positive O 0 0.0018027527257800102
dizygotic O 0 0.017892014235258102
( O 0 0.0018968124641105533
DZ O 0 0.3500605523586273
) O 0 0.001064899144694209
twin O 0 0.001995234517380595
pairs O 0 0.0011738954344764352
( O 0 0.0008284441428259015
27 O 0 0.000886616762727499
% O 0 0.0005279406905174255
) O 0 0.0004025024827569723
and O 0 0.00034180202055722475
4 O 0 0.0005652881227433681
of O 0 0.0006096180295571685
32 O 0 0.001447784248739481
DZ O 0 0.32791948318481445
twin O 0 0.002504512434825301
pairs O 0 0.0011062324047088623
overall O 0 0.0011741487542167306
( O 0 0.000730666215531528
12 O 0 0.0007855881121940911
. O 0 0.0006239485228434205
5 O 0 0.00127118406817317
% O 0 0.0016818605363368988
) O 0 0.0027338918298482895
. O 0 0.004968040157109499

Nonsignificant O 1 0.7341103553771973
increases O 0 0.006373552605509758
in O 0 0.0022418699227273464
similarity O 0 0.002355035860091448
with O 0 0.0009623949299566448
regard O 0 0.0013093037996441126
to O 0 0.0006849705241620541
age O 0 0.004672013223171234
at O 0 0.05240407586097717
disease O 1 0.9999958276748657
onset O 1 0.9999717473983765
and O 0 0.002446411643177271
all O 0 0.0005739357438869774
of O 0 0.0026683546602725983
the O 1 0.528083086013794
disease O 1 0.9999953508377075
severity O 1 0.9938889741897583
scores O 0 0.0019348447676748037
assessed O 0 0.001515913987532258
were O 0 0.0006640826468355954
noted O 0 0.001145515008829534
in O 0 0.001437057857401669
disease O 1 0.9999227523803711
- O 1 0.9957120418548584
concordant O 1 0.9996697902679443
MZ O 1 0.9999970197677612
twins O 0 0.49626508355140686
compared O 0 0.003398754633963108
with O 0 0.003323413198813796
concordant O 1 0.987106204032898
DZ O 1 0.9998531341552734
twins O 1 0.750760018825531
. O 0 0.011336006224155426

HLA O 1 0.9999605417251587
- O 1 0.8735257983207703
B27 O 0 0.4673294723033905
and O 0 0.0024189201649278402
B60 O 0 0.0707220658659935
were O 0 0.0012468986678868532
associated O 0 0.0010480033233761787
with O 0 0.0007560285739600658
the O 0 0.024599045515060425
disease O 1 0.9999568462371826
in O 0 0.005838599056005478
probands O 1 0.9891035556793213
, O 0 0.0007399765308946371
and O 0 0.00043159013148397207
the O 0 0.0006732617039233446
rate O 0 0.0015343334525823593
of O 0 0.005633221007883549
disease O 1 0.9999812841415405
concordance O 1 0.9757276773452759
was O 0 0.07708941400051117
significantly O 0 0.0013440491165965796
increased O 0 0.0009675324545241892
among O 0 0.0009258805657736957
DZ O 1 0.9872783422470093
twin O 0 0.003713870421051979
pairs O 0 0.0008676026482135057
in O 0 0.0004338727449066937
which O 0 0.0004160843091085553
the O 0 0.0007677663816139102
co O 0 0.21761919558048248
- O 0 0.4709758758544922
twin O 0 0.12575051188468933
was O 0 0.0018266591941937804
positive O 0 0.001251743407920003
for O 0 0.0009358314564451575
both O 0 0.0014780231285840273
B27 O 0 0.05505186691880226
and O 0 0.005260557867586613
DR1 O 1 0.9185178875923157
. O 0 0.009523016400635242

Additive O 0 0.03866792470216751
genetic O 0 0.007684559561312199
effects O 0 0.004920548759400845
were O 0 0.0015388517640531063
estimated O 0 0.0016773768002167344
to O 0 0.0007235503289848566
contribute O 0 0.0013564216205850244
97 O 0 0.002104991115629673
% O 0 0.0008503124117851257
of O 0 0.0008130046771839261
the O 0 0.0013626982690766454
population O 0 0.0023341153282672167
variance O 0 0.006317922845482826
. O 0 0.005831550341099501

CONCLUSION O 0 0.017270127311348915
Susceptibility O 0 0.02536209113895893
to O 0 0.0020372055005282164
AS B-Disease 0 0.0024792037438601255
is O 0 0.00125216506421566
largely O 0 0.0013586131390184164
genetically O 0 0.0011921068653464317
determined O 0 0.0008206370985135436
, O 0 0.0005092310602776706
and O 0 0.00042644134373404086
the O 0 0.0006373940850608051
environmental O 0 0.0026763894129544497
trigger O 0 0.010983803309500217
for O 0 0.0009463652968406677
the O 0 0.015404405072331429
disease O 1 0.9999725818634033
is O 0 0.008487674407660961
probably O 0 0.01025946531444788
ubiquitous O 0 0.08032282441854477
. O 0 0.007285427767783403

HLA O 1 0.9998863935470581
- O 0 0.21830396354198456
B27 O 0 0.0187764260917902
accounts O 0 0.003476466052234173
for O 0 0.0014985755551606417
a O 0 0.0015295358607545495
minority O 0 0.0016498678596690297
of O 0 0.0012576393783092499
the O 0 0.0023723000194877386
overall O 1 0.612649142742157
genetic O 0 0.15896187722682953
susceptibility O 1 0.7235856652259827
to O 0 0.0023479426745325327
AS B-Disease 0 0.006283262278884649
. O 0 0.006888783071190119

Cell O 0 0.022490039467811584
cycle O 0 0.10036484897136688
- O 0 0.15782253444194794
dependent O 0 0.005800788756459951
colocalization O 0 0.07604886591434479
of O 0 0.004115742165595293
BARD1 O 1 0.9949272871017456
and O 0 0.0031338005792349577
BRCA1 O 0 0.12635438144207
proteins O 0 0.0020804773084819317
in O 0 0.0017200441798195243
discrete O 0 0.005209865048527718
nuclear O 0 0.005793763790279627
domains O 0 0.010316568426787853
. O 0 0.00899423100054264

Germ O 1 0.9944374561309814
- O 0 0.10035577416419983
line O 0 0.005080846603959799
mutations O 0 0.00236966903321445
of O 0 0.001427769660949707
the O 0 0.002809068188071251
BRCA1 O 1 0.9847710728645325
gene O 0 0.0019747749902307987
predispose O 0 0.004020411055535078
women O 0 0.0010639081010594964
to O 0 0.0006800690316595137
early O 0 0.007578439079225063
- O 1 0.9998109936714172
onset O 1 0.9999998807907104
breast B-Disease 1 1.0
and I-Disease 1 0.9990379810333252
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
by O 0 0.01621260493993759
compromising O 1 0.9048223495483398
the O 0 0.004790211096405983
genes O 0 0.0031528547406196594
presumptive O 1 0.9384243488311768
function O 0 0.0019512687576934695
as O 0 0.0018216728931292892
a O 0 0.007180242799222469
tumor B-Disease 1 0.9992427825927734
suppressor O 1 0.8901559710502625
. O 0 0.008365850895643234

Although O 0 0.0054716868326067924
the O 0 0.002985867904499173
biochemical O 0 0.004453480243682861
properties O 0 0.0025620379019528627
of O 0 0.003868464846163988
BRCA1 O 1 0.996105968952179
polypeptides O 0 0.011237300001084805
are O 0 0.0006555307190865278
not O 0 0.0005487104062922299
understood O 0 0.0010069035924971104
, O 0 0.000526964315213263
their O 0 0.000508807715959847
expression O 0 0.0009924074402078986
pattern O 0 0.0013658765237778425
and O 0 0.0008047766168601811
subcellular O 0 0.0037156841717660427
localization O 0 0.0029531673062592745
suggest O 0 0.0012260472867637873
a O 0 0.001170877949334681
role O 0 0.001630633370950818
in O 0 0.001346295466646552
cell O 0 0.0040625352412462234
- O 0 0.04553520306944847
cycle O 0 0.009138254448771477
regulation O 0 0.009213095530867577
. O 0 0.007609346881508827

When O 0 0.008449014276266098
resting O 0 0.480648398399353
cells O 0 0.0038099016528576612
are O 0 0.001119469990953803
induced O 0 0.014265736564993858
to O 0 0.00088307453552261
proliferate O 0 0.002073460491374135
, O 0 0.0006892731180414557
the O 0 0.0008243300253525376
steady O 0 0.002751363907009363
- O 0 0.0018168773967772722
state O 0 0.0007135436753742397
levels O 0 0.0009545015054754913
of O 0 0.0007720738649368286
BRCA1 O 0 0.30878975987434387
increase O 0 0.0007598334341309965
in O 0 0.0006177944014780223
late O 0 0.0016912088030949235
G1 O 0 0.12678687274456024
and O 0 0.0007351477979682386
reach O 0 0.0013552085729315877
a O 0 0.0013120839139446616
maximum O 0 0.0023704434279352427
during O 0 0.0035640783607959747
S O 0 0.022704603150486946
phase O 0 0.013450458645820618
. O 0 0.007618293631821871

Moreover O 0 0.008741502650082111
, O 0 0.0030103891622275114
in O 0 0.0024954788386821747
S O 0 0.3639802932739258
phase O 0 0.07622455805540085
cells O 0 0.00269438698887825
, O 0 0.0011509610339999199
BRCA1 O 0 0.0802558958530426
polypeptides O 0 0.003203309839591384
are O 0 0.0006571321282535791
hyperphosphorylated O 0 0.003588018473237753
and O 0 0.0007705743773840368
accumulate O 0 0.0023389693815261126
into O 0 0.001314561697654426
discrete O 0 0.0032289361115545034
subnuclear O 0 0.030711762607097626
foci O 0 0.07999255508184433
termed O 0 0.04217902570962906
" O 0 0.00675453245639801
BRCA1 O 0 0.3296275734901428
nuclear O 0 0.009375227615237236
dots O 0 0.016657179221510887
. O 0 0.009221351705491543

" O 0 0.030512195080518723
BRCA1 O 1 0.8331407904624939
associates O 0 0.009751490317285061
in O 0 0.002220067661255598
vivo O 0 0.007431573234498501
with O 0 0.0017760779010131955
a O 0 0.003143629292026162
structurally O 0 0.1308334618806839
related O 0 0.0055735474452376366
protein O 0 0.007785359863191843
termed O 0 0.03693491220474243
BARD1 O 1 0.8914531469345093
. O 0 0.013792217709124088

Here O 0 0.004837823566049337
we O 0 0.001975980820134282
show O 0 0.0017117098905146122
that O 0 0.0008468027808703482
the O 0 0.0009698069770820439
steady O 0 0.002811513841152191
- O 0 0.0022037422750145197
state O 0 0.0007782913744449615
levels O 0 0.0010544087272137403
of O 0 0.000913659983780235
BARD1 O 1 0.5206573605537415
, O 0 0.0006909591611474752
unlike O 0 0.0006488717626780272
those O 0 0.00047016266034916043
of O 0 0.0007802789332345128
BRCA1 O 0 0.29992201924324036
, O 0 0.0007515795878134668
remain O 0 0.0010831279214471579
relatively O 0 0.001240932964719832
constant O 0 0.0022007569205015898
during O 0 0.002562764333561063
cell O 0 0.006810558959841728
cycle O 0 0.032623738050460815
progression O 0 0.43474680185317993
. O 0 0.00977682787925005

However O 0 0.0073120794259011745
, O 0 0.0045788949355483055
immunostaining O 0 0.14676187932491302
revealed O 0 0.006016092374920845
that O 0 0.0018212308641523123
BARD1 O 1 0.7098403573036194
resides O 0 0.005824739579111338
within O 0 0.0018104022601619363
BRCA1 O 0 0.05081900209188461
nuclear O 0 0.0020936294458806515
dots O 0 0.0027704634703695774
during O 0 0.0014416147023439407
S O 0 0.006039762869477272
phase O 0 0.0015623316867277026
of O 0 0.0006594320293515921
the O 0 0.0007643771823495626
cell O 0 0.001365632750093937
cycle O 0 0.0014327241806313396
, O 0 0.0005303535726852715
but O 0 0.00046367396134883165
not O 0 0.0005702091730199754
during O 0 0.001489606685936451
the O 0 0.0026580351404845715
G1 O 1 0.9005216956138611
phase O 0 0.014410345815122128
. O 0 0.008660692721605301

Nevertheless O 0 0.015318663790822029
, O 0 0.0050868140533566475
BARD1 O 0 0.45299583673477173
polypeptides O 0 0.005519377999007702
are O 0 0.0010316087864339352
found O 0 0.0008492172928526998
exclusively O 0 0.0009036633418872952
in O 0 0.0005705108633264899
the O 0 0.00069044204428792
nuclear O 0 0.0010446257656440139
fractions O 0 0.0013499156339094043
of O 0 0.0008369423449039459
both O 0 0.0012496866984292865
G1 O 1 0.9968312382698059
- O 0 0.16907623410224915
and O 0 0.00222678086720407
S O 1 0.9401466250419617
- O 0 0.21914757788181305
phase O 0 0.023642584681510925
cells O 0 0.0072507066652178764
. O 0 0.007179478649049997

Therefore O 0 0.008288650773465633
, O 0 0.004256609361618757
progression O 0 0.13522548973560333
to O 0 0.0017551507335156202
S O 0 0.2587836682796478
phase O 0 0.004059435799717903
is O 0 0.0008986253524199128
accompanied O 0 0.0014619337162002921
by O 0 0.0005920295952819288
the O 0 0.0007223956636153162
aggregation O 0 0.0016675085062161088
of O 0 0.0015329819871112704
nuclear O 0 0.003612031228840351
BARD1 O 0 0.47156453132629395
polypeptides O 0 0.006065454334020615
into O 0 0.003401156049221754
BRCA1 O 0 0.05740693584084511
nuclear O 0 0.008283599279820919
dots O 0 0.016491563990712166
. O 0 0.010023866780102253

This O 0 0.005960625130683184
cell O 0 0.007332736626267433
cycle O 0 0.01309647224843502
- O 0 0.027307791635394096
dependent O 0 0.0034734471701085567
colocalization O 0 0.05019678547978401
of O 0 0.0023381749633699656
BARD1 O 1 0.9925044775009155
and O 0 0.0024389068130403757
BRCA1 O 1 0.7798453569412231
indicates O 0 0.0021428843028843403
a O 0 0.0010283451993018389
role O 0 0.00159087881911546
for O 0 0.0014073537895455956
BARD1 O 1 0.913554847240448
in O 0 0.003965172450989485
BRCA1 O 1 0.9992868304252625
- O 1 0.977471649646759
mediated O 1 0.9626120924949646
tumor B-Disease 1 0.9996517896652222
suppression O 1 0.9892684817314148
. O 0 0.013856974430382252

Ethnic O 0 0.007681345567107201
differences O 0 0.004885890521109104
in O 0 0.002921400358900428
the O 0 0.005075101274996996
HFE O 1 0.9997275471687317
codon O 0 0.21426922082901
282 O 1 0.8351890444755554
( O 0 0.03275793790817261
Cys O 1 0.9996272325515747
/ O 1 0.9699678421020508
Tyr O 1 0.9968344569206238
) O 0 0.008595021441578865
polymorphism O 0 0.01921713352203369
. O 0 0.010579869151115417

Recent O 0 0.007189549505710602
studies O 0 0.0041469088755548
have O 0 0.0019537839107215405
shown O 0 0.0031583462841808796
that O 0 0.0032752451952546835
hereditary B-Disease 1 0.999998927116394
hemochromatosis I-Disease 1 1.0
( O 1 0.999991774559021
HH B-Disease 1 1.0
) O 0 0.016472307965159416
is O 0 0.0009678375790826976
likely O 0 0.0006245964323170483
to O 0 0.0003957625012844801
be O 0 0.00041666303877718747
caused O 0 0.0008612567326053977
by O 0 0.0006066527566872537
homozygosity O 0 0.0032993427012115717
for O 0 0.0006386204622685909
a O 0 0.001351092359982431
Cys282Tyr O 0 0.15931816399097443
mutation O 0 0.0019500127527862787
in O 0 0.0010079008061438799
the O 0 0.0020827327389270067
HFE O 1 0.9917535781860352
gene O 0 0.0037143095396459103
located O 0 0.0042028166353702545
4 O 0 0.006789347156882286
. O 0 0.008095519617199898

5 O 0 0.026484506204724312
Mb O 1 0.546946108341217
telomeric O 0 0.4904358983039856
to O 0 0.01177979726344347
HLA O 1 0.9997259974479675
- O 0 0.42455440759658813
A O 0 0.016226651147007942
. O 0 0.012969995848834515

Population O 0 0.005679268389940262
studies O 0 0.0031582070514559746
of O 0 0.0017957951640710235
this O 0 0.0011128655169159174
polymorphism O 0 0.0023031760938465595
are O 0 0.0005826794658787549
facilitated O 0 0.0017321486957371235
by O 0 0.0006463431636802852
the O 0 0.000829179072752595
fact O 0 0.0010020713089033961
that O 0 0.0007023259531706572
the O 0 0.0014769333647564054
Cys282Tyr O 0 0.27224209904670715
mutation O 0 0.004914603661745787
creates O 0 0.004579010419547558
a O 0 0.0041612619534134865
Rsal O 0 0.12947407364845276
restriction O 0 0.0084740174934268
site O 0 0.00952086504548788
. O 0 0.009273127652704716

We O 0 0.004916726611554623
have O 0 0.0021311419550329447
studied O 0 0.0030052741058170795
the O 0 0.002324134111404419
codon O 0 0.007193219382315874
282 O 0 0.03727024793624878
( O 0 0.009900176897644997
Cys O 1 0.9993127584457397
/ O 1 0.7938336730003357
Tyr O 1 0.9625108242034912
) O 0 0.002178439637646079
polymorphism O 0 0.002854572143405676
in O 0 0.0011651143431663513
different O 0 0.0011327923275530338
ethnic O 0 0.0030131381936371326
groups O 0 0.004136204719543457
. O 0 0.007858870550990105

In O 0 0.004595207050442696
agreement O 0 0.002572422381490469
with O 0 0.0013836747966706753
previous O 0 0.0015046190237626433
observations O 0 0.0018240960780531168
the O 0 0.0015793661586940289
Tyr O 1 0.9833478331565857
allele O 0 0.0027769487351179123
appeared O 0 0.0011392154265195131
to O 0 0.0005085869925096631
be O 0 0.00043091431143693626
rare O 0 0.0007027722895145416
or O 0 0.0005689570098184049
absent O 0 0.0014962315326556563
in O 0 0.0009244097745977342
Asiatic O 1 0.6779232621192932
( O 0 0.0013532418524846435
Indian O 0 0.001414919039234519
, O 0 0.0011833618627861142
Chinese O 0 0.0032262082677334547
) O 0 0.0025341708678752184
populations O 0 0.004763252101838589
. O 0 0.006245942786335945

The O 0 0.005923118442296982
highest O 0 0.006728318519890308
allele O 0 0.005009286105632782
frequency O 0 0.002059834310784936
( O 0 0.0012751191388815641
7 O 0 0.0009787416784092784
. O 0 0.0005765331443399191
5 O 0 0.0008044737041927874
% O 0 0.0008141043945215642
) O 0 0.0007858003373257816
was O 0 0.00105124874971807
found O 0 0.0013396056601777673
in O 0 0.001999377738684416
Swedes O 0 0.011037878692150116
. O 0 0.006710435729473829

Saamis O 0 0.24080155789852142
( O 0 0.005793343763798475
2 O 0 0.0031436262652277946
% O 0 0.0017339627956971526
) O 0 0.001078449422493577
and O 0 0.000814052124042064
Mordvinians O 0 0.0066580455750226974
( O 0 0.0011822725646197796
1 O 0 0.0008697307202965021
. O 0 0.00044909041025675833
8 O 0 0.0008172379457391798
% O 0 0.0006627077818848193
) O 0 0.0005949356127530336
had O 0 0.0007687854813411832
significantly O 0 0.0010200347751379013
lower O 0 0.001202868763357401
frequencies O 0 0.0014603747986257076
of O 0 0.0015868941554799676
the O 0 0.0037625867407768965
Tyr O 1 0.9954485297203064
allele O 0 0.020299257710576057
. O 0 0.009330305270850658

Comparisons O 0 0.011471008881926537
with O 0 0.0032420195639133453
allele O 0 0.003912868443876505
frequencies O 0 0.001699253567494452
based O 0 0.001240768819116056
on O 0 0.0012281476520001888
prevalence O 0 0.08815105259418488
estimates O 0 0.0017771476414054632
of O 0 0.0019825035706162453
HH B-Disease 1 0.9998984336853027
showed O 0 0.002018823754042387
some O 0 0.0005930498009547591
disagreements O 0 0.001328559243120253
with O 0 0.000588859838899225
the O 0 0.0009708506404422224
RFLP O 0 0.016734039410948753
data O 0 0.0011199061991646886
, O 0 0.0011105525773018599
particularly O 0 0.001986068207770586
in O 0 0.002817136701196432
Finns O 0 0.019691765308380127
. O 0 0.009314469061791897

The O 0 0.0077860234305262566
newly O 0 0.018204255029559135
described O 0 0.030910803005099297
HFE O 1 0.9994945526123047
marker O 0 0.1331651508808136
provides O 0 0.0020668082870543003
a O 0 0.001068228273652494
new O 0 0.000672997091896832
approach O 0 0.0007556007476523519
to O 0 0.0004539760702755302
the O 0 0.0006214520544745028
screening O 0 0.0014904976123943925
of O 0 0.001704616006463766
HH B-Disease 1 0.9999263286590576
as O 0 0.0007406848599202931
well O 0 0.00042639439925551414
as O 0 0.0003839443961624056
studies O 0 0.0004722620942629874
of O 0 0.00046293993364088237
the O 0 0.000634120253380388
relationship O 0 0.0011567269684746861
between O 0 0.0009262202074751258
the O 0 0.005093246698379517
HFE O 1 0.9999912977218628
Tyr O 1 0.9998642206192017
allele O 0 0.011263231746852398
and O 0 0.002048718510195613
different O 0 0.002663931343704462
disorders O 1 0.999914288520813
including O 1 0.6185811758041382
cancer B-Disease 1 0.9999938011169434

Autosomal B-Disease 1 0.9999362230300903
dominant I-Disease 1 0.99993896484375
neurohypophyseal I-Disease 1 0.9999997615814209
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999995231628418
associated O 0 0.08812836557626724
with O 0 0.002301252679899335
a O 0 0.004231585655361414
missense O 0 0.3159259557723999
mutation O 0 0.006545816548168659
encoding O 0 0.0051094419322907925
Gly23 O 1 0.9334954023361206
- O 1 0.9237515330314636
- O 1 0.9368719458580017
> O 0 0.3031269311904907
Val O 1 0.7255794405937195
in O 0 0.004922919441014528
neurophysin O 1 0.9077495336532593
II O 1 0.9270036220550537
. O 0 0.011969045735895634

Autosomal B-Disease 1 0.9997832179069519
dominant I-Disease 1 0.9997947812080383
neurohypophyseal I-Disease 1 0.9999995231628418
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9991632699966431
ADNDI B-Disease 1 0.9999830722808838
) O 0 0.0043930429965257645
is O 0 0.0017398121999576688
an O 0 0.044092632830142975
inherited B-Disease 1 0.9999996423721313
disease I-Disease 1 1.0
caused O 1 0.9998557567596436
by O 1 0.9211435914039612
progressive O 1 0.9999994039535522
degeneration O 1 1.0
of O 1 0.9933339953422546
the O 1 0.9970581531524658
magnocellular O 1 0.9999964237213135
neurons O 0 0.15618661046028137
of O 0 0.0016306869219988585
the O 0 0.007935700006783009
hypothalamus O 0 0.4824482798576355
leading O 0 0.0021035431418567896
to O 0 0.0007411434780806303
decreased O 0 0.0019943122752010822
ability O 0 0.0008048172458074987
to O 0 0.0005632980610243976
produce O 0 0.0009147836244665086
the O 0 0.0014546687016263604
hormone O 0 0.37715497612953186
arginine O 0 0.09717962890863419
vasopressin O 0 0.1854396015405655
( O 0 0.006336200516670942
AVP O 1 0.7536502480506897
) O 0 0.0066439188085496426
. O 0 0.00794612430036068

Affected O 0 0.008050129748880863
individuals O 0 0.002221431815996766
are O 0 0.0011235756101086736
not O 0 0.0009866241598501801
symptomatic O 1 0.9148522019386292
at O 0 0.001820697681978345
birth O 0 0.07461139559745789
, O 0 0.0009196929750032723
but O 0 0.0007339997100643814
usually O 0 0.0011458051158115268
develop O 0 0.019334180280566216
diabetes B-Disease 1 0.9999821186065674
insipidus I-Disease 1 0.9998394250869751
at O 0 0.0038582836277782917
1 O 0 0.0038446143735200167
- O 0 0.03976965695619583
6 O 0 0.004391850437968969
yr O 0 0.27612143754959106
of O 0 0.0030654254369437695
age O 0 0.007055675610899925
. O 0 0.007762556429952383

The O 0 0.007515355944633484
genetic O 0 0.007200371008366346
locus O 0 0.008860557340085506
of O 0 0.0028449229430407286
the O 0 0.019950225949287415
disease O 1 0.9999136924743652
is O 0 0.005009556654840708
the O 0 0.07757937908172607
AVP O 1 0.9999946355819702
- O 1 0.9956569671630859
neurophysin O 1 0.9990013241767883
II O 1 0.9995337724685669
( O 0 0.016352619975805283
NPII O 1 0.9717982411384583
) O 0 0.000966729421634227
gene O 0 0.0008098755497485399
, O 0 0.0004663045983761549
and O 0 0.0005522129940800369
mutations O 0 0.0011559712002053857
that O 0 0.0005189527291804552
cause O 0 0.043663568794727325
ADNDI B-Disease 1 0.8994122743606567
have O 0 0.00045388026046566665
been O 0 0.00044834910659119487
found O 0 0.0004272612277418375
in O 0 0.0003123030182905495
both O 0 0.0003678166540339589
the O 0 0.0005243586492724717
signal O 0 0.0008169155335053802
peptide O 0 0.001063613104633987
of O 0 0.0006506955251097679
the O 0 0.0013336462434381247
prepro O 1 0.9694254398345947
- O 1 0.9756895303726196
AVP O 1 0.999800980091095
- O 1 0.8364725112915039
NPII O 1 0.9317371845245361
precursor O 0 0.006218951661139727
and O 0 0.0017970538465306163
within O 0 0.002913634991273284
NPII O 1 0.6774383783340454
itself O 0 0.008448977954685688
. O 0 0.00975767057389021

An O 0 0.006107655353844166
affected O 0 0.006308299954980612
girl O 0 0.026211345568299294
who O 0 0.0017452551983296871
presented O 0 0.001644801814109087
at O 0 0.0010438717436045408
9 O 0 0.0009480593726038933
months O 0 0.0005926633020862937
of O 0 0.00048523355508223176
age O 0 0.001134344027377665
and O 0 0.000630553753580898
her O 0 0.004834963474422693
similarly O 0 0.020643413066864014
affected O 0 0.006970448885113001
younger O 0 0.0027948468923568726
brother O 0 0.003697339678183198
and O 0 0.0005908365128561854
father O 0 0.0013382259057834744
were O 0 0.000460668932646513
all O 0 0.00031560627394355834
found O 0 0.00040463151526637375
to O 0 0.0003496623830869794
have O 0 0.0003421611327212304
a O 0 0.0005936674424447119
novel O 0 0.001655395608395338
missense O 0 0.0034162201918661594
mutation O 0 0.0018114278791472316
( O 0 0.0015286337584257126
G1758 O 1 0.6230499148368835
- O 1 0.7436513900756836
- O 1 0.5402873158454895
> O 0 0.013688023202121258
T O 0 0.004292253404855728
) O 0 0.0007803411572240293
encoding O 0 0.001159018836915493
the O 0 0.0008868596632964909
amino O 0 0.0018820076948031783
acid O 0 0.0030630789697170258
substitution O 0 0.0050087012350559235
Gly23 O 0 0.45255598425865173
- O 0 0.4177219271659851
- O 0 0.3357667326927185
> O 0 0.023524880409240723
Val O 0 0.1223156601190567
within O 0 0.007912376895546913
NPII O 0 0.2692195475101471
. O 0 0.014323007315397263

The O 0 0.010146485641598701
mutation O 0 0.012379213236272335
was O 0 0.005649355705827475
confirmed O 0 0.004961574450135231
by O 0 0.0034125761594623327
restriction O 0 0.009426488541066647
endonuclease O 0 0.031065454706549644
analysis O 0 0.009267676621675491
. O 0 0.010157444514334202

A O 0 0.03906085714697838
T1 O 1 0.9986949563026428
- O 0 0.021456651389598846
weighted O 0 0.005512216128408909
magnetic O 0 0.004266669973731041
resonance O 0 0.003786086570471525
imaging O 0 0.0033348966389894485
of O 0 0.001765170251019299
the O 0 0.003962412942200899
fathers O 1 0.880820095539093
pituitary O 1 0.9999791383743286
gland O 1 0.9999232292175293
demonstrates O 1 0.9597082138061523
an O 0 0.4753433167934418
attenuated O 1 0.9998586177825928
posterior O 1 0.9997865557670593
pituitary O 1 0.9999392032623291
bright O 1 0.8519665002822876
spot O 0 0.04406874626874924
. O 0 0.010252002626657486

This O 0 0.005244472995400429
mutation O 0 0.005672346334904432
may O 0 0.0015254805330187082
be O 0 0.0006449641077779233
valuable O 0 0.0010531698353588581
for O 0 0.0006098150042816997
developing O 0 0.0011082803830504417
models O 0 0.0011756331659853458
of O 0 0.0024694132152944803
dominantly B-Disease 1 0.9999828338623047
inherited I-Disease 1 0.9999972581863403
neurodegeneration I-Disease 1 0.9999988079071045
, O 0 0.0015155987348407507
as O 0 0.0006377380341291428
the O 0 0.000601427920628339
early O 0 0.0008539906702935696
age O 0 0.0015156801091507077
of O 0 0.006895082071423531
onset O 1 0.9999959468841553
of O 1 0.9889657497406006
symptoms O 1 0.9999997615814209
suggests O 1 0.7582231760025024
that O 0 0.0008475374197587371
this O 0 0.0007395289139822125
mutation O 0 0.0017182814190164208
may O 0 0.000737388851121068
be O 0 0.0006454905378632247
particularly O 0 0.0011644224869087338
deleterious O 0 0.003859194228425622
to O 0 0.0012347209267318249
the O 0 0.0029973809141665697
magnocellular O 1 0.9861961603164673
neuron O 0 0.3616207242012024
. O 0 0.004634805489331484
. O 0 0.007367813494056463

Frequent O 0 0.021036501973867416
inactivation O 1 0.5720333456993103
of O 0 0.14069582521915436
PTEN O 1 0.9999891519546509
/ O 1 0.9996069073677063
MMAC1 O 1 0.9997684359550476
in O 0 0.3395894765853882
primary O 1 0.999769389629364
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.3595842123031616

Sporadic B-Disease 1 0.9996751546859741
prostate I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 1.0
is O 0 0.14586299657821655
the O 0 0.010213810950517654
most O 0 0.0018711817683652043
common O 0 0.10986989736557007
male B-Disease 1 0.6924878358840942
cancer I-Disease 1 0.9983857870101929
in O 0 0.0008524309378117323
the O 0 0.0009534190758131444
Western O 0 0.001113147591240704
world O 0 0.0009047071216627955
, O 0 0.00043443619506433606
yet O 0 0.0004087411507498473
many O 0 0.0002454743080306798
of O 0 0.0003801865386776626
the O 0 0.000483541312860325
major O 0 0.0006533754640258849
genetic O 0 0.0006770584150217474
events O 0 0.0004725628823507577
involved O 0 0.0003987034724559635
in O 0 0.00039346376433968544
the O 0 0.0006957122823223472
progression O 0 0.24053260684013367
of O 0 0.0009002480073831975
this O 0 0.0007275226525962353
often O 0 0.0018122077453881502
fatal O 1 0.9999009370803833
cancer B-Disease 1 0.9998791217803955
remain O 0 0.0037030456587672234
to O 0 0.0014129147166386247
be O 0 0.002017650054767728
elucidated O 0 0.024564186111092567
. O 0 0.00747004896402359

Numerous O 0 0.014337166212499142
cytogenetic O 1 0.8525198698043823
and O 0 0.005249296315014362
allelotype O 1 0.8503435254096985
studies O 0 0.0026797272730618715
have O 0 0.001248486922122538
reported O 0 0.0019710238557308912
frequent O 0 0.002237054519355297
loss O 0 0.010273648425936699
of O 0 0.0034389353822916746
heterozygosity O 1 0.999265730381012
on O 0 0.004925526678562164
chromosomal O 1 0.9902735352516174
arm O 1 0.9894084930419922
10q O 1 0.9923089742660522
in O 0 0.032826002687215805
sporadic B-Disease 1 0.9996010661125183
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
. O 0 0.10316988080739975

Deletion O 0 0.021333783864974976
mapping O 0 0.007067140191793442
studies O 0 0.0031339777633547783
have O 0 0.0013234805082902312
unambiguously O 0 0.003520059632137418
identified O 0 0.0016502949874848127
a O 0 0.0010175722418352962
region O 0 0.0013089074054732919
of O 0 0.001265600323677063
chromosome O 0 0.0035370856057852507
10q23 O 0 0.005633567925542593
to O 0 0.0006443018210120499
be O 0 0.0005799197242595255
the O 0 0.0008104993612505496
minimal O 0 0.001916462671943009
area O 0 0.0018269557040184736
of O 0 0.003040855284780264
loss O 0 0.35717958211898804
. O 0 0.009194276295602322

A O 0 0.011169921606779099
new O 0 0.007771867793053389
tumor B-Disease 1 0.9981595873832703
suppressor O 1 0.9276761412620544
gene O 0 0.00416551623493433
, O 0 0.003078154753893614
PTEN O 1 0.999697208404541
/ O 1 0.8871816992759705
MMAC1 O 1 0.965767502784729
, O 0 0.001084006275050342
was O 0 0.0012698397040367126
isolated O 0 0.0011727543314918876
recently O 0 0.0008657845901325345
at O 0 0.0005486209411174059
this O 0 0.0003464158799033612
region O 0 0.0005899547250010073
of O 0 0.0006848301854915917
chromosome O 0 0.0020826447289437056
10q23 O 0 0.0031386571936309338
and O 0 0.00041065705590881407
found O 0 0.0003961720212828368
to O 0 0.0003545052604749799
be O 0 0.00037784333107993007
inactivated O 0 0.0015113624976947904
by O 0 0.0004866686067543924
mutation O 0 0.0011037561343982816
in O 0 0.0008602913585491478
three O 0 0.005896779242902994
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
cell O 1 0.9298703670501709
lines O 0 0.04772917181253433
. O 0 0.007864721119403839

We O 0 0.007937528192996979
screened O 0 0.026884451508522034
80 O 0 0.11377912759780884
prostate B-Disease 1 0.9999905824661255
tumors I-Disease 1 0.9993840456008911
by O 0 0.00253771198913455
microsatellite O 0 0.19795864820480347
analysis O 0 0.0016813401598483324
and O 0 0.0011282166233286262
found O 0 0.0013506761752068996
chromosome O 0 0.0024069403298199177
10q23 O 0 0.0034418946597725153
to O 0 0.0007952750893309712
be O 0 0.0007782016764394939
deleted O 0 0.002006084658205509
in O 0 0.0014768328983336687
23 O 0 0.003065788419917226
cases O 0 0.004207680467516184
. O 0 0.006644630338996649

We O 0 0.004244907293468714
then O 0 0.0026858027558773756
proceeded O 0 0.0026024547405540943
with O 0 0.000893584277946502
sequence O 0 0.0010113168973475695
analysis O 0 0.0008188187493942678
of O 0 0.0007806675275787711
the O 0 0.0012744803680106997
entire O 0 0.08408121764659882
PTEN O 1 0.9999790191650391
/ O 1 0.9820965528488159
MMAC1 O 1 0.9858831763267517
coding O 0 0.004043502267450094
region O 0 0.0011706070508807898
and O 0 0.0005699828616343439
tested O 0 0.001124938135035336
for O 0 0.0005952725769020617
homozygous O 0 0.0015795150538906455
deletion O 0 0.001442699576728046
with O 0 0.0004935348406434059
new O 0 0.0008309768163599074
intragenic O 0 0.011918525211513042
markers O 0 0.0015885434113442898
in O 0 0.0005736307939514518
these O 0 0.0004476637113839388
23 O 0 0.0010372418910264969
cases O 0 0.0010753741953521967
with O 0 0.001197062898427248
10q23 O 0 0.11644534766674042
loss O 0 0.018625473603606224
of O 0 0.00807587243616581
heterozygosity O 1 0.9980924725532532
. O 0 0.012111824937164783

The O 0 0.004990848712623119
identification O 0 0.0034518875181674957
of O 0 0.001836900133639574
the O 0 0.001642260467633605
second O 0 0.0023294484708458185
mutational O 0 0.13647031784057617
event O 0 0.001529419212602079
in O 0 0.0007091957959346473
10 O 0 0.0007017523166723549
( O 0 0.0007573712500743568
43 O 0 0.0012817576061934233
% O 0 0.001034357352182269
) O 0 0.0014061152469366789
tumors B-Disease 1 0.7857753038406372
establishes O 1 0.5710482597351074
PTEN O 1 0.9995133876800537
/ O 0 0.37290245294570923
MMAC1 O 0 0.09877640753984451
as O 0 0.0008747692336328328
a O 0 0.0008880545501597226
main O 0 0.0013752038357779384
inactivation O 0 0.005267701111733913
target O 0 0.0012080548331141472
of O 0 0.0011597770499065518
10q O 1 0.6337036490440369
loss O 0 0.26684650778770447
in O 0 0.008331144228577614
sporadic B-Disease 1 0.9993933439254761
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
. O 0 0.0166342630982399
. O 0 0.008999809622764587

Risk O 0 0.030406663194298744
reversals O 0 0.04665679484605789
in O 0 0.005745251663029194
predictive O 0 0.05162106454372406
testing O 0 0.03788826987147331
for O 0 0.09239097684621811
Huntington B-Disease 1 0.9999979734420776
disease I-Disease 1 0.9999988079071045
. O 0 0.066923126578331

The O 0 0.005757614504545927
first O 0 0.004019680432975292
predictive O 0 0.006172263994812965
testing O 0 0.005262152291834354
for O 0 0.029065297916531563
Huntington B-Disease 1 0.9999996423721313
disease I-Disease 1 0.9999998807907104
( O 1 0.8376129269599915
HD B-Disease 1 0.5383859276771545
) O 0 0.000855324266012758
was O 0 0.0007299887365661561
based O 0 0.000492179999127984
on O 0 0.00044478930067270994
analysis O 0 0.0005986756295897067
of O 0 0.0006882058805786073
linked O 0 0.0016928858822211623
polymorphic O 0 0.002901657484471798
DNA O 0 0.0014047212898731232
markers O 0 0.001450244802981615
to O 0 0.0005426474381238222
estimate O 0 0.0010095739271491766
the O 0 0.0008121065329760313
likelihood O 0 0.0017670709639787674
of O 0 0.0011138432892039418
inheriting O 0 0.222346231341362
the O 0 0.003110347781330347
mutation O 0 0.007436607964336872
for O 0 0.0038245960604399443
HD B-Disease 0 0.02753535658121109
. O 0 0.009364345110952854

Limits O 0 0.007246458902955055
to O 0 0.0025753288064152002
accuracy O 0 0.003266742918640375
included O 0 0.001794443349353969
recombination O 0 0.002700790762901306
between O 0 0.0009228428825736046
the O 0 0.0009194709127768874
DNA O 0 0.0015073580434545875
markers O 0 0.001807256368920207
and O 0 0.0006048838258720934
the O 0 0.0007131809834390879
mutation O 0 0.0015277903294190764
, O 0 0.0007741476874798536
pedigree O 0 0.0028654057532548904
structure O 0 0.0012340577086433768
, O 0 0.0006460086442530155
and O 0 0.0005385761614888906
whether O 0 0.000633936608210206
DNA O 0 0.0007666707970201969
samples O 0 0.0007535786717198789
were O 0 0.0005474628414958715
available O 0 0.0006659205537289381
from O 0 0.0009881072910502553
family O 0 0.0022683851420879364
members O 0 0.0029532008338719606
. O 0 0.005001947749406099

With O 0 0.003278040327131748
direct O 0 0.002450411906465888
tests O 0 0.0016553150489926338
for O 0 0.0009705200791358948
the O 0 0.0012552409898489714
HD B-Disease 0 0.06495925784111023
mutation O 0 0.0012876236578449607
, O 0 0.0004724489408545196
we O 0 0.00034768818295560777
have O 0 0.0003249878063797951
assessed O 0 0.0007239083060994744
the O 0 0.00042475966620258987
accuracy O 0 0.0006803977303206921
of O 0 0.0004850730474572629
results O 0 0.0005749045521952212
obtained O 0 0.0006146283121779561
by O 0 0.000520958798006177
linkage O 0 0.0016278148395940661
approaches O 0 0.0010740995639935136
when O 0 0.0005721022607758641
requested O 0 0.0008136538090184331
to O 0 0.00041645931196399033
do O 0 0.0004977785283699632
so O 0 0.0004720055731013417
by O 0 0.0006468216306529939
the O 0 0.0012849761405959725
test O 0 0.0027318524662405252
individuals O 0 0.002749101258814335
. O 0 0.005562336649745703

For O 0 0.0032614495139569044
six O 0 0.0018851326312869787
such O 0 0.0009714938350953162
individuals O 0 0.0009676144691184163
, O 0 0.0009090802050195634
there O 0 0.0008111746283248067
was O 0 0.0016156936762854457
significant O 0 0.0014834144385531545
disparity O 0 0.006273637991398573
between O 0 0.001627627993002534
the O 0 0.0027557620778679848
tests O 0 0.0061489492654800415
. O 0 0.007608460262417793

Three O 0 0.003143345471471548
went O 0 0.0031836286652833223
from O 0 0.0014673159457743168
a O 0 0.002107773208990693
decreased O 0 0.08542391657829285
risk O 0 0.0036482480354607105
to O 0 0.0005509508191607893
an O 0 0.0007074977038428187
increased O 0 0.001172394840978086
risk O 0 0.0012082676403224468
, O 0 0.0005668913945555687
while O 0 0.0005118756671436131
in O 0 0.0005248304223641753
another O 0 0.0008116562967188656
three O 0 0.0007747997296974063
the O 0 0.001387229305692017
risk O 0 0.0187588632106781
was O 0 0.01335806306451559
decreased O 0 0.058525215834379196
. O 0 0.008546018972992897

Knowledge O 0 0.0064827511087059975
of O 0 0.0027392804622650146
the O 0 0.0018971259705722332
potential O 0 0.0018034960376098752
reasons O 0 0.0008782611694186926
for O 0 0.0005072109051980078
these O 0 0.00036672604619525373
changes O 0 0.0004607773735187948
in O 0 0.0003806518216151744
results O 0 0.0005245288484729826
and O 0 0.00037760319537483156
impact O 0 0.0006224600365385413
of O 0 0.00047013667062856257
these O 0 0.0003997386374976486
risk O 0 0.0021486240439116955
reversals O 0 0.01619301550090313
on O 0 0.0006502151372842491
both O 0 0.0006038768333382905
patients O 0 0.11221764981746674
and O 0 0.0005763359367847443
the O 0 0.000968643871601671
counseling O 0 0.20321860909461975
team O 0 0.0009413765510544181
can O 0 0.0003270902670919895
assist O 0 0.0005700032343156636
in O 0 0.0003108406672254205
the O 0 0.00035763162304647267
development O 0 0.0005274656577967107
of O 0 0.000496922992169857
strategies O 0 0.0013328988570719957
for O 0 0.00044545659329742193
the O 0 0.0007886554813012481
prevention O 1 0.9747604131698608
and O 0 0.000590490351896733
, O 0 0.0004639754770323634
where O 0 0.0004009228141512722
necessary O 0 0.0005027162842452526
, O 0 0.0004524687537923455
management O 0 0.0008636242127977312
of O 0 0.0006012708181515336
a O 0 0.0013109846040606499
risk O 0 0.007659797556698322
reversal O 0 0.004038468934595585
in O 0 0.0008064135909080505
any O 0 0.0010302896844223142
predictive O 0 0.003276275470852852
testing O 0 0.0028061941266059875
program O 0 0.003304003272205591
. O 0 0.0028411448001861572
. O 0 0.006334561854600906

A O 0 0.010197891853749752
novel O 0 0.010358131490647793
common O 0 0.004647548776119947
missense O 0 0.013608706183731556
mutation O 0 0.004517505411058664
G301C O 0 0.006571623496711254
in O 0 0.001273549161851406
the O 0 0.0016142042586579919
N O 0 0.007548716384917498
- O 0 0.04201922565698624
acetylgalactosamine O 1 0.8139282464981079
- O 0 0.31065744161605835
6 O 0 0.010230271145701408
- O 1 0.6471741795539856
sulfate O 1 0.9598662257194519
sulfatase O 1 0.9957525730133057
gene O 0 0.006812266539782286
in O 0 0.005086357239633799
mucopolysaccharidosis B-Disease 1 0.9548225402832031
IVA I-Disease 1 0.9996885061264038
. O 0 0.017928993329405785

Mucopolysaccharidosis B-Disease 1 0.9982695579528809
IVA I-Disease 1 0.9999850988388062
( O 1 0.605986475944519
MPS B-Disease 1 0.995037853717804
IVA I-Disease 1 0.9999992847442627
) O 0 0.0062827980145812035
is O 0 0.0017660106532275677
an O 0 0.005343873519450426
autosomal B-Disease 1 0.9999649524688721
recessive I-Disease 1 0.9999979734420776
lysosomal I-Disease 1 1.0
storage I-Disease 1 0.999996542930603
disorder I-Disease 1 0.9999998807907104
caused O 1 0.9974703788757324
by O 0 0.0030779102817177773
a O 0 0.022000424563884735
genetic B-Disease 0 0.3633521795272827
defect I-Disease 1 0.9914856553077698
in O 0 0.0018125104252249002
N O 0 0.17012743651866913
- O 0 0.21038417518138885
acetylgalactosamine O 1 0.896591305732727
- O 0 0.3512900471687317
6 O 0 0.015581335872411728
- O 1 0.8829928040504456
sulfate O 1 0.9978615641593933
sulfatase O 1 0.9995408058166504
( O 0 0.013701986521482468
GALNS O 1 0.9498546123504639
) O 0 0.007132455240935087
. O 0 0.008492394350469112

In O 0 0.004213995300233364
previous O 0 0.00327794230543077
studies O 0 0.0018471276853233576
, O 0 0.0010796778369694948
we O 0 0.0007588161388412118
have O 0 0.00045640073949471116
found O 0 0.0005739731132052839
two O 0 0.00048585969489067793
common O 0 0.0008507869788445532
mutations O 0 0.001168927177786827
in O 0 0.0008429675363004208
Caucasians O 0 0.08758052438497543
and O 0 0.0013058701297268271
Japanese O 0 0.006022479850798845
, O 0 0.002884621499106288
respectively O 0 0.006413586437702179
. O 0 0.007321596145629883

To O 0 0.006658988073468208
characterize O 0 0.009458699263632298
the O 0 0.0032476314809173346
mutational O 0 0.05372665822505951
spectrum O 0 0.0027748143766075373
in O 0 0.001002548262476921
various O 0 0.000738896953407675
ethnic O 0 0.0010563150281086564
groups O 0 0.0006210680585354567
, O 0 0.0006573187420144677
mutations O 0 0.0007916269823908806
in O 0 0.0005863307742401958
the O 0 0.0009357258095405996
GALNS O 0 0.3585774600505829
gene O 0 0.001328804763033986
in O 0 0.0008922077831812203
Colombian O 0 0.006291625089943409
MPS B-Disease 1 0.7576675415039062
IVA I-Disease 1 0.9999979734420776
patients O 1 0.5498862266540527
were O 0 0.000929365458432585
investigated O 0 0.002565452130511403
, O 0 0.0006480358424596488
and O 0 0.0006110650137998164
genetic O 0 0.0009652287699282169
backgrounds O 0 0.0009114479762502015
were O 0 0.0005139315035194159
extensively O 0 0.0009241279331035912
analyzed O 0 0.0008644479676149786
to O 0 0.00045129022328183055
identify O 0 0.0007001880439929664
racial O 0 0.0011994998203590512
origin O 0 0.000678841897752136
, O 0 0.0005975024541839957
based O 0 0.0006908221985213459
on O 0 0.0008052111370489001
mitochondrial O 0 0.0020019931253045797
DNA O 0 0.0020030958112329245
( O 0 0.0026155193336308002
mtDNA O 0 0.004858477506786585
) O 0 0.003577522234991193
lineages O 0 0.00949777290225029
. O 0 0.007958033122122288

Three O 0 0.005567065440118313
novel O 0 0.013755214400589466
missense O 0 0.161689892411232
mutations O 0 0.004843156319111586
never O 0 0.0019037900492548943
identified O 0 0.0011829067952930927
previously O 0 0.0007852284470573068
in O 0 0.0004188989114481956
other O 0 0.0003247561398893595
populations O 0 0.0005412312457337976
and O 0 0.00034320622216910124
found O 0 0.0004167341685388237
in O 0 0.0003489753871690482
16 O 0 0.0005924761644564569
out O 0 0.00042756929178722203
of O 0 0.0006589900003746152
19 O 0 0.0016090086428448558
Colombian O 0 0.004131739027798176
MPS B-Disease 0 0.027482185512781143
IVA I-Disease 1 0.9997877478599548
unrelated O 0 0.005328522063791752
alleles O 0 0.003809952409937978
account O 0 0.002586456947028637
for O 0 0.0026103437412530184
84 O 0 0.011968754231929779
. O 0 0.007927472703158855

2 O 0 0.007561719045042992
% O 0 0.0035161932464689016
of O 0 0.0018055933760479093
the O 0 0.0020456151105463505
alleles O 0 0.0035484700929373503
in O 0 0.0016189736779779196
this O 0 0.001975333085283637
study O 0 0.004649960435926914
. O 0 0.008279678411781788

The O 0 0.008924727328121662
G301C O 0 0.06237431615591049
and O 0 0.0048193191178143024
S162F O 0 0.19321079552173615
mutations O 0 0.00493282126262784
account O 0 0.003856240538880229
for O 0 0.0035107089206576347
68 O 0 0.014151521027088165
. O 0 0.010238110087811947

4 O 0 0.011721290647983551
% O 0 0.007748838979750872
and O 0 0.0052193328738212585
10 O 0 0.00930020958185196
. O 0 0.012041140347719193

5 O 0 0.006280086003243923
% O 0 0.0029169616755098104
of O 0 0.001822719001211226
mutations O 0 0.0020817441400140524
, O 0 0.0009969923412427306
respectively O 0 0.0014081024564802647
, O 0 0.0007460247143171728
whereas O 0 0.0010343652684241533
the O 0 0.0008943919674493372
remaining O 0 0.0015991696855053306
F69V O 0 0.06579160690307617
is O 0 0.0009506407659500837
limited O 0 0.0010273884981870651
to O 0 0.0008578140405006707
a O 0 0.0020069191232323647
single O 0 0.004019785672426224
allele O 0 0.01050254050642252
. O 0 0.007496625650674105

The O 0 0.009377973154187202
skewed O 0 0.014787506312131882
prevalence O 0 0.4371495246887207
of O 0 0.0034382916055619717
G301C O 1 0.9078752994537354
in O 0 0.0015934614930301905
only O 0 0.0010685917222872376
Colombian O 0 0.013871140778064728
patients O 0 0.010705709457397461
and O 0 0.000795255764387548
haplotype O 0 0.002076800912618637
analysis O 0 0.0008113616495393217
by O 0 0.0006515097338706255
restriction O 0 0.0013862969353795052
fragment O 0 0.001656858716160059
length O 0 0.0013082405785098672
polymorphisms O 0 0.0020540033001452684
in O 0 0.0008198961731977761
the O 0 0.0012242671800777316
GALNS O 0 0.14747120440006256
gene O 0 0.001354820211417973
suggest O 0 0.0011808734852820635
that O 0 0.0006542993360199034
G301C O 0 0.003707098076120019
originated O 0 0.0020292161498218775
from O 0 0.0012311073951423168
a O 0 0.0024164323695003986
common O 0 0.004297611769288778
ancestor O 0 0.015939267352223396
. O 0 0.008783084340393543

Investigation O 0 0.007359872572124004
of O 0 0.002994743175804615
the O 0 0.002349018817767501
genetic O 0 0.0022745986934751272
background O 0 0.0015293624019250274
by O 0 0.000720860727597028
means O 0 0.00086526497034356
of O 0 0.0008790343999862671
mtDNA O 0 0.0022299953270703554
lineages O 0 0.0013688209000974894
indicate O 0 0.0007458455511368811
that O 0 0.0003923190524801612
all O 0 0.0004296370316296816
our O 0 0.0007844361243769526
patients O 0 0.0019502595532685518
are O 0 0.0005353708984330297
probably O 0 0.0013663318241015077
of O 0 0.0016936780884861946
native O 0 0.00455772690474987
American O 0 0.009691410697996616
descent O 0 0.03407350182533264

Low O 0 0.012856373563408852
frequency O 0 0.0064704930409789085
of O 0 0.003759517567232251
BRCA1 O 0 0.3328173756599426
germline O 0 0.05398344621062279
mutations O 0 0.0027826549485325813
in O 0 0.0015488909557461739
45 O 0 0.013610280118882656
German O 1 0.9998036026954651
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 1 0.931281328201294
. O 0 0.01722499541938305

In O 0 0.004210430663079023
this O 0 0.0015233707381412387
study O 0 0.0015433605294674635
we O 0 0.0011544257868081331
investigated O 0 0.002778157126158476
45 O 0 0.004038818646222353
German O 1 0.9938389658927917
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
families O 0 0.0306074321269989
for O 0 0.00364143424667418
germline O 1 0.9136387705802917
mutations O 0 0.0026546826120465994
in O 0 0.001593553344719112
the O 0 0.003983766306191683
BRCA1 O 1 0.9784486293792725
gene O 0 0.008979661390185356
. O 0 0.007306166458874941

We O 0 0.004116212949156761
identified O 0 0.0031888962257653475
four O 0 0.0020073072519153357
germline O 0 0.014787865802645683
mutations O 0 0.0018269913271069527
in O 0 0.0011139654088765383
three O 0 0.0034023134503513575
breast B-Disease 1 0.9999969005584717
cancer I-Disease 1 0.9998390674591064
families O 0 0.0014716638252139091
and O 0 0.000764368858654052
in O 0 0.002214853884652257
one O 1 0.8667534589767456
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
family O 1 0.5239033102989197
. O 0 0.0005739245098084211
among O 0 0.0004285735194571316
these O 0 0.00025830892263911664
were O 0 0.00031828705687075853
one O 0 0.0004851209232583642
frameshift O 0 0.08356191962957382
mutation O 0 0.0011089873732998967
, O 0 0.000479224807349965
one O 0 0.0005058276583440602
nonsense O 0 0.0026195840910077095
mutation O 0 0.0009002634324133396
, O 0 0.0004444580990821123
one O 0 0.0005521314451470971
novel O 0 0.0016661848640069366
splice O 0 0.003189651295542717
site O 0 0.0014884979464113712
mutation O 0 0.001603241660632193
, O 0 0.0008917413069866598
and O 0 0.001159996958449483
one O 0 0.0019269108306616545
missense O 0 0.015844661742448807
mutation O 0 0.01032604742795229
. O 0 0.007200819905847311

The O 0 0.009308988228440285
missense O 0 0.047107160091400146
mutation O 0 0.007496376521885395
was O 0 0.0031061929184943438
also O 0 0.0015989646781235933
found O 0 0.0019221644615754485
in O 0 0.001974689308553934
2 O 0 0.005250501446425915
. O 0 0.0059110913425683975

8 O 0 0.007404029835015535
% O 0 0.0028528773691505194
of O 0 0.001483942149206996
the O 0 0.001369359204545617
general O 0 0.00260014901868999
population O 0 0.0009850590722635388
, O 0 0.0007472492288798094
suggesting O 0 0.0010872036218643188
that O 0 0.0004736452247016132
it O 0 0.0005796424229629338
is O 0 0.0009544810745865107
not O 0 0.0011977405520156026
disease O 1 0.9609634280204773
associated O 0 0.006641610059887171
. O 0 0.007058823015540838

The O 0 0.005360348615795374
average O 0 0.004830048885196447
age O 0 0.005843213759362698
of O 0 0.2615375518798828
disease O 1 0.9999995231628418
onset O 1 0.9999992847442627
in O 0 0.22326701879501343
those O 0 0.005008613225072622
families O 0 0.1624280959367752
harbouring O 1 0.9999322891235352
causative O 1 0.9991466999053955
mutations O 0 0.014028554782271385
was O 0 0.003979428205639124
between O 0 0.002670528134331107
32 O 0 0.006740563083440065
. O 0 0.00730586564168334

3 O 0 0.01840638928115368
and O 0 0.010439577512443066
37 O 0 0.022808074951171875
. O 0 0.015858668833971024

4 O 0 0.008212757296860218
years O 0 0.0033207794185727835
, O 0 0.001811107387766242
whereas O 0 0.0016092929290607572
the O 0 0.0011305431835353374
family O 0 0.002434217371046543
harbouring O 1 0.881542980670929
the O 0 0.0020370706915855408
missense O 0 0.047362279146909714
mutation O 0 0.0018955942941829562
had O 0 0.0007033524452708662
an O 0 0.0006322170374915004
average O 0 0.0011520215775817633
age O 0 0.001366941025480628
of O 0 0.0017559336265549064
onset O 1 0.9958265423774719
of O 0 0.07087675482034683
51 O 0 0.3531631827354431
. O 0 0.009314685128629208

2 O 0 0.03275536373257637
years O 0 0.025712138041853905
. O 0 0.02446524053812027

These O 0 0.00374014163389802
findings O 0 0.0036620397586375475
show O 0 0.0024455063976347446
that O 0 0.001348648453131318
BRCA1 O 0 0.05360763520002365
is O 0 0.0009542052284814417
implicated O 0 0.002106299391016364
in O 0 0.0006021256558597088
a O 0 0.0008723755017854273
small O 0 0.001007158774882555
fraction O 0 0.003266303101554513
of O 1 0.7189643979072571
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 0.014386662282049656
suggesting O 0 0.002449915511533618
the O 0 0.0011019164230674505
involvement O 0 0.0022574521135538816
of O 0 0.0015226041432470083
another O 0 0.03369367495179176
susceptibility O 1 0.9938166737556458
gene O 0 0.012189912609755993
( O 0 0.005600122734904289
s O 0 0.02945060096681118
) O 0 0.009273514151573181

Paternal O 1 0.9992589354515076
transmission O 1 0.9993127584457397
of O 1 0.9998555183410645
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9996065497398376

We O 0 0.004789079073816538
report O 0 0.003506346372887492
a O 0 0.0021932253148406744
rare O 0 0.002423355123028159
case O 0 0.00296782492659986
of O 0 0.1482125222682953
paternally O 1 0.9999970197677612
transmitted O 1 0.9999980926513672
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999991655349731
DM B-Disease 1 1.0
) O 0 0.3584008514881134
. O 0 0.009584877640008926

The O 0 0.008091353811323643
proband O 0 0.024857819080352783
is O 0 0.0021923521999269724
a O 0 0.001748221693560481
23 O 0 0.002285339403897524
year O 0 0.0017317332094535232
old O 0 0.018208634108304977
, O 0 0.007277727127075195
mentally B-Disease 1 0.9999654293060303
retarded I-Disease 1 0.9999171495437622
male O 1 0.9909031987190247
who O 1 0.9991483688354492
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 0.9999998807907104
. O 1 0.9752848148345947

He O 0 0.006989949848502874
presented O 0 0.008884277194738388
with O 0 0.009767028503119946
respiratory O 1 0.9999988079071045
and O 1 0.5109716653823853
feeding O 1 0.9930217862129211
difficulties O 1 0.9990656971931458
at O 0 0.286334365606308
birth O 1 0.9781816601753235
. O 0 0.012573991902172565

His O 0 0.010988901369273663
two O 0 0.008054315112531185
sibs O 1 0.9996798038482666
suffer O 1 0.9966897964477539
from O 0 0.0953967496752739
childhood O 1 0.9999902248382568
onset O 1 0.9999998807907104
DM B-Disease 1 1.0
. O 0 0.49141350388526917

Their O 0 0.004723759833723307
late O 0 0.004504872020334005
father O 0 0.004166964441537857
had O 0 0.0016765582840889692
the O 0 0.0012878469424322248
adult O 0 0.002589469077065587
type O 0 0.015247232280671597
of O 0 0.036601319909095764
DM B-Disease 1 0.9999994039535522
, O 0 0.0018593559507280588
with O 0 0.0013189461315050721
onset O 1 0.9879040122032166
around O 0 0.002121045719832182
30 O 0 0.0026162806898355484
years O 0 0.00324763311073184
. O 0 0.005532309412956238

Only O 0 0.0033182017505168915
six O 0 0.0021110172383487225
other O 0 0.0009918761206790805
cases O 0 0.001423886395059526
of O 0 0.003302169730886817
paternal O 1 0.9996641874313354
transmission O 1 0.9994804263114929
of O 1 0.9998003840446472
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.23391230404376984
been O 0 0.0113424863666296
reported O 0 0.011520793661475182
recently O 0 0.010553804226219654
. O 0 0.007357477210462093

We O 0 0.004920339211821556
review O 0 0.004132142756134272
the O 0 0.0024097152054309845
sex O 0 0.0030198709573596716
related O 0 0.0026604533195495605
effects O 0 0.01802143268287182
on O 0 0.004105813335627317
transmission O 1 0.9252943992614746
of O 1 0.9700543284416199
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.7904811501502991

Decreased O 0 0.07690177857875824
fertility O 0 0.1136704534292221
of O 0 0.003981525078415871
males O 0 0.004947215784341097
with O 0 0.0033316996414214373
adult O 1 0.9318148493766785
onset O 1 0.9999998807907104
DM B-Disease 1 1.0
and O 0 0.026559017598628998
contraction O 1 0.79488205909729
of O 0 0.002062414772808552
the O 0 0.002591644646599889
repeat O 0 0.08774527162313461
upon O 0 0.0013917781179770827
male O 0 0.003187044756487012
transmission O 0 0.0033197286538779736
contribute O 0 0.000888066366314888
to O 0 0.0004551729070954025
the O 0 0.0005785981193184853
almost O 0 0.0007488185656256974
absent O 0 0.001678645028732717
occurrence O 0 0.002440479351207614
of O 0 0.002471254440024495
paternal O 1 0.9784770607948303
transmission O 1 0.9846765398979187
of O 1 0.9940668344497681
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.768208384513855

Also O 0 0.004893395118415356
the O 0 0.0031399645376950502
fathers O 0 0.0035284042824059725
of O 0 0.001750808209180832
the O 0 0.003919288981705904
reported O 1 0.5728104710578918
congenitally O 1 0.9992971420288086
affected O 0 0.006784377153962851
children O 0 0.0015985904028639197
showed O 0 0.0011152127990499139
, O 0 0.0005331477732397616
on O 0 0.0004372314433567226
average O 0 0.0007672273204661906
, O 0 0.0006816763198003173
shorter O 0 0.0016704759327694774
CTG O 0 0.036057248711586
repeat O 0 0.0023278044536709785
lengths O 0 0.0019831776153296232
and O 0 0.0008312604040838778
hence O 0 0.001454511540941894
less O 0 0.0012320680543780327
severe O 1 0.9961987137794495
clinical O 1 0.9994833469390869
symptoms O 1 0.9999700784683228
than O 0 0.0014837980270385742
the O 0 0.005052667576819658
mothers O 1 0.7541009783744812
of O 0 0.12852835655212402
children O 1 0.9882668852806091
with O 1 0.9836170673370361
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.7757892608642578

We O 0 0.005849866196513176
conclude O 0 0.006708618253469467
that O 0 0.0028528175316751003
paternal O 0 0.2970294654369354
transmission O 1 0.9486865401268005
of O 1 0.9969969987869263
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.942742645740509
rare O 1 0.5703889727592468
and O 0 0.00196822895668447
preferentially O 0 0.0031631900928914547
occurs O 0 0.0011216189013794065
with O 0 0.000839823973365128
onset O 1 0.9665637612342834
of O 0 0.04678969457745552
DM B-Disease 1 0.9999985694885254
past O 0 0.002110143657773733
30 O 0 0.0010056132450699806
years O 0 0.0006297099753282964
in O 0 0.0006451301160268486
the O 0 0.0011279162717983127
father O 0 0.004902017768472433
. O 0 0.0025698705576360226
. O 0 0.005383484996855259

The O 0 0.017658112570643425
RB1 O 1 0.9892042279243469
gene O 0 0.006343927700072527
mutation O 0 0.005431894212961197
in O 0 0.002409501001238823
a O 0 0.0036272990982979536
child O 1 0.783268928527832
with O 0 0.23180042207241058
ectopic B-Disease 1 0.9999973773956299
intracranial I-Disease 1 0.9999990463256836
retinoblastoma I-Disease 1 0.9999858140945435
. O 0 0.028820160776376724

The O 0 0.015598605386912823
RB1 O 1 0.9988611936569214
gene O 0 0.004785905126482248
mutation O 0 0.0033545149490237236
was O 0 0.0019398570293560624
investigated O 0 0.0025440931785851717
in O 0 0.0009731273748911917
a O 0 0.0017514217179268599
child O 0 0.4577813148498535
with O 0 0.02878330461680889
ectopic B-Disease 1 0.9999954700469971
intracranial I-Disease 1 0.9999979734420776
retinoblastoma I-Disease 1 0.9994435906410217
using O 0 0.001286769867874682
DNA O 0 0.0010426531080156565
obtained O 0 0.0007826839573681355
from O 0 0.0005372710293158889
both O 0 0.000703157449606806
the O 0 0.0014509825268760324
pineal B-Disease 1 0.9970607161521912
and I-Disease 0 0.054213978350162506
retinal I-Disease 1 0.9999945163726807
tumours I-Disease 1 0.999975323677063
of O 0 0.17863623797893524
the O 1 0.8825569152832031
patient O 1 0.9999160766601562
. O 0 0.01675499975681305

A O 0 0.009756932966411114
nonsense O 0 0.014517871662974358
mutation O 0 0.004533720668405294
in O 0 0.001858440926298499
exon O 0 0.0067834327928721905
17 O 0 0.002484078984707594
( O 0 0.0016472936840727925
codon O 0 0.00291363219730556
556 O 0 0.003966009244322777
) O 0 0.0011387543054297566
of O 0 0.0009761638357304037
the O 0 0.0016098973574116826
RB1 O 1 0.9600695967674255
gene O 0 0.0014919918030500412
was O 0 0.0009292401955462992
found O 0 0.0005398268112912774
to O 0 0.00042770200525410473
be O 0 0.00040716477087698877
present O 0 0.0007182979607023299
homozygously O 0 0.002837042324244976
in O 0 0.0007564639090560377
both O 0 0.000857905950397253
the O 0 0.002137689385563135
retinal B-Disease 1 0.9940550327301025
and I-Disease 0 0.0031131801661103964
the I-Disease 0 0.01602613925933838
pineal I-Disease 1 0.9994524121284485
tumours I-Disease 1 0.999902606010437
. O 0 0.015463198535144329

The O 0 0.004885412752628326
same O 0 0.002812616992741823
mutation O 0 0.003929740283638239
was O 0 0.002223151968792081
present O 0 0.0014338715700432658
heterozygously O 0 0.007584541570395231
in O 0 0.0008324632653966546
the O 0 0.0008000702946446836
DNA O 0 0.0008647466893307865
from O 0 0.000448086328106001
the O 0 0.0005065275472588837
constitutional O 0 0.0009189856937155128
cells O 0 0.0006564087816514075
of O 0 0.0005054175271652639
the O 0 0.0009564888896420598
patient O 1 0.5169720649719238
, O 0 0.0008413870818912983
proving O 0 0.0019865240901708603
it O 0 0.00044803813216276467
to O 0 0.0005125298630446196
be O 0 0.0007911590510047972
of O 0 0.001790121546946466
germline O 0 0.014210015535354614
origin O 0 0.006479030009359121
. O 0 0.007457777392119169

The O 0 0.00640328973531723
initial O 0 0.006410951726138592
mutation O 0 0.005317281931638718
was O 0 0.0023585865274071693
shown O 0 0.0013774898834526539
to O 0 0.0006802784628234804
have O 0 0.0005600159638561308
occurred O 0 0.0012309958692640066
in O 0 0.001068491954356432
the O 0 0.0024286555126309395
paternally O 1 0.7037155628204346
derived O 0 0.012176421470940113
RB1 O 1 0.9880843758583069
allele O 0 0.020129401236772537
. O 0 0.010665384121239185

The O 0 0.007202695123851299
mutation O 0 0.005369722377508879
is O 0 0.0014562744181603193
in O 0 0.0008542783907614648
an O 0 0.0007051991997286677
area O 0 0.000814294908195734
of O 0 0.0007431191042996943
the O 0 0.0008970790077000856
gene O 0 0.0008768355473875999
that O 0 0.0005111799691803753
encodes O 0 0.0010293767554685473
the O 0 0.0006663567037321627
protein O 0 0.0009695995831862092
- O 0 0.0012323895934969187
binding O 0 0.0006305021815933287
region O 0 0.0007474450394511223
known O 0 0.0006443576421588659
as O 0 0.0005312911234796047
the O 0 0.0008566476171836257
pocket O 0 0.14850051701068878
region O 0 0.0010728309862315655
and O 0 0.0005879258387722075
has O 0 0.0005737376632168889
been O 0 0.0005828189314343035
detected O 0 0.0009814982768148184
in O 0 0.0005004302365705371
other O 0 0.0004905290552414954
cases O 0 0.0011894747149199247
of O 0 0.0029399318154901266
retinoblastoma B-Disease 1 0.9980741739273071
. O 0 0.003543224185705185
. O 0 0.006450369488447905

Low O 0 0.013270096853375435
levels O 0 0.005520306993275881
of O 0 0.002763979136943817
beta O 0 0.009432110004127026
hexosaminidase O 0 0.28777116537094116
A O 0 0.0027843506541103125
in O 0 0.0013391936663538218
healthy O 0 0.03509959205985069
individuals O 0 0.001093015307560563
with O 0 0.0018094520783051848
apparent O 1 0.9918270111083984
deficiency O 1 0.9999994039535522
of O 1 0.8995265960693359
this O 0 0.08461196720600128
enzyme O 0 0.4119457006454468
. O 0 0.007468797266483307

Appreciable O 0 0.0834997221827507
beta O 0 0.026627760380506516
hexosaminidase O 0 0.36361929774284363
A O 0 0.009311781264841557
( O 0 0.0051849414594471455
hex O 0 0.01039956510066986
A O 0 0.0021150046959519386
) O 0 0.0009356581140309572
activity O 0 0.0007839417667128146
has O 0 0.0006018536514602602
been O 0 0.0006436285329982638
detected O 0 0.0014340052148327231
in O 0 0.0010729633504524827
cultured O 1 0.9461115002632141
skin O 1 0.9999406337738037
fibroblasts O 1 0.9970533847808838
and O 0 0.24926979839801788
melanoma B-Disease 1 0.9999998807907104
tissue O 1 0.9773147106170654
from O 0 0.0015860709827393293
healthy O 0 0.04613936319947243
individuals O 0 0.0006306901923380792
previously O 0 0.0011537710670381784
reported O 0 0.0022776632104068995
as O 0 0.0011996855027973652
having O 0 0.13267287611961365
deficiency B-Disease 1 0.9999954700469971
of I-Disease 0 0.05098484456539154
hex I-Disease 1 0.8296694755554199
A I-Disease 0 0.0024801224935799837
activity O 0 0.000832297489978373
indistinguishable O 0 0.0009752956102602184
from O 0 0.0003467825008556247
that O 0 0.0003377718385308981
of O 0 0.0006370123592205346
patients O 1 0.7961138486862183
with O 1 0.67029869556427
Tay B-Disease 1 1.0
- I-Disease 1 0.999998927116394
Sachs I-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999997615814209
( O 1 0.8643825650215149
TSD B-Disease 1 0.9999768733978271
) O 0 0.0067871506325900555
. O 0 0.007313401438295841

Identification O 0 0.011766514740884304
and O 0 0.005305871833115816
quantitation O 0 0.046009015291929245
of O 0 0.004552674014121294
hex O 0 0.09532993286848068
A O 0 0.0049431961961090565
, O 0 0.002743063261732459
amounting O 0 0.006804327480494976
to O 0 0.0029260916635394096
3 O 0 0.0055916160345077515
. O 0 0.007823665626347065

5 O 0 0.01805037260055542
% O 0 0.013160712085664272
- O 0 0.02316943183541298
6 O 0 0.019185995683073997
. O 0 0.015212289988994598

9 O 0 0.007410846184939146
% O 0 0.003261868143454194
of O 0 0.0020264775957912207
total O 0 0.002589297713711858
beta O 0 0.009226284921169281
hexosaminidase O 0 0.33315396308898926
activity O 0 0.0013795404229313135
, O 0 0.0007899310439825058
has O 0 0.0006117430748417974
been O 0 0.0004902117070741951
obtained O 0 0.0008237781003117561
by O 0 0.0008999509736895561
cellulose O 1 0.5486685633659363
acetate O 1 0.9431478381156921
gel O 1 0.785545825958252
electrophoresis O 0 0.04070591181516647
, O 0 0.0019104613456875086
DEAE O 1 0.9704024195671082
- O 0 0.3937634825706482
cellulose O 1 0.5590510368347168
ion O 0 0.06170975789427757
- O 0 0.0157546978443861
exchange O 0 0.0020655831322073936
chromatography O 0 0.07659617066383362
, O 0 0.0024938746355473995
radial O 0 0.1612100601196289
immunodiffusion O 0 0.29332664608955383
, O 0 0.00345497764647007
and O 0 0.004994759801775217
radioimmunoassay O 0 0.3004654049873352
. O 0 0.011101709678769112

Previous O 0 0.007968535646796227
family O 0 0.004890060517936945
studies O 0 0.0030725612305104733
suggested O 0 0.0021906611509621143
that O 0 0.0007091508014127612
these O 0 0.0005918600945733488
individuals O 0 0.0006264206604100764
may O 0 0.0007100444636307657
be O 0 0.0005007552681490779
compound O 0 0.001250867499038577
heterozygotes O 0 0.003312915563583374
for O 0 0.00065442273626104
the O 0 0.0009078519069589674
common O 0 0.00193053821567446
mutant O 0 0.33676591515541077
TSD B-Disease 1 0.998611569404602
gene O 0 0.0015590650727972388
and O 0 0.0006943858461454511
a O 0 0.0011823890963569283
rare O 0 0.0033230972476303577
( O 0 0.003919949755072594
allelic O 0 0.35397598147392273
) O 0 0.004206813871860504
mutant O 0 0.013543381355702877
gene O 0 0.007010122295469046
. O 0 0.0066642193123698235

Thus O 0 0.006581554189324379
, O 0 0.00294263637624681
the O 0 0.002238767920061946
postulated O 0 0.008764605969190598
rate O 0 0.003228004788979888
mutant O 0 0.0043216608464717865
gene O 0 0.0012291880557313561
appears O 0 0.0009011058136820793
to O 0 0.0003967068041674793
code O 0 0.0005819116486236453
for O 0 0.00039059045957401395
the O 0 0.0005465447320602834
expression O 0 0.0008437800570391119
of O 0 0.0007789377705194056
low O 0 0.0017571350326761603
amounts O 0 0.0015848480397835374
of O 0 0.002219859743490815
hex O 0 0.025114456191658974
A O 0 0.007989125326275826
. O 0 0.008814232423901558

Heterozygotes O 0 0.09870103746652603
for O 0 0.0039139240980148315
the O 0 0.0034606331028044224
rare O 0 0.005369106773287058
mutant O 0 0.05354287847876549
may O 0 0.0013457488967105746
be O 0 0.0008158839773386717
indistinguishable O 0 0.0022731944918632507
from O 0 0.0014409332070499659
heterozygotes O 0 0.00738266296684742
for O 0 0.0018296099733561277
the O 0 0.0036327026318758726
common O 0 0.016023781150579453
TSD B-Disease 1 0.9997707009315491
mutant O 0 0.3391081392765045
. O 0 0.012162423692643642

However O 0 0.0066532474011182785
, O 0 0.0033584737684577703
direct O 0 0.0032581896521151066
visualization O 0 0.006058563943952322
and O 0 0.001858565490692854
quantitation O 0 0.06731066107749939
of O 0 0.0020843669772148132
hex O 0 0.018165558576583862
A O 0 0.001413938356563449
by O 0 0.0005664036725647748
the O 0 0.0006335246143862605
methods O 0 0.0008325726957991719
described O 0 0.0012673408491536975
may O 0 0.0008445727289654315
prevent O 0 0.0016539649805054069
false O 0 0.011416766792535782
- O 1 0.8571370840072632
positive O 0 0.030544377863407135
prenatal O 1 0.9912749528884888
diagnosis O 1 0.961287260055542
of O 0 0.006813092157244682
TSD B-Disease 1 0.999915361404419
in O 0 0.0016196417855098844
fetuses O 0 0.07940902560949326
having O 0 0.000976444804109633
the O 0 0.0010326097253710032
incomplete O 0 0.012729783542454243
hex B-Disease 1 0.8820765614509583
A I-Disease 0 0.20881988108158112
deficiency I-Disease 1 0.9999549388885498
of O 0 0.003744120243936777
the O 0 0.010993162170052528
type O 0 0.17255541682243347
described O 0 0.0023294573184102774
in O 0 0.0009743520640768111
the O 0 0.0016527945408597589
four O 0 0.0026081595569849014
healthy O 0 0.029476864263415337
individuals O 0 0.0067050280049443245

The O 0 0.04667441174387932
tumor B-Disease 1 0.999954342842102
suppressor O 1 0.9988623857498169
gene O 0 0.07653237879276276
Smad4 O 1 0.9974182844161987
/ O 1 0.8893911838531494
Dpc4 O 0 0.22243835031986237
is O 0 0.0011436347849667072
required O 0 0.0009003907907754183
for O 0 0.0007673354703001678
gastrulation O 0 0.35348543524742126
and O 0 0.0008005976560525596
later O 0 0.000966068240813911
for O 0 0.0008556143729947507
anterior O 0 0.45310714840888977
development O 0 0.002051542978733778
of O 0 0.00254384009167552
the O 0 0.019566763192415237
mouse O 0 0.1024208590388298
embryo O 0 0.013007933273911476
. O 0 0.00748169282451272

Mutations O 0 0.00927748903632164
in O 0 0.003801519051194191
the O 0 0.007696257904171944
SMAD4 O 1 0.9999843835830688
/ O 1 0.9999827146530151
DPC4 O 1 0.9999986886978149
tumor B-Disease 1 0.999996542930603
suppressor O 1 0.9835272431373596
gene O 0 0.0017085528234019876
, O 0 0.0007208200986497104
a O 0 0.0008881327230483294
key O 0 0.0011786629911512136
signal O 0 0.0013623596169054508
transducer O 0 0.0021079881116747856
in O 0 0.0006081573665142059
most O 0 0.0006732443580403924
TGFbeta O 0 0.3769080936908722
- O 0 0.014407705515623093
related O 0 0.0011213377583771944
pathways O 0 0.0013019831385463476
, O 0 0.0005533532239496708
are O 0 0.0002929555776063353
involved O 0 0.0004963802639394999
in O 0 0.0004899374325759709
50 O 0 0.0010332404635846615
% O 0 0.001514188013970852
of O 0 0.004685596562922001
pancreatic B-Disease 1 0.9999972581863403
cancers I-Disease 1 0.9999597072601318
. O 0 0.018346641212701797

Homozygous O 0 0.12049537152051926
Smad4 O 1 0.9772214889526367
mutant O 0 0.4283595383167267
mice O 0 0.061864640563726425
die O 0 0.022872451692819595
before O 0 0.0031680730171501637
day O 0 0.004619699902832508
7 O 0 0.006927659269422293
. O 0 0.007359095849096775

5 O 0 0.03042520023882389
of O 0 0.019943842664361
embryogenesis O 0 0.3629467785358429
. O 0 0.025297746062278748

Mutant O 0 0.04540175572037697
embryos O 0 0.0065047163516283035
have O 0 0.0017200172878801823
reduced O 0 0.002441022777929902
size O 0 0.0013719843700528145
, O 0 0.0008993148803710938
fail O 0 0.0013938918709754944
to O 0 0.0007061265641823411
gastrulate O 0 0.004723242484033108
or O 0 0.0009027016349136829
express O 0 0.0016279086703434587
a O 0 0.0014131009811535478
mesodermal O 1 0.5181069374084473
marker O 0 0.034122828394174576
, O 0 0.0014667825307697058
and O 0 0.001800807542167604
show O 0 0.004618452861905098
abnormal O 1 0.7004907727241516
visceral O 1 0.9904143810272217
endoderm O 1 0.9988014698028564
development O 0 0.03153491020202637
. O 0 0.012877995148301125

Growth B-Disease 1 0.6354948282241821
retardation I-Disease 1 0.9987350106239319
of O 0 0.029856029897928238
the O 1 0.8074623346328735
Smad4 O 1 0.9999979734420776
- O 1 0.9999516010284424
deficient O 1 0.9984135627746582
embryos O 0 0.0021235498134046793
results O 0 0.000992115237750113
from O 0 0.0008532330393791199
reduced O 0 0.0020427843555808067
cell O 0 0.0021330215968191624
proliferation O 0 0.0029296232387423515
rather O 0 0.0013623544946312904
than O 0 0.0015664254315197468
increased O 0 0.005034947767853737
apoptosis O 0 0.013235900551080704
. O 0 0.008654116652905941

Aggregation O 0 0.01800922490656376
of O 0 0.00913307350128889
mutant O 1 0.928264856338501
Smad4 O 1 0.9991124272346497
ES O 1 0.9789533019065857
cells O 0 0.0030572963878512383
with O 0 0.0013585269916802645
wild O 0 0.005334923975169659
- O 1 0.5306373834609985
type O 0 0.1783377230167389
tetraploid O 1 0.8703316450119019
morulae O 1 0.89346843957901
rescues O 1 0.508267879486084
the O 0 0.008171924389898777
gastrulation B-Disease 1 0.9965170621871948
defect I-Disease 1 0.9822073578834534
. O 0 0.011929740197956562

These O 0 0.004351896233856678
results O 0 0.0031509269028902054
indicate O 0 0.002648404100909829
that O 0 0.0011186336632817984
Smad4 O 0 0.02374558337032795
is O 0 0.0008873482584021986
initially O 0 0.0009186153183691204
required O 0 0.0005138162523508072
for O 0 0.00040751657797954977
the O 0 0.0005246443906798959
differentiation O 0 0.0011537676909938455
of O 0 0.0007632439373992383
the O 0 0.0019769768696278334
visceral O 1 0.9618626236915588
endoderm O 1 0.9237437844276428
and O 0 0.0008720678742974997
that O 0 0.0006343463319353759
the O 0 0.0014141080901026726
gastrulation B-Disease 1 0.9813883304595947
defect I-Disease 1 0.6008772253990173
in O 0 0.0009908523643389344
the O 0 0.0018907187040895224
epiblast O 1 0.9947757720947266
is O 0 0.0015379267279058695
secondary O 0 0.003872317960485816
and O 0 0.0013825431233271956
non O 0 0.018811611458659172
- O 0 0.27661725878715515
cell O 0 0.0058882455341517925
autonomous O 0 0.007973347790539265
. O 0 0.007723849266767502

Rescued O 0 0.1999904364347458
embryos O 0 0.021036311984062195
show O 0 0.021118979901075363
severe O 1 0.999879002571106
anterior O 1 0.9999532699584961
truncations O 1 0.9999305009841919
, O 0 0.045554906129837036
indicating O 0 0.012062003836035728
a O 0 0.0015046296175569296
second O 0 0.0017095502698794007
important O 0 0.001000964897684753
role O 0 0.0015254637692123652
for O 0 0.0014152006478980184
Smad4 O 1 0.9095075130462646
in O 0 0.0036888462491333485
anterior O 1 0.9954236149787903
patterning O 1 0.971095085144043
during O 0 0.044115904718637466
embryogenesis O 1 0.9184734225273132
. O 0 0.010069864802062511

Prevalence O 0 0.42481160163879395
of O 0 0.008742239326238632
p16 O 1 0.7750648856163025
and O 0 0.004182950593531132
CDK4 O 1 0.9980165958404541
germline O 1 0.6973885893821716
mutations O 0 0.003416343592107296
in O 0 0.0019097349140793085
48 O 0 0.3789651691913605
melanoma B-Disease 1 0.9999996423721313
- O 1 0.9882310032844543
prone O 1 0.9453951120376587
families O 0 0.0030895068775862455
in O 0 0.0026879904326051474
France O 0 0.01247184444218874
. O 0 0.008061479777097702

The O 0 0.018138736486434937
French O 1 0.902404248714447
Familial B-Disease 1 0.9999935626983643
Melanoma I-Disease 1 0.9999998807907104
Study O 1 0.7854377031326294
Group O 0 0.39055055379867554
. O 0 0.015179337933659554

Germline O 0 0.4521695673465729
mutations O 0 0.006971222348511219
in O 0 0.0027474144008010626
the O 0 0.002550026634708047
p16 O 1 0.514918863773346
and O 0 0.001941443420946598
CDK4 O 1 0.9352194666862488
genes O 0 0.0012728712754324079
have O 0 0.0004941817023791373
been O 0 0.0005799253121949732
reported O 0 0.000672119902446866
in O 0 0.0004966531414538622
a O 0 0.0008673971751704812
subset O 0 0.0023704590275883675
of O 0 0.013092676177620888
melanoma B-Disease 1 0.9999994039535522
pedigrees O 1 0.6831923723220825
, O 0 0.0009064525365829468
but O 0 0.000567728653550148
their O 0 0.0006974282441660762
prevalence O 1 0.6341338157653809
is O 0 0.0009998268214985728
not O 0 0.0008339054184034467
well O 0 0.0014464104315266013
known O 0 0.0037598656490445137
. O 0 0.005323727149516344

We O 0 0.004566299729049206
searched O 0 0.005119513254612684
for O 0 0.0019122024532407522
such O 0 0.0013828802620992064
germline O 0 0.007800979074090719
mutations O 0 0.0017591905780136585
in O 0 0.0010689409682527184
48 O 0 0.004088281188160181
French O 1 0.9690892696380615
melanoma B-Disease 1 1.0
- O 1 0.9972549080848694
prone O 1 0.9428119659423828
families O 0 0.0008769037085585296
selected O 0 0.0007184747373685241
according O 0 0.0004411939880810678
to O 0 0.0002931019407697022
two O 0 0.0002906695008277893
major O 0 0.00047064063255675137
criteria O 0 0.0005199777660891414
families O 0 0.0003663247625809163
with O 0 0.0002686298103071749
at O 0 0.00042192506953142583
least O 0 0.00032690854277461767
three O 0 0.0003328104503452778
affected O 0 0.0004919480415992439
members O 0 0.00036724540404975414
( O 0 0.000596551108174026
n O 0 0.0010177841177210212
= O 0 0.001086830161511898
20 O 0 0.00047654518857598305
) O 0 0.00037208572030067444
or O 0 0.00028071505948901176
families O 0 0.00034503324422985315
with O 0 0.0002648085937835276
two O 0 0.00027279782807454467
affected O 0 0.00046839885180816054
members O 0 0.00030153372790664434
, O 0 0.00031527303508482873
one O 0 0.0003227526613045484
of O 0 0.0003202017687726766
them O 0 0.0002460568503011018
affected O 0 0.00039869415923021734
before O 0 0.00031603503157384694
the O 0 0.0003910643863491714
age O 0 0.0004581014800351113
of O 0 0.0004318529390729964
50 O 0 0.0007358966977335513
( O 0 0.0006774091743864119
n O 0 0.0011329373810440302
= O 0 0.001262887381017208
28 O 0 0.0008189927320927382
) O 0 0.0005849988083355129
, O 0 0.0005584504106082022
and O 0 0.0006586195668205619
one O 0 0.0010384273482486606
additional O 0 0.0020801853388547897
minor O 0 0.006226194091141224
criterion O 0 0.0221677515655756
. O 0 0.009440982714295387

Sixteen O 0 0.01371210627257824
different O 0 0.003571145236492157
p16 O 0 0.04970797523856163
germline O 0 0.04338618740439415
mutations O 0 0.0023240414448082447
were O 0 0.0009623217047192156
found O 0 0.0007747935596853495
in O 0 0.0006404811283573508
21 O 0 0.0009059138246811926
families O 0 0.0005918258684687316
, O 0 0.0005533332005143166
while O 0 0.000604982313234359
one O 0 0.000815489562228322
germline O 0 0.07651460915803909
mutation O 0 0.002054148120805621
, O 0 0.001115937135182321
Arg24His O 0 0.01641729474067688
, O 0 0.0011937310919165611
was O 0 0.0016271090134978294
detected O 0 0.002118245931342244
in O 0 0.0016382000176236033
the O 0 0.003579246113076806
CDK4 O 1 0.8514145016670227
gene O 0 0.010317152366042137
. O 0 0.009067680686712265

The O 0 0.005753292702138424
frequency O 0 0.004020287189632654
of O 0 0.0027676457539200783
p16 O 0 0.018041526898741722
gene O 0 0.0020049738232046366
mutation O 0 0.0014484712155535817
in O 0 0.0006219251663424075
our O 0 0.0007290557259693742
sample O 0 0.0009473584941588342
( O 0 0.0009348734747618437
44 O 0 0.0011575139360502362
% O 0 0.0006819504778832197
) O 0 0.0005468088784255087
is O 0 0.0004759590665344149
among O 0 0.0005005999119020998
the O 0 0.0006052095559425652
highest O 0 0.0014543639263138175
rates O 0 0.0009992840932682157
yet O 0 0.0006463726167567074
reported O 0 0.0008089473121799529
and O 0 0.0005062388954684138
the O 0 0.0008660403545945883
CDK4 O 1 0.864676833152771
mutation O 0 0.0016406242502853274
is O 0 0.0006196986068971455
the O 0 0.0007930449210107327
second O 0 0.001307265949435532
mutation O 0 0.0017068239394575357
detected O 0 0.0014510382898151875
in O 0 0.0007472799043171108
this O 0 0.0010055603925138712
gene O 0 0.002702459692955017
worldwide O 0 0.0038277748972177505
. O 0 0.004909891169518232

In O 0 0.004649439826607704
summary O 0 0.005012992769479752
, O 0 0.001953285885974765
our O 0 0.0014363136142492294
results O 0 0.001031969441100955
show O 0 0.0011573253432288766
frequent O 0 0.001271128305234015
involvement O 0 0.0014462273102253675
of O 0 0.0009000177960842848
the O 0 0.0019025474321097136
p16 O 1 0.7509973645210266
gene O 0 0.00235751667059958
in O 0 0.001642649876885116
familial B-Disease 1 0.9999666213989258
melanoma I-Disease 1 0.9999991655349731
and O 0 0.0016592335887253284
confirm O 0 0.0011745195370167494
the O 0 0.0007313848473131657
role O 0 0.0008185628685168922
of O 0 0.0006954225245863199
the O 0 0.0013139122165739536
CDK4 O 1 0.9272235631942749
gene O 0 0.0018319390946999192
as O 0 0.0013292819494381547
a O 0 0.014416219666600227
melanoma B-Disease 1 0.999998927116394
- O 1 0.990955650806427
predisposing O 1 0.9718989133834839
gene O 0 0.006271200254559517
. O 0 0.003513926640152931
. O 0 0.006943818181753159

Progression O 0 0.26947370171546936
of O 0 0.009321079589426517
somatic O 1 0.906706690788269
CTG O 1 0.990881085395813
repeat O 0 0.011223934590816498
length O 0 0.0032551437616348267
heterogeneity O 0 0.005163647700101137
in O 0 0.001458563725464046
the O 0 0.00325235677883029
blood O 1 0.9484485387802124
cells O 0 0.3683651387691498
of O 1 0.9757879376411438
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999977350234985
. O 0 0.3781517446041107

The O 0 0.006072984077036381
genetic O 0 0.005366830620914698
basis O 0 0.004479304887354374
of O 1 0.7883473038673401
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999959468841553
DM B-Disease 1 1.0
) O 0 0.004368999972939491
is O 0 0.0008233331609517336
the O 0 0.0006339018582366407
expansion O 0 0.0011141622671857476
of O 0 0.0009005496394820511
an O 0 0.001411634380929172
unstable O 0 0.4514491856098175
CTG O 1 0.8273570537567139
repeat O 0 0.002625107765197754
in O 0 0.0008670451934449375
the O 0 0.0010263436706736684
34 O 0 0.0017076602671295404
UTR O 0 0.005542637314647436
of O 0 0.0012927140342071652
the O 0 0.0027422821149230003
DM B-Disease 1 0.9999685287475586
protein O 0 0.0033344211988151073
kinase O 0 0.004485300276428461
gene O 0 0.0023416937328875065
on O 0 0.0024928972125053406
chromosome O 0 0.007180089130997658
19 O 0 0.007482588291168213
. O 0 0.009157083928585052

One O 0 0.003718725638464093
of O 0 0.002474797423928976
the O 0 0.0021164463832974434
principal O 0 0.0031378772109746933
features O 0 0.0015229303389787674
of O 0 0.002100380603224039
the O 0 0.4187963902950287
DM B-Disease 1 0.9999998807907104
mutation O 0 0.028303999453783035
is O 0 0.0007538443896919489
an O 0 0.0006899132858961821
extraordinarily O 0 0.003390298690646887
high O 0 0.0012918259017169476
level O 0 0.0010744541650637984
of O 0 0.0012891279766336083
somatic O 1 0.7644091248512268
mosaicism O 1 0.9464402794837952
, O 0 0.0008353329612873495
due O 0 0.000762834504712373
to O 0 0.00042833539191633463
an O 0 0.0004916286561638117
extremely O 0 0.0009677758789621294
high O 0 0.0009038015850819647
degree O 0 0.0011333919828757644
of O 0 0.0011864895932376385
somatic O 0 0.3252114951610565
instability O 0 0.04675701633095741
both O 0 0.0006402031285688281
within O 0 0.0006396645912900567
and O 0 0.000763751333579421
between O 0 0.001147196744568646
different O 0 0.0017444428522139788
tissues O 0 0.009009352885186672
. O 0 0.007538134697824717

This O 0 0.005427233874797821
instability O 0 0.0987231507897377
appears O 0 0.0028297242242842913
to O 0 0.0010655635269358754
be O 0 0.0006984736537560821
biased O 0 0.0012827703030779958
towards O 0 0.0009591480484232306
further O 0 0.0006890196236781776
expansion O 0 0.0009122872143052518
and O 0 0.0004711838555522263
continuous O 0 0.0009615361341275275
throughout O 0 0.00043888884829357266
the O 0 0.00046133153955452144
life O 0 0.0005528671899810433
of O 0 0.000468267360702157
an O 0 0.0004754813271574676
individual O 0 0.0004910239949822426
, O 0 0.0004616014484781772
features O 0 0.0004962385864928365
that O 0 0.0002948885376099497
could O 0 0.0002989697677548975
be O 0 0.000248722149990499
associated O 0 0.0003773182106669992
with O 0 0.00039816999924369156
the O 0 0.0006989120738580823
progressive O 0 0.031183335930109024
nature O 0 0.0022309867199510336
of O 0 0.004997910000383854
the O 0 0.2879793643951416
disease O 1 0.9999911785125732
. O 0 0.014786379411816597

Although O 0 0.007635158021003008
increasing O 0 0.006274952553212643
measured O 0 0.004144798964262009
allele O 0 0.0037699774838984013
size O 0 0.001999521628022194
between O 0 0.0015848412876948714
patients O 0 0.03256315737962723
clearly O 0 0.0016216387739405036
correlates O 0 0.0027061081491410732
with O 0 0.0006528286030516028
an O 0 0.0009323192643932998
increased O 0 0.0027006366290152073
severity O 1 0.8080345988273621
of O 0 0.014082900248467922
symptoms O 1 0.9997708201408386
and O 0 0.0010234329383820295
an O 0 0.000785154290497303
earlier O 0 0.0011323333019390702
age O 0 0.0016631726175546646
of O 0 0.0037366573233157396
onset O 1 0.9998630285263062
, O 0 0.0009872461669147015
this O 0 0.0004619304381776601
correlation O 0 0.000965702929534018
is O 0 0.0004323257599025965
not O 0 0.00028020565514452755
precise O 0 0.0006132856942713261
and O 0 0.0004609428287949413
measured O 0 0.0008911190670914948
allele O 0 0.0011038549710065126
length O 0 0.0006800635019317269
cannot O 0 0.0004961409140378237
be O 0 0.00028322855359874666
used O 0 0.00034612914896570146
as O 0 0.0004240601265337318
an O 0 0.0005344946403056383
accurate O 0 0.0013996949419379234
predictor O 0 0.003912636078894138
of O 0 0.0013660481199622154
age O 0 0.0031319628469645977
of O 0 0.005951120052486658
onset O 1 0.9998695850372314
. O 0 0.01312698982656002

In O 0 0.0046500046737492085
order O 0 0.0027674769517034292
to O 0 0.0015438683331012726
further O 0 0.0013515906175598502
characterize O 0 0.0027416078373789787
the O 0 0.001402421621605754
dynamics O 0 0.004882995039224625
of O 0 0.06482095271348953
DM B-Disease 1 1.0
CTG O 1 0.9999947547912598
repeat O 1 0.920360267162323
somatic O 0 0.2998387813568115
instability O 0 0.02410782128572464
, O 0 0.0008225803030654788
we O 0 0.00047251555952243507
have O 0 0.00035529109300114214
studied O 0 0.0008847874705679715
repeat O 0 0.0012181978672742844
length O 0 0.0007346607162617147
changes O 0 0.0004700681020040065
over O 0 0.0004663738945964724
time O 0 0.0006727732834406197
in O 0 0.0012198234908282757
111 O 1 0.9972956776618958
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.99945467710495
with O 0 0.002604926470667124
varying O 0 0.008134735748171806
clinical O 1 0.9952652454376221
severity O 1 0.997825026512146
and O 0 0.004290000069886446
CTG O 1 0.9896906614303589
repeat O 0 0.001997130922973156
size O 0 0.0007128976285457611
over O 0 0.0004987712018191814
time O 0 0.0004918972263112664
intervals O 0 0.0009246119880117476
of O 0 0.0008671205141581595
1 O 0 0.0018108859658241272
- O 0 0.003220431273803115
7 O 0 0.002872264012694359
years O 0 0.003499886253848672
. O 0 0.006360119208693504

We O 0 0.0038092515897005796
have O 0 0.0013793624239042401
found O 0 0.0011898028897121549
a O 0 0.0011015328345820308
direct O 0 0.0013303711311891675
progression O 0 0.013788385316729546
of O 0 0.000901820429135114
the O 0 0.0009419238194823265
size O 0 0.0010472658323124051
heterogeneity O 0 0.002309405943378806
over O 0 0.000665784056764096
time O 0 0.0005902005359530449
related O 0 0.0007277684053406119
to O 0 0.0005933435168117285
initial O 0 0.001688821124844253
CTG O 1 0.7184863090515137
repeat O 0 0.002306117909029126
size O 0 0.0009052623063325882
and O 0 0.0005551972426474094
the O 0 0.0006104008061811328
time O 0 0.0006269182777032256
interval O 0 0.0013386140344664454
and O 0 0.0007773581892251968
always O 0 0.0014549734769389033
biased O 0 0.0027669125702232122
towards O 0 0.002626062836498022
further O 0 0.003359102876856923
expansion O 0 0.009311306290328503
. O 0 0.00821285042911768

Attempts O 0 0.007792335934937
to O 0 0.002474794862791896
mathematically O 0 0.0034206779673695564
model O 0 0.0021545279305428267
the O 0 0.001223708619363606
dynamics O 0 0.0022085821256041527
have O 0 0.0006468064966611564
proved O 0 0.0014281525509431958
only O 0 0.0005972243379801512
partially O 0 0.0016539121279492974
successful O 0 0.0009553562849760056
suggesting O 0 0.0009266884881071746
that O 0 0.0003617048787418753
individual O 0 0.000529249373357743
specific O 0 0.0005779722123406827
genetic O 0 0.001163344830274582
and O 0 0.0008443116093985736
/ O 0 0.024994580075144768
or O 0 0.0007020322373136878
environmental O 0 0.0013532881857827306
factors O 0 0.0008504895376972854
also O 0 0.0006103916093707085
play O 0 0.0006778586539439857
a O 0 0.0010334919206798077
role O 0 0.0017753078136593103
in O 0 0.0020731347613036633
somatic O 0 0.3171161115169525
mosaicism O 1 0.9248740673065186
. O 0 0.004558527376502752
. O 0 0.00751014007255435

Aspartylglucosaminuria B-Disease 1 0.8740414977073669
among O 0 0.01679409295320511
Palestinian O 0 0.0240381620824337
Arabs O 0 0.02432367019355297
. O 0 0.017893897369503975

Aspartylglucosaminuria B-Disease 1 0.9996601343154907
( O 1 0.9064889550209045
AGU B-Disease 1 0.9999929666519165
) O 0 0.005239758640527725
is O 0 0.002019741339609027
a O 0 0.002886432223021984
rare O 0 0.4723425507545471
disorder B-Disease 1 0.999994158744812
of I-Disease 1 0.992506206035614
glycoprotein I-Disease 1 0.9999985694885254
metabolism I-Disease 1 0.9995792508125305
caused O 1 0.9434091448783875
by O 0 0.002369106048718095
the O 0 0.17254169285297394
deficiency B-Disease 1 0.9999988079071045
of I-Disease 0 0.3325938582420349
the I-Disease 1 0.9434378743171692
lysosomal I-Disease 1 0.9999995231628418
enzyme I-Disease 1 0.9984353184700012
aspartylglucosaminidase I-Disease 1 0.9995818734169006
( O 0 0.037587929517030716
AGA O 1 0.987514317035675
) O 0 0.007675623521208763
. O 0 0.009708999656140804

AGU B-Disease 1 0.9999665021896362
is O 0 0.01677362620830536
inherited O 1 0.9968674778938293
as O 0 0.012779912911355495
an O 0 0.2614215016365051
autosomal O 1 0.9999964237213135
recessive O 1 0.9999951124191284
trait O 1 0.9974499344825745
and O 0 0.010536972433328629
occurs O 0 0.002012444892898202
with O 0 0.0006142951315268874
a O 0 0.0010835907887667418
high O 0 0.0017220709705725312
frequency O 0 0.0007766296621412039
in O 0 0.0005129094352014363
Finland O 0 0.0015164728974923491
because O 0 0.0007210674812085927
of O 0 0.0011499460088089108
a O 0 0.0026168471667915583
founder O 0 0.17339561879634857
effect O 0 0.00842930655926466
. O 0 0.008867984637618065

While O 0 0.005615513771772385
very O 0 0.0029293617699295282
few O 0 0.00174859375692904
patients O 0 0.12568549811840057
with O 0 0.002345929853618145
AGU B-Disease 1 0.9999924898147583
have O 0 0.0007844431092962623
been O 0 0.000588990340474993
reported O 0 0.0007485421374440193
from O 0 0.0005644406192004681
non O 0 0.0016405124915763736
- O 0 0.0055171349085867405
Finnish O 0 0.022082097828388214
origin O 0 0.0007909159758128226
, O 0 0.0007317521958611906
we O 0 0.0009013840463012457
diagnosed O 1 0.9986644983291626
the O 0 0.0026250851806253195
disorder O 1 0.9998262524604797
in O 0 0.005194709636271
8 O 0 0.01103935670107603
patients O 0 0.07254784554243088
originating O 0 0.0010908662807196379
from O 0 0.0005651219398714602
3 O 0 0.0007007007370702922
unrelated O 0 0.0009691982413642108
families O 0 0.0004945106338709593
, O 0 0.00043191175791434944
all O 0 0.000372323818737641
Palestinian O 0 0.0009671463049016893
Arabs O 0 0.0011235831771045923
from O 0 0.0006569072720594704
the O 0 0.001065496471710503
region O 0 0.0020877616479992867
of O 0 0.003056851914152503
Jerusalem O 0 0.014729977585375309
. O 0 0.009843631647527218

The O 0 0.010862790048122406
clinical O 1 0.9766745567321777
diagnosis O 1 0.9999216794967651
of O 1 0.9862813353538513
AGU B-Disease 1 0.9999998807907104
is O 0 0.010619739070534706
often O 0 0.0008424013503827155
difficult O 0 0.0007888072868809104
, O 0 0.000475827808259055
in O 0 0.0003481767780613154
particular O 0 0.0003827364125754684
early O 0 0.0004119800287298858
in O 0 0.00031987682450562716
the O 0 0.00039678829489275813
course O 0 0.0008540907874703407
of O 0 0.0007368260994553566
the O 0 0.035835426300764084
disease O 1 0.9999383687973022
, O 0 0.0007284081075340509
and O 0 0.00039410783210769296
most O 0 0.00031431540264748037
of O 0 0.0005785026587545872
the O 0 0.008031974546611309
patients O 1 0.9545428156852722
are O 0 0.0006266272976063192
diagnosed O 1 0.9985381364822388
after O 0 0.001320251845754683
the O 0 0.0010613539488986135
age O 0 0.0015125774079933763
of O 0 0.0015020516002550721
5 O 0 0.0030116562265902758
years O 0 0.0034251802135258913
. O 0 0.00547325424849987

However O 0 0.004805288277566433
, O 0 0.0024629586841911077
since O 0 0.0018102653557434678
these O 0 0.0011615476105362177
patients O 0 0.1585431694984436
excrete O 0 0.14869897067546844
early O 0 0.0011853103060275316
large O 0 0.0007806965732015669
amounts O 0 0.0009033373789861798
of O 0 0.0009263565298169851
aspartylglucosamine O 0 0.17879000306129456
in O 0 0.0009078570874407887
urine O 0 0.0030619751196354628
, O 0 0.0008426494896411896
biochemical O 0 0.002201273338869214
screening O 0 0.0018500561127439141
is O 0 0.0009114735294133425
easy O 0 0.0016837615985423326
by O 0 0.0012794658541679382
urine O 0 0.005056772846728563
chromatography O 0 0.01808970794081688
. O 0 0.004423691891133785
. O 0 0.00805322639644146

Detection O 0 0.012953176163136959
of O 0 0.004565469920635223
heterozygous O 0 0.006742146797478199
carriers O 0 0.003864716272801161
of O 0 0.002554996870458126
the O 0 0.17445038259029388
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999895095825195
telangiectasia I-Disease 1 0.9999994039535522
( O 0 0.09234076738357544
ATM O 0 0.013983597978949547
) O 0 0.0011528593022376299
gene O 0 0.0011595633113756776
by O 0 0.0009426096803508699
G2 O 1 0.9438011050224304
phase O 0 0.02341701090335846
chromosomal O 1 0.731117308139801
radiosensitivity O 1 0.9779455661773682
of O 0 0.17144179344177246
peripheral O 1 0.9999850988388062
blood O 1 0.9997734427452087
lymphocytes O 1 0.9945488572120667
. O 0 0.009179960936307907

In O 0 0.013287559151649475
ataxia B-Disease 1 0.9999971389770508
- I-Disease 1 0.9998422861099243
telangiectasia I-Disease 1 0.9999982118606567
( O 1 0.7952722311019897
A B-Disease 1 0.994981586933136
- I-Disease 1 0.9999443292617798
T I-Disease 1 0.9999459981918335
) O 0 0.0017992210341617465
patients O 0 0.008766921237111092
, O 0 0.0005118220578879118
mutations O 0 0.0006764688878320158
in O 0 0.0003847013576887548
a O 0 0.000535204482730478
single O 0 0.0006119958125054836
gene O 0 0.0006050048395991325
, O 0 0.000448347011115402
ATM O 0 0.0012678588973358274
, O 0 0.0004793842963408679
result O 0 0.0005793105228804052
in O 0 0.0007032533176243305
an O 0 0.10687622427940369
autosomal B-Disease 1 0.9999995231628418
recessive I-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
that O 0 0.03786254674196243
embraces O 1 0.7982758283615112
a O 0 0.0015414752997457981
variety O 0 0.0009446321055293083
of O 0 0.0014019013615325093
clinical O 1 0.9637749791145325
features O 0 0.007282917387783527
and O 0 0.001336842542514205
manifests O 0 0.3603036105632782
extreme O 0 0.18206392228603363
radiosensitivity O 1 0.6585054993629456
and O 0 0.0008469929452985525
a O 0 0.0013550613075494766
strong O 0 0.002148926956579089
pre O 0 0.14879369735717773
- O 0 0.47716107964515686
disposition O 0 0.21317528188228607
to O 0 0.00389925017952919
malignancy B-Disease 1 0.9892143607139587
. O 0 0.008786622434854507

Heterozygotes O 0 0.055806852877140045
for O 0 0.004383108578622341
the O 0 0.003446195274591446
ATM O 0 0.009724038653075695
gene O 0 0.001885956502519548
have O 0 0.0006765565485693514
no O 0 0.0007420635665766895
clinical O 0 0.0017629610374569893
expression O 0 0.0011896153446286917
of O 0 0.0019437882583588362
A B-Disease 1 0.9944394826889038
- I-Disease 1 0.9998186230659485
T I-Disease 1 0.9996591806411743
but O 0 0.000651082955300808
may O 0 0.000664148130454123
be O 0 0.0006533103878609836
cancer B-Disease 1 0.8961579203605652
prone O 0 0.144148588180542
with O 0 0.0008106406312435865
a O 0 0.0018461250001564622
moderate O 0 0.020685497671365738
increase O 0 0.00127496849745512
in O 0 0.0009659500210545957
in O 0 0.0020753289572894573
vitro O 0 0.04184824973344803
radiosensitivity O 1 0.5917571187019348
. O 0 0.009302350692451

We O 0 0.005280895158648491
performed O 0 0.004239410627633333
a O 0 0.00284366006962955
blind O 0 0.008540033362805843
chromosomal O 0 0.005388286896049976
analysis O 0 0.0018503430765122175
on O 0 0.001877094735391438
G2 O 1 0.9988290667533875
- O 0 0.027156878262758255
phase O 0 0.004551844671368599
lymphocytes O 0 0.0030420320108532906
from O 0 0.0006866443436592817
7 O 0 0.0012179686455056071
unrelated O 0 0.0021063925232738256
A B-Disease 0 0.3092038929462433
- I-Disease 1 0.9946651458740234
T I-Disease 1 0.9969788789749146
patients O 0 0.00897179264575243
, O 0 0.000699067662935704
13 O 0 0.0011020860401913524
obligate O 0 0.002966854255646467
A B-Disease 0 0.19119051098823547
- I-Disease 1 0.9938490986824036
T I-Disease 1 0.9993380904197693
heterozygotes O 0 0.23483745753765106
( O 0 0.0008226727950386703
parents O 0 0.0005745457601733506
of O 0 0.0004848689422942698
the O 0 0.000863543595187366
patients O 0 0.2055639773607254
) O 0 0.0005017959629185498
, O 0 0.00038745030178688467
and O 0 0.0003579590702429414
14 O 0 0.0005433927290141582
normal O 0 0.0006571834674105048
controls O 0 0.0007691415958106518
following O 0 0.0007855937001295388
X O 0 0.0022298586554825306
- O 0 0.001876050722785294
irradiation O 0 0.0021501630544662476
with O 0 0.0007938875933177769
1 O 0 0.0013963497476652265
Gy O 0 0.007645182311534882
in O 0 0.0006582608912140131
order O 0 0.00061210518470034
to O 0 0.000471538573037833
evaluate O 0 0.0011543558211997151
this O 0 0.000557481951545924
cytogenetic O 0 0.003004558617249131
method O 0 0.0010837699519470334
as O 0 0.0007035441813059151
a O 0 0.0009686723933555186
tool O 0 0.0020727829542011023
for O 0 0.0012141873594373465
detection O 0 0.0037665546406060457
of O 0 0.0033430783078074455
ATM O 0 0.05928125977516174
carriers O 0 0.01081784162670374
. O 0 0.007904872298240662

Both O 0 0.007211627438664436
A B-Disease 1 0.9149059653282166
- I-Disease 1 0.9995808005332947
T I-Disease 1 0.9998712539672852
homozygotes O 1 0.9735053777694702
and O 0 0.002447264501824975
heterozygotes O 0 0.480301171541214
showed O 0 0.0030513356905430555
significantly O 0 0.0015862989239394665
increased O 0 0.001145523856393993
levels O 0 0.001278265961445868
of O 0 0.0015812397468835115
radiation O 1 0.9844056963920593
- O 1 0.9951262474060059
induced O 1 0.9995599389076233
chromatid O 1 0.9998550415039062
damage O 0 0.07442814111709595
relative O 0 0.001465176115743816
to O 0 0.0006506744539365172
that O 0 0.000703423167578876
of O 0 0.0015044492902234197
normal O 0 0.003596940543502569
controls O 0 0.006327860057353973
. O 0 0.006097891367971897

These O 0 0.0041431342251598835
results O 0 0.0027682827785611153
show O 0 0.001895147725008428
that O 0 0.001001269556581974
the O 0 0.002226677257567644
G2 O 1 0.9998749494552612
- O 1 0.7412998676300049
phase O 0 0.21147048473358154
chromosomal O 0 0.4475324749946594
radiosensitivity O 0 0.4331972897052765
assay O 0 0.002555587561801076
can O 0 0.0005468213348649442
be O 0 0.00038336124271154404
used O 0 0.00044359799358062446
for O 0 0.0003880431759171188
the O 0 0.0006493369583040476
detection O 0 0.001854854985140264
of O 0 0.0018867186736315489
A B-Disease 1 0.958313524723053
- I-Disease 1 0.9996650218963623
T I-Disease 1 0.9995900988578796
heterozygotes O 1 0.7588111162185669
. O 0 0.009326347149908543

In O 0 0.004262575879693031
combination O 0 0.004536835476756096
with O 0 0.001343305571936071
molecular O 0 0.0024925298057496548
genetic O 0 0.0023940918035805225
analyses O 0 0.0015683553647249937
, O 0 0.0006997939199209213
this O 0 0.0004882665234617889
test O 0 0.0006013138918206096
may O 0 0.0004131809691898525
be O 0 0.0002496530069038272
of O 0 0.00028784089954569936
value O 0 0.00041142074041999876
in O 0 0.0003664148389361799
studies O 0 0.0006407416076399386
of O 0 0.0008995068492367864
familial B-Disease 1 0.99683678150177
and I-Disease 0 0.006119068246334791
sporadic I-Disease 1 0.8693847060203552
cancers I-Disease 1 0.9931848645210266
aimed O 0 0.0018509016372263432
at O 0 0.0011495955986902118
determination O 0 0.0016157765639945865
of O 0 0.0006879960419610143
the O 0 0.0007320981821976602
potential O 0 0.0010726582258939743
involvement O 0 0.0015998641029000282
of O 0 0.001273258589208126
ATM O 1 0.6195194721221924
mutations O 0 0.00634319381788373
in O 0 0.0019522291840985417
tumor B-Disease 1 0.9991925358772278
risk O 0 0.08077748864889145
or O 0 0.0015266882255673409
development O 0 0.003369599347934127
. O 0 0.0027447370812296867
. O 0 0.005724731367081404

Ataxia B-Disease 1 0.999997615814209
- I-Disease 1 0.9997991919517517
telangiectasia I-Disease 1 0.9999775886535645
: O 0 0.00543219642713666
identification O 0 0.003016285365447402
and O 0 0.001266350969672203
detection O 0 0.002504636300727725
of O 0 0.0017285806825384498
founder O 1 0.9582797884941101
- O 1 0.5196260213851929
effect O 0 0.0015138144372031093
mutations O 0 0.001085755997337401
in O 0 0.0006286455900408328
the O 0 0.0011043550912290812
ATM O 0 0.004626069683581591
gene O 0 0.0019365416374057531
in O 0 0.0013478536857292056
ethnic O 0 0.0035284056793898344
populations O 0 0.006349056959152222
. O 0 0.007786656729876995

To O 0 0.005206129048019648
facilitate O 0 0.00460414495319128
the O 0 0.002681606449186802
evaluation O 0 0.0042140670120716095
of O 0 0.0026832011062651873
ATM O 0 0.31703269481658936
heterozygotes O 0 0.3940385580062866
for O 0 0.0012158815516158938
susceptibility O 0 0.08068501949310303
to O 0 0.0007529092254117131
other O 0 0.0007090579601936042
diseases O 1 0.9975695013999939
, O 0 0.0011843255488201976
such O 0 0.001243956619873643
as O 1 0.6510291695594788
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999871253967285
, O 0 0.0016378303989768028
we O 0 0.0005285496590659022
have O 0 0.00032449091668240726
attempted O 0 0.0007561380625702441
to O 0 0.00043163684313185513
define O 0 0.0007552655879408121
the O 0 0.0004090340808033943
most O 0 0.00035345982178114355
common O 0 0.0005033830530010164
mutations O 0 0.0006269161240197718
and O 0 0.0003567433450371027
their O 0 0.00037699422682635486
frequencies O 0 0.0007532484014518559
in O 0 0.0009722242830321193
ataxia B-Disease 1 0.999992847442627
- I-Disease 1 0.998883068561554
telangiectasia I-Disease 1 0.9999973773956299
( O 0 0.20158109068870544
A B-Disease 1 0.9431036710739136
- I-Disease 1 0.9971696734428406
T I-Disease 1 0.9961584210395813
) O 0 0.0017835980979725718
homozygotes O 0 0.007592272479087114
from O 0 0.001482912339270115
10 O 0 0.0023354627192020416
ethnic O 0 0.004003412090241909
populations O 0 0.008372785523533821
. O 0 0.010061035864055157

Both O 0 0.006517794914543629
genomic O 0 0.011350267566740513
mutations O 0 0.00449485145509243
and O 0 0.0018489883514121175
their O 0 0.0015517096035182476
effects O 0 0.004012326244264841
on O 0 0.002470872364938259
cDNA O 0 0.009864138439297676
were O 0 0.003271528286859393
characterized O 0 0.014904900453984737
. O 0 0.009353317320346832

Protein O 0 0.0139327896758914
- O 0 0.011604470200836658
truncation O 0 0.010097548365592957
testing O 0 0.0029139870312064886
of O 0 0.0018047034973278642
the O 0 0.0014642466558143497
entire O 0 0.0024484386667609215
ATM O 0 0.004118318669497967
cDNA O 0 0.003998031374067068
detected O 0 0.002009551040828228
92 O 0 0.00225472473539412
( O 0 0.0012195503804832697
66 O 0 0.001898347050882876
% O 0 0.0010783589677885175
) O 0 0.0010552493622526526
truncating O 0 0.004150476772338152
mutations O 0 0.0017293080454692245
in O 0 0.001293563167564571
140 O 0 0.004763712640851736
mutant O 0 0.010354319587349892
alleles O 0 0.009721862152218819
screened O 0 0.012382104061543941
. O 0 0.007454198785126209

The O 0 0.009892765432596207
haplotyping O 1 0.6265138387680054
of O 0 0.007560667581856251
patients O 1 0.959953248500824
with O 0 0.0019527615513652563
identical O 0 0.02067679539322853
mutations O 0 0.009189850650727749
indicates O 0 0.0016399387968704104
that O 0 0.0004180284740868956
almost O 0 0.0004698924894910306
all O 0 0.00029628374613821507
of O 0 0.0003553612041287124
these O 0 0.0003455730911809951
represent O 0 0.0006323073175735772
common O 0 0.000720171257853508
ancestry O 0 0.001139946049079299
and O 0 0.0005460771499201655
that O 0 0.00045717053581029177
very O 0 0.000821064633782953
few O 0 0.00106289132963866
spontaneously O 0 0.005455030128359795
recurring O 0 0.49331673979759216
ATM O 0 0.04195794463157654
mutations O 0 0.00572335347533226
exist O 0 0.00425336929038167
. O 0 0.00608876021578908

Assays O 0 0.015175895765423775
requiring O 0 0.006836174987256527
minimal O 0 0.005165138281881809
amounts O 0 0.0025863833725452423
of O 0 0.0017226090421900153
genomic O 0 0.0036030325572937727
DNA O 0 0.0015237514162436128
were O 0 0.0007120098453015089
designed O 0 0.0010286194738000631
to O 0 0.0005651984247379005
allow O 0 0.0007816062425263226
rapid O 0 0.002169400453567505
screening O 0 0.0018105400959029794
for O 0 0.0010586264543235302
common O 0 0.0021377750672399998
ethnic O 0 0.004821327514946461
mutations O 0 0.009645259939134121
. O 0 0.007070273160934448

These O 0 0.00593170989304781
rapid O 0 0.008863396942615509
assays O 0 0.006085468456149101
detected O 0 0.004045872949063778
mutations O 0 0.0020150640048086643
in O 0 0.0008672476978972554
76 O 0 0.0018932456150650978
% O 0 0.0008109083864837885
of O 0 0.0006716729258187115
Costa O 0 0.004670577123761177
Rican O 0 0.08325326442718506
patients O 0 0.24132516980171204
( O 0 0.0011828797869384289
3 O 0 0.0007331775850616395
) O 0 0.0004481100768316537
, O 0 0.00033683216315694153
50 O 0 0.0004565647686831653
% O 0 0.000456525624031201
of O 0 0.000465579068986699
Norwegian O 0 0.0016556506743654609
patients O 0 0.002950492314994335
( O 0 0.0007788448710925877
1 O 0 0.000653355848044157
) O 0 0.00043005438055843115
, O 0 0.0003522808838170022
25 O 0 0.00045017697266303003
% O 0 0.0004031891003251076
of O 0 0.00048316208994947374
Polish O 0 0.06423642486333847
patients O 0 0.074335016310215
( O 0 0.0009517998551018536
4 O 0 0.0007054869784042239
) O 0 0.0003558651660569012
, O 0 0.0002970451314467937
and O 0 0.0002801922964863479
14 O 0 0.0005403614486567676
% O 0 0.0004226667806506157
of O 0 0.0004887937102466822
Italian O 0 0.06576435267925262
patients O 1 0.7605948448181152
( O 0 0.001549609238281846
1 O 0 0.0009740656241774559
) O 0 0.0004341245221439749
, O 0 0.0003027326019946486
as O 0 0.00034641637466847897
well O 0 0.00041617077658884227
as O 0 0.0004482045187614858
in O 0 0.0005348672275431454
patients O 0 0.002983181970193982
of O 0 0.0018404339207336307
Amish O 1 0.8886324167251587
/ O 1 0.8426445126533508
Mennonite O 0 0.07446563243865967
and O 0 0.0016758148558437824
Irish O 0 0.004595490638166666
English O 0 0.004987881984561682
backgrounds O 0 0.008986013941466808
. O 0 0.009302938356995583

Additional O 0 0.006815741304308176
mutations O 0 0.0038641856517642736
were O 0 0.0013389608357101679
observed O 0 0.0014010025188326836
in O 0 0.000896371144335717
Japanese O 0 0.002176416339352727
, O 0 0.00113129080273211
Utah O 0 0.002826856914907694
Mormon O 0 0.0032146212179213762
, O 0 0.001494410913437605
and O 0 0.0017483099363744259
African O 0 0.00482746260240674
American O 0 0.008701696991920471
patients O 1 0.524616539478302
. O 0 0.010002260096371174

These O 0 0.004912803415209055
assays O 0 0.0066036926582455635
should O 0 0.0022401539608836174
facilitate O 0 0.0026926600839942694
screening O 0 0.0032508578151464462
for O 0 0.0015984601341187954
A B-Disease 1 0.5679527521133423
- I-Disease 1 0.9980049729347229
T I-Disease 1 0.9982165694236755
heterozygotes O 0 0.06996157765388489
in O 0 0.0009598913602530956
the O 0 0.0011768534313887358
populations O 0 0.00180533726233989
studied O 0 0.0030552679672837257
. O 0 0.0029241321608424187
. O 0 0.006789613515138626

The O 0 0.012267629615962505
von B-Disease 1 0.9804933667182922
Hippel I-Disease 1 0.9999605417251587
- I-Disease 1 0.9999682903289795
Lindau I-Disease 1 0.9999986886978149
tumor I-Disease 1 0.9999947547912598
suppressor O 1 0.9874073266983032
gene O 0 0.002359268954023719
is O 0 0.0009521295432932675
required O 0 0.0008261642651632428
for O 0 0.00106690579559654
cell O 0 0.002649193862453103
cycle O 0 0.004477333277463913
exit O 0 0.0058914730325341225
upon O 0 0.005136081948876381
serum O 0 0.1770060807466507
withdrawal O 0 0.01498446799814701
. O 0 0.009944462217390537

The O 0 0.007533769588917494
inactivation O 0 0.015776658430695534
of O 0 0.003381341462954879
the O 0 0.004459429066628218
von B-Disease 1 0.9981644749641418
Hippel I-Disease 1 0.9999924898147583
- I-Disease 1 0.9999535083770752
Lindau I-Disease 1 0.9999971389770508
( I-Disease 1 0.9699127078056335
VHL I-Disease 1 0.9999966621398926
) I-Disease 1 0.5753345489501953
tumor I-Disease 1 0.9999244213104248
suppressor O 1 0.97506183385849
gene O 0 0.002860036212950945
predisposes O 0 0.0177085492759943
affected O 0 0.0009934712434187531
individuals O 0 0.0005090029444545507
to O 0 0.0006434617680497468
the O 0 0.0017418904462829232
human O 1 0.9849224090576172
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.25611791014671326
is O 0 0.011532856151461601
associated O 0 0.0024071144871413708
with O 0 0.005837931297719479
sporadic B-Disease 1 0.9997103810310364
renal I-Disease 1 1.0
cell I-Disease 1 0.9999935626983643
carcinomas I-Disease 1 1.0
( O 1 0.9997422099113464
RCC B-Disease 1 0.9999996423721313
) O 0 0.007156193256378174
and O 0 0.003682731883600354
brain B-Disease 1 0.5202451348304749
hemangioblastomas I-Disease 1 0.7882276773452759
. O 0 0.009155742824077606

VHL O 1 0.9965251088142395
- O 0 0.3343891203403473
negative O 0 0.01513636950403452
786 O 1 0.9928262233734131
- O 1 0.9543310403823853
0 O 0 0.015418064780533314
RCC B-Disease 1 0.9985254406929016
cells O 0 0.0020145224407315254
are O 0 0.0007328863139264286
tumorigenic O 0 0.004206566140055656
in O 0 0.0010111015290021896
nude O 0 0.07122669368982315
mice O 0 0.0030663744546473026
which O 0 0.0006459129508584738
is O 0 0.0008736951858736575
suppressed O 0 0.0026606277097016573
by O 0 0.001054015476256609
the O 0 0.001971206162124872
reintroduction O 0 0.02016548067331314
of O 0 0.007341224700212479
VHL B-Disease 1 0.999619722366333
. O 0 0.009645805694162846

Remarkably O 0 0.059752993285655975
, O 0 0.003150703851133585
this O 0 0.0014036335051059723
occurs O 0 0.0014331697020679712
without O 0 0.0008433660841546953
affecting O 0 0.001596476649865508
the O 0 0.0010965154506266117
growth O 0 0.004932350944727659
rate O 0 0.0011827468406409025
and O 0 0.0005963242729194462
cell O 0 0.0010925042442977428
cycle O 0 0.001518124365247786
profile O 0 0.001031694351695478
of O 0 0.0006902401801198721
these O 0 0.000623297062702477
cells O 0 0.0013632759219035506
in O 0 0.001567427534610033
culture O 0 0.006024204194545746
. O 0 0.00674663158133626

The O 0 0.009913749992847443
786 O 1 0.7020882368087769
- O 0 0.04318797215819359
0 O 0 0.0044989073649048805
cell O 0 0.003137510269880295
line O 0 0.0021001086570322514
, O 0 0.0010781185701489449
like O 0 0.0011644823243841529
many O 0 0.0011830792063847184
cancer B-Disease 1 0.9992627501487732
cells O 0 0.004447121638804674
, O 0 0.0007902240031398833
fails O 0 0.0016536618350073695
to O 0 0.0006897324346937239
exit O 0 0.0018181223422288895
the O 0 0.0011713337153196335
cell O 0 0.0025705648586153984
cycle O 0 0.004252557642757893
upon O 0 0.004297775682061911
serum O 0 0.3337375521659851
withdrawal O 0 0.010981637053191662
. O 0 0.009002012200653553

Here O 0 0.005425975192338228
, O 0 0.002517612185329199
it O 0 0.0011121686547994614
is O 0 0.0009007632615976036
shown O 0 0.0008886503637768328
that O 0 0.0005269568064250052
reintroduction O 0 0.0014168141642585397
of O 0 0.0005773624288849533
the O 0 0.0008149138884618878
wild O 0 0.0029016288463026285
- O 0 0.4346749484539032
type O 0 0.08605172485113144
VHL B-Disease 1 0.9895960688591003
gene O 0 0.0017597113037481904
restores O 0 0.002770937979221344
the O 0 0.0008247951627708972
ability O 0 0.0010453833965584636
of O 0 0.0017433279426768422
VHL O 1 0.9999881982803345
- O 1 0.9974879026412964
negative O 1 0.8906875848770142
RCC B-Disease 1 0.9999985694885254
cancer I-Disease 1 0.9978626370429993
cells O 0 0.0014019676018506289
to O 0 0.0005965405143797398
exit O 0 0.0013297342229634523
the O 0 0.0008432849426753819
cell O 0 0.0015458378475159407
cycle O 0 0.0021962225437164307
and O 0 0.0013778886059299111
enter O 0 0.004361501894891262
G0 O 1 0.9981716871261597
/ O 0 0.27536335587501526
quiescence O 0 0.08080847561359406
in O 0 0.003823651699349284
low O 0 0.01460590772330761
serum O 0 0.4485494792461395
. O 0 0.01164760161191225

Both O 0 0.008401255123317242
VHL O 1 0.995736837387085
- O 0 0.06489630788564682
positive O 0 0.004263314884155989
and O 0 0.0033862958662211895
VHL O 1 0.9999401569366455
- O 1 0.982857346534729
negative O 0 0.19767165184020996
RCC B-Disease 1 0.9999324083328247
cells O 0 0.0024457494728267193
exit O 0 0.0021343545522540808
the O 0 0.0013351712841540575
cell O 0 0.002423632889986038
cycle O 0 0.0034772756043821573
by O 0 0.0018400871194899082
contact O 0 0.004658829886466265
inhibition O 0 0.015998026356101036
. O 0 0.008033654652535915

The O 0 0.016864554956555367
cyclin O 1 0.9816579818725586
- O 1 0.8378592133522034
dependent O 0 0.020455017685890198
kinase O 0 0.152494877576828
inhibitor O 1 0.6510342955589294
, O 0 0.0029057511128485203
p27 O 0 0.2317797690629959
, O 0 0.001895200228318572
accumulates O 0 0.0054133301600813866
upon O 0 0.0017577777616679668
serum O 0 0.20575562119483948
withdrawal O 0 0.001980426022782922
, O 0 0.0006124016363173723
only O 0 0.0004226250748615712
in O 0 0.00038718883297406137
the O 0 0.0005004026461392641
presence O 0 0.0007563502877019346
of O 0 0.0011602593585848808
VHL B-Disease 1 0.9996122717857361
, O 0 0.0007116154301911592
as O 0 0.0005107347969897091
a O 0 0.0005709095858037472
result O 0 0.0005980315036140382
of O 0 0.0006565116927959025
the O 0 0.0011615809053182602
stabilization O 0 0.06465607136487961
of O 0 0.0020553707145154476
the O 0 0.0030719770584255457
protein O 0 0.0061439042910933495
. O 0 0.005939078517258167

We O 0 0.004480916541069746
propose O 0 0.005134741775691509
that O 0 0.0013119664508849382
the O 0 0.0010881698690354824
loss O 0 0.0020733557175844908
of O 0 0.001566887367516756
wild O 0 0.3345526456832886
- O 1 0.9897155165672302
type O 1 0.7434191703796387
VHL B-Disease 1 0.9964742064476013
gene O 0 0.001194083713926375
results O 0 0.0005853273905813694
in O 0 0.0003762034757528454
a O 0 0.0005244924104772508
specific O 0 0.0005282019847072661
cellular O 0 0.0019230098696425557
defect O 1 0.7713408470153809
in O 0 0.002049843082204461
serum O 1 0.9994816184043884
- O 1 0.6471388936042786
dependent O 0 0.0017759401816874743
growth O 0 0.001227942993864417
control O 0 0.0009681276278570294
, O 0 0.0008565781754441559
which O 0 0.0009607317624613643
may O 0 0.0019763263408094645
initiate O 0 0.008272133767604828
tumor B-Disease 1 0.9271262884140015
formation O 0 0.018749931827187538
. O 0 0.007727164775133133

This O 0 0.004884518217295408
is O 0 0.0033398231025785208
corrected O 0 0.0047851307317614555
by O 0 0.0011304417857900262
the O 0 0.0012241196818649769
reintroduction O 0 0.0037153137382119894
of O 0 0.0012135005090385675
wild O 0 0.028583580628037453
- O 1 0.9331814646720886
type O 1 0.8426241278648376
VHL B-Disease 1 0.9998032450675964
, O 0 0.0017946416046470404
implicating O 1 0.9352709650993347
VHL B-Disease 1 0.9976516366004944
as O 0 0.0009441965958103538
the O 0 0.0011484355200082064
first O 0 0.004289017990231514
tumor B-Disease 1 0.993687093257904
suppressor O 0 0.04340056702494621
involved O 0 0.0006472060340456665
in O 0 0.0004385273205116391
the O 0 0.0005082724965177476
regulation O 0 0.0006922949105501175
of O 0 0.0006376756937243044
cell O 0 0.0022910067345947027
cycle O 0 0.0029720214661210775
exit O 0 0.0016497373580932617
, O 0 0.0005066226585768163
which O 0 0.00035699596628546715
is O 0 0.0004230922495480627
consistent O 0 0.0006836925749666989
with O 0 0.0004418404714670032
its O 0 0.0006916129495948553
gatekeeper O 0 0.4893896281719208
function O 0 0.0013644113205373287
in O 0 0.0012693075696006417
the O 0 0.0037241531535983086
kidney O 1 0.9998047947883606
. O 0 0.004303211346268654
. O 0 0.007089447230100632

Piebaldism B-Disease 1 0.998960018157959
with O 0 0.015283532440662384
deafness B-Disease 1 0.9999409914016724
: O 0 0.004003495909273624
molecular O 0 0.0035470728762447834
evidence O 0 0.002614891156554222
for O 0 0.0020671547390520573
an O 0 0.00387390935793519
expanded O 1 0.5692043900489807
syndrome O 1 0.9999986886978149
. O 0 0.014588979072868824

In O 0 0.004306460730731487
a O 0 0.0037701893597841263
South O 0 0.0036044232547283173
African O 0 0.0037471347022801638
girl O 0 0.03094620071351528
of O 0 0.005751988850533962
Xhosa O 1 0.9999649524688721
stock O 1 0.6525178551673889
with O 0 0.07345578819513321
severe O 1 0.999997615814209
piebaldism B-Disease 1 0.9999978542327881
and O 1 0.9947484135627747
profound O 1 0.9999996423721313
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.2321392446756363
identified O 0 0.012535260990262032
a O 0 0.0018581039039418101
novel O 0 0.017775943502783775
missense O 0 0.012260986492037773
substitution O 0 0.002092310693114996
at O 0 0.0009861815487965941
a O 0 0.0009351460612379014
highly O 0 0.0011144950985908508
conserved O 0 0.0015079028671607375
residue O 0 0.0019141965312883258
in O 0 0.0008355183526873589
the O 0 0.001063518924638629
intracellular O 0 0.0029933026526123285
kinase O 0 0.002470300067216158
domain O 0 0.0012109579984098673
of O 0 0.0011674156412482262
the O 0 0.0023104872088879347
KIT O 1 0.9990122318267822
proto O 1 0.9992210865020752
- O 1 0.9688186049461365
oncogene O 1 0.988150954246521
, O 0 0.005414356477558613
R796G O 0 0.07692879438400269
. O 0 0.009569987654685974

Though O 0 0.01036631129682064
auditory B-Disease 0 0.18765009939670563
anomalies I-Disease 0 0.0701766237616539
have O 0 0.0012532209511846304
been O 0 0.0009379238472320139
observed O 0 0.0010051612043753266
in O 0 0.0007125305710360408
mice O 0 0.0015854021767154336
with O 0 0.0005981115973554552
dominant O 0 0.003357015084475279
white O 0 0.01536115724593401
spotting O 1 0.9178438186645508
( O 0 0.02378380112349987
W O 1 0.6175865530967712
) O 0 0.0009452379890717566
due O 0 0.0009405284654349089
to O 0 0.0008816124172881246
KIT O 1 0.9945959448814392
mutations O 0 0.013159595429897308
, O 0 0.0019736597314476967
deafness B-Disease 1 0.9995445609092712
is O 0 0.0011757329339161515
not O 0 0.0007327285129576921
typical O 0 0.002028983784839511
in O 0 0.0019215221982449293
human O 0 0.00557970255613327
piebaldism B-Disease 1 0.7618122100830078
. O 0 0.00920170359313488

Thus O 0 0.006439079064875841
, O 0 0.0032444302923977375
the O 0 0.002864381531253457
occurrence O 0 0.048740312457084656
of O 1 0.6953571438789368
sensorineural B-Disease 1 0.9999998807907104
deafness I-Disease 1 1.0
in O 0 0.47789761424064636
this O 0 0.012984531931579113
patient O 1 0.9664270281791687
extends O 0 0.0036416102666407824
considerably O 0 0.0012444306630641222
the O 0 0.000718362454790622
phenotypic O 0 0.0016163659747689962
range O 0 0.0009224473033100367
of O 0 0.001021203468553722
piebaldism B-Disease 0 0.052879635244607925
due O 0 0.0013823489425703883
to O 0 0.000897984195034951
KIT O 1 0.8353239297866821
gene O 0 0.0014575786190107465
mutation O 0 0.001106416224502027
in O 0 0.0005554468953050673
humans O 0 0.0007048508268781006
and O 0 0.0006565336370840669
tightens O 0 0.026254573836922646
the O 0 0.0008920179679989815
clinical O 0 0.02279667556285858
similarity O 0 0.0014414588222280145
between O 0 0.000728825107216835
piebaldism B-Disease 0 0.029783252626657486
and O 0 0.0006299155647866428
the O 0 0.0007639479590579867
various O 0 0.0009100161259993911
forms O 0 0.0030625765211880207
of O 1 0.8010503649711609
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.23411476612091064
. O 0 0.012045014649629593

Cycloheximide O 0 0.23098480701446533
facilitates O 0 0.013780464418232441
the O 0 0.0033942984882742167
identification O 0 0.0033054545056074858
of O 0 0.0018774387426674366
aberrant O 0 0.007635523099452257
transcripts O 0 0.002131367102265358
resulting O 0 0.0013607880100607872
from O 0 0.0007111347513273358
a O 0 0.000990764587186277
novel O 0 0.00420639431104064
splice O 0 0.04728703200817108
- O 0 0.004350768867880106
site O 0 0.0013641187688335776
mutation O 0 0.0015124031342566013
in O 0 0.0007100451039150357
COL17A1 O 0 0.18515312671661377
in O 0 0.0011481237597763538
a O 0 0.003199807135388255
patient O 1 0.9741986393928528
with O 0 0.07603881508111954
generalized O 1 0.9999784231185913
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999994039535522
epidermolysis I-Disease 1 0.9999996423721313
bullosa I-Disease 1 0.999998927116394
. O 0 0.2188190221786499

Patients O 1 0.9801315665245056
with O 0 0.1658651977777481
generalized O 1 0.999990701675415
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999997615814209
often O 0 0.04473239183425903
show O 0 0.004495357163250446
decreased O 0 0.016637712717056274
expression O 0 0.0024625840596854687
of O 0 0.004299912601709366
type O 1 0.998591959476471
XVII O 1 0.9999995231628418
collagen O 1 0.9993857145309448
, O 0 0.0022067606914788485
a O 0 0.00295018102042377
transmembrane O 0 0.07666776329278946
hemidesmosomal O 0 0.040237851440906525
protein O 0 0.0036242154892534018
encoded O 0 0.004337498918175697
by O 0 0.0045522223226726055
COL17A1 O 0 0.0682758241891861
. O 0 0.011818748898804188

This O 0 0.0043343473225831985
report O 0 0.003213105956092477
documents O 0 0.002280054846778512
a O 0 0.00201700022444129
novel O 0 0.0051068589091300964
splice O 0 0.030844654887914658
- O 0 0.005534760653972626
site O 0 0.0017527044983580709
mutation O 0 0.001712689409032464
in O 0 0.0007654892397113144
COL17A1 O 0 0.04836875572800636
in O 0 0.000919978367164731
a O 0 0.001737572718411684
patient O 1 0.9252757430076599
with O 0 0.031084230169653893
generalized O 1 0.9999959468841553
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999997615814209
, O 0 0.006472271401435137
and O 0 0.0011060970136895776
applies O 0 0.0012244116514921188
a O 0 0.0008038790547288954
new O 0 0.0006666667177341878
methodology O 0 0.0012513400288298726
to O 0 0.0006348256720229983
define O 0 0.0014511466724798083
and O 0 0.001033761422149837
characterize O 0 0.003387411357834935
the O 0 0.002161305397748947
resulting O 0 0.005262784194201231
mRNA O 0 0.010505424812436104
splice O 0 0.02057197503745556
variants O 0 0.013564981520175934
. O 0 0.011627462692558765

Mutational O 0 0.032684363424777985
analysis O 0 0.006774481851607561
of O 0 0.004599143285304308
COL17A1 O 0 0.3792409598827362
identified O 0 0.0036648311652243137
a O 0 0.0031884885393083096
maternally O 1 0.9472866654396057
inherited O 1 0.998796820640564
G O 1 0.9809231758117676
- O 0 0.4885750114917755
to O 0 0.00161490379832685
- O 1 0.6841733455657959
T O 0 0.4074310064315796
transversion O 0 0.004576435778290033
at O 0 0.0011025129351764917
the O 0 0.0009970725513994694
- O 0 0.0020068578887730837
1 O 0 0.0015737899811938405
position O 0 0.0018558785086497664
of O 0 0.0024257737677544355
exon O 0 0.013638617470860481
32 O 0 0.008092397823929787
. O 0 0.007152094505727291

This O 0 0.0072758812457323074
acceptor O 0 0.020755544304847717
splice O 0 0.05636001005768776
- O 0 0.011451579630374908
site O 0 0.0030787046998739243
mutation O 0 0.002388871507719159
led O 0 0.0013150363229215145
to O 0 0.0006877966807223856
the O 0 0.0007730109500698745
formation O 0 0.0014624942559748888
of O 0 0.0010204424615949392
aberrant O 0 0.03362734615802765
transcripts O 0 0.0021727050188928843
present O 0 0.0014648924116045237
at O 0 0.0018085574265569448
extremely O 0 0.0037666927091777325
low O 0 0.004833068698644638
levels O 0 0.005817504599690437
. O 0 0.006602044217288494

Based O 0 0.005037365946918726
on O 0 0.002373320749029517
our O 0 0.0016738413833081722
recent O 0 0.0016397309955209494
finding O 0 0.0018365720752626657
that O 0 0.0014572886284440756
cycloheximide O 0 0.3808194100856781
stabilized O 1 0.5408840179443359
mutant O 0 0.014078154228627682
COL17A1 O 0 0.13005077838897705
transcripts O 0 0.0033408645540475845
in O 0 0.001431565615348518
keratinocytes O 0 0.01067294366657734
homozygous O 0 0.00282688089646399
for O 0 0.0009384012664668262
a O 0 0.001621972187422216
frameshift O 0 0.0602220743894577
mutation O 0 0.002109123859554529
, O 0 0.0008253224077634513
the O 0 0.0007329365471377969
effects O 0 0.0012256742920726538
of O 0 0.0008329306147061288
the O 0 0.0013234521029517055
splice O 0 0.07963316142559052
- O 0 0.004042953718453646
site O 0 0.0012064243201166391
mutation O 0 0.001096857595257461
on O 0 0.0006218572380021214
splicing O 0 0.001347736339084804
of O 0 0.0007970544975250959
COL17A1 O 0 0.009108122438192368
transcripts O 0 0.001494950382038951
were O 0 0.0006542584160342813
determined O 0 0.001019948162138462
using O 0 0.0010286439210176468
reverse O 0 0.003258318407461047
transcriptase O 0 0.018108723685145378
polymerase O 0 0.004379119724035263
chain O 0 0.002500692382454872
reaction O 0 0.0015855430392548442
of O 0 0.0011859196238219738
total O 0 0.0015061807353049517
RNA O 0 0.0027427778113633394
from O 0 0.001630850019864738
keratinocytes O 0 0.007181477267295122
incubated O 0 0.006477440241724253
for O 0 0.003325609490275383
2 O 0 0.00805612187832594
. O 0 0.008625311776995659

5 O 0 0.009497781284153461
h O 0 0.008464688435196877
in O 0 0.002171975327655673
the O 0 0.0015715222107246518
presence O 0 0.0013715303502976894
or O 0 0.0009177443571388721
absence O 0 0.0019959574565291405
of O 0 0.001824337407015264
10 O 0 0.0030295352917164564
microg O 1 0.5131593346595764
cycloheximide O 0 0.47140106558799744
per O 0 0.006595558486878872
ml O 0 0.06933429092168808
. O 0 0.010097081772983074

Using O 0 0.004684158600866795
this O 0 0.002074386226013303
approach O 0 0.0021999937016516924
, O 0 0.0012282803654670715
an O 0 0.0012451171642169356
abnormally O 0 0.14806796610355377
spliced O 0 0.004824146628379822
transcript O 0 0.0028426297940313816
was O 0 0.001300367177464068
identified O 0 0.0008956532110460103
that O 0 0.0004121041565667838
contains O 0 0.0006170268170535564
an O 0 0.0005242860061116517
extra O 0 0.000921363418456167
264 O 0 0.0016692118952050805
bases O 0 0.0010242849821224809
upstream O 0 0.001401205314323306
from O 0 0.0008085010922513902
exon O 0 0.0027267453260719776
32 O 0 0.001356841647066176
, O 0 0.0008397559286095202
resulting O 0 0.0011399948270991445
in O 0 0.0008529022452421486
a O 0 0.0014987149043008685
premature O 0 0.006342490669339895
termination O 0 0.0070668356493115425
codon O 0 0.0048756725154817104
27 O 0 0.002720056101679802
bp O 0 0.003419680055230856
downstream O 0 0.002786958822980523
from O 0 0.001645826268941164
the O 0 0.002624649554491043
cryptic O 0 0.013147056102752686
splice O 0 0.01912841387093067
site O 0 0.010586009360849857
. O 0 0.011605508625507355

Three O 0 0.003971833735704422
other O 0 0.0021437364630401134
splice O 0 0.007418791763484478
variants O 0 0.0021981429308652878
, O 0 0.0008886766736395657
including O 0 0.0006096339784562588
one O 0 0.0007038007024675608
derived O 0 0.0008828414720483124
from O 0 0.0005966323660686612
the O 0 0.0008898890810087323
skipping O 0 0.002466803416609764
of O 0 0.001242928672581911
exon O 0 0.011627002619206905
32 O 0 0.0020345204975456
, O 0 0.0011047044536098838
were O 0 0.0012998594902455807
also O 0 0.002391985384747386
identified O 0 0.005542336963117123
. O 0 0.007465372793376446

These O 0 0.004474323242902756
results O 0 0.0028900906909257174
indicate O 0 0.0025745900347828865
the O 0 0.001565699465572834
usefulness O 0 0.004615176934748888
of O 0 0.0025487341918051243
cycloheximide O 1 0.9947145581245422
treatment O 1 0.8027976155281067
in O 0 0.0011806497350335121
evaluating O 0 0.0035317905712872744
the O 0 0.0011112394277006388
abnormal O 0 0.005696238484233618
processing O 0 0.0009301059762947261
of O 0 0.0006336786318570375
mRNA O 0 0.0012117881560698152
due O 0 0.0006219939095899463
to O 0 0.000595110934227705
splice O 0 0.002786598401144147
- O 0 0.0015742494724690914
site O 0 0.0009679165086708963
mutations O 0 0.0009840764105319977
, O 0 0.0006315888604149222
because O 0 0.0006136522279120982
( O 0 0.0008272021077573299
i O 0 0.0008494144422002137
) O 0 0.0008652065298520029
aberrant O 0 0.002276788931339979
splicing O 0 0.0015401028795167804
often O 0 0.0007296295370906591
generates O 0 0.0015148924430832267
a O 0 0.001377298147417605
premature O 0 0.003996292129158974
termination O 0 0.008044065907597542
codon O 0 0.0032182142604142427
, O 0 0.001072158687748015
( O 0 0.001337441150099039
ii O 0 0.0036130337975919247
) O 0 0.0008421710808761418
transcripts O 0 0.0011889380402863026
with O 0 0.0008105023298412561
premature O 0 0.008232586085796356
termination O 0 0.01439997460693121
codons O 0 0.002024218440055847
can O 0 0.0004977794596925378
occur O 0 0.0004417103773448616
at O 0 0.0005297533352859318
low O 0 0.001115952036343515
or O 0 0.0006980776088312268
undetectable O 0 0.02298462763428688
levels O 0 0.001043387921527028
due O 0 0.0006988195236772299
to O 0 0.000609676179010421
nonsense O 0 0.00855732336640358
- O 0 0.005247986875474453
mediated O 0 0.002184441080316901
mRNA O 0 0.0015290618175640702
decay O 0 0.0016921823844313622
, O 0 0.0005938506801612675
and O 0 0.0006026372429914773
( O 0 0.0010281874565407634
iii O 0 0.0034843015018850565
) O 0 0.000530715158674866
the O 0 0.00048370356671512127
levels O 0 0.0006781467236578465
of O 0 0.0004936004988849163
these O 0 0.0004374190466478467
transcripts O 0 0.001294333371333778
can O 0 0.0006117051816545427
be O 0 0.0008223365293815732
increased O 0 0.001925504533573985
by O 0 0.002545777941122651
cycloheximide O 0 0.02724706381559372
. O 0 0.007766079157590866

A O 0 0.01116146706044674
deletion O 0 0.015883732587099075
mutation O 0 0.005173119716346264
in O 0 0.0020452351309359074
COL17A1 O 0 0.1531996726989746
in O 0 0.0012788779567927122
five O 0 0.001418118248693645
Austrian O 0 0.03820988908410072
families O 0 0.0027904899325221777
with O 0 0.003977391868829727
generalized O 1 0.9999321699142456
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999996423721313
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999991655349731
represents O 0 0.2628946304321289
propagation O 0 0.024329395964741707
of O 0 0.0041383602656424046
an O 0 0.006513258442282677
ancestral O 1 0.854504406452179
allele O 0 0.04309793561697006
. O 0 0.009318425320088863

Patients O 1 0.9767175316810608
with O 0 0.0791698694229126
generalized O 1 0.9999865293502808
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999997615814209
, O 0 0.033012665808200836
a O 0 0.0036647741217166185
usually O 0 0.0019849552772939205
nonlethal O 0 0.015416298992931843
form O 0 0.0020093063358217478
of O 0 0.004462885204702616
junctional B-Disease 1 0.9999954700469971
epidermolysis I-Disease 1 0.9999994039535522
bullosa I-Disease 1 0.9999929666519165
, O 0 0.004107234999537468
have O 0 0.001898807822726667
generalized O 1 0.6171934604644775
blistering B-Disease 1 0.9974814057350159
, O 1 0.7425804734230042
nail B-Disease 1 0.9999991655349731
dystrophy I-Disease 1 1.0
, O 1 0.9820267558097839
patchy B-Disease 1 0.9999942779541016
alopecia I-Disease 1 1.0
, O 1 0.822317361831665
and O 1 0.8074963688850403
dental B-Disease 1 0.999998927116394
abnormalities I-Disease 1 0.999987006187439
. O 0 0.05303763970732689

Skin B-Disease 1 0.9999659061431885
fragility I-Disease 1 0.9997523427009583
in O 0 0.004697836935520172
most O 0 0.0017006057314574718
cases O 0 0.0025569116696715355
is O 0 0.0010500396601855755
due O 0 0.000975566916167736
to O 0 0.0006240460788831115
mutations O 0 0.0009150342084467411
in O 0 0.0006171241402626038
the O 0 0.001036060624755919
gene O 0 0.0019483438227325678
encoding O 0 0.003661537077277899
type O 1 0.6297959089279175
XVII O 1 0.9999973773956299
collagen O 1 0.9999405145645142
( O 0 0.025601394474506378
COL17A1 O 1 0.9445770978927612
) O 0 0.006955315824598074
. O 0 0.007873651571571827

Recently O 0 0.009396983310580254
, O 0 0.0027274314779788256
we O 0 0.001694304752163589
reported O 0 0.00203047227114439
five O 0 0.0016057747416198254
Austrian O 0 0.02478773146867752
families O 0 0.0031211222521960735
with O 0 0.006193172186613083
generalized O 1 0.9999712705612183
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999995231628418
who O 0 0.18198131024837494
share O 0 0.0031992762815207243
the O 0 0.002954771276563406
same O 0 0.0042000217363238335
COL17A1 O 1 0.9922987818717957
mutation O 0 0.022461920976638794
. O 0 0.008193271234631538

Affected O 0 0.006849684286862612
individuals O 0 0.0021248317789286375
in O 0 0.0010056975297629833
three O 0 0.0007624533609487116
families O 0 0.0008892467594705522
are O 0 0.0004670975904446095
homozygous O 0 0.0013792765093967319
for O 0 0.000684219878166914
4003delTC O 0 0.03638213127851486
, O 0 0.0006698699435219169
whereas O 0 0.0007588562439195812
those O 0 0.00039666160591877997
in O 0 0.0004924019449390471
two O 0 0.0005902503617107868
others O 0 0.0010276219109073281
are O 0 0.0013409567764028907
compound O 0 0.008020972833037376
heterozygotes O 0 0.11133141815662384
. O 0 0.008828429505228996

To O 0 0.004048275761306286
determine O 0 0.002685141284018755
if O 0 0.0013357900315895677
the O 0 0.001039125956594944
occurrence O 0 0.0019832253456115723
of O 0 0.001200594357214868
4003delTC O 0 0.28149157762527466
in O 0 0.0006931566749699414
these O 0 0.0005129086785018444
unrelated O 0 0.0017677651485428214
families O 0 0.0010675884550437331
signifies O 0 0.008991485461592674
propagation O 0 0.0018151841359212995
of O 0 0.0008853285689838231
an O 0 0.0010738391429185867
ancestral O 0 0.02172420546412468
allele O 0 0.002133321948349476
or O 0 0.0006541795446537435
a O 0 0.0011422655079513788
mutational O 0 0.11844559758901596
hot O 0 0.0037807957269251347
spot O 0 0.0021033650264143944
, O 0 0.0009820748819038272
haplotypes O 0 0.002541634254157543
were O 0 0.0006705485284328461
determined O 0 0.0011254380224272609
for O 0 0.0007876513409428298
polymorphisms O 0 0.002228813711553812
both O 0 0.0009740600944496691
within O 0 0.0013588867150247097
and O 0 0.0025441222824156284
flanking O 1 0.636279284954071
COL17A1 O 1 0.9953418970108032
. O 0 0.011520793661475182

Five O 0 0.009031069464981556
intragenic O 0 0.07457499206066132
polymorphisms O 0 0.00913535337895155
were O 0 0.002075148280709982
chosen O 0 0.002094692550599575
based O 0 0.001825085375458002
on O 0 0.001877826638519764
their O 0 0.003042731899768114
informativeness O 0 0.16660946607589722
. O 0 0.008565625175833702

One O 0 0.003442342858761549
of O 0 0.0020601393189281225
these O 0 0.0009234664612449706
, O 0 0.0009219386265613139
not O 0 0.0005844733095727861
previously O 0 0.0008244895725511014
reported O 0 0.0009274238254874945
, O 0 0.0007302224985323846
was O 0 0.0014192226808518171
2988 O 0 0.042799703776836395
A O 0 0.0016486720414832234
or O 0 0.0007838841993361712
C O 0 0.0021362141706049442
that O 0 0.0005614899564534426
introduces O 0 0.001696188235655427
a O 0 0.0009383846772834659
new O 0 0.0008917930535972118
restriction O 0 0.0017609045607969165
site O 0 0.0019566204864531755
for O 0 0.002128176623955369
Eco0109 O 0 0.021945029497146606
I O 0 0.008898838423192501
. O 0 0.009177775122225285

All O 0 0.005170416086912155
the O 0 0.004908192437142134
4003delTC O 0 0.1013823002576828
alleles O 0 0.005714170169085264
showed O 0 0.0024882464203983545
the O 0 0.0012330672470852733
same O 0 0.0010435619624331594
haplotype O 0 0.002689780667424202
for O 0 0.0008142113802023232
these O 0 0.0008035382488742471
five O 0 0.0018647466786205769
polymorphic O 0 0.012235153466463089
markers O 0 0.011151709593832493
. O 0 0.007651929277926683

Fourteen O 0 0.019161803647875786
microsatellite O 0 0.08384418487548828
polymorphisms O 0 0.007857579737901688
were O 0 0.0016103648813441396
selected O 0 0.0017237284919247031
based O 0 0.001167774898931384
on O 0 0.0008573319064453244
their O 0 0.0007268240442499518
high O 0 0.0016865187790244818
heterozygosity O 0 0.02367517165839672
and O 0 0.0009254567557945848
their O 0 0.0006738667143508792
location O 0 0.0015727024292573333
within O 0 0.001969283912330866
10q23 O 0 0.10477849096059799
- O 0 0.035148028284311295
q25 O 0 0.08769269287586212
near O 0 0.012350231409072876
COL17A1 O 1 0.8261659145355225
. O 0 0.012224300764501095

Three O 0 0.00495735090225935
families O 0 0.004055458586663008
shared O 0 0.004360135179013014
microsatellite O 0 0.049794845283031464
polymorphisms O 0 0.006437638308852911
covering O 0 0.0028588168788701296
at O 0 0.0012090798700228333
most O 0 0.0007345021585933864
19 O 0 0.0014350380515679717
cM O 0 0.002213467610999942
, O 0 0.0005349612329155207
whereas O 0 0.0006970293470658362
the O 0 0.0004876732418779284
others O 0 0.0005127014592289925
shared O 0 0.0006808050093241036
smaller O 0 0.00048544167657382786
regions O 0 0.0005622896715067327
consistent O 0 0.0008181994780898094
with O 0 0.00044233209337107837
cross O 0 0.0013233128702268004
- O 0 0.0017412655288353562
over O 0 0.0005964635638520122
events O 0 0.0006809081532992423
during O 0 0.0008158746641129255
passage O 0 0.0009699708316475153
of O 0 0.0007525058463215828
this O 0 0.0006911405944265425
mutation O 0 0.0014763125218451023
through O 0 0.0010259193368256092
several O 0 0.0016720559215173125
generations O 0 0.006136169191449881
. O 0 0.006729630753397942

These O 0 0.004382515791803598
results O 0 0.003084680298343301
indicate O 0 0.002703615464270115
that O 0 0.001443964894860983
4003delTC O 0 0.007455970160663128
occurs O 0 0.0015925188781693578
on O 0 0.0012441698927432299
a O 0 0.0017388220876455307
single O 0 0.0026375476736575365
ancestral O 0 0.008426027372479439
allele O 0 0.007377465255558491
. O 0 0.003428775817155838
. O 0 0.007700724061578512

The O 0 0.016505472362041473
haptoglobin O 1 0.9562976956367493
- O 0 0.28443989157676697
gene O 0 0.007719742599874735
deletion O 0 0.011735361069440842
responsible O 0 0.006841505412012339
for O 0 0.006623795721679926
anhaptoglobinemia B-Disease 1 0.8197706937789917
. O 0 0.011979455128312111

We O 0 0.004604066722095013
have O 0 0.001893422333523631
found O 0 0.0013133804313838482
an O 0 0.001119846012443304
allelic O 0 0.008237632922828197
deletion O 0 0.003917186055332422
of O 0 0.0014782525831833482
the O 0 0.008718675933778286
haptoglobin O 1 0.9991320967674255
( O 0 0.005492571275681257
Hp O 0 0.008479764685034752
) O 0 0.0007843991043046117
gene O 0 0.0007673556683585048
from O 0 0.0005459691747091711
an O 0 0.0006875719409435987
individual O 0 0.001203731750138104
with O 0 0.0022669455502182245
anhaptoglobinemia B-Disease 1 0.8270881772041321
. O 0 0.008059642277657986

The O 0 0.009570756927132607
Hp O 0 0.11892856657505035
gene O 0 0.004377853590995073
cluster O 0 0.003262103768065572
consists O 0 0.0019389281515032053
of O 0 0.0013967142440378666
coding O 0 0.0029826159588992596
regions O 0 0.001014831941574812
of O 0 0.0008786914986558259
the O 0 0.0011556502431631088
alpha O 0 0.0033379553351551294
chain O 0 0.0017579750856384635
and O 0 0.0006623886292800307
beta O 0 0.0017369043780490756
chain O 0 0.001451676245778799
of O 0 0.0008591346559114754
the O 0 0.0014360516797751188
haptoglobin O 1 0.7437009215354919
gene O 0 0.0015627621905878186
( O 0 0.001059622853063047
Hp O 0 0.0021100041922181845
) O 0 0.0004961731028743088
and O 0 0.00033820391399785876
of O 0 0.000407282990636304
the O 0 0.0006514854612760246
alpha O 0 0.001933725201524794
chain O 0 0.001418151892721653
and O 0 0.0005738927284255624
beta O 0 0.0011841015657410026
chain O 0 0.001116925268433988
of O 0 0.0007410265388898551
the O 0 0.0016492631984874606
haptoglobin O 1 0.9866494536399841
- O 0 0.08142787963151932
related O 0 0.0015465769683942199
gene O 0 0.0015165123622864485
( O 0 0.0011460556415840983
Hpr O 0 0.023456815630197525
) O 0 0.000684296537656337
, O 0 0.0005474314675666392
in O 0 0.0006293074111454189
tandem O 0 0.001968644792214036
from O 0 0.0009319427190348506
the O 0 0.0017383024096488953
5 O 0 0.0034307334572076797
side O 0 0.005165645387023687
. O 0 0.006607775576412678

Southern O 0 0.015808993950486183
blot O 0 0.2669292390346527
and O 0 0.0038148926105350256
PCR O 0 0.009057635441422462
analyses O 0 0.002892531920224428
have O 0 0.0009344153222627938
indicated O 0 0.0012356579536572099
that O 0 0.00045607410720549524
the O 0 0.0005563150043599308
individual O 0 0.0005656038993038237
with O 0 0.0005778672639280558
anhaptoglobinemia B-Disease 0 0.2107311189174652
was O 0 0.0015484712785109878
homozygous O 0 0.0013578577199950814
for O 0 0.00043196900514885783
the O 0 0.0007029902772046626
gene O 0 0.0010096658952534199
deletion O 0 0.001345846219919622
and O 0 0.00045429510646499693
that O 0 0.00037581491051241755
the O 0 0.0005822592065669596
gene O 0 0.0009314113412983716
deletion O 0 0.001279918709769845
was O 0 0.0007192332996055484
included O 0 0.0005048556486144662
at O 0 0.0005284562357701361
least O 0 0.0004683371807914227
from O 0 0.0004890606505796313
the O 0 0.0007557444041594863
promoter O 0 0.005109848920255899
region O 0 0.001288071391172707
of O 0 0.0010625360300764441
Hp O 0 0.01324169896543026
to O 0 0.0010972003219649196
Hpr O 0 0.023030245676636696
alpha O 0 0.0019599252846091986
but O 0 0.0006121414480730891
not O 0 0.0005630753003060818
to O 0 0.001028978149406612
Hpr O 0 0.039306942373514175
beta O 0 0.007002995815128088
( O 0 0.004692357499152422
Hpdel O 0 0.033339861780405045
) O 0 0.005897240247577429
. O 0 0.009176474064588547

In O 0 0.0037089581601321697
addition O 0 0.0025766678154468536
, O 0 0.0012826637830585241
we O 0 0.0007689855410717428
found O 0 0.0006595049635507166
seven O 0 0.0005910944892093539
individuals O 0 0.00043256444041617215
with O 0 0.0005037199589423835
hypohaptoglobinemia B-Disease 0 0.0080728679895401
in O 0 0.0004890576237812638
three O 0 0.00042413253686390817
families O 0 0.0005022586556151509
, O 0 0.0004015049780718982
and O 0 0.00037163333036005497
the O 0 0.0005199177539907396
genotypes O 0 0.0017731626285240054
of O 0 0.0004935737233608961
six O 0 0.00043239869410172105
of O 0 0.0004326384805608541
the O 0 0.0005459715030156076
seven O 0 0.0006312572513706982
individuals O 0 0.00042346128611825407
were O 0 0.0005100283888168633
found O 0 0.0006702540558762848
to O 0 0.0008084660512395203
be O 0 0.0014541174750775099
Hp2 O 1 0.6202625632286072
/ O 0 0.3696140646934509
Hpdel O 0 0.2671625018119812
. O 0 0.009801872074604034

The O 0 0.008101408369839191
phenotypes O 0 0.018861116841435432
and O 0 0.002393655478954315
genotypes O 0 0.007349683437496424
in O 0 0.0009672226733528078
one O 0 0.0006631181458942592
of O 0 0.0006146497325971723
these O 0 0.0003485007619019598
three O 0 0.000463480333564803
families O 0 0.0005311688291840255
showed O 0 0.0007856737938709557
the O 0 0.0005172009696252644
father O 0 0.0008903064299374819
to O 0 0.00041826587403193116
be O 0 0.0004776068381033838
hypohaptoglobinemic B-Disease 0 0.008191093802452087
( O 0 0.0011069709435105324
Hp2 O 0 0.005334592889994383
) O 0 0.0008321063942275941
and O 0 0.000824884045869112
Hp2 O 1 0.5682554244995117
/ O 0 0.0644482746720314
Hpdel O 0 0.020709823817014694
, O 0 0.000764430791605264
the O 0 0.0006385821616277099
mother O 0 0.0011480242246761918
to O 0 0.0004476522153709084
be O 0 0.0004573619517032057
Hp2 O 0 0.005373288877308369
- O 0 0.002189698163419962
1 O 0 0.001084852498024702
and O 0 0.0008649302762933075
Hp1 O 0 0.4567210376262665
/ O 0 0.0331285186111927
Hp2 O 0 0.004670379683375359
, O 0 0.0006417438271455467
one O 0 0.0004185209108982235
of O 0 0.00035848209518007934
the O 0 0.00039196410216391087
two O 0 0.0003455818223301321
children O 0 0.0005568463238887489
to O 0 0.00034504637005738914
be O 0 0.0004911044961772859
hypohaptoglobinemic B-Disease 0 0.012100453488528728
( O 0 0.0011960132978856564
Hp2 O 0 0.014376666396856308
) O 0 0.0008168797357939184
and O 0 0.0007269280031323433
Hp2 O 1 0.9204620718955994
/ O 1 0.5726437568664551
Hpdel O 0 0.20120376348495483
, O 0 0.0005957899265922606
and O 0 0.0003881791199091822
the O 0 0.00045454417704604566
other O 0 0.00032480285153724253
child O 0 0.0009422940784133971
to O 0 0.000372981681721285
be O 0 0.00047626340528950095
Hp1 O 0 0.01001349464058876
and O 0 0.0009354690555483103
Hp1 O 1 0.7247702479362488
/ O 0 0.17330831289291382
Hpdel O 0 0.04255786910653114
, O 0 0.0008673187694512308
showing O 0 0.0013923963997513056
an O 0 0.0008082514395937324
anomalous O 0 0.004438925534486771
inheritance O 0 0.0030491694342345
of O 0 0.0016313671367242932
Hp O 0 0.3100270926952362
phenotypes O 0 0.008114785887300968
in O 0 0.00101282331161201
the O 0 0.0018338932422921062
child O 0 0.2339331954717636
with O 0 0.0038676562253385782
Hp1 O 1 0.9828363060951233
. O 0 0.007618350442498922

The O 0 0.01481772679835558
Hp2 O 1 0.999386191368103
/ O 1 0.9947589039802551
Hpdel O 1 0.9469012022018433
individuals O 0 0.0014827895211055875
had O 0 0.0010956487385556102
an O 0 0.0006968994857743382
extremely O 0 0.0011980130802839994
low O 0 0.0011317187454551458
level O 0 0.0007866803207434714
of O 0 0.000767822319176048
Hp O 0 0.011613835580646992
( O 0 0.001322781783528626
mean O 0 0.0015591817209497094
+ O 0 0.003169998060911894
/ O 0 0.004107223358005285
- O 0 0.00277891056612134
SD O 0 0.0064681582152843475
= O 0 0.0020869083236902952
0 O 0 0.0014320277841761708
. O 0 0.0009086454520002007
049 O 0 0.007720001507550478
+ O 0 0.0032833011355251074
/ O 0 0.0031208524014800787
- O 0 0.0020850393921136856
0 O 0 0.0016644796123728156
. O 0 0.000984488520771265
043 O 0 0.010483648627996445
mg O 0 0.015855908393859863
/ O 0 0.005365286022424698
ml O 0 0.005119760986417532
; O 0 0.0008624375914223492
n O 0 0.0016584416152909398
= O 0 0.0015164390206336975
6 O 0 0.0008007491123862565
) O 0 0.0004331241361796856
, O 0 0.0003549758403096348
compared O 0 0.00040036789141595364
with O 0 0.00026015445473603904
the O 0 0.0003840349963866174
level O 0 0.0006229699356481433
( O 0 0.000544280163012445
1 O 0 0.0005449121817946434
. O 0 0.00044701131992042065
64 O 0 0.0012159475591033697
+ O 0 0.0019024730427190661
/ O 0 0.002036403864622116
- O 0 0.0014925110153853893
1 O 0 0.0011088162427768111
. O 0 0.0008815753972157836
07 O 0 0.005732849705964327
mg O 0 0.018737634643912315
/ O 0 0.005558057222515345
ml O 0 0.003928130026906729
) O 0 0.0007807739893905818
obtained O 0 0.000713302637450397
from O 0 0.0006361402338370681
52 O 0 0.001671454170718789
healthy O 0 0.0021581919863820076
volunteers O 0 0.0019907441455870867
having O 0 0.0015506010968238115
phenotype O 0 0.005252778995782137
Hp2 O 0 0.026730908080935478
, O 0 0.0009056886192411184
whereas O 0 0.0012708111898973584
the O 0 0.00104488804936409
serum O 0 0.141731396317482
Hp O 0 0.0026721239555627108
level O 0 0.0009426648612134159
of O 0 0.0006380288396030664
an O 0 0.0005690611433237791
individual O 0 0.0007431757403537631
with O 0 0.001204405794851482
Hp1 O 1 0.9540510177612305
/ O 0 0.4375467598438263
Hpdel O 0 0.44022491574287415
was O 0 0.006114073563367128
0 O 0 0.007999364286661148
. O 0 0.006164257880300283

50 O 0 0.015456056222319603
mg O 1 0.9930737018585205
/ O 1 0.9119418263435364
ml O 0 0.48404818773269653
, O 0 0.0010675176745280623
which O 0 0.0005080250557512045
was O 0 0.0007144578266888857
approximately O 0 0.0005621287855319679
half O 0 0.0004532695165835321
the O 0 0.0004470215062610805
level O 0 0.0006362430285662413
of O 0 0.0005423878901638091
Hp O 0 0.00528474198654294
in O 0 0.0006198865012265742
control O 0 0.0012510896194726229
sera O 0 0.22511141002178192
from O 0 0.0006105343927629292
the O 0 0.0007298975833691657
Hp1 O 0 0.04647194221615791
phenotype O 0 0.001926751108840108
( O 0 0.0005856295465491712
1 O 0 0.0006053578690625727
. O 0 0.00040842912858352065
26 O 0 0.0008428735891357064
+ O 0 0.0016991401789709926
/ O 0 0.00169180310331285
- O 0 0.001218966906890273
0 O 0 0.0010468983091413975
. O 0 0.0006327800219878554
33 O 0 0.0016170378075912595
mg O 0 0.005712528713047504
/ O 0 0.0034579639323055744
ml O 0 0.0036737360060214996
; O 0 0.0007445456576533616
n O 0 0.0014664031332358718
= O 0 0.001478742458857596
9 O 0 0.0009222992230206728
) O 0 0.0006577307940460742
, O 0 0.0005573440575972199
showing O 0 0.0011568492045626044
a O 0 0.0014741126215085387
gene O 0 0.00314657436683774
- O 0 0.013149814680218697
dosage O 0 0.05166883021593094
effect O 0 0.005838432349264622
. O 0 0.006900256033986807

The O 0 0.005792689044028521
other O 0 0.002708014566451311
allele O 0 0.005780246574431658
( O 0 0.0026969853788614273
Hp2 O 0 0.01055101677775383
) O 0 0.0009756952640600502
of O 0 0.000780752394348383
individuals O 0 0.0008143007871694863
with O 0 0.0012267540441825986
Hp2 O 1 0.9989352822303772
/ O 1 0.9883878827095032
Hpdel O 1 0.8295036554336548
was O 0 0.001588889048434794
found O 0 0.0006140208570286632
to O 0 0.000320563733112067
have O 0 0.00027767918072640896
, O 0 0.0003424807800911367
in O 0 0.00035840689088217914
all O 0 0.0004076125333085656
exons O 0 0.0014666755450889468
, O 0 0.000616222620010376
no O 0 0.0008430631714873016
mutation O 0 0.001505556283518672
, O 0 0.000997113878838718
by O 0 0.0014625478070229292
DNA O 0 0.004281722009181976
sequencing O 0 0.00797252543270588
. O 0 0.006292304489761591

On O 0 0.0043270825408399105
the O 0 0.00261891121044755
basis O 0 0.0017776907188817859
of O 0 0.00136778864543885
the O 0 0.0011468523880466819
present O 0 0.001017122995108366
study O 0 0.0008831985760480165
, O 0 0.000756992434617132
the O 0 0.0007841899059712887
mechanism O 0 0.0012381077976897359
of O 0 0.0009114583372138441
anhaptoglobinemia B-Disease 0 0.2765156030654907
and O 0 0.0007224541041068733
the O 0 0.0008281919872388244
mechanism O 0 0.001622988609597087
of O 0 0.0013419156894087791
anomalous O 1 0.6201820373535156
inheritance O 0 0.2471129298210144
of O 0 0.015298471786081791
Hp O 1 0.9713730812072754
phenotypes O 0 0.15325190126895905
were O 0 0.0015906383050605655
well O 0 0.002529094461351633
explained O 0 0.00831485353410244
. O 0 0.006880329921841621

However O 0 0.0069985403679311275
, O 0 0.0037161591462790966
the O 0 0.0036622986663132906
mechanism O 0 0.007245861459523439
of O 0 0.006557094398885965
hypohaptoglobinemia B-Disease 1 0.9827789664268494
remains O 0 0.08383788913488388
unknown O 0 0.024333406239748

ATM O 0 0.023463832214474678
mutations O 0 0.00815293937921524
and O 0 0.0028951186686754227
phenotypes O 0 0.0815863311290741
in O 0 0.03242514282464981
ataxia B-Disease 1 1.0
- I-Disease 1 0.99997878074646
telangiectasia I-Disease 1 0.9999973773956299
families O 0 0.003242392325773835
in O 0 0.000952692236751318
the O 0 0.0010883751092478633
British O 0 0.001770354458130896
Isles O 0 0.0023631902877241373
: O 0 0.0007715905667282641
expression O 0 0.0009114296408370137
of O 0 0.0007710956269875169
mutant O 0 0.0025737639516592026
ATM O 0 0.001963823102414608
and O 0 0.000556851620785892
the O 0 0.0007789506926201284
risk O 0 0.02695070393383503
of O 1 0.8038233518600464
leukemia B-Disease 1 1.0
, O 1 0.9997990727424622
lymphoma B-Disease 1 1.0
, O 1 0.9883793592453003
and O 1 0.9889149069786072
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999990463256836
. O 0 0.0633813664317131

We O 0 0.004217688459903002
report O 0 0.0033031769562512636
the O 0 0.0018985673086717725
spectrum O 0 0.002359045436605811
of O 0 0.0014786665560677648
59 O 0 0.0029436550103127956
ATM O 0 0.003519033081829548
mutations O 0 0.0016615455970168114
observed O 0 0.001295111607760191
in O 0 0.0015395758673548698
ataxia B-Disease 1 0.999995231628418
- I-Disease 1 0.999523401260376
telangiectasia I-Disease 1 0.9999994039535522
( O 1 0.8620308041572571
A B-Disease 1 0.9991288781166077
- I-Disease 1 0.999981164932251
T I-Disease 1 0.9999295473098755
) O 0 0.001585320569574833
patients O 0 0.0023529473692178726
in O 0 0.000984841724857688
the O 0 0.0018625668017193675
British O 0 0.004787531681358814
Isles O 0 0.015191417187452316
. O 0 0.008961834944784641

Of O 0 0.007644256576895714
51 O 0 0.011168264783918858
ATM O 0 0.017400888726115227
mutations O 0 0.0032443345990031958
identified O 0 0.001684716553427279
in O 0 0.0007928337436169386
families O 0 0.0007599728414788842
native O 0 0.0007679859409108758
to O 0 0.00044890298158861697
the O 0 0.0005018667434342206
British O 0 0.0008006118005141616
Isles O 0 0.0014601764269173145
, O 0 0.0005512696225196123
11 O 0 0.0007151733734644949
were O 0 0.000609742128290236
founder O 0 0.0028998840134590864
mutations O 0 0.0008734567672945559
, O 0 0.0004251167119946331
and O 0 0.000402672536438331
2 O 0 0.0005934524233452976
of O 0 0.0004361067258287221
these O 0 0.00035942450631409883
11 O 0 0.0008363971137441695
conferred O 0 0.0020853248424828053
a O 0 0.0014189023058861494
milder O 0 0.22494755685329437
clinical O 1 0.5067787766456604
phenotype O 0 0.008696730248630047
with O 0 0.0006946430075913668
respect O 0 0.0010323722381144762
to O 0 0.0008490534964948893
both O 0 0.002736504888162017
cerebellar B-Disease 1 0.9999970197677612
degeneration I-Disease 1 0.9999997615814209
and O 0 0.3101414144039154
cellular O 1 0.6770148873329163
features O 0 0.015844425186514854
. O 0 0.008896100334823132

We O 0 0.004701841156929731
report O 0 0.0029868914280086756
, O 0 0.0015989351086318493
in O 0 0.001117543550208211
two O 0 0.001067367848008871
A B-Disease 0 0.031077738851308823
- I-Disease 1 0.7898862957954407
T I-Disease 1 0.6088628768920898
families O 0 0.000714103109203279
, O 0 0.000571017328184098
an O 0 0.0005655557033605874
ATM O 0 0.0025019312743097544
mutation O 0 0.0016762319719418883
( O 0 0.0013128744903951883
7271T O 0 0.06764111667871475
- O 0 0.27742666006088257
- O 0 0.39869025349617004
> O 0 0.03724320977926254
G O 0 0.004491846542805433
) O 0 0.0005395403713919222
that O 0 0.00030045388848520815
may O 0 0.0003746021830011159
be O 0 0.0002445210120640695
associated O 0 0.0003594217705540359
with O 0 0.0003152243734803051
an O 0 0.0005261640180833638
increased O 0 0.0018044988391920924
risk O 0 0.02965373918414116
of O 0 0.1348181664943695
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.999929666519165
in O 0 0.001381800859235227
both O 0 0.0012120738392695785
homozygotes O 1 0.9770548343658447
and O 0 0.0012672152370214462
heterozygotes O 0 0.13891346752643585
( O 0 0.0010434681316837668
relative O 0 0.0011368937557563186
risk O 0 0.0008603757596574724
12 O 0 0.0007079222123138607
. O 0 0.00040882357279770076
7 O 0 0.000843890942633152
; O 0 0.0005818881327286363
P O 0 0.002408758271485567
= O 0 0.0017131168860942125
. O 0 0.0006395959644578397
0025 O 0 0.006781524978578091
) O 0 0.000676379248034209
, O 0 0.0004657115787267685
although O 0 0.000394491566112265
there O 0 0.00034899712773039937
is O 0 0.0004289875505492091
a O 0 0.0006920145242474973
less O 0 0.0009421163704246283
severe O 1 0.9984877109527588
A B-Disease 1 0.9978629946708679
- I-Disease 1 0.9998617172241211
T I-Disease 1 0.9970995187759399
phenotype O 0 0.002026200760155916
in O 0 0.0005369558930397034
terms O 0 0.0006912124226801097
of O 0 0.0007782358443364501
the O 0 0.001373009872622788
degree O 0 0.005617495160549879
of O 0 0.21491214632987976
cerebellar B-Disease 1 0.9999979734420776
degeneration I-Disease 1 0.9999997615814209
. O 1 0.5954762697219849

This O 0 0.005063172895461321
mutation O 0 0.0074088117107748985
( O 0 0.004926422610878944
7271T O 1 0.8245707154273987
- O 1 0.9481973648071289
- O 1 0.913232147693634
> O 0 0.1921471357345581
G O 0 0.005635620094835758
) O 0 0.0008501629345119
also O 0 0.0005141926230862737
allows O 0 0.0005424902774393559
expression O 0 0.0006029290962032974
of O 0 0.0005797529011033475
full O 0 0.0008801913936622441
- O 0 0.0019203666597604752
length O 0 0.001161720254458487
ATM O 0 0.0019457205198705196
protein O 0 0.0007986351265572011
at O 0 0.0006002219161018729
a O 0 0.0006195569294504821
level O 0 0.000926253735087812
comparable O 0 0.0011892595794051886
with O 0 0.0005767920520156622
that O 0 0.0007106889388523996
in O 0 0.0012276950292289257
unaffected O 0 0.008171751163899899
individuals O 0 0.003129382152110338
. O 0 0.005644551478326321

In O 0 0.004065883811563253
addition O 0 0.0023164437152445316
, O 0 0.0013454925501719117
we O 0 0.0006891246885061264
have O 0 0.0004990141605958343
studied O 0 0.0011767413234338164
18 O 0 0.0015738479560241103
A B-Disease 0 0.29161137342453003
- I-Disease 1 0.9975553154945374
T I-Disease 1 0.9995511174201965
patients O 0 0.01696322299540043
, O 0 0.0004073547897860408
in O 0 0.0003400818968657404
15 O 0 0.0004521746304817498
families O 0 0.0004670799826271832
, O 0 0.0005444244598038495
who O 0 0.0011520500993356109
developed O 0 0.10642792284488678
leukemia B-Disease 1 0.9999992847442627
, O 0 0.4610905349254608
lymphoma B-Disease 1 1.0
, O 0 0.4546563923358917
preleukemic O 1 0.999987006187439
T O 1 0.9997972846031189
- O 1 0.7525261640548706
cell O 0 0.028187096118927002
proliferation O 0 0.1376039683818817
, O 0 0.0019477126188576221
or O 0 0.14247433841228485
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.02056361921131611
mostly O 0 0.0024969475343823433
in O 0 0.0033025711309164762
childhood O 1 0.9903345704078674
. O 0 0.009398515336215496

A O 0 0.0072461459785699844
wide O 0 0.0035813741851598024
variety O 0 0.0026490387972444296
of O 0 0.0024478540290147066
ATM O 0 0.14510273933410645
mutation O 0 0.002768309088423848
types O 0 0.000952152768149972
, O 0 0.0006929410737939179
including O 0 0.0006773474742658436
missense O 0 0.004012678749859333
mutations O 0 0.0010363064939156175
and O 0 0.0005906912265345454
in O 0 0.0007748539792373776
- O 0 0.040720079094171524
frame O 0 0.003198049496859312
deletions O 0 0.0018551667453721166
, O 0 0.0006515078130178154
were O 0 0.0005874024354852736
seen O 0 0.0009012345690280199
in O 0 0.0009373570792376995
these O 0 0.0013861516490578651
patients O 0 0.04285901412367821
. O 0 0.006445225328207016

We O 0 0.004412448033690453
also O 0 0.0021049478091299534
show O 0 0.0016829546075314283
that O 0 0.0006317209918051958
25 O 0 0.0007795525598339736
% O 0 0.0005796264158561826
of O 0 0.0005133386584930122
all O 0 0.0005317326285876334
A B-Disease 0 0.306082159280777
- I-Disease 1 0.9950799942016602
T I-Disease 1 0.9976049661636353
patients O 0 0.016940360888838768
carried O 0 0.0008213897817768157
in O 0 0.0006830829661339521
- O 0 0.004013726953417063
frame O 0 0.002210996113717556
deletions O 0 0.0021040127612650394
or O 0 0.0008226084755733609
missense O 0 0.002836583647876978
mutations O 0 0.0009542506886646152
, O 0 0.0004353935073595494
many O 0 0.0003419490240048617
of O 0 0.0004886399256065488
which O 0 0.00044377861195243895
were O 0 0.00046731423935852945
also O 0 0.0005509366164915264
associated O 0 0.0006766445585526526
with O 0 0.000648151442874223
expression O 0 0.001550369313918054
of O 0 0.0020651782397180796
mutant O 0 0.088460274040699
ATM O 0 0.015693379566073418
protein O 0 0.007039458490908146
. O 0 0.006770056206732988

The O 0 0.01045710314065218
DMPK O 1 0.9344244599342346
gene O 0 0.008932499215006828
of O 0 0.07095928490161896
severely O 1 0.9999887943267822
affected O 1 0.9999852180480957
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999997615814209
is O 1 0.9885821342468262
hypermethylated O 1 0.999975323677063
proximal O 1 0.997736930847168
to O 0 0.001387939671985805
the O 0 0.0018451367504894733
largely O 0 0.0036538371350616217
expanded O 0 0.007083578035235405
CTG O 1 0.9356450438499451
repeat O 0 0.020731301978230476
. O 0 0.011407212354242802

Using O 0 0.008693021722137928
methylation O 0 0.0113717932254076
- O 0 0.008928464725613594
sensitive O 0 0.0038949595764279366
restriction O 0 0.0033578004222363234
enzymes O 0 0.002154974266886711
, O 0 0.0011048986343666911
we O 0 0.0007783025503158569
characterized O 0 0.0015594942960888147
the O 0 0.0008355805766768754
methylation O 0 0.0013310459908097982
pattern O 0 0.0010791663080453873
on O 0 0.0005425548297353089
the O 0 0.0005549832712858915
5 O 0 0.0007023661746643484
side O 0 0.0006674247561022639
of O 0 0.000651621725410223
the O 0 0.0010619435925036669
CTG O 1 0.672607421875
repeat O 0 0.002111791167408228
in O 0 0.0005718037718906999
the O 0 0.000727394362911582
DMPK O 0 0.250847727060318
gene O 0 0.0006470804801210761
of O 0 0.00040701107354834676
normal O 0 0.0005958692054264247
individuals O 0 0.0003408009943086654
and O 0 0.00045425791176967323
of O 0 0.013808331452310085
patients O 1 0.9998477697372437
affected O 1 0.968870222568512
with O 1 0.9863095283508301
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.5902475118637085
showing O 0 0.09112045168876648
expansions O 0 0.009323018603026867
of O 0 0.002372145652770996
the O 0 0.003978842869400978
repetitive O 1 0.7766276001930237
sequence O 0 0.008318980224430561
. O 0 0.008099853992462158

The O 0 0.00889661442488432
gene O 0 0.0062757376581430435
segment O 0 0.005169670097529888
analyzed O 0 0.003641219576820731
corresponds O 0 0.003382246010005474
to O 0 0.0012238741619512439
the O 0 0.001695489976555109
genomic O 0 0.006129923276603222
SacI O 0 0.4353480339050293
- O 0 0.007030448876321316
HindIII O 0 0.012262730859220028
fragment O 0 0.004996599163860083
carrying O 0 0.0036312860902398825
exons O 0 0.007419640198349953
11 O 0 0.004877643659710884
- O 0 0.007716919295489788
15 O 0 0.0066138035617768764
. O 0 0.00802804809063673

There O 0 0.005518143065273762
is O 0 0.0036931107752025127
constitutive O 0 0.007980169728398323
methylation O 0 0.003957705106586218
in O 0 0.00155003578402102
intron O 0 0.015883181244134903
12 O 0 0.0013688351027667522
at O 0 0.0010255841771140695
restriction O 0 0.0011457839282229543
sites O 0 0.0006350550102069974
of O 0 0.0006864863680675626
SacII O 0 0.023510001599788666
and O 0 0.0008518614340573549
HhaI O 0 0.02081136777997017
, O 0 0.0008612903184257448
localized O 0 0.0015849710907787085
1 O 0 0.0010234295623376966
, O 0 0.0007839040481485426
159 O 0 0.0021245386451482773
- O 0 0.001706780749373138
1 O 0 0.0009562164195813239
, O 0 0.0008606972405686975
232 O 0 0.0024421780835837126
bp O 0 0.0019412856781855226
upstream O 0 0.0015041333390399814
of O 0 0.000918953213840723
the O 0 0.0011838834034278989
CTG O 1 0.9896424412727356
repeat O 0 0.011685946956276894
, O 0 0.000699237862136215
whereas O 0 0.0007614211644977331
most O 0 0.00035595352528616786
, O 0 0.00036400658427737653
if O 0 0.00026157411048188806
not O 0 0.00020244208280928433
all O 0 0.00020448642317205667
, O 0 0.00028409186052158475
of O 0 0.00027989374939352274
the O 0 0.000326821900671348
other O 0 0.0002598995924927294
sites O 0 0.0003851526998914778
of O 0 0.0006050445372238755
SacII O 1 0.5703624486923218
, O 0 0.0008948160102590919
HhaI O 0 0.15404637157917023
, O 0 0.0005740976775996387
and O 0 0.000548708310816437
HpaII O 0 0.014698288403451443
in O 0 0.000526443705894053
this O 0 0.00039366522105410695
region O 0 0.0006239348440431058
are O 0 0.00037840998265892267
unmethylated O 0 0.00416406849399209
, O 0 0.0005621748859994113
in O 0 0.0004476585891097784
normal O 0 0.000736374466214329
individuals O 0 0.0004281408619135618
and O 0 0.0004703523009084165
most O 0 0.0006115717114880681
of O 0 0.0013789624208584428
the O 0 0.005716011859476566
patients O 1 0.9353795051574707
. O 0 0.009135940112173557

In O 0 0.0032646909821778536
a O 0 0.0023034303449094296
number O 0 0.0013082443038001657
of O 0 0.001639237510971725
young O 1 0.51735520362854
and O 0 0.08300303667783737
severely O 1 0.9997221827507019
affected O 1 0.7317715883255005
patients O 1 0.8775692582130432
, O 0 0.00077424431219697
however O 0 0.0005521269631572068
, O 0 0.0004957561031915247
complete O 0 0.0007594020571559668
methylation O 0 0.0009462814196012914
of O 0 0.0004271404759492725
these O 0 0.0003446493938099593
restriction O 0 0.0008754764567129314
sites O 0 0.0006748156156390905
was O 0 0.0008744384977035224
found O 0 0.0008353581069968641
in O 0 0.0010799235897138715
the O 0 0.0029432016890496016
mutated O 0 0.014393424615263939
allele O 0 0.012434923090040684
. O 0 0.008900163695216179

In O 0 0.0032687385100871325
most O 0 0.0016283626900985837
of O 0 0.0013843316119164228
these O 0 0.0009427063050679862
patients O 0 0.15734010934829712
, O 0 0.0010619597742334008
the O 0 0.0021405545994639397
onset O 1 0.9999121427536011
of O 1 0.867747962474823
the O 1 0.999546229839325
disease O 1 1.0
was O 1 0.9999926090240479
congenital O 1 1.0
. O 1 0.8132597208023071

Preliminary O 0 0.009857573546469212
in O 0 0.004688114859163761
vivo O 0 0.013316310942173004
footprinting O 0 0.09094329923391342
data O 0 0.002109289402142167
gave O 0 0.0018638186156749725
evidence O 0 0.0011137945111840963
for O 0 0.0008232664549723268
protein O 0 0.0012556207366287708
- O 0 0.001654103514738381
DNA O 0 0.00088419922394678
contact O 0 0.0006937065627425909
in O 0 0.0005459979292936623
normal O 0 0.0007573719485662878
genes O 0 0.0006614984595216811
at O 0 0.0007103558164089918
an O 0 0.0007055810419842601
Sp1 O 0 0.02454977110028267
consensus O 0 0.0012735046911984682
binding O 0 0.0008000111556611955
site O 0 0.0008542417781427503
upstream O 0 0.0011922884732484818
of O 0 0.0006954232230782509
the O 0 0.0009905154583975673
CTG O 1 0.9428970217704773
repeat O 0 0.0023022820241749287
and O 0 0.0005289364489726722
for O 0 0.00048060633707791567
a O 0 0.0007083902019076049
significant O 0 0.0006758118979632854
reduction O 0 0.0009310844470746815
of O 0 0.000537729007191956
this O 0 0.00040994404116645455
interaction O 0 0.0006788632599636912
in O 0 0.0005680773174390197
cells O 0 0.0008482185658067465
with O 0 0.0007347566424869001
a O 0 0.0024318345822393894
hypermethylated O 1 0.9187062978744507
DMPK O 1 0.9729280471801758
gene O 0 0.005311394110321999
. O 0 0.003678561421111226
. O 0 0.007607795298099518

The O 0 0.08022397756576538
hemochromatosis B-Disease 1 0.9999916553497314
gene O 0 0.011752450838685036
product O 0 0.004343045875430107
complexes O 0 0.00544995442032814
with O 0 0.0018984490307047963
the O 0 0.003767147194594145
transferrin O 1 0.990114688873291
receptor O 0 0.0061998204328119755
and O 0 0.00180636381264776
lowers O 0 0.07750282436609268
its O 0 0.001626988174393773
affinity O 0 0.003385151969268918
for O 0 0.0024897060357034206
ligand O 0 0.009810122661292553
binding O 0 0.008059361018240452
. O 0 0.009453831240534782

We O 0 0.0051373825408518314
recently O 0 0.004782136995345354
reported O 0 0.0025456862058490515
the O 0 0.0015748311998322606
positional O 0 0.003481833729892969
cloning O 0 0.0021961149759590626
of O 0 0.0011815946782007813
a O 0 0.0018410516204312444
candidate O 0 0.0038384210783988237
gene O 0 0.003964163828641176
for O 0 0.003608090104535222
hereditary B-Disease 1 0.9999924898147583
hemochromatosis I-Disease 1 1.0
called O 1 0.999640703201294
HFE O 1 0.9999923706054688
. O 0 0.024455906823277473

The O 0 0.0070041767321527
gene O 0 0.004058950114995241
product O 0 0.0023567574098706245
, O 0 0.000987067585811019
a O 0 0.0009386525489389896
member O 0 0.0009841772262006998
of O 0 0.0007561863749288023
the O 0 0.0011623379541561007
major O 0 0.010014657862484455
histocompatibility O 1 0.9999545812606812
complex O 0 0.20915745198726654
class O 1 0.7950109243392944
I O 0 0.14330407977104187
- O 0 0.038962554186582565
like O 0 0.0006882924353703856
family O 0 0.0007434349972754717
, O 0 0.0005177748389542103
was O 0 0.0006945417262613773
found O 0 0.00043101763003505766
to O 0 0.0002976622781716287
have O 0 0.00028302831924520433
a O 0 0.0005902860430069268
mutation O 0 0.0009910997468978167
, O 0 0.000942082260735333
Cys O 1 0.605416476726532
- O 0 0.008961161598563194
282 O 0 0.08859270811080933
- O 0 0.17318356037139893
- O 0 0.18858714401721954
> O 0 0.01603524759411812
Tyr O 1 0.8059921860694885
( O 0 0.0017892239848151803
C282Y O 0 0.00354505586437881
) O 0 0.0007841375190764666
, O 0 0.0005557709373533726
in O 0 0.000599219580180943
85 O 0 0.001814246061258018
% O 0 0.0014466473367065191
of O 0 0.0022440976463258266
patient O 0 0.10712900757789612
chromosomes O 0 0.011997613124549389
. O 0 0.008259874768555164

This O 0 0.006098342593759298
mutation O 0 0.0070190769620239735
eliminates O 0 0.006950101349502802
the O 0 0.0019046582747250795
ability O 0 0.0018062571762129664
of O 0 0.00137880421243608
HFE O 1 0.9170461297035217
to O 0 0.0009517762809991837
associate O 0 0.001975961262360215
with O 0 0.0011352397268638015
beta2 O 1 0.856731116771698
- O 1 0.5851987600326538
microglobulin O 1 0.824533224105835
( O 0 0.00230760732665658
beta2m O 0 0.04812772944569588
) O 0 0.0011939610121771693
and O 0 0.0011968474136665463
prevents O 0 0.0033138839062303305
cell O 0 0.003350229002535343
- O 0 0.0064286780543625355
surface O 0 0.005000914912670851
expression O 0 0.007158584427088499
. O 0 0.007076817099004984

A O 0 0.010496586561203003
second O 0 0.006491817533969879
mutation O 0 0.004163406323641539
that O 0 0.0009639899944886565
has O 0 0.0010560498340055346
no O 0 0.0009111302206292748
effect O 0 0.0009992378763854504
on O 0 0.0010137655772268772
beta2m O 0 0.17969562113285065
association O 0 0.0029662377201020718
, O 0 0.0012385447043925524
H63D O 1 0.816638171672821
, O 0 0.0007946589030325413
was O 0 0.0007825520006008446
found O 0 0.00045408602454699576
in O 0 0.00043017350253649056
eight O 0 0.0005533104995265603
out O 0 0.0004764570330735296
of O 0 0.0006436675321310759
nine O 0 0.0013553195167332888
patients O 0 0.02349942736327648
heterozygous O 0 0.0028624264523386955
for O 0 0.001374799176119268
the O 0 0.002936461940407753
C282Y O 1 0.5327195525169373
mutant O 0 0.031724512577056885
. O 0 0.008539121598005295

In O 0 0.004386482760310173
this O 0 0.0018438076367601752
report O 0 0.0017851059092208743
, O 0 0.0009810023475438356
we O 0 0.0007625180296599865
demonstrate O 0 0.0011980565031990409
in O 0 0.0009242899832315743
cultured O 0 0.0032750507816672325
293 O 0 0.013116034679114819
cells O 0 0.002351868897676468
overexpressing O 0 0.3232341706752777
wild O 0 0.003228564513847232
- O 0 0.01871323585510254
type O 0 0.0029582332354038954
or O 0 0.0010897647589445114
mutant O 0 0.00618639076128602
HFE O 0 0.34807610511779785
proteins O 0 0.0007577083888463676
that O 0 0.0003977293672505766
both O 0 0.0003847248153761029
the O 0 0.0005936232046224177
wild O 0 0.0015978910960257053
- O 0 0.02809697948396206
type O 0 0.006088474299758673
and O 0 0.001676251064054668
H63D O 1 0.9931129813194275
HFE O 1 0.9938724040985107
proteins O 0 0.0015235919272527099
form O 0 0.0015688848216086626
stable O 0 0.0032021317165344954
complexes O 0 0.0026168322656303644
with O 0 0.0013262495631352067
the O 0 0.0035176819656044245
transferrin O 1 0.9756764769554138
receptor O 0 0.0219759289175272
( O 0 0.006736822426319122
TfR O 1 0.9602080583572388
) O 0 0.006230388302356005
. O 0 0.008177446201443672

The O 0 0.009365798905491829
C282Y O 0 0.2900182008743286
mutation O 0 0.008627977222204208
nearly O 0 0.0030907467007637024
completely O 0 0.00316250161267817
prevents O 0 0.003076910972595215
the O 0 0.0015937095740810037
association O 0 0.0022598665673285723
of O 0 0.0019078264012932777
the O 0 0.004488492850214243
mutant O 1 0.7242523431777954
HFE O 1 0.9964231848716736
protein O 0 0.0038268351927399635
with O 0 0.002710354281589389
the O 0 0.006985430605709553
TfR O 1 0.9820859432220459
. O 0 0.014146292582154274

Studies O 0 0.008191345259547234
on O 0 0.004219118505716324
cell O 0 0.006887080147862434
- O 0 0.007256557699292898
associated O 0 0.002373862313106656
transferrin O 0 0.009943654760718346
at O 0 0.0013984133256599307
37 O 0 0.0016154651530086994
degrees O 0 0.0012971590040251613
C O 0 0.001712542842142284
suggest O 0 0.0010119467042386532
that O 0 0.0005592493689619005
the O 0 0.0009925784543156624
overexpressed O 0 0.007761277258396149
wild O 0 0.0029653143137693405
- O 0 0.04819321259856224
type O 0 0.027131900191307068
HFE O 1 0.9770228862762451
protein O 0 0.0019757309928536415
decreases O 0 0.002136547351256013
the O 0 0.0011185894254595041
affinity O 0 0.002101767109706998
of O 0 0.0017198281129822135
the O 0 0.004905063658952713
TfR O 1 0.9993441700935364
for O 0 0.008285186253488064
transferrin O 1 0.8352574110031128
. O 0 0.012524411082267761

The O 0 0.01255355216562748
overexpressed O 1 0.9597253203392029
H63D O 1 0.9945015907287598
protein O 0 0.003501666011288762
does O 0 0.001193525968119502
not O 0 0.0005094832158647478
have O 0 0.0003983710485044867
this O 0 0.00038260346627794206
effect O 0 0.0006383716827258468
, O 0 0.0005111343343742192
providing O 0 0.0005835372721776366
the O 0 0.000520670844707638
first O 0 0.0005058631068095565
direct O 0 0.000488434627186507
evidence O 0 0.0004756497801281512
for O 0 0.00048201900790445507
a O 0 0.000797041691839695
functional O 0 0.0016849716193974018
consequence O 0 0.0025156503543257713
of O 0 0.002072257222607732
the O 0 0.006255133077502251
H63D O 1 0.9990285634994507
mutation O 0 0.08304304629564285
. O 0 0.009934566915035248

Addition O 0 0.006566740572452545
of O 0 0.004094778560101986
soluble O 0 0.32380586862564087
wild O 0 0.0283345989882946
- O 1 0.9800840616226196
type O 1 0.9822481274604797
HFE O 1 0.9999932050704956
/ O 1 0.991912841796875
beta2m O 1 0.96538245677948
heterodimers O 1 0.9656567573547363
to O 0 0.0015800604596734047
cultured O 0 0.07876232266426086
cells O 0 0.0014848143327981234
also O 0 0.000857883074786514
decreased O 0 0.0016965403920039535
the O 0 0.0006488971412181854
apparent O 0 0.0018945324700325727
affinity O 0 0.0014185956679284573
of O 0 0.0007704793242737651
the O 0 0.0013245661975815892
TfR O 1 0.9749097228050232
for O 0 0.0006570538389496505
its O 0 0.0006468002684414387
ligand O 0 0.0018393085338175297
under O 0 0.001165998401120305
steady O 0 0.014398607425391674
- O 0 0.0026766997762024403
state O 0 0.0006621020147576928
conditions O 0 0.0007229120819829404
, O 0 0.00043700062087737024
both O 0 0.00040747830644249916
in O 0 0.0007963083335198462
293 O 0 0.07470673322677612
cells O 0 0.0016875860746949911
and O 0 0.0012819988187402487
in O 0 0.0028548475820571184
HeLa O 1 0.9850670099258423
cells O 0 0.010211791843175888
. O 0 0.0074308873154222965

Furthermore O 0 0.007354913279414177
, O 0 0.0025101902429014444
at O 0 0.0017708895029500127
4 O 0 0.001568156061694026
degrees O 0 0.0014361918438225985
C O 0 0.002087731845676899
, O 0 0.0007639050018042326
the O 0 0.0007343509350903332
added O 0 0.0012933980906382203
soluble O 0 0.0026812355499714613
complex O 0 0.0017692095134407282
of O 0 0.004322228953242302
HFE O 1 0.999996542930603
/ O 1 0.9851338863372803
beta2m O 1 0.8115298748016357
inhibited O 0 0.003632006933912635
binding O 0 0.0010440407786518335
of O 0 0.0011666066711768508
transferrin O 0 0.04768509045243263
to O 0 0.001501734834164381
HeLa O 1 0.9497508406639099
cell O 0 0.005431549157947302
TfR O 1 0.9113706350326538
in O 0 0.0014135626843199134
a O 0 0.0025276464875787497
concentration O 0 0.18546009063720703
- O 0 0.29198917746543884
dependent O 0 0.00601310096681118
manner O 0 0.006623736582696438
. O 0 0.008543409407138824

Scatchard O 0 0.02998642437160015
plots O 0 0.008526260033249855
of O 0 0.002992985537275672
these O 0 0.0013974292669445276
data O 0 0.0012796096270903945
indicate O 0 0.0012454723473638296
that O 0 0.0006605764501728117
the O 0 0.001077444525435567
added O 0 0.0021218431647866964
heterodimer O 0 0.26117417216300964
substantially O 0 0.0029231535736471415
reduced O 0 0.0018949421355500817
the O 0 0.0016314215026795864
affinity O 0 0.0038033481687307358
of O 0 0.004273332189768553
TfR O 1 0.9994156360626221
for O 0 0.008153649047017097
transferrin O 1 0.6743945479393005
. O 0 0.010380156338214874

These O 0 0.0031357703264802694
results O 0 0.0023685768246650696
establish O 0 0.002263178350403905
a O 0 0.0014688860392197967
molecular O 0 0.00224844622425735
link O 0 0.002547943964600563
between O 0 0.0015228259144350886
HFE O 1 0.9491028785705566
and O 0 0.0008223706390708685
a O 0 0.000875750498380512
key O 0 0.0009668183047324419
protein O 0 0.0007957503548823297
involved O 0 0.0005050284089520574
in O 0 0.0005698424065485597
iron O 0 0.38512441515922546
transport O 0 0.003383553121238947
, O 0 0.000744092685636133
the O 0 0.001281876233406365
TfR O 1 0.9991123080253601
, O 0 0.0006937984726391733
and O 0 0.00048267599777318537
raise O 0 0.000705413636751473
the O 0 0.0004479467461351305
possibility O 0 0.0007765582413412631
that O 0 0.0003907037025783211
alterations O 0 0.001044740783981979
in O 0 0.00043300920515321195
this O 0 0.00045935146044939756
regulatory O 0 0.001064071198925376
mechanism O 0 0.0010201853001490235
may O 0 0.0005362444208003581
play O 0 0.0004552215395960957
a O 0 0.0005535521195270121
role O 0 0.0008802987867966294
in O 0 0.0007299052667804062
the O 0 0.0021652509458363056
pathogenesis O 1 0.9998737573623657
of O 1 0.9806304574012756
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.47837790846824646
. O 0 0.01390098687261343

Genomic O 0 0.019246457144618034
organization O 0 0.00774384755641222
of O 0 0.004873978905379772
the O 0 0.01765497960150242
UBE3A O 1 0.9999939203262329
/ O 1 0.9995892643928528
E6 O 1 0.9981622099876404
- O 1 0.6418107151985168
AP O 0 0.015017032623291016
gene O 0 0.0044752322137355804
and O 0 0.0027011155616492033
related O 0 0.006739174947142601
pseudogenes O 0 0.04159148409962654
. O 0 0.01164279505610466

The O 0 0.014623109251260757
UBE3A O 1 0.9620477557182312
gene O 0 0.006778094917535782
encodes O 0 0.0057128178887069225
the O 0 0.002949047600850463
E6 O 1 0.824600875377655
- O 0 0.10211930423974991
AP O 0 0.00905405730009079
ubiquitin O 0 0.03305686637759209
- O 0 0.012590359896421432
protein O 0 0.0019230610923841596
ligase O 0 0.0035807685926556587
and O 0 0.0009445452014915645
has O 0 0.0008110494236461818
recently O 0 0.0009854785166680813
been O 0 0.000536638661287725
shown O 0 0.0006457134732045233
to O 0 0.0004941628430970013
be O 0 0.0006519699236378074
mutated O 0 0.034057650715112686
in O 0 0.07764509320259094
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999886751174927
who O 1 0.7485108971595764
lack O 1 0.972066342830658
15q11 O 1 0.99979168176651
- O 1 0.99186772108078
q13 O 1 0.9398706555366516
deletions O 0 0.021247180178761482
or O 0 0.002332163043320179
chromosome O 0 0.006489332765340805
15 O 0 0.005064064171165228
paternal O 1 0.7273569107055664
uniparental B-Disease 1 0.999854326248169
disomy I-Disease 1 0.9935775399208069
. O 0 0.015675555914640427

Previous O 0 0.01709602028131485
UBE3A O 1 0.9017916321754456
cDNA O 0 0.014019159600138664
analysis O 0 0.003877931972965598
has O 0 0.002336678560823202
shown O 0 0.0017640423029661179
a O 0 0.0015920079313218594
coding O 0 0.0031720763072371483
region O 0 0.0019988385029137135
of O 0 0.0016515754396095872
approximately O 0 0.0031358448322862387
2 O 0 0.005083504132926464
. O 0 0.006535999942570925

6 O 0 0.010418063029646873
kb O 0 0.01284379418939352
and O 0 0.0019332231022417545
a O 0 0.002148530213162303
3 O 0 0.002823654329404235
- O 0 0.011892979964613914
untranslated O 0 0.03245324268937111
region O 0 0.0022186054848134518
( O 0 0.0016602474497631192
UTR O 0 0.007948108948767185
) O 0 0.0008687422377988696
of O 0 0.0009812356438487768
< O 0 0.003046434372663498
50 O 0 0.001115378807298839
bp O 0 0.0020276005379855633
, O 0 0.0007736720726825297
whereas O 0 0.0010038925101980567
Northern O 0 0.0009101085597649217
analysis O 0 0.0009027837077155709
has O 0 0.000834826088976115
indicated O 0 0.0011710196267813444
mRNA O 0 0.001555266440846026
sizes O 0 0.0014619419816881418
of O 0 0.0013866996159777045
5 O 0 0.0025065417867153883
- O 0 0.0063166837207973
8 O 0 0.006573690101504326
kb O 0 0.024620890617370605
. O 0 0.009666919708251953

We O 0 0.0042136432603001595
have O 0 0.0019243537681177258
analyzed O 0 0.003467547008767724
additional O 0 0.002784440293908119
cDNA O 0 0.00733921630308032
clones O 0 0.004851717967540026
and O 0 0.001180885941721499
provide O 0 0.0011921478435397148
evidence O 0 0.0012337890220806003
for O 0 0.000992857152596116
an O 0 0.0013670348562300205
additional O 0 0.003236444666981697
0 O 0 0.006759447976946831
. O 0 0.007349363993853331

5 O 0 0.010519249364733696
kb O 0 0.015681274235248566
of O 0 0.004009931813925505
5 O 0 0.005054669454693794
- O 0 0.009233234450221062
UTR O 0 0.02805374376475811
and O 0 0.0018539114389568567
> O 0 0.004856668412685394
2 O 0 0.002967623295262456
kb O 0 0.00730084627866745
of O 0 0.0029299312736839056
3 O 0 0.006728965323418379
- O 0 0.03192359581589699
UTR O 0 0.1498955488204956
. O 0 0.010964745655655861

We O 0 0.004329285584390163
have O 0 0.002099007600918412
established O 0 0.002375500276684761
the O 0 0.001551163732074201
genomic O 0 0.003251896006986499
organization O 0 0.0019552051089704037
of O 0 0.0016550315776839852
UBE3A O 1 0.9639478921890259
and O 0 0.001176380319520831
the O 0 0.0012749526649713516
sequence O 0 0.0022077669855207205
of O 0 0.0028666327707469463
intron O 1 0.9972168207168579
- O 1 0.5481050610542297
exon O 0 0.07998303323984146
borders O 0 0.01001410000026226
. O 0 0.010587068274617195

We O 0 0.004862931091338396
have O 0 0.0017159709241241217
also O 0 0.001447106129489839
mapped O 0 0.0022048759274184704
two O 0 0.000863207911606878
highly O 0 0.0013837781734764576
homologous O 0 0.002454707631841302
processed O 0 0.001763633219525218
pseudogenes O 0 0.0051585654728114605
, O 0 0.00137041206471622
UBE3AP1 O 0 0.33844247460365295
and O 0 0.0011042897822335362
UBE3AP2 O 0 0.04362258315086365
, O 0 0.0006146095111034811
to O 0 0.0004369631060399115
chromosomes O 0 0.0007452467107214034
2 O 0 0.0005820328951813281
and O 0 0.0004003315989393741
21 O 0 0.0006580025656148791
, O 0 0.0005845103296451271
respectively O 0 0.0009363453136757016
, O 0 0.0006144531653262675
and O 0 0.0008030993049032986
determined O 0 0.001691120327450335
their O 0 0.0013552409363910556
genomic O 0 0.00698311161249876
organization O 0 0.00640315655618906
. O 0 0.007718168664723635

These O 0 0.003597712842747569
results O 0 0.002145879901945591
will O 0 0.000994669389910996
form O 0 0.0008623784524388611
the O 0 0.0006468366482295096
basis O 0 0.0006878681597299874
for O 0 0.0005740043707191944
studies O 0 0.0009877070551738143
of O 0 0.0011558098485693336
mutation O 0 0.003459544852375984
and O 0 0.002003573579713702
imprinting O 0 0.04677955061197281
of O 0 0.008576122112572193
UBE3A O 1 0.9988717436790466
. O 0 0.012634343467652798

Mutation O 0 0.01464119739830494
spectrum O 0 0.009040000848472118
and O 0 0.003916856367141008
genotype O 0 0.03648080676794052
- O 0 0.0168318971991539
phenotype O 0 0.006011494435369968
analyses O 0 0.0032512841280549765
in O 0 0.002278965897858143
Cowden B-Disease 1 0.9999783039093018
disease I-Disease 1 0.9999868869781494
and O 1 0.5574665069580078
Bannayan B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999974966049194
Zonana I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
, O 0 0.13237839937210083
two O 0 0.02526981197297573
hamartoma B-Disease 1 0.9999986886978149
syndromes I-Disease 1 0.9999970197677612
with O 1 0.8190029859542847
germline O 1 0.999977707862854
PTEN O 1 0.9999678134918213
mutation O 0 0.2892940044403076
. O 0 0.011220713146030903

The O 0 0.2685492932796478
tumour B-Disease 1 0.9999953508377075
suppressor O 1 0.9975723624229431
gene O 0 0.015013844706118107
PTEN O 1 0.570304811000824
, O 0 0.0028194254264235497
which O 0 0.002297141356393695
maps O 0 0.004367409739643335
to O 0 0.0036365429405122995
10q23 O 0 0.023898592218756676
. O 0 0.009679418057203293

3 O 0 0.008900840766727924
and O 0 0.003899287199601531
encodes O 0 0.005844078958034515
a O 0 0.002813257509842515
403 O 0 0.006534120533615351
amino O 0 0.003012927481904626
acid O 0 0.0036372877657413483
dual O 0 0.003503866260871291
specificity O 0 0.003965651150792837
phosphatase O 0 0.1328594833612442
( O 0 0.002049781382083893
protein O 0 0.0019763177260756493
tyrosine O 0 0.0031077228486537933
phosphatase O 0 0.0162972342222929
; O 0 0.0011684641940519214
PTPase O 0 0.02383783645927906
) O 0 0.0008693525451235473
, O 0 0.0007050150306895375
was O 0 0.0009185462258756161
shown O 0 0.0007043058867566288
recently O 0 0.0007674525259062648
to O 0 0.00041134978528134525
play O 0 0.0005153570673428476
a O 0 0.0006825243472121656
broad O 0 0.001561307581141591
role O 0 0.0019837692379951477
in O 0 0.0018636839231476188
human O 0 0.024744009599089622
malignancy B-Disease 1 0.9999001026153564
. O 0 0.009931640699505806

Somatic O 1 0.8476978540420532
PTEN O 1 0.9582505822181702
deletions O 0 0.011685545556247234
and O 0 0.002158035058528185
mutations O 0 0.002033818978816271
were O 0 0.000919605023227632
observed O 0 0.0011635193368420005
in O 0 0.000945332576520741
sporadic B-Disease 0 0.4800003468990326
breast I-Disease 1 0.9999940395355225
, I-Disease 1 0.595528244972229
brain I-Disease 1 0.9998928308486938
, I-Disease 1 0.980420708656311
prostate I-Disease 1 1.0
and I-Disease 1 0.9982404708862305
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cell O 1 0.9055489301681519
lines O 0 0.0017360548954457045
and O 0 0.0004883238580077887
in O 0 0.0005157057312317193
several O 0 0.0006894708494655788
primary O 0 0.011274473741650581
tumours B-Disease 1 0.9901366233825684
such O 0 0.0010882127098739147
as O 0 0.05473389849066734
endometrial B-Disease 1 0.9999995231628418
carcinomas I-Disease 1 1.0
, O 1 0.9999908208847046
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999986886978149
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9753318428993225

In O 0 0.0049967956729233265
addition O 0 0.0037206020206212997
, O 0 0.0030452252831310034
PTEN O 1 0.9424570798873901
was O 0 0.002477474743500352
identified O 0 0.001372986356727779
as O 0 0.0006833665538579226
the O 0 0.0007981141097843647
susceptibility O 0 0.008965503424406052
gene O 0 0.0011753857834264636
for O 0 0.0008669919334352016
two O 0 0.001986317802220583
hamartoma B-Disease 1 0.999997615814209
syndromes I-Disease 1 0.9999997615814209
Cowden B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999998807907104
( O 1 0.6725159883499146
CD B-Disease 0 0.4099326729774475
; O 0 0.002043628366664052
MIM O 1 0.9793116450309753
158350 O 0 0.024510458111763
) O 0 0.0010179670061916113
and O 0 0.0009559103637002409
Bannayan B-Disease 0 0.3537960350513458
- I-Disease 0 0.14833687245845795
Zonana I-Disease 1 0.9881677031517029
( I-Disease 0 0.002518473193049431
BZS I-Disease 0 0.25749799609184265
) I-Disease 0 0.0012603024952113628
or I-Disease 0 0.0015062225284054875
Ruvalcaba I-Disease 1 0.9222283959388733
- I-Disease 1 0.6399205327033997
Riley I-Disease 1 0.9683266282081604
- I-Disease 1 0.9865261912345886
Smith I-Disease 1 0.9687981605529785
syndrome I-Disease 1 0.9999995231628418
( O 1 0.8108509182929993
MIM O 1 0.99996018409729
153480 O 1 0.9805563688278198
) O 0 0.008185490034520626
. O 0 0.008226876147091389

Constitutive O 0 0.02739507146179676
DNA O 0 0.0063460408709943295
from O 0 0.0023138346150517464
37 O 0 0.003366406075656414
CD B-Disease 0 0.0030230525881052017
families O 0 0.0013598882360383868
and O 0 0.001141228131018579
seven O 0 0.002073688432574272
BZS B-Disease 1 0.6364337205886841
families O 0 0.002684028120711446
was O 0 0.003096794243901968
screened O 0 0.006678433157503605
for O 0 0.004644386935979128
germline O 1 0.8847730159759521
PTEN O 1 0.9897638559341431
mutations O 0 0.015291671268641949
. O 0 0.010456250980496407

PTEN O 1 0.7379366755485535
mutations O 0 0.00601328955963254
were O 0 0.0015234599122777581
identified O 0 0.0014908767770975828
in O 0 0.0007734619430266321
30 O 0 0.0007398672751151025
of O 0 0.0006583789363503456
37 O 0 0.0011551589705049992
( O 0 0.0008236155845224857
81 O 0 0.0016053770668804646
% O 0 0.0007990252925083041
) O 0 0.0006373050273396075
CD B-Disease 0 0.0010243215365335345
families O 0 0.0005337121547199786
, O 0 0.00045760005014017224
including O 0 0.000549500691704452
missense O 0 0.0021498820278793573
and O 0 0.0006285065901465714
nonsense O 0 0.003154007950797677
point O 0 0.0011813956080004573
mutations O 0 0.0011845044791698456
, O 0 0.0007058329065330327
deletions O 0 0.0017720389878377318
, O 0 0.000863913563080132
insertions O 0 0.0029480555094778538
, O 0 0.0011322072241455317
a O 0 0.0017517420928925276
deletion O 0 0.0809488594532013
/ O 0 0.16192497313022614
insertion O 0 0.007395704742521048
and O 0 0.0024609281681478024
splice O 0 0.012895392253994942
site O 0 0.006808576174080372
mutations O 0 0.010722783394157887
. O 0 0.00832356046885252

These O 0 0.004099351353943348
mutations O 0 0.0034324571024626493
were O 0 0.0014063736889511347
scattered O 0 0.0017563047586008906
over O 0 0.001049287267960608
the O 0 0.0010100328363478184
entire O 0 0.0015319472877308726
length O 0 0.0013633959461003542
of O 0 0.0012822621501982212
PTEN O 1 0.9717907905578613
, O 0 0.0006380632403306663
with O 0 0.0004546525306068361
the O 0 0.0005973641527816653
exception O 0 0.0007584192790091038
of O 0 0.000532803067471832
the O 0 0.0006752631161361933
first O 0 0.0009803149150684476
, O 0 0.0009767573792487383
fourth O 0 0.002584013855084777
and O 0 0.001714882324449718
last O 0 0.003988212905824184
exons O 0 0.014287276193499565
. O 0 0.007137245032936335

A O 0 0.012073146179318428
hot O 0 0.013743367977440357
spot O 0 0.007429094053804874
for O 0 0.003366385120898485
PTEN O 1 0.9347673654556274
mutation O 0 0.003223768202587962
in O 0 0.0010558959329500794
CD B-Disease 0 0.0028208442963659763
was O 0 0.0014395054895430803
identified O 0 0.0009693736210465431
in O 0 0.0006324227433651686
exon O 0 0.002430338179692626
5 O 0 0.000671494344715029
that O 0 0.0003955569409299642
contains O 0 0.0005858129006810486
the O 0 0.000632462848443538
PTPase O 0 0.00899787899106741
core O 0 0.0014121283311396837
motif O 0 0.00149111810605973
, O 0 0.00044304991024546325
with O 0 0.00036715195165015757
13 O 0 0.000541195971891284
of O 0 0.000397550844354555
30 O 0 0.000617036537732929
( O 0 0.0006721247336827219
43 O 0 0.000967256841249764
% O 0 0.0007627763552591205
) O 0 0.0008371823932975531
CD B-Disease 0 0.0017425540136173368
mutations O 0 0.0014282442862167954
identified O 0 0.0014593021478503942
in O 0 0.0013733975356444716
this O 0 0.002478957176208496
exon O 0 0.016713038086891174
. O 0 0.008644897490739822

Seven O 0 0.004433720838278532
of O 0 0.0023578922264277935
30 O 0 0.0017135768430307508
( O 0 0.0013638699892908335
23 O 0 0.0012168468674644828
% O 0 0.0006243720417842269
) O 0 0.0004516267217695713
were O 0 0.000313846132485196
within O 0 0.00031845798366703093
the O 0 0.0004340462328400463
core O 0 0.0010555469198152423
motif O 0 0.0015605519292876124
, O 0 0.0004635541990865022
the O 0 0.0004924555541947484
majority O 0 0.00047622888814657927
( O 0 0.0004539254296105355
five O 0 0.0003189255658071488
of O 0 0.0003442640299908817
seven O 0 0.0004730528162326664
) O 0 0.00042916261008940637
of O 0 0.00036548529169522226
which O 0 0.00035528652369976044
were O 0 0.0005510523333214223
missense O 0 0.00342396623454988
mutations O 0 0.001044449512846768
, O 0 0.0005915589281357825
possibly O 0 0.0007505652611143887
pointing O 0 0.001025943667627871
to O 0 0.00046962586930021644
the O 0 0.0006258799694478512
functional O 0 0.0014419222716242075
significance O 0 0.0017422436503693461
of O 0 0.0014135345118120313
this O 0 0.0017039160011336207
region O 0 0.005891571287065744
. O 0 0.006506592966616154

Germline O 1 0.9837108254432678
PTEN O 1 0.9673535823822021
mutations O 0 0.006148523185402155
were O 0 0.0017085268627852201
identified O 0 0.0014791812282055616
in O 0 0.000698525516781956
four O 0 0.0006938837468624115
of O 0 0.0007718328852206469
seven O 0 0.0010672996286302805
( O 0 0.0014748161192983389
57 O 0 0.0030724911484867334
% O 0 0.0018793868366628885
) O 0 0.002485185395926237
BZS B-Disease 0 0.18544791638851166
families O 0 0.003675381885841489
studied O 0 0.008375747129321098
. O 0 0.009052466601133347

Interestingly O 0 0.018775567412376404
, O 0 0.0028256503865122795
none O 0 0.0020751820411533117
of O 0 0.0013937351759523153
these O 0 0.0009077218128368258
mutations O 0 0.001701796194538474
was O 0 0.001475875498726964
observed O 0 0.001255459152162075
in O 0 0.00111256237141788
the O 0 0.0028404223266988993
PTPase O 1 0.8862603306770325
core O 0 0.021619945764541626
motif O 0 0.03159964457154274
. O 0 0.010051902383565903

It O 0 0.004711607005447149
is O 0 0.002410782501101494
also O 0 0.0014903033152222633
worthy O 0 0.00250617484562099
of O 0 0.0011130928760394454
note O 0 0.0013351209927350283
that O 0 0.0005430973251350224
a O 0 0.000758028996642679
single O 0 0.0009455379331484437
nonsense O 0 0.003106118878349662
point O 0 0.00111021613702178
mutation O 0 0.0013778802240267396
, O 0 0.0006849368801340461
R233X O 0 0.003691179445013404
, O 0 0.0007012946880422533
was O 0 0.0008159656426869333
observed O 0 0.000688705244101584
in O 0 0.00044037276529707015
the O 0 0.0007106101256795228
germline O 0 0.004106828942894936
DNA O 0 0.0008593171951361
from O 0 0.0004726957995444536
two O 0 0.00045959913404658437
unrelated O 0 0.0016196758951991796
CD B-Disease 0 0.0024173003621399403
families O 0 0.0013322693994268775
and O 0 0.001471981406211853
one O 0 0.0030202989000827074
BZS B-Disease 1 0.9026646614074707
family O 0 0.009942363947629929
. O 0 0.010240420699119568

Genotype O 1 0.8168272972106934
- O 0 0.4591000974178314
phenotype O 0 0.01347413007169962
studies O 0 0.0019022575579583645
were O 0 0.0009956074645742774
not O 0 0.000739121634978801
performed O 0 0.0008987155742943287
on O 0 0.0007137065404094756
this O 0 0.000530985533259809
small O 0 0.0008718469180166721
group O 0 0.0018043306190520525
of O 0 0.0038781531620770693
BZS B-Disease 1 0.9825783967971802
families O 0 0.009456689469516277
. O 0 0.010139352641999722

However O 0 0.007441040128469467
, O 0 0.005087151657789946
genotype O 0 0.05240090563893318
- O 0 0.011728975921869278
phenotype O 0 0.004578499589115381
analysis O 0 0.001907389727421105
inthe O 0 0.007265410851687193
group O 0 0.001143312780186534
of O 0 0.0008402426028624177
CD B-Disease 0 0.0026012270245701075
families O 0 0.0007993577164597809
revealed O 0 0.001134791993536055
two O 0 0.00041496811900287867
possible O 0 0.0005712988204322755
associations O 0 0.0008349716663360596
worthy O 0 0.0015250955475494266
of O 0 0.0009327266016043723
follow O 0 0.0014668955700471997
- O 0 0.0026678992435336113
up O 0 0.001402339432388544
in O 0 0.0014225323684513569
independent O 0 0.003230821108445525
analyses O 0 0.007226910907775164
. O 0 0.007834837771952152

The O 0 0.005875685252249241
first O 0 0.003614766290411353
was O 0 0.002556907944381237
an O 0 0.0012707820860669017
association O 0 0.002193509368225932
noted O 0 0.0011876808712258935
in O 0 0.0006031673401594162
the O 0 0.0007608982268720865
group O 0 0.0007985217962414026
of O 0 0.0011216119164600968
CD B-Disease 0 0.20430587232112885
families O 0 0.0036846809089183807
with O 0 0.04230503365397453
breast B-Disease 1 0.9999982118606567
disease I-Disease 1 0.9999969005584717
. O 0 0.040843937546014786

A O 0 0.008689053356647491
correlation O 0 0.00584010174497962
was O 0 0.0027195338625460863
observed O 0 0.0016490842681378126
between O 0 0.0009913690155372024
the O 0 0.00105190253816545
presence O 0 0.002154734218493104
/ O 0 0.19407495856285095
absence O 0 0.002614529337733984
of O 0 0.0012827359605580568
a O 0 0.041209861636161804
PTEN O 1 0.9980267882347107
mutation O 0 0.0015198912005871534
and O 0 0.0004659881815314293
the O 0 0.0006275118212215602
type O 0 0.0019157357746735215
of O 0 0.002094978466629982
breast O 1 0.9999827146530151
involvement O 1 0.9823911786079407
( O 1 0.6452465653419495
unaffected O 1 0.9455443024635315
versus O 1 0.9552441239356995
benign O 1 0.9997065663337708
versus O 1 0.9885085225105286
malignant O 1 0.999980092048645
) O 0 0.008462410420179367
. O 0 0.009463222697377205

Specifically O 0 0.0063338503241539
and O 0 0.0019742767326533794
more O 0 0.0008502002456225455
directly O 0 0.0008639938314445317
, O 0 0.0007490330608561635
an O 0 0.000686722865793854
association O 0 0.0020137736573815346
was O 0 0.0014687868533656001
also O 0 0.0005517031531780958
observed O 0 0.0005424838163889945
between O 0 0.00040785546298138797
the O 0 0.0004806001379620284
presence O 0 0.0006802570424042642
of O 0 0.0007535879849456251
a O 0 0.021689364686608315
PTEN O 1 0.9999698400497437
mutation O 1 0.9041337370872498
and O 1 0.613452136516571
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
. O 0 0.4108799695968628

Secondly O 0 0.03229300305247307
, O 0 0.003257700242102146
there O 0 0.001780437771230936
appeared O 0 0.0017241364112123847
to O 0 0.0008131992071866989
be O 0 0.0006544130737893283
an O 0 0.0008477696101181209
interdependent O 0 0.007397560402750969
association O 0 0.0021339168306440115
between O 0 0.0009669380378909409
mutations O 0 0.0012924375478178263
upstream O 0 0.0011491477489471436
and O 0 0.0005415927735157311
within O 0 0.0005438171210698783
the O 0 0.0008526182500645518
PTPase O 0 0.21155835688114166
core O 0 0.0028683762066066265
motif O 0 0.0031777508556842804
, O 0 0.0007641281117685139
the O 0 0.0007400262402370572
core O 0 0.0014783174265176058
motif O 0 0.0019322038860991597
containing O 0 0.0009917005663737655
the O 0 0.0006915460689924657
majority O 0 0.0007480450440198183
of O 0 0.0008960688137449324
missense O 0 0.07023033499717712
mutations O 0 0.0014893243787810206
, O 0 0.0005056849913671613
and O 0 0.00041381202754564583
the O 0 0.0005116245592944324
involvement O 0 0.0010238561080768704
of O 0 0.0006598032778128982
all O 0 0.0005380176589824259
major O 0 0.007886647246778011
organ O 1 0.9416792988777161
systems O 0 0.0698297768831253
( O 0 0.001979254186153412
central O 0 0.0023837846238166094
nervous O 0 0.33881208300590515
system O 0 0.0035274673718959093
, O 0 0.012603046372532845
thyroid O 1 0.9999992847442627
, O 1 0.7624569535255432
breast O 1 0.9999995231628418
, O 1 0.910337507724762
skin O 1 0.9999986886978149
and O 1 0.9850753545761108
gastrointestinal O 1 1.0
tract O 1 0.9999997615814209
) O 1 0.6915336847305298
. O 0 0.010431059636175632

However O 0 0.005494900047779083
, O 0 0.0024975936394184828
these O 0 0.0011433718027547002
observations O 0 0.0015736381756141782
would O 0 0.0007115832413546741
need O 0 0.0006438494310714304
to O 0 0.00042013238999061286
be O 0 0.0003605379315558821
confirmed O 0 0.0006241716328077018
by O 0 0.0003881478914991021
studying O 0 0.0007389758247882128
a O 0 0.0007003162172622979
larger O 0 0.0007950477302074432
number O 0 0.0007932070293463767
of O 0 0.001518821227364242
CD B-Disease 0 0.007969021797180176
families O 0 0.005486282054334879
. O 0 0.007788863033056259

Molecular O 0 0.015592917799949646
defects O 1 0.6286298632621765
leading O 0 0.005652096122503281
to O 0 0.001955387881025672
human O 0 0.007148689590394497
complement B-Disease 1 0.903313159942627
component I-Disease 1 0.9996058344841003
C6 I-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999974966049194
in O 0 0.002022701781243086
an O 0 0.0029972726479172707
African O 0 0.17339646816253662
- O 1 0.67375648021698
American O 0 0.006095037329941988
family O 0 0.007580712903290987
. O 0 0.007244116626679897

Complement B-Disease 1 0.8042259216308594
component I-Disease 1 0.9996194839477539
C6 I-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
( O 1 0.9730355739593506
C6D B-Disease 1 0.9999521970748901
) O 0 0.003550437046214938
was O 0 0.007843032479286194
diagnosed O 1 0.9915591478347778
in O 0 0.0006209863349795341
a O 0 0.000775915861595422
16 O 0 0.0009566511143930256
- O 0 0.0036234890576452017
year O 0 0.00089874560944736
- O 0 0.005839254707098007
old O 0 0.004360545426607132
African O 0 0.004392752889543772
- O 0 0.1893395334482193
American O 0 0.006821108050644398
male O 0 0.10003331303596497
with O 0 0.10027147829532623
meningococcal B-Disease 1 0.9999988079071045
meningitis I-Disease 1 0.9999991655349731
. O 0 0.06749580800533295

The O 0 0.010962667874991894
patients O 1 0.7466146945953369
father O 0 0.02197621576488018
and O 0 0.0012099849991500378
two O 0 0.0008004996343515813
brothers O 0 0.011062119156122208
also O 0 0.0011081213597208261
had O 0 0.0016218586824834347
C6D B-Disease 1 0.919946551322937
, O 0 0.0007114655454643071
but O 0 0.00043219656799919903
gave O 0 0.0007186979637481272
no O 0 0.0005766067188233137
history O 0 0.0012773715425282717
of O 0 0.003471663687378168
meningitis B-Disease 1 0.9999915361404419
or O 0 0.0060663106851279736
other O 0 0.003926208708435297
neisserial B-Disease 1 0.9997029900550842
infection I-Disease 1 0.9999206066131592
. O 0 0.0133262500166893

By O 0 0.004978666547685862
using O 0 0.004128765314817429
exon O 0 0.013379120267927647
- O 0 0.004763961769640446
specific O 0 0.0016796315321698785
polymerase O 0 0.0035590336192399263
chain O 0 0.002315632766112685
reaction O 0 0.0017575750825926661
( O 0 0.0013802461326122284
PCR O 0 0.003326327307149768
) O 0 0.0010251157218590379
/ O 0 0.0026255694683641195
single O 0 0.0012001249706372619
- O 0 0.002291508950293064
strand O 0 0.0019898393657058477
conformation O 0 0.0016092683654278517
polymorphism O 0 0.0015000762650743127
as O 0 0.0005550200585275888
a O 0 0.0007366249919869006
screening O 0 0.0010874848812818527
step O 0 0.0008953213109634817
and O 0 0.0005519394180737436
nucleotide O 0 0.001197142875753343
sequencing O 0 0.0011335386661812663
of O 0 0.0006426101899705827
target O 0 0.000983794336207211
exons O 0 0.001654051593504846
, O 0 0.000643581326585263
we O 0 0.000581109372433275
determined O 0 0.00075865990947932
that O 0 0.0004705172614194453
the O 0 0.0007802072213962674
proband O 0 0.0048526618629693985
was O 0 0.001317281392402947
a O 0 0.0010729157365858555
compound O 0 0.002882982837036252
heterozygote O 0 0.010579952970147133
for O 0 0.0014050268800929189
two O 0 0.002300070831552148
C6 O 1 0.9964380264282227
gene O 0 0.00735666835680604
mutations O 0 0.009149355813860893
. O 0 0.007306239567697048

The O 0 0.005071834661066532
first O 0 0.0030958123970776796
, O 0 0.0017878786893561482
1195delC O 0 0.007007951848208904
located O 0 0.0018745869165286422
in O 0 0.0011106182355433702
exon O 0 0.005513204727321863
7 O 0 0.0012692289892584085
, O 0 0.0006188697298057377
is O 0 0.0005381302325986326
a O 0 0.0006231967126950622
novel O 0 0.0013958871131762862
mutation O 0 0.000849477481096983
, O 0 0.0004399081226438284
while O 0 0.0003777218225877732
the O 0 0.0004628620226867497
second O 0 0.000726324156858027
, O 0 0.000591944670304656
1936delG O 0 0.0030066717881709337
in O 0 0.0005877132061868906
exon O 0 0.002485468750819564
12 O 0 0.0006848945049569011
, O 0 0.0004893516888841987
has O 0 0.00046684627886861563
been O 0 0.0003673033497761935
described O 0 0.000624285836238414
before O 0 0.0004554029437713325
to O 0 0.0004556626081466675
cause O 0 0.0014020716771483421
C6D B-Disease 0 0.09457218647003174
in O 0 0.0006192732835188508
an O 0 0.0008636530255898833
unrelated O 0 0.0037458776496350765
African O 0 0.005052921362221241
- O 0 0.022220956161618233
American O 0 0.0037079378962516785
individual O 0 0.004676729906350374
. O 0 0.007848318666219711

Both O 0 0.007012214045971632
mutations O 0 0.006468482781201601
result O 0 0.003528846660628915
in O 0 0.0035218398552387953
premature O 0 0.3467472791671753
termination O 1 0.8110873699188232
codons O 0 0.06202789768576622
and O 0 0.006453793030232191
C6 O 1 0.9936416745185852
null O 0 0.02470131777226925
alleles O 0 0.021193750202655792
. O 0 0.011808301322162151

Allele O 0 0.026458237320184708
- O 0 0.010512755252420902
specific O 0 0.0027995475102216005
PCR O 0 0.005861363373696804
indicated O 0 0.0017897962825372815
that O 0 0.0005662164185196161
the O 0 0.0007917442708276212
probands O 0 0.003654981032013893
two O 0 0.0006109684472903609
brothers O 0 0.0020384329836815596
also O 0 0.0010197705123573542
inherited O 0 0.17139747738838196
the O 0 0.0013404753990471363
1195delC O 0 0.4154481887817383
mutation O 0 0.00141086895018816
from O 0 0.00046931818360462785
their O 0 0.0004702290170826018
heterozygous O 0 0.0016565447440370917
mother O 0 0.0016952560981735587
and O 0 0.0005871769390068948
the O 0 0.0010562073439359665
1936delG O 0 0.1311301290988922
mutation O 0 0.0015265108086168766
from O 0 0.0006797414389438927
their O 0 0.0008919014362618327
homozygous O 0 0.00447529461234808
father O 0 0.005169253796339035
. O 0 0.0029316938016563654
. O 0 0.005385320633649826

PAX6 O 1 0.9982490539550781
mutations O 0 0.05799573287367821
reviewed O 0 0.04057746008038521
. O 0 0.02440699003636837

Mutations O 0 0.014296332374215126
in O 0 0.004504764918237925
PAX6 O 1 0.9549003839492798
are O 0 0.001428512274287641
responsible O 0 0.001931499456986785
for O 0 0.0009961099131032825
human O 0 0.002821982139721513
aniridia B-Disease 1 0.9897543787956238
and O 0 0.0007735200924798846
have O 0 0.0004159122472628951
also O 0 0.00041968890582211316
been O 0 0.0003760546969715506
found O 0 0.00040915614226832986
in O 0 0.00047209038166329265
patients O 0 0.03136838600039482
with O 0 0.0012361976550891995
Peters B-Disease 1 0.9991888403892517
anomaly I-Disease 1 0.999810516834259
, O 0 0.257857084274292
with O 1 0.9252679944038391
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9907286167144775
with O 1 0.8617045283317566
autosomal B-Disease 1 0.9999979734420776
dominant I-Disease 1 0.9999109506607056
keratitis I-Disease 1 0.9999996423721313
, O 0 0.07086507230997086
and O 0 0.0034477843437343836
with O 0 0.005553307011723518
isolated B-Disease 1 0.9373551607131958
foveal I-Disease 1 0.9999653100967407
hypoplasia I-Disease 1 0.9999929666519165
. O 0 0.018373146653175354

No O 0 0.006241626106202602
locus O 0 0.009594868868589401
other O 0 0.0018366659060120583
than O 0 0.0016989844152703881
chromosome O 0 0.0044007981196045876
11p13 O 0 0.023796869441866875
has O 0 0.0011810422874987125
been O 0 0.0008957539102993906
implicated O 0 0.0215082298964262
in O 0 0.0014840755611658096
aniridia B-Disease 1 0.9990522265434265
, O 0 0.0017803090158849955
and O 0 0.0016467273235321045
PAX6 O 1 0.9992679953575134
is O 0 0.0011803798843175173
clearly O 0 0.0010491732973605394
the O 0 0.0006976284203119576
major O 0 0.0010201712138950825
, O 0 0.0005952963838353753
if O 0 0.0004033388977404684
not O 0 0.0003963452181778848
only O 0 0.0005696442094631493
, O 0 0.0013257621321827173
gene O 0 0.003095722757279873
responsible O 0 0.004659871105104685
. O 0 0.0062347534112632275

Twenty O 0 0.012182064354419708
- O 0 0.006611779797822237
eight O 0 0.0024488400667905807
percent O 0 0.0019647052977234125
of O 0 0.0014786651590839028
identified O 0 0.003652123734354973
PAX6 O 1 0.9963183403015137
mutations O 0 0.002546007977798581
are O 0 0.0008677800069563091
C O 0 0.03672399744391441
- O 0 0.02991456165909767
T O 0 0.004732785280793905
changes O 0 0.0007694389205425978
at O 0 0.0009846255416050553
CpG O 0 0.00427826726809144
dinucleotides O 0 0.00348400860093534
, O 0 0.0007345490739680827
20 O 0 0.000728665734641254
% O 0 0.0006102331099100411
are O 0 0.0003690627054311335
splicing O 0 0.0011879156809300184
errors O 0 0.0010416852310299873
, O 0 0.000531014462467283
and O 0 0.000474575295811519
more O 0 0.0003677367640193552
than O 0 0.00039831746835261583
30 O 0 0.0007719223503954709
% O 0 0.00076485046884045
are O 0 0.0007210853509604931
deletion O 0 0.00358398724347353
or O 0 0.0022003650665283203
insertion O 0 0.008636212907731533
events O 0 0.006498722359538078
. O 0 0.008457702584564686

There O 0 0.004678894765675068
is O 0 0.002848014235496521
a O 0 0.002834675833582878
noticeably O 0 0.05608370900154114
elevated O 0 0.3113131821155548
level O 0 0.0013878013705834746
of O 0 0.0010536371264606714
mutation O 0 0.002126128412783146
in O 0 0.0005699942703358829
the O 0 0.0007707418408244848
paired O 0 0.0015337879303842783
domain O 0 0.000910780334379524
compared O 0 0.0007387518999166787
with O 0 0.0005339866620488465
the O 0 0.0006779697141610086
rest O 0 0.001071028527803719
of O 0 0.0013749983627349138
the O 0 0.0028873865958303213
gene O 0 0.0065909577533602715
. O 0 0.006608984433114529

Increased O 0 0.012133616954088211
mutation O 0 0.006293038371950388
in O 0 0.0021365098655223846
the O 0 0.00218594865873456
homeodomain O 1 0.5784177780151367
is O 0 0.0015359532553702593
accounted O 0 0.0018972947727888823
for O 0 0.0010204230202361941
by O 0 0.0011877595679834485
the O 0 0.002352715702727437
hypermutable O 0 0.4932135343551636
CpG O 0 0.0704193189740181
dinucleotide O 0 0.0335514098405838
in O 0 0.004715985152870417
codon O 0 0.016851359978318214
240 O 0 0.015394255518913269
. O 0 0.011726632714271545

Very O 0 0.006325072608888149
nearly O 0 0.0036003615241497755
all O 0 0.001643456402234733
mutations O 0 0.0023843664675951004
appear O 0 0.001330195227637887
to O 0 0.0008293853024952114
cause O 0 0.0026332437992095947
loss O 0 0.0021402244456112385
of O 0 0.0008598488057032228
function O 0 0.001071510254405439
of O 0 0.0009458470158278942
the O 0 0.001534311450086534
mutant O 0 0.041588157415390015
allele O 0 0.0011974374065175653
, O 0 0.0004126350104343146
and O 0 0.0002741724601946771
more O 0 0.0002394029579591006
than O 0 0.0002722179051488638
80 O 0 0.000639102712739259
% O 0 0.0005672543775290251
of O 0 0.0007328984211198986
exonic O 0 0.030480211600661278
substitutions O 0 0.0023171755019575357
result O 0 0.001708978321403265
in O 0 0.002205868484452367
nonsense O 0 0.018482685089111328
codons O 0 0.01790503039956093
. O 0 0.00805266946554184

In O 0 0.0049948664382100105
a O 0 0.0036131141241639853
gene O 0 0.0022546174004673958
with O 0 0.0009455739636905491
such O 0 0.0008532378706149757
extraordinarily O 0 0.013381877914071083
high O 0 0.0017506424337625504
sequence O 0 0.0010378635488450527
conservation O 0 0.0010770283406600356
throughout O 0 0.0005454104393720627
evolution O 0 0.0007998858345672488
, O 0 0.0005669149104505777
there O 0 0.00048650530516169965
are O 0 0.0004726624465547502
presumed O 0 0.0021626222878694534
undiscovered O 0 0.006435885094106197
missense O 0 0.004506262019276619
mutations O 0 0.0013020285405218601
, O 0 0.0005660901661030948
these O 0 0.000337921897880733
are O 0 0.0003347349411342293
hypothesized O 0 0.001153932767920196
to O 0 0.0004259602865204215
exist O 0 0.0005820645019412041
in O 0 0.0006055076373741031
as O 0 0.0010408529778942466
- O 0 0.003319018753245473
yet O 0 0.0020364599768072367
unidentified O 0 0.004854065366089344
phenotypes O 0 0.008479420095682144
. O 0 0.0033396196085959673
. O 0 0.005961610935628414

Genetic O 0 0.01410399004817009
heterogeneity O 0 0.018525853753089905
and O 0 0.0034997127950191498
penetrance O 0 0.02212590165436268
analysis O 0 0.002181037561967969
of O 0 0.0016089902492240071
the O 0 0.002841381123289466
BRCA1 O 1 0.9900109171867371
and O 0 0.003293251618742943
BRCA2 O 1 0.9972409009933472
genes O 0 0.00760590098798275
in O 0 0.014386830851435661
breast B-Disease 1 0.9999971389770508
cancer I-Disease 1 0.9999755620956421
families O 0 0.03104509599506855
. O 0 0.012279132381081581

The O 1 0.9771826863288879
Breast B-Disease 1 0.9999997615814209
Cancer I-Disease 1 0.9999991655349731
Linkage O 1 0.9993594288825989
Consortium O 1 0.706195056438446
. O 0 0.019802704453468323

The O 0 0.007954827509820461
contribution O 0 0.008320526219904423
of O 0 0.004540566820651293
BRCA1 O 1 0.9889971017837524
and O 0 0.006487433332949877
BRCA2 O 1 0.9998155236244202
to O 0 0.09001750499010086
inherited B-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
was O 1 0.9543918371200562
assessed O 0 0.08140735328197479
by O 0 0.0009116356377489865
linkage O 0 0.0031773007940500975
and O 0 0.0005730614066123962
mutation O 0 0.0008372710435651243
analysis O 0 0.0005347972619347274
in O 0 0.0004698723496403545
237 O 0 0.0012772229965776205
families O 0 0.0004975873162038624
, O 0 0.00031674958881922066
each O 0 0.00022218383674044162
with O 0 0.00021461806318257004
at O 0 0.0003450361837167293
least O 0 0.0003067605721298605
four O 0 0.00038027443224564195
cases O 0 0.000650120317004621
of O 0 0.01968049816787243
breast B-Disease 1 0.9999991655349731
cancer I-Disease 1 0.9999430179595947
, O 0 0.0011891849571838975
collected O 0 0.001229381887242198
by O 0 0.0012011543149128556
the O 0 0.23560725152492523
Breast B-Disease 1 0.9999998807907104
Cancer I-Disease 1 0.9999992847442627
Linkage O 1 0.9983716607093811
Consortium O 0 0.16774612665176392
. O 0 0.009433393366634846

Families O 0 0.006409539375454187
were O 0 0.002383108716458082
included O 0 0.0018610840197652578
without O 0 0.0012078062864020467
regard O 0 0.0014419791987165809
to O 0 0.0008024869603104889
the O 0 0.0010716960532590747
occurrence O 0 0.007997839711606503
of O 0 0.16982197761535645
ovarian B-Disease 1 0.9999996423721313
or I-Disease 0 0.07643330097198486
other I-Disease 0 0.004780214745551348
cancers I-Disease 1 0.9989326596260071
. O 0 0.010079346597194672

Overall O 0 0.47480833530426025
, O 0 0.02406761422753334
disease O 1 0.9996875524520874
was O 0 0.03348908573389053
linked O 0 0.01501593180000782
to O 0 0.0008579909335821867
BRCA1 O 0 0.039505165070295334
in O 0 0.0004834321152884513
an O 0 0.00045871807378716767
estimated O 0 0.0007239882834255695
52 O 0 0.000821551016997546
% O 0 0.0004206720623187721
of O 0 0.000378391268895939
families O 0 0.000450915249530226
, O 0 0.0004228860489092767
to O 0 0.0004599409585352987
BRCA2 O 0 0.002407231368124485
in O 0 0.0004618639941327274
32 O 0 0.0007572207832708955
% O 0 0.0004718723939731717
of O 0 0.00040541376802138984
families O 0 0.0004997762152925134
, O 0 0.0004165629216004163
and O 0 0.0003292383917141706
to O 0 0.0003398307308088988
neither O 0 0.0005580231081694365
gene O 0 0.0004630334733519703
in O 0 0.00033947211341001093
16 O 0 0.0005366478580981493
% O 0 0.0004868838586844504
( O 0 0.000594564073253423
95 O 0 0.0009177964529953897
% O 0 0.0007034064037725329
confidence O 0 0.0012310744496062398
interval O 0 0.0019033497665077448
[ O 0 0.0020998790860176086
CI O 0 0.1950022131204605
] O 0 0.001651395345106721
6 O 0 0.0011417848290875554
% O 0 0.0007810843526385725
- O 0 0.001181790605187416
28 O 0 0.0010061513166874647
% O 0 0.0008974162628874183
) O 0 0.0008258156012743711
, O 0 0.0008173336973413825
suggesting O 0 0.0020403340458869934
other O 0 0.0017306767404079437
predisposition O 0 0.06031239777803421
genes O 0 0.007650864310562611
. O 0 0.009107988327741623

The O 0 0.0047663431614637375
majority O 0 0.0033190124668180943
( O 0 0.0023917625658214092
81 O 0 0.002893473021686077
% O 0 0.0011256750440225005
) O 0 0.0008452381589449942
of O 0 0.0010531191946938634
the O 0 0.49122199416160583
breast B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.026690300554037094
were O 0 0.0007973021711222827
due O 0 0.0010848732199519873
to O 0 0.0005500005790963769
BRCA1 O 0 0.08543108403682709
, O 0 0.00047123769763857126
with O 0 0.00036826738505624235
most O 0 0.00034088623942807317
others O 0 0.0004597791994456202
( O 0 0.0007542186649516225
14 O 0 0.0010701199062168598
% O 0 0.001124561415053904
) O 0 0.0013159391237422824
due O 0 0.002093324437737465
to O 0 0.003096381900832057
BRCA2 O 0 0.2406253069639206
. O 0 0.0073463027365505695

Conversely O 0 0.012836999259889126
, O 0 0.0029280066955834627
the O 0 0.0017703737830743194
majority O 0 0.00132474594283849
of O 0 0.0008972990908659995
families O 0 0.0011211982928216457
with O 0 0.0008409450529143214
male B-Disease 0 0.04384636506438255
and I-Disease 0 0.018375419080257416
female I-Disease 1 0.9963966012001038
breast I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999641180038452
were O 0 0.0014474218478426337
due O 0 0.0019380528246983886
to O 0 0.001191519433632493
BRCA2 O 1 0.9429203867912292
( O 0 0.0023635681718587875
76 O 0 0.0053883944638073444
% O 0 0.0028604648541659117
) O 0 0.004264984279870987
. O 0 0.006375682074576616

The O 0 0.005457809194922447
largest O 0 0.004980941768735647
proportion O 0 0.0037829389329999685
( O 0 0.0018513111863285303
67 O 0 0.0023482386022806168
% O 0 0.0009279894875362515
) O 0 0.0005167449126020074
of O 0 0.00044430792331695557
families O 0 0.0005336200702004135
due O 0 0.00047829680261202157
to O 0 0.00030679392511956394
other O 0 0.00029838402406312525
genes O 0 0.000483154522953555
was O 0 0.0005008855368942022
found O 0 0.00032083617406897247
in O 0 0.0003178273618686944
families O 0 0.00033020053524523973
with O 0 0.00024982442846521735
four O 0 0.00032473477767780423
or O 0 0.000398148171370849
five O 0 0.00044527355930767953
cases O 0 0.0009535026620142162
of O 0 0.021821165457367897
female O 1 0.9995253086090088
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999979734420776
only O 0 0.006816073786467314
. O 0 0.007816358469426632

These O 0 0.0035384660586714745
estimates O 0 0.0036951270885765553
were O 0 0.0016125282272696495
not O 0 0.0010875739390030503
substantially O 0 0.001918512280099094
affected O 0 0.001138864317908883
either O 0 0.0007676457171328366
by O 0 0.0006498322472907603
changing O 0 0.001001068390905857
the O 0 0.0009174873703159392
assumed O 0 0.003010898595675826
penetrance O 0 0.07021529227495193
model O 0 0.0015064073959365487
for O 0 0.0008364575915038586
BRCA1 O 0 0.018945686519145966
or O 0 0.0006776793161407113
by O 0 0.0005460049724206328
including O 0 0.0008649798692204058
or O 0 0.0015013437950983644
excluding O 0 0.005776512902230024
BRCA1 O 1 0.5167095065116882
mutation O 0 0.006366375833749771
data O 0 0.005338200367987156
. O 0 0.007374585140496492

Among O 0 0.004953452385962009
those O 0 0.002260924782603979
families O 0 0.0034149184357374907
with O 0 0.009440453723073006
disease O 1 0.999972939491272
due O 0 0.1356411874294281
to O 0 0.0017060894751921296
BRCA1 O 1 0.9552420377731323
that O 0 0.0004577182698994875
were O 0 0.00045875480282120407
tested O 0 0.0007871377747505903
by O 0 0.00031944375950843096
one O 0 0.0003356022934895009
of O 0 0.0004049077979288995
the O 0 0.0005324106896296144
standard O 0 0.0009441025904379785
screening O 0 0.0009232782758772373
methods O 0 0.0006107273511588573
, O 0 0.0005046773585490882
mutations O 0 0.0006325322319753468
were O 0 0.00038955113268457353
detected O 0 0.0007393083069473505
in O 0 0.0003727883449755609
the O 0 0.0005524088628590107
coding O 0 0.001192356226965785
sequence O 0 0.0007020141347311437
or O 0 0.0004149777814745903
splice O 0 0.001220016274601221
sites O 0 0.00045827621943317354
in O 0 0.0003974667051807046
an O 0 0.0004235230735503137
estimated O 0 0.0006982297636568546
63 O 0 0.0012161772465333343
% O 0 0.0007319266442209482
( O 0 0.0009026809711940587
95 O 0 0.001336687826551497
% O 0 0.0012859897688031197
CI O 0 0.022195950150489807
51 O 0 0.002700525103136897
% O 0 0.0020280289463698864
- O 0 0.003530497197061777
77 O 0 0.004896164406090975
% O 0 0.0035472698509693146
) O 0 0.0044386303052306175
. O 0 0.006842951290309429

The O 0 0.006686583161354065
estimated O 0 0.0059175556525588036
sensitivity O 0 0.005549790803343058
was O 0 0.002382169244810939
identical O 0 0.001794452895410359
for O 0 0.0011154105886816978
direct O 0 0.0016350727528333664
sequencing O 0 0.002447625622153282
and O 0 0.0015142628690227866
other O 0 0.0018458869308233261
techniques O 0 0.007632849272340536
. O 0 0.008746180683374405

The O 0 0.008633559569716454
penetrance O 1 0.5811983942985535
of O 0 0.008513033390045166
BRCA2 O 1 0.9897239208221436
was O 0 0.00516483373939991
estimated O 0 0.001911609317176044
by O 0 0.0008587344200350344
maximizing O 0 0.002820982364937663
the O 0 0.001206893241032958
LOD O 0 0.24223950505256653
score O 0 0.0012855790555477142
in O 0 0.0012037467677146196
BRCA2 O 1 0.9070241451263428
- O 0 0.007441576570272446
mutation O 0 0.001525508938357234
families O 0 0.0007877255557104945
, O 0 0.0006250026053749025
over O 0 0.0007652697386220098
all O 0 0.0007986610871739686
possible O 0 0.00215392024256289
penetrance O 0 0.02295585162937641
functions O 0 0.005412713624536991
. O 0 0.007488809525966644

The O 0 0.0058352588675916195
estimated O 0 0.005863231606781483
cumulative O 0 0.06042277440428734
risk O 0 0.07631314545869827
of O 0 0.1513092815876007
breast B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999086856842041
reached O 0 0.009453277103602886
28 O 0 0.0018976650899276137
% O 0 0.0008338649058714509
( O 0 0.000785618438385427
95 O 0 0.0010339997243136168
% O 0 0.0009431684738956392
CI O 0 0.033152781426906586
9 O 0 0.001219479599967599
% O 0 0.0008256196160800755
- O 0 0.0011138948611915112
44 O 0 0.000913217372726649
% O 0 0.0005544830928556621
) O 0 0.0003898823633790016
by O 0 0.0002863084664568305
age O 0 0.0004609537427313626
50 O 0 0.00046877001295797527
years O 0 0.0003946610086131841
and O 0 0.0003742340486496687
84 O 0 0.0012719858204945922
% O 0 0.0006251708837226033
( O 0 0.0005930345505475998
95 O 0 0.0009241777006536722
% O 0 0.000869518204126507
CI O 0 0.020944634452462196
43 O 0 0.001372140017338097
% O 0 0.0009056492708623409
- O 0 0.0012115049175918102
95 O 0 0.0010583798866719007
% O 0 0.0008225528290495276
) O 0 0.0006880973232910037
by O 0 0.0006101637845858932
age O 0 0.0015427294420078397
70 O 0 0.0029990854673087597
years O 0 0.003551278728991747
. O 0 0.005452803336083889

The O 0 0.02436971478164196
corresponding O 1 0.9873140454292297
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
risks O 1 0.9991718530654907
were O 0 0.022860337048768997
0 O 0 0.014961160719394684
. O 0 0.011218654923141003

4 O 0 0.007100730203092098
% O 0 0.0035481771919876337
( O 0 0.0022661921102553606
95 O 0 0.002405365463346243
% O 0 0.001777184777893126
CI O 0 0.050920579582452774
0 O 0 0.0019204206764698029
% O 0 0.0011036740615963936
- O 0 0.0014753352152183652
1 O 0 0.000903631909750402
% O 0 0.0005823835381306708
) O 0 0.0004538475477602333
by O 0 0.0003151552227791399
age O 0 0.0006091232062317431
50 O 0 0.0005009094602428377
years O 0 0.00046060411841608584
and O 0 0.00040545008960179985
27 O 0 0.0008740141056478024
% O 0 0.0006252337479963899
( O 0 0.0008157448028214276
95 O 0 0.001254710485227406
% O 0 0.0012823102297261357
CI O 0 0.012651421129703522
0 O 0 0.0014022806426510215
% O 0 0.0009638061746954918
- O 0 0.0014599860878661275
47 O 0 0.001420707325451076
% O 0 0.0008383551030419767
) O 0 0.0007057444890961051
by O 0 0.0006778651149943471
age O 0 0.0014690413372591138
70 O 0 0.0028980677016079426
years O 0 0.003721203189343214
. O 0 0.006301228888332844

The O 0 0.008363984525203705
lifetime O 0 0.36756107211112976
risk O 1 0.9547904133796692
of O 1 0.9895271062850952
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
appears O 0 0.4688850939273834
similar O 0 0.001229616696946323
to O 0 0.0005639093578793108
the O 0 0.001019298448227346
risk O 0 0.052260082215070724
in O 0 0.0015053850365802646
BRCA1 O 1 0.9875597357749939
carriers O 0 0.0016990108415484428
, O 0 0.0004953049938194454
but O 0 0.00037406457704491913
there O 0 0.0003644859534688294
was O 0 0.0005775348981842399
some O 0 0.0003819206904154271
suggestion O 0 0.0009725054842419922
of O 0 0.0005938620306551456
a O 0 0.0010203925194218755
lower O 0 0.0020658858120441437
risk O 0 0.0033922861330211163
in O 0 0.0013481439091265202
BRCA2 O 1 0.808014988899231
carriers O 0 0.0035796493757516146
< O 0 0.004201005212962627
50 O 0 0.0018194917356595397
years O 0 0.0018495849799364805
of O 0 0.002740192227065563
age O 0 0.006791607476770878
. O 0 0.008269048295915127

Eye B-Disease 1 0.9794203639030457
movement I-Disease 0 0.0387968085706234
abnormalities I-Disease 1 0.819035530090332
correlate O 0 0.010243446566164494
with O 0 0.0030628168024122715
genotype O 0 0.4511359632015228
in O 0 0.010300543159246445
autosomal O 1 0.9999680519104004
dominant O 1 0.9998798370361328
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999947547912598
I I-Disease 1 0.9974473714828491
. O 0 0.014861686155200005

We O 0 0.005019316449761391
compared O 0 0.0048943618312478065
horizontal O 0 0.007856248877942562
eye O 0 0.060349561274051666
movements O 0 0.0023720688186585903
( O 0 0.001996304141357541
visually O 0 0.0031378590501844883
guided O 0 0.004123416263610125
saccades O 1 0.5231394171714783
, O 0 0.0011894023045897484
antisaccades O 0 0.01909683644771576
, O 0 0.0006568311946466565
and O 0 0.0005285099032334983
smooth O 0 0.001227490371093154
pursuit O 0 0.0017192329978570342
) O 0 0.000476816640002653
in O 0 0.0003323247074149549
control O 0 0.0005476238438859582
subjects O 0 0.0007676843670196831
( O 0 0.0008316355524584651
n O 0 0.0011934253852814436
= O 0 0.001413840102031827
14 O 0 0.0007338983123190701
) O 0 0.0005044133868068457
and O 0 0.00038331220275722444
patients O 0 0.0008077121456153691
with O 0 0.0003368917678017169
three O 0 0.00043867839849554
forms O 0 0.0009536276338621974
of O 0 0.015395907685160637
autosomal O 1 0.9999237060546875
dominant O 1 0.9983404874801636
cerebellar B-Disease 1 0.9999991655349731
ataxias I-Disease 1 0.9999880790710449
type I-Disease 1 0.996960461139679
I I-Disease 1 0.6496511101722717
spinocerebellar B-Disease 1 0.9999524354934692
ataxias I-Disease 1 0.6920886039733887
1 I-Disease 0 0.0015395830851048231
and I-Disease 0 0.0008038196829147637
2 I-Disease 0 0.0011485338909551501
( O 0 0.001017449190840125
SCA1 B-Disease 0 0.004433117341250181
, O 0 0.0008193243993446231
n O 0 0.0015533919213339686
= O 0 0.001665749354287982
11 O 0 0.0008590862853452563
; O 0 0.000659703859128058
SCA2 B-Disease 0 0.0030341604724526405
, O 0 0.0007369372178800404
n O 0 0.0013708567712455988
= O 0 0.0014818210620433092
10 O 0 0.0006251527229323983
) O 0 0.0006067365757189691
and O 0 0.0008386707631871104
SCA3 B-Disease 1 0.8943973183631897
/ O 0 0.23367446660995483
Machado B-Disease 1 0.7914635539054871
- I-Disease 0 0.47752276062965393
Joseph I-Disease 1 0.7456724047660828
disease I-Disease 1 0.9997438788414001
( O 0 0.00858724769204855
MJD B-Disease 1 0.9973322153091431
) O 0 0.0014324206858873367
( O 0 0.001532711205072701
n O 0 0.002812844468280673
= O 0 0.0035716593265533447
16 O 0 0.002507987432181835
) O 0 0.003211446339264512
. O 0 0.00556984031572938

In O 0 0.008823344483971596
SCA1 B-Disease 1 0.7167585492134094
, O 0 0.006083804648369551
saccade O 0 0.3084911108016968
amplitude O 0 0.009141621179878712
was O 0 0.004740952514111996
significantly O 0 0.0031968243420124054
increased O 0 0.0025551426224410534
, O 0 0.0020826933905482292
resulting O 0 0.0041373856365680695
in O 0 0.0042090932838618755
hypermetria B-Disease 0 0.47433626651763916
. O 0 0.011337983421981335

The O 0 0.012195603922009468
smooth O 0 0.01909760944545269
pursuit O 0 0.11655046790838242
gain O 0 0.011682120151817799
was O 0 0.034174881875514984
decreased O 0 0.12870784103870392
. O 0 0.014553641900420189

In O 0 0.011633306741714478
SCA2 B-Disease 1 0.8575610518455505
, O 0 0.008191430941224098
saccade O 0 0.40011730790138245
velocity O 0 0.012740401551127434
was O 0 0.012179680168628693
markedly O 0 0.034940119832754135
decreased O 0 0.04120461270213127
. O 0 0.012015307322144508

The O 0 0.0047493139281868935
percentage O 0 0.0036235270090401173
of O 0 0.0017426519189029932
errors O 0 0.01372644491493702
in O 0 0.0023559927940368652
antisaccades O 1 0.9978354573249817
was O 0 0.10770421475172043
greatly O 0 0.002985855331644416
increased O 0 0.0011775520397350192
and O 0 0.000647560809738934
was O 0 0.0016649328172206879
significantly O 0 0.0010990797309204936
correlated O 0 0.0015533394180238247
with O 0 0.0008233186090365052
age O 0 0.005900445394217968
at O 0 0.2131911963224411
disease O 1 0.9999979734420776
onset O 1 0.9999955892562866
. O 0 0.06292302161455154

In O 0 0.004453055560588837
addition O 0 0.002822114620357752
, O 0 0.001476689474657178
a O 0 0.001566477818414569
correlation O 0 0.002015193458646536
between O 0 0.0009414863889105618
smooth O 0 0.002101647201925516
pursuit O 0 0.002859775209799409
gain O 0 0.0012638679472729564
and O 0 0.000659202691167593
the O 0 0.0007566440617665648
number O 0 0.0008585773757658899
of O 0 0.0015397371025756001
trinucleotide O 1 0.9903305768966675
repeats O 0 0.010118206962943077
was O 0 0.003912860993295908
found O 0 0.0039220284670591354
. O 0 0.006436199881136417

In O 0 0.008505836129188538
SCA3 B-Disease 1 0.99673992395401
, O 0 0.005382920615375042
gaze B-Disease 1 0.9207531213760376
- I-Disease 1 0.9741132259368896
evoked I-Disease 1 0.9808579087257385
nystagmus I-Disease 1 0.9988948702812195
was O 0 0.004362927284091711
often O 0 0.0007526771514676511
present O 0 0.0008823578245937824
as O 0 0.0009556253789924085
was O 0 0.002159561263397336
saccade O 0 0.2806866765022278
hypometria O 0 0.065249964594841
and O 0 0.0012491755187511444
smooth O 0 0.0035360828042030334
pursuit O 0 0.009798267856240273
gain O 0 0.004070415627211332
was O 0 0.009960295632481575
markedly O 0 0.05338627099990845
decreased O 0 0.027618935331702232
. O 0 0.009215859696269035

Three O 0 0.005634562578052282
major O 0 0.004906699992716312
criteria O 0 0.004551745485514402
, O 0 0.0028811560478061438
saccade O 0 0.03105790540575981
amplitude O 0 0.004729048814624548
, O 0 0.0017574663506820798
saccade O 0 0.008955475874245167
velocity O 0 0.002254222519695759
, O 0 0.0009068084182217717
and O 0 0.0007907301769591868
presence O 0 0.0010778153082355857
of O 0 0.001548007596284151
gaze B-Disease 1 0.7311882376670837
- I-Disease 1 0.8670729994773865
evoked I-Disease 1 0.6114019155502319
nystagmus I-Disease 1 0.6608580350875854
, O 0 0.0009440180729143322
permitted O 0 0.0008375690667890012
the O 0 0.0007215376826934516
correct O 0 0.0011556410463526845
assignment O 0 0.0011315634474158287
of O 0 0.0005617905990220606
90 O 0 0.0006942101172171533
% O 0 0.0005059860413894057
of O 0 0.0005038139643147588
the O 0 0.0007215672521851957
SCA1 B-Disease 0 0.1638917475938797
, O 0 0.0005884789279662073
90 O 0 0.0007538555073551834
% O 0 0.0005657707224600017
of O 0 0.0004485838289838284
the O 0 0.0006393424700945616
SCA2 B-Disease 0 0.05337689444422722
, O 0 0.0004842742928303778
and O 0 0.0003913927648682147
93 O 0 0.0011123811127617955
% O 0 0.00047159113455563784
of O 0 0.0004327403148636222
the O 0 0.0007814272539690137
patients O 0 0.14400498569011688
with O 0 0.0008597917621955276
SCA3 B-Disease 1 0.995036780834198
to O 0 0.0005114231607876718
their O 0 0.0004344569460954517
genetically O 0 0.0011619681026786566
confirmed O 0 0.0010862930212169886
patient O 0 0.017866753041744232
group O 0 0.0006622844957746565
and O 0 0.0003923704207409173
, O 0 0.0004482414515223354
therefore O 0 0.00046887906501069665
, O 0 0.00045111513463780284
may O 0 0.0005010044551454484
help O 0 0.0006200259667821229
orient O 0 0.002420963253825903
diagnoses O 0 0.04195527732372284
of O 0 0.0014232307439669967
SCA1 B-Disease 1 0.9964185953140259
, O 0 0.0014704493805766106
SCA2 B-Disease 1 0.8423848152160645
, O 0 0.0008647157228551805
and O 0 0.0007473296718671918
SCA3 B-Disease 1 0.7701507210731506
at O 0 0.0009752091718837619
early O 0 0.001024599769152701
clinical O 0 0.016534510999917984
stages O 0 0.003805289277806878
of O 0 0.002635840093716979
the O 0 0.10013950616121292
diseases O 1 0.9999816417694092
. O 0 0.005571887828409672
. O 0 0.007431157398968935

Genetic O 0 0.00858505629003048
basis O 0 0.0043283202685415745
and O 0 0.002886397996917367
molecular O 0 0.008911848068237305
mechanism O 0 0.4129352867603302
for O 0 0.4576807916164398
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999998807907104
fibrillation I-Disease 1 0.9999997615814209
. O 1 0.7830295562744141

Ventricular B-Disease 1 0.9999850988388062
fibrillation I-Disease 1 0.9999805688858032
causes O 1 0.6120700836181641
more O 0 0.0012653277954086661
than O 0 0.0009668191778473556
300 O 0 0.0015527288196608424
, O 0 0.0011943898862227798
000 O 0 0.0024935081601142883
sudden O 0 0.0037297229282557964
deaths O 0 0.001337474095635116
each O 0 0.0005634532426483929
year O 0 0.0007467142422683537
in O 0 0.0008590887882746756
the O 0 0.0017451031599193811
USA O 0 0.007187092211097479
alone O 0 0.005348573438823223
. O 0 0.005737352184951305

In O 0 0.003868177765980363
approximately O 0 0.0031485583167523146
5 O 0 0.0021835234947502613
- O 0 0.0023824323434382677
12 O 0 0.0009938670555129647
% O 0 0.0006051530945114791
of O 0 0.00038720195880159736
these O 0 0.0002866649010684341
cases O 0 0.0004475668538361788
, O 0 0.00039699487388134
there O 0 0.00034902122570201755
are O 0 0.00034194966428913176
no O 0 0.0007623774581588805
demonstrable O 1 0.955388605594635
cardiac O 1 0.9998462200164795
or O 0 0.011330578476190567
non O 1 0.9242023825645447
- O 1 0.9992790818214417
cardiac O 1 0.9999899864196777
causes O 0 0.21005205810070038
to O 0 0.00047850608825683594
account O 0 0.0005391190061345696
for O 0 0.0003907530626747757
the O 0 0.000521196227055043
episode O 0 0.0012169203255325556
, O 0 0.0005295574082992971
which O 0 0.00039453725912608206
is O 0 0.0005756589816883206
therefore O 0 0.0009056423441506922
classified O 0 0.004157726187258959
as O 0 0.023566540330648422
idiopathic B-Disease 1 0.9999998807907104
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9998701810836792
IVF B-Disease 1 0.9999946355819702
) O 0 0.015841778367757797
. O 0 0.010038916021585464

A O 0 0.00640002079308033
distinct O 0 0.0037409665528684855
group O 0 0.0029880108777433634
of O 0 0.0839853510260582
IVF B-Disease 1 0.9999986886978149
patients O 1 0.9985004663467407
has O 0 0.002098569180816412
been O 0 0.0006619676714763045
found O 0 0.0005347698461264372
to O 0 0.0004989228909835219
present O 0 0.0007479891646653414
with O 0 0.0008442863472737372
a O 0 0.0024093620013445616
characteristic O 0 0.0707458108663559
electrocardiographic O 1 0.915519654750824
pattern O 0 0.034377120435237885
. O 0 0.00913200806826353

Because O 0 0.004530304577201605
of O 0 0.0025801786687225103
the O 0 0.001616555848158896
small O 0 0.001135320751927793
size O 0 0.0010186454746872187
of O 0 0.0007804243359714746
most O 0 0.0006239915965124965
pedigrees O 0 0.0019938205368816853
and O 0 0.0007519763894379139
the O 0 0.0010112379677593708
high O 0 0.005219407379627228
incidence O 1 0.9598267078399658
of O 0 0.022192860022187233
sudden B-Disease 1 0.9980806112289429
death I-Disease 1 0.7212768197059631
, O 0 0.0008207520586438477
however O 0 0.000571468670386821
, O 0 0.0005461033433675766
molecular O 0 0.0009140747715719044
genetic O 0 0.0008677609730511904
studies O 0 0.0008658914593979716
of O 0 0.0012046672636643052
IVF B-Disease 1 0.9908661246299744
have O 0 0.000831866986118257
not O 0 0.0007016368908807635
yet O 0 0.0012950393138453364
been O 0 0.0018679091008380055
done O 0 0.0037960130721330643
. O 0 0.005658856593072414

Because O 0 0.18238769471645355
IVF B-Disease 1 0.9999799728393555
causes O 1 0.999675989151001
cardiac O 1 0.9999988079071045
rhythm O 1 0.9998225569725037
disturbance O 1 0.9977485537528992
, O 0 0.0022411441896110773
we O 0 0.0009897890267893672
investigated O 0 0.0021242492366582155
whether O 0 0.0010253133950755
malfunction O 0 0.1187005490064621
of O 0 0.0012594555737450719
ion O 0 0.0321907140314579
channels O 0 0.001347245299257338
could O 0 0.0007544070831499994
cause O 0 0.0017728657694533467
the O 0 0.0011310535483062267
disorder O 1 0.9536406993865967
by O 0 0.0007546069682575762
studying O 0 0.001664807670749724
mutations O 0 0.001673919497989118
in O 0 0.0009304964332841337
the O 0 0.0024303358513861895
cardiac O 1 0.9996401071548462
sodium O 0 0.08925651758909225
channel O 0 0.006195276044309139
gene O 0 0.006843314506113529
SCN5A O 0 0.12883886694908142
. O 0 0.008854896761476994

We O 0 0.004162099678069353
have O 0 0.0016194978961721063
now O 0 0.0013486145762726665
identified O 0 0.0014308472163975239
a O 0 0.0012276857160031796
missense O 0 0.003996232058852911
mutation O 0 0.0016199372475966811
, O 0 0.0007025703089311719
a O 0 0.0012635320890694857
splice O 0 0.4320478141307831
- O 0 0.33720076084136963
donor O 0 0.005012229550629854
mutation O 0 0.0015052889939397573
, O 0 0.0005947700701653957
and O 0 0.0005955762462690473
a O 0 0.0009707220597192645
frameshift O 0 0.04057120159268379
mutation O 0 0.001510830596089363
in O 0 0.0005693668499588966
the O 0 0.0008508364553563297
coding O 0 0.0020504742860794067
region O 0 0.001315396511927247
of O 0 0.0012589528923854232
SCN5A O 0 0.4113330841064453
in O 0 0.001482584048062563
three O 0 0.002437109360471368
IVF B-Disease 1 0.9585047960281372
families O 0 0.007133752107620239
. O 0 0.006844636052846909

We O 0 0.0051003070548176765
show O 0 0.003573579015210271
that O 0 0.0015340048121288419
sodium O 0 0.002578050596639514
channels O 0 0.0013052888680249453
with O 0 0.0007832369301468134
the O 0 0.0010702686849981546
missense O 0 0.013557287864387035
mutation O 0 0.003197906306013465
recover O 0 0.006060419604182243
from O 0 0.0009367892052978277
inactivation O 0 0.10882821679115295
more O 0 0.0005435450584627688
rapidly O 0 0.0010009151883423328
than O 0 0.00035234939423389733
normal O 0 0.0006395127857103944
and O 0 0.00038853377918712795
that O 0 0.0003822700527962297
the O 0 0.0008711419068276882
frameshift O 0 0.10758329182863235
mutation O 0 0.0022348789498209953
causes O 0 0.0017790120327845216
the O 0 0.0010287309996783733
sodium O 0 0.002206422621384263
channel O 0 0.0012399489060044289
to O 0 0.0008004317060112953
be O 0 0.0011969511397182941
non O 0 0.002892182907089591
- O 0 0.008846568875014782
functional O 0 0.008737033233046532
. O 0 0.008520417846739292

Our O 0 0.007663698401302099
results O 0 0.0038510621525347233
indicate O 0 0.002790373284369707
that O 0 0.0012549058301374316
mutations O 0 0.00243513030000031
in O 0 0.0016606861026957631
cardiac O 1 0.9973607659339905
ion O 1 0.6286738514900208
- O 0 0.12477210909128189
channel O 0 0.0017328101675957441
genes O 0 0.0008694311254657805
contribute O 0 0.0008953260257840157
to O 0 0.0005577261326834559
the O 0 0.0009247089037671685
risk O 0 0.0018103185575455427
of O 0 0.0019219666719436646
developing O 0 0.13565753400325775
IVF B-Disease 1 0.9980225563049316
. O 0 0.004592017270624638
. O 0 0.008230311796069145

Molecular O 0 0.012058459222316742
heterogeneity O 0 0.02296893484890461
in O 0 0.004600394517183304
mucopolysaccharidosis B-Disease 1 0.9954290390014648
IVA I-Disease 1 0.9999208450317383
in O 0 0.001676696352660656
Australia O 0 0.0014343432849273086
and O 0 0.0005657874862663448
Northern O 0 0.0007973344763740897
Ireland O 0 0.0007491157739423215
: O 0 0.0006363979773595929
nine O 0 0.00071022316114977
novel O 0 0.00160014140419662
mutations O 0 0.0010688656475394964
including O 0 0.0006673901807516813
T312S O 0 0.07187186926603317
, O 0 0.0009295594063587487
a O 0 0.0013486010720953345
common O 0 0.001826446270570159
allele O 0 0.003727671690285206
that O 0 0.0016354892868548632
confers O 0 0.03412481024861336
a O 0 0.007355648558586836
mild O 1 0.991456925868988
phenotype O 1 0.6873757243156433
. O 0 0.012345504015684128

Mucopolysaccharidosis B-Disease 1 0.9984806180000305
IVA I-Disease 1 0.999988317489624
( O 0 0.3082394599914551
MPS B-Disease 1 0.9766521453857422
IVA I-Disease 1 0.999995231628418
) O 0 0.0036696381866931915
is O 0 0.0020510712638497353
an O 0 0.0037025182973593473
autosomal B-Disease 1 0.999862790107727
recessive I-Disease 1 0.9999960660934448
lysosomal I-Disease 1 0.9999998807907104
storage I-Disease 1 0.9999914169311523
disorder I-Disease 1 0.9999998807907104
caused O 1 0.9968587160110474
by O 0 0.0024461185093969107
a O 0 0.005428137723356485
genetic B-Disease 0 0.16181689500808716
defect I-Disease 1 0.9526116847991943
in O 0 0.0015687070554122329
N O 0 0.05719948932528496
- O 0 0.14087596535682678
acetylgalactosamine O 1 0.82524174451828
- O 0 0.4272662103176117
6 O 0 0.030727142468094826
- O 1 0.9149283766746521
sulfate O 1 0.9986568689346313
sulfatase O 1 0.9996697902679443
( O 0 0.01390098687261343
GALNS O 1 0.8798574209213257
) O 0 0.006611438933759928
. O 0 0.008252614177763462

Previous O 0 0.006186354905366898
studies O 0 0.003255771705880761
of O 0 0.0020806309767067432
patients O 0 0.08133714646100998
from O 0 0.0009593336144462228
a O 0 0.0015745018608868122
British O 0 0.03532562032341957
- O 1 0.5914832949638367
Irish O 0 0.017934929579496384
population O 0 0.000718288472853601
showed O 0 0.0009360054973512888
that O 0 0.00045489094918593764
the O 0 0.0006805144366808236
I113F O 0 0.047882068902254105
mutation O 0 0.001135455910116434
is O 0 0.0004677090619225055
the O 0 0.0004312755190767348
most O 0 0.0003433991514611989
common O 0 0.0006313974736258388
single O 0 0.0008695321739651263
mutation O 0 0.002121148630976677
among O 0 0.0022733653895556927
MPS B-Disease 1 0.9978914856910706
IVA I-Disease 1 1.0
patients O 1 0.9996111989021301
and O 0 0.008128732442855835
produces O 0 0.05185758322477341
a O 0 0.020632147789001465
severe O 1 0.9999315738677979
clinical O 1 0.9998114705085754
phenotype O 1 0.9892898201942444
. O 0 0.011311662383377552

We O 0 0.004987264517694712
studied O 0 0.004607358481734991
mutations O 0 0.00305273593403399
in O 0 0.0013703801669180393
the O 0 0.0014154830714687705
GALNS O 0 0.19281356036663055
gene O 0 0.0016344626201316714
from O 0 0.0007585369748994708
23 O 0 0.0014743625652045012
additional O 0 0.0014154096134006977
MPS B-Disease 0 0.06028442084789276
IVA I-Disease 1 0.9999918937683105
patients O 1 0.5323028564453125
( O 0 0.0010609820019453764
15 O 0 0.0006091229151934385
from O 0 0.0003663425159174949
Australia O 0 0.0004694633826147765
, O 0 0.0003250686568208039
8 O 0 0.0004916117177344859
from O 0 0.0003013739187736064
Northern O 0 0.0004818634770344943
Ireland O 0 0.0005504778819158673
) O 0 0.0003495138662401587
, O 0 0.00030288356356322765
with O 0 0.0002775282773654908
various O 0 0.0005358732305467129
clinical O 1 0.8004850745201111
phenotypes O 1 0.8432471752166748
( O 0 0.0052979933097958565
severe O 1 0.9596782326698303
, O 0 0.000767580175306648
16 O 0 0.0007106835255399346
cases O 0 0.0006013078964315355
; O 0 0.00047861397615633905
intermediate O 0 0.0009617258911021054
, O 0 0.00045138312270864844
4 O 0 0.0007022818317636847
cases O 0 0.0006317170918919146
; O 0 0.0006795928347855806
mild O 0 0.0034340263810008764
, O 0 0.0009742916445247829
3 O 0 0.0018483353778719902
cases O 0 0.0021213991567492485
) O 0 0.0033753898460417986
. O 0 0.0052004107274115086

We O 0 0.003721063258126378
found O 0 0.0022301641292870045
two O 0 0.0012604405637830496
common O 0 0.0013431047555059195
mutations O 0 0.0011648674262687564
that O 0 0.00046975704026408494
together O 0 0.0005186321213841438
accounted O 0 0.0009395692031830549
for O 0 0.0004722067096736282
32 O 0 0.0007930694846436381
% O 0 0.0005258616874925792
of O 0 0.000525264535099268
the O 0 0.0007933672168292105
44 O 0 0.0016401244793087244
unrelated O 0 0.0025381192099303007
alleles O 0 0.002432359615340829
in O 0 0.001206687418743968
these O 0 0.001708740834146738
patients O 0 0.03146650642156601
. O 0 0.0070660728961229324

One O 0 0.0042821611277759075
is O 0 0.0024506256449967623
the O 0 0.0019107714761048555
T312S O 0 0.1435592621564865
mutation O 0 0.0027834067586809397
, O 0 0.0008949212497100234
a O 0 0.0011030524037778378
novel O 0 0.0035448456183075905
mutation O 0 0.0021090744994580746
found O 0 0.0009948678780347109
exclusively O 0 0.0018215557793155313
in O 0 0.0025330788921564817
milder O 1 0.5847537517547607
patients O 1 0.6482149362564087
. O 0 0.008891410194337368

The O 0 0.0047338432632386684
other O 0 0.0017440376104786992
is O 0 0.0013097592163830996
the O 0 0.00134873331990093
previously O 0 0.0021569395903497934
described O 0 0.00334365526214242
I113F O 0 0.24570533633232117
that O 0 0.0014167021727189422
produces O 0 0.004013814497739077
a O 0 0.004617023281753063
severe O 1 0.9996263980865479
phenotype O 1 0.9676529765129089
. O 0 0.010519462637603283

The O 0 0.00841396115720272
I113F O 0 0.029973581433296204
and O 0 0.003479916602373123
T312S O 0 0.07391021400690079
mutations O 0 0.0026249440852552652
accounted O 0 0.0018471752991899848
for O 0 0.000821014167740941
8 O 0 0.0013508544070646167
( O 0 0.000858111132401973
18 O 0 0.0007809347589500248
% O 0 0.0006446783663704991
) O 0 0.0004919089842587709
and O 0 0.0004271476063877344
6 O 0 0.0008557489491067827
( O 0 0.0006542362389154732
14 O 0 0.000779657275415957
% O 0 0.0006585658993571997
) O 0 0.0006857174448668957
of O 0 0.0008759112097322941
44 O 0 0.001966064563021064
unrelated O 0 0.003015835303813219
alleles O 0 0.0038139030802994967
, O 0 0.0025209395680576563
respectively O 0 0.006501915864646435
. O 0 0.007403336465358734

The O 0 0.006548949517309666
relatively O 0 0.004969223868101835
high O 0 0.008289830759167671
residual O 1 0.8008459210395813
GALNS O 1 0.9577363729476929
activity O 0 0.002238126704469323
seen O 0 0.0015399334952235222
when O 0 0.0009012604132294655
the O 0 0.0013114383909851313
T312S O 0 0.039127416908741
mutant O 0 0.005903348792344332
cDNA O 0 0.004548643250018358
is O 0 0.0009988258825615048
overexpressed O 0 0.004867274314165115
in O 0 0.001002923701889813
mutant O 0 0.003907111007720232
cells O 0 0.0009452911908738315
provides O 0 0.0007348564104177058
an O 0 0.0004876957682427019
explanation O 0 0.0008500980911776423
for O 0 0.0005751278367824852
the O 0 0.0012495784321799874
mild O 1 0.962225079536438
phenotype O 0 0.27552109956741333
in O 0 0.0012901980662718415
patients O 0 0.2969161868095398
with O 0 0.0014650158118456602
this O 0 0.0019219431560486555
mutation O 0 0.012882445938885212
. O 0 0.005446337629109621

The O 0 0.005566056817770004
distribution O 0 0.0032331589609384537
and O 0 0.001518872450105846
relative O 0 0.0018840574193745852
frequencies O 0 0.0012798802927136421
of O 0 0.0009290158050134778
the O 0 0.0010923950467258692
I113F O 0 0.11502464860677719
and O 0 0.0010434887371957302
T312S O 0 0.051203519105911255
mutations O 0 0.0011092615313827991
in O 0 0.00048093401710502803
Australia O 0 0.0007070881547406316
corresponded O 0 0.0009241565130650997
to O 0 0.0003444690373726189
those O 0 0.00031426295754499733
observed O 0 0.00047475993051193655
in O 0 0.00037398471613414586
Northern O 0 0.0007423005299642682
Ireland O 0 0.0006739762029610574
and O 0 0.0003308755112811923
are O 0 0.00023184243764262646
unique O 0 0.00037242815596982837
to O 0 0.0002378338249400258
these O 0 0.00022154708858579397
two O 0 0.00026743358466774225
populations O 0 0.00047232687938958406
, O 0 0.000383982463972643
suggesting O 0 0.0005939729744568467
that O 0 0.0002817467611748725
both O 0 0.00033529382199048996
mutations O 0 0.0005855087656527758
were O 0 0.00040888049989007413
probably O 0 0.0005719332839362323
introduced O 0 0.0004980984376743436
to O 0 0.00032492802711203694
Australia O 0 0.0006805157172493637
by O 0 0.0005587983760051429
Irish O 0 0.0014344361843541265
migrants O 0 0.0015325454296544194
during O 0 0.001752307522110641
the O 0 0.0017319574253633618
19th O 0 0.006220006849616766
century O 0 0.009144244715571404
. O 0 0.008228194899857044

Haplotype O 0 0.018558841198682785
analysis O 0 0.004947856534272432
using O 0 0.002910348353907466
6 O 0 0.0036026679445058107
RFLPs O 0 0.00759840477257967
provides O 0 0.0017685198690742254
additional O 0 0.0010227183811366558
data O 0 0.0008019941742531955
that O 0 0.0007078537601046264
the O 0 0.0010748329805210233
I113F O 0 0.01119693648070097
mutation O 0 0.0022221526596695185
originated O 0 0.0016841021133586764
from O 0 0.0011007330613210797
a O 0 0.0020558517426252365
common O 0 0.004362243693321943
ancestor O 0 0.014089077711105347
. O 0 0.008812437765300274

The O 0 0.004120859783142805
other O 0 0.0016326482873409986
9 O 0 0.002499132649973035
novel O 0 0.0032702956814318895
mutations O 0 0.0016387273790314794
identified O 0 0.0007711661164648831
in O 0 0.0005421480746008456
these O 0 0.0004749509389512241
23 O 0 0.0010759638389572501
patients O 0 0.0014340269844979048
were O 0 0.0005064290598966181
each O 0 0.0004278300330042839
limited O 0 0.0006901352317072451
to O 0 0.0007151710451580584
a O 0 0.0014472355833277106
single O 0 0.0028289721813052893
family O 0 0.004566306713968515
. O 0 0.00700027123093605

These O 0 0.004141363315284252
data O 0 0.0030991765670478344
provide O 0 0.002079987432807684
further O 0 0.0013990453444421291
evidence O 0 0.0011633704416453838
for O 0 0.0009771586628630757
extensive O 0 0.0024135205894708633
allelic O 0 0.01921318657696247
heterogeneity O 0 0.01090655941516161
in O 0 0.0016271561617031693
MPS B-Disease 0 0.21497254073619843
IVA I-Disease 1 0.999914288520813
in O 0 0.0014314797008410096
British O 0 0.07836209237575531
- O 1 0.9313260912895203
Irish O 0 0.2959645390510559
patients O 0 0.1463843137025833
and O 0 0.0005290587432682514
provide O 0 0.0005167742492631078
evidence O 0 0.0004605211433954537
for O 0 0.00033486547181382775
their O 0 0.000346851913491264
transmission O 0 0.0007033179863356054
to O 0 0.000343538005836308
Australia O 0 0.0005642976029776037
by O 0 0.00045101562864147127
British O 0 0.0013671009801328182
- O 0 0.0036561498418450356
Irish O 0 0.0033332013990730047
migrants O 0 0.003800162812694907
. O 0 0.0028208119329065084
. O 0 0.006499941926449537

Identification O 0 0.008072338998317719
of O 0 0.0036517251282930374
constitutional O 0 0.011255391873419285
WT1 O 1 0.9996737241744995
mutations O 0 0.006328519433736801
, O 0 0.001259121927432716
in O 0 0.0011347238905727863
patients O 1 0.6958420276641846
with O 0 0.003861617064103484
isolated O 1 0.9982231259346008
diffuse B-Disease 1 0.9999990463256836
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.002994905225932598
and O 0 0.0008441560203209519
analysis O 0 0.0009834999218583107
of O 0 0.0019368391949683428
genotype O 1 0.600121259689331
/ O 0 0.08313356339931488
phenotype O 0 0.0025144529063254595
correlations O 0 0.0016686510061845183
by O 0 0.0006415716488845646
use O 0 0.0007168978336267173
of O 0 0.0010659928666427732
a O 0 0.002760663628578186
computerized O 0 0.0963820070028305
mutation O 0 0.010289520025253296
database O 0 0.009596500545740128
. O 0 0.00941955391317606

Constitutional O 0 0.011848893016576767
mutations O 0 0.006408583372831345
of O 0 0.0032241540029644966
the O 0 0.004604131914675236
WT1 O 1 0.9909720420837402
gene O 0 0.0031578540802001953
, O 0 0.001475560711696744
encoding O 0 0.0022305557504296303
a O 0 0.0026510602328926325
zinc O 1 0.9978358149528503
- O 1 0.725228488445282
finger O 0 0.24558721482753754
transcription O 0 0.011476444080471992
factor O 0 0.0029652933590114117
involved O 0 0.0016039899783208966
in O 0 0.008015291765332222
renal O 1 0.9999998807907104
and O 1 0.5694237351417542
gonadal O 1 0.9999921321868896
development O 0 0.027547111734747887
, O 0 0.0007187140872702003
are O 0 0.0003303985868114978
found O 0 0.00045136030530557036
in O 0 0.0004046222602482885
most O 0 0.0005069704493507743
patients O 0 0.017836740240454674
with O 0 0.004300029017031193
Denys B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999979734420776
Drash I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 1 0.9876784682273865
DDS B-Disease 1 0.9999978542327881
) O 0 0.0017773599829524755
, O 0 0.0012364425929263234
or O 0 0.0030338014476001263
diffuse B-Disease 1 0.9994626641273499
mesangial I-Disease 1 0.9999998807907104
sclerosis I-Disease 1 1.0
( O 1 0.9844724535942078
DMS B-Disease 1 0.9999700784683228
) O 0 0.0014089052565395832
associated O 0 0.0010421228362247348
with O 0 0.0009919339790940285
pseudohermaphroditism B-Disease 1 0.9817146062850952
and O 0 0.003150137374177575
/ O 1 0.9739215970039368
or O 0 0.012745512649416924
Wilms B-Disease 1 0.9999958276748657
tumor I-Disease 1 0.9999622106552124
( O 0 0.14807450771331787
WT B-Disease 1 0.9960691928863525
) O 0 0.007878778502345085
. O 0 0.00877631176263094

Most O 0 0.00546486210078001
mutations O 0 0.006997937802225351
in O 0 0.003930159844458103
DDS B-Disease 1 0.9999799728393555
patients O 1 0.5266262292861938
lie O 0 0.003914535045623779
in O 0 0.0012797033414244652
exon O 0 0.00550393620505929
8 O 0 0.0013171810423955321
or O 0 0.0008500341209582984
exon O 0 0.002872420009225607
9 O 0 0.0013386351056396961
, O 0 0.0008224878692999482
encoding O 0 0.001535773160867393
zinc O 0 0.030097363516688347
finger O 0 0.00294636283069849
2 O 0 0.0011216758284717798
or O 0 0.000781745242420584
zinc O 0 0.04135550186038017
finger O 0 0.0022052042186260223
3 O 0 0.0007462778012268245
, O 0 0.00045515119563788176
respectively O 0 0.0006374441436491907
, O 0 0.0004020802734885365
with O 0 0.00039630100945942104
a O 0 0.0007475035381503403
hot O 0 0.002144538564607501
spot O 0 0.002378659788519144
( O 0 0.0017559604020789266
R394W O 0 0.005162703339010477
) O 0 0.001370768528431654
in O 0 0.001805162988603115
exon O 0 0.01009807176887989
9 O 0 0.0063135623931884766
. O 0 0.007054824382066727

We O 0 0.0034577713813632727
analyzed O 0 0.0032135823275893927
a O 0 0.0016274915542453527
series O 0 0.0012299949303269386
of O 0 0.0009188188123516738
24 O 0 0.0013572609750553966
patients O 0 0.005908721126616001
, O 0 0.000525988289155066
10 O 0 0.0005973957595415413
with O 0 0.0005601536249741912
isolated B-Disease 0 0.004291837569326162
DMS I-Disease 1 0.9986777901649475
( O 0 0.002752909203991294
IDMS B-Disease 1 0.9425102472305298
) O 0 0.0007585579878650606
, O 0 0.0005028694868087769
10 O 0 0.0005854472983628511
with O 0 0.0006285461131483316
DDS B-Disease 1 0.9146623611450195
, O 0 0.000819144886918366
and O 0 0.0006452878005802631
4 O 0 0.001340963295660913
with O 0 0.0015680036740377545
urogenital B-Disease 1 0.9999773502349854
abnormalities I-Disease 1 0.9996556043624878
and O 0 0.07484868913888931
/ O 1 0.9960348010063171
or O 0 0.011696591973304749
WT B-Disease 1 0.9954121708869934
. O 0 0.010839068330824375

We O 0 0.007118590176105499
report O 0 0.006321124266833067
WT1 O 0 0.268458753824234
heterozygous O 0 0.005371956620365381
mutations O 0 0.0026736909057945013
in O 0 0.0012022394221276045
16 O 0 0.0016481156926602125
patients O 0 0.0024423152208328247
, O 0 0.0009119100868701935
4 O 0 0.00131801120005548
of O 0 0.0012762806145474315
whom O 0 0.002762333955615759
presented O 0 0.0045405603013932705
with O 0 0.004603284411132336
IDMS B-Disease 1 0.9993247985839844
. O 0 0.011324360966682434

One O 0 0.005213330499827862
male O 0 0.004272583406418562
and O 0 0.001749304705299437
two O 0 0.0016289878403767943
female O 1 0.6096700429916382
IDMS B-Disease 1 0.9999979734420776
patients O 1 0.9989726543426514
with O 0 0.3011046350002289
WT1 O 1 0.9999951124191284
mutations O 1 0.8874455094337463
underwent O 1 0.9997357726097107
normal O 0 0.21873384714126587
puberty O 1 0.920606791973114
. O 0 0.010279680602252483

Two O 0 0.004750057123601437
mutations O 0 0.005168728530406952
associated O 0 0.002363209379836917
with O 0 0.0015370752662420273
IDMS B-Disease 1 0.9803469181060791
are O 0 0.0006907092756591737
different O 0 0.000556926999706775
from O 0 0.0007582801044918597
those O 0 0.0008743676589801908
described O 0 0.0030230109114199877
in O 0 0.004262053407728672
DDS B-Disease 1 0.999987006187439
patients O 1 0.9834549427032471
. O 0 0.01128418929874897

No O 0 0.009753534570336342
WT1 O 1 0.9288601279258728
mutations O 0 0.0041667390614748
were O 0 0.001422253204509616
detected O 0 0.0016196920769289136
in O 0 0.0006683066603727639
the O 0 0.0007451798883266747
six O 0 0.0009575971635058522
other O 0 0.0010845765937119722
IDMS B-Disease 1 0.9999823570251465
patients O 1 0.7047799825668335
, O 0 0.0012964117340743542
suggesting O 0 0.002717390423640609
genetic O 0 0.002610288793221116
heterogeneity O 0 0.014372679404914379
of O 0 0.003209225833415985
this O 0 0.00561857083812356
disease O 1 0.999896764755249
. O 0 0.011685208417475224

We O 0 0.006543975323438644
analyzed O 0 0.01037419680505991
genotype O 0 0.14827030897140503
/ O 0 0.12928490340709686
phenotype O 0 0.005448357202112675
correlations O 0 0.002917066914960742
, O 0 0.0008213854744099081
on O 0 0.0006005690083838999
the O 0 0.0004926066612824798
basis O 0 0.000571364420466125
of O 0 0.0005712966085411608
the O 0 0.0006527400109916925
constitution O 0 0.0008210070664063096
of O 0 0.0009413724765181541
a O 0 0.001678028260357678
WT1 O 1 0.8261867761611938
mutation O 0 0.0015840899432078004
database O 0 0.0011919245589524508
of O 0 0.001192272175103426
84 O 0 0.05468248203396797
germ O 1 0.9985359907150269
- O 0 0.19405439496040344
line O 0 0.0015402729623019695
mutations O 0 0.0009620728087611496
, O 0 0.0004723645106423646
to O 0 0.0003819176054093987
compare O 0 0.0008717472082935274
the O 0 0.0005391996819525957
distribution O 0 0.0006468058563768864
and O 0 0.0005681482143700123
type O 0 0.0010494986781850457
of O 0 0.0007463411893695593
mutations O 0 0.0011648106155917048
, O 0 0.0005959327681921422
according O 0 0.0006787119200453162
to O 0 0.0006627100519835949
the O 0 0.0013591398019343615
different O 0 0.0018943090690299869
symptoms O 1 0.9268737435340881
. O 0 0.008405097760260105

This O 0 0.004838052671402693
demonstrated O 0 0.00539223151281476
( O 0 0.002856362843886018
1 O 0 0.002163618803024292
) O 0 0.0009526917710900307
the O 0 0.0007768169743940234
association O 0 0.0013485741801559925
between O 0 0.0007357824360951781
mutations O 0 0.0009670135914348066
in O 0 0.0005652611725963652
exons O 0 0.0015051942318677902
8 O 0 0.0007770711672492325
and O 0 0.0004921947838738561
9 O 0 0.0008624120964668691
and O 0 0.00065951346186921
DMS B-Disease 0 0.3907396197319031
; O 0 0.000756381603423506
( O 0 0.0008619754808023572
2 O 0 0.0008639591978862882
) O 0 0.000601278617978096
among O 0 0.0006215489120222628
patients O 0 0.0021513954270631075
with O 0 0.0008168306085281074
DMS B-Disease 1 0.9875571727752686
, O 0 0.0006620393833145499
a O 0 0.0006984686478972435
higher O 0 0.0007825889624655247
frequency O 0 0.0006935985293239355
of O 0 0.0006872830563224852
exon O 0 0.002448686631396413
8 O 0 0.0010156353237107396
mutations O 0 0.0008501961710862815
among O 0 0.0005924221477471292
46 O 0 0.0015009549679234624
, O 0 0.0011492229532450438
XY O 1 0.9495421051979065
patients O 0 0.013089491985738277
with O 0 0.0007005785591900349
female O 0 0.001878106384538114
phenotype O 0 0.002366430126130581
than O 0 0.0003915358684025705
among O 0 0.0005875804927200079
46 O 0 0.0014869963051751256
, O 0 0.0011634987313300371
XY O 1 0.971321702003479
patients O 0 0.010486051440238953
with O 0 0.0006347854505293071
sexual O 0 0.0022479766048491
ambiguity O 0 0.029237821698188782
or O 0 0.0013143032556399703
male O 0 0.004798921290785074
phenotype O 0 0.012350744567811489
; O 0 0.0005600794684141874
and O 0 0.0005229423404671252
( O 0 0.0007998705841600895
3 O 0 0.0007288063643500209
) O 0 0.0005584890022873878
statistically O 0 0.0009102849871851504
significant O 0 0.0005935955559834838
evidence O 0 0.0006180500495247543
that O 0 0.0003919930022675544
mutations O 0 0.0007354477420449257
in O 0 0.0004940584767609835
exons O 0 0.0016714701196178794
8 O 0 0.0009996026055887341
and O 0 0.0006250402075238526
9 O 0 0.001189006376080215
preferentially O 0 0.0014925331342965364
affect O 0 0.0009015279356390238
amino O 0 0.0010772249661386013
acids O 0 0.0009707932476885617
with O 0 0.0005530859343707561
different O 0 0.0007131368038244545
functions O 0 0.0018571562832221389
. O 0 0.002616685349494219
. O 0 0.005982635077089071

The O 0 0.012970167212188244
185delAG O 1 0.9160373210906982
BRCA1 O 1 0.896416962146759
mutation O 0 0.005701001733541489
originated O 0 0.0028724910225719213
before O 0 0.0010840337490662932
the O 0 0.0009632242727093399
dispersion O 0 0.0021664670202881098
of O 0 0.0008935902733355761
Jews O 0 0.0013780086301267147
in O 0 0.0007877728785388172
the O 0 0.0010033585131168365
diaspora O 0 0.0017006383277475834
and O 0 0.0007878029136918485
is O 0 0.0008694908465258777
not O 0 0.0006080425227992237
limited O 0 0.0014001642121002078
to O 0 0.0023299017921090126
Ashkenazim O 0 0.020032690837979317
. O 0 0.007563935127109289

The O 0 0.009882076643407345
185delAG O 1 0.5072119235992432
mutation O 0 0.009170952253043652
in O 0 0.0024954478722065687
BRCA1 O 1 0.6096333265304565
is O 0 0.001191044575534761
detected O 0 0.0016072988510131836
in O 0 0.0007392367697320879
Ashkenazi O 0 0.003953422419726849
Jews O 0 0.0013122801901772618
both O 0 0.0007433220744132996
in O 0 0.0066915955394506454
familial B-Disease 1 0.9999997615814209
breast I-Disease 1 1.0
and I-Disease 1 0.9999887943267822
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.08712025731801987
in O 0 0.0019769619684666395
the O 0 0.0033221275079995394
general O 0 0.011750445701181889
population O 0 0.004109181929379702
. O 0 0.0061385310254991055

All O 0 0.005414412822574377
tested O 0 0.01602070964872837
Ashkenazi O 0 0.3919828236103058
mutation O 0 0.006766994949430227
carriers O 0 0.0029038216453045607
share O 0 0.0015152697451412678
the O 0 0.0011897807708010077
same O 0 0.0012749782763421535
allelic O 0 0.008763839490711689
pattern O 0 0.0037838483694940805
at O 0 0.0029332106932997704
the O 0 0.005067217163741589
BRCA1 O 1 0.9744486212730408
locus O 0 0.12747249007225037
. O 0 0.011172330938279629

Our O 0 0.006413297262042761
previous O 0 0.0033460170961916447
study O 0 0.002798852976411581
showed O 0 0.002621048130095005
that O 0 0.0009002236765809357
this O 0 0.0009567049564793706
Ashkenazi O 0 0.14500899612903595
mutation O 0 0.00222014170140028
also O 0 0.0008165824110619724
occurs O 0 0.0008486065198667347
in O 0 0.0005882562254555523
Iraqi O 0 0.0012409234186634421
Jews O 0 0.0013371303211897612
with O 0 0.0008603290771134198
a O 0 0.0016498059267178178
similar O 0 0.003086304059252143
allelic O 0 0.18556548655033112
pattern O 0 0.02584722824394703
. O 0 0.009541834704577923

We O 0 0.0062067750841379166
extended O 0 0.004900766536593437
our O 0 0.002065075095742941
analysis O 0 0.0016037165187299252
to O 0 0.0008895059581845999
other O 0 0.0008332235738635063
non O 0 0.0020246943458914757
- O 0 0.004231534898281097
Ashkenazi O 0 0.005146159790456295
subsets O 0 0.003112443257123232
354 O 0 0.0037214525509625673
of O 0 0.0012644404778257012
Moroccan O 0 0.0030887990724295378
origin O 0 0.0014055549399927258
, O 0 0.0012793050846084952
200 O 0 0.0025811274535954
Yemenites O 0 0.01002424955368042
and O 0 0.002232983009889722
150 O 0 0.004870286677032709
Iranian O 0 0.008983009494841099
Jews O 0 0.012152383103966713
. O 0 0.011022419668734074

Heteroduplex O 0 0.052096590399742126
analysis O 0 0.00731052178889513
complemented O 0 0.009961772710084915
by O 0 0.0022165500558912754
direct O 0 0.0027114874683320522
DNA O 0 0.0030801554676145315
sequencing O 0 0.0038453408051282167
of O 0 0.002665967680513859
abnormally O 0 0.3931456208229065
migrating O 0 0.004791511222720146
bands O 0 0.0041704620234668255
were O 0 0.00348025094717741
employed O 0 0.010820755735039711
. O 0 0.009935123845934868

Four O 0 0.0050809746608138084
of O 0 0.0032449145801365376
Moroccan O 0 0.006251162383705378
origin O 0 0.002138118725270033
( O 0 0.0018289628205820918
1 O 0 0.0013447442324832082
. O 0 0.000528787262737751
1 O 0 0.0008669535163789988
% O 0 0.0006280674133449793
) O 0 0.00045685257646255195
and O 0 0.000338125741109252
none O 0 0.0005033638444729149
of O 0 0.00044760166201740503
the O 0 0.0007951050065457821
Yemenites O 0 0.1554625779390335
or O 0 0.0008828574209474027
Iranians O 0 0.001298696268349886
was O 0 0.0011544774752110243
a O 0 0.0013845210196450353
carrier O 0 0.003471703501418233
of O 0 0.0020526573061943054
the O 0 0.004483148455619812
185delAG O 0 0.42348480224609375
mutation O 0 0.014681081287562847
. O 0 0.009979434311389923

BRCA1 O 1 0.949834406375885
allelic O 0 0.12290096282958984
patterns O 0 0.005111289210617542
were O 0 0.0018280385993421078
determined O 0 0.0014813293237239122
for O 0 0.0006549814715981483
four O 0 0.0005546179017983377
of O 0 0.0005302818026393652
these O 0 0.0003249521541874856
individuals O 0 0.00032927229767665267
and O 0 0.0003160404448863119
for O 0 0.00039727389230392873
12 O 0 0.0006190997664816678
additional O 0 0.0008061819826252759
non O 0 0.0017590430798009038
- O 0 0.008663192391395569
Ashkenazi O 0 0.023523885756731033
185delAG O 0 0.04940244182944298
mutation O 0 0.003272694768384099
carriers O 0 0.0034107298124581575
who O 0 0.004134274087846279
had O 1 0.8556354641914368
breast B-Disease 1 1.0
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.3128572404384613

Six O 0 0.007970775477588177
non O 0 0.034333378076553345
- O 0 0.3613295257091522
Ashkenazi O 0 0.11801955103874207
individuals O 0 0.0012535910354927182
shared O 0 0.001792370923794806
the O 0 0.0015021753497421741
common O 0 0.008854039013385773
Ashkenazi O 1 0.8396255373954773
haplotype O 0 0.014336020685732365
, O 0 0.0007045892416499555
four O 0 0.0005893767229281366
had O 0 0.0005663251504302025
a O 0 0.000563213019631803
closely O 0 0.0005792392184957862
related O 0 0.0005998393753543496
pattern O 0 0.001158104045316577
, O 0 0.00048134036478586495
and O 0 0.0003715375205501914
the O 0 0.0005071928026154637
rest O 0 0.0008984617306850851
( O 0 0.0008899324457161129
n O 0 0.0014747108798474073
= O 0 0.001705692382529378
6 O 0 0.0010322424350306392
) O 0 0.0008139883866533637
displayed O 0 0.001504767220467329
a O 0 0.0016846762737259269
distinct O 0 0.0037841987796127796
BRCA1 O 1 0.5468685626983643
allelic O 0 0.35694634914398193
pattern O 0 0.030371015891432762
. O 0 0.011443356983363628

We O 0 0.004186730831861496
conclude O 0 0.005379960872232914
that O 0 0.0016313111409544945
the O 0 0.0022612495813518763
185delAG O 1 0.9622725248336792
BRCA1 O 1 0.9634067416191101
mutation O 0 0.002602956024929881
occurs O 0 0.0008438511868007481
in O 0 0.0005644293851219118
some O 0 0.0005487691960297525
non O 0 0.0028386779595166445
- O 0 0.08259817957878113
Ashkenazi O 0 0.024092737585306168
populations O 0 0.0010161028476431966
at O 0 0.0010430847760289907
rates O 0 0.001377334468998015
comparable O 0 0.0016509268898516893
with O 0 0.0008970393100753427
that O 0 0.0014532378409057856
of O 0 0.0035523888655006886
Ashkenazim O 0 0.10224416106939316
. O 0 0.011179380118846893

The O 0 0.0064182947389781475
majority O 0 0.003437723033130169
of O 0 0.0030409737955778837
Jewish O 0 0.019106172025203705
185delAG O 1 0.993158757686615
mutation O 0 0.12592843174934387
carriers O 0 0.0027980462182313204
have O 0 0.0006295950151979923
a O 0 0.000916744233109057
common O 0 0.0012886850163340569
allelic O 0 0.18396328389644623
pattern O 0 0.004793494939804077
, O 0 0.0008798128110356629
supporting O 0 0.001242934726178646
the O 0 0.0009243291569873691
founder O 0 0.06077753007411957
effect O 0 0.0010241311974823475
notion O 0 0.0011737735476344824
, O 0 0.00046154818846844137
but O 0 0.0003781108825933188
dating O 0 0.0008450621971860528
the O 0 0.0004903521621599793
mutations O 0 0.0006319793756119907
origin O 0 0.00041150159086100757
to O 0 0.000302642525639385
an O 0 0.0004343869804870337
earlier O 0 0.0007276893593370914
date O 0 0.0009743297123350203
than O 0 0.000904828601051122
currently O 0 0.0023436921183019876
estimated O 0 0.005112992133945227
. O 0 0.006473169662058353

However O 0 0.005518550984561443
, O 0 0.0024301079101860523
the O 0 0.0016940465429797769
different O 0 0.001136035192757845
allelic O 0 0.005856219679117203
pattern O 0 0.0027554624248296022
at O 0 0.0015171103877946734
the O 0 0.0018852789653465152
BRCA1 O 1 0.6422117948532104
locus O 0 0.004232131876051426
even O 0 0.0007342725875787437
in O 0 0.0006321501568891108
some O 0 0.0006838232511654496
Jewish O 0 0.001731868484057486
mutation O 0 0.0026670077349990606
carriers O 0 0.001643734285607934
, O 0 0.000886314723175019
might O 0 0.0008230875828303397
suggest O 0 0.0008731595589779317
that O 0 0.0005518836551345885
the O 0 0.0010089089628309011
mutation O 0 0.002081126207485795
arose O 0 0.0028002371545881033
independently O 0 0.002585367299616337
. O 0 0.0026037523057311773
. O 0 0.005729100201278925

Crystal O 0 0.0219219122081995
structure O 0 0.01008693315088749
of O 0 0.008369800634682178
the O 1 0.7296428680419922
hemochromatosis B-Disease 1 0.9999998807907104
protein O 1 0.6005765199661255
HFE O 1 0.9988501071929932
and O 0 0.0017004382098093629
characterization O 0 0.0038643216248601675
of O 0 0.0016315286047756672
its O 0 0.0018048201454803348
interaction O 0 0.0033131148666143417
with O 0 0.004150274209678173
transferrin O 1 0.6661388278007507
receptor O 0 0.016084957867860794
. O 0 0.01078446488827467

HFE O 1 0.9918522238731384
is O 0 0.006334871053695679
an O 0 0.005137909669429064
MHC O 1 0.9913883805274963
- O 0 0.1733449101448059
related O 0 0.002356885001063347
protein O 0 0.0013401551404967904
that O 0 0.000574902631342411
is O 0 0.0007643557037226856
mutated O 0 0.0018126450013369322
in O 0 0.0009199791820719838
the O 0 0.00911386962980032
iron B-Disease 1 0.9999978542327881
- I-Disease 1 0.9999995231628418
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9863590598106384

HFE O 1 0.9836671352386475
binds O 0 0.014533011242747307
to O 0 0.005231543444097042
transferrin O 1 0.797104001045227
receptor O 0 0.01755242981016636
( O 0 0.005066818092018366
TfR O 1 0.9216246008872986
) O 0 0.0014490174362435937
and O 0 0.0008879597298800945
reduces O 0 0.0018935393309220672
its O 0 0.0007171807810664177
affinity O 0 0.0015087504871189594
for O 0 0.0010730354115366936
iron O 1 0.9409920573234558
- O 1 0.6208163499832153
loaded O 0 0.013163745403289795
transferrin O 1 0.695035994052887
, O 0 0.003615468740463257
implicating O 1 0.9574528336524963
HFE O 1 0.999799907207489
in O 0 0.0065109808929264545
iron O 1 0.9974896907806396
metabolism O 1 0.7312532067298889
. O 0 0.011687015183269978

The O 0 0.022169604897499084
2 O 0 0.026320330798625946
. O 0 0.022327927872538567

6 O 0 0.01018457766622305
A O 0 0.005362749099731445
crystal O 0 0.008899535983800888
structure O 0 0.004214443266391754
of O 0 0.004852879326790571
HFE O 1 0.9997677206993103
reveals O 0 0.03267372027039528
the O 0 0.0013541649095714092
locations O 0 0.001384536037221551
of O 0 0.0022345837205648422
hemochromatosis B-Disease 1 0.9999984502792358
mutations O 0 0.043410249054431915
and O 0 0.0011311548296362162
a O 0 0.007690747268497944
patch O 1 0.9938259720802307
of O 0 0.015884246677160263
histidines O 1 0.9893414974212646
that O 0 0.00047364115016534925
could O 0 0.0004382257757242769
be O 0 0.00041466995025984943
involved O 0 0.0007255921955220401
in O 0 0.0011841581435874104
pH O 0 0.3011611998081207
- O 0 0.027058014646172523
dependent O 0 0.00522101204842329
interactions O 0 0.006496795453131199
. O 0 0.007252655923366547

We O 0 0.0044587901793420315
also O 0 0.0023891965392977
demonstrate O 0 0.0030384922865778208
that O 0 0.0016800337471067905
soluble O 0 0.3066161870956421
TfR O 1 0.9962663054466248
and O 0 0.0025987988337874413
HFE O 1 0.9919406771659851
bind O 0 0.0024249115958809853
tightly O 0 0.0017940753605216742
at O 0 0.0009291776805184782
the O 0 0.000866767717525363
basic O 0 0.0018554299604147673
pH O 0 0.0032722949981689453
of O 0 0.00071640161331743
the O 0 0.0007864214130677283
cell O 0 0.0009443670860491693
surface O 0 0.0007512139854952693
, O 0 0.0004680476267822087
but O 0 0.00033682884532026947
not O 0 0.00036527507472783327
at O 0 0.0008201954187825322
the O 0 0.0012048222124576569
acidic O 0 0.01014678180217743
pH O 0 0.011098254472017288
of O 0 0.0038642664439976215
intracellular O 0 0.12971146404743195
vesicles O 0 0.04871836677193642
. O 0 0.009895119816064835

TfR O 1 0.9987810254096985
HFE O 1 0.9962486624717712
stoichiometry O 0 0.07222018390893936
( O 0 0.005506149958819151
2 O 0 0.0033864763099700212
1 O 0 0.0025431762915104628
) O 0 0.0013031641719862819
differs O 0 0.0015694571193307638
from O 0 0.0015012887306511402
TfR O 1 0.8631895184516907
transferrin O 0 0.0972573310136795
stoichiometry O 0 0.00691729411482811
( O 0 0.0014970666961744428
2 O 0 0.0011874970514327288
2 O 0 0.000986197148449719
) O 0 0.0006564359646290541
, O 0 0.000507676973938942
implying O 0 0.0009612302528694272
a O 0 0.00044769892701879144
different O 0 0.00031927452073432505
mode O 0 0.0008191277156583965
of O 0 0.0005869013257324696
binding O 0 0.000800079433247447
for O 0 0.0008741336641833186
HFE O 1 0.8186935782432556
and O 0 0.001279418240301311
transferrin O 0 0.041643477976322174
to O 0 0.0012843533186241984
TfR O 1 0.8899847269058228
, O 0 0.0009543796768411994
consistent O 0 0.0013436856679618359
with O 0 0.0005681899492628872
our O 0 0.000842653913423419
demonstration O 0 0.001974503044039011
that O 0 0.0010627290466800332
HFE O 1 0.9921563863754272
, O 0 0.0019302546279504895
transferrin O 0 0.14028184115886688
, O 0 0.0016223290003836155
and O 0 0.0016707414761185646
TfR O 1 0.9305142164230347
form O 0 0.003107343101873994
a O 0 0.0037568090483546257
ternary O 0 0.041003551334142685
complex O 0 0.012283431366086006
. O 0 0.010726486332714558

Identification O 0 0.005916812922805548
of O 0 0.002478118985891342
three O 0 0.001690580858848989
novel O 0 0.013661377131938934
mutations O 0 0.002238795394077897
and O 0 0.0007322216988541186
a O 0 0.0008411622256971896
high O 0 0.0011014867341145873
frequency O 0 0.0009417524561285973
of O 0 0.0006475617410615087
the O 0 0.0009887441992759705
Arg778Leu O 1 0.7073132395744324
mutation O 0 0.0026071947067976
in O 0 0.0013184825656935573
Korean O 1 0.9198307394981384
patients O 1 0.9658110737800598
with O 0 0.015189163386821747
Wilson B-Disease 1 0.9980923533439636
disease I-Disease 1 0.9999847412109375
. O 0 0.020047442987561226

Four O 0 0.006819625850766897
mutations O 0 0.013447408564388752
- O 0 0.35101690888404846
- O 0 0.15555602312088013
R778L O 0 0.1776258796453476
, O 0 0.001612904598005116
A874V O 0 0.0067749726586043835
, O 0 0.0011439534137025476
L1083F O 0 0.004087588284164667
, O 0 0.0008375494508072734
and O 0 0.0008616342674940825
2304delC O 0 0.211694598197937
- O 0 0.018840964883565903
- O 0 0.002154791494831443
in O 0 0.0006433014059439301
the O 0 0.0008059469400905073
copper O 0 0.10356077551841736
- O 0 0.00646174093708396
transporting O 0 0.0027761778328567743
enzyme O 0 0.0017052110051736236
, O 0 0.0010493816807866096
P O 0 0.02951238676905632
- O 0 0.011048367246985435
type O 0 0.0037920773029327393
ATPase O 0 0.0645260289311409
( O 0 0.0016264445148408413
ATP7B O 0 0.012197786010801792
) O 0 0.0005891186883673072
, O 0 0.0004128461005166173
were O 0 0.00040932119009085
identified O 0 0.0007425711373798549
in O 0 0.000804175972007215
Korean O 0 0.40284374356269836
Patients O 1 0.9427400231361389
with O 0 0.014381044544279575
Wilson B-Disease 1 0.9989224672317505
disease I-Disease 1 0.999992847442627
. O 0 0.01553343515843153

Arg778Leu O 0 0.42900151014328003
, O 0 0.003825364401564002
the O 0 0.002176655689254403
most O 0 0.0013110059080645442
frequently O 0 0.0014334877487272024
reported O 0 0.001738727674819529
mutation O 0 0.0014670157106593251
of O 0 0.0008293805294670165
this O 0 0.0007073860615491867
enzyme O 0 0.00134025770239532
, O 0 0.0005608169012703001
was O 0 0.0007359987357631326
found O 0 0.00047287510824389756
in O 0 0.00037782659637741745
six O 0 0.0003995508304797113
of O 0 0.00044364877976477146
eight O 0 0.000805616844445467
unrelated O 0 0.00877643283456564
patients O 0 0.03481399267911911
studied O 0 0.0014134221710264683
, O 0 0.0007871366105973721
an O 0 0.0008698098827153444
allele O 0 0.0022361022420227528
frequency O 0 0.0016657414380460978
of O 0 0.0020247981883585453
37 O 0 0.006314562167972326
. O 0 0.0060561238788068295

5 O 0 0.006876632105559111
% O 0 0.002986198989674449
, O 0 0.0017554330406710505
which O 0 0.001025201054289937
is O 0 0.0009042205638252199
considerably O 0 0.001269029569812119
higher O 0 0.0008209757506847382
than O 0 0.0005110103520564735
those O 0 0.000541654706466943
in O 0 0.0008591858204454184
other O 0 0.001188935711979866
Asian O 0 0.005219762213528156
populations O 0 0.006088503170758486
. O 0 0.00754306698217988

The O 0 0.006986125372350216
novel O 0 0.008760886266827583
single O 0 0.0040466804057359695
nucleotide O 0 0.005539273843169212
deletion O 0 0.006710938178002834
, O 0 0.0018327867146581411
2304delC O 0 0.07979115098714828
, O 0 0.0013011674163863063
was O 0 0.0016835553105920553
found O 0 0.001163593027740717
in O 0 0.0012320908717811108
one O 0 0.0023955442011356354
patient O 0 0.3125598728656769
. O 0 0.007082519121468067

Since O 0 0.007421840447932482
a O 0 0.004759708885103464
mutation O 0 0.0053666727617383
at O 0 0.003460835898295045
cDNA O 0 0.009470537304878235
nucleotide O 0 0.00786686036735773
2302 O 0 0.4409664273262024
( O 0 0.0034117787145078182
2302insC O 0 0.009064844809472561
) O 0 0.0012639871565625072
had O 0 0.0009921692544594407
been O 0 0.0006291184690780938
previously O 0 0.000860313477460295
described O 0 0.001036185072734952
, O 0 0.0005342985386960208
this O 0 0.0003990067052654922
region O 0 0.0006465846672654152
of O 0 0.0006582182832062244
the O 0 0.0017976210219785571
ATP7B O 1 0.9989956021308899
gene O 0 0.0018487893976271152
may O 0 0.0006909354124218225
be O 0 0.0005446473369374871
susceptible O 0 0.002349979942664504
to O 0 0.0010249677579849958
gene O 0 0.003529938403517008
rearrangements O 0 0.09453417360782623
causing O 0 0.46013185381889343
Wilson B-Disease 1 0.9656211733818054
disease I-Disease 1 0.9999457597732544
. O 0 0.017366532236337662

Disruption O 0 0.016082126647233963
of O 0 0.004975456744432449
splicing O 0 0.00648673577234149
regulated O 0 0.0033004232682287693
by O 0 0.0014201054582372308
a O 0 0.0027302394155412912
CUG O 1 0.9825129508972168
- O 0 0.1354546695947647
binding O 0 0.003972026519477367
protein O 0 0.005949156358838081
in O 0 0.006715456489473581
myotonic B-Disease 1 0.9999674558639526
dystrophy I-Disease 1 0.9999966621398926
. O 0 0.02337275817990303

Myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 1.0
( O 1 0.9999853372573853
DM B-Disease 1 1.0
) O 0 0.0446503683924675
is O 0 0.0016124362591654062
caused O 0 0.0026863152161240578
by O 0 0.0007665319717489183
a O 0 0.001499165897257626
CTG O 1 0.7176328897476196
expansion O 0 0.001501748338341713
in O 0 0.0007376263965852559
the O 0 0.0009709487203508615
3 O 0 0.0018162410706281662
untranslated O 0 0.005386276636272669
region O 0 0.0020035014022141695
of O 0 0.0023961118422448635
the O 0 0.011518997140228748
DM B-Disease 1 0.9999914169311523
gene O 0 0.015715772286057472
. O 0 0.008571364916861057

One O 0 0.0064816949889063835
model O 0 0.007154184393584728
of O 0 0.057222701609134674
DM B-Disease 1 0.9999997615814209
pathogenesis O 1 0.9999195337295532
suggests O 0 0.006067323032766581
that O 0 0.0009756469517014921
RNAs O 0 0.002594338497146964
from O 0 0.0007539880461990833
the O 0 0.0007446773233823478
expanded O 0 0.001183912856504321
allele O 0 0.0013550278963521123
create O 0 0.0008212617831304669
a O 0 0.0009733452461659908
gain O 0 0.001517405267804861
- O 0 0.002869772957637906
of O 0 0.0010942931985482574
- O 0 0.046206098049879074
function O 0 0.0010169511660933495
mutation O 0 0.0010667782044038177
by O 0 0.0004974218318238854
the O 0 0.0006729323067702353
inappropriate O 0 0.0011588919442147017
binding O 0 0.0007342260214500129
of O 0 0.0006522154435515404
proteins O 0 0.0009357441449537873
to O 0 0.0009719288209453225
the O 0 0.002982622943818569
CUG O 1 0.7739065289497375
repeats O 0 0.01786031946539879
. O 0 0.009473185054957867

Data O 0 0.006849927827715874
presented O 0 0.004605517257004976
here O 0 0.002165920799598098
indicate O 0 0.0018144447822123766
that O 0 0.0008907680166885257
the O 0 0.0009345929720439017
conserved O 0 0.0019993220921605825
heterogeneous O 0 0.0030932133086025715
nuclear O 0 0.00231194868683815
ribonucleoprotein O 0 0.2214304357767105
, O 0 0.0015209319535642862
CUG O 0 0.21997256577014923
- O 0 0.002363417064771056
binding O 0 0.0009563741041347384
protein O 0 0.0011928337626159191
( O 0 0.0013533738674595952
CUG O 0 0.07540911436080933
- O 0 0.003932089079171419
BP O 0 0.0030096638947725296
) O 0 0.0007895668386481702
, O 0 0.0006134724826551974
may O 0 0.0006209165439940989
mediate O 0 0.0014773723669350147
the O 0 0.0010441815247759223
trans O 0 0.009719879366457462
- O 0 0.007257698103785515
dominant O 0 0.0026829533744603395
effect O 0 0.001916444394737482
of O 0 0.0019002287881448865
the O 0 0.003941135015338659
RNA O 0 0.012789152562618256
. O 0 0.008593094535171986

CUG O 1 0.9893245100975037
- O 0 0.36851319670677185
BP O 0 0.021574517711997032
was O 0 0.002533573191612959
found O 0 0.0012438880512490869
to O 0 0.000828648975584656
bind O 0 0.0010671918280422688
to O 0 0.0005927921156398952
the O 0 0.0010510915890336037
human O 0 0.003590912790969014
cardiac O 1 0.9999747276306152
troponin O 1 0.9999897480010986
T O 1 0.9897353649139404
( O 0 0.0025326129980385303
cTNT O 0 0.09202471375465393
) O 0 0.0013699645642191172
pre O 0 0.005217274185270071
- O 0 0.011752246879041195
messenger O 0 0.0038791904225945473
RNA O 0 0.0025641322135925293
and O 0 0.0010201819241046906
regulate O 0 0.002229416510090232
its O 0 0.0022056857123970985
alternative O 0 0.005699331406503916
splicing O 0 0.013091247528791428
. O 0 0.00950064416974783

Splicing O 0 0.015887271612882614
of O 0 0.006509679835289717
cTNT O 1 0.7825227379798889
was O 0 0.04785894602537155
disrupted O 1 0.6518888473510742
in O 0 0.47508278489112854
DM B-Disease 1 1.0
striated O 1 0.999993085861206
muscle O 1 0.9891033172607422
and O 0 0.001396972336806357
in O 0 0.0013615789357572794
normal O 0 0.0028351841028779745
cells O 0 0.001933964667841792
expressing O 0 0.002713320078328252
transcripts O 0 0.00334238912910223
that O 0 0.002011331729590893
contain O 0 0.005754012614488602
CUG O 0 0.21311524510383606
repeats O 0 0.018367402255535126
. O 0 0.010604499839246273

Altered O 0 0.009904365055263042
expression O 0 0.004714103415608406
of O 0 0.0026922093238681555
genes O 0 0.0022149928845465183
regulated O 0 0.002793170278891921
posttranscriptionally O 0 0.029113363474607468
by O 0 0.001850401284173131
CUG O 1 0.9986386895179749
- O 1 0.7614622712135315
BP O 0 0.05107397958636284
therefore O 0 0.0014381174696609378
may O 0 0.001598288188688457
contribute O 0 0.0027936515398323536
to O 0 0.0033856136724352837
DM B-Disease 1 0.9999665021896362
pathogenesis O 1 0.9814039468765259
. O 0 0.004965909756720066
. O 0 0.007955729961395264

Identification O 0 0.007381049450486898
of O 0 0.0036678097676485777
a O 0 0.003568129613995552
novel O 0 0.07896699756383896
nonsense O 0 0.4301082193851471
mutation O 0 0.0032799916807562113
and O 0 0.0010232038330286741
a O 0 0.0013047991087660193
missense O 0 0.003612335305660963
substitution O 0 0.0017273896373808384
in O 0 0.0009316732175648212
the O 0 0.001847137464210391
vasopressin O 1 0.8711705803871155
- O 1 0.5476420521736145
neurophysin O 1 0.7089077234268188
II O 1 0.5519309639930725
gene O 0 0.0014194929972290993
in O 0 0.0007457943283952773
two O 0 0.0008040889515541494
Spanish O 0 0.0030366918072104454
kindreds O 1 0.5879055261611938
with O 0 0.010860714130103588
familial B-Disease 1 0.9999979734420776
neurohypophyseal I-Disease 1 0.9999996423721313
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999997615814209
. O 1 0.6642709970474243

Familial B-Disease 1 0.9999761581420898
neurohypophyseal I-Disease 1 0.9999955892562866
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
( O 1 0.9991506338119507
FNDI B-Disease 1 0.9999958276748657
) O 0 0.009660517796874046
is O 0 0.0018885990139096975
an O 0 0.00618499843403697
autosomal B-Disease 1 0.9999700784683228
dominant I-Disease 1 0.9999843835830688
disease I-Disease 1 1.0
caused O 1 0.9999973773956299
by O 1 0.9973000884056091
deficiency O 1 1.0
in O 1 0.6076936721801758
the O 1 0.9750971794128418
antidiuretic O 1 0.9999995231628418
hormone O 1 0.9994382262229919
arginine O 1 0.752186119556427
vasopressin O 0 0.2564225196838379
( O 0 0.0018297518836334348
AVP O 0 0.015165614895522594
) O 0 0.0007487953407689929
encoded O 0 0.0008152342634275556
by O 0 0.0006209372659213841
the O 0 0.0012124122586101294
AVP O 1 0.788815975189209
- O 0 0.0829056054353714
neurophysin O 1 0.8104700446128845
II O 1 0.9952647686004639
( O 0 0.02186535857617855
AVP O 1 0.9989985823631287
- O 1 0.7108893394470215
NPII O 1 0.9550096392631531
) O 0 0.0017740458715707064
gene O 0 0.002075726166367531
on O 0 0.0019973209127783775
chromosome O 0 0.008125408552587032
20p13 O 0 0.023361483588814735
. O 0 0.008100704289972782

In O 0 0.0041589816100895405
this O 0 0.0015330688329413533
study O 0 0.0015826057642698288
, O 0 0.0009443486924283206
we O 0 0.0006023187888786197
analyzed O 0 0.0009449840290471911
two O 0 0.0005066763260401785
families O 0 0.000700000615324825
with O 0 0.0006150215049274266
FNDI B-Disease 0 0.08594651520252228
using O 0 0.0008308597025461495
direct O 0 0.0009926542406901717
automated O 0 0.001965117873623967
fluorescent O 0 0.0023348683025687933
, O 0 0.0008359444909729064
solid O 0 0.0014321354683488607
phase O 0 0.0014942579437047243
, O 0 0.0007526098052039742
single O 0 0.0011079383548349142
- O 0 0.0019154231995344162
stranded O 0 0.002439122647047043
DNA O 0 0.0015976302092894912
sequencing O 0 0.0018843801226466894
of O 0 0.0015664936508983374
PCR O 0 0.008986006490886211
- O 0 0.018031669780611992
amplified O 0 0.013434827327728271
AVP O 1 0.983954668045044
- O 0 0.08926655352115631
NPII O 1 0.5499216914176941
DNA O 0 0.011799183674156666
. O 0 0.009771452285349369

In O 0 0.004002515226602554
one O 0 0.0017558650579303503
of O 0 0.0013610032619908452
the O 0 0.0013954770984128118
families O 0 0.0013212563935667276
, O 0 0.0009431266807951033
affected O 0 0.0009863352170214057
individuals O 0 0.0005688786623068154
presented O 0 0.0009461669251322746
a O 0 0.0008389329304918647
novel O 0 0.003055648412555456
nonsense O 0 0.01126132532954216
mutation O 0 0.0014410773292183876
in O 0 0.000699096592143178
exon O 0 0.002554532838985324
3 O 0 0.000673844653647393
of O 0 0.000508745841216296
the O 0 0.0006105713546276093
gene O 0 0.0007646973826922476
, O 0 0.00042711468995548785
consisting O 0 0.000748982303775847
in O 0 0.0005152082303538918
a O 0 0.0008033185149542987
G O 0 0.0027474521193653345
to O 0 0.0006849715136922896
T O 0 0.0033585727214813232
transition O 0 0.0011556983226910233
at O 0 0.0008607509080320597
nucleotide O 0 0.0018718355568125844
2101 O 0 0.005740753374993801
, O 0 0.0007035646704025567
which O 0 0.0005639647133648396
produces O 0 0.0010619490640237927
a O 0 0.0009903785539790988
stop O 0 0.001306880614720285
signal O 0 0.001397209009155631
in O 0 0.0010331824887543917
codon O 0 0.004674695432186127
82 O 0 0.004543611314147711
( O 0 0.003876039059832692
Glu O 1 0.6933149695396423
) O 0 0.003240201622247696
of O 0 0.00501607358455658
NPII O 1 0.6591858863830566
. O 0 0.012367477640509605

The O 0 0.010993717238307
premature O 0 0.245420902967453
termination O 0 0.17156104743480682
eliminates O 0 0.0132564352825284
part O 0 0.0023477624636143446
of O 0 0.0017179650021716952
the O 0 0.00282292696647346
C O 1 0.6699337959289551
- O 0 0.10223755985498428
terminal O 0 0.004149032291024923
domain O 0 0.0012982398038730025
of O 0 0.0009833003859966993
NPII O 0 0.3023812770843506
, O 0 0.0005608348292298615
including O 0 0.0005254372954368591
a O 0 0.000785884156357497
cysteine O 0 0.0014719152823090553
residue O 0 0.0015186823438853025
in O 0 0.0005416731000877917
position O 0 0.0008668816881254315
85 O 0 0.0009811060735955834
, O 0 0.0004672505601774901
which O 0 0.00034643951221369207
could O 0 0.0003595657180994749
be O 0 0.0003141598717775196
involved O 0 0.0005050395266152918
in O 0 0.0005568133783526719
the O 0 0.0010941888904199004
correct O 0 0.0025829728692770004
folding O 0 0.006562274880707264
of O 0 0.0033068715129047632
the O 0 0.007669868879020214
prohormone O 1 0.9981750249862671
. O 0 0.012570220045745373

In O 0 0.003948552533984184
the O 0 0.0024400369729846716
second O 0 0.0023100213147699833
family O 0 0.0016775579424574971
, O 0 0.0009969633538275957
a O 0 0.0010927749099209905
G279A O 0 0.008250107988715172
substitution O 0 0.0017287136288359761
at O 0 0.0008204302866943181
position O 0 0.0009708701400086284
- O 0 0.0015296908095479012
1 O 0 0.0008374385652132332
of O 0 0.0005921393749304116
the O 0 0.0006932152318768203
signal O 0 0.001156561658717692
peptide O 0 0.001641091308556497
was O 0 0.000851794087793678
observed O 0 0.0008576109539717436
in O 0 0.0007103714160621166
all O 0 0.0009386480669490993
affected O 0 0.002484468976035714
individuals O 0 0.003109259530901909
. O 0 0.005985297728329897

This O 0 0.005856178235262632
missense O 0 0.016039302572607994
mutation O 0 0.006302963942289352
, O 0 0.0021352742332965136
which O 0 0.001859860261902213
replaces O 1 0.8094070553779602
Ala O 1 0.9972757697105408
with O 0 0.004006112925708294
Thr O 1 0.9997759461402893
, O 0 0.001410087337717414
is O 0 0.000998445670120418
frequent O 0 0.0028285051230341196
among O 0 0.01272523496299982
FNDI B-Disease 1 0.9999972581863403
patients O 1 0.980686366558075
and O 0 0.0007934269960969687
is O 0 0.0006190986023284495
thought O 0 0.0007240010891109705
to O 0 0.0004478582995943725
reduce O 0 0.0010599788511171937
the O 0 0.0007239975966513157
efficiency O 0 0.001985530834645033
of O 0 0.0015972857363522053
cleavage O 0 0.08330225944519043
by O 0 0.0021680693607777357
signal O 0 0.005353889893740416
peptidases O 0 0.01856265403330326
. O 0 0.0037044042255729437
. O 0 0.007599339354783297

Genetic O 0 0.013264734297990799
heterogeneity O 0 0.02199707180261612
of O 0 0.09649961441755295
Saethre B-Disease 1 0.9999967813491821
- I-Disease 1 0.9999979734420776
Chotzen I-Disease 1 0.9999992847442627
syndrome I-Disease 1 1.0
, O 0 0.01988840475678444
due O 0 0.00613808911293745
to O 0 0.001602429780177772
TWIST O 0 0.2895880341529846
and O 0 0.004449693486094475
FGFR O 1 0.9957320094108582
mutations O 0 0.015134870074689388
. O 0 0.009183825924992561

Thirty O 0 0.016552291810512543
- O 0 0.009667330421507359
two O 0 0.0019159081857651472
unrelated O 0 0.004311166238039732
patients O 0 0.004327875562012196
with O 0 0.0009759798413142562
features O 0 0.0015344270505011082
of O 0 0.008028700947761536
Saethre B-Disease 1 0.9999916553497314
- I-Disease 1 0.9999752044677734
Chotzen I-Disease 1 0.9999964237213135
syndrome I-Disease 1 0.9999997615814209
, O 0 0.0032448081765323877
a O 0 0.003927685786038637
common O 0 0.10095113515853882
autosomal B-Disease 1 0.9992324113845825
dominant I-Disease 1 0.9058723449707031
condition I-Disease 1 0.9938346147537231
of O 1 0.9934304356575012
craniosynostosis B-Disease 1 1.0
and O 1 0.9976546168327332
limb B-Disease 1 0.9999988079071045
anomalies I-Disease 1 0.9982537627220154
, O 0 0.0015273729804903269
were O 0 0.0009081751341000199
screened O 0 0.0016366411000490189
for O 0 0.0007770297816023231
mutations O 0 0.0013170682359486818
in O 0 0.0008888570591807365
TWIST O 0 0.006150621920824051
, O 0 0.001982250018045306
FGFR2 O 1 0.5328140258789062
, O 0 0.0029424824751913548
and O 0 0.003950977697968483
FGFR3 O 1 0.6961643099784851
. O 0 0.011650671251118183

Nine O 0 0.007159165106713772
novel O 0 0.007456323131918907
and O 0 0.002275475300848484
three O 0 0.0023415323812514544
recurrent O 1 0.9994617104530334
TWIST O 1 0.8476997017860413
mutations O 0 0.0029761388432234526
were O 0 0.0011151045328006148
found O 0 0.001275599468499422
in O 0 0.0014692351687699556
12 O 0 0.0032815225422382355
families O 0 0.0049820998683571815
. O 0 0.0073460242711007595

Seven O 0 0.005907791666686535
families O 0 0.0028044453356415033
were O 0 0.0012970410753041506
found O 0 0.001056014676578343
to O 0 0.0007211067131720483
have O 0 0.0006640541250817478
the O 0 0.0012284073745831847
FGFR3 O 1 0.9666885137557983
P250R O 1 0.5388307571411133
mutation O 0 0.0018510285299271345
, O 0 0.000547182688023895
and O 0 0.0003824029117822647
one O 0 0.00040107686072587967
individual O 0 0.0004398085584398359
was O 0 0.0006667871493846178
found O 0 0.0004148933512624353
to O 0 0.0003856308467220515
have O 0 0.0004948092391714454
an O 0 0.0011656354181468487
FGFR2 O 1 0.8267868757247925
VV269 O 0 0.4266827404499054
- O 0 0.024207666516304016
270 O 0 0.010376081801950932
deletion O 0 0.016895916312932968
. O 0 0.010047989897429943

To O 0 0.004653749521821737
date O 0 0.0034453014377504587
, O 0 0.0018619070760905743
our O 0 0.0014827125705778599
detection O 0 0.002252544043585658
rate O 0 0.0013491688296198845
for O 0 0.000838342821225524
TWIST O 0 0.004168794956058264
or O 0 0.0009965815115720034
FGFR O 0 0.015520302578806877
mutations O 0 0.001207193243317306
is O 0 0.0006666457047685981
68 O 0 0.0012668847339227796
% O 0 0.0006537943845614791
in O 0 0.0006217123591341078
our O 0 0.001344264135695994
Saethre B-Disease 1 0.9990243911743164
- I-Disease 1 0.9999046325683594
Chotzen I-Disease 1 0.9999974966049194
syndrome I-Disease 1 1.0
patients O 1 0.9972320199012756
, O 0 0.0010910044657066464
including O 0 0.000732296728529036
our O 0 0.0009247722919099033
five O 0 0.0010477514006197453
patients O 0 0.043915972113609314
elsewhere O 0 0.0014524685684591532
reported O 0 0.002236993983387947
with O 0 0.0019491765415295959
TWIST O 0 0.2691209614276886
mutations O 0 0.010117222554981709
. O 0 0.006959796883165836

More O 0 0.0034263539128005505
than O 0 0.0020708634983748198
35 O 0 0.0022662144619971514
different O 0 0.0011283934582024813
TWIST O 0 0.005075148772448301
mutations O 0 0.0017632790841162205
are O 0 0.0006855919491499662
now O 0 0.0010768396314233541
known O 0 0.0011499931570142508
in O 0 0.0012857866240665317
the O 0 0.0022437111474573612
literature O 0 0.007405709009617567
. O 0 0.007698189001530409

The O 0 0.005731653887778521
most O 0 0.0023371621500700712
common O 0 0.0022514681331813335
phenotypic O 0 0.004410973750054836
features O 0 0.0016228711465373635
, O 0 0.0007617801311425865
present O 0 0.0006637966143898666
in O 0 0.000412861438235268
more O 0 0.0002879775711335242
than O 0 0.0002908807364292443
a O 0 0.00046805807505734265
third O 0 0.0006093612755648792
of O 0 0.0006072124233469367
our O 0 0.0008404143154621124
patients O 0 0.008842797949910164
with O 0 0.0006005432223901153
TWIST O 0 0.016258573159575462
mutations O 0 0.0011007352732121944
, O 0 0.0006031391094438732
are O 0 0.0005758478073403239
coronal B-Disease 0 0.005545363295823336
synostosis I-Disease 0 0.04186520352959633
, O 0 0.0012255148030817509
brachycephaly B-Disease 0 0.12084905803203583
, O 0 0.0017813907470554113
low B-Disease 0 0.04025263711810112
frontal I-Disease 1 0.9991602897644043
hairline I-Disease 1 0.9999969005584717
, O 0 0.2025536447763443
facial B-Disease 1 0.9999598264694214
asymmetry I-Disease 1 0.9976619482040405
, O 0 0.09269668161869049
ptosis B-Disease 1 0.9999921321868896
, O 0 0.010796288959681988
hypertelorism B-Disease 1 0.9984048008918762
, O 0 0.0021995457354933023
broad B-Disease 0 0.004375551361590624
great I-Disease 0 0.009814051911234856
toes I-Disease 1 0.6622909307479858
, O 0 0.0033197985030710697
and O 0 0.004253613296896219
clinodactyly B-Disease 1 0.6088762879371643
. O 0 0.011268268339335918

Significant O 0 0.013698352500796318
intra O 1 0.9284250140190125
- O 0 0.3333819806575775
and O 0 0.003090717364102602
interfamilial O 0 0.34199434518814087
phenotypic O 0 0.008434763178229332
variability O 0 0.004265995696187019
is O 0 0.0011727559613063931
present O 0 0.000959930766839534
for O 0 0.000885214249137789
either O 0 0.0016595212509855628
TWIST O 0 0.016021644696593285
mutations O 0 0.004470174666494131
or O 0 0.0032476966734975576
FGFR O 1 0.9280892610549927
mutations O 0 0.014076128602027893
. O 0 0.009066768921911716

The O 0 0.00663111312314868
overlap O 0 0.004726429004222155
in O 0 0.0019290706841275096
clinical O 0 0.05806517228484154
features O 0 0.0017263045301660895
and O 0 0.0008119560079649091
the O 0 0.0007490291027352214
presence O 0 0.0007038201438263059
, O 0 0.00043260236270725727
in O 0 0.00033456264645792544
the O 0 0.00042397872311994433
same O 0 0.00042748445412144065
genes O 0 0.0004317543643992394
, O 0 0.0002980439749080688
of O 0 0.0003204408858437091
mutations O 0 0.0005129204364493489
for O 0 0.0002610952069517225
more O 0 0.0002450365573167801
than O 0 0.00030620425241068006
one O 0 0.0005361539660952985
craniosynostotic B-Disease 0 0.024021871387958527
condition I-Disease 0 0.003454311052337289
- O 0 0.0016173458425328135
such O 0 0.000590448675211519
as O 0 0.0009743473492562771
Saethre B-Disease 1 0.7246410250663757
- I-Disease 0 0.1030803993344307
Chotzen I-Disease 0 0.2794221341609955
, I-Disease 0 0.0012628283584490418
Crouzon I-Disease 0 0.13144251704216003
, I-Disease 0 0.0014160068240016699
and I-Disease 0 0.002539361361414194
Pfeiffer I-Disease 1 0.999946117401123
syndromes I-Disease 1 0.9999847412109375
- O 1 0.866915225982666
support O 0 0.0015332556795328856
the O 0 0.0010088625131174922
hypothesis O 0 0.0016629700548946857
that O 0 0.0006021047011017799
TWIST O 0 0.0030216590967029333
and O 0 0.0007554913172498345
FGFRs O 0 0.005965899210423231
are O 0 0.0004630012554116547
components O 0 0.0007200268446467817
of O 0 0.0006474661058746278
the O 0 0.0006341026746667922
same O 0 0.0006306474679149687
molecular O 0 0.0010487980907782912
pathway O 0 0.0011009385343641043
involved O 0 0.0005673107807524502
in O 0 0.0004717923002317548
the O 0 0.0009671463049016893
modulation O 0 0.012944723479449749
of O 0 0.010543491691350937
craniofacial O 1 0.9999997615814209
and O 1 0.617011547088623
limb O 1 0.9998729228973389
development O 0 0.030335159972310066
in O 0 0.0017361242789775133
humans O 0 0.0028207881841808558
. O 0 0.0026284721679985523
. O 0 0.005196548532694578

Mutation O 0 0.019963571801781654
analysis O 0 0.009866906329989433
of O 0 0.016908349469304085
UBE3A O 1 0.9999935626983643
in O 1 0.9974815249443054
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999994039535522
. O 1 0.9646888375282288

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9965177774429321
AS B-Disease 1 0.9294885396957397
) O 0 0.003233853727579117
is O 0 0.0013403905322775245
caused O 0 0.0033089204225689173
by O 0 0.0011275369906798005
chromosome O 0 0.006045794580131769
15q11 O 1 0.5193759799003601
- O 0 0.0558437742292881
q13 O 0 0.045506324619054794
deletions O 0 0.0026149360928684473
of O 0 0.0010089229326695204
maternal O 0 0.17983466386795044
origin O 0 0.00100520602427423
, O 0 0.0009258845238946378
by O 0 0.0009424674208275974
paternal O 1 0.9137728810310364
uniparental B-Disease 1 0.9999964237213135
disomy I-Disease 1 0.9999122619628906
( O 0 0.21914145350456238
UPD B-Disease 1 0.9999204874038696
) O 0 0.0011237020371481776
15 O 0 0.0008075824589468539
, O 0 0.000693691021297127
by O 0 0.0008881162502802908
imprinting O 0 0.08490500599145889
defects O 0 0.4366495907306671
, O 0 0.0008643594337627292
and O 0 0.0006334129720926285
by O 0 0.00072846858529374
mutations O 0 0.001484347740188241
in O 0 0.0011655932758003473
the O 0 0.0041488888673484325
UBE3A O 1 0.9994781613349915
gene O 0 0.011109523475170135
. O 0 0.0068526798859238625

UBE3A O 1 0.8892366886138916
encodes O 0 0.017194684594869614
a O 0 0.007336638867855072
ubiquitin O 0 0.04257628694176674
- O 0 0.04180210083723068
protein O 0 0.0039220224134624004
ligase O 0 0.008793609216809273
and O 0 0.0021905163303017616
shows O 0 0.004025658592581749
brain O 0 0.0668024867773056
- O 0 0.013358301483094692
specific O 0 0.005537107586860657
imprinting O 0 0.08181744068861008
. O 0 0.010257737711071968

Here O 0 0.007259429432451725
we O 0 0.004062238149344921
describe O 0 0.0084052924066782
UBE3A O 1 0.9920569062232971
coding O 0 0.048164721578359604
- O 0 0.01880287006497383
region O 0 0.0029804615769535303
mutations O 0 0.002334399614483118
detected O 0 0.0015747523866593838
by O 0 0.000777458946686238
SSCP O 0 0.008217590861022472
analysis O 0 0.0008628161740489304
in O 0 0.000688477186486125
13 O 0 0.001127141760662198
AS B-Disease 0 0.0014771507121622562
individuals O 0 0.0011807323899120092
or O 0 0.0021331708412617445
families O 0 0.0050146193243563175
. O 0 0.007232139818370342

Two O 0 0.005362176802009344
identical O 0 0.005993235856294632
de O 0 0.009402910247445107
novo O 0 0.01717965491116047
5 O 0 0.0037588425911962986
- O 0 0.004788727033883333
bp O 0 0.004086689557880163
duplications O 0 0.004805180709809065
in O 0 0.0016232901252806187
exon O 0 0.0063972193747758865
16 O 0 0.0020142460707575083
were O 0 0.001876329304650426
found O 0 0.003801318584010005
. O 0 0.0067753866314888

Among O 0 0.004282547160983086
the O 0 0.0021843768190592527
other O 0 0.000979661475867033
11 O 0 0.0012661282671615481
unique O 0 0.0010218851966783404
mutations O 0 0.0010905410163104534
, O 0 0.0006175331072881818
8 O 0 0.0008259711321443319
were O 0 0.0005027755396440625
small O 0 0.0006847881013527513
deletions O 0 0.001718750223517418
or O 0 0.0008968457113951445
insertions O 0 0.002887151436880231
predicted O 0 0.0017453322652727365
to O 0 0.0007981243543326855
cause O 0 0.0019768348429352045
frameshifts O 0 0.012239919975399971
, O 0 0.0007970227161422372
1 O 0 0.0009929484222084284
was O 0 0.0009084679768420756
a O 0 0.0006515643908642232
mutation O 0 0.0007821092149242759
to O 0 0.0004034624726045877
a O 0 0.0005456660874187946
stop O 0 0.0007586414576508105
codon O 0 0.001383144990541041
, O 0 0.0006111162365414202
1 O 0 0.0007662825519219041
was O 0 0.0007463902002200484
a O 0 0.0007407448720186949
missense O 0 0.0022590584121644497
mutation O 0 0.001034366199746728
, O 0 0.000513381150085479
and O 0 0.0004486276884563267
1 O 0 0.0008175938855856657
was O 0 0.0008521346026100218
predicted O 0 0.0009493717807345092
to O 0 0.0004338981816545129
cause O 0 0.0009922566823661327
insertion O 0 0.001202148967422545
of O 0 0.0006422130391001701
an O 0 0.0008667359361425042
isoleucine O 0 0.44435688853263855
in O 0 0.0006711757741868496
the O 0 0.0008598644053563476
hect O 0 0.005164864007383585
domain O 0 0.001033605425618589
of O 0 0.0008874987834133208
the O 0 0.0015550102107226849
UBE3A O 1 0.9902239441871643
protein O 0 0.0012098525185137987
, O 0 0.0006330765318125486
which O 0 0.0004756819689646363
functions O 0 0.0007912793080322444
in O 0 0.0009482146124355495
E2 O 0 0.010196683928370476
binding O 0 0.0019907059613615274
and O 0 0.0019373197574168444
ubiquitin O 0 0.009229397401213646
transfer O 0 0.005855690222233534
. O 0 0.007713655941188335

Eight O 0 0.0044180843979120255
of O 0 0.0026542709674686193
the O 0 0.0019889569375663996
cases O 0 0.002533884020522237
were O 0 0.0015647513791918755
familial O 1 0.9857622385025024
, O 0 0.0013454477302730083
and O 0 0.0010647421004250646
five O 0 0.0013380004093050957
were O 0 0.002241457812488079
sporadic O 0 0.01125724334269762
. O 0 0.006874362472444773

In O 0 0.004066760186105967
two O 0 0.0025349785573780537
familial O 1 0.9719337821006775
cases O 0 0.012463385239243507
and O 0 0.0015425047604367137
one O 0 0.0011542125139385462
sporadic O 0 0.01003924198448658
case O 0 0.002389276633039117
, O 0 0.0012568238889798522
mosaicism O 1 0.9165496826171875
for O 0 0.0014120341511443257
UBE3A O 1 0.9990917444229126
mutations O 0 0.0019588442519307137
was O 0 0.0012176421005278826
detected O 0 0.0010433228453621268
in O 0 0.00044242441072128713
the O 0 0.0005418742075562477
mother O 0 0.0012625386007130146
of O 0 0.0005927621969021857
three O 0 0.0005784092354588211
AS B-Disease 0 0.01178061868995428
sons O 0 0.02980343997478485
, O 0 0.000445177051005885
in O 0 0.00040051675750873983
the O 0 0.000784403586294502
maternal O 1 0.8521842956542969
grandfather O 0 0.16620853543281555
of O 0 0.0006685607950203121
two O 0 0.0003911322564817965
AS B-Disease 0 0.0018311728490516543
first O 0 0.0006768550956621766
cousins O 0 0.0014811044093221426
, O 0 0.000412588007748127
and O 0 0.00032873431337065995
in O 0 0.00036934783565811813
the O 0 0.0005782751832157373
mother O 0 0.0029161686543375254
of O 0 0.0013990551233291626
an O 0 0.0031503159552812576
AS B-Disease 0 0.2605556547641754
daughter O 1 0.9312605857849121
. O 0 0.008563170209527016

The O 0 0.004204104654490948
frequencies O 0 0.002056834055110812
with O 0 0.0010415228316560388
which O 0 0.0006946483044885099
we O 0 0.0006195593159645796
detected O 0 0.0010623453417792916
mutations O 0 0.0007916477625258267
were O 0 0.0004045543901156634
5 O 0 0.0006642845692113042
( O 0 0.0005225581699050963
14 O 0 0.000579488230869174
% O 0 0.00043651601299643517
) O 0 0.0003884506586473435
of O 0 0.0003654185857158154
35 O 0 0.0005386192351579666
in O 0 0.00041157371015287936
sporadic O 0 0.0008702719933353364
cases O 0 0.0004599659878294915
and O 0 0.00045461984700523317
8 O 0 0.0007277493714354932
( O 0 0.0006071340176276863
80 O 0 0.0006236524786800146
% O 0 0.0005681528127752244
) O 0 0.000522588612511754
of O 0 0.0006076639401726425
10 O 0 0.0009654104360379279
in O 0 0.0012982175685465336
familial O 0 0.18430019915103912
cases O 0 0.003923621494323015
. O 0 0.0038316918071359396
. O 0 0.007319090887904167

The O 0 0.024772262200713158
hemochromatosis B-Disease 1 0.9999933242797852
845 O 1 0.999792754650116
G O 1 0.9929827451705933
- O 1 0.8141703009605408
- O 0 0.0825200006365776
> O 0 0.0038783778436481953
A O 0 0.0016285550082102418
and O 0 0.0009535117424093187
187 O 0 0.0033621948678046465
C O 0 0.005532889626920223
- O 0 0.012244598008692265
- O 0 0.016254570335149765
> O 0 0.006607093382626772
G O 0 0.004605474416166544
mutations O 0 0.0015360498800873756
: O 0 0.0011403063545003533
prevalence O 0 0.027389604598283768
in O 0 0.0015402884455397725
non O 0 0.03922862932085991
- O 1 0.8356304168701172
Caucasian O 1 0.8849371075630188
populations O 0 0.008890930563211441
. O 0 0.008810102008283138

Hemochromatosis B-Disease 1 0.9999812841415405
, O 0 0.03096584789454937
the O 1 0.7706469297409058
inherited B-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
of I-Disease 1 0.9999284744262695
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999769926071167
, O 0 0.1823524534702301
leads O 0 0.33592167496681213
, O 0 0.0015144115313887596
if O 0 0.0008850632002577186
untreated O 1 0.9440183043479919
, O 0 0.0009597075986675918
to O 0 0.0011825336841866374
progressive O 1 0.9901794195175171
iron B-Disease 1 0.9998562335968018
overload I-Disease 1 0.9998995065689087
and O 0 0.014225956052541733
premature B-Disease 1 0.9177682995796204
death I-Disease 0 0.2789282500743866
. O 0 0.009133834391832352

The O 0 0.07654808461666107
hemochromatosis B-Disease 1 0.9999983310699463
gene O 0 0.15752112865447998
, O 0 0.007878104224801064
HFE O 1 0.9998025298118591
, O 0 0.0023469331208616495
recently O 0 0.0030234537553042173
has O 0 0.0008618083084002137
been O 0 0.0005758006009273231
identified O 0 0.0006990296533331275
, O 0 0.0004213091160636395
and O 0 0.0004310683289077133
characterization O 0 0.0015149350510910153
of O 0 0.0006879878346808255
this O 0 0.0005432451143860817
gene O 0 0.0008223639451898634
has O 0 0.00048198451986536384
shown O 0 0.0004644145956262946
that O 0 0.00028111328720115125
it O 0 0.0002561741857789457
contains O 0 0.00043320050463080406
two O 0 0.00034691195469349623
mutations O 0 0.000639406789559871
that O 0 0.00031535723246634007
result O 0 0.0004524834221228957
in O 0 0.00045747769763693213
amino O 0 0.0010744004976004362
acid O 0 0.001533773960545659
substitutions O 0 0.002055529970675707
- O 0 0.0025609133299440145
cDNA O 0 0.005017902236431837
nucleotides O 0 0.0035115398932248354
845 O 0 0.01002342626452446
G O 0 0.007400435395538807
- O 0 0.005087260622531176
- O 0 0.0032336662989109755
> O 0 0.0026150033809244633
A O 0 0.0013770628720521927
( O 0 0.0010896687163040042
C282Y O 0 0.0023924328852444887
) O 0 0.0007922756485641003
and O 0 0.0006915483972989023
187 O 0 0.0026292295660823584
C O 0 0.00465113902464509
- O 0 0.00973587017506361
- O 0 0.02051595225930214
> O 0 0.01032381970435381
G O 0 0.010749329812824726
( O 0 0.004277312662452459
H63D O 0 0.0297321118414402
) O 0 0.005683911964297295
. O 0 0.00826230552047491

Although O 0 0.02326897718012333
hemochromatosis B-Disease 1 0.9999868869781494
is O 0 0.003495601238682866
common O 0 0.0022571783047169447
in O 0 0.0015652410220354795
Caucasians O 1 0.7798726558685303
, O 0 0.0017729357350617647
affecting O 0 0.011271174065768719
> O 0 0.06646369397640228
= O 0 0.0036493923980742693
1 O 0 0.0013981495285406709
/ O 0 0.0016277977265417576
300 O 0 0.0007148487493395805
individuals O 0 0.000393275375245139
of O 0 0.00040629858267493546
northern O 0 0.0005874824710190296
European O 0 0.0005159940337762237
origin O 0 0.0004600089159794152
, O 0 0.0004644821456167847
it O 0 0.00030586053617298603
has O 0 0.0003686168638523668
not O 0 0.0002939442347269505
been O 0 0.0004436929302755743
recognized O 0 0.0008610113291069865
in O 0 0.0007433517603203654
other O 0 0.001183206564746797
populations O 0 0.003638193244114518
. O 0 0.004711593501269817

The O 0 0.005682609975337982
present O 0 0.00309297489002347
study O 0 0.0021705857943743467
used O 0 0.0014456474455073476
PCR O 0 0.004225502256304026
and O 0 0.0011758450418710709
restriction O 0 0.0027226496022194624
- O 0 0.0070788003504276276
enzyme O 0 0.001993841491639614
digestion O 0 0.002138740150257945
to O 0 0.0005962816067039967
analyze O 0 0.0009817264508455992
the O 0 0.0005429004086181521
frequency O 0 0.0006319360691122711
of O 0 0.0005250668618828058
the O 0 0.0008639321313239634
845 O 0 0.23523536324501038
G O 0 0.06530231237411499
- O 0 0.010992374271154404
- O 0 0.0028562501538544893
> O 0 0.0017956497613340616
A O 0 0.0009158441098406911
and O 0 0.0006336203077808022
187 O 0 0.002168770879507065
C O 0 0.003129486460238695
- O 0 0.003869043430313468
- O 0 0.0049126036465168
> O 0 0.003877887735143304
G O 0 0.003280680626630783
mutations O 0 0.0013043108629062772
in O 0 0.0009417900582775474
HLA O 1 0.9167070984840393
- O 0 0.0021738375071436167
typed O 0 0.0016501160571351647
samples O 0 0.0008319798507727683
from O 0 0.0007706786855123937
non O 0 0.0021063117310404778
- O 0 0.015148368664085865
Caucasian O 0 0.017238827422261238
populations O 0 0.0010471980785951018
, O 0 0.0007267042528837919
comprising O 0 0.001282412908039987
Australian O 0 0.0016310146311298013
Aboriginal O 0 0.0028031188994646072
, O 0 0.0009739529341459274
Chinese O 0 0.0019493928411975503
, O 0 0.0012403770815581083
and O 0 0.0018016343237832189
Pacific O 0 0.006992757320404053
Islanders O 0 0.01360285747796297
. O 0 0.007952922023832798

Results O 0 0.007094698026776314
showed O 0 0.004298907704651356
that O 0 0.0014724278589710593
the O 0 0.0021424824371933937
845 O 1 0.749815821647644
G O 1 0.925681471824646
- O 1 0.745742678642273
- O 0 0.18793851137161255
> O 0 0.003919493872672319
A O 0 0.0012297941138967872
mutation O 0 0.0012353836791589856
was O 0 0.0007086478290148079
present O 0 0.0004482132208067924
in O 0 0.00034953656722791493
these O 0 0.00028691915213130414
populations O 0 0.0005707879900000989
( O 0 0.0005945346201770008
allele O 0 0.0007781913154758513
frequency O 0 0.0005224386695772409
0 O 0 0.0006527347140945494
. O 0 0.0003131193225272
32 O 0 0.0006054813275113702
% O 0 0.0005244204076007009
) O 0 0.0003804753068834543
, O 0 0.0003461908781901002
and O 0 0.0003552753187250346
, O 0 0.00040962680941447616
furthermore O 0 0.0006537080626003444
, O 0 0.00035268443753011525
it O 0 0.0002668304950930178
was O 0 0.0005700635374523699
always O 0 0.0005800685030408204
seen O 0 0.0005974318482913077
in O 0 0.0004981686943210661
conjunction O 0 0.001704717637039721
with O 0 0.0014571596402674913
HLA O 1 0.9996671676635742
haplotypes O 0 0.005922031123191118
common O 0 0.0009256511693820357
in O 0 0.0007057854672893882
Caucasians O 0 0.003220438491553068
, O 0 0.0007587160798721015
suggesting O 0 0.0013690306805074215
that O 0 0.0008150490466505289
845 O 1 0.6915322542190552
G O 1 0.8852832913398743
- O 1 0.8295500874519348
- O 1 0.6497305035591125
> O 0 0.00831488985568285
A O 0 0.0012205183738842607
may O 0 0.0006021107546985149
have O 0 0.000415110494941473
been O 0 0.0004917406477034092
introduced O 0 0.0008152699447236955
into O 0 0.0007115949993021786
these O 0 0.000791496888268739
populations O 0 0.0018150847172364593
by O 0 0.002216273918747902
Caucasian O 0 0.2828802168369293
admixture O 0 0.20468014478683472
. O 0 0.009167591109871864

187 O 0 0.032558608800172806
C O 0 0.3152809739112854
- O 1 0.5886903405189514
- O 0 0.42557090520858765
> O 0 0.031692832708358765
G O 0 0.006211865693330765
was O 0 0.001484486274421215
present O 0 0.0009430215577594936
at O 0 0.0010130617301911116
an O 0 0.0009647117694839835
allele O 0 0.00216503138653934
frequency O 0 0.0015296530909836292
of O 0 0.0019396463176235557
2 O 0 0.0046492675319314
. O 0 0.0067146457731723785

68 O 0 0.011604770086705685
% O 0 0.002995867980644107
in O 0 0.0012285764096304774
the O 0 0.001009137835353613
two O 0 0.0007288667256943882
populations O 0 0.0010594007326290011
analyzed O 0 0.0017200197326019406
( O 0 0.0015387521125376225
Australian O 0 0.0024284764658659697
Aboriginal O 0 0.004122335463762283
and O 0 0.0016114708269014955
Chinese O 0 0.00528985308483243
) O 0 0.004476384725421667
. O 0 0.006713080685585737

In O 0 0.0043614711612463
the O 0 0.0027347069699317217
Australian O 0 0.003255290212109685
Aboriginal O 0 0.003358400659635663
samples O 0 0.001454999903216958
, O 0 0.0010161162354052067
187 O 0 0.00329409702681005
C O 0 0.007539911661297083
- O 0 0.04482889175415039
- O 0 0.04969757795333862
> O 0 0.005757166538387537
G O 0 0.002630595350638032
was O 0 0.0008427475695498288
found O 0 0.0004673111252486706
to O 0 0.0003705304698087275
be O 0 0.00038615765515714884
associated O 0 0.0006824335432611406
with O 0 0.0009537580190226436
HLA O 1 0.9998199343681335
haplotypes O 0 0.04079104959964752
common O 0 0.0010893226135522127
in O 0 0.0007596922805532813
Caucasians O 0 0.05366740748286247
, O 0 0.0007682504947297275
suggesting O 0 0.0009879209101200104
that O 0 0.0004883086658082902
it O 0 0.00046460216981358826
was O 0 0.0010344323236495256
introduced O 0 0.0014315670123323798
by O 0 0.0014930390752851963
recent O 0 0.004619268234819174
admixture O 0 0.018753835931420326
. O 0 0.008802550844848156

In O 0 0.004093565978109837
the O 0 0.0025206038262695074
Chinese O 0 0.002223125658929348
samples O 0 0.001459623221307993
analyzed O 0 0.0014837111812084913
, O 0 0.0009814618388190866
187 O 0 0.0029518113005906343
C O 0 0.005692045670002699
- O 0 0.06551573425531387
- O 0 0.09823955595493317
> O 0 0.008061808533966541
G O 0 0.002592560602352023
was O 0 0.0008494285284541547
present O 0 0.0005227385554462671
in O 0 0.0003832055372186005
association O 0 0.000763413030654192
with O 0 0.00046123770880512893
a O 0 0.000641578109934926
wide O 0 0.0007277139229699969
variety O 0 0.000977665651589632
of O 0 0.007193753961473703
HLA O 1 0.9999978542327881
haplotypes O 1 0.720651388168335
, O 0 0.0008851156453602016
showing O 0 0.0011311873095110059
this O 0 0.0004170930478721857
mutation O 0 0.0007515103789046407
to O 0 0.00034881936153396964
be O 0 0.0003557593154255301
widespread O 0 0.000721495714969933
and O 0 0.00041475845500826836
likely O 0 0.0004828129312954843
to O 0 0.00044102518586441875
predate O 0 0.0012747985310852528
the O 0 0.0005748779512941837
more O 0 0.0004627709276974201
genetically O 0 0.0012127991067245603
restricted O 0 0.0016214424977079034
845 O 0 0.25411564111709595
G O 0 0.2963969111442566
- O 0 0.16536249220371246
- O 0 0.11364254355430603
> O 0 0.008457590825855732
A O 0 0.005943790543824434
mutation O 0 0.010498270392417908
. O 0 0.00706360163167119

Genotype O 1 0.8693175911903381
- O 1 0.6611284017562866
phenotype O 0 0.13762450218200684
correlations O 0 0.034158773720264435
in O 0 0.0219617560505867
attenuated B-Disease 1 0.9998793601989746
adenomatous I-Disease 1 0.9999992847442627
polyposis I-Disease 1 0.9999997615814209
coli I-Disease 1 0.999996542930603
. O 0 0.12979461252689362

Germ O 1 0.9949813485145569
- O 0 0.10567010939121246
line O 0 0.005698180757462978
mutations O 0 0.003076814580708742
of O 0 0.002207384444773197
the O 0 0.07064122706651688
tumor B-Disease 1 0.9999911785125732
suppressor O 1 0.9987940788269043
APC O 1 0.7407384514808655
are O 0 0.0010876832529902458
implicated O 0 0.029810471460223198
in O 0 0.0052564674988389015
attenuated B-Disease 1 0.9999445676803589
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9953081011772156
AAPC B-Disease 1 0.9999933242797852
) O 0 0.0021029214840382338
, O 0 0.0012086660135537386
a O 0 0.0017425805563107133
variant O 0 0.09135334193706512
of O 1 0.5431473851203918
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999936819076538
FAP B-Disease 1 0.9999996423721313
) O 0 0.14392045140266418
. O 0 0.0096950214356184

AAPC B-Disease 1 0.9964784979820251
is O 0 0.005712674465030432
recognized O 0 0.0033104238100349903
by O 0 0.0014125817688181996
the O 0 0.0014902749098837376
occurrence O 0 0.0037462159525603056
of O 0 0.0031200305093079805
< O 1 0.8001396656036377
100 O 0 0.0041211689822375774
colonic B-Disease 1 0.9990575909614563
adenomas I-Disease 1 0.9433789849281311
and O 0 0.0012349148746579885
a O 0 0.0014329153345897794
later O 0 0.0025179272051900625
onset O 1 0.9999322891235352
of O 1 0.9981208443641663
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.8067338466644287
age O 0 0.10442259162664413
> O 0 0.02406023070216179
40 O 0 0.0021039345301687717
years O 0 0.0023694420233368874
) O 0 0.0038614755030721426
. O 0 0.005503941792994738

The O 0 0.0053183771669864655
aim O 0 0.004478753544390202
of O 0 0.0019723770674318075
this O 0 0.000972901179920882
study O 0 0.0012896512635052204
was O 0 0.001515028765425086
to O 0 0.0011295139556750655
assess O 0 0.004394872579723597
genotype O 0 0.026728367432951927
- O 0 0.010145092383027077
phenotype O 0 0.006685430184006691
correlations O 0 0.00649626599624753
in O 0 0.003977833315730095
AAPC B-Disease 1 0.993796706199646
families O 0 0.010635051876306534
. O 0 0.011303992010653019

By O 0 0.006207566242665052
protein O 0 0.005959351547062397
- O 0 0.006183896213769913
truncation O 0 0.00950137060135603
test O 0 0.0026753509882837534
( O 0 0.0019180539529770613
PTT O 0 0.005075238645076752
) O 0 0.0013206190196797252
assay O 0 0.001982717774808407
, O 0 0.0008513773791491985
the O 0 0.0009260433143936098
entire O 0 0.0013930470449849963
coding O 0 0.002041188534349203
region O 0 0.0010823585325852036
of O 0 0.0008470558095723391
the O 0 0.0015481292502954602
APC B-Disease 1 0.9111869931221008
gene O 0 0.0012827249011024833
was O 0 0.001112567726522684
screened O 0 0.0012816722737625241
in O 0 0.0005467606824822724
affected O 0 0.000626959721557796
individuals O 0 0.0004414155555423349
from O 0 0.0006991719128564
11 O 0 0.0018543157493695617
AAPC B-Disease 1 0.9989513158798218
kindreds O 0 0.08938232809305191
, O 0 0.000981166260316968
and O 0 0.0007237072568386793
their O 0 0.0009084260673262179
phenotypic O 0 0.003493100870400667
differences O 0 0.0030104564502835274
were O 0 0.003224908374249935
examined O 0 0.011723189614713192
. O 0 0.008541988208889961

Five O 0 0.009544862434267998
novel O 0 0.2565482556819916
germ O 1 0.9998196959495544
- O 1 0.972247838973999
line O 0 0.03577335551381111
APC B-Disease 1 0.8483993411064148
mutations O 0 0.0028814533725380898
were O 0 0.0015171915292739868
identified O 0 0.002443675184622407
in O 0 0.0021990498062223196
seven O 0 0.005064066499471664
kindreds O 0 0.21804647147655487
. O 0 0.011008507572114468

Mutations O 0 0.00806517992168665
were O 0 0.0022086692042648792
located O 0 0.0019434790592640638
in O 0 0.0008416849304921925
three O 0 0.0005231288378126919
different O 0 0.0003424282476771623
regions O 0 0.0005185268237255514
of O 0 0.0005365427932702005
the O 0 0.000983003992587328
APC B-Disease 1 0.6728308796882629
gene O 0 0.0009180221240967512
( O 0 0.0006924743065610528
1 O 0 0.000596830272115767
) O 0 0.0004076928016729653
at O 0 0.00040896586142480373
the O 0 0.00044677272671833634
5 O 0 0.0005975753883831203
end O 0 0.000648786430247128
spanning O 0 0.0011865688720718026
exons O 0 0.0018292205641046166
4 O 0 0.0007931715226732194
and O 0 0.0004841445479542017
5 O 0 0.0007189965690486133
, O 0 0.0005614792462438345
( O 0 0.0006483932374976575
2 O 0 0.0007825460052117705
) O 0 0.000490775506477803
within O 0 0.0005089444457553327
exon O 0 0.0017800091300159693
9 O 0 0.0007132047903724015
, O 0 0.00045999098801985383
and O 0 0.0004325432237237692
( O 0 0.000658724457025528
3 O 0 0.0006159172626212239
) O 0 0.0004299765278119594
at O 0 0.0005140314460732043
the O 0 0.0006038759602233768
3 O 0 0.0013421853072941303
distal O 0 0.0036121325101703405
end O 0 0.0015111344400793314
of O 0 0.0015325945569202304
the O 0 0.0036790964659303427
gene O 0 0.007601213175803423
. O 0 0.0069572399370372295

Variability O 0 0.010689834132790565
in O 0 0.0028259605169296265
the O 0 0.002192723797634244
number O 0 0.0019347305642440915
of O 1 0.5945830345153809
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999997615814209
was O 1 0.862949013710022
most O 0 0.0011069074971601367
apparent O 0 0.01068681851029396
in O 0 0.0005839354125782847
individuals O 0 0.0004553404578473419
with O 0 0.00044828609679825604
mutations O 0 0.0008103209547698498
in O 0 0.0003959707682952285
region O 0 0.0009296523057855666
1 O 0 0.0008667524671182036
, O 0 0.0005247974186204374
and O 0 0.0008296903106383979
upper O 1 0.9784339070320129
- O 1 0.9996834993362427
gastrointestinal O 1 0.9999986886978149
manifestations O 1 0.9984440207481384
were O 0 0.002648984780535102
more O 0 0.001031736028380692
severe O 1 0.9599042534828186
in O 0 0.002042362466454506
them O 0 0.0029085944406688213
. O 0 0.006035962142050266

In O 0 0.003908051643520594
individuals O 0 0.0022300060372799635
with O 0 0.001478073769249022
mutations O 0 0.001776574063114822
in O 0 0.0008116555400192738
either O 0 0.0007263649604283273
region O 0 0.0010366308270022273
2 O 0 0.0008566471515223384
or O 0 0.0004929598653689027
region O 0 0.0006152524729259312
3 O 0 0.0005773043376393616
, O 0 0.0003254190378356725
the O 0 0.00035824807127937675
average O 0 0.0005303373909555376
number O 0 0.0004242526483722031
of O 0 0.0006490214145742357
adenomas B-Disease 1 0.960595965385437
tended O 0 0.0013447816018015146
to O 0 0.0004158975789323449
be O 0 0.0003228628484066576
lower O 0 0.0004773546534124762
than O 0 0.0002619239967316389
those O 0 0.00020742652122862637
in O 0 0.00024404472787864506
individuals O 0 0.00027655705343931913
with O 0 0.00035795412259176373
mutations O 0 0.0006467605708166957
in O 0 0.0004004751390311867
region O 0 0.0006872364901937544
1 O 0 0.0006518599693663418
, O 0 0.00045102572767063975
although O 0 0.0005684467032551765
age O 0 0.0010704697342589498
at O 0 0.001443836954422295
diagnosis O 1 0.9419571757316589
was O 0 0.0062393490225076675
similar O 0 0.0036483921576291323
. O 0 0.006399238482117653

In O 0 0.00697994465008378
all O 0 0.0044871363788843155
AAPC B-Disease 1 0.9979642629623413
kindreds O 0 0.12517142295837402
, O 0 0.0023349402472376823
a O 0 0.002420427743345499
predominance O 0 0.06277487426996231
of O 0 0.009782915003597736
right O 1 0.9052956700325012
- O 1 0.9999889135360718
sided O 1 0.9999985694885254
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9991744160652161
rectal B-Disease 1 1.0
polyp I-Disease 1 0.9999998807907104
sparing O 1 0.9997819066047668
was O 1 0.5290419459342957
observed O 0 0.012811427935957909
. O 0 0.01053011417388916

No O 0 0.01711275614798069
desmoid B-Disease 1 0.9911858439445496
tumors I-Disease 1 0.9908157587051392
were O 0 0.0030260535422712564
found O 0 0.0030021725688129663
in O 0 0.002703757956624031
these O 0 0.0038979907985776663
kindreds O 0 0.18226361274719238
. O 0 0.012361480854451656

Our O 0 0.0057640764862298965
data O 0 0.00298171304166317
suggest O 0 0.0022218525409698486
that O 0 0.0010836258297786117
, O 0 0.0011521741980686784
in O 0 0.0011535705998539925
AAPC B-Disease 1 0.9871187210083008
families O 0 0.0012192485155537724
, O 0 0.0006767896702513099
the O 0 0.0006232828018255532
location O 0 0.000824447488412261
of O 0 0.000986240804195404
the O 0 0.0023908300790935755
APC B-Disease 1 0.9925985336303711
mutation O 0 0.0035193541552871466
may O 0 0.001398430555127561
partially O 0 0.0026229270733892918
predict O 0 0.002336711622774601
specific O 0 0.001995128346607089
phenotypic O 0 0.008181754499673843
expression O 0 0.008304888382554054
. O 0 0.008983884006738663

This O 0 0.0037902076728641987
should O 0 0.0019026643130928278
help O 0 0.0012255236506462097
in O 0 0.0007878922624513507
the O 0 0.0008712365524843335
design O 0 0.0012738953810185194
of O 0 0.0017849835567176342
tailored O 1 0.7523717284202576
clinical O 1 0.9944842457771301
- O 1 0.7069864273071289
management O 0 0.006222560536116362
protocols O 0 0.0021968537475913763
in O 0 0.0009353554924018681
this O 0 0.000998280243948102
subset O 0 0.0037454438861459494
of O 0 0.004504807759076357
FAP B-Disease 1 0.999988317489624
patients O 1 0.9528164267539978
. O 0 0.004824547562748194
. O 0 0.007993853650987148

Wilms B-Disease 1 0.999911904335022
' I-Disease 0 0.43321555852890015
tumor I-Disease 1 0.9579622149467468
1 O 0 0.005043272394686937
and O 0 0.0025021620094776154
Dax O 1 0.9858489036560059
- O 0 0.03752657771110535
1 O 0 0.0022288584150373936
modulate O 0 0.003606429323554039
the O 0 0.0014757320750504732
orphan O 0 0.30187177658081055
nuclear O 0 0.0033105274196714163
receptor O 0 0.004631647374480963
SF O 1 0.9671899676322937
- O 0 0.0038865103852003813
1 O 0 0.0012856029206886888
in O 0 0.0009141688933596015
sex O 0 0.0021682169754058123
- O 0 0.004061877727508545
specific O 0 0.0019735442474484444
gene O 0 0.0042698620818555355
expression O 0 0.005755027290433645
. O 0 0.00734662264585495

Products O 0 0.008431597612798214
of O 0 0.0057069407775998116
steroidogenic O 1 0.9949551224708557
factor O 0 0.007081626448780298
1 O 0 0.0033793768379837275
( O 0 0.0026606505271047354
SF O 1 0.9555558562278748
- O 0 0.004550820216536522
1 O 0 0.001388275297358632
) O 0 0.001084089046344161
and O 0 0.0012199501506984234
Wilms B-Disease 1 0.9998867511749268
tumor I-Disease 1 0.9908180236816406
1 O 0 0.002931763418018818
( O 0 0.002374627161771059
WT1 O 1 0.8369529843330383
) O 0 0.0008470796747133136
genes O 0 0.0006175813032314181
are O 0 0.00037596147740259767
essential O 0 0.00082543765893206
for O 0 0.0008297899039462209
mammalian O 0 0.0025528918486088514
gonadogenesis O 0 0.007589762099087238
prior O 0 0.0021540862508118153
to O 0 0.0019504145020619035
sexual O 0 0.006551450118422508
differentiation O 0 0.02066761627793312
. O 0 0.010360633954405785

In O 0 0.00564074469730258
males O 0 0.005772515200078487
, O 0 0.004129169043153524
SF O 1 0.9992179870605469
- O 0 0.12707746028900146
1 O 0 0.0024221932981163263
participates O 0 0.002234268933534622
in O 0 0.0009135610889643431
sexual O 0 0.0012602006318047643
development O 0 0.0010182802798226476
by O 0 0.0006818815600126982
regulating O 0 0.001393523532897234
expression O 0 0.0011070894543081522
of O 0 0.0012026355834677815
the O 0 0.004782847128808498
polypeptide O 1 0.989888608455658
hormone O 1 0.9939311742782593
Mullerian O 1 0.9996520280838013
inhibiting O 1 0.7704249620437622
substance O 0 0.459702730178833
( O 0 0.015113470144569874
MIS O 1 0.9896997809410095
) O 0 0.007101744879037142
. O 0 0.008410817943513393

Here O 0 0.007812857627868652
, O 0 0.003825095947831869
we O 0 0.0020649402868002653
show O 0 0.0026460362132638693
that O 0 0.0021803167182952166
WT1 O 1 0.9425390362739563
- O 0 0.05489532649517059
KTS O 1 0.6451206207275391
isoforms O 0 0.003881577169522643
associate O 0 0.003208123380318284
and O 0 0.0015336981741711497
synergize O 0 0.10557623207569122
with O 0 0.0023019977379590273
SF O 1 0.9994193315505981
- O 0 0.050860390067100525
1 O 0 0.0029973038472235203
to O 0 0.001771998475305736
promote O 0 0.006022867746651173
MIS O 1 0.5595167279243469
expression O 0 0.010773656889796257
. O 0 0.01024696696549654

In O 0 0.006570256315171719
contrast O 0 0.007784719578921795
, O 0 0.004811323247849941
WT1 O 1 0.9817523956298828
missense O 0 0.027603469789028168
mutations O 0 0.003106629941612482
, O 0 0.0013567156856879592
associated O 0 0.001264491816982627
with O 0 0.0010656517697498202
male B-Disease 0 0.005757702048867941
pseudohermaphroditism I-Disease 1 0.997292697429657
in O 0 0.09247017651796341
Denys B-Disease 1 0.999998927116394
- I-Disease 1 0.9999932050704956
Drash I-Disease 1 0.9999984502792358
syndrome I-Disease 1 0.9999998807907104
, O 0 0.006324760615825653
fail O 0 0.004319443367421627
to O 0 0.0018477917183190584
synergize O 1 0.5411835312843323
with O 0 0.003644694807007909
SF O 1 0.9997065663337708
- O 0 0.4457734227180481
1 O 0 0.01021671760827303
. O 0 0.010218213312327862

Additionally O 0 0.008383228443562984
, O 0 0.002741970121860504
the O 0 0.0023013909813016653
X O 0 0.010827673599123955
- O 0 0.010399664752185345
linked O 0 0.0019634163472801447
, O 0 0.0008866636781021953
candidate O 0 0.0018006792524829507
dosage O 0 0.012358221225440502
- O 0 0.0029732477851212025
sensitive O 0 0.001552314730361104
sex O 0 0.0017759435577318072
- O 0 0.0038235208485275507
reversal O 0 0.0036301384679973125
gene O 0 0.0012077492428943515
, O 0 0.000991648412309587
Dax O 0 0.44514626264572144
- O 0 0.003766506677493453
1 O 0 0.0015942862955853343
, O 0 0.0011361008509993553
antagonizes O 0 0.0400032214820385
synergy O 0 0.006266582291573286
between O 0 0.001813035923987627
SF O 1 0.9998010993003845
- O 0 0.42429518699645996
1 O 0 0.0019776190165430307
and O 0 0.000997072202153504
WT1 O 1 0.8455334305763245
, O 0 0.0006672177696600556
most O 0 0.00043594895396381617
likely O 0 0.0005686759250238538
through O 0 0.0004927917034365237
a O 0 0.0006619203486479819
direct O 0 0.0008897429215721786
interaction O 0 0.001395219238474965
with O 0 0.002027154667302966
SF O 1 0.9986603260040283
- O 0 0.21573859453201294
1 O 0 0.007458426523953676
. O 0 0.006565797608345747

We O 0 0.00555104436352849
propose O 0 0.007041032426059246
that O 0 0.0027121526654809713
WT1 O 0 0.4858829081058502
and O 0 0.003067056881263852
Dax O 1 0.9910564422607422
- O 0 0.2389203906059265
1 O 0 0.002307287650182843
functionally O 0 0.0027688227128237486
oppose O 0 0.0013706197496503592
each O 0 0.00048758703633211553
other O 0 0.0004413090646266937
in O 0 0.00079132872633636
testis O 0 0.09229913353919983
development O 0 0.0018542221514508128
by O 0 0.0016623082337900996
modulating O 1 0.8217164278030396
SF O 1 0.9998723268508911
- O 1 0.6630055904388428
1 O 0 0.005887227598577738
- O 0 0.02733842469751835
mediated O 0 0.012053028680384159
transactivation O 0 0.06458485871553421
. O 0 0.00463272538036108
. O 0 0.0086728036403656

A O 0 0.011999011039733887
mouse O 0 0.012734206393361092
model O 0 0.008787739090621471
for O 0 0.012619322165846825
Prader B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999994039535522
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999994039535522
- O 1 0.9999699592590332
centre O 1 0.9978876709938049
mutations O 1 0.5604617595672607
. O 0 0.009830794297158718

Imprinting O 0 0.02071917988359928
in O 0 0.004573056008666754
the O 0 0.004095892887562513
15q11 O 1 0.6450603008270264
- O 0 0.16332069039344788
q13 O 0 0.05053585395216942
region O 0 0.0019891615957021713
involves O 0 0.0017369110137224197
an O 0 0.0011053333291783929
imprinting O 0 0.18939879536628723
centre O 0 0.07012124359607697
( O 0 0.005488168448209763
IC O 1 0.8466109037399292
) O 0 0.0007861576159484684
, O 0 0.0005309117259457707
mapping O 0 0.0009825349552556872
in O 0 0.0005305646336637437
part O 0 0.0006832575309090316
to O 0 0.0005266283988021314
the O 0 0.0008734005386941135
promoter O 0 0.003921590279787779
and O 0 0.0010147788561880589
first O 0 0.002089914632961154
exon O 0 0.009212441742420197
of O 0 0.004667990375310183
SNRPN O 1 0.9842433929443359
. O 0 0.009894611313939095

Deletion O 0 0.02249324880540371
of O 0 0.006458509247750044
this O 0 0.004123991820961237
IC O 1 0.9860667586326599
abolishes O 1 0.6333967447280884
local O 0 0.0029709620866924524
paternally O 0 0.015956373885273933
derived O 0 0.0023999351542443037
gene O 0 0.0015120216412469745
expression O 0 0.0012105301721021533
and O 0 0.0009407484321855009
results O 0 0.0019862670451402664
in O 0 0.008910217322409153
Prader B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.999944806098938
PWS B-Disease 1 0.9999996423721313
) O 0 0.048869408667087555
. O 0 0.01122722215950489

We O 0 0.004228485748171806
have O 0 0.0017629845533519983
created O 0 0.002025301568210125
two O 0 0.0012204580707475543
deletion O 0 0.004966578911989927
mutations O 0 0.0020669784862548113
in O 0 0.0009201466455124319
mice O 0 0.0024542254395782948
to O 0 0.0009463469032198191
understand O 0 0.0026440031360834837
PWS B-Disease 1 0.9990721940994263
and O 0 0.0010276101529598236
the O 0 0.0013254779623821378
mechanism O 0 0.0026604379527270794
of O 0 0.002324669389054179
this O 0 0.003720096545293927
IC O 1 0.7888451218605042
. O 0 0.009786472655832767

Mice O 0 0.3265894949436188
harbouring O 1 0.659166157245636
an O 0 0.005905103869736195
intragenic O 1 0.7904045581817627
deletion O 0 0.041229695081710815
in O 0 0.0026242348831146955
Snrpn O 1 0.6582642793655396
are O 0 0.0013367629144340754
phenotypically O 0 0.01604904606938362
normal O 0 0.0018209109548479319
, O 0 0.0010279773268848658
suggesting O 0 0.001527311746031046
that O 0 0.0007556144264526665
mutations O 0 0.0014480462996289134
of O 0 0.0013624322600662708
SNRPN O 1 0.6904820799827576
are O 0 0.0011362546356394887
not O 0 0.001314336434006691
sufficient O 0 0.0038831904530525208
to O 0 0.004003250505775213
induce O 0 0.024198729544878006
PWS B-Disease 1 0.9993714690208435
. O 0 0.013972070999443531

Mice O 0 0.01185335498303175
with O 0 0.0025835223495960236
a O 0 0.002150151180103421
larger O 0 0.0018333347979933023
deletion O 0 0.0037127481773495674
involving O 0 0.0018527470529079437
both O 0 0.0011818581260740757
Snrpn O 0 0.371383935213089
and O 0 0.0012428740737959743
the O 0 0.003268561325967312
putative O 1 0.9983441829681396
PWS O 1 0.9999998807907104
- O 1 0.9972050786018372
IC O 1 0.9813437461853027
lack O 0 0.0027933004312217236
expression O 0 0.001378015847876668
of O 0 0.0009979212190955877
the O 0 0.0013253159122541547
imprinted O 0 0.11583089083433151
genes O 0 0.0019477042369544506
Zfp127 O 0 0.16870054602622986
( O 0 0.0015166780212894082
mouse O 0 0.0022145418915897608
homologue O 0 0.004241573624312878
of O 0 0.001327765523456037
ZNF127 O 1 0.9681240320205688
) O 0 0.0011191134108230472
, O 0 0.0009528047521598637
Ndn O 1 0.521661102771759
and O 0 0.0010357674909755588
Ipw O 0 0.07219788432121277
, O 0 0.000874178484082222
and O 0 0.0007777346763759851
manifest O 0 0.0029178797267377377
several O 0 0.001112496480345726
phenotypes O 0 0.01560437586158514
common O 0 0.004192919936031103
to O 0 0.0051950872875750065
PWS B-Disease 1 0.9999972581863403
infants O 1 0.99866783618927
. O 0 0.013094567693769932

These O 0 0.0035058280918747187
data O 0 0.002305904868990183
demonstrate O 0 0.001987100811675191
that O 0 0.0006875168764963746
both O 0 0.0005216916906647384
the O 0 0.0005762052023783326
position O 0 0.0007673270301893353
of O 0 0.0006594040314666927
the O 0 0.0012724316911771894
IC O 1 0.8334737420082092
and O 0 0.0005972448270767927
its O 0 0.0004879838088527322
role O 0 0.0007247829344123602
in O 0 0.00039378119981847703
the O 0 0.0005177963175810874
coordinate O 0 0.0009505280177108943
expression O 0 0.0006517630536109209
of O 0 0.0005709993420168757
genes O 0 0.0006518886075355113
is O 0 0.0004510626895353198
conserved O 0 0.0007792417309246957
between O 0 0.0005068120080977678
mouse O 0 0.0012076854472979903
and O 0 0.0005288522806949914
human O 0 0.0006386710447259247
, O 0 0.00045758389751426876
and O 0 0.00038701281300745904
indicate O 0 0.0006011124351061881
that O 0 0.0003256549243815243
the O 0 0.000512637896463275
mouse O 0 0.001260042772628367
is O 0 0.000492412771563977
a O 0 0.0005564151797443628
suitable O 0 0.0009346735314466059
model O 0 0.0007789966184645891
system O 0 0.0005953363724984229
in O 0 0.00039009127067402005
which O 0 0.00032959922100417316
to O 0 0.0003139927866868675
investigate O 0 0.000694119546096772
the O 0 0.0005051185144111514
molecular O 0 0.0009236231562681496
mechanisms O 0 0.0009240033687092364
of O 0 0.0007298363489098847
imprinting O 0 0.004288254771381617
in O 0 0.0005882988916710019
this O 0 0.00048136559780687094
region O 0 0.0009348939638584852
of O 0 0.0010224870638921857
the O 0 0.0018347663572058082
genome O 0 0.0055399201810359955
. O 0 0.0029063133988529444
. O 0 0.0060021961107850075

Mutations O 0 0.01030698698014021
of O 0 0.003960868809372187
the O 0 0.0030670538544654846
ATM O 0 0.009172031655907631
gene O 0 0.0023949688766151667
detected O 0 0.002389618894085288
in O 0 0.001637808047235012
Japanese O 1 0.9868283271789551
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999979734420776
telangiectasia I-Disease 1 0.9999998807907104
patients O 1 0.9952875375747681
: O 0 0.001684892806224525
possible O 0 0.001171001815237105
preponderance O 0 0.0037459596060216427
of O 0 0.0009592778515070677
the O 0 0.0011198539286851883
two O 0 0.0011684995843097568
founder O 0 0.09896320104598999
mutations O 0 0.006447363644838333
4612del165 O 0 0.060966309159994125
and O 0 0.00424480065703392
7883del5 O 0 0.15085996687412262
. O 0 0.010034864768385887

The O 0 0.007215746212750673
ATM O 0 0.027218837291002274
( O 0 0.005719969980418682
A O 0 0.06754148006439209
- O 1 0.8792991638183594
T O 1 0.9038438200950623
, O 0 0.0016174227930605412
mutated O 0 0.003388427197933197
) O 0 0.0013032977003604174
gene O 0 0.0016928253462538123
on O 0 0.0015744786942377687
human O 0 0.003014414804056287
chromosome O 0 0.010824303142726421
11q22 O 0 0.04323294013738632
. O 0 0.00814600195735693

3 O 0 0.007897011935710907
has O 0 0.002972156973555684
recently O 0 0.002738543087616563
been O 0 0.001145936199463904
identified O 0 0.0011689711827784777
as O 0 0.0007273658411577344
the O 0 0.0006169762928038836
gene O 0 0.0008229362429119647
responsible O 0 0.000760373892262578
for O 0 0.000536716659553349
the O 0 0.0013297656551003456
human O 1 0.7241954803466797
recessive B-Disease 1 0.9999990463256836
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9994577765464783
A B-Disease 1 0.99989914894104
- I-Disease 1 0.9999561309814453
T I-Disease 1 0.9997462630271912
) O 0 0.0050900583155453205
. O 0 0.006430682260543108

In O 0 0.003521503647789359
order O 0 0.0019946442916989326
to O 0 0.0010317787528038025
define O 0 0.0013966874685138464
the O 0 0.0009794492507353425
types O 0 0.0011011866154149175
of O 0 0.02191479690372944
disease O 1 0.9999991655349731
- O 1 0.9980432987213135
causing O 1 0.7950971722602844
ATM O 0 0.16401484608650208
mutations O 0 0.0013903453946113586
in O 0 0.0006259832298383117
Japanese O 0 0.18465928733348846
A B-Disease 1 0.9934044480323792
- I-Disease 1 0.9999668598175049
T I-Disease 1 0.9999125003814697
patients O 0 0.11348538100719452
as O 0 0.0004849722608923912
well O 0 0.00037538938340730965
as O 0 0.0003201630024705082
to O 0 0.00027535081608220935
look O 0 0.0005290703265927732
for O 0 0.00043260137317702174
possible O 0 0.0007783736800774932
mutational O 0 0.011713950894773006
hotspots O 0 0.003197810612618923
, O 0 0.0009887428022921085
reverse O 0 0.0020477762445807457
- O 0 0.00261961598880589
transcribed O 0 0.0020998890977352858
RNA O 0 0.0018502285238355398
derived O 0 0.001037714653648436
from O 0 0.0006389694171957672
ten O 0 0.0011478678788989782
patients O 0 0.001329578342847526
belonging O 0 0.0011286417720839381
to O 0 0.0005486374138854444
eight O 0 0.000814153696410358
unrelated O 0 0.0020599665585905313
Japanese O 0 0.046973250806331635
A B-Disease 1 0.9208077192306519
- I-Disease 1 0.9956095814704895
T I-Disease 1 0.9818615913391113
families O 0 0.0011402255622670054
was O 0 0.0011989778140559793
analyzed O 0 0.0011550819035619497
for O 0 0.0007843131315894425
mutations O 0 0.001420712098479271
by O 0 0.0010069927666336298
the O 0 0.0023918356746435165
restriction O 0 0.006391429807990789
endonuclease O 0 0.02236178331077099
fingerprinting O 0 0.012161917984485626
method O 0 0.01016900036484003
. O 0 0.010938436724245548

As O 0 0.004988490603864193
has O 0 0.002366670873016119
been O 0 0.0012032492086291313
reported O 0 0.0014028568984940648
by O 0 0.0006687957211397588
others O 0 0.0006894820253364742
, O 0 0.0005737363244406879
mutations O 0 0.0007685173768550158
that O 0 0.0003350420738570392
lead O 0 0.000664089631754905
to O 0 0.0005762018845416605
exon O 0 0.004035577643662691
skipping O 0 0.002641442697495222
or O 0 0.0009566074004396796
premature O 0 0.002534705912694335
protein O 0 0.0012934079859405756
truncation O 0 0.003130971221253276
were O 0 0.0008759916527196765
also O 0 0.0013255493249744177
predominant O 0 0.0029547137673944235
in O 0 0.0018506171181797981
our O 0 0.003956376574933529
mutants O 0 0.015694506466388702
. O 0 0.008504818193614483

Six O 0 0.00492123095318675
different O 0 0.0019548353739082813
mutations O 0 0.002331716939806938
were O 0 0.0010648779571056366
identified O 0 0.001414357335306704
on O 0 0.0008765782113187015
12 O 0 0.0011069613974541426
of O 0 0.0010225187288597226
the O 0 0.001540901605039835
16 O 0 0.003218672936782241
alleles O 0 0.006486250087618828
examined O 0 0.008978184312582016
. O 0 0.007251646835356951

Four O 0 0.004632487893104553
were O 0 0.0025837039574980736
deletions O 0 0.0044182706624269485
involving O 0 0.0022175449412316084
a O 0 0.001953194383531809
loss O 0 0.006848264019936323
of O 0 0.0017163000302389264
a O 0 0.0028880040626972914
single O 0 0.0031016054563224316
exon O 0 0.09212245792150497
exon O 0 0.006224052514880896
7 O 0 0.0014709143433719873
, O 0 0.0010397715959697962
exon O 0 0.004427796229720116
16 O 0 0.001791514572687447
, O 0 0.001536225201562047
exon O 0 0.006452569738030434
33 O 0 0.003791576251387596
or O 0 0.0032354637514799833
exon O 0 0.015266725793480873
35 O 0 0.009371914900839329
. O 0 0.009042227640748024

The O 0 0.006075256038457155
others O 0 0.0033006882295012474
were O 0 0.0017230797093361616
minute O 0 0.0027691174764186144
deletions O 0 0.004378348123282194
, O 0 0.0017660855082795024
4649delA O 0 0.0065906052477657795
in O 0 0.0017386000836268067
exon O 0 0.006806789897382259
33 O 0 0.002969860564917326
and O 0 0.002084860811010003
7883del5 O 0 0.00959701742976904
in O 0 0.0035886666737496853
exon O 0 0.022042736411094666
55 O 0 0.01242256723344326
. O 0 0.010915091261267662

The O 0 0.008841139264404774
mutations O 0 0.009120064787566662
4612del165 O 0 0.05544385686516762
and O 0 0.0021991783287376165
7883del5 O 0 0.008678775280714035
were O 0 0.001172535470686853
found O 0 0.0007154092891141772
in O 0 0.0004685211752075702
more O 0 0.00030191519181244075
than O 0 0.0002553409431129694
two O 0 0.00029974919743835926
unrelated O 0 0.0006462355959229171
families O 0 0.00047899235505610704
; O 0 0.00043268263107165694
44 O 0 0.0007047020480968058
% O 0 0.0005680039757862687
( O 0 0.0005271386471576989
7 O 0 0.0006528304656967521
of O 0 0.00043673449545167387
16 O 0 0.0006131579866632819
) O 0 0.0003880553413182497
of O 0 0.0004227528115734458
the O 0 0.0007752395467832685
mutant O 0 0.002620456274598837
alleles O 0 0.0012419725535437465
had O 0 0.0006192605942487717
one O 0 0.0005172222154214978
of O 0 0.0007710367790423334
the O 0 0.0013080710778012872
two O 0 0.0015828295145183802
mutations O 0 0.006205145735293627
. O 0 0.005504586733877659

The O 0 0.007167808711528778
4612del165 O 0 0.13577862083911896
mutations O 0 0.0031388334464281797
in O 0 0.0008366542169824243
three O 0 0.0005758831975981593
different O 0 0.0004046836111228913
families O 0 0.0004981487873010337
were O 0 0.00036958028795197606
all O 0 0.000340411439538002
ascribed O 0 0.0012113455450162292
to O 0 0.0004242669674567878
the O 0 0.000669789791572839
same O 0 0.0011212454410269856
T O 1 0.9321920275688171
- O 0 0.2110266238451004
- O 0 0.014484794810414314
> O 0 0.0023206959012895823
A O 0 0.001217682845890522
substitution O 0 0.0017245877534151077
at O 0 0.001140797627158463
the O 0 0.00136618094984442
splice O 0 0.005042922683060169
donor O 0 0.0025881589390337467
site O 0 0.0021182862110435963
in O 0 0.002438049763441086
intron O 0 0.17114150524139404
33 O 0 0.008974723517894745
. O 0 0.007845534011721611

Microsatellite O 0 0.317432165145874
genotyping O 0 0.0350470207631588
around O 0 0.0036540888249874115
the O 0 0.002959736855700612
ATM O 0 0.031144220381975174
locus O 0 0.01407177560031414
also O 0 0.0013148216530680656
indicated O 0 0.0013845486100763083
that O 0 0.000595720368437469
a O 0 0.0008522661519236863
common O 0 0.0010377132566645741
haplotype O 0 0.002930043963715434
was O 0 0.001060976879671216
shared O 0 0.000983684090897441
by O 0 0.0006726652500219643
the O 0 0.0011116232490167022
mutant O 0 0.00583662511780858
alleles O 0 0.0030456059612333775
in O 0 0.0014494825154542923
both O 0 0.0024883458390831947
mutations O 0 0.007119951769709587
. O 0 0.00649351766332984

This O 0 0.004687896929681301
suggests O 0 0.004214481450617313
that O 0 0.0014511081390082836
these O 0 0.0008524798322468996
two O 0 0.0010332867968827486
founder O 0 0.02452164515852928
mutations O 0 0.00273448065854609
may O 0 0.0011782656656578183
be O 0 0.0008402369567193091
predominant O 0 0.003329211613163352
among O 0 0.0021036199759691954
Japanese O 0 0.021850304678082466
ATM O 0 0.1412230134010315
mutant O 0 0.04063118249177933
alleles O 0 0.01570644974708557
. O 0 0.010033576749265194

W474C O 0 0.24516981840133667
amino O 0 0.015240160748362541
acid O 0 0.0735030323266983
substitution O 0 0.007248485926538706
affects O 0 0.003659163136035204
early O 0 0.001373525825329125
processing O 0 0.0012963295448571444
of O 0 0.001011356827802956
the O 0 0.0010636505903676152
alpha O 0 0.0024982779286801815
- O 0 0.0019209757447242737
subunit O 0 0.0014675339916720986
of O 0 0.0008690907852724195
beta O 0 0.010512755252420902
- O 0 0.030193382874131203
hexosaminidase O 0 0.03571464493870735
A O 0 0.0010382231557741761
and O 0 0.0005661742761731148
is O 0 0.000622214749455452
associated O 0 0.0010872067650780082
with O 0 0.0019051497802138329
subacute O 1 0.9999977350234985
G B-Disease 1 0.9984686970710754
( I-Disease 0 0.09043245017528534
M2 I-Disease 1 0.9844138622283936
) I-Disease 0 0.005489475093781948
gangliosidosis I-Disease 0 0.027545632794499397
. O 0 0.009892855770885944

Mutations O 0 0.009626203216612339
in O 0 0.003414049046114087
the O 0 0.00396555894985795
HEXA O 1 0.995376467704773
gene O 0 0.0026363013312220573
, O 0 0.0011143198935315013
encoding O 0 0.001539295888505876
the O 0 0.0009722395334392786
alpha O 0 0.00238575367256999
- O 0 0.001588486018590629
subunit O 0 0.0014790312852710485
of O 0 0.0008468492887914181
beta O 0 0.003068696241825819
- O 0 0.004693208262324333
hexosaminidase O 0 0.022961441427469254
A O 0 0.0016399933956563473
( O 0 0.0012582625495269895
Hex O 0 0.002662112470716238
A O 0 0.0012470072833821177
) O 0 0.0006419477867893875
, O 0 0.0005280521581880748
that O 0 0.0004734141402877867
abolish O 0 0.0020413275342434645
Hex O 0 0.0035468926653265953
A O 0 0.0017574797384440899
enzyme O 0 0.0026393055450171232
activity O 0 0.0022124210372567177
cause O 1 0.8886329531669617
Tay B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999464750289917
Sachs I-Disease 1 0.9999953508377075
disease I-Disease 1 0.9999991655349731
( O 1 0.6664702892303467
TSD B-Disease 1 0.9999552965164185
) O 0 0.0012908001663163304
, O 0 0.0007243301952257752
the O 0 0.0012536824215203524
fatal O 1 0.9805943369865417
infantile B-Disease 1 0.9998770952224731
form I-Disease 0 0.0025509269908070564
of I-Disease 0 0.03434285894036293
G I-Disease 1 0.9973270893096924
( I-Disease 0 0.008467585779726505
M2 I-Disease 1 0.9342031478881836
) I-Disease 0 0.001996817300096154
gangliosidosis I-Disease 0 0.008497881703078747
, I-Disease 0 0.002162310527637601
Type I-Disease 0 0.005137154366821051
1 I-Disease 0 0.005702964961528778
. O 0 0.007531299255788326

Less O 0 0.010948401875793934
severe O 1 0.9903789758682251
, O 0 0.05649585649371147
subacute O 1 0.9999996423721313
( O 1 0.9927166104316711
juvenile O 1 0.9999967813491821
- O 1 0.9999796152114868
onset O 1 0.9999995231628418
) O 0 0.44607359170913696
and O 0 0.19681809842586517
chronic O 1 1.0
( O 1 0.9845088124275208
adult O 1 0.981765627861023
- O 1 0.9996969699859619
onset O 1 0.9999899864196777
) O 0 0.001579020288772881
variants O 0 0.0010047531686723232
are O 0 0.00036548302159644663
characterized O 0 0.0010140234371647239
by O 0 0.0005083578289486468
a O 0 0.0008220161544159055
broad O 0 0.0015623858198523521
spectrum O 0 0.0013713978696614504
of O 0 0.001429794472642243
clinical O 1 0.992793083190918
manifestations O 1 0.9896981120109558
and O 0 0.0010680004488676786
are O 0 0.00046107082744129
associated O 0 0.0007119511719793081
with O 0 0.0007275142706930637
residual O 0 0.026306848973035812
levels O 0 0.0017351277638226748
of O 0 0.00200529838912189
Hex O 0 0.1513676643371582
A O 0 0.005634748842567205
enzyme O 0 0.007399167865514755
activity O 0 0.006498239003121853
. O 0 0.007756656501442194

We O 0 0.004550483543425798
identified O 0 0.004759234841912985
a O 0 0.0036245808005332947
1422 O 1 0.8728687167167664
G O 1 0.6188818216323853
- O 0 0.3160659372806549
- O 0 0.12416016310453415
> O 0 0.006861977279186249
C O 0 0.003233478870242834
( O 0 0.001295998110435903
amino O 0 0.001311613479629159
acid O 0 0.001729471143335104
W474C O 0 0.0034890430979430676
) O 0 0.0007556417258456349
substitution O 0 0.0011436433997005224
in O 0 0.0005048898747190833
the O 0 0.00056663021678105
first O 0 0.0005849096924066544
position O 0 0.0008653668337501585
of O 0 0.0007556759519502521
exon O 0 0.002577008679509163
13 O 0 0.0010030015837401152
of O 0 0.0009256287012249231
HEXA O 1 0.8160156011581421
of O 0 0.0009079440496861935
a O 0 0.0014385886024683714
non O 0 0.004332863260060549
- O 0 0.017628947272896767
Jewish O 0 0.0022699092514812946
proband O 0 0.133222296833992
who O 0 0.002032341668382287
manifested O 0 0.06032242625951767
a O 0 0.0028510272968560457
subacute O 1 0.9999864101409912
variant O 1 0.7779760360717773
of O 0 0.21942007541656494
G B-Disease 1 0.9993378520011902
( I-Disease 0 0.08337894082069397
M2 I-Disease 1 0.9626361727714539
) I-Disease 0 0.0046707987785339355
gangliosidosis I-Disease 0 0.02460971660912037
. O 0 0.008318350650370121

On O 0 0.0053753359243273735
the O 0 0.00337997917085886
second O 0 0.006623073946684599
maternally O 1 0.9461923241615295
inherited O 1 0.9892122745513916
allele O 0 0.005116374231874943
, O 0 0.0009800703264772892
we O 0 0.0006998698809184134
identified O 0 0.0010061148786917329
the O 0 0.0012832821812480688
common O 0 0.1848737597465515
infantile O 1 0.9999997615814209
disease O 1 0.9999998807907104
- O 1 0.9991618394851685
causing O 1 0.9288510680198669
4 O 0 0.023337557911872864
- O 0 0.11938483268022537
bp O 0 0.004055693745613098
insertion O 0 0.003961878828704357
, O 0 0.0015959067968651652
+ O 0 0.0047660465352237225
TATC O 0 0.06025974452495575
1278 O 0 0.05659022554755211
, O 0 0.0021860443521291018
in O 0 0.00261769350618124
exon O 0 0.013773882761597633
11 O 0 0.0077636209316551685
. O 0 0.00880203116685152

Pulse O 0 0.14401613175868988
- O 0 0.01604420319199562
chase O 0 0.007342047523707151
analysis O 0 0.002682133112102747
using O 0 0.0022657348308712244
proband O 0 0.03410153090953827
fibroblasts O 0 0.0053292447701096535
revealed O 0 0.002120141638442874
that O 0 0.0007269304478541017
the O 0 0.001074095955118537
W474C O 0 0.007959224283695221
- O 0 0.0029496930073946714
containing O 0 0.00179735675919801
alpha O 0 0.003754132892936468
- O 0 0.0029661236330866814
subunit O 0 0.00200090860016644
precursor O 0 0.0022027587983757257
was O 0 0.001199916354380548
normally O 0 0.0008073939825408161
synthesized O 0 0.0011884192936122417
, O 0 0.0005007027648389339
but O 0 0.0004587648727465421
not O 0 0.00046927123912610114
phosphorylated O 0 0.0014533926732838154
or O 0 0.0005644632619805634
secreted O 0 0.0013674630317837
, O 0 0.0006366527522914112
and O 0 0.0007550392183475196
the O 0 0.001259737415239215
mature O 0 0.0037382268346846104
lysosomal O 1 0.9751562476158142
alpha O 0 0.015749014914035797
- O 0 0.00927556399255991
subunit O 0 0.00423770397901535
was O 0 0.002912147669121623
not O 0 0.0022521796636283398
detected O 0 0.00896780751645565
. O 0 0.00802638940513134

When O 0 0.004912932403385639
the O 0 0.003163084853440523
W474C O 0 0.02706463821232319
- O 0 0.006324445828795433
containing O 0 0.0029383443761616945
alpha O 0 0.004964082036167383
- O 0 0.003688778029754758
subunit O 0 0.0031108756083995104
was O 0 0.001993784448131919
transiently O 0 0.008446297608315945
co O 0 0.005602837540209293
- O 0 0.002478744136169553
expressed O 0 0.0010718880221247673
with O 0 0.0005646667559631169
the O 0 0.0009351162007078528
beta O 0 0.002573657315224409
- O 0 0.0016831348184496164
subunit O 0 0.001271681860089302
to O 0 0.00044723975588567555
produce O 0 0.0006351491902023554
Hex O 0 0.0022163265384733677
A O 0 0.001135453232564032
( O 0 0.0010027699172496796
alphabeta O 0 0.003325315425172448
) O 0 0.0008262599003501236
in O 0 0.0007932515582069755
COS O 1 0.9856481552124023
- O 0 0.0038277108687907457
7 O 0 0.001037134206853807
cells O 0 0.0006421050638891757
, O 0 0.0004385107895359397
the O 0 0.0006326991715468466
mature O 0 0.001205765875056386
alpha O 0 0.0018993737176060677
- O 0 0.00134360883384943
subunit O 0 0.0010281442664563656
was O 0 0.0006729994202032685
present O 0 0.00044763917685486376
, O 0 0.0003639064962044358
but O 0 0.0002827561693266034
its O 0 0.00031794889946468174
level O 0 0.0005404196563176811
was O 0 0.0005988667253404856
much O 0 0.0004447975952643901
lower O 0 0.0005505819572135806
than O 0 0.00028549859416671097
that O 0 0.0002952351060230285
from O 0 0.0004387524677440524
normal O 0 0.0008302198257297277
alpha O 0 0.0020581732969731092
- O 0 0.002576774451881647
subunit O 0 0.0019301872234791517
transfections O 0 0.0037035206332802773
, O 0 0.0005806340486742556
although O 0 0.00048588216304779053
higher O 0 0.0005671142716892064
than O 0 0.0003620434436015785
in O 0 0.0004755545814987272
those O 0 0.0004991059540770948
cells O 0 0.0010241487761959434
transfected O 0 0.0036086230538785458
with O 0 0.000718971190508455
an O 0 0.0009488115319982171
alpha O 0 0.004002454224973917
- O 0 0.003771127900108695
subunit O 0 0.003787838853895664
associated O 0 0.002978306030854583
with O 0 0.0043829153291881084
infantile O 1 0.9997856020927429
TSD B-Disease 1 0.999854326248169
. O 0 0.01654396578669548

Furthermore O 0 0.009478005580604076
, O 0 0.00304138520732522
the O 0 0.0021170247346162796
precursor O 0 0.002892495132982731
level O 0 0.0014364805538207293
of O 0 0.00107031618244946
the O 0 0.0014209379442036152
W474C O 1 0.5122246146202087
alpha O 0 0.005738797597587109
- O 0 0.0024663389194756746
subunit O 0 0.0013899076730012894
was O 0 0.0007838342571631074
found O 0 0.0004928584094159305
to O 0 0.0003977919404860586
accumulate O 0 0.0008585040923207998
in O 0 0.0004197983362246305
comparison O 0 0.000655061099678278
to O 0 0.0004414177965372801
the O 0 0.0007582179387100041
normal O 0 0.0014828720595687628
alpha O 0 0.00428082374855876
- O 0 0.004709403030574322
subunit O 0 0.005366336554288864
precursor O 0 0.007855427451431751
levels O 0 0.006514791399240494
. O 0 0.0074408818036317825

We O 0 0.004689144901931286
conclude O 0 0.004951973911374807
that O 0 0.0017256446881219745
the O 0 0.0021969866938889027
1422 O 1 0.9118133187294006
G O 1 0.8180080056190491
- O 1 0.7758352160453796
- O 0 0.4872472286224365
> O 0 0.015521133318543434
C O 0 0.0035392530262470245
mutation O 0 0.0017862957902252674
is O 0 0.0007496017497032881
the O 0 0.0006909180083312094
cause O 0 0.0017240740125998855
of O 0 0.0019697186071425676
Hex B-Disease 1 0.9774104952812195
A I-Disease 1 0.8741101622581482
enzyme I-Disease 1 0.9964908957481384
deficiency I-Disease 1 0.9999966621398926
in O 0 0.0042059412226080894
the O 0 0.009886564686894417
proband O 1 0.9644584655761719
. O 0 0.011444916017353535

The O 0 0.009444120340049267
resulting O 0 0.010165308602154255
W474C O 0 0.269019216299057
substitution O 0 0.007230805233120918
clearly O 0 0.003905552439391613
interferes O 0 0.0052124010398983955
with O 0 0.001400099485181272
alpha O 0 0.0048034959472715855
- O 0 0.0038694238755851984
subunit O 0 0.001890404848381877
processing O 0 0.0010979542275890708
, O 0 0.0006153011345304549
but O 0 0.00038564574788324535
because O 0 0.0004316633567214012
the O 0 0.0005294812726788223
base O 0 0.0008544168085791171
substitution O 0 0.0011427761055529118
falls O 0 0.001410096068866551
at O 0 0.0005482299602590501
the O 0 0.00048415010678581893
first O 0 0.0005427009309642017
position O 0 0.0007042093202471733
of O 0 0.0006368624744936824
exon O 0 0.002621449762955308
13 O 0 0.0009906523628160357
, O 0 0.0007991403108462691
aberrant O 0 0.0024088690988719463
splicing O 0 0.0016023871721699834
may O 0 0.000728136335965246
also O 0 0.000630317023023963
contribute O 0 0.0010581847745925188
to O 0 0.0008540668059140444
Hex B-Disease 0 0.04601607471704483
A I-Disease 0 0.022484034299850464
deficiency I-Disease 1 0.9998825788497925
in O 0 0.0017234192928299308
this O 0 0.001945065101608634
proband O 0 0.34813058376312256
. O 0 0.0030977921560406685
. O 0 0.007033677771687508

Two O 0 0.007296016439795494
frequent O 0 0.013795987702906132
missense O 0 0.46390247344970703
mutations O 0 0.08744484931230545
in O 0 0.08066730201244354
Pendred B-Disease 1 0.9999961853027344
syndrome I-Disease 1 1.0
. O 1 0.613591194152832

Pendred B-Disease 1 0.9999960660934448
syndrome I-Disease 1 1.0
is O 1 0.9829621911048889
an O 1 0.9997929930686951
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999998807907104
by O 1 0.9997352957725525
early O 1 0.9999970197677612
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999858140945435
goiter B-Disease 1 1.0
. O 1 0.9654619097709656

A O 0 0.007411312311887741
century O 0 0.004316429141908884
after O 0 0.0020380576606839895
its O 0 0.00120985705871135
recognition O 0 0.0017682235920801759
as O 0 0.0012981063919141889
a O 0 0.017426565289497375
syndrome O 1 0.999998927116394
by O 0 0.004821628797799349
Vaughan O 1 0.9602394700050354
Pendred O 1 0.980678379535675
, O 0 0.0012222984805703163
the O 0 0.0023602612782269716
disease O 1 0.999881386756897
gene O 0 0.010690135881304741
( O 0 0.0034217769280076027
PDS O 1 0.9737952351570129
) O 0 0.001156145241111517
was O 0 0.0013491488061845303
mapped O 0 0.002261584158986807
to O 0 0.0014469189336523414
chromosome O 0 0.0060176667757332325
7q22 O 0 0.04240566864609718
- O 0 0.04107391834259033
q31 O 0 0.07491640001535416
. O 0 0.010348291136324406

1 O 0 0.008904202841222286
and O 0 0.0025571000296622515
, O 0 0.0018423761939629912
recently O 0 0.002233839360997081
, O 0 0.0012214593589305878
found O 0 0.0011809084098786116
to O 0 0.0012836562236770988
encode O 0 0.0032946604769676924
a O 0 0.003635066095739603
putative O 1 0.6460334062576294
sulfate O 1 0.9973258972167969
transporter O 1 0.830223560333252
. O 0 0.013434755615890026

We O 0 0.004777819383889437
performed O 0 0.0037482434418052435
mutation O 0 0.002388217719271779
analysis O 0 0.0014515075599774718
of O 0 0.001204261789098382
the O 0 0.002738657873123884
PDS B-Disease 1 0.9997007846832275
gene O 0 0.0017661745660007
in O 0 0.00076594966230914
patients O 0 0.005715920589864254
from O 0 0.0006460212753154337
14 O 0 0.0011758959153667092
Pendred B-Disease 0 0.0782354474067688
families O 0 0.0007160630775615573
originating O 0 0.0008808458223938942
from O 0 0.000471755483886227
seven O 0 0.0006086246576160192
countries O 0 0.0005429816665127873
and O 0 0.0007342806784436107
identified O 0 0.0017826088005676866
all O 0 0.0018759238300845027
mutations O 0 0.006481068208813667
. O 0 0.0068712541833519936

The O 0 0.006447118707001209
mutations O 0 0.004342216998338699
include O 0 0.001775045762769878
three O 0 0.001333127380348742
single O 0 0.0015829878393560648
base O 0 0.001665211864747107
deletions O 0 0.0024167336523532867
, O 0 0.001065299496985972
one O 0 0.0010325772454962134
splice O 0 0.003543703816831112
site O 0 0.0020864626858383417
mutation O 0 0.0024666625540703535
and O 0 0.001481271698139608
10 O 0 0.0031612152233719826
missense O 0 0.014953446574509144
mutations O 0 0.009723781608045101
. O 0 0.00794202834367752

One O 0 0.00780611764639616
missense O 0 0.033535972237586975
mutation O 0 0.013568593189120293
( O 0 0.004447159357368946
L236P O 0 0.041884832084178925
) O 0 0.0015960055170580745
was O 0 0.0010359204607084394
found O 0 0.0006449511856772006
in O 0 0.0004827947122976184
a O 0 0.0006795378285460174
homozygous O 0 0.001196853700093925
state O 0 0.0004857034364249557
in O 0 0.0004169964522588998
two O 0 0.0004739903088193387
consanguineous O 0 0.0046873074024915695
families O 0 0.0007538734353147447
and O 0 0.0004821729089599103
in O 0 0.00047287490451708436
a O 0 0.0006789632607251406
heterozygous O 0 0.0011310913832858205
state O 0 0.0004478856862988323
in O 0 0.000496206630486995
five O 0 0.0006620588828809559
additional O 0 0.001350758015178144
non O 0 0.004090507049113512
- O 0 0.0870850458741188
consanguineous O 0 0.4282223880290985
families O 0 0.006260109134018421
. O 0 0.0078056673519313335

Another O 0 0.011456028558313847
missense O 0 0.05289456248283386
mutation O 0 0.018828023225069046
( O 0 0.005584610626101494
T416P O 0 0.2809370458126068
) O 0 0.001321113551966846
was O 0 0.0010018349858000875
found O 0 0.0004942353698424995
in O 0 0.00047445183736272156
a O 0 0.0006910288939252496
homozygous O 0 0.001276455819606781
state O 0 0.00046570313861593604
in O 0 0.0003718248917721212
one O 0 0.00037100291228853166
family O 0 0.0005548891494981945
and O 0 0.0003798575489781797
in O 0 0.0004925780813209713
a O 0 0.000869316456373781
heterozygous O 0 0.0017321734922006726
state O 0 0.000823501730337739
in O 0 0.0009924396872520447
four O 0 0.0017146463505923748
families O 0 0.003900105832144618
. O 0 0.005961907561868429

Pendred B-Disease 1 0.6300756335258484
patients O 0 0.02432098239660263
in O 0 0.0019631697796285152
three O 0 0.0018498612334951758
non O 0 0.10832308977842331
- O 1 0.8088932633399963
consanguineous O 1 0.8376067280769348
families O 0 0.0011656986316666007
were O 0 0.0006119264289736748
shown O 0 0.0007377406000159681
to O 0 0.00048763531958684325
be O 0 0.0006439991411752999
compound O 0 0.002452370710670948
heterozygotes O 0 0.013438832946121693
for O 0 0.001805859967134893
L236P O 0 0.10205823928117752
and O 0 0.003714268794283271
T416P O 0 0.08224211633205414
. O 0 0.009866994805634022

In O 0 0.004322057124227285
total O 0 0.00272299163043499
, O 0 0.0012767147272825241
one O 0 0.0008141874568536878
or O 0 0.0005679462337866426
both O 0 0.0004952910239808261
of O 0 0.0005241130711510777
these O 0 0.00041593657806515694
mutations O 0 0.0007198670064099133
were O 0 0.00043098084279336035
found O 0 0.00046098738675937057
in O 0 0.00046140767517499626
nine O 0 0.0007254566880874336
of O 0 0.0006820037961006165
the O 0 0.001126457005739212
14 O 0 0.0019432739354670048
families O 0 0.0026532274205237627
analyzed O 0 0.0063265105709433556
. O 0 0.005859179887920618

The O 0 0.005271890666335821
identification O 0 0.003288489067927003
of O 0 0.0021704763639718294
two O 0 0.0016236433293670416
frequent O 0 0.069575734436512
PDS B-Disease 1 0.9996461868286133
mutations O 0 0.0028942928183823824
will O 0 0.0008840876398608088
facilitate O 0 0.0015867642359808087
the O 0 0.0014616093831136823
molecular O 0 0.006606267299503088
diagnosis O 1 0.9961531758308411
of O 1 0.894411563873291
Pendred B-Disease 1 0.9999992847442627
syndrome I-Disease 1 1.0
. O 0 0.24543967843055725

Insertional O 0 0.45575809478759766
mutation O 0 0.012552281841635704
by O 0 0.004339311271905899
transposable O 1 0.6449249386787415
element O 0 0.007404734380543232
, O 0 0.0023146590683609247
L1 O 0 0.18260182440280914
, O 0 0.0012017488479614258
in O 0 0.0009240104118362069
the O 0 0.0017693620175123215
DMD B-Disease 1 0.9998798370361328
gene O 0 0.0016919312765821815
results O 0 0.0010704919695854187
in O 0 0.0014395712641999125
X B-Disease 1 0.8614122271537781
- I-Disease 1 0.9769129753112793
linked I-Disease 1 0.9766290783882141
dilated I-Disease 1 0.999954342842102
cardiomyopathy I-Disease 1 0.9999996423721313
. O 0 0.09341506659984589

X B-Disease 1 0.8478114604949951
- I-Disease 1 0.993261992931366
linked I-Disease 1 0.9980752468109131
dilated I-Disease 1 0.9999979734420776
cardiomyopathy I-Disease 1 1.0
( O 1 0.9988822340965271
XLDCM B-Disease 1 0.9999865293502808
) O 0 0.0034897644072771072
is O 0 0.0011936749797314405
a O 0 0.0015429366612806916
clinical O 1 0.6704208254814148
phenotype O 0 0.06185498833656311
of O 0 0.0034747880417853594
dystrophinopathy B-Disease 1 0.9859390258789062
which O 0 0.0009751869365572929
is O 0 0.0010207415325567126
characterized O 0 0.023337097838521004
by O 0 0.001976708648726344
preferential O 1 0.8613999485969543
myocardial B-Disease 1 0.9999946355819702
involvement I-Disease 0 0.24469496309757233
without O 0 0.001704706810414791
any O 0 0.0015860905405133963
overt O 0 0.03525349497795105
clinical O 1 0.9049899578094482
signs O 1 0.9183987975120544
of O 1 0.9579595923423767
skeletal B-Disease 1 0.9999998807907104
myopathy I-Disease 1 0.9999998807907104
. O 1 0.5603737831115723

To O 0 0.004291034769266844
date O 0 0.002798072760924697
, O 0 0.0013486690586432815
several O 0 0.0009582132333889604
mutations O 0 0.0019267639145255089
in O 0 0.001734655350446701
the O 1 0.9029964804649353
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9991886019706726
, O 1 0.7640708088874817
DMD O 1 0.9999985694885254
, O 0 0.0012342446716502309
have O 0 0.0004286411567591131
been O 0 0.00045776666956953704
identified O 0 0.0007471196004189551
in O 0 0.0005992830847389996
patients O 0 0.03872736915946007
with O 0 0.00090751115931198
XLDCM B-Disease 1 0.9945106506347656
, O 0 0.0008080612751655281
but O 0 0.0004524549294728786
a O 0 0.0006727860891260207
pathogenic O 0 0.001487583969719708
correlation O 0 0.0010871378472074866
of O 0 0.0005270472029224038
these O 0 0.0005303123616613448
cardiospecific O 0 0.03512834012508392
mutations O 0 0.001491040107794106
in O 0 0.0009331986657343805
DMD O 1 0.9995371103286743
with O 0 0.0011860840022563934
the O 0 0.004635311663150787
XLDCM B-Disease 1 0.9998294115066528
phenotype O 0 0.12830744683742523
has O 0 0.0013832675758749247
remained O 0 0.00258773029781878
to O 0 0.0015981252072378993
be O 0 0.0025786724872887135
elucidated O 0 0.01839948259294033
. O 0 0.00736236060038209

We O 0 0.005331729538738728
report O 0 0.0037152643781155348
here O 0 0.0018498771823942661
the O 0 0.0012097745202481747
identification O 0 0.0014227490173652768
of O 0 0.0010979975340887904
a O 0 0.0013289592461660504
unique O 0 0.0018405003938823938
de O 0 0.007679023779928684
novo O 0 0.18013359606266022
L1 O 0 0.234576016664505
insertion O 0 0.00370617164298892
in O 0 0.0010389527305960655
the O 0 0.0014230493688955903
muscle O 0 0.26387345790863037
exon O 0 0.01943562738597393
1 O 0 0.0016843114281073213
in O 0 0.0010772912064567208
DMD O 1 0.9817304611206055
in O 0 0.0010450120316818357
three O 0 0.00123471743427217
XLDCM B-Disease 1 0.9480583667755127
patients O 0 0.01549645233899355
from O 0 0.0010311336955055594
two O 0 0.001135414931923151
unrelated O 0 0.0050533791072666645
Japanese O 0 0.013660542666912079
families O 0 0.006354883778840303
. O 0 0.007118395064026117

The O 0 0.0072991386987268925
insertion O 0 0.009861121885478497
was O 0 0.0038062201347202063
a O 0 0.0023692010436207056
5 O 0 0.002729980042204261
- O 0 0.009399083442986012
truncated O 0 0.003227737732231617
form O 0 0.0008064627763815224
of O 0 0.0008525325101800263
human O 0 0.0016999752260744572
L1 O 0 0.4339968264102936
inversely O 0 0.0020741138141602278
integrated O 0 0.0015340019017457962
in O 0 0.0006037772400304675
the O 0 0.0007797122234478593
5 O 0 0.0012962308246642351
- O 0 0.0029809162952005863
untranslated O 0 0.0036090053617954254
region O 0 0.0009677808848209679
in O 0 0.0005938838585279882
the O 0 0.0009341047261841595
muscle O 0 0.23662300407886505
exon O 0 0.06506605446338654
1 O 0 0.0010867442470043898
, O 0 0.0005456394865177572
which O 0 0.00044247720506973565
affected O 0 0.0006172588327899575
the O 0 0.0005798476631753147
transcription O 0 0.0010172155452892184
or O 0 0.000454987253760919
the O 0 0.000580680905841291
stability O 0 0.0013630461180582643
of O 0 0.0008079581311903894
the O 0 0.0027329816948622465
muscle O 1 0.7595900297164917
form O 0 0.0011228129733353853
of O 0 0.0018442748114466667
dystrophin O 1 0.9572650194168091
transcripts O 0 0.0012696044286713004
but O 0 0.00035854068119078875
not O 0 0.0002606129564810544
that O 0 0.00026406205142848194
of O 0 0.00045654908171854913
the O 0 0.0011360910721123219
brain O 1 0.7230092883110046
or O 0 0.0015379098476842046
Purkinje O 1 0.9985759258270264
cell O 0 0.00842298474162817
form O 0 0.0011263914639130235
, O 0 0.000681509671267122
probably O 0 0.0008670352981425822
due O 0 0.0006677206256426871
to O 0 0.0004504774115048349
its O 0 0.0006471082451753318
unique O 0 0.0010587520664557815
site O 0 0.0017726951045915484
of O 0 0.0028616455383598804
integration O 0 0.009448269382119179
. O 0 0.008202889934182167

We O 0 0.005751476157456636
speculate O 0 0.005475154612213373
that O 0 0.0016462837811559439
this O 0 0.001231212867423892
insertion O 0 0.002453533234074712
of O 0 0.0011806440306827426
an O 0 0.0015189687255769968
L1 O 1 0.9479886889457703
sequence O 0 0.0017857763450592756
in O 0 0.0011921862605959177
DMD O 1 0.9998946189880371
is O 0 0.000738948117941618
responsible O 0 0.0008335904567502439
for O 0 0.0003809698100667447
some O 0 0.0002816207997966558
of O 0 0.0004046469402965158
the O 0 0.0005488696042448282
population O 0 0.0006449112552218139
of O 0 0.0009920222219079733
Japanese O 0 0.21975141763687134
patients O 1 0.7587217092514038
with O 0 0.0023196684196591377
XLDCM B-Disease 1 0.9760059118270874
. O 0 0.0033296486362814903
. O 0 0.005769325885921717

Severe O 1 0.9995498061180115
early O 1 0.8769044280052185
- O 1 0.9999886751174927
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999798536300659
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9998002648353577
red O 1 0.9999954700469971
hair O 1 0.9999951124191284
pigmentation O 1 0.9999978542327881
caused O 1 0.9994261264801025
by O 0 0.35917267203330994
POMC O 1 0.9999916553497314
mutations O 0 0.025849517434835434
in O 0 0.004109919536858797
humans O 0 0.007671498693525791
. O 0 0.008077736012637615

Sequential O 0 0.018016522750258446
cleavage O 0 0.014318827539682388
of O 0 0.0030981043819338083
the O 0 0.002542905043810606
precursor O 0 0.0057602981105446815
protein O 0 0.002264054026454687
pre O 0 0.007757294457405806
- O 0 0.073375403881073
pro O 0 0.02652713656425476
- O 1 0.7817580699920654
opiomelanocortin O 1 0.9801235795021057
( O 0 0.0058343843556940556
POMC O 1 0.9870581030845642
) O 0 0.001231035916134715
generates O 0 0.001839841017499566
the O 0 0.0015157386660575867
melanocortin O 1 0.6729097962379456
peptides O 0 0.004731657914817333
adrenocorticotrophin O 0 0.10925019532442093
( O 0 0.0030272966250777245
ACTH O 1 0.6773325204849243
) O 0 0.00176363589707762
, O 0 0.0016744725871831179
melanocyte O 1 0.9970904588699341
- O 1 0.8918757438659668
stimulating O 1 0.9455506801605225
hormones O 1 0.7885951399803162
( O 0 0.008665701374411583
MSH O 1 0.9975634813308716
) O 0 0.0012434935197234154
alpha O 0 0.0019265218870714307
, O 0 0.0007342887111008167
beta O 0 0.0013296144315972924
and O 0 0.0005972001818008721
gamma O 0 0.001405167393386364
as O 0 0.0005325215752236545
well O 0 0.0005062861600890756
as O 0 0.0007729807985015213
the O 0 0.0014792678412050009
opioid O 1 0.9063886404037476
- O 0 0.40278780460357666
receptor O 0 0.008737191557884216
ligand O 0 0.013795921579003334
beta O 0 0.03061484731733799
- O 0 0.14887338876724243
endorphin O 1 0.7686727643013
. O 0 0.013727141544222832

While O 0 0.005095054395496845
a O 0 0.002653352217748761
few O 0 0.001696719671599567
cases O 0 0.0017440493684262037
of O 0 0.012888682074844837
isolated O 1 0.9995129108428955
ACTH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999994039535522
have O 0 0.0009977405425161123
been O 0 0.0009789440082386136
reported O 0 0.0031872885301709175
( O 0 0.003237489378079772
OMIM O 1 0.9964093565940857
201400 O 0 0.14841671288013458
) O 0 0.0008300651679746807
, O 0 0.0007605404825881124
an O 0 0.0015386986779049039
inherited O 1 0.999929666519165
POMC O 1 0.9999995231628418
defect O 1 0.9992666840553284
has O 0 0.0014492025366052985
not O 0 0.0006357354577630758
been O 0 0.0009567386587150395
described O 0 0.0019860591273754835
so O 0 0.001839719247072935
far O 0 0.0030125523917376995
. O 0 0.0057330019772052765

Recent O 0 0.006457255221903324
studies O 0 0.00384367723017931
in O 0 0.0019922235514968634
animal O 0 0.0026759335305541754
models O 0 0.0016842760378494859
elucidated O 0 0.0038074913900345564
a O 0 0.001038325484842062
central O 0 0.001104446011595428
role O 0 0.0011083732824772596
of O 0 0.001859126496128738
alpha O 1 0.7307917475700378
- O 1 0.8816969990730286
MSH O 1 0.9969636797904968
in O 0 0.0007457240717485547
the O 0 0.0006600047927349806
regulation O 0 0.0009301547543145716
of O 0 0.0006840901914983988
food O 0 0.0014840946532785892
intake O 0 0.0020325477235019207
by O 0 0.0006478623836301267
activation O 0 0.001113021862693131
of O 0 0.0007436886662617326
the O 0 0.0012300031958147883
brain O 0 0.1091475710272789
melanocortin O 1 0.9737944602966309
- O 0 0.008827544748783112
4 O 0 0.001905561308376491
- O 0 0.0035887842532247305
receptor O 0 0.002665478503331542
( O 0 0.0016805385239422321
MC4 O 1 0.6491739153862
- O 0 0.003219177247956395
R O 0 0.002873828401789069
; O 0 0.0007813139818608761
refs O 0 0.0026868160348385572
3 O 0 0.0011614348040893674
- O 0 0.0013813048135489225
5 O 0 0.0008353791199624538
) O 0 0.0005004403064958751
and O 0 0.0003924665797967464
the O 0 0.0005850537563674152
linkage O 0 0.001534249517135322
of O 0 0.0008853027829900384
human O 0 0.006206200923770666
obesity B-Disease 1 0.999404788017273
to O 0 0.0006839007837697864
chromosome O 0 0.0012688174610957503
2 O 0 0.0007130980957299471
in O 0 0.0003949922393076122
close O 0 0.0005674884305335581
proximity O 0 0.0007524760439991951
to O 0 0.00047490245196968317
the O 0 0.0010080591309815645
POMC O 1 0.9936235547065735
locus O 0 0.0033927971962839365
, O 0 0.0006987189990468323
led O 0 0.0008371625444851816
to O 0 0.00043404437019489706
the O 0 0.0005026092403568327
proposal O 0 0.0009071506792679429
of O 0 0.000680281373206526
an O 0 0.0009499391308054328
association O 0 0.002794400556012988
of O 0 0.005575521849095821
POMC O 1 0.9999756813049316
with O 0 0.009643220342695713
human O 1 0.5324828624725342
obesity B-Disease 1 0.9999829530715942
. O 0 0.01528905052691698

The O 0 0.0066927047446370125
dual O 0 0.006874408107250929
role O 0 0.0036046337336301804
of O 0 0.0034247147850692272
alpha O 1 0.7955371737480164
- O 1 0.9699019193649292
MSH O 1 0.9995567202568054
in O 0 0.0015500187873840332
regulating O 0 0.0035626122262328863
food O 0 0.004111899062991142
intake O 0 0.024307703599333763
and O 0 0.0014407300623133779
influencing O 0 0.04966690018773079
hair O 1 0.821264386177063
pigmentation O 1 0.9913386106491089
predicts O 0 0.02364927902817726
that O 0 0.0007542233797721565
the O 0 0.0009468352072872221
phenotype O 0 0.0025262089911848307
associated O 0 0.0006169998086988926
with O 0 0.0004722207086160779
a O 0 0.0013018802274018526
defect O 1 0.984154224395752
in O 0 0.005615407135337591
POMC O 1 0.999950647354126
function O 0 0.0015005575260147452
would O 0 0.0007837020675651729
include O 0 0.0018240545177832246
obesity B-Disease 1 0.9998713731765747
, O 0 0.0023093544878065586
alteration O 1 0.7813475131988525
in O 0 0.02943514473736286
pigmentation O 1 0.999994158744812
and O 1 0.993607759475708
ACTH B-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.9999996423721313
. O 0 0.03634253516793251

The O 0 0.004926676396280527
observation O 0 0.006195889785885811
of O 0 0.0027092897798866034
these O 0 0.0013482363428920507
symptoms O 1 0.9873036742210388
in O 0 0.0011981328716501594
two O 0 0.0008320492343045771
probands O 1 0.7966729998588562
prompted O 0 0.0020500703249126673
us O 0 0.0008231872343458235
to O 0 0.0004913615412078798
search O 0 0.0009881448931992054
for O 0 0.0007939364295452833
mutations O 0 0.001581476186402142
within O 0 0.001215239055454731
their O 0 0.002648546127602458
POMC O 1 0.9875213503837585
genes O 0 0.007801281753927469
. O 0 0.007899163290858269

Patient O 1 0.6984549760818481
1 O 0 0.006354950834065676
was O 0 0.002725403755903244
found O 0 0.0010986269917339087
to O 0 0.0006445975159294903
be O 0 0.0005903817946091294
a O 0 0.0008621278684586287
compound O 0 0.0017828698037192225
heterozygote O 0 0.004023249726742506
for O 0 0.0006310371099971235
two O 0 0.0004984879051335156
mutations O 0 0.0008335841121152043
in O 0 0.0006781235570088029
exon O 0 0.003066405188292265
3 O 0 0.0011239707237109542
( O 0 0.0011625781189650297
G7013T O 0 0.003840397810563445
, O 0 0.0009899125434458256
C7133delta O 0 0.006427916698157787
) O 0 0.0008631100645288825
which O 0 0.000552089826669544
interfere O 0 0.0009617158211767673
with O 0 0.000593510631006211
appropriate O 0 0.001221726997755468
synthesis O 0 0.0018769634189084172
of O 0 0.0019491672283038497
ACTH O 1 0.9812664985656738
and O 0 0.0038948003202676773
alpha O 0 0.1803758591413498
- O 1 0.8381842374801636
MSH O 1 0.9989510774612427
. O 0 0.010864203795790672

Patient O 0 0.14411088824272156
2 O 0 0.005161848850548267
was O 0 0.003052273066714406
homozygous O 0 0.003314030123874545
for O 0 0.0009375486406497657
a O 0 0.0012431667419150472
mutation O 0 0.0017891675233840942
in O 0 0.0010010941186919808
exon O 0 0.006243095733225346
2 O 0 0.0023220751900225878
( O 0 0.0020748423412442207
C3804A O 0 0.008036809973418713
) O 0 0.002529793418943882
which O 0 0.003632552456110716
abolishes O 0 0.1516043245792389
POMC O 1 0.98711758852005
translation O 0 0.01763162575662136
. O 0 0.012308638542890549

These O 0 0.003116908948868513
findings O 0 0.003089512698352337
represent O 0 0.001699848216958344
the O 0 0.0010556706693023443
first O 0 0.000953083042986691
examples O 0 0.0010705858003348112
of O 0 0.0011453687911853194
a O 0 0.00698621803894639
genetic B-Disease 1 0.774652898311615
defect I-Disease 1 0.9944998025894165
within O 0 0.0012251168955117464
the O 0 0.003036163281649351
POMC O 1 0.9992376565933228
gene O 0 0.0011858484940603375
and O 0 0.000548290554434061
define O 0 0.0010747724445536733
a O 0 0.0009329306776635349
new O 0 0.002374555915594101
monogenic B-Disease 1 0.9999933242797852
endocrine I-Disease 1 0.9999957084655762
disorder I-Disease 1 0.9999959468841553
resulting O 1 0.5306666493415833
in O 0 0.028441503643989563
early O 1 0.9733926057815552
- O 1 0.9999953508377075
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9998880624771118
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9966155886650085
red O 1 0.9999780654907227
hair O 1 0.9999046325683594
pigmentation O 1 0.9999558925628662
. O 0 0.006415397394448519
. O 0 0.008688777685165405

A O 0 0.010217905044555664
European O 0 0.006255838554352522
multicenter O 1 0.9135112166404724
study O 0 0.0058087995275855064
of O 0 0.30893099308013916
phenylalanine B-Disease 1 0.999993085861206
hydroxylase I-Disease 1 0.9999867677688599
deficiency I-Disease 1 0.9999995231628418
: O 0 0.0031544577796012163
classification O 0 0.008393357507884502
of O 0 0.002001602668315172
105 O 0 0.023897215723991394
mutations O 0 0.0014531029155477881
and O 0 0.0005142255686223507
a O 0 0.0006351319025270641
general O 0 0.0010849518002942204
system O 0 0.000984359998255968
for O 0 0.0009013874805532396
genotype O 0 0.012635711580514908
- O 0 0.004347341135144234
based O 0 0.0014987149043008685
prediction O 0 0.004259106237441301
of O 0 0.004051608499139547
metabolic O 1 0.9386150240898132
phenotype O 0 0.09567908197641373
. O 0 0.009308988228440285

Phenylketonuria B-Disease 1 0.9998854398727417
( O 1 0.6133908033370972
PKU B-Disease 1 0.9999785423278809
) O 0 0.0055212657898664474
and O 0 0.004003060515969992
mild B-Disease 1 0.9998966455459595
hyperphenylalaninemia I-Disease 1 0.9999983310699463
( O 1 0.9969058632850647
MHP B-Disease 1 0.9999997615814209
) O 0 0.0028832214884459972
are O 0 0.001021402538754046
allelic B-Disease 1 0.9951930046081543
disorders I-Disease 1 0.999967098236084
caused O 1 0.8501785397529602
by O 0 0.001384345581755042
mutations O 0 0.0019380898447707295
in O 0 0.00080667226575315
the O 0 0.0013059487100690603
gene O 0 0.002673798007890582
encoding O 0 0.0041464404202997684
phenylalanine O 0 0.15775004029273987
hydroxylase O 1 0.8855431079864502
( O 0 0.013318591751158237
PAH O 1 0.999596893787384
) O 0 0.009670937433838844
. O 0 0.010419655591249466

Previous O 0 0.007199770305305719
studies O 0 0.003864343510940671
have O 0 0.0013465412193909287
suggested O 0 0.0018792750779539347
that O 0 0.0008762392099015415
the O 0 0.0013934539165347815
highly O 0 0.0026563508436083794
variable O 0 0.005130221135914326
metabolic O 1 0.9801525473594666
phenotypes O 1 0.989077091217041
of O 1 0.9984530210494995
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9993205070495605
with O 1 0.9026037454605103
PAH O 1 0.9999997615814209
genotypes O 1 0.9988756775856018
. O 0 0.017016643658280373

We O 0 0.005841862875968218
identified O 0 0.004885245580226183
both O 0 0.0023626124020665884
causative O 0 0.1210973858833313
mutations O 0 0.0036742996890097857
in O 0 0.001886910991743207
686 O 1 0.9873725771903992
patients O 0 0.37364885210990906
from O 0 0.0015426926547661424
seven O 0 0.0026978140231221914
European O 0 0.0032297002617269754
centers O 0 0.009100954979658127
. O 0 0.007507318630814552

On O 0 0.003910948522388935
the O 0 0.0021714733447879553
basis O 0 0.001372803933918476
of O 0 0.001113184611313045
the O 0 0.001203046995215118
phenotypic O 0 0.0027969738002866507
characteristics O 0 0.0019077938050031662
of O 0 0.0018049025675281882
297 O 1 0.9652247428894043
functionally O 1 0.97714763879776
hemizygous O 1 0.9641073346138
patients O 0 0.15417172014713287
, O 0 0.0008044595015235245
105 O 0 0.0015094033442437649
of O 0 0.0007006492814980447
the O 0 0.0007418666500598192
mutations O 0 0.0009180982015095651
were O 0 0.00045754198799841106
assigned O 0 0.000903800711967051
to O 0 0.0004372576659079641
one O 0 0.0005562882288359106
of O 0 0.0008568292250856757
four O 0 0.0014040992828086019
arbitrary O 0 0.0037252744659781456
phenotype O 0 0.009105730801820755
categories O 0 0.00708693265914917
. O 0 0.008160941302776337

We O 0 0.006083741784095764
proposed O 0 0.004416702780872583
and O 0 0.0019660082180052996
tested O 0 0.0032447294797748327
a O 0 0.001738696126267314
simple O 0 0.001794214709661901
model O 0 0.0016781000886112452
for O 0 0.0011353413574397564
correlation O 0 0.0025831672828644514
between O 0 0.0016455621225759387
genotype O 0 0.005304115824401379
and O 0 0.002092899288982153
phenotypic O 0 0.00884587038308382
outcome O 0 0.007265266962349415
. O 0 0.00863311905413866

The O 0 0.0074126869440078735
observed O 0 0.005896332208067179
phenotype O 0 0.007561766542494297
matched O 0 0.002822647802531719
the O 0 0.0015357673401013017
predicted O 0 0.0026377635076642036
phenotype O 0 0.0024683831725269556
in O 0 0.0007983293035067618
79 O 0 0.0019785461481660604
% O 0 0.00074447609949857
of O 0 0.000546839612070471
the O 0 0.0006324755377136171
cases O 0 0.0006396922981366515
, O 0 0.0003978678141720593
and O 0 0.0003006375627592206
in O 0 0.00027683089138008654
only O 0 0.00027378223603591323
5 O 0 0.0004598112136591226
of O 0 0.0004891297430731356
184 O 0 0.0033604216296225786
patients O 0 0.002871827455237508
was O 0 0.000780733535066247
the O 0 0.000575351354200393
observed O 0 0.000766313576605171
phenotype O 0 0.001125797163695097
more O 0 0.00032945783459581435
than O 0 0.00037288552266545594
one O 0 0.00046815487439744174
category O 0 0.0010599353117868304
away O 0 0.0009138375171460211
from O 0 0.0010436787270009518
that O 0 0.0014660099986940622
expected O 0 0.00390894478186965
. O 0 0.005144821479916573

Among O 0 0.00539168668910861
the O 0 0.0024417159147560596
seven O 0 0.0019423492485657334
contributing O 0 0.003307241015136242
centers O 0 0.0020829688291996717
, O 0 0.0011482046684250236
the O 0 0.0010489398846402764
proportion O 0 0.001774351578205824
of O 0 0.0012365521397441626
patients O 0 0.13909175992012024
for O 0 0.0008230821113102138
whom O 0 0.00125796755310148
the O 0 0.000844678608700633
observed O 0 0.0011334719602018595
phenotype O 0 0.0017289408715441823
did O 0 0.0004587587609421462
not O 0 0.0002636834396980703
match O 0 0.0005115876556374133
the O 0 0.0004369043745100498
predicted O 0 0.0009099996532313526
phenotype O 0 0.0010382008040323853
was O 0 0.0006260029040277004
4 O 0 0.0006653108866885304
% O 0 0.0005578434211201966
- O 0 0.0009702829411253333
23 O 0 0.0009109886013902724
% O 0 0.0007406763616017997
( O 0 0.0011435721535235643
P O 0 0.00429031765088439
< O 0 0.0027060990687459707
. O 0 0.000741952215321362
0001 O 0 0.00449758768081665
) O 0 0.0007775730337016284
, O 0 0.0005460965912789106
suggesting O 0 0.0007977623608894646
that O 0 0.0003504686465021223
differences O 0 0.0005132295191287994
in O 0 0.0003969615790992975
methods O 0 0.000606995658017695
used O 0 0.000515976338647306
for O 0 0.0005357605987228453
mutation O 0 0.0013416868168860674
detection O 0 0.0020460900850594044
or O 0 0.0009605852537788451
phenotype O 0 0.0036850222386419773
classification O 0 0.002060012659057975
may O 0 0.0006481677410192788
account O 0 0.0006897153216414154
for O 0 0.0005358055350370705
a O 0 0.000765475386288017
considerable O 0 0.0016937322216108441
proportion O 0 0.002307108836248517
of O 0 0.003047203179448843
genotype O 1 0.7122286558151245
- O 0 0.34036511182785034
phenotype O 0 0.0279716607183218
inconsistencies O 0 0.0205439031124115
. O 0 0.010391623713076115

Our O 0 0.006262298673391342
data O 0 0.00337419006973505
indicate O 0 0.0032570164185017347
that O 0 0.0015631678979843855
the O 0 0.004918873310089111
PAH O 1 0.9999996423721313
- O 1 0.9340255856513977
mutation O 0 0.013000021688640118
genotype O 0 0.0031083477661013603
is O 0 0.0008396059274673462
the O 0 0.0008469937602058053
main O 0 0.0014535782393068075
determinant O 0 0.007406182121485472
of O 0 0.002093577291816473
metabolic O 1 0.9888020753860474
phenotype O 0 0.17008580267429352
in O 0 0.0016766691114753485
most O 0 0.00534485001116991
patients O 1 0.9997702240943909
with O 1 0.9984011054039001
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.8863181471824646

In O 0 0.003924611024558544
the O 0 0.0023516113869845867
present O 0 0.0018759880913421512
study O 0 0.0014424159890040755
, O 0 0.0009017839329317212
the O 0 0.0008950644987635314
classification O 0 0.0029871773440390825
of O 0 0.0022538346238434315
105 O 1 0.9486527442932129
PAH O 1 0.9999979734420776
mutations O 0 0.002407870488241315
may O 0 0.0006978923920542002
allow O 0 0.000517126580234617
the O 0 0.0005133748636581004
prediction O 0 0.0011057963129132986
of O 0 0.00048559028073213995
the O 0 0.0006691057933494449
biochemical O 0 0.0022067450918257236
phenotype O 0 0.0018210235284641385
in O 0 0.0005852826870977879
> O 0 0.0014155172975733876
10 O 0 0.0005437310319393873
, O 0 0.0005824036197736859
000 O 0 0.0015517310239374638
genotypes O 0 0.0024950397200882435
, O 0 0.0006020946311764419
which O 0 0.0004362676409073174
may O 0 0.0004679987032432109
be O 0 0.0003068184887524694
useful O 0 0.0005226465873420238
for O 0 0.00043377495603635907
the O 0 0.0006999206379987299
management O 0 0.001962329028174281
of O 0 0.0022551161237061024
hyperphenylalaninemia B-Disease 1 0.99874347448349
in O 0 0.006975626572966576
newborns O 1 0.9867357611656189
. O 0 0.007513243239372969

Somatic O 0 0.10515689849853516
instability O 0 0.02159184403717518
of O 0 0.003408597083762288
the O 0 0.008119446225464344
CTG O 1 0.9995324611663818
repeat O 0 0.08030322194099426
in O 0 0.001512322691269219
mice O 0 0.00841741356998682
transgenic O 0 0.00864279642701149
for O 0 0.0014341315254569054
the O 0 0.3366882801055908
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.8283864259719849
is O 0 0.005227469839155674
age O 0 0.0046096621081233025
dependent O 0 0.0010935778263956308
but O 0 0.00040418526623398066
not O 0 0.00034354437957517803
correlated O 0 0.0009538506856188178
to O 0 0.00046598888002336025
the O 0 0.0008076445665210485
relative O 0 0.002168221166357398
intertissue O 0 0.08238961547613144
transcription O 0 0.005318548064678907
levels O 0 0.0045356061309576035
and O 0 0.004413175862282515
proliferative O 1 0.999049961566925
capacities O 0 0.15519140660762787
. O 0 0.013020869344472885

A O 0 0.011463754810392857
( O 0 0.00857990700751543
CTG O 1 0.7072882056236267
) O 0 0.002432807581499219
nexpansion O 0 0.0042364043183624744
in O 0 0.0009621044155210257
the O 0 0.0010280178394168615
3 O 0 0.0019575555343180895
- O 0 0.01180723775178194
untranslated O 0 0.010038834996521473
region O 0 0.0015055012190714478
( O 0 0.0014197741402313113
UTR O 0 0.004849329125136137
) O 0 0.0008385236724279821
of O 0 0.0008605216862633824
the O 0 0.0019432071130722761
DM O 1 0.9999581575393677
protein O 0 0.002329561859369278
kinase O 0 0.0028528065886348486
gene O 0 0.0014075252693146467
( O 0 0.0011376298498362303
DMPK O 0 0.0062482282519340515
) O 0 0.0008679627790115774
is O 0 0.0007498789927922189
responsible O 0 0.001659720204770565
for O 0 0.0022125986870378256
causing O 1 0.9979966282844543
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999628067016602
DM B-Disease 1 0.9999998807907104
) O 0 0.019103016704320908
. O 0 0.0094264792278409

Major O 0 0.027937715873122215
instability O 0 0.48754340410232544
, O 0 0.0027775021735578775
with O 0 0.001376995351165533
very O 0 0.001104561728425324
large O 0 0.0009724508854560554
expansions O 0 0.0024124286137521267
between O 0 0.0007966771954670548
generations O 0 0.0012541247997432947
and O 0 0.0006168413092382252
high O 0 0.0013806491624563932
levels O 0 0.0013672123895958066
of O 0 0.0015348040033131838
somatic O 1 0.7653348445892334
mosaicism O 1 0.9659697413444519
, O 0 0.0011876050848513842
is O 0 0.0010318498825654387
observed O 0 0.0016597891226410866
in O 0 0.002164670033380389
patients O 0 0.1744457632303238
. O 0 0.00684531731531024

There O 0 0.005143621005117893
is O 0 0.0024037412367761135
a O 0 0.001779232989065349
good O 0 0.001466635032556951
correlation O 0 0.0017281774198636413
between O 0 0.0007410328835248947
repeat O 0 0.0015182781498879194
size O 0 0.0007739787688478827
( O 0 0.0006401768769137561
at O 0 0.0005730488337576389
least O 0 0.00041628311737440526
in O 0 0.000553136458620429
leucocytes O 0 0.0371721014380455
) O 0 0.0007845134241506457
, O 0 0.0008393758907914162
clinical O 0 0.009824853390455246
severity O 0 0.18177351355552673
and O 0 0.001263895072042942
age O 0 0.0036985836923122406
of O 0 0.008779975585639477
onset O 1 0.9999620914459229
. O 0 0.014138363301753998

The O 0 0.014438485726714134
trinucleotide O 1 0.9974853992462158
repeat O 0 0.3761976361274719
instability O 1 0.5078471899032593
mechanisms O 0 0.0063558961264789104
involved O 0 0.0029719320591539145
in O 0 0.007944200187921524
DM B-Disease 1 0.9999992847442627
and O 0 0.001489188987761736
other O 0 0.0009456510888412595
human O 0 0.11125853657722473
genetic B-Disease 1 0.9948641657829285
diseases I-Disease 1 0.9999934434890747
are O 0 0.0021741962991654873
unknown O 0 0.007421326823532581
. O 0 0.00790057610720396

We O 0 0.005104099866002798
studied O 0 0.006603858433663845
somatic O 0 0.010648057796061039
instability O 0 0.007340060081332922
by O 0 0.0017176632536575198
measuring O 0 0.004434640984982252
the O 0 0.0024300492368638515
CTG O 1 0.9826399683952332
repeat O 0 0.004382432904094458
length O 0 0.00120136933401227
at O 0 0.0006388092297129333
several O 0 0.00047408201498910785
ages O 0 0.0007137500215321779
in O 0 0.00046783682773821056
various O 0 0.0004850642872042954
tissues O 0 0.001328792655840516
of O 0 0.0011146542383357882
transgenic O 0 0.11709851026535034
mice O 0 0.0021870764903724194
carrying O 0 0.00127409549895674
a O 0 0.00125796755310148
( O 0 0.0017020474188029766
CTG O 0 0.2345598191022873
) O 0 0.0011535286903381348
55expansion O 0 0.0034708206076174974
surrounded O 0 0.0018576770089566708
by O 0 0.00072276167338714
45 O 0 0.0013880949700251222
kb O 0 0.0036106621846556664
of O 0 0.000984781188890338
the O 0 0.0013745020842179656
human O 0 0.014983270317316055
DM B-Disease 1 0.9999867677688599
region O 0 0.0017733753193169832
, O 0 0.0009162158821709454
using O 0 0.00110461818985641
small O 0 0.0019672915805131197
- O 0 0.0074130697175860405
pool O 0 0.013063270598649979
PCR O 0 0.019584106281399727
. O 0 0.0076785157434642315

These O 0 0.004393737763166428
mice O 0 0.005347210448235273
have O 0 0.0012254086323082447
been O 0 0.0009451605728827417
shown O 0 0.0008770368876866996
to O 0 0.0005247228546068072
reproduce O 0 0.0011523233260959387
the O 0 0.0008896644576452672
intergenerational O 0 0.02904694899916649
and O 0 0.0009209360578097403
somatic O 0 0.003714481135830283
instability O 0 0.003515800694003701
of O 0 0.000999846844933927
the O 0 0.0015962738543748856
55 O 0 0.005551377777010202
CTG O 1 0.9763579964637756
repeat O 0 0.004251372534781694
suggesting O 0 0.0012873905943706632
that O 0 0.0005711175035685301
surrounding O 0 0.000970121065620333
sequences O 0 0.0009821912972256541
and O 0 0.0005719623877666891
the O 0 0.0008079284452833235
chromatin O 0 0.002170262858271599
environment O 0 0.0012111662654206157
are O 0 0.0006469242507591844
involved O 0 0.0012727512512356043
in O 0 0.0018677152693271637
instability O 0 0.3888155221939087
mechanisms O 0 0.014236102811992168
. O 0 0.007437177933752537

As O 0 0.004827577155083418
observed O 0 0.0027366725262254477
in O 0 0.0010730057256296277
some O 0 0.0007346309721469879
of O 0 0.0008529750048182905
the O 0 0.001464144210331142
tissues O 1 0.7328934669494629
of O 1 0.974840521812439
DM B-Disease 1 1.0
patients O 1 0.9987406134605408
, O 0 0.0010531581938266754
there O 0 0.0004889639676548541
is O 0 0.0004568277217913419
a O 0 0.0006082677282392979
tendency O 0 0.0010766058694571257
for O 0 0.0005248937522992492
repeat O 0 0.002135880757123232
length O 0 0.0009445790201425552
and O 0 0.0007580103119835258
somatic O 0 0.005741570144891739
mosaicism O 0 0.0945015475153923
to O 0 0.0005221344763413072
increase O 0 0.0006069077644497156
with O 0 0.00045357723138295114
the O 0 0.0007955646724440157
age O 0 0.0013368322979658842
of O 0 0.0016761801671236753
the O 0 0.004491942469030619
mouse O 0 0.06032901629805565
. O 0 0.006901043001562357

Furthermore O 0 0.010006595402956009
, O 0 0.0027699735946953297
we O 0 0.0012213552836328745
observed O 0 0.0013666234444826841
no O 0 0.0010086572729051113
correlation O 0 0.0015469570644199848
between O 0 0.0009954632259905338
the O 0 0.0014045856660231948
somatic O 0 0.06193489953875542
mutation O 0 0.010643227957189083
rate O 0 0.0031093601137399673
and O 0 0.0025949685368686914
tissue O 0 0.3511310815811157
proliferation O 0 0.05987510830163956
capacity O 0 0.0107284439727664
. O 0 0.010479636490345001

The O 0 0.009554198943078518
somatic O 1 0.5261472463607788
mutation O 0 0.010316100902855396
rates O 0 0.0021572497207671404
in O 0 0.0008777533075772226
different O 0 0.0005754763260483742
tissues O 0 0.0012744148261845112
were O 0 0.00046432585804723203
also O 0 0.0004523776879068464
not O 0 0.0003044425684493035
correlated O 0 0.0007642384734936059
to O 0 0.00033024497679434717
the O 0 0.0005522625287994742
relative O 0 0.0013078860938549042
inter O 0 0.10059189796447754
- O 0 0.14899766445159912
tissue O 0 0.007373855449259281
difference O 0 0.0008878657245077193
in O 0 0.0006093833362683654
transcriptional O 0 0.0012694086180999875
levels O 0 0.0006054604891687632
of O 0 0.00046109504182823
the O 0 0.0005380222573876381
three O 0 0.0005434362683445215
genes O 0 0.0009485887130722404
( O 0 0.001141718472354114
DMAHP O 0 0.016794148832559586
, O 0 0.0012987853260710835
DMPK O 0 0.01800030656158924
and O 0 0.0009408452315256
59 O 0 0.002179841510951519
) O 0 0.0010705384192988276
surrounding O 0 0.0015862974105402827
the O 0 0.0019175283377990127
repeat O 0 0.0070908088237047195
. O 0 0.003268432104960084
. O 0 0.0065153068862855434

A O 0 0.011027639731764793
novel O 0 0.022255748510360718
missense O 0 0.15285664796829224
mutation O 0 0.009933829307556152
in O 0 0.0016682095592841506
patients O 0 0.21285870671272278
from O 0 0.0014517625095322728
a O 0 0.013027176260948181
retinoblastoma B-Disease 1 0.9996707439422607
pedigree O 1 0.5104790329933167
showing O 0 0.006337486207485199
only O 0 0.0010877915192395449
mild O 0 0.09578292071819305
expression O 0 0.002390118082985282
of O 0 0.0031182337552309036
the O 0 0.0903080627322197
tumor B-Disease 1 0.999879002571106
phenotype O 1 0.6737923622131348
. O 0 0.00862591527402401

We O 0 0.0043982104398310184
have O 0 0.0020484202541410923
used O 0 0.0018157759914174676
single O 0 0.0019690750632435083
strand O 0 0.002494975458830595
conformation O 0 0.0022389423102140427
polymorphism O 0 0.0018657161854207516
analysis O 0 0.0008055454236455262
to O 0 0.0004927757545374334
study O 0 0.0007416178705170751
the O 0 0.0006706795538775623
27 O 0 0.001122978632338345
exons O 0 0.0015721237286925316
of O 0 0.0007586288265883923
the O 0 0.0015196603490039706
RB1 O 1 0.9536086320877075
gene O 0 0.0010101260850206017
in O 0 0.00048066777526400983
individuals O 0 0.00044162722770124674
from O 0 0.00047314612311311066
a O 0 0.0007896973984315991
family O 0 0.0016223343554884195
showing O 0 0.0047022332437336445
mild O 1 0.7404561638832092
expression O 0 0.002735721180215478
of O 0 0.0031935800798237324
the O 0 0.11790216714143753
retinoblastoma B-Disease 1 0.9999532699584961
phenotype O 1 0.9442508220672607
. O 0 0.008972440846264362

In O 0 0.004449437838047743
this O 0 0.0020731803961098194
family O 0 0.002813973231241107
affected O 0 0.002363123930990696
individuals O 0 0.0012123631313443184
developed O 0 0.08896314352750778
unilateral B-Disease 1 0.9476132392883301
tumors I-Disease 1 0.9999444484710693
and O 0 0.0013117290800437331
, O 0 0.0008239173912443221
as O 0 0.0005330146523192525
a O 0 0.000599361548665911
result O 0 0.0005810263683088124
of O 0 0.0005612229579128325
linkage O 0 0.0026248067151755095
analysis O 0 0.0007309448556043208
, O 0 0.0008356358739547431
unaffected O 0 0.005709519609808922
mutation O 0 0.0016287014586851
carriers O 0 0.0010867308592423797
were O 0 0.0005766936810687184
also O 0 0.000701262557413429
identified O 0 0.00117980083450675
within O 0 0.0012396174715831876
the O 0 0.0027627358213067055
pedigree O 0 0.030400443822145462
. O 0 0.007267351262271404

A O 0 0.008762908168137074
single O 0 0.004391049966216087
band O 0 0.003769855946302414
shift O 0 0.002802240662276745
using O 0 0.0015541414031758904
SSCP O 0 0.0695156455039978
was O 0 0.0017845348920673132
identified O 0 0.0013632605550810695
in O 0 0.0009442042210139334
exon O 0 0.0036875619553029537
21 O 0 0.0011942044366151094
which O 0 0.0005458600935526192
resulted O 0 0.0010401926701888442
in O 0 0.0006678138743154705
a O 0 0.001114959130063653
missense O 0 0.003213646588847041
mutation O 0 0.0015478389104828238
converting O 0 0.0016898721223697066
a O 0 0.0022582223173230886
cys O 1 0.9983215928077698
- O 0 0.36172157526016235
- O 0 0.053232837468385696
> O 0 0.005997443571686745
arg O 0 0.006195717491209507
at O 0 0.0014537950046360493
nucleotide O 0 0.0021616818848997355
position O 0 0.0013513981830328703
28 O 0 0.0018581678159534931
in O 0 0.0016674360958859324
the O 0 0.0037263331469148397
exon O 0 0.022614406421780586
. O 0 0.00958332046866417

The O 0 0.00826448667794466
mutation O 0 0.010352653451263905
destroyed O 0 0.00985727645456791
an O 0 0.0043257721699774265
NdeI O 1 0.8380947113037109
restriction O 0 0.011354390531778336
enzyme O 0 0.009779585525393486
site O 0 0.008557784371078014
. O 0 0.009236302226781845

Analysis O 0 0.005541462451219559
of O 0 0.0023959658574312925
all O 0 0.0012189988046884537
family O 0 0.0014751356793567538
members O 0 0.000891547417268157
demonstrated O 0 0.0013181599788367748
that O 0 0.0005986043252050877
the O 0 0.0009485363843850791
missense O 0 0.04509766027331352
mutation O 0 0.016889028251171112
co O 1 0.566501259803772
- O 1 0.8541394472122192
segregated O 1 0.5958454608917236
with O 0 0.003841456025838852
patients O 1 0.993880033493042
with O 0 0.21596191823482513
tumors B-Disease 1 0.999997615814209
or O 0 0.007140415254980326
who O 0 0.0015077147400006652
, O 0 0.0004617385275196284
as O 0 0.00036325608380138874
a O 0 0.00043040994205512106
result O 0 0.00041949411388486624
of O 0 0.000478535977890715
linkage O 0 0.0023730008397251368
analysis O 0 0.0006401168066076934
had O 0 0.0006873891688883305
been O 0 0.0006045575719326735
predicted O 0 0.001133601414039731
to O 0 0.0007215239456854761
carry O 0 0.0015985179925337434
the O 0 0.0027306315023452044
predisposing O 0 0.04880083352327347
mutation O 0 0.012463150545954704
. O 0 0.009482613764703274

These O 0 0.003226929111406207
observations O 0 0.0032245542388409376
point O 0 0.0018365365685895085
to O 0 0.0007746310438960791
another O 0 0.0009848610498011112
region O 0 0.0011362117948010564
of O 0 0.0011079789837822318
the O 0 0.005388913210481405
RB1 O 1 0.9990090131759644
gene O 0 0.0011016950011253357
where O 0 0.0006480247247964144
mutations O 0 0.0007402832270599902
only O 0 0.00031734866206534207
modify O 0 0.0006781041738577187
the O 0 0.0004112411697860807
function O 0 0.0004606838629115373
of O 0 0.00045577227137982845
the O 0 0.0006786730955354869
gene O 0 0.0007560018566437066
and O 0 0.00039793114410713315
raise O 0 0.0005838046199642122
important O 0 0.00040305350557900965
questions O 0 0.0005866572610102594
for O 0 0.0005080569535493851
genetic O 0 0.0013064020313322544
counseling O 0 0.004373221192508936
in O 0 0.0006721525569446385
families O 0 0.0008855466730892658
with O 0 0.0008139752317219973
these O 0 0.0009888858767226338
distinctive O 0 0.007854387164115906
phenotypes O 0 0.02624015510082245
. O 0 0.004222559276968241
. O 0 0.007554019335657358

Maternal B-Disease 1 0.9991243481636047
disomy I-Disease 1 0.999671220779419
and O 1 0.9943915009498596
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9961341619491577
with O 0 0.10794997215270996
gamete O 1 0.9975678324699402
complementation O 1 0.9965785145759583
in O 0 0.0012228894047439098
a O 0 0.0013052970170974731
case O 0 0.0012110042152926326
of O 0 0.0014942068373784423
familial O 1 0.9881181120872498
translocation O 0 0.23602394759655
( O 0 0.001111222431063652
3 O 0 0.0007767399656586349
; O 0 0.0005168912466615438
15 O 0 0.0008191093802452087
) O 0 0.0007962172967381775
( O 0 0.0010468898108229041
p25 O 0 0.005334843881428242
; O 0 0.0010454561561346054
q11 O 0 0.004119216464459896
. O 0 0.0014042777474969625
2 O 0 0.003948942758142948
) O 0 0.0043520620092749596
. O 0 0.006851407699286938

Maternal B-Disease 1 0.9995266199111938
uniparental I-Disease 1 0.9999828338623047
disomy I-Disease 1 0.9998902082443237
( I-Disease 1 0.9099416136741638
UPD I-Disease 1 0.9999536275863647
) I-Disease 0 0.0022470345720648766
for I-Disease 0 0.0009666828555054963
chromosome I-Disease 0 0.0015598750906065106
15 I-Disease 0 0.0007609370513819158
is O 0 0.0004456145688891411
responsible O 0 0.0006530912942253053
for O 0 0.00035389390541240573
an O 0 0.00040502671618014574
estimated O 0 0.0006319687818177044
30 O 0 0.0005870151799172163
% O 0 0.0005197089049033821
of O 0 0.0005902944831177592
cases O 0 0.0017035802593454719
of O 0 0.38328149914741516
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999635219573975
PWS B-Disease 1 0.9999997615814209
) O 0 0.030423834919929504
. O 0 0.010033595375716686

We O 0 0.0039695631712675095
report O 0 0.002754173008725047
on O 0 0.001359476475045085
an O 0 0.0009202398941852152
unusual O 0 0.0013295802054926753
case O 0 0.001373034669086337
of O 0 0.0015551700489595532
maternal B-Disease 1 0.9900381565093994
disomy I-Disease 1 0.9427880048751831
15 I-Disease 0 0.0017099156975746155
in O 0 0.0011506967712193727
PWS B-Disease 1 0.9999529123306274
that O 0 0.0005181236192584038
is O 0 0.0004372695693746209
most O 0 0.00027013433282263577
consistent O 0 0.0005242624320089817
with O 0 0.00033664616057649255
adjacent O 0 0.00108530733268708
- O 0 0.0028828636277467012
1 O 0 0.0010003981878980994
segregation O 0 0.0018499951111152768
of O 0 0.0007755735423415899
a O 0 0.001224285690113902
paternal O 0 0.15401631593704224
t O 0 0.014500902034342289
( O 0 0.0007640247349627316
3 O 0 0.0006429897039197385
; O 0 0.00042471190681681037
15 O 0 0.0006286209682002664
) O 0 0.0006838606204837561
( O 0 0.0008708058157935739
p25 O 0 0.0034146266989409924
; O 0 0.0008705627406015992
q11 O 0 0.002509190933778882
. O 0 0.0006187267135828733
2 O 0 0.001005904981866479
) O 0 0.0006639592465944588
with O 0 0.0007152447360567749
simultaneous O 0 0.002128640888258815
maternal O 0 0.3251829445362091
meiotic O 1 0.9803465604782104
nondisjunction O 0 0.4789784848690033
for O 0 0.0028706942684948444
chromosome O 0 0.00923146866261959
15 O 0 0.005644688382744789
. O 0 0.0074469344690442085

The O 0 0.008939272724092007
patient O 1 0.8439598083496094
( O 0 0.008780213072896004
J O 1 0.5304061770439148
. O 0 0.000987011007964611
B O 0 0.0019359150901436806
. O 0 0.0004865695082116872
) O 0 0.00042484307778067887
, O 0 0.00034141121432185173
a O 0 0.0005321774515323341
17 O 0 0.0008402938256040215
- O 0 0.0016147486167028546
year O 0 0.0009362105629406869
- O 0 0.007744957227259874
old O 0 0.004203459247946739
white O 0 0.0037988200783729553
male O 0 0.00229273596778512
with O 0 0.0012182350037619472
PWS B-Disease 1 0.9999915361404419
, O 0 0.0009785392321646214
was O 0 0.0009186188690364361
found O 0 0.00046240317169576883
to O 0 0.00035438750637695193
have O 0 0.0003828223270829767
47 O 0 0.0009601318743079901
chromosomes O 0 0.0008318522595800459
with O 0 0.0004218669782858342
a O 0 0.0008630434749647975
supernumerary O 0 0.31614765524864197
, O 0 0.0011674772249534726
paternal O 0 0.1301279366016388
der O 1 0.630964994430542
( O 0 0.0011251979740336537
15 O 0 0.0006934689590707421
) O 0 0.00042785017285495996
consisting O 0 0.000533084268681705
of O 0 0.0004640804836526513
the O 0 0.0006181034259498119
short O 0 0.0012119296006858349
arm O 0 0.009869911707937717
and O 0 0.0005739291664212942
the O 0 0.0010615582577884197
proximal O 1 0.831920325756073
long O 0 0.0021043771412223577
arm O 0 0.010075380094349384
of O 0 0.0013060332275927067
chromosome O 0 0.0026992373168468475
15 O 0 0.0011849704897031188
, O 0 0.0010978434002026916
and O 0 0.002134846057742834
distal O 1 0.6979188323020935
chromosome O 0 0.08014020323753357
arm O 0 0.37871646881103516
3p O 1 0.7053044438362122
. O 0 0.012850552797317505

The O 0 0.008038612082600594
t O 0 0.03206785395741463
( O 0 0.0022743779700249434
3 O 0 0.0013783939648419619
; O 0 0.0007450768607668579
15 O 0 0.0007615758804604411
) O 0 0.0005228346562944353
was O 0 0.0005338490009307861
present O 0 0.00044586844160221517
in O 0 0.0003380602865945548
the O 0 0.00046159548219293356
balanced O 0 0.0009258500067517161
state O 0 0.0004973928444087505
in O 0 0.0005868384032510221
the O 0 0.0009983691852539778
patients O 0 0.21228724718093872
father O 0 0.01618393510580063
and O 0 0.0018096787389367819
a O 0 0.0040374137461185455
sister O 0 0.0551413968205452
. O 0 0.007445111870765686

Fluorescent O 0 0.01906779408454895
in O 0 0.004222183022648096
situ O 0 0.01986100524663925
hybridization O 0 0.0054477425292134285
analysis O 0 0.00206402107141912
demonstrated O 0 0.0022380435839295387
that O 0 0.0009374164510518312
the O 0 0.0019527932163327932
PWS B-Disease 1 0.9999760389328003
critical O 0 0.00406980887055397
region O 0 0.0017071838956326246
resided O 0 0.0024410646874457598
on O 0 0.0007307094056159258
the O 0 0.000764140160754323
derivative O 0 0.0020959735848009586
chromosome O 0 0.0011953607900068164
3 O 0 0.0005892548360861838
and O 0 0.00036375250783748925
that O 0 0.00030102013261057436
there O 0 0.0003967328811995685
was O 0 0.0006430668872781098
no O 0 0.0005052316118963063
deletion O 0 0.0012945394264534116
of O 0 0.0007542626699432731
the O 0 0.0030046843457967043
PWS B-Disease 1 0.9999818801879883
region O 0 0.0012913474347442389
on O 0 0.0006569060496985912
the O 0 0.0007354672998189926
normal O 0 0.0009583990322425961
pair O 0 0.0013624452985823154
of O 0 0.001466304180212319
15s O 0 0.3020949363708496
present O 0 0.0028327989857643843
in O 0 0.003819291479885578
J O 1 0.7844054102897644
. O 0 0.008482483215630054

B O 0 0.2921101748943329
. O 0 0.04586472734808922

Methylation O 0 0.015295690856873989
analysis O 0 0.004917155485600233
at O 0 0.004000086337327957
exon O 0 0.007545101922005415
alpha O 0 0.003323370823636651
of O 0 0.0011943806894123554
the O 0 0.001114515122026205
small O 0 0.0014442653628066182
nuclear O 0 0.002894757082685828
ribonucleoprotein O 1 0.6500346064567566
- O 0 0.004796357359737158
associated O 0 0.001865931204520166
polypeptide O 0 0.028490543365478516
N O 0 0.005797253455966711
( O 0 0.002282475121319294
SNRPN O 0 0.2505565285682678
) O 0 0.001139247789978981
gene O 0 0.0010811202228069305
showed O 0 0.0010834427084773779
a O 0 0.0007625340949743986
pattern O 0 0.0012361129047349095
characteristic O 0 0.0011712004197761416
of O 0 0.0007306470070034266
only O 0 0.0006611543358303607
the O 0 0.001204423955641687
maternal O 1 0.6612715721130371
chromosome O 0 0.003849694738164544
15 O 0 0.0021304129622876644
in O 0 0.002564569003880024
J O 0 0.33815324306488037
. O 0 0.007654713932424784

B O 0 0.18080347776412964
. O 0 0.0462484173476696

Maternal B-Disease 1 0.9955326318740845
disomy I-Disease 1 0.9532470107078552
was O 0 0.011542338877916336
confirmed O 0 0.0042612929828464985
by O 0 0.0017038463847711682
polymerase O 0 0.00515826465561986
chain O 0 0.0026240742299705744
reaction O 0 0.0015632497379556298
analysis O 0 0.001073242980055511
of O 0 0.0010069357231259346
microsatellite O 0 0.005694688763469458
repeats O 0 0.002179461997002363
at O 0 0.0009959755698218942
the O 0 0.0012556470464915037
gamma O 0 0.020023377612233162
- O 0 0.08499407023191452
aminobutyric O 0 0.482708603143692
acid O 0 0.008015928789973259
receptor O 0 0.004492443520575762
beta3 O 0 0.009183323010802269
subunit O 0 0.006597676780074835
( O 0 0.004167736042290926
GABRB3 O 0 0.0856703445315361
) O 0 0.005151699297130108
locus O 0 0.016107462346553802
. O 0 0.009259224869310856

A O 0 0.018826011568307877
niece O 1 0.9867528676986694
( O 0 0.01619815267622471
B O 0 0.11166058480739594
. O 0 0.0010109464637935162
B O 0 0.0021826273296028376
. O 0 0.0004499491478782147
) O 0 0.00046611169818788767
with O 0 0.00034188167774118483
45 O 0 0.0006085162167437375
chromosomes O 0 0.0006568731041625142
and O 0 0.00032148094032891095
the O 0 0.0004327090282458812
derivative O 0 0.0010760484728962183
3 O 0 0.0006137683521956205
but O 0 0.0003350538609083742
without O 0 0.0004116934142075479
the O 0 0.0006821429706178606
der O 0 0.1293475180864334
( O 0 0.0010170630412176251
15 O 0 0.0008737680036574602
) O 0 0.0006357553647831082
demonstrated O 0 0.0009689779835753143
a O 0 0.0008090035989880562
phenotype O 0 0.001734524848870933
consistent O 0 0.0008713935385458171
with O 0 0.00044842372881248593
that O 0 0.0004818191519007087
reported O 0 0.0011548036709427834
for O 0 0.0009692743187770247
haploinsufficiency O 0 0.012510454282164574
of O 0 0.0025344048626720905
distal O 1 0.9298893213272095
3 O 0 0.007118626963347197
p O 0 0.01668480597436428
. O 0 0.008022736757993698

Uniparental B-Disease 1 0.9999334812164307
disomy I-Disease 1 0.9904507994651794
associated O 0 0.007247600704431534
with O 0 0.0033830225002020597
unbalanced O 0 0.35142648220062256
segregation O 0 0.4261762797832489
of O 0 0.01370232179760933
non O 1 0.9842494130134583
- O 1 0.9990689158439636
Robertsonian O 1 0.9991928935050964
translocations O 0 0.33286163210868835
has O 0 0.0009891942609101534
been O 0 0.0006563118076883256
reported O 0 0.001094651292078197
previously O 0 0.0007766985800117254
but O 0 0.0003724279813468456
has O 0 0.00043584342347458005
not O 0 0.0002635112905409187
, O 0 0.00034479927853681147
to O 0 0.0003249181027058512
our O 0 0.0004147703293710947
knowledge O 0 0.0006574130966328084
, O 0 0.0004845905350521207
been O 0 0.0005066255107522011
observed O 0 0.0007202117121778429
in O 0 0.0006004545139148831
a O 0 0.0014138576807454228
case O 0 0.0030548919457942247
of O 0 0.0100522730499506
PWS B-Disease 1 0.9999912977218628
. O 0 0.013233901001513004

Furthermore O 0 0.011350155808031559
, O 0 0.0033962009474635124
our O 0 0.0021713459864258766
findings O 0 0.00179375521838665
are O 0 0.0007598457741551101
best O 0 0.0011204498587176204
interpreted O 0 0.0013091586297377944
as O 0 0.001143427100032568
true O 0 0.0027528766077011824
gamete O 0 0.20673663914203644
complementation O 1 0.9816395044326782
resulting O 0 0.01996058039367199
in O 0 0.007109183352440596
maternal B-Disease 1 0.9999529123306274
UPD I-Disease 1 0.9999953508377075
15 I-Disease 0 0.03526296466588974
and O 0 0.018001636490225792
PWS B-Disease 1 0.9998316764831543

Schwartz B-Disease 1 0.9437353610992432
- I-Disease 1 0.9916491508483887
Jampel I-Disease 1 0.9997524619102478
syndrome I-Disease 1 0.9999985694885254
type I-Disease 1 0.9048119783401489
2 I-Disease 0 0.02752506360411644
and O 0 0.010547959245741367
Stuve B-Disease 1 0.9999911785125732
- I-Disease 1 0.9999897480010986
Wiedemann I-Disease 1 0.9999988079071045
syndrome I-Disease 1 0.9999996423721313
: O 0 0.0023907844442874193
a O 0 0.0015373521018773317
case O 0 0.0018131515244022012
for O 0 0.0014029117301106453
" O 0 0.003899735864251852
lumping O 0 0.0172344408929348
" O 0 0.007173254620283842
. O 0 0.007209439761936665

Recent O 0 0.008658790029585361
studies O 0 0.004375511314719915
demonstrated O 0 0.00337667646817863
the O 0 0.001390528050251305
existence O 0 0.001829218934290111
of O 0 0.0011491806944832206
a O 0 0.0031549015548080206
genetically O 0 0.002813131781294942
distinct O 0 0.0007637117523699999
, O 0 0.00046983783249743283
usually O 0 0.0004895831225439906
lethal O 0 0.000806450960226357
form O 0 0.0005173789686523378
of O 0 0.0005763936205767095
the O 0 0.0018837640527635813
Schwartz B-Disease 1 0.9976224303245544
- I-Disease 1 0.9997209906578064
Jampel I-Disease 1 0.9999910593032837
syndrome I-Disease 1 1.0
( O 1 0.9576193690299988
SJS B-Disease 1 0.9999940395355225
) O 0 0.0015796812949702144
of O 0 0.004196264315396547
myotonia B-Disease 1 0.9999977350234985
and O 0 0.4251258373260498
skeletal B-Disease 1 0.9999974966049194
dysplasia I-Disease 1 0.9999983310699463
, O 0 0.0031114874873310328
which O 0 0.0009317664662376046
we O 0 0.0012577909510582685
called O 0 0.005111833103001118
SJS B-Disease 1 0.9995118379592896
type I-Disease 0 0.007824013940989971
2 I-Disease 0 0.006323409732431173
. O 0 0.007136464584618807

This O 0 0.009890496730804443
disorder O 1 0.9995456337928772
is O 0 0.004194017034024
reminiscent O 0 0.09839863330125809
of O 0 0.0036913587246090174
another O 0 0.01785024255514145
rare O 0 0.03379165381193161
condition O 0 0.2483544796705246
, O 0 0.0012675580801442266
the O 0 0.008738050237298012
Stuve B-Disease 1 0.9999847412109375
- I-Disease 1 0.9999772310256958
Wiedemann I-Disease 1 0.9999995231628418
syndrome I-Disease 1 1.0
( O 1 0.6525062322616577
SWS B-Disease 1 0.9992825388908386
) O 0 0.0007870368426665664
, O 0 0.000484583608340472
which O 0 0.000452425389084965
comprises O 0 0.001029524370096624
campomelia B-Disease 0 0.004250090103596449
at O 0 0.0010992399184033275
birth O 0 0.026306599378585815
with O 0 0.019714724272489548
skeletal B-Disease 1 0.999998927116394
dysplasia I-Disease 1 0.9999997615814209
, O 1 0.5089429616928101
contractures B-Disease 1 0.9999853372573853
, O 0 0.0030715446919202805
and O 0 0.001733226701617241
early B-Disease 0 0.0036689795088022947
death I-Disease 0 0.03890276700258255
. O 0 0.007233818061649799

To O 0 0.0035087645519524813
test O 0 0.002420893171802163
for O 0 0.0011124865850433707
possible O 0 0.001374004757963121
nosologic O 0 0.0124507499858737
identity O 0 0.0013840054161846638
between O 0 0.0007733492529951036
these O 0 0.0005983122391626239
disorders O 1 0.9949906468391418
, O 0 0.0007921552169136703
we O 0 0.0005281563499011099
reviewed O 0 0.000801870075520128
the O 0 0.00044661114225164056
literature O 0 0.0006366904708556831
and O 0 0.000383003061870113
obtained O 0 0.0005458512459881604
a O 0 0.0005407612188719213
follow O 0 0.0005978342960588634
- O 0 0.0009407426114194095
up O 0 0.0004236981039866805
of O 0 0.00034735407098196447
the O 0 0.00036551436642184854
only O 0 0.00028234240016900003
two O 0 0.00034870547824539244
surviving O 0 0.0022711169440299273
patients O 0 0.005367772653698921
, O 0 0.00038856363971717656
one O 0 0.0004021870263386518
with O 0 0.0006843587616458535
SJS B-Disease 1 0.9977472424507141
type I-Disease 0 0.0011314102448523045
2 I-Disease 0 0.0005482962587848306
at O 0 0.00046197473420761526
age O 0 0.0005323094665072858
10 O 0 0.0004226831078995019
years O 0 0.0004086393164470792
and O 0 0.0003652590385172516
another O 0 0.0006764059653505683
with O 0 0.0007778440485708416
SWS B-Disease 1 0.5987008810043335
at O 0 0.0013103268574923277
age O 0 0.0020936927758157253
7 O 0 0.002835242310538888
years O 0 0.0034620643127709627
. O 0 0.006444367580115795

Patients O 1 0.5011442303657532
reported O 0 0.005661620292812586
as O 0 0.0020788079127669334
having O 0 0.0043857707642018795
either O 0 0.03753868117928505
neonatal O 1 0.9999998807907104
SJS B-Disease 1 0.9999984502792358
or O 0 0.005140137858688831
SWS B-Disease 1 0.9848321080207825
presented O 0 0.0014870342565700412
a O 0 0.0008824940887279809
combination O 0 0.0012941953027620912
of O 0 0.0008816498448140919
a O 0 0.009256444871425629
severe O 1 0.9999703168869019
, O 1 0.9544792771339417
prenatal O 1 0.9999998807907104
- O 1 0.9999998807907104
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999417066574097
with O 1 0.9987805485725403
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.999957799911499
respiratory O 1 1.0
and O 1 0.9953987002372742
feeding O 1 0.9984935522079468
difficulties O 1 0.9989185333251953
, O 0 0.016573484987020493
tendency O 0 0.1954309195280075
to O 0 0.0009244243265129626
hyperthermia B-Disease 1 0.9985709190368652
, O 0 0.0006710971356369555
and O 0 0.0005269834073260427
frequent O 0 0.0010501706274226308
death O 0 0.0015057111158967018
in O 0 0.0006503458716906607
infancy O 0 0.011968798004090786
) O 0 0.000638836354482919
with O 0 0.000555782055016607
a O 0 0.001235484378412366
distinct O 0 0.004316134378314018
campomelic B-Disease 1 0.9994602799415588
- I-Disease 1 0.9997398257255554
metaphyseal I-Disease 1 0.9999476671218872
skeletal I-Disease 1 0.9999922513961792
dysplasia I-Disease 1 0.9999946355819702
. O 0 0.019411355257034302

The O 0 0.005001883488148451
similarity O 0 0.004252446349710226
of O 0 0.0022335099056363106
the O 0 0.00570683553814888
clinical O 1 0.99298495054245
and O 0 0.023883285000920296
radiographic O 1 0.9996405839920044
findings O 0 0.01088068075478077
is O 0 0.001027934718877077
so O 0 0.0004897784092463553
extensive O 0 0.0010021242778748274
that O 0 0.0004982645623385906
these O 0 0.0005399166257120669
disorders O 1 0.9897562861442566
appear O 0 0.0009457168052904308
to O 0 0.000647792941890657
be O 0 0.0006970748072490096
a O 0 0.001589744002558291
single O 0 0.0025925301015377045
entity O 0 0.007691674865782261
. O 0 0.0066507006995379925

The O 0 0.005051914602518082
follow O 0 0.003458585124462843
- O 0 0.004042878746986389
up O 0 0.0013539339415729046
observation O 0 0.001958739012479782
of O 0 0.0008279086323454976
an O 0 0.0006568809621967375
identical O 0 0.000822356145363301
and O 0 0.0005094526568427682
unique O 0 0.0009420472197234631
pattern O 0 0.0027250086423009634
of O 0 0.07622329145669937
progressive O 1 0.9999963045120239
bone B-Disease 1 0.9999994039535522
dysplasia I-Disease 1 0.9999963045120239
in O 0 0.0023025472182780504
the O 0 0.0022069013211876154
two O 0 0.0009708228753879666
patients O 1 0.6697770953178406
( O 0 0.0011469427263364196
one O 0 0.0006531578837893903
with O 0 0.0010157286887988448
SJS B-Disease 1 0.9993554949760437
type I-Disease 0 0.0019193488406017423
2 I-Disease 0 0.000756648019887507
, O 0 0.0004796201246790588
one O 0 0.0004838382010348141
with O 0 0.0006039671716280282
SWS B-Disease 1 0.7915106415748596
) O 0 0.000847799121402204
surviving O 0 0.0016477392055094242
beyond O 0 0.0013126531848683953
infancy O 0 0.0036285847891122103
adds O 0 0.0012864015297964215
to O 0 0.0004896174068562686
the O 0 0.0005924368742853403
evidence O 0 0.0007608667365275323
in O 0 0.000672186550218612
favor O 0 0.001328092417679727
of O 0 0.0019169333390891552
identity O 0 0.006009101402014494
. O 0 0.006777784321457148

The O 0 0.007442748639732599
hypothesis O 0 0.00952653307467699
that O 0 0.0036992060486227274
SWS B-Disease 1 0.9876893758773804
and O 0 0.004555382765829563
SJS B-Disease 1 0.9996798038482666
type I-Disease 0 0.004218393471091986
2 I-Disease 0 0.0013931957073509693
are O 0 0.0004913986194878817
the O 0 0.0007817373843863606
same O 0 0.001034325803630054
disorder O 1 0.9831027388572693
should O 0 0.0008629948715679348
be O 0 0.0006709372391924262
testable O 0 0.0024890867061913013
by O 0 0.0008750986307859421
molecular O 0 0.0021332399919629097
methods O 0 0.0026066761929541826
. O 0 0.003036322072148323
. O 0 0.006485921796411276

A O 0 0.009874277748167515
mouse O 0 0.008508751168847084
model O 0 0.0051332442089915276
of O 0 0.027403583750128746
severe O 1 0.9999995231628418
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9996833801269531
defects O 1 0.9999992847442627
in O 1 0.9729546904563904
hemostasis O 1 0.9999997615814209
and O 1 0.944878339767456
thrombosis B-Disease 1 0.9999986886978149
. O 0 0.07501915097236633

von B-Disease 1 0.9988584518432617
Willebrand I-Disease 1 0.9999934434890747
factor I-Disease 1 0.9948828220367432
( I-Disease 1 0.9952656030654907
vWf I-Disease 1 0.9999920129776001
) I-Disease 1 0.9982653260231018
deficiency I-Disease 1 1.0
causes O 1 0.9999992847442627
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9955639839172363
humans O 1 0.7852417230606079
. O 0 0.010361426509916782

We O 0 0.004529900383204222
generated O 0 0.003232068382203579
a O 0 0.0023814404848963022
mouse O 0 0.003481729654595256
model O 0 0.002123422920703888
for O 0 0.0012631657300516963
this O 0 0.0011910069733858109
disease O 1 0.6743705868721008
by O 0 0.0013790978118777275
using O 0 0.002731143496930599
gene O 0 0.005699358880519867
targeting O 0 0.007558309938758612
. O 0 0.0076043931767344475

vWf B-Disease 1 0.999794065952301
- I-Disease 1 0.9983709454536438
deficient I-Disease 1 0.997969925403595
mice O 0 0.034682635217905045
appeared O 0 0.0027163850609213114
normal O 0 0.0015617292374372482
at O 0 0.0011335392482578754
birth O 0 0.0022612959146499634
; O 0 0.0007503711967729032
they O 0 0.0006836192333139479
were O 0 0.0009883855236694217
viable O 0 0.0034212470054626465
and O 0 0.0027117878198623657
fertile O 0 0.01603471301496029
. O 0 0.008863844908773899

Neither O 0 0.02485816553235054
vWf O 1 0.7695469856262207
nor O 0 0.01500563882291317
vWf O 1 0.8747764825820923
propolypeptide O 1 0.9169637560844421
( O 0 0.03935907781124115
von B-Disease 1 0.9965496063232422
Willebrand I-Disease 1 0.9999974966049194
antigen O 1 0.9962322115898132
II O 1 0.9881977438926697
) O 0 0.0016706205205991864
were O 0 0.001042230986058712
detectable O 0 0.0029056970961391926
in O 0 0.0009081516764126718
plasma O 0 0.004335198551416397
, O 0 0.0013174446066841483
platelets O 0 0.21305929124355316
, O 0 0.0013438507448881865
or O 0 0.0012806045124307275
endothelial O 0 0.013657580129802227
cells O 0 0.001551050110720098
of O 0 0.001419251086190343
the O 0 0.002883975161239505
homozygous O 0 0.06811828911304474
mutant O 0 0.11188776791095734
mice O 0 0.015183443203568459
. O 0 0.008790598250925541

The O 0 0.01115831546485424
mutant O 1 0.6242217421531677
mice O 0 0.2334723323583603
exhibited O 0 0.4494905471801758
defects O 1 0.997494101524353
in O 0 0.0103627173230052
hemostasis O 1 0.9999736547470093
with O 0 0.0032716463319957256
a O 0 0.11270703375339508
highly O 1 0.9808005094528198
prolonged O 1 0.9999979734420776
bleeding O 1 0.9999997615814209
time O 0 0.004145326558500528
and O 0 0.001717836712487042
spontaneous O 0 0.17594009637832642
bleeding O 1 0.9934291243553162
events O 0 0.0008403530810028315
in O 0 0.0006185380043461919
approximately O 0 0.0010237605310976505
10 O 0 0.001134777907282114
% O 0 0.0015966775827109814
of O 0 0.0029808965045958757
neonates O 0 0.19052232801914215
. O 0 0.0070451004430651665

As O 0 0.004687839187681675
in O 0 0.002589477226138115
the O 0 0.002661716192960739
human O 0 0.09041490405797958
disease O 1 0.9999556541442871
, O 0 0.0027121296152472496
the O 0 0.0035807553213089705
factor O 0 0.08618009835481644
VIII O 1 0.955894410610199
level O 0 0.0008828548598103225
in O 0 0.00043465697672218084
these O 0 0.00036870333133265376
mice O 0 0.0013373505789786577
was O 0 0.0009128497331403196
reduced O 0 0.0008793434826657176
strongly O 0 0.0006160511402413249
as O 0 0.0004602413682732731
a O 0 0.0006616993341594934
result O 0 0.0006178716430440545
of O 0 0.0006617002654820681
the O 0 0.0010746598709374666
lack O 0 0.003128881100565195
of O 0 0.0023045965936034918
protection O 1 0.5295767784118652
provided O 0 0.0061626252718269825
by O 0 0.0044911387376487255
vWf O 0 0.4561173617839813
. O 0 0.008203405886888504

Defective O 1 0.9999234676361084
thrombosis B-Disease 1 0.9999911785125732
in O 0 0.12240763753652573
mutant O 1 0.9886142015457153
mice O 0 0.21302853524684906
was O 0 0.0030679728370159864
also O 0 0.0009910393273457885
evident O 0 0.001448161550797522
in O 0 0.0005774727906100452
an O 0 0.0007136049098335207
in O 0 0.0011521840933710337
vivo O 0 0.11559855192899704
model O 0 0.004905603360384703
of O 0 0.08577442914247513
vascular B-Disease 1 0.9999994039535522
injury I-Disease 1 0.9999338388442993
. O 0 0.02215888537466526

In O 0 0.004083467647433281
this O 0 0.0018865157617256045
model O 0 0.0022026151418685913
, O 0 0.0011897280346602201
the O 0 0.0016090132994577289
exteriorized O 1 0.828034520149231
mesentery O 1 0.9916037917137146
was O 0 0.09631746262311935
superfused O 1 0.9358455538749695
with O 0 0.003957027103751898
ferric O 1 0.9999796152114868
chloride O 1 0.8879387974739075
and O 0 0.0015635890886187553
the O 0 0.001971397316083312
accumulation O 0 0.048332564532756805
of O 0 0.006412823218852282
fluorescently O 1 0.9997827410697937
labeled O 1 0.8970566391944885
platelets O 1 0.6929575800895691
was O 0 0.003744792426005006
observed O 0 0.0030017844401299953
by O 0 0.002992534078657627
intravital O 0 0.12385480105876923
microscopy O 0 0.015381278470158577
. O 0 0.008859220892190933

We O 0 0.0047791488468647
conclude O 0 0.004595394711941481
that O 0 0.001325778546743095
these O 0 0.0009030801593326032
mice O 0 0.0019658624660223722
very O 0 0.000962921476457268
closely O 0 0.0015428351471200585
mimic O 0 0.33226287364959717
severe O 1 0.9998422861099243
human O 1 0.9982783794403076
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.29458093643188477
will O 0 0.0007442590431310236
be O 0 0.0003510026726871729
very O 0 0.0003446582704782486
useful O 0 0.0004162126570008695
for O 0 0.000305902271065861
investigating O 0 0.0006404564483091235
the O 0 0.0004453830770216882
role O 0 0.0007324024918489158
of O 0 0.0008314125007018447
vWf O 0 0.09095381945371628
in O 0 0.0007510650902986526
normal O 0 0.001386970398016274
physiology O 0 0.09503787755966187
and O 0 0.0010829479433596134
in O 0 0.0023907129652798176
disease O 1 0.9994751811027527
models O 0 0.005645762197673321
. O 0 0.00333426590077579
. O 0 0.006960532162338495

Oral O 1 0.7631348967552185
contraceptives O 1 0.8940792083740234
and O 0 0.0050117517821490765
the O 0 0.0072194361127913
risk O 1 0.9645664691925049
of O 1 0.9974591135978699
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9913183450698853

Hereditary B-Disease 1 0.9999974966049194
Ovarian I-Disease 1 0.9999998807907104
Cancer I-Disease 1 0.9999995231628418
Clinical O 1 0.9999310970306396
Study O 1 0.8906394839286804
Group O 0 0.34280216693878174
. O 0 0.01720365509390831

BACKGROUND O 0 0.012818806804716587
Women O 0 0.004354347474873066
with O 0 0.0013698170660063624
mutations O 0 0.001681020949035883
in O 0 0.0007560660596936941
either O 0 0.0007713571540080011
the O 0 0.001008528983220458
BRCA1 O 1 0.5464606285095215
or O 0 0.0009548218222334981
the O 0 0.0014465991407632828
BRCA2 O 1 0.6954239010810852
gene O 0 0.0009903323370963335
have O 0 0.00046641836524941027
a O 0 0.0009460533619858325
high O 0 0.0026766147930175066
lifetime O 1 0.5054699182510376
risk O 1 0.9640066027641296
of O 1 0.9951417446136475
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 1 0.6885555982589722

Oral O 1 0.9937512278556824
contraceptives O 1 0.9998461008071899
protect O 1 0.9939213991165161
against O 1 0.9997134804725647
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.7569630742073059
general O 1 0.9429189562797546
, O 0 0.003134689759463072
but O 0 0.0005028215236961842
it O 0 0.0003216425538994372
is O 0 0.0003436705155763775
not O 0 0.0002780415816232562
known O 0 0.00037958589382469654
whether O 0 0.0003848106716759503
they O 0 0.0003028009959962219
also O 0 0.0004980272497050464
protect O 0 0.0010579075897112489
against O 0 0.001551027991808951
hereditary B-Disease 1 0.9978698492050171
forms I-Disease 1 0.8955742120742798
of I-Disease 1 0.999931812286377
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.928321361541748

METHODS O 0 0.006921350955963135
We O 0 0.0035450290888547897
enrolled O 0 0.007398718968033791
207 O 0 0.04927871376276016
women O 0 0.010694362223148346
with O 0 0.10687930136919022
hereditary B-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.6887788772583008
161 O 1 0.7745316028594971
of O 0 0.006051945965737104
their O 0 0.0008925504516810179
sisters O 0 0.04637710005044937
as O 0 0.0007884736987762153
controls O 0 0.0011164859170094132
in O 0 0.0006160740740597248
a O 0 0.001202352112159133
case O 0 0.002635197015479207
- O 0 0.021152423694729805
control O 0 0.003283747471868992
study O 0 0.0055611287243664265
. O 0 0.007409411016851664

All O 0 0.005156596191227436
the O 0 0.003956078086048365
patients O 0 0.015295060351490974
carried O 0 0.0020236202981323004
a O 0 0.001814492978155613
pathogenic O 0 0.011248022317886353
mutation O 0 0.0015341838588938117
in O 0 0.0007144918781705201
either O 0 0.0009523160406388342
BRCA1 O 0 0.022033827379345894
( O 0 0.0011298391036689281
179 O 0 0.0021261766087263823
women O 0 0.001115488586947322
) O 0 0.000984691665507853
or O 0 0.0009373659268021584
BRCA2 O 0 0.03888624906539917
( O 0 0.001961595145985484
28 O 0 0.002606406342238188
women O 0 0.0031871325336396694
) O 0 0.0036672507412731647
. O 0 0.005003300029784441

The O 0 0.006150021683424711
control O 0 0.005017684772610664
women O 0 0.003234833013266325
were O 0 0.0013024320360273123
enrolled O 0 0.003925481345504522
regardless O 0 0.001312378328293562
of O 0 0.0008751611458137631
whether O 0 0.0006954209529794753
or O 0 0.0005734149017371237
not O 0 0.0004726739425677806
they O 0 0.0005994293023832142
had O 0 0.0015939917648211122
either O 0 0.0024779082741588354
mutation O 0 0.007574825081974268
. O 0 0.0068382504396140575

Lifetime O 0 0.01837472803890705
histories O 0 0.013197945430874825
of O 0 0.01140547078102827
oral O 1 0.999509334564209
- O 1 0.9982771873474121
contraceptive O 1 0.9961453676223755
use O 0 0.0010528452694416046
were O 0 0.0005525670712813735
obtained O 0 0.0006441983277909458
by O 0 0.00043896434362977743
interview O 0 0.0007620276883244514
or O 0 0.0003610578423831612
by O 0 0.00033894323860295117
written O 0 0.00046558526810258627
questionnaire O 0 0.0010747552150860429
and O 0 0.0003550344263203442
were O 0 0.00036820874083787203
compared O 0 0.0006080866442061961
between O 0 0.0004950467846356332
patients O 0 0.0057315342128276825
and O 0 0.0005278199096210301
control O 0 0.0009755952632986009
women O 0 0.000993282301351428
, O 0 0.0005272306152619421
after O 0 0.0008019094238989055
adjustment O 0 0.002475583925843239
for O 0 0.0005939187249168754
year O 0 0.0008354743476957083
of O 0 0.001093488186597824
birth O 0 0.01168778631836176
and O 0 0.0027830852195620537
parity O 0 0.10452479869127274
. O 0 0.006661798804998398

RESULTS O 0 0.006293968763202429
The O 0 0.003167104907333851
adjusted O 0 0.006883265450596809
odds O 0 0.022986644878983498
ratio O 0 0.08938519656658173
for O 0 0.11277035623788834
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999949932098389
associated O 0 0.0031863099429756403
with O 0 0.0007129451842047274
any O 0 0.0006245464901439846
past O 0 0.0008127444889396429
use O 0 0.0007458648178726435
of O 0 0.0013103766832500696
oral O 1 0.7684502601623535
contraceptives O 1 0.9941222071647644
was O 0 0.05406810715794563
0 O 0 0.008580672554671764
. O 0 0.007562210317701101

5 O 0 0.008013789542019367
( O 0 0.004332834389060736
95 O 0 0.003954937681555748
percent O 0 0.0023708424996584654
confidence O 0 0.0028009084053337574
interval O 0 0.0020717198494821787
, O 0 0.0009325596038252115
0 O 0 0.0011814996832981706
. O 0 0.0005214327247813344
3 O 0 0.0007133971084840596
to O 0 0.0006109782843850553
0 O 0 0.0013196478830650449
. O 0 0.0009176508756354451
8 O 0 0.0024427659809589386
) O 0 0.003441770561039448
. O 0 0.005903491750359535

The O 0 0.010130799375474453
risk O 0 0.06347016990184784
decreased O 0 0.009908106178045273
with O 0 0.0013806084170937538
increasing O 0 0.0018907854100689292
duration O 0 0.0023338685277849436
of O 0 0.001002357224933803
use O 0 0.0007897166069597006
( O 0 0.001092369551770389
P O 0 0.0019216859946027398
for O 0 0.0005811412120237947
trend O 0 0.00126807508058846
, O 0 0.0006968214875087142
< O 0 0.002022692235186696
0 O 0 0.00110625138040632
. O 0 0.0005620050942525268
001 O 0 0.003339391201734543
) O 0 0.0005925351288169622
; O 0 0.0003492018149700016
use O 0 0.00032483262475579977
for O 0 0.00030159694142639637
six O 0 0.00041478261118754745
or O 0 0.000319664046401158
more O 0 0.0002542097063269466
years O 0 0.00044721821905113757
was O 0 0.0005716089508496225
associated O 0 0.0005076333764009178
with O 0 0.00037854042602702975
a O 0 0.0007437088643200696
60 O 0 0.0010854908032342792
percent O 0 0.001285291975364089
reduction O 0 0.0026543368585407734
in O 0 0.0018731902819126844
risk O 0 0.008401291444897652
. O 0 0.006713465787470341

Oral O 1 0.9883861541748047
- O 1 0.9776518940925598
contraceptive O 1 0.9980721473693848
use O 0 0.004493987653404474
protected O 1 0.840193510055542
against O 1 0.9748533368110657
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999985694885254
both O 0 0.0013421137118712068
for O 0 0.0010223559802398086
carriers O 0 0.0018477309495210648
of O 0 0.0010300345020368695
the O 0 0.0031935623846948147
BRCA1 O 1 0.975102424621582
mutation O 0 0.0020789504051208496
( O 0 0.0009547899244353175
odds O 0 0.0016360203735530376
ratio O 0 0.0009985421784222126
, O 0 0.00046842030133120716
0 O 0 0.0006084318738430738
. O 0 0.00034542501089163125
5 O 0 0.0005149917560629547
; O 0 0.0004587851872202009
95 O 0 0.0007591835455968976
percent O 0 0.0007307195337489247
confidence O 0 0.0012154745636507869
interval O 0 0.0010983010288327932
, O 0 0.0005078279646113515
0 O 0 0.000743002281524241
. O 0 0.00032221278524957597
3 O 0 0.0004558177024591714
to O 0 0.000299007078865543
0 O 0 0.0006797800306230783
. O 0 0.00031838598079048097
9 O 0 0.0006220917566679418
) O 0 0.0003988650569226593
and O 0 0.00030609453096985817
for O 0 0.0003768680908251554
carriers O 0 0.0007816494908183813
of O 0 0.0005938790272921324
the O 0 0.0012651749420911074
BRCA2 O 1 0.7851656675338745
mutation O 0 0.002256508218124509
( O 0 0.0011320259654894471
odds O 0 0.001982081914320588
ratio O 0 0.0012136115692555904
, O 0 0.0006012677331455052
0 O 0 0.0008655668352730572
. O 0 0.00037689809687435627
4 O 0 0.0007212440250441432
; O 0 0.0004883455694653094
95 O 0 0.0008419756777584553
percent O 0 0.0007600319222547114
confidence O 0 0.0011198342544957995
interval O 0 0.0011710966937243938
, O 0 0.0005701233167201281
0 O 0 0.0008171670488081872
. O 0 0.0003937191213481128
2 O 0 0.0006607392570003867
to O 0 0.00048570067156106234
1 O 0 0.0009686448611319065
. O 0 0.0008821711526252329
1 O 0 0.0022027797531336546
) O 0 0.0030346305575221777
. O 0 0.005066839512437582

CONCLUSIONS O 0 0.01892579160630703
Oral O 1 0.8934507966041565
- O 1 0.8942155838012695
contraceptive O 1 0.9128234386444092
use O 0 0.002395610325038433
may O 0 0.0017422157106921077
reduce O 0 0.0023243918549269438
the O 0 0.0015011351788416505
risk O 1 0.7790753245353699
of O 1 0.9967592358589172
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
in O 0 0.15996460616588593
women O 0 0.4837195873260498
with O 0 0.0030149249359965324
pathogenic O 1 0.9250134229660034
mutations O 0 0.005879510194063187
in O 0 0.001289697247557342
the O 0 0.01462098490446806
BRCA1 O 1 0.999427318572998
or O 0 0.011438697576522827
BRCA2 O 1 0.9960954785346985
gene O 0 0.02562723681330681

A O 0 0.011940844357013702
Japanese O 0 0.013124914839863777
family O 0 0.005110118538141251
with O 0 0.0025914611760526896
adrenoleukodystrophy B-Disease 1 0.9999850988388062
with O 0 0.0020416025072336197
a O 0 0.002801331924274564
codon O 0 0.014326333068311214
291 O 0 0.011061790399253368
deletion O 0 0.00366384070366621
: O 0 0.0008541641291230917
a O 0 0.0008125465828925371
clinical O 0 0.015228320844471455
, O 0 0.000923207844607532
biochemical O 0 0.0036591857206076384
, O 0 0.0009984319331124425
pathological O 0 0.1302761286497116
, O 0 0.0014151419745758176
and O 0 0.0015650608111172915
genetic O 0 0.005972752347588539
report O 0 0.006244507618248463
. O 0 0.00652605015784502

We O 0 0.004936024080961943
report O 0 0.003408132353797555
a O 0 0.0026708468794822693
Japanese O 0 0.004641328006982803
family O 0 0.0034762348514050245
with O 0 0.005927367601543665
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9881473183631897
ALD B-Disease 1 0.9999991655349731
) O 0 0.0013054170412942767
with O 0 0.0005019073723815382
a O 0 0.0006168095860630274
three O 0 0.0005055676447227597
base O 0 0.0008383096428588033
pair O 0 0.0012725427513942122
deletion O 0 0.0033843107521533966
( O 0 0.001696719671599567
delGAG O 0 0.008859187364578247
291 O 0 0.0038447275292128325
) O 0 0.0015030325157567859
in O 0 0.0016416742000728846
the O 0 0.004185446072369814
ALD B-Disease 1 0.9998503923416138
gene O 0 0.012605074793100357
. O 0 0.008998175151646137

A O 0 0.008647545240819454
variety O 0 0.00396642554551363
of O 0 0.002933503594249487
phenotypes O 0 0.008260098285973072
were O 0 0.0017054796917364001
observed O 0 0.0020724376663565636
within O 0 0.0015741767128929496
this O 0 0.001931486651301384
family O 0 0.005606403574347496
. O 0 0.007254276890307665

While O 0 0.005968660116195679
the O 0 0.003632058622315526
proband O 1 0.7725455164909363
( O 0 0.008852822706103325
patient O 0 0.4915449023246765
1 O 0 0.002594259101897478
) O 0 0.001003352808766067
was O 0 0.000937528966460377
classified O 0 0.0009335658396594226
as O 0 0.0004674888914451003
having O 0 0.0005580542492680252
a O 0 0.0006254286272451282
rare O 0 0.001033926848322153
intermediate O 0 0.0020925276912748814
type O 0 0.0012815464287996292
of O 0 0.0009064189507625997
adult O 0 0.029312869533896446
cerebral O 1 0.9983577132225037
and O 0 0.020380208268761635
cerebello O 1 0.9999566078186035
- O 1 0.997198224067688
brain O 1 0.8085495829582214
stem O 0 0.00648144306614995
forms O 0 0.0008569708443246782
, O 0 0.0006321073160506785
his O 0 0.0011359996860846877
younger O 0 0.01128823310136795
brother O 0 0.04410450905561447
( O 0 0.0012846506433561444
patient O 0 0.021034812554717064
2 O 0 0.0008395942277275026
) O 0 0.0004983101971447468
and O 0 0.0004886110546067357
nephew O 0 0.047695670276880264
( O 0 0.0013904081424698234
patient O 0 0.007954014465212822
3 O 0 0.0011103388387709856
) O 0 0.0007676157401874661
had O 0 0.0011386984260752797
a O 0 0.0034596272744238377
childhood O 1 0.9992104768753052
ALD B-Disease 1 0.9999996423721313
type O 1 0.9612294435501099
. O 0 0.012658290565013885

Another O 0 0.008413988165557384
nephew O 1 0.8183241486549377
( O 0 0.00912463292479515
patient O 0 0.17017501592636108
4 O 0 0.0018062321469187737
) O 0 0.0008048847666941583
of O 0 0.0008067652815952897
patient O 0 0.2607308328151703
1 O 0 0.0013015676522627473
was O 0 0.0010571370366960764
classified O 0 0.0012733538169413805
as O 0 0.0006775105139240623
having O 0 0.0010681769344955683
an O 0 0.0015608684625476599
adolescent O 1 0.9859436750411987
form O 0 0.007873211987316608
. O 0 0.007273901253938675

The O 0 0.007766206748783588
tau O 0 0.015822920948266983
level O 0 0.003502334700897336
in O 0 0.0017862694803625345
the O 0 0.0027238077018409967
cerebrospinal O 1 0.999871015548706
fluid O 1 0.9954462647438049
( O 0 0.26802343130111694
CSF O 1 0.9968722462654114
) O 0 0.001023199874907732
in O 0 0.0007344776531681418
patient O 0 0.013219834305346012
1 O 0 0.0008687226800248027
was O 0 0.0006429890636354685
as O 0 0.0004472165019251406
high O 0 0.0006840790738351643
as O 0 0.0004221264098305255
that O 0 0.00038315789424814284
of O 0 0.0008959168917499483
patients O 1 0.8959221839904785
with O 1 0.5831753611564636
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
( O 1 0.9246487617492676
AD B-Disease 1 0.8325750231742859
) O 0 0.005251998547464609
. O 0 0.006894784979522228

His O 0 0.012655978091061115
brain O 0 0.018334247171878815
magnetic O 0 0.007504516281187534
resonance O 0 0.006389131303876638
image O 0 0.011111744679510593
( O 0 0.004198293201625347
MRI O 0 0.43586093187332153
) O 0 0.001449675764888525
showed O 0 0.0017328349640592933
abnormalities B-Disease 0 0.006966509856283665
in I-Disease 0 0.0008718718308955431
the I-Disease 0 0.001481564249843359
bilateral I-Disease 1 0.7262901663780212
cerebellar I-Disease 1 0.9999939203262329
hemispheres I-Disease 1 0.8923431038856506
and O 0 0.015865644440054893
brain O 1 0.9738203287124634
stem O 0 0.07573492079973221
, O 0 0.0006711899186484516
but O 0 0.00037771317875012755
not O 0 0.0003176750033162534
in O 0 0.0004974749172106385
the O 0 0.0009687204728834331
cerebral O 1 0.9681082963943481
white O 0 0.002762134186923504
matter O 0 0.0007311230874620378
, O 0 0.0005307745304889977
where O 0 0.0005485681467689574
marked O 0 0.0011263674823567271
reductions O 0 0.0013912672875449061
of O 0 0.0008563337032683194
the O 0 0.03681206330657005
cerebral O 1 0.9999853372573853
blood O 1 0.9838054180145264
flow O 0 0.004808385390788317
and O 0 0.0010063439840450883
oxygen O 0 0.003256262047216296
metabolism O 0 0.0016528440173715353
were O 0 0.0005810770089738071
clearly O 0 0.0009217804181389511
demonstrated O 0 0.001182705513201654
by O 0 0.0009318770025856793
positron O 0 0.005412764847278595
emission O 0 0.0033589175436645746
tomography O 0 0.0054974001832306385
( O 0 0.0030487258918583393
PET O 0 0.01009349711239338
) O 0 0.004603218752890825
. O 0 0.006573172751814127

In O 0 0.005802592262625694
patients O 0 0.01943766139447689
2 O 0 0.002838635817170143
and O 0 0.0010064303642138839
3 O 0 0.0012215059250593185
, O 0 0.0006663516978733242
the O 0 0.0007380580645985901
autopsy O 0 0.0045890118926763535
findings O 0 0.0018651285208761692
showed O 0 0.0034535296726971865
massive O 0 0.37371572852134705
demyelination B-Disease 1 0.9999302625656128
of I-Disease 0 0.04365427792072296
the I-Disease 0 0.2280225306749344
cerebral I-Disease 1 0.999622106552124
white I-Disease 0 0.006605695001780987
matter I-Disease 0 0.000796069682110101
with O 0 0.0004967002314515412
sparing O 0 0.002516787266358733
of O 0 0.0010463193757459521
the O 0 0.04807499796152115
U O 1 0.9999356269836426
- O 1 0.985251784324646
fibers O 0 0.27585262060165405
, O 0 0.0008052813354879618
compatible O 0 0.0011265021748840809
with O 0 0.0007339395815506577
the O 0 0.0010891333222389221
findings O 0 0.0024694367311894894
of O 0 0.006801143754273653
childhood O 1 0.9999598264694214
ALD B-Disease 1 0.9999995231628418
. O 0 0.029892852529883385

Oleic O 1 0.8709911108016968
and O 0 0.007659935392439365
erucic O 1 0.9889914989471436
acids O 0 0.007462659850716591
( O 0 0.004309373442083597
Lorenzos O 0 0.027726536616683006
Oil O 0 0.002471969462931156
) O 0 0.0011578226694837213
were O 0 0.0008937048260122538
administered O 0 0.0016901997150853276
to O 0 0.0007403524941764772
patients O 0 0.0027284547686576843
1 O 0 0.0008963297004811466
and O 0 0.0004902532091364264
4 O 0 0.0008723725331947207
, O 0 0.0006300269742496312
but O 0 0.0006477395072579384
sufficient O 0 0.0015641787322238088
effectiveness O 0 0.002619692590087652
was O 0 0.0016985435504466295
not O 0 0.001448927796445787
obtained O 0 0.0038110525347292423
. O 0 0.0062252795323729515

The O 0 0.005679128225892782
findings O 0 0.003608137834817171
in O 0 0.0015595328295603395
this O 0 0.0010213932255282998
family O 0 0.001306616235524416
suggest O 0 0.0013606894062831998
that O 0 0.000709882122464478
delGAG291 O 0 0.00420287624001503
is O 0 0.0007334047113545239
part O 0 0.0007083024829626083
of O 0 0.0006509678205475211
the O 0 0.0009954337729141116
cause O 0 0.00840386189520359
of O 0 0.005083421710878611
Japanese O 1 0.9974254965782166
ALD B-Disease 1 0.9999992847442627
with O 0 0.005183013621717691
phenotypic O 0 0.09104093909263611
variations O 0 0.009284928441047668
. O 0 0.00705703953281045

Moreover O 0 0.010376222431659698
, O 0 0.002787931589409709
although O 0 0.0013826043577864766
the O 0 0.0010368337389081717
scale O 0 0.001118525629863143
of O 0 0.0007116825436241925
the O 0 0.0008827202836982906
study O 0 0.0010023185750469565
is O 0 0.0005596280097961426
limited O 0 0.00043297262163832784
, O 0 0.0003502455656416714
there O 0 0.0003302711120340973
is O 0 0.00030243315268307924
a O 0 0.0003954477433580905
possibility O 0 0.0007555395131930709
that O 0 0.00042750893044285476
PET O 0 0.002067842287942767
can O 0 0.00047249015187844634
detect O 0 0.001354773761704564
an O 0 0.0009688432328402996
insidious B-Disease 1 0.8336394429206848
lesion I-Disease 1 0.9490517973899841
which O 0 0.0006723229889757931
is O 0 0.0007003148784860969
undetectable O 0 0.019293969497084618
by O 0 0.0007129996083676815
computed O 0 0.0024854771327227354
tomogram O 0 0.4174475371837616
( O 0 0.002473046537488699
CT O 1 0.6045981049537659
) O 0 0.0007611020701006055
or O 0 0.0005230589886195958
MRI O 0 0.0017040360253304243
analysis O 0 0.0006338338716886938
, O 0 0.00040722920675762
and O 0 0.00031914759892970324
that O 0 0.00027035511448048055
the O 0 0.0004282790469005704
higher O 0 0.00068178481888026
level O 0 0.000853559176903218
of O 0 0.0008145214524120092
tau O 0 0.008072434924542904
reflects O 0 0.0015819218242540956
the O 0 0.0009302619728259742
process O 0 0.001167998998425901
of O 0 0.002786513650789857
neuronal B-Disease 1 0.7706041932106018
degeneration I-Disease 1 0.9999816417694092
in O 0 0.141713485121727
ALD B-Disease 1 0.9999985694885254
. O 0 0.01928955875337124

Lorenzos O 0 0.30447879433631897
Oil O 0 0.006909601390361786
should O 0 0.002571858698502183
be O 0 0.0012152842245995998
given O 0 0.0012079408625140786
in O 0 0.0008080062107183039
the O 0 0.001186742796562612
early O 0 0.0019606598652899265
stage O 0 0.00579235702753067
. O 0 0.0030698503833264112
. O 0 0.005994738079607487

Nonsense O 0 0.02743992954492569
mutation O 0 0.008141410537064075
in O 0 0.0028925996739417315
exon O 0 0.008635657839477062
4 O 0 0.0026536521036177874
of O 0 0.0016282100696116686
human O 0 0.002958504715934396
complement O 0 0.07909256964921951
C9 O 1 0.9993288516998291
gene O 0 0.0019373639952391386
is O 0 0.0009455392719246447
the O 0 0.0009814734803512692
major O 0 0.0019279527477920055
cause O 0 0.00885248277336359
of O 0 0.013368605636060238
Japanese O 1 0.9977335929870605
complement B-Disease 1 0.9993330836296082
C9 I-Disease 1 0.9999982118606567
deficiency I-Disease 1 0.9999991655349731
. O 0 0.021862607449293137

Deficiency B-Disease 1 0.9998767375946045
of I-Disease 0 0.007132279220968485
the I-Disease 0 0.018055463209748268
ninth I-Disease 1 0.9655020236968994
component I-Disease 0 0.03038771264255047
of I-Disease 0 0.002522698137909174
human I-Disease 0 0.0159614197909832
complement I-Disease 0 0.19681459665298462
( O 0 0.014191338792443275
C9 O 1 0.9959639310836792
) O 0 0.0007444990915246308
is O 0 0.0005373578169383109
the O 0 0.0005514798103831708
most O 0 0.0006003870512358844
common O 0 0.03727466240525246
complement B-Disease 1 0.9958196878433228
deficiency I-Disease 1 0.9999997615814209
in O 0 0.003995893988758326
Japan O 0 0.293367862701416
but O 0 0.000638659461401403
is O 0 0.0006734192720614374
rare O 0 0.0010153342736884952
in O 0 0.0008257275330834091
other O 0 0.001046482939273119
countries O 0 0.002624112879857421
. O 0 0.00568755716085434

We O 0 0.004142819903790951
studied O 0 0.003574429778382182
the O 0 0.001707030343823135
molecular O 0 0.002007154980674386
basis O 0 0.0016989617142826319
of O 0 0.004367166664451361
C9 B-Disease 1 0.999991774559021
deficiency I-Disease 1 0.9999686479568481
in O 0 0.001569874002598226
four O 0 0.0024941072333604097
Japanese O 1 0.9963087439537048
C9 B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999793767929077
deficient I-Disease 1 0.9999550580978394
patients O 1 0.9715017676353455
who O 0 0.0278585497289896
had O 0 0.1782074123620987
suffered O 1 0.9999822378158569
from O 1 0.9677847027778625
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 0.9999998807907104
. O 0 0.4847986400127411

Direct O 0 0.010513750836253166
sequencing O 0 0.010447811335325241
of O 0 0.004827629309147596
amplified O 0 0.01718240976333618
C9 O 1 0.9170505404472351
cDNA O 0 0.007129248231649399
and O 0 0.0015487042255699635
DNA O 0 0.001998224062845111
revealed O 0 0.0017789620906114578
a O 0 0.0012035237159579992
nonsense O 0 0.0038606945890933275
substitution O 0 0.0030577555298805237
( O 0 0.0019929951522499323
CGA O 0 0.06205544248223305
- O 0 0.060667429119348526
- O 0 0.10583419352769852
> O 0 0.00869582500308752
TGA O 0 0.1367982029914856
) O 0 0.0009745042189024389
at O 0 0.0008944013388827443
codon O 0 0.0021515991538763046
95 O 0 0.0012769505847245455
in O 0 0.0007283209706656635
exon O 0 0.0024758169893175364
4 O 0 0.0010384689085185528
in O 0 0.0006848318153060973
the O 0 0.0012074088444933295
four O 0 0.002836583647876978
C9 B-Disease 1 0.999880313873291
- I-Disease 1 0.935940682888031
deficient I-Disease 1 0.9008445143699646
individuals O 0 0.00499091949313879
. O 0 0.007677697576582432

An O 0 0.00739272590726614
allele O 0 0.012808100320398808
- O 0 0.008888781070709229
specific O 0 0.0023819778580218554
polymerase O 0 0.008627505041658878
chain O 0 0.0045980955474078655
reaction O 0 0.001969810575246811
system O 0 0.0012196097522974014
designed O 0 0.001218208228237927
to O 0 0.0005077423411421478
detect O 0 0.0010674267541617155
exclusively O 0 0.0006890242220833898
only O 0 0.0003621461510192603
one O 0 0.00031973657314665616
of O 0 0.0003845513565465808
the O 0 0.0005244154017418623
normal O 0 0.0008401828818023205
and O 0 0.0005848784348927438
mutant O 0 0.002254785969853401
alleles O 0 0.0010905337985605001
indicated O 0 0.0006503093172796071
that O 0 0.0002672480477485806
all O 0 0.00024315981136169285
the O 0 0.0003978708409704268
four O 0 0.0004767148639075458
patients O 0 0.0014005557168275118
were O 0 0.00039974451647140086
homozygous O 0 0.0009681530646048486
for O 0 0.0003581488854251802
the O 0 0.0004919030470773578
mutation O 0 0.0010343509493395686
in O 0 0.0005338892224244773
exon O 0 0.0026099947281181812
4 O 0 0.0007360095623880625
and O 0 0.0003768018214032054
that O 0 0.0003278048534411937
the O 0 0.0005101072019897401
parents O 0 0.0008988475310616195
of O 0 0.0009678072528913617
patient O 0 0.12901318073272705
2 O 0 0.002653286559507251
were O 0 0.0025854483246803284
heterozygous O 0 0.009996384382247925
. O 0 0.007065055891871452

The O 0 0.006273058708757162
common O 0 0.0037333890795707703
mutation O 0 0.0036377161741256714
at O 0 0.0017701438628137112
codon O 0 0.0034684138372540474
95 O 0 0.001861634198576212
in O 0 0.0010190032189711928
exon O 0 0.003552949521690607
4 O 0 0.0011823424138128757
might O 0 0.0006749564781785011
be O 0 0.0004538060165941715
responsible O 0 0.0009603770449757576
for O 0 0.0007674741209484637
most O 0 0.0014660072047263384
Japanese O 1 0.9812158942222595
C9 B-Disease 1 0.9999988079071045
deficiency I-Disease 1 0.9999988079071045
. O 0 0.005041175987571478
. O 0 0.007086791563779116

BRCA1 O 0 0.09632346779108047
required O 0 0.004527376499027014
for O 0 0.0035060415975749493
transcription O 1 0.6243464946746826
- O 1 0.937080442905426
coupled O 1 0.5839032530784607
repair O 1 0.9131373167037964
of O 0 0.011334776878356934
oxidative O 1 0.9715067148208618
DNA O 0 0.019439445808529854
damage O 0 0.05711537227034569
. O 0 0.011237707920372486

The O 0 0.42482614517211914
breast B-Disease 1 0.9999990463256836
and I-Disease 1 0.9990710020065308
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999991655349731
gene O 1 0.9947308301925659
BRCA1 O 1 0.9997586607933044
encodes O 0 0.07706070691347122
a O 0 0.005264970473945141
zinc O 1 0.9809799790382385
finger O 0 0.03359655663371086
protein O 0 0.002405275125056505
of O 0 0.002236632164567709
unknown O 0 0.004919340368360281
function O 0 0.006989241577684879
. O 0 0.008371454663574696

Association O 0 0.009169597178697586
of O 0 0.0040519279427826405
the O 0 0.0040718140080571175
BRCA1 O 1 0.731519341468811
protein O 0 0.0016346664633601904
with O 0 0.0007769960211589932
the O 0 0.0011225939961150289
DNA O 0 0.0028118721675127745
repair O 0 0.4529241621494293
protein O 0 0.0017912518233060837
Rad51 O 0 0.032845862209796906
and O 0 0.0006515246350318193
changes O 0 0.0006132096750661731
in O 0 0.0004827427619602531
the O 0 0.0005924676661379635
phosphorylation O 0 0.0009453974780626595
and O 0 0.0005562319420278072
cellular O 0 0.000987345352768898
localization O 0 0.0013259301194921136
of O 0 0.0005531191709451377
the O 0 0.0006550470134243369
protein O 0 0.000778395973611623
after O 0 0.0006706753629259765
exposure O 0 0.0013754521496593952
to O 0 0.0005370646831579506
DNA O 0 0.001363959163427353
- O 0 0.002696923678740859
damaging O 0 0.0018562051700428128
agents O 0 0.0007584333070553839
are O 0 0.00039839232340455055
consistent O 0 0.0007589510059915483
with O 0 0.0004206884768791497
a O 0 0.0007635935326106846
role O 0 0.0015165002550929785
for O 0 0.0014511647168546915
BRCA1 O 1 0.5997390747070312
in O 0 0.002426472958177328
DNA O 0 0.008255512453615665
repair O 0 0.43963131308555603
. O 0 0.008022426627576351

Here O 0 0.0057626222260296345
, O 0 0.002821871777996421
it O 0 0.0012078873114660382
is O 0 0.0012368025491014123
shown O 0 0.0013888406101614237
that O 0 0.0008334906306117773
mouse O 0 0.0035697186831384897
embryonic O 0 0.01382061094045639
stem O 0 0.07869589328765869
cells O 0 0.007205150555819273
deficient B-Disease 1 0.5625672340393066
in I-Disease 0 0.0011244543129578233
BRCA1 I-Disease 0 0.46419450640678406
are O 0 0.0007163102272897959
defective O 0 0.018857942894101143
in O 0 0.0004878199251834303
the O 0 0.0005087392637506127
ability O 0 0.0004596529761329293
to O 0 0.0003187337424606085
carry O 0 0.0005561620346270502
out O 0 0.0005798728088848293
transcription O 0 0.00261795986443758
- O 0 0.06727691739797592
coupled O 0 0.017721569165587425
repair O 0 0.45488354563713074
of O 0 0.0032371077686548233
oxidative O 1 0.9821516275405884
DNA O 0 0.018535317853093147
damage O 0 0.022919166833162308
, O 0 0.0006052882527001202
and O 0 0.0006299993256106973
are O 0 0.0006202827207744122
hypersensitive O 0 0.00838024728000164
to O 0 0.0014714214485138655
ionizing O 0 0.09353573620319366
radiation O 0 0.008068697527050972
and O 0 0.002484550466760993
hydrogen O 0 0.00795454066246748
peroxide O 0 0.02593642845749855
. O 0 0.008026585914194584

These O 0 0.004117115866392851
results O 0 0.0028749066404998302
suggest O 0 0.00225874874740839
that O 0 0.0012272886233404279
BRCA1 O 0 0.15662458539009094
participates O 0 0.0023245487827807665
, O 0 0.0007909457199275494
directly O 0 0.000633460353128612
or O 0 0.0006114536663517356
indirectly O 0 0.0011470348108559847
, O 0 0.0006240674993023276
in O 0 0.0009058970026671886
transcription O 0 0.007274304516613483
- O 0 0.22662541270256042
coupled O 0 0.044004905968904495
repair O 0 0.3456878066062927
of O 0 0.0046805450692772865
oxidative O 1 0.9575541615486145
DNA O 0 0.011681872420012951
damage O 0 0.04283050447702408
. O 0 0.0035589190665632486
. O 0 0.006761804223060608

Truncation O 0 0.07939647883176804
mutations O 0 0.008415007032454014
in O 0 0.002903273794800043
the O 0 0.003435626393184066
transactivation O 1 0.5641997456550598
region O 0 0.0043035950511693954
of O 0 0.005357933696359396
PAX6 O 1 0.99989914894104
result O 0 0.004448105115443468
in O 0 0.0028723652940243483
dominant O 0 0.1659700870513916
- O 1 0.6629282832145691
negative O 0 0.012560984119772911
mutants O 0 0.026303177699446678
. O 0 0.008902636356651783

PAX6 O 1 0.9944398403167725
is O 0 0.004706314764916897
a O 0 0.00276679708622396
transcription O 0 0.003184284083545208
factor O 0 0.0017177760601043701
with O 0 0.0006364234141074121
two O 0 0.0005357718910090625
DNA O 0 0.0011776413302868605
- O 0 0.001442854874767363
binding O 0 0.0008373867603950202
domains O 0 0.00123777415137738
( O 0 0.0009860608261078596
paired O 0 0.0015793172642588615
box O 0 0.0017437005881220102
and O 0 0.0009562874911352992
homeobox O 0 0.19996868073940277
) O 0 0.0007692353683523834
and O 0 0.0005975790554657578
a O 0 0.0011352775618433952
proline O 0 0.024438422173261642
- O 0 0.010241725482046604
serine O 0 0.0076935566030442715
- O 0 0.014064148999750614
threonine O 0 0.011372780427336693
( O 0 0.003985723480582237
PST O 0 0.2182915210723877
) O 0 0.0035711079835891724
- O 0 0.007186411879956722
rich O 0 0.005862650461494923
transactivation O 0 0.025735508650541306
domain O 0 0.010285135358572006
. O 0 0.010432357899844646

PAX6 O 1 0.9996830224990845
regulates O 1 0.5844653844833374
eye O 0 0.4847268760204315
development O 0 0.003562584985047579
in O 0 0.0015036973636597395
animals O 0 0.00138164684176445
ranging O 0 0.0018229713896289468
from O 0 0.0013598022051155567
jellyfish O 0 0.00373827270232141
to O 0 0.001472319127060473
Drosophila O 0 0.0055555859580636024
to O 0 0.0023765696678310633
humans O 0 0.005786088760942221
. O 0 0.0074769277125597

Heterozygous O 0 0.0170600563287735
mutations O 0 0.006012908183038235
in O 0 0.002237411215901375
the O 0 0.0024272555019706488
human O 0 0.006811497732996941
PAX6 O 1 0.9997420907020569
gene O 0 0.0023086974397301674
result O 0 0.0008392551681026816
in O 0 0.0005854406044818461
various O 0 0.0006504059419967234
phenotypes O 0 0.002296530408784747
, O 0 0.0007856891606934369
including O 0 0.0009323553531430662
aniridia B-Disease 1 0.9955713152885437
, O 0 0.00462734792381525
Peters B-Disease 1 0.9983980059623718
anomaly I-Disease 1 0.9958244562149048
, O 0 0.017928404733538628
autosomal B-Disease 1 0.9989932179450989
dominant I-Disease 1 0.9918632507324219
keratitis I-Disease 1 0.9999982118606567
, O 0 0.28282031416893005
and O 0 0.3997332751750946
familial B-Disease 1 0.9999984502792358
foveal I-Disease 1 0.9999980926513672
dysplasia I-Disease 1 0.9999994039535522
. O 0 0.1413160264492035

It O 0 0.004001414403319359
is O 0 0.002170332707464695
believed O 0 0.002019100356847048
that O 0 0.000979743548668921
the O 0 0.0011652284301817417
mutated O 0 0.0037126957904547453
allele O 0 0.0024884664453566074
of O 0 0.0015392055502161384
PAX6 O 1 0.9925150275230408
produces O 0 0.002078177174553275
an O 0 0.0011759166372939944
inactive O 0 0.0038711370434612036
protein O 0 0.0013333228416740894
and O 0 0.0009787947637960315
aniridia B-Disease 1 0.7901273369789124
is O 0 0.0015467213233932853
caused O 0 0.005240367725491524
due O 0 0.0028382267337292433
to O 0 0.0022630048915743828
genetic O 0 0.013268142007291317
haploinsufficiency O 1 0.8100080490112305
. O 0 0.009889669716358185

However O 0 0.005093686282634735
, O 0 0.0025563242379575968
several O 0 0.0018020819406956434
truncation O 0 0.030254308134317398
mutations O 0 0.0019807673525065184
have O 0 0.0005073001375421882
been O 0 0.0005627480568364263
found O 0 0.00045394536573439837
to O 0 0.00034357927506789565
occur O 0 0.00033533573150634766
in O 0 0.00037475235876627266
the O 0 0.0006443110178224742
C O 0 0.009145833551883698
- O 0 0.0034614361356943846
terminal O 0 0.002201653318479657
half O 0 0.0007714934763498604
of O 0 0.0009712036116980016
PAX6 O 1 0.9972434043884277
in O 0 0.001134428777731955
patients O 0 0.11454734206199646
with O 0 0.000979292904958129
Aniridia B-Disease 1 0.990290105342865
resulting O 0 0.002092505805194378
in O 0 0.0006837649270892143
mutant O 0 0.0027512500528246164
proteins O 0 0.0005816940101794899
that O 0 0.0003686780110001564
retain O 0 0.0008944771252572536
the O 0 0.0005976027459837496
DNA O 0 0.0011295565636828542
- O 0 0.001414909609593451
binding O 0 0.0006449795328080654
domains O 0 0.0008163552265614271
but O 0 0.0004051732539664954
have O 0 0.0004043694934807718
lost O 0 0.0011231283424422145
most O 0 0.0007442731875926256
of O 0 0.0015353966737166047
the O 0 0.0039048923645168543
transactivation O 1 0.584284782409668
domain O 0 0.010351470671594143
. O 0 0.008688363246619701

It O 0 0.004145200364291668
is O 0 0.0020836684852838516
not O 0 0.000905668712221086
clear O 0 0.001059198402799666
whether O 0 0.000826299365144223
such O 0 0.0008318101754412055
mutants O 0 0.0031605418771505356
really O 0 0.0013783519389107823
behave O 0 0.0013514026068150997
as O 0 0.0007728596683591604
loss O 0 0.002086637308821082
- O 0 0.0032411932479590178
of O 0 0.0015249868156388402
- O 0 0.1269463747739792
function O 0 0.001951509271748364
mutants O 0 0.004427076783031225
as O 0 0.0012857242254540324
predicted O 0 0.003444564761593938
by O 0 0.0028487129602581263
haploinsufficiency O 0 0.02772161364555359
. O 0 0.008056242018938065

Contrary O 0 0.007676807232201099
to O 0 0.002276464831084013
this O 0 0.0011723298812285066
theory O 0 0.001586517901159823
, O 0 0.000819348671939224
our O 0 0.0006491144886240363
data O 0 0.0006356747471727431
showed O 0 0.0008514155633747578
that O 0 0.0003529538807924837
these O 0 0.00037664882256649435
mutants O 0 0.0014642549213021994
are O 0 0.0005059137474745512
dominant O 0 0.0014756034361198545
- O 0 0.00402457220479846
negative O 0 0.0013364083133637905
in O 0 0.0008183841709978878
transient O 0 0.1406373530626297
transfection O 0 0.31427085399627686
assays O 0 0.0016633516643196344
when O 0 0.0006272140308283269
they O 0 0.00042522940202616155
are O 0 0.0005129673518240452
coexpressed O 0 0.0038161720149219036
with O 0 0.001351365353912115
wild O 0 0.005415918305516243
- O 0 0.271224707365036
type O 0 0.145896315574646
PAX6 O 1 0.9961802959442139
. O 0 0.01154008787125349

We O 0 0.0035896673798561096
found O 0 0.0024537844583392143
that O 0 0.0012599150650203228
the O 0 0.0017676969291642308
dominant O 0 0.020159583538770676
- O 0 0.23629826307296753
negative O 0 0.0024334185291081667
effects O 0 0.0021611659321933985
result O 0 0.0008471378241665661
from O 0 0.0006217307527549565
the O 0 0.0009058749419637024
enhanced O 0 0.002066209213808179
DNA O 0 0.0013358892174437642
binding O 0 0.000991222565062344
ability O 0 0.0013171948958188295
of O 0 0.001346107805147767
these O 0 0.0021754316985607147
mutants O 0 0.01196252927184105
. O 0 0.007643004879355431

Kinetic O 0 0.01351627055555582
studies O 0 0.004875996150076389
of O 0 0.0024661184288561344
binding O 0 0.0019571043085306883
and O 0 0.0013562318636104465
dissociation O 0 0.006435553077608347
revealed O 0 0.0017405295511707664
that O 0 0.0005730515695177019
various O 0 0.0006894456455484033
truncation O 0 0.003570242552086711
mutants O 0 0.002138378331437707
have O 0 0.0006110636168159544
3 O 0 0.0010841293260455132
- O 0 0.0016902824863791466
5 O 0 0.001082971110008657
- O 0 0.0016951048746705055
fold O 0 0.001177244703285396
higher O 0 0.0007073658634908497
affinity O 0 0.0007636516238562763
to O 0 0.00036643195198848844
various O 0 0.0004377049917820841
DNA O 0 0.00100282474886626
- O 0 0.0009949076920747757
binding O 0 0.0005245525389909744
sites O 0 0.0004749092331621796
when O 0 0.0005052415071986616
compared O 0 0.0007083264063112438
with O 0 0.0005735597806051373
the O 0 0.0013947933912277222
wild O 0 0.004718579817563295
- O 0 0.19936339557170868
type O 0 0.07018304616212845
PAX6 O 1 0.9885744452476501
. O 0 0.012767947278916836

These O 0 0.003739317413419485
results O 0 0.002230213023722172
provide O 0 0.0015396614326164126
a O 0 0.0014333717990666628
new O 0 0.000949402863625437
insight O 0 0.00196654349565506
into O 0 0.0008188210777007043
the O 0 0.0009271295857615769
role O 0 0.0015677864430472255
of O 0 0.002253476297482848
mutant O 1 0.7986876368522644
PAX6 O 1 0.9992150068283081
in O 0 0.0034795862156897783
causing O 0 0.3787840008735657
aniridia B-Disease 1 0.9825208783149719
. O 0 0.005692412611097097
. O 0 0.009615744464099407

Reversal O 1 0.8779569864273071
of O 1 0.9553865194320679
severe O 1 0.9999998807907104
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9989134073257446
excellent O 1 0.9967622756958008
neuropsychologic O 1 0.9959515333175659
outcome O 0 0.0019207095028832555
in O 0 0.0007857340970076621
very B-Disease 0 0.0009862412698566914
- I-Disease 0 0.02171207033097744
long I-Disease 0 0.004255889914929867
- I-Disease 0 0.35806336998939514
chain I-Disease 1 0.6028589606285095
acyl I-Disease 1 0.9978502988815308
- I-Disease 1 0.9890031218528748
coenzyme I-Disease 1 0.9877481460571289
A I-Disease 1 0.8921600580215454
dehydrogenase I-Disease 1 0.9998340606689453
deficiency I-Disease 1 0.9999822378158569
. O 0 0.018054524436593056

Very B-Disease 0 0.0075426241382956505
- I-Disease 0 0.024753332138061523
long I-Disease 0 0.007292121648788452
- I-Disease 0 0.13081195950508118
chain I-Disease 0 0.18253403902053833
acyl I-Disease 1 0.9704105257987976
- I-Disease 1 0.7436684966087341
coenzyme I-Disease 1 0.6175846457481384
A I-Disease 0 0.18040584027767181
dehydrogenase I-Disease 1 0.9980134963989258
( I-Disease 0 0.40886953473091125
VLCAD I-Disease 1 0.9999727010726929
) I-Disease 0 0.2858411371707916
deficiency I-Disease 1 0.9999946355819702
is O 0 0.004027371294796467
a O 0 0.041354257613420486
disorder O 1 0.9999887943267822
of O 1 0.9943127632141113
fatty O 1 0.9999983310699463
acid O 1 0.9997416138648987
beta O 1 0.6878505945205688
oxidation O 0 0.03902440518140793
that O 0 0.000748000165913254
reportedly O 0 0.0019195572240278125
has O 0 0.0008429282461293042
high O 0 0.0016432825941592455
rates O 0 0.0022646314464509487
of O 0 0.002983132377266884
morbidity O 1 0.9976420998573303
and O 0 0.006272235419601202
mortality O 1 0.8978943824768066
. O 0 0.009803815744817257

We O 0 0.004847929812967777
describe O 0 0.004383510444313288
the O 0 0.0018826249288395047
outcome O 0 0.0014136777026578784
of O 0 0.0008217126596719027
a O 0 0.0010073404991999269
5 O 0 0.0012067001080140471
- O 0 0.003059491515159607
year O 0 0.0011074286885559559
- O 0 0.01458044070750475
old O 0 0.026771999895572662
girl O 1 0.6737184524536133
with O 0 0.021469784900546074
VLCAD B-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
who O 0 0.03844836726784706
was O 0 0.003736309241503477
first O 0 0.0006060615414753556
seen O 0 0.0005318342591635883
at O 0 0.0004242327995598316
5 O 0 0.0004633354546967894
months O 0 0.0004310638178139925
of O 0 0.0005725313094444573
age O 0 0.020146185532212257
with O 0 0.38167545199394226
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9999992847442627
hepatomegaly B-Disease 1 1.0
, O 1 0.9999947547912598
encephalopathy B-Disease 1 1.0
, O 1 0.9246429800987244
and O 1 0.6248235106468201
hypotonia B-Disease 1 0.999948263168335
. O 0 0.015351567417383194

Biochemical O 0 0.04212510958313942
studies O 0 0.021986640989780426
indicated O 1 0.9798647165298462
VLCAD B-Disease 1 0.9999996423721313
deficiency I-Disease 1 1.0
caused O 1 0.9958251714706421
by O 0 0.00850030779838562
a O 0 0.1650530993938446
stable O 1 0.9433055520057678
yet O 0 0.005565006751567125
inactive O 0 0.05257575213909149
enzyme O 0 0.012694778852164745
. O 0 0.008803416974842548

Molecular O 0 0.008136426098644733
genetic O 0 0.004249091725796461
analysis O 0 0.002229713136330247
of O 0 0.0019258948741480708
her O 0 0.01012477558106184
VLCAD O 1 0.9922339916229248
gene O 0 0.0027121449820697308
revealed O 0 0.002430279040709138
a O 0 0.0015997033333405852
T1372C O 0 0.10488879680633545
( O 0 0.002377338707447052
F458L O 0 0.011088055558502674
) O 0 0.0015656562754884362
missense O 0 0.005205995868891478
mutation O 0 0.002576986560598016
and O 0 0.001448900206014514
a O 0 0.003502920502796769
1668 O 1 0.9732843041419983
ACAG O 1 0.9955987930297852
1669 O 1 0.931145429611206
splice O 0 0.038381773978471756
site O 0 0.01063568890094757
mutation O 0 0.015450005419552326
. O 0 0.010845624841749668

After O 0 0.011295249685645103
initial O 0 0.0424310527741909
treatment O 1 0.982673168182373
with O 0 0.05843789875507355
intravenous O 1 0.9999943971633911
glucose O 1 0.9970418810844421
and O 0 0.04580339416861534
carnitine O 1 0.9998908042907715
, O 0 0.0012748287990689278
the O 0 0.0010828678496181965
patient O 0 0.10688349604606628
has O 0 0.000696397852152586
thrived O 0 0.001731397002004087
on O 0 0.0004967792774550617
a O 0 0.0007936781039461493
low O 0 0.0057769534178078175
- O 0 0.2778734564781189
fat O 0 0.006059782113879919
diet O 0 0.0024846107698976994
supplemented O 0 0.0017320472979918122
with O 0 0.0007265342283062637
medium O 0 0.002323044463992119
- O 0 0.006566712167114019
chain O 0 0.005508625414222479
triglyceride O 0 0.05255267396569252
oil O 0 0.003071425249800086
and O 0 0.0024636993184685707
carnitine O 1 0.910271406173706
and O 0 0.003413247875869274
avoidance O 1 0.6103278994560242
of O 0 0.02321283333003521
fasting O 1 0.7601385116577148
. O 0 0.012715869583189487

Her O 1 0.8683943748474121
ventricular O 1 0.9999780654907227
hypertrophy O 1 0.99996018409729
resolved O 0 0.12957410514354706
significantly O 0 0.0030095421243458986
over O 0 0.0013858525780960917
1 O 0 0.0015001505380496383
year O 0 0.0008482484263367951
, O 0 0.0007350913947448134
and O 0 0.0007219668477773666
cognitively O 0 0.03967960178852081
, O 0 0.0008253180421888828
she O 0 0.0008176647243089974
is O 0 0.0005242314655333757
in O 0 0.0005671967519447207
the O 0 0.0010135675547644496
superior O 0 0.002553958212956786
range O 0 0.0015686779515817761
for O 0 0.001865170313976705
age O 0 0.005370094440877438
. O 0 0.00651303306221962

Clinical O 1 0.6129257082939148
recognition O 0 0.18031425774097443
of O 1 0.9968692660331726
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 1 0.8602546453475952
important O 0 0.004903292749077082
because O 0 0.0006812593201175332
it O 0 0.00034567867987789214
is O 0 0.00032591086346656084
one O 0 0.0002903891436289996
of O 0 0.00037437083665281534
the O 0 0.0005816358025185764
few O 0 0.0007860223995521665
directly O 0 0.001632372266612947
treatable O 1 0.9999446868896484
causes O 1 0.936399519443512
of O 1 0.833175539970398
cardiomyopathy B-Disease 1 1.0
in O 1 0.7786761522293091
children O 1 0.9256188869476318
. O 0 0.004947079811245203
. O 0 0.007874298840761185

Cloning O 0 0.009668548591434956
of O 0 0.0029479546938091516
a O 0 0.0022746440954506397
novel O 0 0.0034430082887411118
member O 0 0.001730069750919938
of O 0 0.0012492216192185879
the O 0 0.002441949676722288
low O 0 0.49443334341049194
- O 1 0.9765839576721191
density O 0 0.19118300080299377
lipoprotein O 1 0.9980852603912354
receptor O 0 0.009384204633533955
family O 0 0.006553473882377148
. O 0 0.008198123425245285

A O 0 0.010547447949647903
gene O 0 0.005247377324849367
encoding O 0 0.004023691173642874
a O 0 0.0025352572556585073
novel O 0 0.005065508186817169
transmembrane O 0 0.010019897483289242
protein O 0 0.0018729825969785452
was O 0 0.0014016552595421672
identified O 0 0.0011375973699614406
by O 0 0.0005611920496448874
DNA O 0 0.0008957192185334861
sequence O 0 0.0007498865015804768
analysis O 0 0.0006171189015731215
within O 0 0.0007099088397808373
the O 0 0.001450790325179696
insulin B-Disease 1 0.9663065075874329
- I-Disease 1 0.9946828484535217
dependent I-Disease 1 0.9626843333244324
diabetes I-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.9999988079071045
( O 0 0.44845443964004517
IDDM B-Disease 1 0.9958906173706055
) O 0 0.003008773550391197
locus O 0 0.012441271916031837
IDDM4 O 0 0.16645537316799164
on O 0 0.004432869143784046
chromosome O 0 0.013443664647638798
11q13 O 0 0.03358149901032448
. O 0 0.010762101039290428

Based O 0 0.006422924343496561
on O 0 0.003169083734974265
its O 0 0.0023815971799194813
chromosomal O 0 0.006015575956553221
position O 0 0.002094418276101351
, O 0 0.0011607075575739145
this O 0 0.0007016108720563352
gene O 0 0.0010023096110671759
is O 0 0.0005875395727343857
a O 0 0.0009175490704365075
candidate O 0 0.0014321068301796913
for O 0 0.001315798843279481
conferring O 0 0.035572268068790436
susceptibility O 1 0.8427037000656128
to O 0 0.004422755446285009
diabetes B-Disease 1 0.9998325109481812
. O 0 0.01278571505099535

The O 0 0.006014703772962093
gene O 0 0.004548820201307535
, O 0 0.002398888813331723
termed O 0 0.006827529985457659
low O 0 0.005842774175107479
- O 0 0.034579481929540634
density O 0 0.004264545626938343
lipoprotein O 1 0.7684269547462463
receptor O 0 0.0022579364012926817
related O 0 0.0010405376087874174
protein O 0 0.001042626448906958
5 O 0 0.001131485914811492
( O 0 0.0011593998642638326
LRP5 O 0 0.00515827676281333
) O 0 0.0006764408317394555
, O 0 0.0006185757811181247
encodes O 0 0.0009596002055332065
a O 0 0.0006298774387687445
protein O 0 0.0006828822079114616
of O 0 0.0006499493028968573
1615 O 0 0.003644840093329549
amino O 0 0.001054947730153799
acids O 0 0.0007759231957606971
that O 0 0.00042513315565884113
contains O 0 0.0005872356705367565
conserved O 0 0.0008658430888317525
modules O 0 0.0009833384538069367
which O 0 0.000372806447558105
are O 0 0.0002839502121787518
characteristic O 0 0.0007372669060714543
of O 0 0.0005332980072125793
the O 0 0.0010729413479566574
low O 0 0.023623697459697723
- O 1 0.6393577456474304
density O 0 0.1011899933218956
lipoprotein O 1 0.9997134804725647
( O 0 0.13839340209960938
LDL O 1 0.9985176920890808
) O 0 0.0036979299038648605
receptor O 0 0.006678913254290819
family O 0 0.005998436361551285
. O 0 0.007884827442467213

These O 0 0.0038217066321521997
modules O 0 0.00595126673579216
include O 0 0.0026827200781553984
a O 0 0.002633456839248538
putative O 0 0.010732513852417469
signal O 0 0.0024116176646202803
peptide O 0 0.0018470566719770432
for O 0 0.0006685499683953822
protein O 0 0.0009371797787025571
export O 0 0.0010570522863417864
, O 0 0.0006434752140194178
four O 0 0.0010303515009582043
epidermal O 1 0.7251145839691162
growth O 0 0.003927163779735565
factor O 0 0.0036492678336799145
( O 0 0.002466622507199645
EGF O 1 0.7819647789001465
) O 0 0.0009646753896959126
repeats O 0 0.0014130608178675175
with O 0 0.0005315005546435714
associated O 0 0.0008942632121033967
spacer O 0 0.003719720058143139
domains O 0 0.0013421899639070034
, O 0 0.0008836644701659679
three O 0 0.001178007572889328
LDL O 1 0.9984625577926636
- O 0 0.27373501658439636
receptor O 0 0.0031601712107658386
( O 0 0.0015830021584406495
LDLR O 0 0.025254858657717705
) O 0 0.0009798057144507766
repeats O 0 0.0015806073788553476
, O 0 0.0006532073020935059
a O 0 0.0008946577436290681
single O 0 0.0012467916822060943
transmembrane O 0 0.0035584927536547184
spanning O 0 0.0023360918276011944
domain O 0 0.0016716372920200229
, O 0 0.0012006601318717003
and O 0 0.0014228784712031484
a O 0 0.0029963781125843525
cytoplasmic O 0 0.0086748655885458
domain O 0 0.0077667818404734135
. O 0 0.0075476509518921375

The O 0 0.007036019582301378
encoded O 0 0.004598719999194145
protein O 0 0.0026318239979445934
has O 0 0.001346104545518756
a O 0 0.0012092359829694033
unique O 0 0.001133226789534092
organization O 0 0.0015282167587429285
of O 0 0.0018945011543110013
EGF O 1 0.9986923336982727
and O 0 0.0022398694418370724
LDLR O 1 0.9945534467697144
repeats O 0 0.008894684724509716
; O 0 0.0008334144367836416
therefore O 0 0.00082507508341223
, O 0 0.0009311523754149675
LRP5 O 0 0.016149697825312614
likely O 0 0.0010937758488580585
represents O 0 0.0011989224003627896
a O 0 0.0009024729370139539
new O 0 0.0008809645078144968
category O 0 0.0016445339424535632
of O 0 0.0014459469821304083
the O 0 0.002954185474663973
LDLR O 1 0.9705471396446228
family O 0 0.008057272993028164
. O 0 0.008159149438142776

Both O 0 0.004841405898332596
human O 0 0.0038634438533335924
and O 0 0.0028659848030656576
mouse O 0 0.15078309178352356
LRP5 O 1 0.9970045685768127
cDNAs O 1 0.6499143242835999
have O 0 0.0009823335567489266
been O 0 0.0008778588380664587
isolated O 0 0.0012474069371819496
and O 0 0.0005720752524212003
the O 0 0.0006670557195320725
encoded O 0 0.0009090550593100488
mature O 0 0.00080230797175318
proteins O 0 0.0004928060225211084
are O 0 0.00030245681409724057
95 O 0 0.0009605821105651557
% O 0 0.0006171929417178035
identical O 0 0.0007878821925260127
, O 0 0.0007342054741457105
indicating O 0 0.0010841003386303782
a O 0 0.0008424801053479314
high O 0 0.001160282175987959
degree O 0 0.0013851348776370287
of O 0 0.0014336148742586374
evolutionary O 0 0.004295347724109888
conservation O 0 0.005032043904066086
. O 0 0.002998230280354619
. O 0 0.0056351227685809135

The O 0 0.010314632207155228
APC B-Disease 1 0.7955107688903809
variants O 0 0.006711872294545174
I1307K O 0 0.08375650644302368
and O 0 0.00172825634945184
E1317Q O 0 0.24194872379302979
are O 0 0.0010580073576420546
associated O 0 0.004291951656341553
with O 1 0.6688489317893982
colorectal B-Disease 1 1.0
tumors I-Disease 1 0.9999998807907104
, O 0 0.01644292287528515
but O 0 0.0008081845007836819
not O 0 0.0005616077105514705
always O 0 0.0009133765706792474
with O 0 0.0007352451793849468
a O 0 0.001425267430022359
family O 0 0.002850856864824891
history O 0 0.0062751248478889465
. O 0 0.00744381221011281

Classical O 1 0.7519028186798096
familial B-Disease 1 0.9999990463256836
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.999980092048645
FAP B-Disease 1 0.9999996423721313
) O 0 0.026302563026547432
is O 0 0.0020035889465361834
a O 0 0.004335587844252586
high O 1 0.8455168604850769
- O 1 0.9999054670333862
penetrance O 1 0.9999902248382568
autosomal B-Disease 1 0.9999938011169434
dominant I-Disease 1 0.9995030164718628
disease I-Disease 1 0.9999966621398926
that O 0 0.0016701992135494947
predisposes O 1 0.7043996453285217
to O 0 0.000722748227417469
hundreds O 0 0.0008859930676408112
or O 0 0.0008043372654356062
thousands O 0 0.0016952098812907934
of O 0 0.48890817165374756
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9918796420097351
carcinoma I-Disease 1 1.0
and O 0 0.0026462385430932045
that O 0 0.0007220872212201357
results O 0 0.0008654661942273378
from O 0 0.0009501902386546135
truncating O 0 0.027579665184020996
mutations O 0 0.0020805159583687782
in O 0 0.0011966468300670385
the O 0 0.0028509218245744705
APC B-Disease 1 0.8537113070487976
gene O 0 0.008626976050436497
. O 0 0.0067085325717926025

A O 0 0.011855159886181355
variant O 0 0.08208612352609634
of O 0 0.046417661011219025
FAP B-Disease 1 0.9999995231628418
is O 1 0.9872819781303406
attenuated B-Disease 1 0.9999988079071045
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999988079071045
, O 0 0.00311411265283823
which O 0 0.000746862671803683
results O 0 0.00095892243552953
from O 0 0.0010669468902051449
germ O 1 0.9983691573143005
- O 0 0.10650144517421722
line O 0 0.001171796233393252
mutations O 0 0.0007944577955640852
in O 0 0.0004405753861647099
the O 0 0.0005404683179222047
5 O 0 0.0007970188744366169
and O 0 0.0005965098389424384
3 O 0 0.0008711925474926829
regions O 0 0.000937772449105978
of O 0 0.001313165295869112
the O 0 0.003429134376347065
APC B-Disease 1 0.892327070236206
gene O 0 0.007488547824323177
. O 0 0.00660008704289794

Attenuated B-Disease 1 0.9999597072601318
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999998807907104
patients O 1 0.999933123588562
have O 0 0.006883285474032164
" O 0 0.07862092554569244
multiple O 1 0.541444718837738
" O 1 0.9976372718811035
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999998807907104
( O 0 0.12099789828062057
typically O 0 0.0011500704567879438
fewer O 0 0.0007878277683630586
than O 0 0.00047050946159288287
100 O 0 0.00082396250218153
) O 0 0.0007184133864939213
without O 0 0.0007854852010495961
the O 0 0.0015587534289807081
florid O 0 0.10151505470275879
phenotype O 0 0.008172512985765934
of O 0 0.004585458897054195
classical O 0 0.018325433135032654
FAP B-Disease 1 0.9998243451118469
. O 0 0.01428441796451807

Another O 0 0.0072571588680148125
group O 0 0.0035350259859114885
of O 0 0.0031864778138697147
patients O 1 0.8749052286148071
with O 0 0.0029579531401395798
multiple O 0 0.40158984065055847
adenomas B-Disease 1 0.9999721050262451
has O 0 0.004793738480657339
no O 0 0.0009888088097795844
mutations O 0 0.0012120098108425736
in O 0 0.0006304179551079869
the O 0 0.0012150319525972009
APC B-Disease 1 0.9049501419067383
gene O 0 0.0010620492976158857
, O 0 0.0004893558798357844
and O 0 0.00041915831388905644
their O 0 0.0004998839576728642
phenotype O 0 0.0013116479385644197
probably O 0 0.0005879700765945017
results O 0 0.0004909919225610793
from O 0 0.0003588202816899866
variation O 0 0.000709503423422575
at O 0 0.0005205239867791533
a O 0 0.0007527582929469645
locus O 0 0.0028798782732337713
, O 0 0.0006695740157738328
or O 0 0.0006684194086119533
loci O 0 0.0019317017868161201
, O 0 0.0007839245372451842
elsewhere O 0 0.001114827347919345
in O 0 0.001200830447487533
the O 0 0.0025344588793814182
genome O 0 0.00877715926617384
. O 0 0.006642257794737816

Recently O 0 0.008684184402227402
, O 0 0.0030877478420734406
however O 0 0.00178901432082057
, O 0 0.0012162986677139997
a O 0 0.0016972948797047138
missense O 0 0.006754010450094938
variant O 0 0.00620606355369091
of O 0 0.0033768597058951855
APC B-Disease 1 0.9996609687805176
( O 0 0.009238078258931637
I1307K O 0 0.38024425506591797
) O 0 0.0008725275401957333
was O 0 0.0008126468164846301
described O 0 0.0008952223579399288
that O 0 0.00046384811867028475
confers O 0 0.002293436322361231
an O 0 0.0007354564731940627
increased O 0 0.0031603891402482986
risk O 0 0.2990422546863556
of O 1 0.8705640435218811
colorectal B-Disease 1 1.0
tumors I-Disease 1 0.9999998807907104
, O 0 0.011130744591355324
including O 0 0.003497382625937462
multiple O 0 0.20900188386440277
adenomas B-Disease 1 0.99986732006073
, O 0 0.0049315630458295345
in O 0 0.004859831649810076
Ashkenazim O 1 0.7636314630508423
. O 0 0.00998650211840868

We O 0 0.004620840307325125
have O 0 0.0018265435937792063
studied O 0 0.0020266876090317965
a O 0 0.001222435967065394
set O 0 0.001037148991599679
of O 0 0.0012107850052416325
164 O 0 0.3410438001155853
patients O 1 0.5803943872451782
with O 0 0.0029891387093812227
multiple O 1 0.9665864109992981
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9860591292381287
/ I-Disease 1 0.9999210834503174
or I-Disease 0 0.034226879477500916
carcinoma I-Disease 1 0.9999978542327881
and O 0 0.0016977934865280986
analyzed O 0 0.0031738863326609135
codons O 0 0.00611451081931591
1263 O 0 0.10928986221551895
- O 0 0.02273671329021454
1377 O 0 0.3389340341091156
( O 0 0.002765691839158535
exon O 0 0.006068306043744087
15G O 0 0.007536544464528561
) O 0 0.0011258304584771395
of O 0 0.000974828377366066
the O 0 0.001452049589715898
APC B-Disease 0 0.281589150428772
gene O 0 0.0018965796334668994
for O 0 0.0017881460953503847
germ O 1 0.9956762194633484
- O 0 0.3917897939682007
line O 0 0.007168063893914223
variants O 0 0.009066528640687466
. O 0 0.008508807979524136

Three O 0 0.005454308353364468
patients O 0 0.024123333394527435
with O 0 0.0016715163365006447
the O 0 0.0025545668322592974
I1307K O 1 0.7052813768386841
allele O 0 0.0032781772315502167
were O 0 0.0010665119625627995
detected O 0 0.0015860762214288116
, O 0 0.0008960739360190928
each O 0 0.0010726357577368617
of O 0 0.0021922853775322437
Ashkenazi O 0 0.13307450711727142
descent O 0 0.021393930539488792
. O 0 0.01081464160233736

Four O 0 0.006239745765924454
patients O 0 0.07581573724746704
had O 0 0.0030644552316516638
a O 0 0.004757761489599943
germ O 1 0.9996163845062256
- O 1 0.7775747776031494
line O 0 0.00845012441277504
E1317Q O 0 0.38479045033454895
missense O 0 0.07033522427082062
variant O 0 0.00560319097712636
of O 0 0.0013299360871315002
APC O 1 0.8961806893348694
that O 0 0.0005216191639192402
was O 0 0.0007192789926193655
not O 0 0.000281967397313565
present O 0 0.0003596013702917844
in O 0 0.00029145757434889674
controls O 0 0.0005747809773311019
; O 0 0.0002917954116128385
one O 0 0.000247887393925339
of O 0 0.00029166077729314566
these O 0 0.00022841017926111817
individuals O 0 0.00028405041666701436
had O 0 0.00047838775208219886
an O 0 0.0004334560362622142
unusually O 0 0.001404911163263023
large O 0 0.0006222399533726275
number O 0 0.0006573726423084736
of O 0 0.0013466790551319718
metaplastic B-Disease 1 0.9573774337768555
polyps I-Disease 1 0.8378212451934814
of I-Disease 0 0.0037464152555912733
the I-Disease 0 0.012048499658703804
colorectum I-Disease 1 0.9896730184555054
. O 0 0.00987387727946043

There O 0 0.00477202795445919
is O 0 0.0021326697897166014
increasing O 0 0.0016417930601164699
evidence O 0 0.0011396505869925022
that O 0 0.0006131284753791988
there O 0 0.0005820899968966842
exist O 0 0.0008904820424504578
germ O 1 0.745395302772522
- O 0 0.009092492051422596
line O 0 0.0010188969317823648
variants O 0 0.0008691736729815602
of O 0 0.0005967015167698264
the O 0 0.001305680605582893
APC B-Disease 1 0.8076854348182678
gene O 0 0.0008614741964265704
that O 0 0.0004059628990944475
predispose O 0 0.0012448704801499844
to O 0 0.00040650973096489906
the O 0 0.000479839596664533
development O 0 0.0009325062274001539
of O 0 0.007183333858847618
multiple O 1 0.9990177154541016
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9980314373970032
carcinoma I-Disease 1 1.0
, O 0 0.011709397658705711
but O 0 0.000568247283808887
without O 0 0.0005486204172484577
the O 0 0.0008789543062448502
florid O 1 0.6974419951438904
phenotype O 0 0.002976874588057399
of O 0 0.0009693427127785981
classical O 0 0.00526268407702446
FAP B-Disease 1 0.9998743534088135
, O 0 0.0010144129628315568
and O 0 0.0005210915696807206
possibly O 0 0.0008054364006966352
with O 0 0.0006084634806029499
importance O 0 0.03484279662370682
for O 1 0.7461607456207275
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9847057461738586
in O 0 0.0026552758645266294
the O 0 0.0035215821117162704
general O 0 0.013155348598957062
population O 0 0.0028245190624147654
. O 0 0.0026838532648980618
. O 0 0.006030434276908636

Genomic O 0 0.01655258610844612
structure O 0 0.007145541720092297
of O 0 0.005217313300818205
the O 0 0.35640886425971985
human O 1 0.9999171495437622
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999992847442627
CLD B-Disease 1 1.0
) O 1 0.5092253088951111
gene O 0 0.015095154754817486
. O 0 0.008631967939436436

Congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999998807907104
diarrhea I-Disease 1 1.0
( O 1 0.9999985694885254
CLD B-Disease 1 1.0
) O 1 0.5251495242118835
is O 0 0.00288383848965168
caused O 0 0.01874513365328312
by O 0 0.0008255051798187196
mutations O 0 0.001342501025646925
in O 0 0.0006732591427862644
a O 0 0.0012274067848920822
gene O 0 0.001573850866407156
which O 0 0.0010258849943056703
encodes O 0 0.004454172216355801
an O 0 0.004023525398224592
intestinal O 1 0.9999912977218628
anion O 1 0.9997760653495789
transporter O 1 0.9779024124145508
. O 0 0.012772426940500736

We O 0 0.0044307103380560875
report O 0 0.00330518395639956
here O 0 0.0016476825112476945
the O 0 0.0011504036374390125
complete O 0 0.0016677695093676448
genomic O 0 0.002544969320297241
organization O 0 0.001291234279051423
of O 0 0.0008894814527593553
the O 0 0.0012271249433979392
human O 0 0.008471453562378883
CLD B-Disease 1 0.9998531341552734
gene O 0 0.0018195782322436571
which O 0 0.000782115152105689
spans O 0 0.0021788938902318478
approximately O 0 0.0015747155994176865
39kb O 0 0.006973612122237682
, O 0 0.0013077304465696216
and O 0 0.00150311179459095
comprises O 0 0.005004579667001963
21 O 0 0.007203319575637579
exons O 0 0.017722902819514275
. O 0 0.009619886055588722

All O 0 0.009327215142548084
exon O 0 0.0878617987036705
/ O 0 0.045130081474781036
intron O 0 0.035885877907276154
boundaries O 0 0.003528955625370145
conform O 0 0.004473838955163956
to O 0 0.002017807215452194
the O 0 0.004419316072016954
GT O 1 0.9315635561943054
/ O 1 0.7892125248908997
AG O 1 0.8961661458015442
rule O 0 0.014908449724316597
. O 0 0.01078854501247406

An O 0 0.004615181125700474
analysis O 0 0.003216712037101388
of O 0 0.0019316788529977202
the O 0 0.002355777658522129
putative O 0 0.13675665855407715
promoter O 0 0.17754490673542023
region O 0 0.0019550230354070663
sequence O 0 0.0014015461783856153
shows O 0 0.00118302833288908
a O 0 0.0017066914588212967
putative O 0 0.1262993961572647
TATA O 1 0.9609304070472717
box O 0 0.004318729974329472
and O 0 0.0013371506938710809
predicts O 0 0.004814536776393652
multiple O 0 0.001960007008165121
transcription O 0 0.004117458127439022
factor O 0 0.003484837943688035
binding O 0 0.0031811888329684734
sites O 0 0.004255801439285278
. O 0 0.006934689357876778

The O 0 0.007549973204731941
genomic O 0 0.009575895965099335
structure O 0 0.004220371134579182
was O 0 0.002686832332983613
determined O 0 0.0016195200150832534
using O 0 0.0007678066031076014
DNA O 0 0.0007739475113339722
from O 0 0.00041893619345501065
several O 0 0.0002815950138028711
sources O 0 0.00038893960299901664
including O 0 0.00037807176704518497
multiple O 0 0.0006547608645632863
large O 0 0.0010703002335503697
- O 0 0.17926296591758728
insert O 0 0.11749894171953201
libaries O 0 0.02890842966735363
and O 0 0.0007970918086357415
genomic O 0 0.002235221676528454
DNA O 0 0.0017745677614584565
from O 0 0.0016897282330319285
Finnish O 1 0.923744797706604
CLD B-Disease 1 0.999992847442627
patients O 1 0.9441661834716797
and O 0 0.00475655822083354
controls O 0 0.011856857687234879
. O 0 0.009132119826972485

Exon O 1 0.7139403223991394
- O 0 0.030434709042310715
specific O 0 0.0025117730256170034
primers O 0 0.0076388223096728325
developed O 0 0.002061143284663558
in O 0 0.0008162163430824876
this O 0 0.000585183675866574
study O 0 0.000859136285725981
will O 0 0.0005771929281763732
facilitate O 0 0.001172696240246296
mutation O 0 0.0013077198527753353
screening O 0 0.0013450050028041005
studies O 0 0.001152476412244141
of O 0 0.0013954032910987735
patients O 1 0.5300890207290649
with O 0 0.003168038558214903
the O 1 0.6142675876617432
disease O 1 0.9999959468841553
. O 0 0.030294615775346756

Genomic O 0 0.016982879489660263
sequencing O 0 0.008568495512008667
of O 0 0.0040116687305271626
a O 0 0.007680534850805998
BAC O 1 0.9999198913574219
clone O 1 0.992921769618988
H O 1 0.9767122864723206
_ O 0 0.0017393029993399978
RG364P16 O 0 0.00861278735101223
revealed O 0 0.0018498755525797606
the O 0 0.000724266457837075
presence O 0 0.000795724627096206
of O 0 0.0006271423771977425
another O 0 0.0008937419042922556
, O 0 0.0006549275130964816
highly O 0 0.0010839634342119098
homologous O 0 0.0016250218031927943
gene O 0 0.0009409599588252604
3 O 0 0.0007986329146660864
of O 0 0.00071559107163921
the O 0 0.0015028298366814852
CLD B-Disease 1 0.9995539784431458
gene O 0 0.0012220259523019195
, O 0 0.0005833902396261692
with O 0 0.0004044426023028791
a O 0 0.0006422498263418674
similar O 0 0.0006185285747051239
genomic O 0 0.0014487181324511766
structure O 0 0.0009419503039680421
, O 0 0.0005427299765869975
recently O 0 0.0008880384266376495
identified O 0 0.0009400877170264721
as O 0 0.0009509586961939931
the O 0 0.007453316822648048
Pendred B-Disease 1 0.9999984502792358
syndrome I-Disease 1 1.0
gene O 1 0.94553542137146
( O 0 0.3997567296028137
PDS B-Disease 1 0.9997645020484924
) O 0 0.003393967403098941
. O 0 0.0029421073850244284
. O 0 0.006120631471276283

The O 0 0.01501902099698782
APCI1307K O 1 0.9975718855857849
allele O 0 0.32675814628601074
and O 0 0.007667252793908119
cancer B-Disease 1 0.9990614056587219
risk O 0 0.06368877738714218
in O 0 0.0011963419383391738
a O 0 0.0017073617782443762
community O 0 0.0016093142330646515
- O 0 0.004302469082176685
based O 0 0.001263533951714635
study O 0 0.0018080505542457104
of O 0 0.002583408262580633
Ashkenazi O 0 0.1570243388414383
Jews O 0 0.009507597424089909
. O 0 0.009145022369921207

Mutations O 0 0.011292465031147003
in O 0 0.004015362821519375
APC O 1 0.7547348737716675
are O 0 0.001779984449967742
classically O 0 0.3031075894832611
associated O 0 0.0031259183306246996
with O 0 0.04021263122558594
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999902248382568
FAP B-Disease 1 0.9999998807907104
) O 0 0.009133970364928246
, O 0 0.0015451550716534257
a O 0 0.003729499876499176
highly O 1 0.8721223473548889
penetrant O 1 0.9999986886978149
autosomal B-Disease 1 0.9999994039535522
dominant I-Disease 1 0.9999880790710449
disorder I-Disease 1 1.0
characterized O 1 0.9999934434890747
by O 1 0.9697434902191162
multiple O 1 0.9999685287475586
intestinal O 1 1.0
polyps B-Disease 1 0.9999998807907104
and O 0 0.2508220970630646
, O 0 0.007998941466212273
without O 0 0.0014016620116308331
surgical O 1 0.9991040825843811
intervention O 0 0.22445297241210938
, O 0 0.0008933484787121415
the O 0 0.0010113944299519062
development O 0 0.013067574240267277
of O 1 0.983290433883667
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9992384910583496
CRC B-Disease 1 0.9999806880950928
) O 0 0.009523173794150352
. O 0 0.007674984633922577

APC B-Disease 1 0.8034992814064026
is O 0 0.007125684060156345
a O 0 0.22042207419872284
tumour O 1 0.9999996423721313
- O 1 0.999622106552124
suppressor O 1 0.9923822283744812
gene O 0 0.0027780714444816113
, O 0 0.0011844851542264223
and O 0 0.001318368362262845
somatic O 0 0.0793854370713234
loss O 0 0.09292159974575043
occurs O 0 0.004129006993025541
in O 0 0.004756488837301731
tumours B-Disease 1 0.9994083642959595
. O 0 0.01085930597037077

The O 0 0.01199414860457182
germline O 1 0.9582562446594238
T O 1 0.9131668210029602
- O 0 0.013987064361572266
to O 0 0.00141719460953027
- O 0 0.005029601976275444
A O 0 0.0017968323081731796
transversion O 0 0.015316945500671864
responsible O 0 0.0013964243698865175
for O 0 0.00081397604662925
the O 0 0.0013418778544291854
APC O 1 0.650426983833313
I1307K O 0 0.016756366938352585
allele O 0 0.001941398368217051
converts O 0 0.0012034137034788728
the O 0 0.0007027886458672583
wild O 0 0.0012920646695420146
- O 0 0.0014733766438439488
type O 0 0.000819959444925189
sequence O 0 0.0006358657265082002
to O 0 0.00043382536387071013
a O 0 0.0011019448284059763
homopolymer O 1 0.9342558979988098
tract O 1 0.9991583824157715
( O 0 0.1411648839712143
A8 O 1 0.9991946816444397
) O 0 0.0009129115496762097
that O 0 0.0005007626605220139
is O 0 0.000833174679428339
genetically O 0 0.0021718968637287617
unstable O 0 0.06591818481683731
and O 0 0.0015950766392052174
prone O 0 0.19367505609989166
to O 0 0.0027653013821691275
somatic O 0 0.08610416948795319
mutation O 0 0.012141437269747257
. O 0 0.008121585473418236

The O 0 0.01219409890472889
I1307K O 0 0.16791297495365143
allele O 0 0.010814321227371693
was O 0 0.004059657454490662
found O 0 0.003056094516068697
in O 0 0.003316543297842145
6 O 0 0.007585844490677118
. O 0 0.00737677700817585

1 O 0 0.009089442901313305
% O 0 0.0044867657124996185
of O 0 0.0032339857425540686
unselected O 1 0.6884862184524536
Ashkenazi O 0 0.299485445022583
Jews O 0 0.0034709726460278034
and O 0 0.0012232542503625154
higher O 0 0.0015847552567720413
proportions O 0 0.0033678063191473484
of O 0 0.001510229310952127
Ashkenazim O 1 0.6285600662231445
with O 0 0.001060850452631712
family O 0 0.0015310876769945025
or O 0 0.000900402432307601
personal O 0 0.0018549035303294659
histories O 0 0.00717500364407897
of O 0 0.02045808918774128
CRC B-Disease 1 0.9999607801437378
( O 0 0.014402876608073711
ref O 0 0.052481748163700104
. O 0 0.0017334513831883669
2 O 0 0.0031322978902608156
) O 0 0.0036437080707401037
. O 0 0.005149621982127428

To O 0 0.004434693139046431
evaluate O 0 0.004436287563294172
the O 0 0.001671523554250598
role O 0 0.002043089596554637
of O 0 0.001966394716873765
I1307K O 1 0.8967985510826111
in O 0 0.0032142421696335077
cancer B-Disease 1 0.996126115322113
, O 0 0.0011832875898107886
we O 0 0.0010295095853507519
genotyped O 0 0.008000049740076065
5 O 0 0.0016280851559713483
, O 0 0.0014019160298630595
081 O 0 0.17702125012874603
Ashkenazi O 0 0.007581380661576986
volunteers O 0 0.002513386309146881
in O 0 0.0012468843488022685
a O 0 0.002057128818705678
community O 0 0.0032086751889437437
survey O 0 0.006797489710152149
. O 0 0.007454551290720701

Risk O 0 0.05856962129473686
of O 0 0.04941157251596451
developing O 1 0.9992961883544922
colorectal B-Disease 1 1.0
, I-Disease 1 0.9642288684844971
breast I-Disease 1 0.9999951124191284
and I-Disease 0 0.005434059072285891
other I-Disease 0 0.00112794095184654
cancers I-Disease 1 0.9718305468559265
were O 0 0.0008836972992867231
compared O 0 0.0012453580275177956
between O 0 0.0009960491443052888
genotyped O 1 0.6797049641609192
I1307K O 0 0.4141578674316406
carriers O 0 0.002333808923140168
and O 0 0.0008764922386035323
non O 0 0.002897916128858924
- O 0 0.023756207898259163
carriers O 0 0.0013723542215302587
and O 0 0.0005684504867531359
their O 0 0.000600973260588944
first O 0 0.0014297086745500565
- O 0 0.0058165062218904495
degree O 0 0.004966421518474817
relatives O 0 0.008077801205217838
. O 0 0.007474932353943586

Sperm O 0 0.013623462058603764
DNA O 0 0.006810368970036507
analysis O 0 0.003371234517544508
in O 0 0.0026130243204534054
a O 0 0.005626707803457975
Friedreich B-Disease 1 0.9999274015426636
ataxia I-Disease 1 0.9999955892562866
premutation O 1 0.9997742772102356
carrier O 1 0.8480812907218933
suggests O 0 0.006135733798146248
both O 0 0.0022253256756812334
meiotic O 1 0.9780510663986206
and O 0 0.0025895650032907724
mitotic O 0 0.2662564218044281
expansion O 0 0.004033236298710108
in O 0 0.0022631650790572166
the O 0 0.004891043994575739
FRDA B-Disease 1 0.9890210032463074
gene O 0 0.0112726129591465
. O 0 0.008764407597482204

Friedreich B-Disease 1 0.9999923706054688
ataxia I-Disease 1 0.9999940395355225
is O 0 0.05891546607017517
usually O 0 0.003437533276155591
caused O 0 0.014949008822441101
by O 0 0.001147924573160708
an O 0 0.0010792871471494436
expansion O 0 0.0017608635826036334
of O 0 0.0012519611045718193
a O 0 0.0023232786916196346
GAA O 0 0.0873362123966217
trinucleotide O 1 0.8273055553436279
repeat O 0 0.0035677736159414053
in O 0 0.0013265792513266206
intron O 0 0.1813645213842392
1 O 0 0.0018539291340857744
of O 0 0.0016178132500499487
the O 0 0.0031987077090889215
FRDA B-Disease 1 0.9721704721450806
gene O 0 0.008515017107129097
. O 0 0.006799865514039993

Occasionally O 0 0.007743488531559706
, O 0 0.002594303572550416
a O 0 0.002077872399240732
fully O 0 0.0023585460148751736
expanded O 0 0.002083821455016732
allele O 0 0.0018708702409639955
has O 0 0.0006570744444616139
been O 0 0.0005913205095566809
found O 0 0.0005171408411115408
to O 0 0.00043490028474479914
arise O 0 0.0007578564691357315
from O 0 0.0005723867216147482
a O 0 0.0009064222685992718
premutation O 0 0.0042595150880515575
of O 0 0.001089114579372108
100 O 0 0.0017142570577561855
or O 0 0.0017559410771355033
less O 0 0.002945889485999942
triplet O 0 0.024398552253842354
repeats O 0 0.015066484920680523
. O 0 0.007945448160171509

We O 0 0.0052111526019871235
have O 0 0.0024648504331707954
examined O 0 0.004257056396454573
the O 0 0.0021505069453269243
sperm O 0 0.0034480548929423094
DNA O 0 0.0028825632762163877
of O 0 0.002259110799059272
a O 0 0.0053883204236626625
premutation O 1 0.7287229299545288
carrier O 0 0.04861440137028694
. O 0 0.010247643105685711

This O 0 0.006253622006624937
mans O 0 0.02266225405037403
leucocyte O 0 0.09821309894323349
DNA O 0 0.004108482971787453
showed O 0 0.0029967285227030516
one O 0 0.0012609113473445177
normal O 0 0.001671941252425313
allele O 0 0.002030280651524663
and O 0 0.0008849932928569615
one O 0 0.001118508051149547
allele O 0 0.0022357511334121227
of O 0 0.0013978480128571391
approximately O 0 0.0026447500567883253
100 O 0 0.004433264024555683
repeats O 0 0.011233962140977383
. O 0 0.008256930857896805

His O 0 0.009220493026077747
sperm O 0 0.006564706098288298
showed O 0 0.003245781408622861
an O 0 0.0015020451974123716
expanded O 0 0.002042342210188508
allele O 0 0.001977241598069668
in O 0 0.000784947129432112
a O 0 0.0010160907404497266
tight O 0 0.0017303734784945846
range O 0 0.0012091725366190076
centering O 0 0.00218208902515471
on O 0 0.000896854733582586
a O 0 0.0010851894039660692
size O 0 0.0012003262527287006
of O 0 0.0013371423119679093
approximately O 0 0.0031576710753142834
320 O 0 0.014019330963492393
trinucleotide O 1 0.8540394902229309
repeats O 0 0.017365626990795135
. O 0 0.009317703545093536

His O 0 0.016538364812731743
affected O 0 0.015321568585932255
son O 0 0.24305491149425507
has O 0 0.0032796503510326147
repeat O 0 0.0069684432819485664
sizes O 0 0.003944953437894583
of O 0 0.0039125182665884495
1040 O 0 0.45587649941444397
and O 0 0.00561167486011982
540 O 0 0.02635902352631092
. O 0 0.010612987913191319

These O 0 0.0037816038820892572
data O 0 0.0026666398625820875
suggest O 0 0.0021501765586435795
that O 0 0.000858545012306422
expansion O 0 0.0013432479463517666
occurs O 0 0.0008227445650845766
in O 0 0.000488562451209873
two O 0 0.00046603885130025446
stages O 0 0.0010776256676763296
, O 0 0.0005328778643161058
the O 0 0.0005239337333478034
first O 0 0.0007056570611894131
during O 0 0.0010141631355509162
meiosis O 0 0.0028164726682007313
followed O 0 0.0009362721466459334
by O 0 0.0006746587459929287
a O 0 0.0013784870970994234
second O 0 0.0038043970707803965
mitotic O 0 0.40755847096443176
expansion O 0 0.010868417099118233
. O 0 0.008545966818928719

We O 0 0.003907528705894947
also O 0 0.002241874113678932
show O 0 0.001764846732839942
that O 0 0.0007251338684000075
in O 0 0.0006618283223360777
all O 0 0.000636652170214802
informative O 0 0.0020804626401513815
carrier O 0 0.0031139617785811424
father O 0 0.0018543385667726398
to O 0 0.0008418678189627826
affected O 0 0.0016679816180840135
child O 0 0.004236702341586351
transmissions O 0 0.0012593450956046581
, O 0 0.0005107513279654086
with O 0 0.00037732880446128547
the O 0 0.0005225210334174335
notable O 0 0.0007353271939791739
exception O 0 0.0008564137388020754
of O 0 0.0007239007391035557
the O 0 0.002061736537143588
premutation O 1 0.9746418595314026
carrier O 0 0.021285612136125565
, O 0 0.0009100161259993911
the O 0 0.0011017380747944117
expansion O 0 0.0022694061044603586
size O 0 0.0022934088483452797
decreases O 0 0.004513562191277742
. O 0 0.002774595282971859
. O 0 0.006203746423125267

The O 0 0.008908852934837341
R496H O 0 0.08061345666646957
mutation O 0 0.006716856267303228
of O 0 0.0038203310687094927
arylsulfatase O 1 0.9840410947799683
A O 0 0.025438960641622543
does O 0 0.0025637117214500904
not O 0 0.002629573456943035
cause O 0 0.3941219747066498
metachromatic B-Disease 1 0.999733030796051
leukodystrophy I-Disease 1 0.9999727010726929
. O 0 0.017843356356024742

Deficiency B-Disease 1 0.9998750686645508
of I-Disease 0 0.0195280984044075
arylsulfatase I-Disease 1 0.998134434223175
A I-Disease 1 0.8423516154289246
( O 1 0.8171765804290771
ARSA O 1 0.9999696016311646
) O 0 0.004198914859443903
enzyme O 0 0.005809019319713116
activity O 0 0.0038114995695650578
causes O 1 0.5652592778205872
metachromatic B-Disease 1 0.999956488609314
leukodystrophy I-Disease 1 0.9999994039535522
( O 1 0.9111008048057556
MLD B-Disease 1 0.9999862909317017
) O 0 0.009002168662846088
. O 0 0.008013683371245861

A O 0 0.007880284450948238
number O 0 0.00386603269726038
of O 0 0.00483849598094821
ARSA O 1 0.9999209642410278
gene O 0 0.005972109269350767
mutations O 0 0.003710198914632201
responsible O 0 0.0031972485594451427
for O 0 0.003071229439228773
MLD B-Disease 1 0.9999533891677856
have O 0 0.0020656108390539885
been O 0 0.002971791196614504
identified O 0 0.0064757345244288445
. O 0 0.00734024727717042

Recently O 0 0.01017565093934536
, O 0 0.0035387820098549128
the O 0 0.00292842835187912
R496H O 0 0.10983875393867493
mutation O 0 0.004090860486030579
of O 0 0.002579453634098172
ARSA O 1 0.9991089701652527
was O 0 0.0023765787482261658
proposed O 0 0.0013037476455792785
to O 0 0.0005294731818139553
be O 0 0.0004721562727354467
a O 0 0.0007257439428940415
cause O 0 0.0015459484420716763
of O 0 0.003165900707244873
MLD B-Disease 1 0.999997615814209
( O 0 0.04536835849285126
Draghia O 1 0.8678032755851746
et O 0 0.01889251172542572
al O 0 0.0035225495230406523
. O 0 0.000973415793851018
, O 0 0.0015486578922718763
1997 O 0 0.003859188873320818
) O 0 0.004014219157397747
. O 0 0.006679413374513388

We O 0 0.0041655912064015865
have O 0 0.0018351244507357478
investigated O 0 0.0030973830725997686
the O 0 0.0018954564584419131
R496H O 0 0.4102360010147095
mutation O 0 0.002755100606009364
and O 0 0.0006239294889383018
found O 0 0.0006006977637298405
this O 0 0.00042606645729392767
mutation O 0 0.0007387251826003194
at O 0 0.0005091752391308546
a O 0 0.0005148002528585494
relatively O 0 0.0005330019630491734
high O 0 0.0006240211077965796
frequency O 0 0.00048418654478155077
in O 0 0.00031035474967211485
an O 0 0.0003519061428960413
African O 0 0.0006510590901598334
American O 0 0.0006273946492001414
population O 0 0.0005701688933186233
( O 0 0.0008490304462611675
f O 0 0.0015699800569564104
= O 0 0.0014761651400476694
0 O 0 0.0008845451520755887
. O 0 0.0005925280856899917
09 O 0 0.002634504111483693
, O 0 0.0009645650861784816
n O 0 0.0024760053493082523
= O 0 0.0037726829759776592
61 O 0 0.003367785830050707
subjects O 0 0.0036815996281802654
) O 0 0.004397913813591003
. O 0 0.006234325002878904

The O 0 0.01619774103164673
ARSA O 1 0.9987857937812805
enzyme O 0 0.008295532315969467
activity O 0 0.0025381247978657484
in O 0 0.0009742600377649069
subjects O 0 0.0012640028726309538
with O 0 0.0005621101008728147
and O 0 0.0005241210456006229
without O 0 0.0006016059196554124
the O 0 0.001048036850988865
R496H O 1 0.5792667865753174
mutation O 0 0.002065372886136174
was O 0 0.001214680029079318
determined O 0 0.0010241331765428185
and O 0 0.0006102630286477506
found O 0 0.0008835613843984902
to O 0 0.0009532528929412365
be O 0 0.0013809541705995798
normal O 0 0.004221335053443909
. O 0 0.006493429187685251

It O 0 0.004620853811502457
is O 0 0.0026149111799895763
therefore O 0 0.001924340846017003
concluded O 0 0.0019804404582828283
that O 0 0.000816705753095448
the O 0 0.0011929776519536972
R496H O 0 0.08485318720340729
mutation O 0 0.0032282331958413124
of O 0 0.0020147801842540503
ARSA O 1 0.9996157884597778
does O 0 0.0010501469951123
not O 0 0.0006038480205461383
negatively O 0 0.0009946100180968642
influence O 0 0.0007556719938293099
the O 0 0.0006084722117520869
activity O 0 0.0009714303305372596
of O 0 0.0014506535371765494
ARSA O 1 0.9986920952796936
and O 0 0.0012503095204010606
is O 0 0.0011383118107914925
not O 0 0.001027685939334333
a O 0 0.002543877810239792
cause O 0 0.023159295320510864
of O 0 0.11844965815544128
MLD B-Disease 1 0.9999773502349854

Down O 0 0.014377962797880173
- O 0 0.010199403390288353
regulation O 0 0.004829247482120991
of O 0 0.004055360797792673
transmembrane O 1 0.9893340468406677
carbonic O 1 0.9998910427093506
anhydrases O 1 0.9996740818023682
in O 1 0.5309517979621887
renal B-Disease 1 1.0
cell I-Disease 1 0.9999350309371948
carcinoma I-Disease 1 1.0
cell O 0 0.33753249049186707
lines O 0 0.0021495181135833263
by O 0 0.0009735020576044917
wild O 0 0.00492630060762167
- O 1 0.6247460842132568
type O 0 0.3081435561180115
von B-Disease 1 0.9860296845436096
Hippel I-Disease 1 0.9999016523361206
- I-Disease 1 0.9946358799934387
Lindau I-Disease 1 0.99933260679245
transgenes O 1 0.8578351736068726
. O 0 0.012931082397699356

To O 0 0.005555009003728628
discover O 0 0.006251506507396698
genes O 0 0.002391091315075755
involved O 0 0.001812743372283876
in O 0 0.0017476292559877038
von B-Disease 1 0.8283178806304932
Hippel I-Disease 1 0.9999170303344727
- I-Disease 1 0.9986097812652588
Lindau I-Disease 1 0.9999711513519287
( O 0 0.13289518654346466
VHL B-Disease 1 0.9995761513710022
) O 0 0.002768665784969926
- O 0 0.03552692010998726
mediated O 0 0.025569895282387733
carcinogenesis O 1 0.937884509563446
, O 0 0.001184928696602583
we O 0 0.0011949416948482394
used O 0 0.002842097310349345
renal B-Disease 1 0.9999997615814209
cell I-Disease 1 0.9979362487792969
carcinoma I-Disease 1 1.0
cell O 0 0.3484511971473694
lines O 0 0.00503603694960475
stably O 0 0.4387192130088806
transfected O 0 0.26272302865982056
with O 0 0.0014376712497323751
wild O 0 0.006935300771147013
- O 1 0.8677011728286743
type O 1 0.8381658792495728
VHL O 1 0.9998867511749268
- O 1 0.7260750532150269
expressing O 0 0.07792916148900986
transgenes O 1 0.5672649145126343
. O 0 0.013217272236943245

Large O 0 0.00987268891185522
- O 0 0.0427086241543293
scale O 0 0.005885458085685968
RNA O 0 0.0048644463531672955
differential O 0 0.003787489840760827
display O 0 0.002287467010319233
technology O 0 0.0014449201989918947
applied O 0 0.0010249558836221695
to O 0 0.0005531390779651701
these O 0 0.0005045109428465366
cell O 0 0.0009575155563652515
lines O 0 0.0008037106017582119
identified O 0 0.0007565453415736556
several O 0 0.0005514511722140014
differentially O 0 0.0024754118639975786
expressed O 0 0.0013507226249203086
genes O 0 0.0009742758702486753
, O 0 0.0007813940173946321
including O 0 0.0009649303974583745
an O 0 0.001683936920017004
alpha O 0 0.04901289939880371
carbonic O 1 0.9790467023849487
anhydrase O 1 0.9872899651527405
gene O 0 0.005531656555831432
, O 0 0.004358893726021051
termed O 0 0.021163824945688248
CA12 O 1 0.8824225664138794
. O 0 0.013647100888192654

The O 0 0.006656752433627844
deduced O 0 0.008289732038974762
protein O 0 0.0030656717717647552
sequence O 0 0.001960678491741419
was O 0 0.001313397311605513
classified O 0 0.0013380780583247542
as O 0 0.0006954623968340456
a O 0 0.0007722582085989416
one O 0 0.0007791916141286492
- O 0 0.004960046615451574
pass O 0 0.0016038470203056931
transmembrane O 0 0.01687372289597988
CA O 0 0.002340202685445547
possessing O 0 0.0017841323278844357
an O 0 0.0010804412886500359
apparently O 0 0.0017783947987481952
intact O 0 0.0022817282006144524
catalytic O 0 0.002075111959129572
domain O 0 0.0014993164222687483
in O 0 0.0011540398700162768
the O 0 0.0020992616191506386
extracellular O 0 0.008248798549175262
CA O 0 0.011103369295597076
module O 0 0.019879065454006195
. O 0 0.009115459397435188

Reintroduced O 0 0.04524219408631325
wild O 0 0.04204479232430458
- O 1 0.9473487138748169
type O 1 0.7319756746292114
VHL B-Disease 1 0.9993608593940735
strongly O 0 0.00477136205881834
inhibited O 0 0.006199332419782877
the O 0 0.00153465720359236
overexpression O 0 0.004731643944978714
of O 0 0.0014735120348632336
the O 0 0.0021435674279928207
CA12 O 1 0.9666465520858765
gene O 0 0.0016881282208487391
in O 0 0.0010302759474143386
the O 0 0.003902622265741229
parental O 1 0.9937917590141296
renal B-Disease 1 1.0
cell I-Disease 1 0.9999632835388184
carcinoma I-Disease 1 1.0
cell O 1 0.9645929932594299
lines O 0 0.01848708838224411
. O 0 0.010028177872300148

Similar O 0 0.005095520988106728
results O 0 0.0027283707167953253
were O 0 0.0013938399497419596
obtained O 0 0.001741238054819405
with O 0 0.0014185827458277345
CA9 O 1 0.9718087911605835
, O 0 0.0014664639020338655
encoding O 0 0.0022097211331129074
another O 0 0.001708503346890211
transmembrane O 0 0.007773717865347862
CA O 0 0.002540657529607415
with O 0 0.0010542662348598242
an O 0 0.0016903831856325269
intact O 0 0.006006710231304169
catalytic O 0 0.008125131018459797
domain O 0 0.007184918038547039
. O 0 0.0073473043739795685

Although O 0 0.005620207171887159
both O 0 0.0025292939972132444
domains O 0 0.0033461113926023245
of O 0 0.001911638188175857
the O 0 0.0036780647933483124
VHL B-Disease 1 0.999433696269989
protein O 0 0.001994333928450942
contribute O 0 0.001353263738565147
to O 0 0.0006127505330368876
regulation O 0 0.0012151169357821345
of O 0 0.0011597704142332077
CA12 O 0 0.2013610303401947
expression O 0 0.0015855709789320827
, O 0 0.0010424297070130706
the O 0 0.001133029698394239
elongin O 0 0.007313754875212908
binding O 0 0.001568528008647263
domain O 0 0.001924537937156856
alone O 0 0.0021066584158688784
could O 0 0.0017662015743553638
effectively O 0 0.004541174974292517
regulate O 0 0.008365916088223457
CA9 O 1 0.9441127777099609
expression O 0 0.011875945143401623
. O 0 0.01021656859666109

We O 0 0.007439064793288708
mapped O 0 0.015509989112615585
CA12 O 1 0.5756630301475525
and O 0 0.004787945654243231
CA9 O 1 0.9856243133544922
loci O 0 0.00948213879019022
to O 0 0.002681792713701725
chromosome O 0 0.0066531868651509285
bands O 0 0.005385147873312235
15q22 O 0 0.021746614947915077
and O 0 0.0067055304534733295
17q21 O 0 0.08996018022298813
. O 0 0.01298578456044197

2 O 0 0.008340154774487019
respectively O 0 0.0042060986161231995
, O 0 0.0020987531170248985
regions O 0 0.0021639810875058174
prone O 0 0.03590543195605278
to O 0 0.0012346208095550537
amplification O 0 0.004043850116431713
in O 0 0.0013335084076970816
some O 0 0.0018023819429799914
human O 0 0.00738229975104332
cancers B-Disease 1 0.9743616580963135
. O 0 0.009905018843710423

Additional O 0 0.006295566912740469
experiments O 0 0.003530866000801325
are O 0 0.0012297244975343347
needed O 0 0.001397335552610457
to O 0 0.000691803521476686
define O 0 0.00118060817476362
the O 0 0.0008471483597531915
role O 0 0.001330715254880488
of O 0 0.0015973784029483795
CA O 0 0.3432134985923767
IX O 1 0.9974610805511475
and O 0 0.0017531701596453786
CA O 0 0.024375582113862038
XII O 1 0.874669075012207
enzymes O 0 0.001185895875096321
in O 0 0.0006110332906246185
the O 0 0.0006540404865518212
regulation O 0 0.0009130985708907247
of O 0 0.0007835429278202355
pH O 0 0.0034818470012396574
in O 0 0.0006760309333913028
the O 0 0.000830922625027597
extracellular O 0 0.002657646080479026
microenvironment O 0 0.006082864478230476
and O 0 0.0007115462212823331
its O 0 0.0007320277509279549
potential O 0 0.0011866455897688866
impact O 0 0.002058599842712283
on O 0 0.0025110847782343626
cancer B-Disease 1 0.9997401833534241
cell O 0 0.16238470375537872
growth O 0 0.017185620963573456
. O 0 0.007523747626692057

A O 0 0.010320551693439484
gene O 0 0.005112882703542709
encoding O 0 0.003720911219716072
a O 0 0.0024236112367361784
transmembrane O 0 0.006239543668925762
protein O 0 0.001937157241627574
is O 0 0.0012117010774090886
mutated O 0 0.003487967187538743
in O 0 0.0016435643192380667
patients O 1 0.9892995357513428
with O 1 0.9294166564941406
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.999997615814209
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9999984502792358
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.4783868193626404
. O 0 0.011169337667524815

Wolfram B-Disease 1 0.9999858140945435
syndrome I-Disease 1 1.0
( O 1 0.9919108748435974
WFS B-Disease 1 0.9999963045120239
; O 0 0.12486745417118073
OMIM O 1 0.9999659061431885
222300 O 1 0.9774153828620911
) O 0 0.002026765141636133
is O 0 0.0013326857006177306
an O 0 0.003757715690881014
autosomal B-Disease 1 0.9999066591262817
recessive I-Disease 1 0.9999957084655762
neurodegenerative I-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999995231628418
defined O 1 0.6686467528343201
by O 0 0.05782782658934593
young O 1 0.9961063265800476
- O 1 0.9999775886535645
onset O 1 0.9999998807907104
non O 1 0.9999926090240479
- O 1 0.9999996423721313
immune O 1 0.9999998807907104
insulin B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999996423721313
dependent I-Disease 1 0.9999816417694092
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9996190071105957
progressive O 1 0.9999997615814209
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999992847442627
. O 0 0.32824933528900146

Linkage O 0 0.020481282845139503
to O 0 0.004332822747528553
markers O 0 0.007399388588964939
on O 0 0.0034910414833575487
chromosome O 0 0.00896430853754282
4p O 0 0.42343980073928833
was O 0 0.003818837460130453
confirmed O 0 0.0029404140077531338
in O 0 0.0018901844741776586
five O 0 0.0027475564274936914
families O 0 0.005201058927923441
. O 0 0.008210222236812115

On O 0 0.003966246731579304
the O 0 0.002356770448386669
basis O 0 0.002190703060477972
of O 0 0.0028630527667701244
meiotic O 1 0.9999505281448364
recombinants O 1 0.9999555349349976
and O 1 0.8349048495292664
disease O 1 0.9999997615814209
- O 1 0.9981807470321655
associated O 0 0.04714222252368927
haplotypes O 0 0.3153153359889984
, O 0 0.0010635624639689922
the O 0 0.0017503666458651423
WFS B-Disease 1 0.9995679259300232
gene O 0 0.0019011326367035508
was O 0 0.0013466996606439352
localized O 0 0.001961159287020564
to O 0 0.0007931911968626082
a O 0 0.0021046376787126064
BAC O 1 0.9973076581954956
/ O 1 0.60960453748703
P1 O 0 0.1621447205543518
contig O 0 0.005790825001895428
of O 0 0.0012508907821029425
less O 0 0.001340246177278459
than O 0 0.001554610556922853
250 O 0 0.005017313174903393
kb O 0 0.024364957585930824
. O 0 0.008803756907582283

Mutations O 0 0.007754930295050144
in O 0 0.0026664813049137592
a O 0 0.0023319076281040907
novel O 0 0.005528619512915611
gene O 0 0.002932973438873887
( O 0 0.002086328575387597
WFS1 O 0 0.15193507075309753
) O 0 0.0009645126410759985
encoding O 0 0.0011971073690801859
a O 0 0.0009570139227434993
putative O 0 0.00287999608553946
transmembrane O 0 0.0026336496230214834
protein O 0 0.0008024772978387773
were O 0 0.0003900210140272975
found O 0 0.00036931491922587156
in O 0 0.0003355637309141457
all O 0 0.0003296045761089772
affected O 0 0.0005527201574295759
individuals O 0 0.0003972227859776467
in O 0 0.0003966596850659698
six O 0 0.0008540814160369337
WFS B-Disease 1 0.9953851103782654
families O 0 0.000783069699537009
, O 0 0.0004624796856660396
and O 0 0.00038462691009044647
these O 0 0.00033220494515262544
mutations O 0 0.0006394725642167032
were O 0 0.0004773378313984722
associated O 0 0.0008929511532187462
with O 0 0.001178762991912663
the O 0 0.18230153620243073
disease O 1 0.999997615814209
phenotype O 1 0.9961918592453003
. O 0 0.010615547187626362

WFS1 O 1 0.8747086524963379
appears O 0 0.006474451627582312
to O 0 0.0019060865743085742
function O 0 0.0017970016924664378
in O 0 0.0012026734184473753
survival O 0 0.0055397674441337585
of O 0 0.002872450277209282
islet O 1 0.998129665851593
beta O 1 0.9965267777442932
- O 1 0.9932267069816589
cells O 0 0.007093220949172974
and O 0 0.0020095922518521547
neurons O 0 0.00481459591537714
. O 0 0.002994116861373186
. O 0 0.005479332059621811

Stable O 0 0.012850360944867134
interaction O 0 0.0040916260331869125
between O 0 0.0020355454180389643
the O 0 0.0016048584366217256
products O 0 0.001703804824501276
of O 0 0.0020125703886151314
the O 0 0.03924243152141571
BRCA1 O 1 0.9995249509811401
and O 0 0.10936764627695084
BRCA2 O 1 0.9999833106994629
tumor B-Disease 1 0.9999511241912842
suppressor O 1 0.8587012887001038
genes O 0 0.0026647786144167185
in O 0 0.0022793107200413942
mitotic O 0 0.39234283566474915
and O 0 0.0050337486900389194
meiotic O 1 0.9986594915390015
cells O 0 0.018353067338466644
. O 0 0.010091038420796394

BRCA1 O 1 0.9770759344100952
and O 0 0.005088431295007467
BRCA2 O 1 0.5687253475189209
account O 0 0.0020868340507149696
for O 0 0.0009244546527042985
most O 0 0.0006343562854453921
cases O 0 0.0007417701999656856
of O 0 0.0014445246197283268
familial O 1 0.9994365572929382
, O 0 0.0806637704372406
early O 1 0.7672417759895325
onset O 1 0.9999998807907104
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9703365564346313
/ I-Disease 1 0.9999929666519165
or I-Disease 1 0.9772927761077881
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
and O 0 0.02252049371600151
encode O 0 0.0027333081234246492
products O 0 0.001503903535194695
that O 0 0.0007747351191937923
each O 0 0.0010106218978762627
interact O 0 0.002029449911788106
with O 0 0.0026559224352240562
hRAD51 O 0 0.039674606174230576
. O 0 0.008545602671802044

Results O 0 0.00662625627592206
presented O 0 0.005302667152136564
here O 0 0.002615922363474965
show O 0 0.002394886687397957
that O 0 0.0011982881696894765
BRCA1 O 0 0.2555627226829529
and O 0 0.0012537081493064761
BRCA2 O 0 0.4425789415836334
coexist O 0 0.0018457394326105714
in O 0 0.0006713452748954296
a O 0 0.0008094414952211082
biochemical O 0 0.0018015732057392597
complex O 0 0.0011881047394126654
and O 0 0.0008256511064246297
colocalize O 0 0.04600662738084793
in O 0 0.0010161874815821648
subnuclear O 0 0.25487571954727173
foci O 0 0.041814494878053665
in O 0 0.001103899092413485
somatic O 0 0.019801154732704163
cells O 0 0.0010543509852141142
and O 0 0.0004945793771184981
on O 0 0.0006322176195681095
the O 0 0.0008134952513501048
axial O 0 0.002544003538787365
elements O 0 0.0014783990336582065
of O 0 0.0021892806980758905
developing O 0 0.13405677676200867
synaptonemal O 1 0.9763770699501038
complexes O 0 0.1047433391213417
. O 0 0.009308811277151108

Like O 0 0.014427267014980316
BRCA1 O 1 0.7695027589797974
and O 0 0.006188260857015848
RAD51 O 1 0.9973140358924866
, O 0 0.006108738016337156
BRCA2 O 1 0.9632905721664429
relocates O 0 0.15352390706539154
to O 0 0.0026314312126487494
PCNA O 1 0.8391673564910889
+ O 0 0.004860352259129286
replication O 0 0.0028884983621537685
sites O 0 0.0011177384294569492
following O 0 0.001173934550024569
exposure O 0 0.00232998700812459
of O 0 0.0018839584663510323
S O 1 0.9604088068008423
phase O 0 0.20504134893417358
cells O 0 0.0031015968415886164
to O 0 0.0019909609109163284
hydroxyurea O 1 0.6725066900253296
or O 0 0.006300599314272404
UV O 1 0.788067638874054
irradiation O 0 0.04510637745261192
. O 0 0.015131310559809208

Thus O 0 0.008880315348505974
, O 0 0.006573914550244808
BRCA1 O 1 0.7591130137443542
and O 0 0.002805170603096485
BRCA2 O 0 0.2600722014904022
participate O 0 0.0016249757027253509
, O 0 0.0009716501226648688
together O 0 0.0007324247271753848
, O 0 0.0006446648621931672
in O 0 0.00063227245118469
a O 0 0.0010569461155682802
pathway O 0 0.0025940060149878263
( O 0 0.001538434298709035
s O 0 0.0023821908980607986
) O 0 0.0006282287649810314
associated O 0 0.0005469819298014045
with O 0 0.00038126029539853334
the O 0 0.0005583736929111183
activation O 0 0.0009919562144204974
of O 0 0.0007864722283557057
double O 0 0.014592153951525688
- O 0 0.21060562133789062
strand O 0 0.0034542980138212442
break O 0 0.00250374642200768
repair O 0 0.18125468492507935
and O 0 0.0018141510663554072
/ O 0 0.10366649925708771
or O 0 0.002882923698052764
homologous O 0 0.010506515391170979
recombination O 0 0.01138692069798708
. O 0 0.008512557484209538

Dysfunction O 1 0.9993084669113159
of O 0 0.016909601166844368
this O 0 0.0036374640185385942
pathway O 0 0.08330707252025604
may O 0 0.0012749545276165009
be O 0 0.0005319617339409888
a O 0 0.000642540049739182
general O 0 0.000983568374067545
phenomenon O 0 0.0010042920475825667
in O 0 0.00042840527021326125
the O 0 0.000476278830319643
majority O 0 0.00047776775318197906
of O 0 0.0005287858075462282
cases O 0 0.0011890454916283488
of O 0 0.24350127577781677
hereditary B-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
and I-Disease 1 0.9982547163963318
/ I-Disease 1 0.9999990463256836
or I-Disease 1 0.998345136642456
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.013127471320331097
. O 0 0.00956760160624981

A O 0 0.013348099775612354
novel O 0 0.014219236560165882
Arg362Ser O 0 0.037920787930488586
mutation O 0 0.004640068393200636
in O 0 0.0013160156086087227
the O 0 0.0017768853576853871
sterol O 0 0.13009214401245117
27 O 0 0.004874800331890583
- O 0 0.2097022831439972
hydroxylase O 0 0.15912215411663055
gene O 0 0.0019771370571106672
( O 0 0.0014792530564591289
CYP27 O 0 0.03098844550549984
) O 0 0.0008434392511844635
: O 0 0.0006434782408177853
its O 0 0.000530002114828676
effects O 0 0.001052708481438458
on O 0 0.0010554710170254111
pre O 0 0.004894859157502651
- O 0 0.005482877139002085
mRNA O 0 0.0036003822460770607
splicing O 0 0.0040374756790697575
and O 0 0.00240485742688179
enzyme O 0 0.005499631632119417
activity O 0 0.006880244240164757
. O 0 0.007525958586484194

A O 0 0.008932575583457947
novel O 0 0.00837775133550167
C O 0 0.005819032900035381
to O 0 0.0014526137383654714
A O 0 0.0016474034637212753
mutation O 0 0.001518714940175414
in O 0 0.0006242453819140792
the O 0 0.0010155317140743136
sterol O 0 0.007190849166363478
27 O 0 0.0022972100414335728
- O 0 0.00892731361091137
hydroxylase O 0 0.013467692770063877
gene O 0 0.001901394221931696
( O 0 0.0014402199303731322
CYP27 O 0 0.022372813895344734
) O 0 0.0009175945306196809
was O 0 0.0010732613736763597
identified O 0 0.0009841617429628968
by O 0 0.0007450463599525392
sequencing O 0 0.0021279349457472563
amplified O 0 0.0034569387789815664
CYP27 O 0 0.0693419873714447
gene O 0 0.0014221951132640243
products O 0 0.0008873093174770474
from O 0 0.00074556446634233
a O 0 0.0014057671651244164
patient O 0 0.20010831952095032
with O 0 0.0035504268016666174
cerebrotendinous B-Disease 1 0.9999620914459229
xanthomatosis I-Disease 1 0.9999799728393555
( O 0 0.4137602746486664
CTX B-Disease 1 0.9999721050262451
) O 0 0.0074680764228105545
. O 0 0.008758406154811382

The O 0 0.009082834236323833
mutation O 0 0.00894945114850998
changed O 0 0.004235428757965565
the O 0 0.0028785639442503452
adrenodoxin O 0 0.17417819797992706
cofactor O 0 0.014508814550936222
binding O 0 0.002771887695416808
residue O 0 0.005793286021798849
362Arg O 0 0.007337847724556923
to O 0 0.0018026859033852816
362Ser O 0 0.06244506686925888
( O 0 0.003715721657499671
CGT O 1 0.9069011211395264
362Arg O 0 0.09332894533872604
to O 0 0.0023584351874887943
AGT O 1 0.9998499155044556
362Ser O 0 0.4617811143398285
) O 0 0.0012773690978065133
, O 0 0.0007226971792988479
and O 0 0.0005810362636111677
was O 0 0.0011968183098360896
responsible O 0 0.00165805802680552
for O 0 0.0013556540943682194
deficiency O 1 0.999788224697113
in O 0 0.0011548292823135853
the O 0 0.0019819489680230618
sterol O 1 0.8769705295562744
27 O 0 0.004252801649272442
- O 0 0.037999510765075684
hydroxylase O 0 0.007903559133410454
activity O 0 0.0010080048814415932
, O 0 0.000677666743285954
as O 0 0.0006323519628494978
confirmed O 0 0.0008325660019181669
by O 0 0.0004960869555361569
expression O 0 0.0009908562060445547
of O 0 0.0009973794221878052
mutant O 0 0.004011472687125206
cDNA O 0 0.004718224052339792
into O 0 0.0023029076401144266
COS O 1 0.9870811104774475
- O 0 0.05039304494857788
1 O 0 0.005535450764000416
cells O 0 0.006790311075747013
. O 0 0.007195950485765934

Quantitative O 0 0.011760201305150986
analysis O 0 0.0045327842235565186
showed O 0 0.0033231289125978947
that O 0 0.0011164395837113261
the O 0 0.0012905420735478401
expression O 0 0.0015969224041327834
of O 0 0.001585079706273973
CYP27 O 1 0.8638157248497009
gene O 0 0.002017359947785735
mRNA O 0 0.002002511639147997
in O 0 0.0011915027862414718
the O 0 0.001594447297975421
patient O 0 0.0070132724940776825
represented O 0 0.004257509019225836
52 O 0 0.010778098367154598
. O 0 0.008298337459564209

5 O 0 0.008142019622027874
% O 0 0.004197124857455492
of O 0 0.0029047869611531496
the O 0 0.003827734850347042
normal O 0 0.006257807370275259
level O 0 0.007715962827205658
. O 0 0.008084261789917946

As O 0 0.005274734925478697
the O 0 0.003550084540620446
mutation O 0 0.0038320613093674183
occurred O 0 0.0023845124524086714
at O 0 0.0017968929605558515
the O 0 0.0014090696349740028
penultimate O 0 0.008143098093569279
nucleotide O 0 0.0024264256935566664
of O 0 0.001152497949078679
exon O 0 0.004324622452259064
6 O 0 0.0015880217542871833
( O 0 0.0011280610924586654
- O 0 0.0012847656616941094
2 O 0 0.0008234813576564193
position O 0 0.0007240973063744605
of O 0 0.0007562548271380365
exon O 0 0.0035080858506262302
6 O 0 0.0018732035532593727
- O 0 0.003206060966476798
intron O 0 0.023945411667227745
6 O 0 0.0014467203291133046
splice O 0 0.0022194436751306057
site O 0 0.0009091940592043102
) O 0 0.000588026421610266
of O 0 0.0004434599541127682
the O 0 0.000581228407099843
gene O 0 0.0007576340576633811
, O 0 0.00040042249020189047
we O 0 0.00040201545925810933
hypothesized O 0 0.001160064828582108
that O 0 0.0004057203477714211
the O 0 0.0007079279748722911
mutation O 0 0.00142870272975415
may O 0 0.0007344650221057236
partially O 0 0.0012293028412386775
affect O 0 0.000697907991707325
the O 0 0.0006794393411837518
normal O 0 0.001018968760035932
splicing O 0 0.0013417871668934822
efficiency O 0 0.001315239118412137
in O 0 0.0007541008526459336
exon O 0 0.003426638664677739
6 O 0 0.0011693710694089532
and O 0 0.0006382974097505212
cause O 0 0.0012494130060076714
alternative O 0 0.0010213562054559588
splicing O 0 0.0015059944707900286
elsewhere O 0 0.0008655833662487566
, O 0 0.0005388444405980408
which O 0 0.0004534870677161962
resulted O 0 0.001083764829672873
in O 0 0.0008665905916132033
decreased O 0 0.003742752829566598
transcript O 0 0.0024789150338619947
in O 0 0.0011605898616835475
the O 0 0.002519208937883377
patient O 0 0.38571697473526
. O 0 0.006025917828083038

Transfection O 0 0.43517640233039856
of O 0 0.006419450044631958
constructed O 0 0.29352614283561707
minigenes O 1 0.8839850425720215
, O 0 0.0013350523076951504
with O 0 0.0006911437958478928
or O 0 0.0005802796804346144
without O 0 0.0005465408321470022
the O 0 0.0006419529672712088
mutation O 0 0.0010763622121885419
, O 0 0.0005719602340832353
into O 0 0.0008575480314902961
COS O 1 0.9990860223770142
- O 0 0.06769362092018127
1 O 0 0.0011389658320695162
cells O 0 0.0006595784216187894
confirmed O 0 0.0005683453637175262
that O 0 0.0003385019372217357
the O 0 0.0005346378311514854
mutant O 0 0.0023954121861606836
minigene O 0 0.00932819489389658
was O 0 0.0009646711987443268
responsible O 0 0.0008140915306285024
for O 0 0.00048486594459973276
a O 0 0.0007981943199411035
mRNA O 0 0.0011982944561168551
species O 0 0.0005708924727514386
alternatively O 0 0.0011982664000242949
spliced O 0 0.0015119854360818863
at O 0 0.0008250640239566565
an O 0 0.0007898343610577285
activated O 0 0.002366623841226101
cryptic O 0 0.0027809487655758858
5 O 0 0.0012060065055266023
splice O 0 0.0022833591792732477
site O 0 0.0014369100099429488
88 O 0 0.0019705682061612606
bp O 0 0.001781004830263555
upstream O 0 0.0013917562318965793
from O 0 0.0005800281651318073
the O 0 0.0007498214254155755
3 O 0 0.0012464775936678052
end O 0 0.0013765377225354314
of O 0 0.0019798760768026114
exon O 0 0.014090072363615036
6 O 0 0.006007358431816101
. O 0 0.006303441245108843

Our O 0 0.005348088685423136
data O 0 0.0027755426708608866
suggest O 0 0.0018077899003401399
that O 0 0.0007508511771447957
the O 0 0.0007770589436404407
C O 0 0.001661775168031454
to O 0 0.0005769943818449974
A O 0 0.0009182075737044215
mutation O 0 0.0009965773206204176
at O 0 0.0006806983146816492
the O 0 0.0006620408967137337
penultimate O 0 0.003781769424676895
nucleotide O 0 0.0012927443021908402
of O 0 0.0006608129478991032
exon O 0 0.0022377115674316883
6 O 0 0.0008923982386477292
of O 0 0.0006397957331500947
the O 0 0.000921196595299989
CYP27 O 1 0.909173846244812
gene O 0 0.0008674294804222882
not O 0 0.00035367332748137414
only O 0 0.00045042290003038943
causes O 0 0.0023114902433007956
the O 0 0.001665762159973383
deficiency B-Disease 1 0.9999170303344727
in I-Disease 0 0.0010121428640559316
the I-Disease 0 0.002277277410030365
sterol I-Disease 1 0.9055802226066589
27 I-Disease 0 0.007994890213012695
- I-Disease 0 0.08663062751293182
hydroxylase I-Disease 0 0.013072248548269272
activity I-Disease 0 0.0009193873265758157
, O 0 0.0005349447019398212
but O 0 0.00042261683847755194
also O 0 0.0004781557072419673
partially O 0 0.0010373768163844943
leads O 0 0.0008405989501625299
to O 0 0.0005119405686855316
alternative O 0 0.0010887820972129703
pre O 0 0.00270161428488791
- O 0 0.0026947367005050182
mRNA O 0 0.002732460619881749
splicing O 0 0.003146212315186858
of O 0 0.0020146584138274193
the O 0 0.0032284248154610395
gene O 0 0.008245046250522137
. O 0 0.007940142415463924

To O 0 0.00379665894433856
our O 0 0.00225725001655519
knowledge O 0 0.0019487714162096381
, O 0 0.000966189312748611
this O 0 0.0005111941136419773
is O 0 0.0005020040553063154
the O 0 0.0005367433186620474
first O 0 0.0005318656913004816
report O 0 0.0006274131592363119
regarding O 0 0.0006707805441692472
effects O 0 0.0010007027303799987
on O 0 0.0006278217188082635
pre O 0 0.0048226723447442055
- O 0 0.0021534182596951723
mRNA O 0 0.001337283756583929
splicing O 0 0.0011721485061571002
of O 0 0.0006089814705774188
a O 0 0.0008058685925789177
mutation O 0 0.0010564830154180527
at O 0 0.0008361496729776263
the O 0 0.0008325627422891557
- O 0 0.0018119849264621735
2 O 0 0.0010650946060195565
position O 0 0.001069548074156046
of O 0 0.0009757296647876501
a O 0 0.0018683751113712788
5 O 0 0.0031330168712884188
splice O 0 0.012292394414544106
site O 0 0.007298281881958246
. O 0 0.008391064591705799

ATM O 0 0.052558936178684235
germline O 0 0.06433797627687454
mutations O 0 0.007776451762765646
in O 0 0.0035922946408391
classical O 1 0.8125545382499695
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
telangiectasia I-Disease 1 0.9999998807907104
patients O 1 0.9985960125923157
in O 0 0.003958690445870161
the O 0 0.0048207505606114864
Dutch O 0 0.05391121655702591
population O 0 0.0063264695927500725
. O 0 0.008537378162145615

Germline O 0 0.4694506824016571
mutations O 0 0.005807248875498772
in O 0 0.002218010136857629
the O 0 0.0017016221536323428
ATM O 0 0.0040009901858866215
gene O 0 0.0011731978738680482
are O 0 0.00045699955080635846
responsible O 0 0.0010196083458140492
for O 0 0.0009058330324478447
the O 0 0.027583349496126175
autosomal B-Disease 1 0.9999996423721313
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999837875366211
A B-Disease 1 0.9999933242797852
- I-Disease 1 0.9999938011169434
T I-Disease 1 0.9999401569366455
) O 0 0.006138886325061321
. O 0 0.007238354068249464

In O 0 0.0038031316362321377
our O 0 0.0022736433893442154
study O 0 0.0017927582375705242
, O 0 0.0009186359238810837
we O 0 0.0005570564535446465
have O 0 0.00041006362880580127
determined O 0 0.0007747211493551731
the O 0 0.0006204420351423323
ATM O 0 0.0017407516716048121
mutation O 0 0.0009867422049865127
spectrum O 0 0.0007620941032655537
in O 0 0.0004905255045741796
19 O 0 0.0009120074682869017
classical O 0 0.001636271714232862
A B-Disease 1 0.8421962261199951
- I-Disease 1 0.9996366500854492
T I-Disease 1 0.9997487664222717
patients O 0 0.07014425098896027
, O 0 0.0004883940564468503
including O 0 0.0004137079231441021
some O 0 0.0003424297028686851
immigrant O 0 0.001174010569229722
populations O 0 0.0006296319770626724
, O 0 0.0004662703722715378
as O 0 0.0004705477913375944
well O 0 0.0004372208204586059
as O 0 0.000485129450680688
12 O 0 0.0008541074930690229
of O 0 0.0010148765286430717
Dutch O 0 0.003681725589558482
ethnic O 0 0.0038598361425101757
origin O 0 0.005681980401277542
. O 0 0.00755501352250576

Both O 0 0.005350201856344938
the O 0 0.0038562866393476725
protein O 0 0.0034649858716875315
truncation O 0 0.007543152663856745
test O 0 0.0022432918194681406
( O 0 0.0017342045903205872
PTT O 0 0.004072281997650862
) O 0 0.0008734509465284646
and O 0 0.00060830864822492
the O 0 0.0008235390996560454
restriction O 0 0.0017927838489413261
endonuclease O 0 0.008167845197021961
fingerprinting O 0 0.0037828581407666206
( O 0 0.0016646918375045061
REF O 0 0.009696394205093384
) O 0 0.0007145620184019208
method O 0 0.0005712489364668727
were O 0 0.0003260908415541053
used O 0 0.00039238054887391627
and O 0 0.00037231101305224
compared O 0 0.0005737527390010655
for O 0 0.0003788802132476121
their O 0 0.00036983154132030904
detection O 0 0.0009164019720628858
efficiency O 0 0.0009482669993303716
, O 0 0.0004789585655089468
identifying O 0 0.0008925598231144249
76 O 0 0.0014036567881703377
% O 0 0.0005456088110804558
and O 0 0.0004289689823053777
60 O 0 0.000738594273570925
% O 0 0.000668718246743083
of O 0 0.0007123926770873368
the O 0 0.0011835593031719327
mutations O 0 0.002602430060505867
, O 0 0.0021316406782716513
respectively O 0 0.0053474209271371365
. O 0 0.006983733735978603

Most O 0 0.007324951700866222
patients O 0 0.11951884627342224
were O 0 0.0021420535631477833
found O 0 0.002447501989081502
to O 0 0.0020793245639652014
be O 0 0.0028660271782428026
compound O 0 0.011695611290633678
heterozygote O 0 0.14322973787784576
. O 0 0.011353448033332825

Seventeen O 0 0.013654978945851326
mutations O 0 0.005399845074862242
were O 0 0.0017974457005038857
distinct O 0 0.0016714654630050063
, O 0 0.0008971205097623169
of O 0 0.0008342945366166532
which O 0 0.0007228252943605185
10 O 0 0.000939494464546442
were O 0 0.000731847423594445
not O 0 0.0010604221606627107
reported O 0 0.003263595513999462
previously O 0 0.005635166075080633
. O 0 0.007157907355576754

Mutations O 0 0.009429196827113628
are O 0 0.002022683387622237
small O 0 0.0024318541400134563
deletions O 0 0.0047341687604784966
or O 0 0.0018401641864329576
point O 0 0.00301947770640254
mutations O 0 0.0045423926785588264
frequently O 0 0.0038040876388549805
affecting O 0 0.007492039352655411
splice O 0 0.020021002739667892
sites O 0 0.009514410980045795
. O 0 0.00992885883897543

Moreover O 0 0.021761706098914146
, O 0 0.009206734597682953
a O 0 0.009294429793953896
16 O 0 0.012861131690442562
. O 0 0.011364804580807686

7 O 0 0.016584288328886032
- O 0 0.017432093620300293
kb O 0 0.02235542982816696
genomic O 0 0.005872103851288557
deletion O 0 0.004128817934542894
of O 0 0.001251012901775539
the O 0 0.0009600812336429954
3 O 0 0.0010212016059085727
end O 0 0.0007370073581114411
of O 0 0.0006168436957523227
the O 0 0.0007990360027179122
gene O 0 0.000921964063309133
, O 0 0.0005124696181155741
most O 0 0.0004072106094099581
likely O 0 0.0004886648966930807
a O 0 0.0005751443677581847
result O 0 0.0005390123696997762
of O 0 0.0005097278626635671
recombination O 0 0.0011898198863491416
between O 0 0.0005495304940268397
two O 0 0.0005025838036090136
LINE O 0 0.0016291877254843712
elements O 0 0.0012733725598081946
, O 0 0.0013123751850798726
was O 0 0.0030121428426355124
identified O 0 0.005367028992623091
. O 0 0.0068007963709533215

The O 0 0.005295847542583942
most O 0 0.0022239519748836756
frequently O 0 0.0019832991529256105
found O 0 0.0012598723405972123
mutation O 0 0.0016363576287403703
, O 0 0.0005992864025756717
identified O 0 0.0006875997642055154
in O 0 0.0004369714588392526
three O 0 0.0004619093087967485
unrelated O 0 0.0015343143604695797
Turkish O 0 0.00423865532502532
A B-Disease 1 0.8073437809944153
- I-Disease 1 0.9929221868515015
T I-Disease 1 0.973838746547699
individuals O 0 0.0006089765811339021
, O 0 0.0005209945375099778
was O 0 0.000709999818354845
previously O 0 0.0005833360482938588
described O 0 0.0007481354987248778
to O 0 0.0003799273108597845
be O 0 0.00035319183371029794
a O 0 0.0008053027559071779
Turkish O 0 0.002796149579808116
A B-Disease 0 0.36889106035232544
- I-Disease 1 0.9927116632461548
T I-Disease 1 0.9978475570678711
founder O 1 0.5527174472808838
mutation O 0 0.016761722043156624
. O 0 0.008253444917500019

The O 0 0.005220952909439802
presence O 0 0.003480796702206135
of O 0 0.002076545963063836
a O 0 0.003527421969920397
founder O 1 0.9707415699958801
mutation O 0 0.10910605639219284
among O 0 0.0011284674983471632
relatively O 0 0.0011300552869215608
small O 0 0.0006494298577308655
ethnic O 0 0.0008823040407150984
population O 0 0.0006204326055012643
groups O 0 0.0004183742858003825
in O 0 0.0004371638933662325
Western O 0 0.0007791748503223062
Europe O 0 0.0007085032993927598
could O 0 0.000530191813595593
indicate O 0 0.0008433468756265938
a O 0 0.000759011716581881
high O 0 0.001430736156180501
carrier O 0 0.002517117653042078
frequency O 0 0.0012044803006574512
in O 0 0.0011247317306697369
such O 0 0.0015878538833931088
communities O 0 0.004301206674426794
. O 0 0.007325589656829834

In O 0 0.005297875497490168
patients O 0 0.01763143390417099
of O 0 0.0021929803770035505
Dutch O 0 0.06106870248913765
ethnic O 0 0.0027988129295408726
origin O 0 0.0015458085108548403
, O 0 0.0009724776609800756
however O 0 0.0007357834256254137
, O 0 0.0007199016399681568
no O 0 0.0008235425921157002
significant O 0 0.0012994831195101142
founder O 0 0.0055653550662100315
effect O 0 0.0018940981244668365
could O 0 0.001372068771161139
be O 0 0.0016621958930045366
identified O 0 0.004714051727205515
. O 0 0.0058266399428248405

The O 0 0.007493801414966583
observed O 0 0.0048840842209756374
genetic O 0 0.003919761627912521
heterogeneity O 0 0.006117751821875572
including O 0 0.0015448004705831409
the O 0 0.0013888883404433727
relative O 0 0.0016773055540397763
high O 0 0.0017886465648189187
percentage O 0 0.001891767606139183
of O 0 0.0011920302640646696
splice O 0 0.0755239874124527
- O 0 0.017225107178092003
site O 0 0.0016407911898568273
mutations O 0 0.0014784327941015363
had O 0 0.0009910236112773418
no O 0 0.0010005636140704155
reflection O 0 0.002508649369701743
on O 0 0.0018392193596810102
the O 0 0.0035046341363340616
phenotype O 0 0.02045588009059429
. O 0 0.007003513630479574

All O 0 0.006575888954102993
patients O 0 0.11240912973880768
manifested O 1 0.5737192034721375
classical O 0 0.08752597868442535
A B-Disease 1 0.9996106028556824
- I-Disease 1 0.9999865293502808
T I-Disease 1 0.9999276399612427
and O 0 0.0026089102029800415
increased O 0 0.003998181317001581
cellular O 0 0.006592875346541405
radioresistant O 0 0.0958910584449768
DNA O 0 0.006484099198132753
synthesis O 0 0.00971752218902111
. O 0 0.008874517865478992

Determination O 0 0.012136755511164665
of O 0 0.003622566582635045
the O 0 0.002362259430810809
genomic O 0 0.004286001902073622
structure O 0 0.0019706713501363993
of O 0 0.001332373358309269
the O 0 0.0022279710974544287
COL4A4 O 1 0.9772323966026306
gene O 0 0.0015350276371464133
and O 0 0.0007266498287208378
of O 0 0.001635074382647872
novel O 1 0.7806066870689392
mutations O 1 0.9377851486206055
causing O 1 0.9995618462562561
autosomal B-Disease 1 0.9999986886978149
recessive I-Disease 1 0.9999998807907104
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9948215484619141

Autosomal B-Disease 1 0.9999957084655762
recessive I-Disease 1 0.9999997615814209
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9976581335067749
a O 1 0.9991199374198914
progressive O 1 0.9999996423721313
hematuric B-Disease 1 0.9999998807907104
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9999582767486572
by O 1 0.9130764603614807
glomerular B-Disease 1 0.9999998807907104
basement I-Disease 1 0.9999915361404419
membrane I-Disease 1 0.9928858876228333
abnormalities I-Disease 1 0.9876132011413574
and O 0 0.0008863818948157132
associated O 0 0.0008594277314841747
with O 0 0.0005933483480475843
mutations O 0 0.0009048518841154873
in O 0 0.0004971013986505568
either O 0 0.000605826557148248
the O 0 0.0009127185912802815
COL4A3 O 1 0.5140566825866699
or O 0 0.0008586354670114815
the O 0 0.00110290152952075
COL4A4 O 1 0.5624547600746155
gene O 0 0.0011892664479091763
, O 0 0.0006510798702947795
which O 0 0.000563089270144701
encode O 0 0.0012721701059490442
the O 0 0.0011108831968158484
alpha3 O 0 0.031071465462446213
and O 0 0.0018485387554392219
alpha4 O 1 0.9817671179771423
type O 1 0.9633112549781799
IV O 1 0.9999854564666748
collagen O 1 0.9996080994606018
chains O 0 0.011643003672361374
, O 0 0.003972552716732025
respectively O 0 0.007551613263785839
. O 0 0.007314398419111967

To O 0 0.004022399894893169
date O 0 0.003210716415196657
, O 0 0.0018092590617015958
mutation O 0 0.0020904180128127337
screening O 0 0.001384203089401126
in O 0 0.000573660887312144
the O 0 0.0005091443890705705
two O 0 0.00040126737440004945
genes O 0 0.000703857687767595
has O 0 0.0005151706282049417
been O 0 0.0006675854092463851
hampered O 0 0.0035438586492091417
by O 0 0.000676681927870959
the O 0 0.0008204964105971158
lack O 0 0.0019692780915647745
of O 0 0.002233499428257346
genomic O 0 0.013099233619868755
structure O 0 0.004645884037017822
information O 0 0.004642573185265064
. O 0 0.0070510003715753555

We O 0 0.005612970795482397
report O 0 0.0037706620059907436
here O 0 0.001995956525206566
the O 0 0.0013699665432795882
complete O 0 0.001698681735433638
characterization O 0 0.002537074964493513
of O 0 0.0009931763634085655
the O 0 0.0009379238472320139
48 O 0 0.0015313558978959918
exons O 0 0.0020366497337818146
of O 0 0.000852165394462645
the O 0 0.0011792402947321534
COL4A4 O 1 0.8218620419502258
gene O 0 0.0011641179444268346
, O 0 0.0007124031544663012
a O 0 0.0008903819252736866
comprehensive O 0 0.0020182470325380564
gene O 0 0.001040634699165821
screen O 0 0.0009924826445057988
, O 0 0.0005199946463108063
and O 0 0.00042653255513869226
the O 0 0.0005182723398320377
subsequent O 0 0.0008024945855140686
detection O 0 0.0008496220107190311
of O 0 0.0005573023809120059
10 O 0 0.0006657036137767136
novel O 0 0.0014959394466131926
mutations O 0 0.0009727380820550025
in O 0 0.0007147537544369698
eight O 0 0.004146751947700977
patients O 1 0.9995593428611755
diagnosed O 1 0.9999996423721313
with O 1 0.9984194040298462
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9983651041984558

Furthermore O 0 0.010181405581533909
, O 0 0.002835703082382679
we O 0 0.001401457586325705
identified O 0 0.0019334143726155162
a O 0 0.0014833586756139994
glycine O 0 0.003925093915313482
to O 0 0.0009414298692718148
alanine O 0 0.004249233286827803
substitution O 0 0.0019796499982476234
in O 0 0.0009018272976391017
the O 0 0.0013896127929911017
collagenous O 1 0.8311567306518555
domain O 0 0.0013502093497663736
that O 0 0.0005880236276425421
is O 0 0.0006394625524990261
apparently O 0 0.0009179140906780958
silent O 0 0.0014675710117444396
in O 0 0.0005968843470327556
the O 0 0.0009140355978161097
heterozygous O 0 0.0020026478450745344
carriers O 0 0.0015575106954202056
, O 0 0.0009976461296901107
in O 0 0.0014573815278708935
11 O 0 0.003664077492430806
. O 0 0.0054007056169211864

5 O 0 0.006930842529982328
% O 0 0.002834815764799714
of O 0 0.0013244986766949296
all O 0 0.0008617607527412474
control O 0 0.0011286658700555563
individuals O 0 0.0005861264653503895
, O 0 0.0005103442817926407
and O 0 0.0004872835997957736
in O 0 0.000514323590323329
one O 0 0.0005689133540727198
control O 0 0.0009530336246825755
individual O 0 0.0009388541802763939
homozygous O 0 0.002460974035784602
for O 0 0.0011152027873322368
this O 0 0.001963172573596239
glycine O 0 0.013107435777783394
substitution O 0 0.010656663216650486
. O 0 0.009339756332337856

There O 0 0.004615097772330046
has O 0 0.002244553528726101
been O 0 0.0012028703931719065
no O 0 0.0008936885860748589
previous O 0 0.0008819274371489882
finding O 0 0.0009603629005141556
of O 0 0.0009822597494348884
a O 0 0.002985967556014657
glycine O 0 0.20124360918998718
substitution O 0 0.002134618815034628
that O 0 0.0005507832393050194
is O 0 0.0005643080803565681
not O 0 0.0004045322129968554
associated O 0 0.0005824757390655577
with O 0 0.0005338831106200814
any O 0 0.0007913414156064391
obvious O 0 0.0026199661660939455
phenotype O 0 0.004023259039968252
in O 0 0.0015551241813227534
homozygous O 0 0.006345472298562527
individuals O 0 0.00335363345220685
. O 0 0.0064675756730139256

Founder O 1 0.9436666965484619
BRCA1 O 1 0.9720013737678528
and O 0 0.005729268305003643
BRCA2 O 1 0.904518723487854
mutations O 0 0.004430251661688089
in O 0 0.002293539931997657
French O 1 0.6819210648536682
Canadian O 1 0.9973503351211548
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9993693232536316
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9387313723564148
. O 0 0.01968144252896309

We O 0 0.004205573350191116
have O 0 0.0017338019097223878
identified O 0 0.0016425842186436057
four O 0 0.0008969666669145226
mutations O 0 0.0009836475364863873
in O 0 0.0004934864118695259
each O 0 0.00047606369480490685
of O 0 0.0008517237729392946
the O 0 0.1509508192539215
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999995231628418
- O 1 0.9997339844703674
susceptibility O 1 0.9876224398612976
genes O 0 0.0015446373727172613
, O 0 0.0009754262282513082
BRCA1 O 0 0.03476729989051819
and O 0 0.0007243078434839845
BRCA2 O 0 0.0074992189183831215
, O 0 0.0006711821770295501
in O 0 0.000734127766918391
French O 0 0.021511025726795197
Canadian O 1 0.9783880114555359
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 1.0
and O 1 0.999950647354126
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.6540365219116211
from O 0 0.010900851339101791
Quebec O 1 0.8086211085319519
. O 0 0.009164104238152504

To O 0 0.004318352323025465
identify O 0 0.004636396188288927
founder O 0 0.035944413393735886
effects O 0 0.005068229511380196
, O 0 0.0011116659734398127
we O 0 0.0007378492737188935
examined O 0 0.0013833952834829688
independently O 0 0.0011329310946166515
ascertained O 0 0.002834922634065151
French O 0 0.003384465118870139
Canadian O 0 0.016627738252282143
cancer B-Disease 1 0.909832775592804
families O 0 0.0008951412746682763
for O 0 0.0006620080675929785
the O 0 0.000822496076580137
distribution O 0 0.0009467482450418174
of O 0 0.001220516744069755
these O 0 0.0013679965632036328
eight O 0 0.003291503991931677
mutations O 0 0.007627259939908981
. O 0 0.007369532249867916

Mutations O 0 0.007262357976287603
were O 0 0.002329849638044834
found O 0 0.0017194099491462111
in O 0 0.0015578512102365494
41 O 0 0.0034956377930939198
of O 0 0.002700111363083124
97 O 0 0.014276335947215557
families O 0 0.00625564344227314
. O 0 0.007493063807487488

Six O 0 0.00514519028365612
of O 0 0.0025271752383559942
eight O 0 0.0024513518437743187
mutations O 0 0.002290588105097413
were O 0 0.0011138921836391091
observed O 0 0.0016569565050303936
at O 0 0.0018596353475004435
least O 0 0.002248993143439293
twice O 0 0.005576613824814558
. O 0 0.007514299359172583

The O 0 0.01708119362592697
BRCA1 O 1 0.9964712858200073
C4446T O 1 0.9498615264892578
mutation O 0 0.03154967725276947
was O 0 0.0032611300703138113
the O 0 0.0012863456504419446
most O 0 0.0007516042096540332
common O 0 0.0012062725145369768
mutation O 0 0.0017520973924547434
found O 0 0.0006780615076422691
, O 0 0.0006929846713319421
followed O 0 0.0009659325587563217
by O 0 0.001071188715286553
the O 0 0.003607760649174452
BRCA2 O 1 0.9980059266090393
8765delAG O 1 0.9758201837539673
mutation O 0 0.0212955791503191
. O 0 0.008435601368546486

Together O 0 0.005657113157212734
, O 0 0.0024927882477641106
these O 0 0.0011922738049179316
mutations O 0 0.0015675072791054845
were O 0 0.0006969439564272761
found O 0 0.0006231284933164716
in O 0 0.0005763073568232358
28 O 0 0.0008486736915074289
of O 0 0.0007546480046585202
41 O 0 0.001536015304736793
families O 0 0.0008450151653960347
identified O 0 0.0011011253809556365
to O 0 0.0008261599577963352
have O 0 0.0009659712668508291
a O 0 0.0025108996778726578
mutation O 0 0.007738221436738968
. O 0 0.006464686710387468

The O 0 0.006287857890129089
odds O 0 0.006665852386504412
of O 0 0.002645726315677166
detection O 0 0.003207089612260461
of O 0 0.0013875561999157071
any O 0 0.0008414291660301387
of O 0 0.0009258478530682623
the O 0 0.001225114450789988
four O 0 0.0018482236191630363
BRCA1 O 1 0.9277628660202026
mutations O 0 0.004197678994387388
was O 0 0.004395799245685339
18 O 0 0.0060363225638866425
. O 0 0.006980533245950937

7x O 1 0.6783949136734009
greater O 0 0.005405094940215349
if O 0 0.00149154057726264
one O 0 0.0009889435023069382
or O 0 0.0007648869650438428
more O 0 0.0005640367744490504
cases O 0 0.0013876256998628378
of O 1 0.688779354095459
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
were O 0 0.003914946690201759
also O 0 0.0010845971992239356
present O 0 0.0010583240073174238
in O 0 0.0010938518680632114
the O 0 0.0021882555447518826
family O 0 0.0051096645183861256
. O 0 0.005443006753921509

The O 0 0.006693019066005945
odds O 0 0.007822223007678986
of O 0 0.0024037333205342293
detection O 0 0.0030726955737918615
of O 0 0.0013298062840476632
any O 0 0.0008037664229050279
of O 0 0.001027307123877108
the O 0 0.0016904659569263458
four O 0 0.0026311534456908703
BRCA2 O 1 0.9844349026679993
mutations O 0 0.004452592693269253
was O 0 0.004148338921368122
5 O 0 0.005864376667886972
. O 0 0.00651301397010684

3x O 0 0.11467308551073074
greater O 0 0.0042949095368385315
if O 0 0.0013919350458309054
there O 0 0.0008762371726334095
were O 0 0.0006903480389155447
at O 0 0.0006515522254630923
least O 0 0.000587773451115936
five O 0 0.0006523982156068087
cases O 0 0.0009967259829863906
of O 0 0.026100026443600655
breast B-Disease 1 0.9999991655349731
cancer I-Disease 1 0.9999667406082153
in O 0 0.003979496657848358
the O 0 0.0074141076765954494
family O 0 0.021656211465597153
. O 0 0.007487058639526367

Interestingly O 0 0.01357351429760456
, O 0 0.003247880144044757
the O 0 0.0018145206850022078
presence O 0 0.001967472257092595
of O 0 0.0023093721829354763
a O 1 0.8936663866043091
breast B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999886751174927
case O 0 0.2609451711177826
< O 0 0.1611948013305664
36 O 0 0.0010615269420668483
years O 0 0.0005017177318222821
of O 0 0.0005444430280476809
age O 0 0.0011336531024426222
was O 0 0.0011941747507080436
strongly O 0 0.0007506865658797324
predictive O 0 0.0010868106037378311
of O 0 0.0005204634508118033
the O 0 0.0005080802366137505
presence O 0 0.0006246006232686341
of O 0 0.0005242141778580844
any O 0 0.0004930223803967237
of O 0 0.0009252649615518749
the O 0 0.0015780763933435082
eight O 0 0.0030373039189726114
mutations O 0 0.006372552365064621
screened O 0 0.009668923914432526
. O 0 0.00759112648665905

Carriers O 0 0.010046547278761864
of O 0 0.0032864329405128956
the O 0 0.002164125442504883
same O 0 0.0013958412455394864
mutation O 0 0.0018470751820132136
, O 0 0.0006499353912658989
from O 0 0.0004621566040441394
different O 0 0.0003443313471507281
families O 0 0.00048290149425156415
, O 0 0.0005350053543224931
shared O 0 0.0008949801558628678
similar O 0 0.0007939549977891147
haplotypes O 0 0.004610029514878988
, O 0 0.0006305450806394219
indicating O 0 0.0009240451618097723
that O 0 0.0004097186028957367
the O 0 0.0006576558225788176
mutant O 0 0.002161904238164425
alleles O 0 0.0009744755225256085
were O 0 0.00036795291816815734
likely O 0 0.0004114648327231407
to O 0 0.00024566022329963744
be O 0 0.0002487292804289609
identical O 0 0.00044107355643063784
by O 0 0.0003466651542112231
descent O 0 0.0010081869550049305
for O 0 0.0005363849923014641
a O 0 0.0009365298901684582
mutation O 0 0.0013813094701617956
in O 0 0.0008664209744893014
the O 0 0.001648655510507524
founder O 0 0.038996610790491104
population O 0 0.004119181539863348
. O 0 0.006612876430153847

The O 0 0.005611345171928406
identification O 0 0.004860444460064173
of O 0 0.0036693401634693146
common O 0 0.16470879316329956
BRCA1 O 1 0.9987925291061401
and O 0 0.011968312785029411
BRCA2 O 1 0.9939112663269043
mutations O 0 0.0029236094560474157
will O 0 0.0008492204360663891
facilitate O 0 0.0014910718891769648
carrier O 0 0.0022445309441536665
detection O 0 0.0015325084095820785
in O 0 0.0008483644342049956
French O 0 0.031046027317643166
Canadian O 1 0.9732416272163391
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999998807907104
and O 1 0.9999604225158691
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 1 0.903906524181366
. O 0 0.013854836113750935

Are O 0 0.008082050830125809
Dp71 O 0 0.4047686457633972
and O 0 0.0074311718344688416
Dp140 O 1 0.9443677067756653
brain O 1 0.9008054733276367
dystrophin O 1 0.8445316553115845
isoforms O 0 0.005882504396140575
related O 0 0.003738708095625043
to O 0 0.0029311783146113157
cognitive B-Disease 1 0.9980928301811218
impairment I-Disease 1 0.9999983310699463
in O 1 0.9988405108451843
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9996242523193359

Molecular O 0 0.007905962876975536
study O 0 0.00392961734905839
and O 0 0.0019745135214179754
neuropsychological O 0 0.00624844990670681
analysis O 0 0.0014226597268134356
were O 0 0.0008587393676862121
performed O 0 0.0012518526054918766
concurrently O 0 0.0018009464256465435
on O 0 0.0010257287649437785
49 O 0 0.00414729118347168
patients O 1 0.8976202607154846
with O 1 0.6058841943740845
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999994158744812
DMD B-Disease 1 1.0
) O 0 0.0020803597290068865
in O 0 0.000551035045646131
order O 0 0.0004627800080925226
to O 0 0.0003562071069609374
find O 0 0.00047692572115920484
a O 0 0.0004929197020828724
molecular O 0 0.0008294603321701288
explanation O 0 0.000885436893440783
for O 0 0.0005358147318474948
the O 0 0.001095774001441896
cognitive B-Disease 0 0.3887159526348114
impairment I-Disease 1 0.988272488117218
observed O 0 0.0025930649135261774
in O 0 0.0020168398041278124
most O 0 0.0064033991657197475
DMD B-Disease 1 0.9999988079071045
patients O 1 0.9968557357788086
. O 0 0.011216962710022926

Complete O 0 0.0075084129348397255
analysis O 0 0.004090184811502695
of O 0 0.0024024767335504293
the O 0 0.0026006954722106457
dystrophin O 1 0.9439884424209595
gene O 0 0.0021987748332321644
was O 0 0.001329998834989965
performed O 0 0.0011199505534023046
to O 0 0.000499740126542747
define O 0 0.0010584902483969927
the O 0 0.000818608037661761
localization O 0 0.0020848566200584173
of O 0 0.0008833840838633478
deletions O 0 0.002995999064296484
and O 0 0.0008836291381157935
duplications O 0 0.003908458165824413
in O 0 0.0008741202764213085
relation O 0 0.001766063622198999
to O 0 0.001099233515560627
the O 0 0.0022075714077800512
different O 0 0.003573155030608177
DMD B-Disease 1 0.9997057318687439
promoters O 0 0.1359144151210785
. O 0 0.011464661918580532

Qualitative O 0 0.01124181505292654
analysis O 0 0.0034494001884013414
of O 0 0.0019727805629372597
the O 0 0.002123200334608555
Dp71 O 0 0.22854188084602356
transcript O 0 0.002821493661031127
and O 0 0.000893311167601496
testing O 0 0.0010532430605962873
for O 0 0.000602447078563273
the O 0 0.000745722558349371
specific O 0 0.0006580063491128385
first O 0 0.0007934844470582902
exon O 0 0.0028433692641556263
of O 0 0.0010279949055984616
Dp140 O 0 0.007043483201414347
were O 0 0.001266238745301962
also O 0 0.0014147828333079815
carried O 0 0.0031470905523747206
out O 0 0.0034771233331412077
. O 0 0.0064954599365592

Neuropsychological O 0 0.05613703280687332
analysis O 0 0.00578326964750886
assessed O 0 0.006547864060848951
verbal O 0 0.006850972305983305
and O 0 0.002426213352009654
visuospatial O 1 0.9569907784461975
intelligence O 0 0.004393105860799551
, O 0 0.001824122155085206
verbal O 0 0.009503183886408806
memory O 0 0.0659923255443573
, O 0 0.0017350269481539726
and O 0 0.0020696662832051516
reading O 0 0.007622294593602419
skills O 0 0.016103442758321762
. O 0 0.009933173656463623

Comparison O 0 0.00955495797097683
of O 0 0.0040395259857177734
molecular O 0 0.0046489546075463295
and O 0 0.002141662873327732
psychometric O 0 0.029650280252099037
findings O 0 0.0025865088682621717
demonstrated O 0 0.002518415916711092
that O 0 0.0008293315186165273
deletions O 0 0.002504344331100583
and O 0 0.0009151165722869337
duplications O 0 0.0047444794327020645
that O 0 0.0005493058706633747
were O 0 0.0005848148139193654
localized O 0 0.001974171493202448
in O 0 0.0007038413314148784
the O 0 0.0010040720226243138
distal O 0 0.11018843203783035
part O 0 0.001126896939240396
of O 0 0.0010060117347165942
the O 0 0.0015550219686701894
gene O 0 0.0015590315451845527
seemed O 0 0.0010898825712502003
to O 0 0.0006090233218856156
be O 0 0.0007149972952902317
preferentially O 0 0.0021383953280746937
associated O 0 0.0018440901767462492
with O 0 0.002456490183249116
cognitive B-Disease 1 0.8775339722633362
impairment I-Disease 1 0.9992813467979431
. O 0 0.014245729893445969

Two O 0 0.004653766751289368
altered O 0 0.005582211539149284
Dp71 O 0 0.010647647082805634
transcripts O 0 0.003676461521536112
and O 0 0.0012581305345520377
two O 0 0.0010580559028312564
deleted O 0 0.002387087792158127
Dp140 O 0 0.003881359938532114
DNA O 0 0.0012540562311187387
sequences O 0 0.000996405491605401
were O 0 0.0005458512459881604
found O 0 0.0006728800944983959
in O 0 0.0008551616338081658
four O 0 0.0015232762088999152
patients O 1 0.8961440324783325
with O 0 0.4207194149494171
severe O 1 0.9999998807907104
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9561142325401306

These O 0 0.0035508014261722565
findings O 0 0.0029511069878935814
suggest O 0 0.0017301496118307114
that O 0 0.0005478115053847432
some O 0 0.0005290736444294453
sequences O 0 0.0006799912662245333
located O 0 0.0006764120771549642
in O 0 0.00043172985897399485
the O 0 0.0007125708507373929
distal O 0 0.10850000381469727
part O 0 0.0010161801474168897
of O 0 0.0008001014939509332
the O 0 0.0010680524865165353
gene O 0 0.0008884581038728356
and O 0 0.0003880531876347959
, O 0 0.00039209393435157835
in O 0 0.0004165526188444346
particular O 0 0.0005552948568947613
, O 0 0.0006031261873431504
some O 0 0.0008006141288205981
DMD B-Disease 1 0.9988831877708435
isoforms O 0 0.0013983333483338356
expressed O 0 0.0009266858105547726
in O 0 0.00064988830126822
the O 0 0.001071352045983076
brain O 0 0.15407395362854004
may O 0 0.0006155053270049393
be O 0 0.00033106328919529915
related O 0 0.000535111699718982
to O 0 0.0005338337505236268
the O 0 0.0015767263248562813
cognitive B-Disease 1 0.9733192920684814
impairment I-Disease 1 0.9998220801353455
associated O 0 0.06327313184738159
with O 0 0.056026358157396317
DMD B-Disease 1 0.9999972581863403
. O 0 0.00590943219140172
. O 0 0.0075836447067558765

I1307K O 1 0.8924261927604675
APC O 1 0.9269199371337891
and O 0 0.003771906951442361
hMLH1 O 0 0.11912008374929428
mutations O 0 0.0022706002928316593
in O 0 0.0009919216390699148
a O 0 0.0012475211406126618
non O 0 0.003629633691161871
- O 0 0.03843870759010315
Jewish O 0 0.0019712592475116253
family O 0 0.0021084954496473074
with O 0 0.0031035877764225006
hereditary B-Disease 1 0.9999973773956299
non I-Disease 1 0.9999995231628418
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9598114490509033

We O 0 0.0055547538213431835
describe O 0 0.004336373880505562
a O 0 0.002888286951929331
French O 0 0.005819092504680157
Canadian O 0 0.10167582333087921
hereditary B-Disease 1 0.9999891519546509
non I-Disease 1 0.9999973773956299
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.999994158744812
HNPCC B-Disease 1 1.0
) O 0 0.05270397663116455
kindred O 1 0.7251009941101074
which O 0 0.0011915011564269662
carries O 0 0.0018671046709641814
a O 0 0.0020944043062627316
novel O 0 0.009240486659109592
truncating O 1 0.6176607012748718
mutation O 0 0.007772831711918116
in O 0 0.004934188909828663
hMLH1 O 0 0.2273743897676468
. O 0 0.011689742095768452

Interestingly O 0 0.0143533730879426
, O 0 0.0036739646457135677
the O 0 0.0033891291823238134
I1307K O 1 0.9699485898017883
APC O 1 0.9729102253913879
polymorphism O 0 0.004657865967601538
, O 0 0.0008079986437223852
associated O 0 0.0007014491129666567
with O 0 0.0004794939304701984
an O 0 0.0007148358272388577
increased O 0 0.008283163420855999
risk O 1 0.9059203863143921
of O 1 0.9964655637741089
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.15030360221862793
is O 0 0.0017406140686944127
also O 0 0.0007870574481785297
present O 0 0.0007937189657241106
in O 0 0.0007882459321990609
this O 0 0.0012418759288266301
family O 0 0.0036189332604408264
. O 0 0.005425672046840191

The O 0 0.0086361113935709
I1307K O 0 0.04784497618675232
polymorphism O 0 0.008002657443284988
has O 0 0.0020105831790715456
previously O 0 0.0015184112126007676
only O 0 0.000624094856902957
been O 0 0.0005804866086691618
identified O 0 0.0006963182240724564
in O 0 0.000497534463647753
individuals O 0 0.0005063634016551077
of O 0 0.000988141167908907
self O 0 0.4694730043411255
- O 1 0.9276857972145081
reported O 0 0.019027139991521835
Ashkenazi O 0 0.12407306581735611
Jewish O 0 0.006685975007712841
origins O 0 0.01184149831533432
. O 0 0.009439160116016865

In O 0 0.004443674813956022
addition O 0 0.002502355957403779
, O 0 0.0013157004723325372
in O 0 0.0009109829552471638
this O 0 0.0005651168175972998
family O 0 0.0009017276461236179
, O 0 0.0005663089687004685
there O 0 0.0005035717622376978
appears O 0 0.0006863740854896605
to O 0 0.00039853647467680275
be O 0 0.00031135763856582344
no O 0 0.0003771851188503206
relationship O 0 0.0005977143882773817
between O 0 0.00045774225145578384
the O 0 0.0008104352164082229
I1307K O 0 0.08524461835622787
polymorphism O 0 0.002010679803788662
and O 0 0.000621942977886647
the O 0 0.0006525132921524346
presence O 0 0.0009605564409866929
or O 0 0.0007519992650486529
absence O 0 0.0038060666993260384
of O 0 0.04074820131063461
cancer B-Disease 1 0.9999836683273315
. O 0 0.0052766213193535805
. O 0 0.008541080169379711

Identification O 0 0.006932056974619627
of O 0 0.00302229099906981
a O 0 0.0029418054036796093
novel O 0 0.007293302100151777
mutation O 0 0.0031261825934052467
of O 0 0.0015092509565874934
the O 0 0.0026195403188467026
CPO O 1 0.781231164932251
gene O 0 0.0016896872548386455
in O 0 0.0009878153214231133
a O 0 0.001961130416020751
Japanese O 0 0.09402735531330109
hereditary B-Disease 1 0.9987678527832031
coproporphyria I-Disease 1 0.9980493783950806
family O 0 0.0368819385766983
. O 0 0.009020322002470493

Hereditary B-Disease 1 0.9987228512763977
coproporphyria I-Disease 1 0.9996160268783569
( O 1 0.8086506128311157
HCP B-Disease 1 0.9998223185539246
) O 0 0.0027807343285530806
is O 0 0.001347832498140633
an O 0 0.0026305653154850006
autosomal B-Disease 1 0.9999126195907593
dominant I-Disease 1 0.999230146408081
disease I-Disease 1 0.9999995231628418
characterized O 1 0.9992071986198425
by O 0 0.2555844783782959
a O 1 0.9854845404624939
deficiency B-Disease 1 1.0
of I-Disease 1 0.9986478686332703
coproporphyrinogen I-Disease 1 0.9999997615814209
oxidase I-Disease 1 0.999993085861206
( O 0 0.45174503326416016
CPO O 1 0.9540894031524658
) O 0 0.0011246277717873454
caused O 0 0.0011651958338916302
by O 0 0.0005440938984975219
a O 0 0.0010005006333813071
mutation O 0 0.0015683007659390569
in O 0 0.0011241779429838061
the O 0 0.002871193690225482
CPO O 1 0.5884929299354553
gene O 0 0.008215500973165035
. O 0 0.007423863280564547

Only O 0 0.004516244865953922
11 O 0 0.0034307464957237244
mutations O 0 0.0025767215993255377
of O 0 0.0012200773926451802
the O 0 0.0014288843376562
gene O 0 0.0015152969863265753
have O 0 0.0007383522461168468
been O 0 0.0011695893481373787
reported O 0 0.0027910592034459114
in O 0 0.004156269133090973
HCP B-Disease 1 0.9997780919075012
patients O 1 0.914216160774231
. O 0 0.009612048044800758

We O 0 0.005777245853096247
report O 0 0.004978574346750975
another O 0 0.0033527298364788294
mutation O 0 0.00354309962131083
in O 0 0.001587645267136395
a O 0 0.0030035858508199453
Japanese O 0 0.043324146419763565
family O 0 0.010335407219827175
. O 0 0.008923988789319992

Polymerase O 0 0.0361843965947628
chain O 0 0.019636470824480057
reaction O 0 0.009451455436646938
- O 0 0.03884681314229965
single O 0 0.0028339035343378782
strand O 0 0.0038015604950487614
conformational O 0 0.0033163889311254025
polymorphism O 0 0.002970621222630143
and O 0 0.0009242288069799542
direct O 0 0.0009968214435502887
sequence O 0 0.0011979800183326006
analyses O 0 0.0014727481175214052
demonstrated O 0 0.00158900476526469
a O 0 0.0011679287999868393
C O 0 0.0022259079851210117
to O 0 0.0009522598120383918
T O 0 0.0027823601849377155
substitution O 0 0.001319429138675332
in O 0 0.0006871697842143476
exon O 0 0.0024651754647493362
1 O 0 0.0009972084080800414
of O 0 0.0006806052988395095
the O 0 0.000971471075899899
CPO O 0 0.0047372072003781796
gene O 0 0.0009830619674175978
at O 0 0.000800476293079555
nucleotide O 0 0.001203414867632091
position O 0 0.0008572330698370934
85 O 0 0.0011554340599104762
, O 0 0.0006701690144836903
which O 0 0.0005726394010707736
lies O 0 0.0011495574144646525
in O 0 0.0007720345165580511
the O 0 0.0013100485084578395
putative O 0 0.012748501263558865
presequence O 0 0.01438513956964016
for O 0 0.0016925466479733586
targeting O 0 0.0034418620634824038
to O 0 0.0031097859609872103
mitochondria O 0 0.011049064807593822
. O 0 0.008322308771312237

This O 0 0.005101603921502829
mutation O 0 0.0047742570750415325
changes O 0 0.001961843576282263
the O 0 0.0020696870051324368
codon O 0 0.004571723751723766
for O 0 0.0014672770630568266
glutamine O 0 0.004112285561859608
to O 0 0.0011354575399309397
a O 0 0.001656786072999239
termination O 0 0.004502043593674898
codon O 0 0.004583640489727259
at O 0 0.0022410512901842594
amino O 0 0.003040146781131625
acid O 0 0.004227068740874529
position O 0 0.004272733815014362
29 O 0 0.008203424513339996
. O 0 0.008072507567703724

MaeI O 0 0.07450686395168304
restriction O 0 0.008307913318276405
analysis O 0 0.0035966821014881134
showed O 0 0.0029931787867099047
two O 0 0.0012624351074919105
other O 0 0.0010194727219641209
carriers O 0 0.0025234564673155546
in O 0 0.0016322016017511487
the O 0 0.0030281287617981434
family O 0 0.007078643888235092
. O 0 0.008410257287323475

The O 0 0.01733960211277008
C O 1 0.9872934818267822
- O 1 0.9958166480064392
T O 1 0.9490562081336975
mutation O 0 0.0031725154258310795
is O 0 0.0009800862753763795
located O 0 0.0011303588980808854
within O 0 0.0006295215571299195
a O 0 0.000851180637255311
recently O 0 0.0013635166687890887
proposed O 0 0.0012515269918367267
putative O 0 0.002441638382151723
alternative O 0 0.0012179131153970957
translation O 0 0.0016940265195444226
initiation O 0 0.0026249890215694904
codon O 0 0.003719916334375739
( O 0 0.0021820354741066694
TIC O 1 0.6586620211601257
- O 0 0.0028313675429672003
1 O 0 0.0010692313080653548
) O 0 0.0006273111794143915
, O 0 0.000487022683955729
supporting O 0 0.0008694448042660952
that O 0 0.0006492871907539666
TIC O 1 0.9251026511192322
- O 0 0.0031223841942846775
1 O 0 0.0009632260771468282
is O 0 0.0005399492802098393
the O 0 0.0006492986576631665
real O 0 0.0016035883454605937
TIC O 0 0.4427061080932617
rather O 0 0.0012696231715381145
than O 0 0.0014339472400024533
TIC O 1 0.9225955009460449
- O 0 0.007584602106362581
2 O 0 0.0039167930372059345
. O 0 0.003289647400379181
. O 0 0.006122151389718056

Human B-Disease 0 0.02810610458254814
complement I-Disease 1 0.8022719621658325
factor I-Disease 1 0.9984258413314819
H I-Disease 1 0.999998927116394
deficiency I-Disease 1 1.0
associated O 1 0.9996811151504517
with O 1 0.9999451637268066
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999251365661621

This O 0 0.003807032248005271
study O 0 0.0026534392964094877
reports O 0 0.0018531318055465817
on O 0 0.0011185090988874435
six O 0 0.0010617990046739578
cases O 0 0.0015035540563985705
of O 0 0.011077267117798328
deficiency B-Disease 1 0.9999948740005493
in I-Disease 0 0.00169662747066468
the I-Disease 0 0.001504809013567865
human I-Disease 0 0.0013794511323794723
complement I-Disease 0 0.0019325846806168556
regulatory I-Disease 0 0.002171479631215334
protein I-Disease 0 0.0014355165185406804
Factor I-Disease 0 0.002620949875563383
H I-Disease 1 0.6294699907302856
( O 0 0.0017410035943612456
FH O 1 0.5127410888671875
) O 0 0.0006295638740994036
in O 0 0.000425545935286209
the O 0 0.0006032710080035031
context O 0 0.0012040591100230813
of O 0 0.0026300251483917236
an O 1 0.9690818786621094
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9993129968643188

Five O 0 0.003589530708268285
of O 0 0.0017858595820143819
the O 0 0.001365848002023995
cases O 0 0.0011326692765578628
were O 0 0.0007548097637481987
observed O 0 0.0008884920389391482
in O 0 0.0007623708806931973
children O 0 0.004697964061051607
presenting O 1 0.8035926222801208
with O 1 0.9930261373519897
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999998807907104
HUS B-Disease 1 1.0
) O 1 0.9850181937217712
. O 0 0.015268796123564243

Two O 0 0.003353410167619586
of O 0 0.0022694177459925413
the O 0 0.002523640403524041
children O 0 0.024446183815598488
exhibited O 1 0.83846515417099
a O 1 0.9079387784004211
homozygous O 1 0.9998002648353577
deficiency O 1 0.9999995231628418
characterized O 1 0.9118165373802185
by O 0 0.0010590391466394067
the O 0 0.0009271282469853759
absence O 0 0.001581687480211258
of O 0 0.000759829068556428
the O 0 0.0011387845734134316
150 O 0 0.002993440954014659
- O 0 0.45360010862350464
kD O 1 0.7786034345626831
form O 0 0.0007941134390421212
of O 0 0.0009295602212660015
Factor O 0 0.0089038647711277
H O 0 0.2813529968261719
and O 0 0.0005303391953930259
the O 0 0.0005064478609710932
presence O 0 0.0006266141426749527
, O 0 0.0004213189531583339
upon O 0 0.0005941910203546286
immunoblotting O 0 0.0018751559546217322
, O 0 0.0005267789820209146
of O 0 0.0005526129389181733
the O 0 0.0007925829268060625
42 O 0 0.0030865974258631468
- O 0 0.2603611946105957
kD O 1 0.9623821377754211
Factor O 0 0.0028481469489634037
H O 0 0.023597920313477516
- O 0 0.0015501088928431273
like O 0 0.000696456350851804
protein O 0 0.0009773625060915947
1 O 0 0.0010772746754810214
( O 0 0.0012550618266686797
FHL O 0 0.07253171503543854
- O 0 0.0018178168684244156
1 O 0 0.0009938068687915802
) O 0 0.0006310431053861976
and O 0 0.0005135172395966947
other O 0 0.0006495319539681077
FH O 1 0.9885455965995789
- O 0 0.007164220325648785
related O 0 0.001835279748775065
protein O 0 0.0021325519774109125
( O 0 0.0024465422611683607
FHR O 0 0.07101104408502579
) O 0 0.003133886493742466
bands O 0 0.0066254716366529465
. O 0 0.007416017819195986

Southern O 0 0.014193753711879253
blot O 0 0.025614580139517784
and O 0 0.0032244345638900995
PCR O 0 0.005335941910743713
analysis O 0 0.0016571664018556476
of O 0 0.0010878313332796097
DNA O 0 0.0013867523521184921
of O 0 0.0008428285946138203
one O 0 0.0011145458556711674
patient O 0 0.46840545535087585
with O 0 0.003990484401583672
homozygous O 1 0.9806987643241882
deficiency O 1 0.9999958276748657
ruled O 0 0.0139223113656044
out O 0 0.0007113442406989634
the O 0 0.0006024172762408853
presence O 0 0.0006482675671577454
of O 0 0.0005438927328214049
a O 0 0.0007055678870528936
large O 0 0.0007038949406705797
deletion O 0 0.0017797210020944476
of O 0 0.0009687688434496522
the O 0 0.005345010198652744
FH O 1 0.9999639987945557
gene O 0 0.0016651040641590953
as O 0 0.0006811261991970241
the O 0 0.001186760375276208
underlying O 1 0.7281642556190491
defect O 1 0.9895340800285339
for O 0 0.004437561612576246
the O 0 0.40321600437164307
deficiency O 1 0.999998927116394
. O 0 0.01961861550807953

The O 0 0.004539129324257374
other O 0 0.0015430304920300841
four O 0 0.0012915809638798237
children O 0 0.0022217966616153717
presented O 0 0.0035650725476443768
with O 0 0.006813427433371544
heterozygous O 1 0.9519400596618652
deficiency O 1 0.9999971389770508
and O 0 0.0017898217774927616
exhibited O 0 0.1085599809885025
a O 0 0.0020875290501862764
normal O 0 0.003113726619631052
immunoblotting O 0 0.1870116889476776
pattern O 0 0.0015951896784827113
of O 0 0.0008173219976015389
proteins O 0 0.0010506630642339587
of O 0 0.0015116020804271102
the O 0 0.010623963549733162
FH O 1 0.9998863935470581
family O 0 0.009835722856223583
. O 0 0.007803618907928467

Factor B-Disease 1 0.9990733861923218
H I-Disease 1 0.9999923706054688
deficiency I-Disease 1 0.9999970197677612
is O 0 0.0053824507631361485
the O 0 0.006945738568902016
only O 0 0.006320908199995756
complement B-Disease 1 0.9985573887825012
deficiency I-Disease 1 0.9999998807907104
associated O 1 0.801160454750061
with O 0 0.3614808917045593
HUS B-Disease 1 0.9999983310699463
. O 0 0.0282913725823164

These O 0 0.0031082741916179657
observations O 0 0.003846053034067154
suggest O 0 0.003031095489859581
a O 0 0.0017156791873276234
role O 0 0.002111926442012191
for O 0 0.0019455706933513284
FH O 1 0.9999536275863647
and O 0 0.00883819442242384
/ O 1 0.9612888097763062
or O 0 0.0031494577415287495
FH O 1 0.9973317384719849
receptors O 0 0.0020941433031111956
in O 0 0.0010994053445756435
the O 0 0.002275977749377489
pathogenesis O 1 0.9994664788246155
of O 1 0.9616991281509399
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.1326926052570343
. O 0 0.013427535071969032

Further O 0 0.0055481065064668655
evidence O 0 0.0028345531318336725
for O 0 0.001756350859068334
a O 0 0.001956006046384573
major O 0 0.0033647329546511173
ancient O 0 0.2728915810585022
mutation O 1 0.9992688298225403
underlying O 1 0.999995231628418
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.7357672452926636
linkage O 1 0.9951809644699097
disequilibrium O 1 0.987449049949646
studies O 0 0.002137615345418453
in O 0 0.0013488322729244828
the O 0 0.002144116209819913
Japanese O 0 0.010157584212720394
population O 0 0.004914197605103254
. O 0 0.007369821425527334

The O 1 0.8720369338989258
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 1.0
( O 1 0.9998968839645386
DM B-Disease 1 0.9999998807907104
) O 0 0.008208094164729118
mutation O 0 0.0033952551893889904
is O 0 0.0009325119899585843
an O 0 0.0009820276172831655
unstable O 1 0.7053391337394714
( O 0 0.008450803346931934
CTG O 1 0.982973575592041
) O 0 0.0011566426837816834
n O 0 0.0014378599589690566
repeat O 0 0.0013167859287932515
, O 0 0.0006059772567823529
present O 0 0.0005860701203346252
at O 0 0.0005154676036909223
a O 0 0.0005435748607851565
copy O 0 0.0006846741889603436
number O 0 0.000425360951339826
of O 0 0.0005666544893756509
5 O 0 0.0008748347172513604
- O 0 0.0012871712679043412
37 O 0 0.0010739128338173032
repeats O 0 0.0011264075292274356
on O 0 0.0005504668224602938
normal O 0 0.0008211306994780898
chromosomes O 0 0.000886466761585325
but O 0 0.0005431501194834709
amplified O 0 0.0012549195671454072
to O 0 0.0006672530435025692
50 O 0 0.0012309947051107883
- O 0 0.002604640321806073
3000 O 0 0.004789501894265413
copies O 0 0.003297948744148016
on O 0 0.0042775156907737255
DM B-Disease 1 0.9924529194831848
chromosomes O 0 0.014575754292309284
. O 0 0.00998116284608841

Previous O 0 0.00787633378058672
findings O 0 0.004475580528378487
in O 0 0.002261427463963628
Caucasian O 0 0.13540063798427582
populations O 0 0.0021027163602411747
of O 0 0.0021693077869713306
a O 1 0.8759596943855286
DM B-Disease 1 1.0
founder O 1 0.9989573955535889
chromosome O 0 0.04902486130595207
raise O 0 0.0011777994222939014
a O 0 0.0007115714251995087
question O 0 0.0007027598912827671
about O 0 0.0004935941542498767
the O 0 0.0005276707815937698
molecular O 0 0.000812385231256485
events O 0 0.0007392780389636755
involved O 0 0.0008047758601605892
in O 0 0.000853043282404542
the O 0 0.001838024822063744
expansion O 0 0.008411840535700321
mutation O 0 0.011350508779287338
. O 0 0.006048287730664015

To O 0 0.0051155975088477135
investigate O 0 0.0056252568028867245
whether O 0 0.0025266031734645367
a O 0 0.002102083992213011
founder O 0 0.045554373413324356
chromosome O 0 0.0037144452799111605
for O 0 0.0011269935639575124
the O 0 0.01460178941488266
DM B-Disease 1 0.9999994039535522
mutation O 0 0.005793714430183172
exists O 0 0.0008703222265467048
in O 0 0.0005347757251001894
the O 0 0.0006030969088897109
Japanese O 0 0.0017784913070499897
population O 0 0.0006044722395017743
, O 0 0.0005449372692964971
we O 0 0.0005182293825782835
genotyped O 0 0.00206423900090158
families O 0 0.0006229870487004519
using O 0 0.000750181614421308
polymorphic O 0 0.0021675354801118374
markers O 0 0.001593897002749145
near O 0 0.0013588117435574532
the O 0 0.0013024333165958524
( O 0 0.002314615296199918
CTG O 0 0.22945910692214966
) O 0 0.0018498448189347982
n O 0 0.003618479473516345
repeat O 0 0.004217874258756638
region O 0 0.002836778061464429
and O 0 0.002567124320194125
constructed O 0 0.011332741938531399
haplotypes O 0 0.027702055871486664
. O 0 0.010950627736747265

Six O 0 0.005951086524873972
different O 0 0.002577034058049321
haplotypes O 0 0.007611626293510199
were O 0 0.002113558351993561
found O 0 0.002141703851521015
and O 0 0.003782829502597451
DM B-Disease 1 0.9999923706054688
alleles O 0 0.00852314941585064
were O 0 0.0022818585857748985
always O 0 0.004586114082485437
haplotype O 0 0.013278390280902386
A O 0 0.008401329629123211
. O 0 0.00913296639919281

To O 0 0.0034605576656758785
find O 0 0.002552198711782694
an O 0 0.0013088001869618893
origin O 0 0.001152324490249157
of O 0 0.0011032156180590391
the O 0 0.00155385653488338
( O 0 0.003711251076310873
CTG O 1 0.9776250123977661
) O 0 0.0011738865869119763
n O 0 0.001574561232700944
repeat O 0 0.0016172158066183329
mutation O 0 0.0009030784713104367
and O 0 0.00032412513974122703
to O 0 0.0003534539428073913
investigate O 0 0.0007796988356858492
the O 0 0.0005694249994121492
mechanism O 0 0.0008557526161894202
of O 0 0.0005848020664416254
the O 0 0.0006994015420787036
expansion O 0 0.001308236736804247
mutation O 0 0.0009471464436501265
in O 0 0.0004789343511220068
the O 0 0.0005560910212807357
Japanese O 0 0.0014125091256573796
population O 0 0.00044390512630343437
we O 0 0.0003348964382894337
have O 0 0.000318708858685568
studied O 0 0.0008330420823767781
90 O 0 0.0012123729102313519
Japanese O 0 0.006893177982419729
DM B-Disease 1 0.9996414184570312
families O 0 0.0013233998324722052
comprising O 0 0.001749885967001319
190 O 0 0.002420747885480523
affected O 0 0.0016839058371260762
and O 0 0.001320241717621684
130 O 0 0.004010430537164211
unaffected O 0 0.007175750099122524
members O 0 0.003668395336717367
. O 0 0.006376135163009167

The O 0 0.006481000687927008
results O 0 0.003497711382806301
suggest O 0 0.002168904058635235
that O 0 0.0008372968877665699
a O 0 0.0009797164238989353
few O 0 0.0007814688142389059
common O 0 0.0009734523482620716
ancestral O 0 0.0025254639331251383
mutations O 0 0.0011896244250237942
in O 0 0.0005483676213771105
both O 0 0.0005838569486513734
Caucasian O 0 0.3011801540851593
and O 0 0.000755096843931824
Japanese O 0 0.029013697057962418
populations O 0 0.0006754291243851185
have O 0 0.0003394106461200863
originated O 0 0.0007321833982132375
by O 0 0.00039350020233541727
expansion O 0 0.0007224578876048326
of O 0 0.0005112122744321823
an O 0 0.0006493387627415359
ancestral O 0 0.0026021823287010193
n O 0 0.0021933061070740223
= O 0 0.0019134314497932792
5 O 0 0.000925807747989893
repeat O 0 0.0013868336100131273
to O 0 0.0008294896106235683
n O 0 0.0024151913821697235
= O 0 0.003560469951480627
19 O 0 0.002816092222929001
- O 0 0.004493130370974541
37 O 0 0.006239961367100477
copies O 0 0.0069930218160152435
. O 0 0.008234621956944466

These O 0 0.004027736838907003
data O 0 0.0033430815674364567
support O 0 0.002658116165548563
multistep O 0 0.007352567743510008
models O 0 0.0026141901034861803
of O 0 0.00222570076584816
triplet O 1 0.8710445165634155
repeat O 0 0.007917831651866436
expansion O 0 0.0017398380441591144
that O 0 0.0005501437117345631
have O 0 0.00042368433787487447
been O 0 0.0005321212229318917
proposed O 0 0.0008755569579079747
for O 0 0.0007664826698601246
both O 0 0.0017622546292841434
DM B-Disease 1 0.9999970197677612
and O 0 0.01377605739980936
Friedreichs B-Disease 1 0.999570906162262
ataxia I-Disease 1 0.9999703168869019
. O 0 0.005298297852277756
. O 0 0.008440197445452213

The O 0 0.006008930969983339
molecular O 0 0.005028683692216873
basis O 0 0.003899687435477972
of O 0 0.4918704628944397
C6 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999995231628418
in O 0 0.003779625054448843
the O 0 0.0033022621646523476
western O 0 0.0038732250686734915
Cape O 0 0.1457120031118393
, O 0 0.002224654657766223
South O 0 0.004298298619687557
Africa O 0 0.007429234217852354
. O 0 0.006387715227901936

Deficiency B-Disease 1 0.9997606873512268
of I-Disease 0 0.006806677207350731
the I-Disease 0 0.008334795944392681
sixth I-Disease 1 0.9255679845809937
component I-Disease 0 0.10092880576848984
of I-Disease 0 0.003321090480312705
human I-Disease 0 0.04516766965389252
complement I-Disease 1 0.6150222420692444
( O 0 0.11227717250585556
C6 O 1 0.9982907176017761
) O 0 0.0008368829730898142
has O 0 0.0004991811001673341
been O 0 0.00041788301314227283
reported O 0 0.0005180911393836141
in O 0 0.0003057459834963083
a O 0 0.0003938676090911031
number O 0 0.0002985559112858027
of O 0 0.00039639868191443384
families O 0 0.000513009144924581
from O 0 0.0004785113560501486
the O 0 0.0006791246705688536
western O 0 0.0013513227459043264
Cape O 0 0.005240685772150755
, O 0 0.0018407212337478995
South O 0 0.0038786923978477716
Africa O 0 0.006155398208647966
. O 0 0.0068994746543467045

Meningococcal B-Disease 1 0.9999978542327881
disease I-Disease 1 0.9999982118606567
is O 0 0.04933258146047592
endemic O 1 0.9415646195411682
in O 0 0.001457520411349833
the O 0 0.0014470593305304646
Cape O 0 0.005321328993886709
and O 0 0.0006430975045077503
almost O 0 0.0006183128571137786
all O 0 0.0004361279134172946
pedigrees O 0 0.0019313900265842676
of O 0 0.0015203151851892471
total O 1 0.9244271516799927
C6 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
( O 0 0.27892330288887024
C6Q0 O 1 0.99382084608078
) O 0 0.0010488638654351234
have O 0 0.0005970174679532647
been O 0 0.0007682603900320828
ascertained O 0 0.0033205808140337467
because O 0 0.0016268069157376885
of O 0 0.011112640611827374
recurrent O 1 0.9999991655349731
disease O 1 0.9999995231628418
. O 0 0.25669747591018677

We O 0 0.004374870099127293
have O 0 0.0018276001792401075
sequenced O 0 0.0033945227041840553
the O 0 0.0015732109313830733
expressed O 0 0.0017491638427600265
exons O 0 0.002604618202894926
of O 0 0.00120345049072057
the O 0 0.0022993485908955336
C6 O 1 0.9974825978279114
gene O 0 0.0012659631902351975
from O 0 0.0005130118224769831
selected O 0 0.0007099183276295662
cases O 0 0.000620573409833014
and O 0 0.0004482741351239383
have O 0 0.00032373692374676466
found O 0 0.00041501555824652314
three O 0 0.00044632662320509553
molecular O 0 0.0012336528161540627
defects O 0 0.45921337604522705
leading O 0 0.0037358941044658422
to O 0 0.0009648058912716806
total O 1 0.6096450686454773
deficiency O 1 0.9999998807907104
879delG O 1 0.99946528673172
, O 0 0.0011030854657292366
which O 0 0.0004458605544641614
is O 0 0.0005036816583015025
the O 0 0.0005960526177659631
common O 0 0.0010144824627786875
defect O 0 0.39045533537864685
in O 0 0.0006388092297129333
the O 0 0.0008972948999144137
Cape O 0 0.009078532457351685
and O 0 0.0007598015945404768
hitherto O 0 0.006649964489042759
unreported O 0 0.0034701363183557987
, O 0 0.0007561124511994421
and O 0 0.0006611943827010691
1195delC O 0 0.043487437069416046
and O 0 0.000875299156177789
1936delG O 0 0.06183254346251488
, O 0 0.0008274749270640314
which O 0 0.0005555569659918547
have O 0 0.00042358055361546576
been O 0 0.00062078662449494
previously O 0 0.0009638287592679262
reported O 0 0.0013606634456664324
in O 0 0.0013009746326133609
African O 0 0.0043784272857010365
- O 0 0.07793553173542023
Americans O 0 0.006637926213443279
. O 0 0.006733855698257685

We O 0 0.004922968801110983
also O 0 0.0023884112015366554
show O 0 0.0016898063477128744
that O 0 0.000881705607753247
the O 0 0.0013629826717078686
879delG O 0 0.14178775250911713
and O 0 0.0017396663315594196
1195delC O 1 0.8290212154388428
defects O 1 0.7212010622024536
are O 0 0.0007366625941358507
associated O 0 0.0013233247445896268
with O 0 0.001874858164228499
characteristic O 1 0.9880335330963135
C6 O 1 0.9999990463256836
/ O 1 0.9990422129631042
C7 O 1 0.9995617270469666
region O 0 0.0032919386867433786
DNA O 0 0.0028101131319999695
marker O 0 0.004910072311758995
haplotypes O 0 0.004317405167967081
, O 0 0.0009280156227760017
although O 0 0.000851123477332294
small O 0 0.0011141998693346977
variations O 0 0.002191344741731882
were O 0 0.002282071392983198
observed O 0 0.005605816375464201
. O 0 0.0062521337531507015

The O 0 0.01358708180487156
1936delG O 1 0.9782851338386536
defect O 1 0.9433352947235107
was O 0 0.005919307004660368
observed O 0 0.00189847347792238
only O 0 0.0007850630790926516
once O 0 0.0008708671666681767
in O 0 0.0005657101282849908
the O 0 0.0008034349302761257
Cape O 0 0.004205533768981695
, O 0 0.0007998720975592732
but O 0 0.0006360269035212696
its O 0 0.00084252143278718
associated O 0 0.001535905641503632
haplotype O 0 0.004821652080863714
could O 0 0.0017205232288688421
be O 0 0.002392886206507683
deduced O 0 0.011306427419185638
. O 0 0.00811699591577053

The O 0 0.004877377301454544
data O 0 0.002586750779300928
from O 0 0.0014574052765965462
the O 0 0.0014598985435441136
haplotypes O 0 0.003724607639014721
indicate O 0 0.0012195081217214465
that O 0 0.0004145120328757912
these O 0 0.0003497712023090571
three O 0 0.0004773310211021453
molecular O 0 0.001185114961117506
defects O 0 0.110385961830616
account O 0 0.0007657518144696951
for O 0 0.000488399644382298
the O 0 0.0009123620693571866
defects O 1 0.7729083895683289
in O 0 0.0004611495533026755
all O 0 0.00036612313124351203
the O 0 0.00063049525488168
38 O 0 0.0015127618098631501
unrelated O 0 0.002250530058518052
C6Q0 O 0 0.11029195040464401
individuals O 0 0.0005572790396399796
we O 0 0.00045287690591067076
have O 0 0.00043676115456037223
studied O 0 0.0013476298190653324
from O 0 0.0014052416663616896
the O 0 0.0029592402279376984
Cape O 0 0.020700696855783463
. O 0 0.008521473035216331

We O 0 0.003970312420278788
have O 0 0.0015128187369555235
also O 0 0.0013543061213567853
observed O 0 0.0013428879901766777
the O 0 0.0012571393745020032
879delG O 0 0.02386179193854332
defect O 0 0.010389711707830429
in O 0 0.000886489637196064
two O 0 0.0011211108649149537
Dutch O 1 0.9635211825370789
C6 B-Disease 1 0.9999997615814209
- I-Disease 1 0.9986345171928406
deficient I-Disease 1 0.9982932209968567
kindreds O 0 0.10379091650247574
, O 0 0.0008818636415526271
but O 0 0.0005575669347308576
the O 0 0.0009532174444757402
879delG O 0 0.2433328777551651
defect O 0 0.23287920653820038
in O 0 0.0007775116246193647
the O 0 0.0010385706555098295
Cape O 0 0.010047055780887604
probably O 0 0.0010691079078242183
did O 0 0.0005983576411381364
not O 0 0.000393551163142547
come O 0 0.0005377546767704189
from O 0 0.0008061862317845225
The O 0 0.0013913466827943921
Netherlands O 0 0.004516358952969313
. O 0 0.0029363639187067747
. O 0 0.005715865641832352

Complement B-Disease 1 0.9991111159324646
C7 I-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.999998927116394
: O 0 0.005997759755700827
seven O 0 0.0033797668293118477
further O 0 0.002593782963231206
molecular O 0 0.005579219199717045
defects O 1 0.879094123840332
and O 0 0.0018856126116588712
their O 0 0.0019180530216544867
associated O 0 0.005725945346057415
marker O 0 0.34976381063461304
haplotypes O 0 0.06191471591591835
. O 0 0.009886742569506168

Seven O 0 0.007098159287124872
further O 0 0.004734510090202093
molecular O 0 0.005835739895701408
bases O 0 0.005655157845467329
of O 0 0.41079989075660706
C7 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
are O 0 0.00621533440425992
described O 0 0.06088751554489136
. O 0 0.010812097229063511

All O 0 0.0036990828812122345
these O 0 0.0018321954412385821
new O 0 0.0018921195296570659
molecular O 0 0.0030186281073838472
defects O 1 0.5901798009872437
involve O 0 0.0022265331353992224
single O 0 0.002523086965084076
- O 0 0.021434227004647255
nucleotide O 0 0.00184379902202636
events O 0 0.0009185270173475146
, O 0 0.0007343803881667554
deletions O 0 0.0015773650957271457
and O 0 0.000623534491751343
substitutions O 0 0.0012484845938161016
, O 0 0.0006033366662450135
some O 0 0.00045493844663724303
of O 0 0.0006628315895795822
which O 0 0.0007164477719925344
alter O 0 0.0017660896992310882
splice O 0 0.0029270476661622524
sites O 0 0.001077804947271943
, O 0 0.0010184966959059238
and O 0 0.0014035479398444295
others O 0 0.0032253130339086056
codons O 0 0.011729809455573559
. O 0 0.008008326403796673

They O 0 0.003431613789871335
are O 0 0.0017646789783611894
distributed O 0 0.002132214605808258
along O 0 0.0020315044093877077
the O 0 0.0024252973962575197
C7 O 1 0.9622520208358765
gene O 0 0.0019091162830591202
, O 0 0.0009857964469119906
but O 0 0.0007399492897093296
predominantly O 0 0.001228349981829524
towards O 0 0.0015035112155601382
the O 0 0.001826705178245902
3 O 0 0.003496867138892412
end O 0 0.004991402383893728
. O 0 0.00628682691603899

All O 0 0.003423702670261264
were O 0 0.0021641922648996115
found O 0 0.00216916436329484
in O 0 0.0020911977626383305
compound O 0 0.008612672798335552
heterozygous O 0 0.00873689353466034
individuals O 0 0.004379238002002239
. O 0 0.007377514615654945

The O 0 0.2570051848888397
C6 O 1 0.9999880790710449
/ O 1 0.9995409250259399
C7 O 1 0.9997695088386536
marker O 0 0.4864244759082794
haplotypes O 0 0.04348668456077576
associated O 0 0.0029320032335817814
with O 0 0.001834163093008101
most O 0 0.0029141129925847054
C7 B-Disease 1 0.9999372959136963
defects I-Disease 1 0.9930411577224731
are O 0 0.0024121052119880915
tabulated O 0 0.01042608916759491
. O 0 0.003943847957998514
. O 0 0.007282586768269539

A O 0 0.01030783262103796
genome O 0 0.008514353074133396
- O 0 0.005263755563646555
wide O 0 0.0019236478256061673
search O 0 0.002045917557552457
for O 0 0.0013768536737188697
chromosomal O 0 0.01955435425043106
loci O 0 0.009166199713945389
linked O 0 0.006475967820733786
to O 0 0.0016103596426546574
mental O 1 0.9995429515838623
health O 1 0.9888775944709778
wellness O 1 0.9982544779777527
in O 0 0.0014316473389044404
relatives O 0 0.0026279017329216003
at O 0 0.0017189973732456565
high O 0 0.23531296849250793
risk O 1 0.9428919553756714
for O 1 0.6475595831871033
bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999997615814209
among O 1 0.5738443732261658
the O 0 0.24468263983726501
Old O 1 0.9342052340507507
Order O 0 0.009038720279932022
Amish O 0 0.061276037245988846
. O 0 0.008363135159015656

Bipolar B-Disease 1 0.9999998807907104
affective I-Disease 1 0.9999992847442627
disorder I-Disease 1 0.9999998807907104
( O 1 0.9999476671218872
BPAD B-Disease 1 1.0
; O 1 0.9999271631240845
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 1 0.5808900594711304
is O 0 0.0017748938407748938
characterized O 0 0.01966330222785473
by O 0 0.0007473176228813827
episodes O 0 0.002193635795265436
of O 0 0.013074999675154686
mania B-Disease 1 0.9999974966049194
and O 0 0.3438405692577362
/ O 1 0.9965008497238159
or O 0 0.0037257454823702574
hypomania B-Disease 1 0.9998893737792969
interspersed O 0 0.013280196115374565
with O 0 0.0017174424137920141
periods O 0 0.006971039809286594
of O 0 0.05842221528291702
depression B-Disease 1 0.9999918937683105
. O 0 0.03152601048350334

Compelling O 0 0.011503745801746845
evidence O 0 0.005341489799320698
supports O 0 0.004808691330254078
a O 0 0.0020587199833244085
significant O 0 0.001872377353720367
genetic O 0 0.0022724538575857878
component O 0 0.0023471955209970474
in O 0 0.0011098893592134118
the O 0 0.002171665197238326
susceptibility O 0 0.34816184639930725
to O 0 0.0023684187326580286
develop O 0 0.012314505875110626
BPAD B-Disease 1 0.9905707836151123
. O 0 0.009027967229485512

To O 0 0.003714354010298848
date O 0 0.0033457977697253227
, O 0 0.0015211160061880946
however O 0 0.001151253585703671
, O 0 0.000997725292108953
linkage O 0 0.00212790141813457
studies O 0 0.0009269281872548163
have O 0 0.0004866115050390363
attempted O 0 0.0010738044511526823
only O 0 0.0004405213985592127
to O 0 0.0005096328677609563
identify O 0 0.0010197549127042294
chromosomal O 0 0.005489975214004517
loci O 0 0.003128430340439081
that O 0 0.0007198721286840737
cause O 0 0.0019289640476927161
or O 0 0.0008032344048842788
increase O 0 0.0011118523543700576
the O 0 0.001311004627496004
risk O 0 0.005900201853364706
of O 0 0.005786014720797539
developing O 1 0.5042621493339539
BPAD B-Disease 1 0.9997645020484924
. O 0 0.012440557591617107

To O 0 0.004132142756134272
determine O 0 0.002507574623450637
whether O 0 0.0012476214906200767
there O 0 0.000883242697454989
could O 0 0.0008083728025667369
be O 0 0.0007515312172472477
protective O 0 0.005261403974145651
alleles O 0 0.0015283701941370964
that O 0 0.0005167333292774856
prevent O 0 0.001084326533600688
or O 0 0.0006231207516975701
reduce O 0 0.0012954286066815257
the O 0 0.00068754079984501
risk O 0 0.0023503543343394995
of O 0 0.0010745857143774629
developing O 0 0.22263143956661224
BPAD B-Disease 1 0.9993316531181335
, O 0 0.0005744078080169857
similar O 0 0.00040943321073427796
to O 0 0.00028815853875130415
what O 0 0.0002593510434962809
is O 0 0.00028850301168859005
observed O 0 0.00037657865323126316
in O 0 0.0003561129269655794
other O 0 0.00046830688370391726
genetic B-Disease 0 0.32457026839256287
disorders I-Disease 1 0.9999840259552002
, O 0 0.0029487169813364744
we O 0 0.0007742735324427485
used O 0 0.0019680694676935673
mental O 1 0.9999700784683228
health O 1 0.9997751116752625
wellness O 1 0.9999710321426392
( O 0 0.029169166460633278
absence O 0 0.0342746376991272
of O 0 0.01579425297677517
any O 0 0.10596194863319397
psychiatric B-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999997615814209
) O 0 0.02224314771592617
as O 0 0.0009241838124580681
the O 0 0.0009563668281771243
phenotype O 0 0.0021106465719640255
in O 0 0.0005251886905170977
our O 0 0.0007288341294042766
genome O 0 0.0016631964826956391
- O 0 0.001996674807742238
wide O 0 0.0010978103382512927
linkage O 0 0.0025845449417829514
scan O 0 0.001502852770499885
of O 0 0.000650991452857852
several O 0 0.000613484182395041
large O 0 0.0010297057451680303
multigeneration O 0 0.034147731959819794
Old O 0 0.0032039678189903498
Order O 0 0.0012947558425366879
Amish O 0 0.004649901296943426
pedigrees O 0 0.004008815158158541
exhibiting O 0 0.003309867111966014
an O 0 0.001307498780079186
extremely O 0 0.0034418602008372545
high O 0 0.008578507229685783
incidence O 1 0.9389500617980957
of O 0 0.09386781603097916
BPAD B-Disease 1 0.9999427795410156
. O 0 0.015662966296076775

We O 0 0.004366899374872446
have O 0 0.0020148763433098793
found O 0 0.0016074652085080743
strong O 0 0.0013659363612532616
evidence O 0 0.0010178262600675225
for O 0 0.0006838818080723286
a O 0 0.0011003933614119887
locus O 0 0.003156524384394288
on O 0 0.0010950852883979678
chromosome O 0 0.002355609554797411
4p O 0 0.010469015687704086
at O 0 0.0014885899145156145
D4S2949 O 0 0.005079854279756546
( O 0 0.0016576648922637105
maximum O 0 0.002021807711571455
GENEHUNTER O 0 0.3590339422225952
- O 0 0.003947374876588583
PLUS O 0 0.002893204800784588
nonparametric O 0 0.005306328181177378
linkage O 0 0.002794878790155053
score O 0 0.0016903228824958205
= O 0 0.0020244880579411983
4 O 0 0.0012137305457144976
. O 0 0.0007066004909574986
05 O 0 0.0032013433519750834
, O 0 0.0008713976130820811
P O 0 0.002526408527046442
= O 0 0.0013894584262743592
5 O 0 0.0006699726800434291
. O 0 0.0003906566125806421
22 O 0 0.000693294801749289
x O 0 0.0007873845752328634
10 O 0 0.0005482189590111375
( O 0 0.0007575149647891521
- O 0 0.0011121804127469659
4 O 0 0.0008737188181839883
) O 0 0.0006706680869683623
; O 0 0.0007193989586085081
SIBPAL O 0 0.003751102602109313
Pempirical O 0 0.0027620289474725723
value O 0 0.0010502517689019442
< O 0 0.0022123304661363363
3 O 0 0.0010673536453396082
x O 0 0.0011640352895483375
10 O 0 0.0007300144643522799
( O 0 0.0007804034976288676
- O 0 0.001145271584391594
5 O 0 0.0007123386603780091
) O 0 0.0005033048801124096
) O 0 0.0003953062405344099
and O 0 0.0003238983917981386
suggestive O 0 0.001072292448952794
evidence O 0 0.0005125785246491432
for O 0 0.0004339155275374651
a O 0 0.0006682887906208634
locus O 0 0.0019441803451627493
on O 0 0.0007664370932616293
chromosome O 0 0.002178430324420333
4q O 0 0.02215483970940113
at O 0 0.0011190654477104545
D4S397 O 0 0.005120628513395786
( O 0 0.0013619860401377082
maximum O 0 0.0018508679931983352
GENEHUNTER O 0 0.13328921794891357
- O 0 0.0031602357048541307
PLUS O 0 0.0021347589790821075
nonparametric O 0 0.004900243133306503
linkage O 0 0.002528467681258917
score O 0 0.001227799104526639
= O 0 0.0014472412876784801
3 O 0 0.0007177040679380298
. O 0 0.0004567493451759219
29 O 0 0.0008856445783749223
, O 0 0.0006349004688672721
P O 0 0.0018260115757584572
= O 0 0.0012073295656591654
2 O 0 0.0006778276292607188
. O 0 0.00036746583646163344
57 O 0 0.0009401400457136333
x O 0 0.0009749972959980369
10 O 0 0.0006345338770188391
( O 0 0.0008545104647055268
- O 0 0.0012787020532414317
3 O 0 0.0009222038788720965
) O 0 0.0007513363962061703
; O 0 0.0007400886388495564
SIBPAL O 0 0.004271326120942831
Pempirical O 0 0.003576956456527114
value O 0 0.0011718597961589694
< O 0 0.0025517463218420744
1 O 0 0.0009994982974603772
x O 0 0.0011275531724095345
10 O 0 0.0008263061172328889
( O 0 0.0007818423910066485
- O 0 0.001158914528787136
3 O 0 0.0007817175937816501
) O 0 0.0005724385264329612
) O 0 0.0004586787545122206
that O 0 0.0003662397211883217
are O 0 0.0005303316283971071
linked O 0 0.0020852715242654085
to O 0 0.0016820622840896249
mental O 1 0.9998304843902588
health O 1 0.9991563558578491
wellness O 1 0.9999583959579468
. O 0 0.020746100693941116

These O 0 0.003845585510134697
findings O 0 0.0033661790657788515
are O 0 0.0011475047795102
consistent O 0 0.0015602337662130594
with O 0 0.0006992086418904364
the O 0 0.0008504967554472387
hypothesis O 0 0.0017827224219217896
that O 0 0.0005506218876689672
certain O 0 0.0005901060649193823
alleles O 0 0.0012423895532265306
could O 0 0.000528087664861232
prevent O 0 0.000861814827658236
or O 0 0.0005408457946032286
modify O 0 0.0013934351736679673
the O 0 0.0009940657764673233
clinical O 0 0.16920329630374908
manifestations O 1 0.5891396999359131
of O 0 0.049046408385038376
BPAD B-Disease 1 0.9999802112579346
and O 0 0.003842925187200308
perhaps O 0 0.0037615469191223383
other O 0 0.002164660720154643
related O 1 0.815261960029602
affective B-Disease 1 0.9999954700469971
disorders I-Disease 1 0.9999988079071045
. O 0 0.4104030132293701

Segregation O 1 0.9967759251594543
distortion O 1 0.9983785152435303
in O 1 0.9274181127548218
myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999998807907104
. O 1 0.9252265095710754

Myotonic B-Disease 1 0.9999994039535522
dystrophy I-Disease 1 1.0
( O 1 0.9999222755432129
DM B-Disease 1 1.0
) O 0 0.07749161124229431
is O 0 0.002879103645682335
an O 0 0.02015969716012478
autosomal B-Disease 1 0.9999735355377197
dominant I-Disease 1 0.999420166015625
disease I-Disease 1 0.9999960660934448
which O 0 0.001534327631816268
, O 0 0.0006318892701528966
in O 0 0.00047707490739412606
the O 0 0.0006647196132689714
typical O 0 0.0020230147056281567
pedigree O 0 0.003149445867165923
, O 0 0.0006868662312626839
shows O 0 0.0010027039097622037
a O 0 0.0011350817512720823
three O 0 0.00161323556676507
generation O 0 0.007257148623466492
anticipation O 0 0.011925057508051395
cascade O 0 0.10645938664674759
. O 0 0.00836772657930851

This O 0 0.004742232616990805
results O 0 0.004033803474158049
in O 0 0.005090116523206234
infertility B-Disease 1 0.9999978542327881
and O 1 0.9997308850288391
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999964237213135
CDM B-Disease 1 0.9999984502792358
) O 0 0.0023653653915971518
with O 0 0.0006050326046533883
the O 0 0.001150605734437704
disappearance O 0 0.037105049937963486
of O 0 0.05712931230664253
DM B-Disease 1 0.9999985694885254
in O 0 0.00290913344360888
that O 0 0.002809765748679638
pedigree O 0 0.01653926447033882
. O 0 0.006744577549397945

The O 0 0.006408252287656069
concept O 0 0.005739784333854914
of O 0 0.00408260989934206
segregation O 1 0.9567327499389648
distortion O 1 0.8786701560020447
, O 0 0.001387817319482565
where O 0 0.0007318094721995294
there O 0 0.000600903935264796
is O 0 0.0006721820682287216
preferential O 0 0.001727915951050818
transmission O 0 0.0009914671536535025
of O 0 0.00048175163101404905
the O 0 0.0005416997009888291
larger O 0 0.0007039445918053389
allele O 0 0.0011504151625558734
at O 0 0.0007214846555143595
the O 0 0.0018311728490516543
DM B-Disease 1 0.9999979734420776
locus O 0 0.08028319478034973
, O 0 0.00068717694375664
has O 0 0.0005308545660227537
been O 0 0.0004940938670188189
put O 0 0.0006492292741313577
forward O 0 0.0006757345981895924
to O 0 0.00041756645077839494
explain O 0 0.0010621242690831423
partially O 0 0.0013573248870670795
the O 0 0.0009506941423751414
maintenance O 0 0.022438442334532738
of O 0 0.0050918408669531345
DM B-Disease 1 0.9999921321868896
in O 0 0.00200769305229187
the O 0 0.0027826023288071156
population O 0 0.004429873079061508
. O 0 0.006648465059697628

In O 0 0.0053438106551766396
a O 0 0.004165994934737682
survey O 0 0.004549682140350342
of O 0 0.004525752738118172
DM B-Disease 1 0.9999817609786987
in O 0 0.0017128142062574625
Northern O 0 0.0022167430724948645
Ireland O 0 0.0023563983850181103
, O 0 0.0017831806326285005
59 O 0 0.004413290414959192
pedigrees O 0 0.00718124583363533
were O 0 0.0032645079772919416
ascertained O 0 0.013355385512113571
. O 0 0.008553970605134964

Sibships O 0 0.055786509066820145
where O 0 0.00370144029147923
the O 0 0.0019594882614910603
status O 0 0.001654913299717009
of O 0 0.000885603076312691
all O 0 0.0005637293215841055
the O 0 0.0006395598175004125
members O 0 0.0004670141206588596
had O 0 0.0005616543348878622
been O 0 0.00043185229878872633
identified O 0 0.0005438060034066439
were O 0 0.000362642778782174
examined O 0 0.0007321533630602062
to O 0 0.0003416805120650679
determine O 0 0.00045478041283786297
the O 0 0.0005203215405344963
transmission O 0 0.000959372497163713
of O 0 0.0008063901332207024
the O 0 0.005273343063890934
DM B-Disease 1 0.9999984502792358
expansion O 0 0.009895985014736652
from O 0 0.0011215609265491366
affected O 0 0.0014682182809337974
parents O 0 0.0013428004458546638
to O 0 0.001129515003412962
their O 0 0.0017525426810607314
offspring O 0 0.007027756422758102
. O 0 0.005795169621706009

Where O 0 0.006681985687464476
the O 0 0.004766030237078667
transmitting O 0 0.03425994887948036
parent O 0 0.01396941114217043
was O 0 0.005128140095621347
male O 0 0.004927076864987612
, O 0 0.0032557565718889236
58 O 0 0.009651273488998413
. O 0 0.007302816025912762

3 O 0 0.0068484945222735405
% O 0 0.0035925782285630703
of O 0 0.0017398272175341845
the O 0 0.001689509372226894
offspring O 0 0.00328623759560287
were O 0 0.0009616800234653056
affected O 0 0.0011814023600891232
, O 0 0.0005616473499685526
and O 0 0.0004436407471075654
in O 0 0.00039504101732745767
the O 0 0.0004933464806526899
case O 0 0.0006603546207770705
of O 0 0.0007093749009072781
a O 0 0.0016364181647077203
female O 0 0.007580884732306004
transmitting O 0 0.08756294846534729
parent O 0 0.005174565594643354
, O 0 0.0025463798083364964
68 O 0 0.008381119929254055
. O 0 0.00681062089279294

7 O 0 0.014430005103349686
% O 0 0.007683029398322105
were O 0 0.006074190139770508
affected O 0 0.012352412566542625
. O 0 0.010749430395662785

Studies O 0 0.007197749335318804
on O 0 0.00423431908711791
meiotic O 1 0.9853105545043945
drive O 0 0.009185097180306911
in O 0 0.005167416762560606
DM B-Disease 1 0.9999978542327881
have O 0 0.001047551748342812
shown O 0 0.0012006290489807725
increased O 0 0.0009955817367881536
transmission O 0 0.001255314564332366
of O 0 0.0006831376813352108
the O 0 0.0007826611981727183
larger O 0 0.0009294850169681013
allele O 0 0.0014259801246225834
at O 0 0.0009242974920198321
the O 0 0.0015549859963357449
DM B-Disease 1 0.9999191761016846
locus O 0 0.008516720496118069
in O 0 0.00208454136736691
non O 0 0.4986063539981842
- O 1 0.9985743761062622
DM O 1 0.9999984502792358
heterozygotes O 1 0.9084230065345764
for O 0 0.005199919454753399
CTGn O 0 0.16968655586242676
. O 0 0.011159209534525871

This O 0 0.00457007484510541
study O 0 0.003211612580344081
provides O 0 0.0024445655290037394
further O 0 0.001395822619087994
evidence O 0 0.001321981311775744
that O 0 0.001046293182298541
the O 0 0.002620163606479764
DM B-Disease 1 0.9999963045120239
expansion O 0 0.008338002488017082
tends O 0 0.002624404849484563
to O 0 0.0012997937155887485
be O 0 0.0016924724914133549
transmitted O 0 0.006394458469003439
preferentially O 0 0.011197359301149845
. O 0 0.00739478413015604

Diagnosis O 1 0.9991439580917358
of O 1 0.9213617444038391
hemochromatosis B-Disease 1 0.9999990463256836
. O 0 0.46967676281929016

If O 0 0.01419749204069376
untreated O 1 0.9999285936355591
, O 1 0.8451188802719116
hemochromatosis B-Disease 1 0.9999998807907104
can O 0 0.15548788011074066
cause O 1 0.998566210269928
serious O 1 0.999733030796051
illness O 1 0.9999970197677612
and O 0 0.12486887723207474
early B-Disease 0 0.10910091549158096
death I-Disease 1 0.5226615071296692
, O 0 0.0009784740395843983
but O 0 0.0005608000792562962
the O 0 0.0013238404644653201
disease O 1 0.9981932044029236
is O 0 0.0013427798403427005
still O 0 0.0016150790033861995
substantially O 0 0.0057191867381334305
under O 0 0.017430996522307396
- O 1 0.9976698756217957
diagnosed O 1 0.9999743700027466
. O 0 0.011276191100478172

The O 0 0.007786775007843971
cornerstone O 0 0.357989639043808
of O 0 0.003804105333983898
screening O 0 0.0135475043207407
and O 0 0.0014316521119326353
case O 0 0.001845576916821301
detection O 0 0.002703507198020816
is O 0 0.0008902284316718578
the O 0 0.0009701155941002071
measurement O 0 0.0026567575987428427
of O 0 0.0027125899214297533
serum O 1 0.990365207195282
transferrin O 1 0.5647477507591248
saturation O 0 0.00838612113147974
and O 0 0.001996150240302086
the O 0 0.0036254299338907003
serum O 1 0.7760366797447205
ferritin O 1 0.5179994106292725
level O 0 0.00901423767209053
. O 0 0.00926587637513876

Once O 0 0.010449354536831379
the O 0 0.005398398265242577
diagnosis O 1 0.9880849719047546
is O 0 0.0029601464048027992
suspected O 0 0.0172105822712183
, O 0 0.0015045668696984649
physicians O 0 0.015801580622792244
must O 0 0.0012566533405333757
use O 0 0.0015223388327285647
serum O 1 0.9279803037643433
ferritin O 1 0.933443009853363
levels O 0 0.0027749582659453154
and O 0 0.001571335131302476
hepatic O 1 0.9992539286613464
iron O 1 0.9914131164550781
stores O 0 0.005058560520410538
on O 0 0.0035528598818928003
liver O 1 0.9998190999031067
biopsy O 1 0.9895021319389343
specimens O 0 0.0027316862251609564
to O 0 0.0008465576102025807
assess O 0 0.002124710474163294
patients O 0 0.0024903174489736557
for O 0 0.0005519933183677495
the O 0 0.000919354846701026
presence O 0 0.0020659726578742266
of O 0 0.008306480012834072
iron B-Disease 1 0.9999011754989624
overload I-Disease 1 0.9999172687530518
. O 0 0.011945744976401329

Liver O 1 0.9999910593032837
biopsy O 1 0.9992557168006897
is O 0 0.0033589142840355635
also O 0 0.0011856501223519444
used O 0 0.0007055251626297832
to O 0 0.00046414113603532314
establish O 0 0.0007506757974624634
the O 0 0.00048256467562168837
presence O 0 0.0006868937634862959
or O 0 0.0005900858086533844
absence O 0 0.0027134364936500788
of O 0 0.04069782793521881
cirrhosis B-Disease 1 0.9999996423721313
, O 0 0.028487296774983406
which O 0 0.00124898471403867
can O 0 0.0012537427246570587
affect O 0 0.0032394519075751305
prognosis O 1 0.9888655543327332
and O 0 0.003422344569116831
management O 0 0.03492027148604393
. O 0 0.008585582487285137

A O 0 0.008610588498413563
DNA O 0 0.004888596013188362
- O 0 0.0031545551028102636
based O 0 0.0010982962558045983
test O 0 0.001031222054734826
for O 0 0.0007164556300267577
the O 0 0.0013018156168982387
HFE O 1 0.9982104301452637
gene O 0 0.0011254486162215471
is O 0 0.0005544006708078086
commercially O 0 0.0006797988316975534
available O 0 0.0003806432941928506
, O 0 0.0003618954215198755
but O 0 0.000274225021712482
its O 0 0.0002667963854037225
place O 0 0.00039999248110689223
in O 0 0.00039543421007692814
the O 0 0.0009387459722347558
diagnosis O 1 0.9978906512260437
of O 1 0.607409656047821
hemochromatosis B-Disease 1 1.0
is O 0 0.0695938840508461
still O 0 0.0025307622272521257
being O 0 0.002791935345157981
evaluated O 0 0.00872453860938549
. O 0 0.00627893814817071

Currently O 0 0.005777125712484121
, O 0 0.0021570308599621058
the O 0 0.0012274367036297917
most O 0 0.0006613305304199457
useful O 0 0.0008508590399287641
role O 0 0.0007883572252467275
for O 0 0.0004007703682873398
this O 0 0.00034945408697240055
test O 0 0.0005300887278281152
is O 0 0.00037983368383720517
in O 0 0.0003779818944167346
the O 0 0.0005010223831050098
detection O 0 0.0018666204996407032
of O 0 0.0015932663809508085
hemochromatosis B-Disease 1 0.9999924898147583
in O 0 0.0007562162936665118
the O 0 0.0007814029231667519
family O 0 0.0009239822393283248
members O 0 0.00048268752289004624
of O 0 0.0007940756622701883
patients O 0 0.27271974086761475
with O 0 0.0005898788804188371
a O 0 0.001511964830569923
proven O 0 0.020483339205384254
case O 0 0.0016637808876112103
of O 0 0.0026025688275694847
the O 0 0.390486478805542
disease O 1 0.999994158744812
. O 0 0.014209975488483906

It O 0 0.005427479278296232
is O 0 0.0037720880936831236
crucial O 0 0.005616871640086174
to O 0 0.004137642681598663
diagnose O 1 0.9999845027923584
hemochromatosis B-Disease 1 1.0
before O 1 0.9981694221496582
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.999998927116394
because O 1 0.9954504370689392
phlebotomy O 1 0.9999997615814209
therapy O 1 0.9999853372573853
can O 0 0.11930947005748749
avert O 1 0.9999895095825195
serious O 1 0.9999996423721313
chronic O 1 1.0
disease O 1 1.0
and O 1 0.8710587620735168
can O 0 0.0014221875462681055
even O 0 0.000712116074282676
lead O 0 0.0010269999038428068
to O 0 0.0007217439124360681
normal O 0 0.0015526318456977606
life O 0 0.0027266726829111576
expectancy O 0 0.06298387050628662
. O 0 0.0032792463898658752
. O 0 0.006550121586769819

Prevalence O 0 0.3510877192020416
of O 0 0.007467821706086397
the O 0 0.013688062317669392
I1307K O 1 0.9976474642753601
APC B-Disease 1 0.9977462887763977
gene O 0 0.0032455548644065857
variant O 0 0.0027182588819414377
in O 0 0.0008263292838819325
Israeli O 0 0.001004085293971002
Jews O 0 0.0009458776330575347
of O 0 0.0006473312969319522
differing O 0 0.000885270768776536
ethnic O 0 0.0011987853795289993
origin O 0 0.00137995439581573
and O 0 0.0019497055327519774
risk O 1 0.9227439165115356
for O 1 0.8474328517913818
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.41599640250205994

BACKGROUND O 0 0.016695337370038033
& O 0 0.019460832700133324
AIMS O 0 0.007675794418901205
Israeli O 0 0.003252987749874592
Jews O 0 0.002285630675032735
of O 0 0.0014621217269450426
European O 0 0.00195913203060627
birth O 0 0.06556711345911026
, O 0 0.0011776475002989173
i O 0 0.0009583300561644137
. O 0 0.00048798040370456874
e O 0 0.0011528218165040016
. O 0 0.0005187161732465029
, O 0 0.0007397576118819416
Ashkenazim O 0 0.0026234337128698826
, O 0 0.0007120122318156064
have O 0 0.0006081941537559032
the O 0 0.001970791257917881
highest O 1 0.9984506368637085
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
incidence O 1 0.9999396800994873
of O 0 0.09784616529941559
any O 0 0.002325986744835973
Israeli O 0 0.00475870119407773
ethnic O 0 0.005299541167914867
group O 0 0.005977926775813103
. O 0 0.0077223218977451324

The O 0 0.013474042527377605
I1307K O 1 0.9364980459213257
APC B-Disease 1 0.9867627024650574
gene O 0 0.008860352449119091
variant O 0 0.021954253315925598
was O 0 0.0031813657842576504
found O 0 0.0021040106657892466
in O 0 0.0025744603481143713
6 O 0 0.007270950824022293
. O 0 0.006566392257809639

1 O 0 0.008349332958459854
% O 0 0.0031864705961197615
of O 0 0.0015077937860041857
American O 0 0.001404903712682426
Jews O 0 0.0014231508830562234
, O 0 0.0009384494624100626
28 O 0 0.00119653285946697
% O 0 0.0007318638381548226
of O 0 0.0009549677488394082
their O 0 0.007124234456568956
familial O 1 0.9999998807907104
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9938005805015564
, O 0 0.02108626626431942
but O 0 0.0006803899304941297
not O 0 0.0006192948203533888
in O 0 0.0010638618841767311
non O 0 0.0049295201897621155
- O 0 0.09107628464698792
Jews O 0 0.008403594605624676
. O 0 0.007621812634170055

We O 0 0.005405425559729338
assessed O 0 0.007459267042577267
the O 0 0.0035789350513368845
I1307K O 0 0.33773136138916016
prevalence O 0 0.2544642388820648
in O 0 0.0012268521822988987
Israeli O 0 0.0013405533973127604
Jews O 0 0.0012725511332973838
of O 0 0.000808732642326504
differing O 0 0.0010313866659998894
ethnic O 0 0.001284620026126504
origin O 0 0.001611801446415484
and O 0 0.0024240699131041765
risk O 1 0.9685036540031433
for O 1 0.9209372401237488
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.4572162330150604

METHODS O 0 0.01040994469076395
DNA O 0 0.005735982209444046
samples O 0 0.0029292083345353603
from O 0 0.0015542287146672606
500 O 0 0.00211082655005157
unrelated O 0 0.0016867835074663162
Jews O 0 0.0014050082536414266
of O 0 0.0008598684216849506
European O 0 0.0010335539700463414
or O 0 0.0009979705791920424
non O 0 0.005277577787637711
- O 0 0.01791232079267502
European O 0 0.0006747268489561975
origin O 0 0.0006070876261219382
, O 0 0.0004195967048872262
with O 0 0.0003297419170849025
or O 0 0.0003833436931017786
without O 0 0.0003940888273064047
a O 0 0.0006131565314717591
personal O 0 0.0014529458712786436
and O 0 0.0009450741927139461
/ O 0 0.08946139365434647
or O 0 0.0005132075166329741
family O 0 0.0007132625323720276
history O 0 0.000813601422123611
of O 0 0.0014227043138816953
neoplasia B-Disease 1 0.9992971420288086
, O 0 0.0006887500640004873
were O 0 0.00047100443043746054
examined O 0 0.000893293647095561
for O 0 0.0005393922328948975
the O 0 0.0007473941659554839
I1307K O 0 0.015560774132609367
variant O 0 0.0018130108946934342
by O 0 0.0006463880417868495
the O 0 0.000927733548451215
allele O 0 0.0023823855444788933
- O 0 0.0027560389135032892
specific O 0 0.001390611520037055
oligonucleotide O 0 0.008501836098730564
( O 0 0.0034977877512574196
ASO O 0 0.4817747473716736
) O 0 0.003597182920202613
method O 0 0.00534799974411726
. O 0 0.0072282422333955765

RESULTS O 0 0.004760791081935167
In O 0 0.0015558418817818165
persons O 0 0.0014899001689627767
at O 0 0.0011649620719254017
average O 0 0.002256695181131363
risk O 0 0.24757473170757294
for O 0 0.2132592797279358
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
, O 0 0.0854426696896553
I1307K O 1 0.9820636510848999
was O 0 0.003642847528681159
found O 0 0.0014349315315485
in O 0 0.0017202849267050624
5 O 0 0.004301590844988823
. O 0 0.005704754497855902

0 O 0 0.010586598888039589
% O 0 0.0038795112632215023
of O 0 0.002830243669450283
120 O 0 0.0037209591828286648
European O 0 0.002622949657961726
and O 0 0.0029580940026789904
1 O 0 0.0071999612264335155
. O 0 0.007791887037456036

6 O 0 0.010175245814025402
% O 0 0.004283602815121412
of O 0 0.002964594168588519
188 O 0 0.006102881859987974
non O 0 0.0034618733916431665
- O 0 0.003302879398688674
European O 0 0.0015162440249696374
Jews O 0 0.0023687141947448254
( O 0 0.0023761773481965065
P O 0 0.00681262044236064
= O 0 0.003926069010049105
0 O 0 0.002708675106987357
. O 0 0.0017466520657762885
08 O 0 0.008584924973547459
) O 0 0.00458633853122592
. O 0 0.006788413506001234

It O 0 0.007916992530226707
occurred O 0 0.007912926375865936
in O 0 0.005248898174613714
15 O 0 0.009236324578523636
. O 0 0.010503849945962429

4 O 0 0.007338243070989847
% O 0 0.002766074612736702
of O 0 0.0016107360133901238
52 O 0 0.0029968535527586937
Ashkenazi O 0 0.011187027208507061
Israelis O 0 0.002185884164646268
with O 0 0.001574070192873478
familial O 1 0.9998421669006348
cancer B-Disease 1 0.9999781847000122
( O 0 0.10074044018983841
P O 0 0.44443196058273315
= O 0 0.002179791685193777
0 O 0 0.0011070768814533949
. O 0 0.0005218933802098036
02 O 0 0.004471533466130495
) O 0 0.0005324980011209846
and O 0 0.0004023026558570564
was O 0 0.0005479342653416097
not O 0 0.000345594686223194
detected O 0 0.0006926126079633832
in O 0 0.0004282096342649311
51 O 0 0.0012355747167021036
non O 0 0.0012445368338376284
- O 0 0.0021442037541419268
European O 0 0.001133844256401062
Jews O 0 0.001878119888715446
at O 0 0.002867720555514097
increased O 0 0.06665163487195969
cancer B-Disease 1 0.9993680119514465
risk O 1 0.7293520569801331
. O 0 0.010716562159359455

Colorectal B-Disease 1 0.9999945163726807
neoplasia I-Disease 1 0.9999608993530273
occurred O 0 0.16679014265537262
personally O 0 0.04607901722192764
or O 0 0.0013806787319481373
in O 0 0.000860166794154793
the O 0 0.0007053336012177169
families O 0 0.0006956973229534924
of O 0 0.0005634328117594123
13 O 0 0.0008611212833784521
of O 0 0.000760515860747546
20 O 0 0.0011791166616603732
Ashkenazi O 0 0.05680527910590172
I1307K O 0 0.042128462344408035
carriers O 0 0.0013732523657381535
, O 0 0.0006548697710968554
8 O 0 0.0008103123982436955
of O 0 0.0005948205362074077
whom O 0 0.0008638098952360451
also O 0 0.0006014115642756224
had O 0 0.0006663231179118156
a O 0 0.0007306185434572399
personal O 0 0.0015946523053571582
or O 0 0.0009587086387909949
family O 0 0.0019157076021656394
history O 0 0.0031605977565050125
of O 0 0.03785428777337074
noncolonic O 1 0.999873161315918
neoplasia B-Disease 1 0.9999003410339355
. O 0 0.01322498731315136

CONCLUSIONS O 0 0.015182558447122574
The O 0 0.008928755298256874
I1307K O 1 0.9383538961410522
APC O 1 0.9913458228111267
variant O 0 0.11193257570266724
may O 0 0.0014621098525822163
represent O 0 0.0013208278687670827
a O 0 0.001981695182621479
susceptibility O 1 0.9321142435073853
gene O 0 0.004525421187281609
for O 0 0.0018044844036921859
colorectal B-Disease 1 0.9999914169311523
, I-Disease 0 0.0012274599866941571
or I-Disease 0 0.0006060407613404095
other I-Disease 0 0.00039266585372388363
, I-Disease 0 0.0007848076638765633
cancers I-Disease 1 0.6012597680091858
in O 0 0.000871894764713943
Ashkenazi O 1 0.5001962184906006
Jews O 0 0.0014595912070944905
, O 0 0.0007251038332469761
and O 0 0.0006501131574623287
partially O 0 0.0022534956224262714
explains O 0 0.0015968895750120282
the O 0 0.0010263319127261639
higher O 0 0.0032424202654510736
incidence O 1 0.9994606375694275
of O 1 0.9961342811584473
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
in O 0 0.21614111959934235
European O 0 0.09484965354204178
Israelis O 0 0.014732842333614826
. O 0 0.008003614842891693

Systematic O 0 0.015301459468901157
analysis O 0 0.005834255367517471
of O 0 0.005792983807623386
coproporphyrinogen O 1 0.9988040924072266
oxidase O 1 0.9980695843696594
gene O 0 0.11154703795909882
defects O 1 0.9915204644203186
in O 0 0.006009961944073439
hereditary B-Disease 1 0.999976396560669
coproporphyria I-Disease 1 0.9999600648880005
and O 0 0.08475026488304138
mutation O 0 0.4087716042995453
update O 0 0.0168622974306345
. O 0 0.008286094292998314

Hereditary B-Disease 1 0.9992345571517944
coproporphyria I-Disease 1 0.999739944934845
( O 1 0.9103211164474487
HC B-Disease 1 0.9999974966049194
) O 0 0.10555459558963776
is O 0 0.014432075433433056
an O 1 0.838293194770813
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.99981290102005
autosomal O 1 0.9999997615814209
dominant O 1 0.9999899864196777
inheritance O 1 0.9999815225601196
caused O 1 0.9995613694190979
by O 0 0.2320091873407364
deficient B-Disease 1 0.9992805123329163
activity I-Disease 0 0.0026312186382710934
of I-Disease 0 0.016135921701788902
coproporphyrinogen I-Disease 1 0.9999299049377441
III I-Disease 1 0.9999570846557617
oxidase I-Disease 1 0.9934185743331909
( O 0 0.010525082238018513
CPO O 0 0.3482729196548462
) O 0 0.006438291631639004
. O 0 0.007910695858299732

Clinical O 1 0.6484330296516418
manifestations O 1 0.8983467817306519
of O 0 0.2065618932247162
the O 1 0.9755865335464478
disease O 1 0.9999996423721313
are O 0 0.008156070485711098
characterized O 1 0.9919636249542236
by O 0 0.07107967883348465
acute O 1 0.9999998807907104
attacks O 1 0.9607644081115723
of O 1 0.9991564750671387
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9513360261917114
precipitated O 1 0.9999825954437256
by O 0 0.02577979676425457
drugs O 1 0.7773252725601196
, O 0 0.0033605205826461315
fasting O 0 0.40559515357017517
, O 0 0.0023247390054166317
cyclical O 1 0.9929412603378296
hormonal O 1 0.9918704032897949
changes O 0 0.0024595088325440884
, O 0 0.003761173225939274
or O 0 0.04950542002916336
infectious B-Disease 1 0.9999949932098389
diseases I-Disease 1 0.9999960660934448
. O 0 0.03479389101266861

Skin O 1 0.9999842643737793
photosensitivity O 1 0.9998862743377686
may O 0 0.010360829532146454
also O 0 0.003790728049352765
be O 0 0.0027835259679704905
present O 0 0.005849766079336405
. O 0 0.008345945738255978

The O 0 0.006342646200209856
seven O 0 0.004182245582342148
exons O 0 0.006919139064848423
, O 0 0.002344027627259493
the O 0 0.002424703212454915
exon O 0 0.297791451215744
/ O 0 0.026906022801995277
intron O 0 0.018491486087441444
boundaries O 0 0.001283464371226728
and O 0 0.0007937408518046141
part O 0 0.000967170693911612
of O 0 0.0009700300870463252
3 O 0 0.001352363033220172
noncoding O 0 0.0029553528875112534
sequence O 0 0.0009273817995563149
of O 0 0.0007757324492558837
the O 0 0.0009658124763518572
CPO O 0 0.009378425776958466
gene O 0 0.000936051772441715
were O 0 0.0004879443149548024
systematically O 0 0.001221357029862702
analyzed O 0 0.0010580088710412383
by O 0 0.0005929503822699189
an O 0 0.0008217197027988732
exon O 0 0.00389083637855947
- O 0 0.002026994712650776
by O 0 0.0012409130576997995
- O 0 0.006840553134679794
exon O 0 0.011366519145667553
denaturing O 0 0.42038199305534363
gradient O 0 0.07643426954746246
gel O 1 0.8024469017982483
electrophoresis O 0 0.18849346041679382
( O 0 0.0028989880811423063
DGGE O 0 0.03350231796503067
) O 0 0.001215584110468626
strategy O 0 0.0013035960728302598
followed O 0 0.0008475762442685664
by O 0 0.0005824251566082239
direct O 0 0.0006979831960052252
sequencing O 0 0.001126051414757967
in O 0 0.0006516220746561885
seven O 0 0.0010361296590417624
unrelated O 0 0.002673786599189043
heterozygous O 0 0.005806279368698597
HC B-Disease 1 0.9998674392700195
patients O 0 0.3364817202091217
from O 0 0.001395830069668591
France O 0 0.0030377483926713467
, O 0 0.0014584067976102233
Holland O 0 0.009297429583966732
, O 0 0.001558848423883319
and O 0 0.0018609237158671021
Czech O 0 0.010818755254149437
Republic O 0 0.012616291642189026
. O 0 0.008702651597559452

Seven O 0 0.008981451392173767
novel O 0 0.009929328225553036
mutations O 0 0.004832106176763773
and O 0 0.0020172966178506613
two O 0 0.0016039412003010511
new O 0 0.002744725439697504
polymorphisms O 0 0.009133807383477688
were O 0 0.0036894192453473806
detected O 0 0.010518727824091911
. O 0 0.008203914389014244

Among O 0 0.004890965297818184
these O 0 0.001844481797888875
mutations O 0 0.002066235989332199
two O 0 0.0007852697162888944
are O 0 0.0007680854178033769
missense O 0 0.004353661090135574
( O 0 0.0018231786089017987
G197W O 0 0.008579788729548454
, O 0 0.0010187377920374274
W427R O 0 0.003906047670170665
) O 0 0.0007352808606810868
, O 0 0.00044501430238597095
two O 0 0.00032280097366310656
are O 0 0.00035447365371510386
nonsense O 0 0.002146488521248102
( O 0 0.0010370134841650724
Q306X O 0 0.004151058848947287
, O 0 0.0008068006136454642
Q385X O 0 0.003218891564756632
) O 0 0.0006215874454937875
, O 0 0.0003914562112186104
two O 0 0.00033227086532860994
are O 0 0.00033019488910213113
small O 0 0.0007076814072206616
deletions O 0 0.001958630047738552
( O 0 0.0013327808119356632
662de14bp O 0 0.00416759354993701
; O 0 0.0011314210714772344
1168del3bp O 0 0.004258956294506788
removing O 0 0.001681418507359922
a O 0 0.0010303775779902935
glycine O 0 0.0022332128137350082
at O 0 0.0008379734354093671
position O 0 0.0010722634615376592
390 O 0 0.0022771907970309258
) O 0 0.0007037772447802126
, O 0 0.0005070074694231153
and O 0 0.00046819684212096035
one O 0 0.0004084657703060657
is O 0 0.00040981470374390483
a O 0 0.000653221970424056
splicing O 0 0.0014540246920660138
mutation O 0 0.0015675716567784548
( O 0 0.001478212303481996
IVS1 O 0 0.29914432764053345
- O 0 0.09505350142717361
15c O 1 0.6889321208000183
- O 0 0.43214714527130127
- O 0 0.1819128394126892
> O 0 0.006907572504132986
g O 0 0.002383061219006777
) O 0 0.0008973196963779628
which O 0 0.0006774176144972444
creates O 0 0.0016917918110266328
a O 0 0.0016822167672216892
new O 0 0.0024756051134318113
acceptor O 0 0.009799355641007423
splice O 0 0.015092696063220501
site O 0 0.008841084316372871
. O 0 0.010012978687882423

The O 0 0.006930852308869362
pathological O 0 0.010731709189713001
significance O 0 0.0038504202384501696
of O 0 0.002013365738093853
the O 0 0.00182912137825042
point O 0 0.002206327160820365
mutations O 0 0.0023983411956578493
G197W O 0 0.02638024091720581
, O 0 0.0008311320561915636
W427R O 0 0.004103326238691807
, O 0 0.000461162329884246
and O 0 0.00036355716292746365
the O 0 0.0004858467145822942
in O 0 0.0005893657798878849
- O 0 0.01177923008799553
frame O 0 0.002475851448252797
deletion O 0 0.0029709506779909134
390delGly O 0 0.003321622498333454
were O 0 0.0005317546892911196
assessed O 0 0.000970663852058351
by O 0 0.00038647381006740034
their O 0 0.00041004177182912827
respective O 0 0.00069652427919209
expression O 0 0.0008075856021605432
in O 0 0.0006027288036420941
a O 0 0.000996564980596304
prokaryotic O 0 0.002056814730167389
system O 0 0.00118521717377007
using O 0 0.0010827252408489585
site O 0 0.0023969700559973717
- O 0 0.006430067587643862
directed O 0 0.007712663616985083
mutagenesis O 0 0.0237636286765337
. O 0 0.010457178577780724

These O 0 0.004608968272805214
mutations O 0 0.004758783150464296
resulted O 0 0.0024758337531238794
in O 0 0.0011141436407342553
the O 0 0.0012631736462935805
absence O 0 0.006416263524442911
or O 0 0.001018110546283424
a O 0 0.0017163710435852408
dramatic O 0 0.017546476796269417
decrease O 0 0.011137028224766254
of O 0 0.005594725254923105
CPO O 1 0.9716563820838928
activity O 0 0.008332228288054466
. O 0 0.007024243474006653

The O 0 0.005563747603446245
two O 0 0.002706546802073717
polymorphisms O 0 0.0059800404123961926
were O 0 0.0014772969298064709
localized O 0 0.0034862374886870384
in O 0 0.0009427493205294013
noncoding O 0 0.004305732902139425
part O 0 0.0008748097461648285
of O 0 0.0007494025048799813
the O 0 0.0007961033843457699
gene O 0 0.0008280061301775277
1 O 0 0.000812989252153784
) O 0 0.0005607783677987754
a O 0 0.0008258876041509211
C O 0 0.003773765405640006
/ O 0 0.006747168488800526
G O 0 0.002658998593688011
polymorphism O 0 0.0013011129340156913
in O 0 0.0005196898709982634
the O 0 0.0008466633153147995
promotor O 0 0.12179501354694366
region O 0 0.0012585074873641133
, O 0 0.0009567622910253704
142 O 0 0.002479411428794265
bp O 0 0.0020264354534447193
upstream O 0 0.0016423652414232492
from O 0 0.0006861458532512188
the O 0 0.0008178926073014736
transcriptional O 0 0.002116384217515588
initiation O 0 0.0021765229757875204
site O 0 0.00168309872969985
( O 0 0.001875292626209557
- O 0 0.004755412228405476
142C O 0 0.05789593979716301
/ O 0 0.016132039949297905
G O 0 0.002614719793200493
) O 0 0.0006850184872746468
, O 0 0.00046548497630283237
and O 0 0.0004966458072885871
2 O 0 0.0006508363294415176
) O 0 0.0004577714717015624
a O 0 0.000625197368208319
6 O 0 0.0009743399568833411
bp O 0 0.001475922646932304
deletion O 0 0.001522681675851345
polymorphism O 0 0.0012150539550930262
in O 0 0.0004725291219074279
the O 0 0.0006002373993396759
3 O 0 0.0009248449932783842
noncoding O 0 0.0025182359386235476
part O 0 0.0008132124203257263
of O 0 0.0007520749350078404
the O 0 0.0011037503136321902
CPO O 0 0.07988068461418152
gene O 0 0.001733128447085619
, O 0 0.0010089051211252809
574 O 0 0.003973272163420916
bp O 0 0.0020569192711263895
downstream O 0 0.0014399968786165118
of O 0 0.000629485584795475
the O 0 0.000679614779073745
last O 0 0.0007322789169847965
base O 0 0.0008166696061380208
of O 0 0.0006766645819880068
the O 0 0.000963123282417655
normal O 0 0.001778319594450295
termination O 0 0.005529862828552723
codon O 0 0.006382917519658804
( O 0 0.0033444291912019253
+ O 0 0.007767273113131523
574 O 0 0.02875448763370514
delATTCTT O 0 0.04046105965971947
) O 0 0.00522720767185092
. O 0 0.007144865579903126

Five O 0 0.008709251880645752
intragenic O 1 0.9347743391990662
dimorphisms O 1 0.7087236642837524
are O 0 0.0011897813528776169
now O 0 0.0011353305308148265
well O 0 0.0008150292560458183
characterized O 0 0.0021666125394403934
and O 0 0.0006166879320517182
the O 0 0.0007424018112942576
high O 0 0.0013100359356030822
degree O 0 0.0015337382210418582
of O 0 0.0016533604357391596
allelic O 1 0.9634329676628113
heterogeneity O 1 0.7649316787719727
in O 0 0.003422004636377096
HC B-Disease 1 0.9999915361404419
is O 0 0.001598670263774693
demonstrated O 0 0.0013805379858240485
with O 0 0.0004640884872060269
seven O 0 0.0005079373368062079
new O 0 0.00043015831033699214
different O 0 0.00028634039335884154
mutations O 0 0.0005712319980375469
making O 0 0.00047525204718112946
a O 0 0.0005650252569466829
total O 0 0.0007506207912229002
of O 0 0.0010903228539973497
nineteen O 0 0.39890626072883606
CPO O 1 0.9932408332824707
gene B-Disease 0 0.008255868218839169
defects I-Disease 1 0.7739874720573425
reported O 0 0.002244400791823864
so O 0 0.001150026568211615
far O 0 0.00165581947658211
. O 0 0.002123718848451972
. O 0 0.0050617242231965065

Coincidence O 0 0.010987709276378155
of O 0 0.003262721002101898
two O 0 0.0021363613195717335
novel O 0 0.005961238406598568
arylsulfatase O 0 0.20937228202819824
A O 0 0.003029078943654895
alleles O 0 0.0029879852663725615
and O 0 0.0012791685294359922
mutation O 0 0.007854260504245758
459 O 1 0.8680425882339478
+ O 0 0.06343752890825272
1G O 1 0.511634886264801
> O 0 0.0035846498794853687
A O 0 0.0013083266094326973
within O 0 0.0008356976322829723
a O 0 0.0011527631431818008
family O 0 0.0015862120781093836
with O 0 0.0018866684986278415
metachromatic B-Disease 1 0.9977578520774841
leukodystrophy I-Disease 1 0.9999061822891235
: O 0 0.0024624811485409737
molecular O 0 0.002969337860122323
basis O 0 0.002320754574611783
of O 0 0.0034374615643173456
phenotypic O 0 0.01964949071407318
heterogeneity O 0 0.06146311014890671
. O 0 0.012293204665184021

In O 0 0.003526706248521805
a O 0 0.0023203787859529257
family O 0 0.001776537043042481
with O 0 0.0007731516379863024
three O 0 0.0007574434275738895
siblings O 0 0.0036649410612881184
, O 0 0.0006178557523526251
one O 0 0.000605500943493098
developed O 0 0.001140354317612946
classical O 0 0.0019108634442090988
late O 0 0.012155567295849323
infantile O 1 0.999997615814209
metachromatic B-Disease 1 0.9999966621398926
leukodystrophy I-Disease 1 0.9999998807907104
( O 1 0.8923537731170654
MLD B-Disease 1 0.9999898672103882
) O 0 0.0015289823058992624
, O 0 0.0008723463397473097
fatal O 0 0.007615294307470322
at O 0 0.0009365691803395748
age O 0 0.0010561207309365273
5 O 0 0.0007884000078774989
years O 0 0.0005284128710627556
, O 0 0.0006090599345043302
with O 0 0.0007229814073070884
deficient O 1 0.794127881526947
arylsulfatase O 0 0.4304701089859009
A O 0 0.007863045670092106
( O 0 0.005872688721865416
ARSA O 1 0.990198016166687
) O 0 0.001124432310461998
activity O 0 0.0012303834082558751
and O 0 0.0012009117053821683
increased O 0 0.0029428796842694283
galactosylsulfatide O 1 0.8029451370239258
( O 0 0.016173111274838448
GS O 1 0.9985427856445312
) O 0 0.008054872043430805
excretion O 0 0.027360862120985985
. O 0 0.012088887393474579

The O 0 0.0049222675152122974
two O 0 0.0018367042066529393
other O 0 0.001122887246310711
siblings O 0 0.0028114255983382463
, O 0 0.0010128208668902516
apparently O 0 0.0012213593581691384
healthy O 0 0.001285278471186757
at O 0 0.0007440154440701008
12 O 0 0.0008380927611142397
( O 0 0.0008402193780057132
1 O 0 0.0009254871401935816
/ O 0 0.0014519328251481056
2 O 0 0.0005618379800580442
) O 0 0.00031640217639505863
and O 0 0.00021537879365496337
15 O 0 0.00037252437323331833
years O 0 0.000332901778165251
, O 0 0.0003141317283734679
respectively O 0 0.0005203905166126788
, O 0 0.0003271913155913353
and O 0 0.00031067238887771964
their O 0 0.0003357365494593978
father O 0 0.0020570133347064257
, O 0 0.0006158497999422252
apparently O 0 0.0013295973185449839
healthy O 0 0.0020363698713481426
as O 0 0.00040010001976042986
well O 0 0.0004434906004462391
, O 0 0.0005803392268717289
presented O 0 0.002089147921651602
ARSA O 1 0.9918246865272522
and O 0 0.0013084859820082784
GS O 1 0.728257417678833
values O 0 0.0012083695037290454
within O 0 0.0008448887383565307
the O 0 0.0010704022133722901
range O 0 0.0020818570628762245
of O 0 0.005017537623643875
MLD B-Disease 1 0.9999951124191284
patients O 1 0.9910846948623657
. O 0 0.009623061865568161

Mutation O 0 0.01487151812762022
screening O 0 0.0071859825402498245
and O 0 0.002339589409530163
sequence O 0 0.002180596813559532
analysis O 0 0.001646007294766605
disclosed O 0 0.001991386292502284
the O 0 0.000974528375081718
involvement O 0 0.0014471047325059772
of O 0 0.0008875647326931357
three O 0 0.000835547863971442
different O 0 0.0008662528707645833
ARSA O 1 0.7979986667633057
mutations O 0 0.0013270988129079342
being O 0 0.0007110473234206438
the O 0 0.0008097458630800247
molecular O 0 0.0015056179836392403
basis O 0 0.0014331656275317073
of O 0 0.0025675564538687468
intrafamilial O 1 0.5218004584312439
phenotypic O 0 0.03148958459496498
heterogeneity O 0 0.09525128453969955
. O 0 0.012528946623206139

The O 0 0.011608889326453209
late O 1 0.5318150520324707
infantile O 1 0.9999980926513672
patient O 1 0.9999157190322876
inherited O 1 0.9998252987861633
from O 0 0.00732512166723609
his O 0 0.0759410485625267
mother O 0 0.3390696346759796
the O 0 0.0017256257124245167
frequent O 0 0.0033702158834785223
0 O 0 0.002365129068493843
- O 0 0.0034452523104846478
type O 0 0.002893457654863596
mutation O 0 0.0035814251750707626
459 O 0 0.39296451210975647
+ O 0 0.012617353349924088
1G O 0 0.2095753699541092
> O 0 0.0024379745591431856
A O 0 0.0010197714436799288
, O 0 0.0005480240797623992
and O 0 0.0004083137318957597
from O 0 0.0004421334888320416
his O 0 0.0007129224250093102
father O 0 0.0016801560996100307
a O 0 0.0010203769197687507
novel O 0 0.002619568957015872
, O 0 0.000998333445750177
single O 0 0.0014874422922730446
basepair O 0 0.011870995163917542
microdeletion O 0 0.004384409170597792
of O 0 0.0012882119044661522
guanine O 0 0.002713278867304325
at O 0 0.001133262412622571
nucleotide O 0 0.0018223450751975179
7 O 0 0.001509728841483593
in O 0 0.0012850055936723948
exon O 0 0.006266388576477766
1 O 0 0.0034415381960570812
( O 0 0.004310322925448418
7delG O 0 0.01599440723657608
) O 0 0.0056465063244104385
. O 0 0.007170673925429583

The O 0 0.006310350727289915
two O 0 0.0030242083594202995
clinically O 1 0.7508314251899719
unaffected O 0 0.028770992532372475
siblings O 0 0.005033490713685751
carried O 0 0.0021954819094389677
the O 0 0.001954643288627267
maternal O 1 0.9863386750221252
mutation O 0 0.39937886595726013
459 O 1 0.9972085356712341
+ O 1 0.656367301940918
1G O 1 0.8616850972175598
> O 0 0.00291460077278316
A O 0 0.000984468962997198
and O 0 0.0005232392577454448
, O 0 0.0004820885951630771
on O 0 0.0004771456588059664
their O 0 0.000519949768204242
paternal O 0 0.003202815307304263
allele O 0 0.0015717019559815526
, O 0 0.0005897189257666469
a O 0 0.0008421482634730637
novel O 0 0.0018116348655894399
cytosine O 0 0.0024841593112796545
to O 0 0.0006659363862127066
thymidine O 0 0.0022648931480944157
transition O 0 0.0013326335465535522
at O 0 0.0009498431463725865
nucleotide O 0 0.001835656468756497
2435 O 0 0.007442861795425415
in O 0 0.0009286224376410246
exon O 0 0.0034594235476106405
8 O 0 0.0011658481089398265
, O 0 0.0007187544251792133
resulting O 0 0.0009543951600790024
in O 0 0.000651768350508064
substitution O 0 0.0018954508705064654
of O 0 0.0013183607952669263
alanine O 0 0.01592310331761837
464 O 0 0.11014684289693832
by O 0 0.002056926256045699
valine O 0 0.4199424684047699
( O 0 0.005863156169652939
A464V O 0 0.027608582749962807
) O 0 0.006978665944188833
. O 0 0.008852935396134853

The O 0 0.011964423581957817
fathers O 0 0.01899034157395363
genotype O 0 0.020644769072532654
thus O 0 0.006854714825749397
was O 0 0.01289169117808342
7delG O 1 0.969157338142395
/ O 1 0.8926478028297424
A464V O 1 0.6156183481216431
. O 0 0.014533339999616146

Mutation O 0 0.024340258911252022
A464V O 0 0.0778558999300003
was O 0 0.0038421419449150562
not O 0 0.0009588758694007993
found O 0 0.0009550510440021753
in O 0 0.0010659127729013562
18 O 0 0.0029498361982405186
unrelated O 1 0.729979932308197
MLD B-Disease 1 0.9999986886978149
patients O 1 0.9526118040084839
and O 0 0.0024918136186897755
50 O 0 0.0039469473995268345
controls O 0 0.00816431362181902
. O 0 0.007264400366693735

A464V O 0 0.030400676652789116
, O 0 0.004507584031671286
although O 0 0.002962093334645033
clearly O 0 0.0036301473155617714
modifying O 0 0.0362149216234684
ARSA O 1 0.9993969202041626
and O 0 0.005021464079618454
GS O 1 0.9999070167541504
levels O 0 0.0030599585734307766
, O 0 0.0010215577203780413
apparently O 0 0.0014249144587665796
bears O 0 0.001547298044897616
little O 0 0.0010694196680560708
significance O 0 0.0012825574958696961
for O 0 0.0010356559650972486
clinical O 0 0.3227481245994568
manifestation O 1 0.9890256524085999
of O 0 0.34941303730010986
MLD B-Disease 1 0.999998927116394
, O 0 0.00798020325601101
mimicking O 0 0.45791783928871155
the O 0 0.004860378336161375
frequent O 0 0.1368555873632431
ARSA O 1 0.999860405921936
pseudodeficiency O 1 0.9799537658691406
allele O 0 0.024830607697367668
. O 0 0.011096063069999218

Our O 0 0.006457346957176924
results O 0 0.0032794943545013666
demonstrate O 0 0.0024781052488833666
that O 0 0.0008277012966573238
in O 0 0.0008226148202084005
certain O 0 0.0009696909692138433
genetic O 0 0.003422399749979377
conditions O 0 0.18498282134532928
MLD B-Disease 1 0.9999988079071045
- O 1 0.9576736092567444
like O 0 0.01170774269849062
ARSA O 1 0.9996733665466309
and O 0 0.0023602917790412903
GS O 1 0.9951593279838562
values O 0 0.0010965843684971333
need O 0 0.0007133244071155787
not O 0 0.0003845722822006792
be O 0 0.00042324556852690876
paralleled O 0 0.0017408310668542981
by O 0 0.0008516256348229945
clinical O 1 0.9861462712287903
disease O 1 0.9999411106109619
, O 0 0.0013910592533648014
a O 0 0.0014701104955747724
finding O 0 0.002339521422982216
with O 0 0.0015695557231083512
serious O 1 0.936581552028656
diagnostic O 1 0.9805527329444885
and O 0 0.005114636849611998
prognostic O 1 0.9875187277793884
implications O 0 0.06993118673563004
. O 0 0.009958419017493725

Moreover O 0 0.013299142010509968
, O 0 0.004474021960049868
further O 0 0.004499484319239855
ARSA O 1 0.9975088834762573
alleles O 0 0.006634796038269997
functionally O 0 0.0049196272157132626
similar O 0 0.001131525612436235
to O 0 0.0008154028910212219
A464V O 0 0.00391832459717989
might O 0 0.0006472172099165618
exist O 0 0.0005135434330441058
which O 0 0.0003147108945995569
, O 0 0.0003347748424857855
together O 0 0.00041346129728481174
with O 0 0.000509562436491251
0 O 0 0.0012927829520776868
- O 0 0.004687759093940258
type O 0 0.0020941903349012136
mutations O 0 0.0011633028043434024
, O 0 0.0006969957030378282
may O 0 0.0009805766167119145
cause O 0 0.02384147420525551
pathological O 1 0.9951745867729187
ARSA O 1 0.9999934434890747
and O 0 0.024167627096176147
GS O 1 0.9999648332595825
levels O 0 0.0019918004982173443
, O 0 0.0005681057809852064
but O 0 0.0004490587452892214
not O 0 0.000530255027115345
clinical O 0 0.0069388351403176785
outbreak O 1 0.8047549724578857
of O 0 0.010429454036056995
the O 1 0.5582836270332336
disease O 1 0.9999918937683105
. O 0 0.005741325207054615
. O 0 0.008119500242173672

Human O 1 0.9954326152801514
MLH1 O 1 0.9999985694885254
deficiency O 1 1.0
predisposes O 1 0.9999797344207764
to O 0 0.23271465301513672
hematological B-Disease 1 0.9999983310699463
malignancy I-Disease 1 0.9999997615814209
and O 1 0.9871620535850525
neurofibromatosis B-Disease 1 0.9999997615814209
type I-Disease 1 0.9968302845954895
1 I-Disease 0 0.050532422959804535
. O 0 0.011820314452052116

Heterozygous O 0 0.04767750948667526
germ O 1 0.9920587539672852
- O 0 0.04640381410717964
line O 0 0.0033873855136334896
mutations O 0 0.0018340346869081259
in O 0 0.0008555272361263633
the O 0 0.0012120588216930628
DNA O 0 0.003493900876492262
mismatch O 1 0.933746337890625
repair O 1 0.726004421710968
genes O 0 0.002216205233708024
lead O 0 0.002741811331361532
to O 0 0.002620371524244547
hereditary B-Disease 1 0.9999827146530151
nonpolyposis I-Disease 1 0.9999996423721313
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 1 0.524019181728363

The O 0 0.23108108341693878
disease O 1 0.9999780654907227
susceptibility O 1 0.9496873021125793
of O 0 0.009404510259628296
individuals O 0 0.002812979044392705
who O 0 0.005818251520395279
constitutionally O 0 0.0720742791891098
lack O 0 0.004817654378712177
both O 0 0.0013332836097106338
wild O 0 0.01160955149680376
- O 0 0.47050973773002625
type O 0 0.02452024817466736
alleles O 0 0.005128478165715933
is O 0 0.0028296622913330793
unknown O 0 0.005828761495649815
. O 0 0.007495241705328226

We O 0 0.003793545300140977
have O 0 0.0014360101195052266
identified O 0 0.0014663591282442212
three O 0 0.0008573118830099702
offspring O 0 0.0016543365782126784
in O 0 0.001015872461721301
a O 0 0.048425741493701935
hereditary B-Disease 1 0.9999994039535522
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9994078874588013
who O 1 0.9941583871841431
developed O 1 0.9992107152938843
hematological B-Disease 1 0.9999995231628418
malignancy I-Disease 1 0.9999984502792358
at O 0 0.0038868170231580734
a O 0 0.0011700661852955818
very O 0 0.0005415128543972969
early O 0 0.0005349579150788486
age O 0 0.0006460733711719513
, O 0 0.00037382892332971096
and O 0 0.0002450744214002043
at O 0 0.0003791148483287543
least O 0 0.00026525885914452374
two O 0 0.00020150712225586176
of O 0 0.00031490507535636425
them O 0 0.0003306270809844136
displayed O 0 0.000979444943368435
signs O 0 0.0019325301982462406
of O 0 0.0024680171627551317
neurofibromatosis B-Disease 1 0.9999942779541016
type I-Disease 1 0.7245558500289917
1 I-Disease 0 0.008305136114358902
( O 0 0.005604408215731382
NF1 B-Disease 1 0.8108808398246765
) O 0 0.004961851984262466
. O 0 0.0070643299259245396

DNA O 0 0.008365229703485966
sequence O 0 0.004082604311406612
analysis O 0 0.00237881182692945
and O 0 0.0017157266847789288
allele O 0 0.0034921481274068356
- O 0 0.0024453308433294296
specific O 0 0.0009667335543781519
amplification O 0 0.0017077748198062181
in O 0 0.0006842668517492712
two O 0 0.0006778049864806235
siblings O 0 0.0020162202417850494
revealed O 0 0.0022457768209278584
a O 0 0.0020825467072427273
homozygous O 0 0.007957721129059792
MLH1 O 1 0.9849036931991577
mutation O 0 0.0067499238066375256
( O 0 0.004058674443513155
C676T O 1 0.7639949917793274
- O 1 0.84152752161026
- O 1 0.7741500735282898
> O 0 0.10463700443506241
Arg226Stop O 0 0.1460614949464798
) O 0 0.007986883632838726
. O 0 0.009708513505756855

Thus O 0 0.006654019467532635
, O 0 0.0033765833359211683
a O 0 0.003603803226724267
homozygous O 0 0.024295566603541374
germ O 1 0.9986679553985596
- O 1 0.9266894459724426
line O 0 0.1808137148618698
MLH1 O 1 0.9999246597290039
mutation O 0 0.36048316955566406
and O 0 0.006210029125213623
consequent O 1 0.9999892711639404
mismatch O 1 0.9999996423721313
repair O 1 0.9999992847442627
deficiency O 1 0.9999997615814209
results O 0 0.005427015013992786
in O 0 0.0017550920601934195
a O 0 0.050568170845508575
mutator O 1 0.9999829530715942
phenotype O 1 0.9269941449165344
characterized O 1 0.8831360936164856
by O 0 0.03689638525247574
leukemia B-Disease 1 0.9999998807907104
and O 1 0.9563726186752319
/ O 1 0.9999923706054688
or O 1 0.8022284507751465
lymphoma B-Disease 1 1.0
associated O 1 0.637620210647583
with O 0 0.3398970663547516
neurofibromatosis B-Disease 1 0.9999995231628418
type I-Disease 1 0.9271014928817749
1 I-Disease 0 0.005919668823480606
. O 0 0.0030062447767704725
. O 0 0.006773785687983036

Missense O 0 0.03881204500794411
mutations O 0 0.006971386726945639
in O 0 0.0020341856870800257
the O 0 0.001344608492217958
most O 0 0.0010039781918749213
ancient O 0 0.001716466504149139
residues O 0 0.0020956783555448055
of O 0 0.0014652146492153406
the O 0 0.0032198403496295214
PAX6 O 1 0.9995055198669434
paired O 0 0.007885882630944252
domain O 0 0.0025291016791015863
underlie O 0 0.007884527556598186
a O 0 0.001946076168678701
spectrum O 0 0.004976344760507345
of O 0 0.0983012318611145
human O 1 0.9995896220207214
congenital B-Disease 1 1.0
eye I-Disease 1 0.9999997615814209
malformations I-Disease 1 0.9999998807907104
. O 1 0.8974136114120483

Mutations O 0 0.009801909327507019
of O 0 0.0045244162902235985
the O 0 0.004991397727280855
human O 0 0.122495636343956
PAX6 O 1 0.9999786615371704
gene O 0 0.4545990228652954
underlie O 1 0.9995458722114563
aniridia B-Disease 1 0.9999949932098389
( O 1 0.953201949596405
congenital B-Disease 1 0.9999997615814209
absence I-Disease 1 0.9337716698646545
of I-Disease 1 0.6904938817024231
the I-Disease 1 0.9771750569343567
iris I-Disease 1 0.9999637603759766
) O 0 0.0038173214998096228
, O 0 0.0008540513808839023
a O 0 0.0012754793278872967
rare O 0 0.005839406978338957
dominant O 0 0.2340383231639862
malformation B-Disease 1 0.9999619722366333
of I-Disease 0 0.3573622703552246
the I-Disease 1 0.8481665253639221
eye I-Disease 1 0.9996970891952515
. O 0 0.01438888069242239

The O 0 0.006701307836920023
spectrum O 0 0.007226414512842894
of O 0 0.00500643253326416
PAX6 O 1 0.9999101161956787
mutations O 0 0.05316193774342537
in O 0 0.005105557851493359
aniridia B-Disease 1 0.9999728202819824
patients O 1 0.9609512686729431
is O 0 0.0012913645477965474
highly O 0 0.0016386237693950534
biased O 0 0.0013812297256663442
, O 0 0.0005479598767124116
with O 0 0.0004549698787741363
92 O 0 0.0013584119733422995
% O 0 0.0005420038942247629
of O 0 0.0004353181866463274
all O 0 0.0003782320418395102
reported O 0 0.0009202947258017957
mutations O 0 0.000799230532720685
leading O 0 0.0008577972766943276
to O 0 0.0005170555668883026
premature O 0 0.002036947524175048
truncation O 0 0.0022109495475888252
of O 0 0.0007213011267594993
the O 0 0.0008589206263422966
protein O 0 0.0010021863272413611
( O 0 0.0008847572607919574
nonsense O 0 0.0016869698883965611
, O 0 0.0006067116628400981
splicing O 0 0.0012865541502833366
, O 0 0.0006380103877745569
insertions O 0 0.0019144316902384162
and O 0 0.0005895248032175004
deletions O 0 0.0015475000254809856
) O 0 0.0006313637713901699
and O 0 0.0004319292784202844
just O 0 0.0006129353423602879
2 O 0 0.0007026727544143796
% O 0 0.0005901483236812055
leading O 0 0.0006134262075647712
to O 0 0.00045734926243312657
substitution O 0 0.000845263828523457
of O 0 0.0005380079383030534
one O 0 0.0006745243445038795
amino O 0 0.0010880918707698584
acid O 0 0.001372659346088767
by O 0 0.0009344050195068121
another O 0 0.001927020726725459
( O 0 0.003146493574604392
missense O 0 0.012169741094112396
) O 0 0.005141356959939003
. O 0 0.007151735480874777

The O 0 0.006961480714380741
extraordinary O 0 0.006865087430924177
conservation O 0 0.0041849929839372635
of O 0 0.0021390782203525305
the O 0 0.0024570815730839968
PAX6 O 1 0.9693534970283508
protein O 0 0.001529125845991075
at O 0 0.0009027059422805905
the O 0 0.000868464820086956
amino O 0 0.0012790100881829858
acid O 0 0.001913475221954286
level O 0 0.0012535469140857458
amongst O 0 0.001670324825681746
vertebrates O 0 0.0028030574321746826
predicts O 0 0.0036823449190706015
that O 0 0.000952916918322444
pathological O 0 0.06017954647541046
missense O 0 0.07473211735486984
mutations O 0 0.001747993752360344
should O 0 0.0005788005073554814
in O 0 0.0005128573393449187
fact O 0 0.0006821893621236086
be O 0 0.0004022305365651846
common O 0 0.0005273233400657773
even O 0 0.0004275187384337187
though O 0 0.0004583637637551874
they O 0 0.0003563854261301458
are O 0 0.00037385281757451594
hardly O 0 0.0014902245020493865
ever O 0 0.0012983463238924742
seen O 0 0.0019809682853519917
in O 0 0.0024042786099016666
aniridia B-Disease 1 0.9996565580368042
patients O 1 0.9450220465660095
. O 0 0.009554347954690456

This O 0 0.005182736087590456
indicates O 0 0.003940110560506582
that O 0 0.0009559064055792987
there O 0 0.0008851492893882096
is O 0 0.0008858107612468302
a O 0 0.0011697921436280012
heavy O 0 0.06577425450086594
ascertainment O 1 0.9965178966522217
bias O 0 0.003821754129603505
in O 0 0.0005940455012023449
the O 0 0.0006665415712632239
selection O 0 0.0009377005626447499
of O 0 0.0011828385759145021
patients O 1 0.5372894406318665
for O 0 0.001549044973216951
PAX6 O 1 0.9995142221450806
mutation O 0 0.0020216763950884342
analysis O 0 0.0007293712114915252
and O 0 0.0005724991206079721
that O 0 0.000577803875785321
the O 0 0.0012045835610479116
missing O 0 0.005223782267421484
PAX6 O 1 0.9979825019836426
missense O 0 0.09391035884618759
mutations O 0 0.0031510470435023308
frequently O 0 0.002060648752376437
may O 0 0.001989882905036211
underlie O 0 0.01277465745806694
phenotypes O 0 0.010460425168275833
distinct O 0 0.00428623566403985
from O 0 0.004389524459838867
textbook O 1 0.8844959139823914
aniridia B-Disease 1 0.9992903470993042
. O 0 0.016616037115454674

Here O 0 0.005532013718038797
we O 0 0.002079050289466977
present O 0 0.0020245076157152653
four O 0 0.0017541784327477217
novel O 0 0.009779451414942741
PAX6 O 1 0.9956058859825134
missense O 0 0.04616493359208107
mutations O 0 0.0020508412271738052
, O 0 0.000753780419472605
two O 0 0.0005092191277071834
in O 0 0.0007740171276964247
association O 0 0.0021835369989275932
with O 0 0.0016299574635922909
atypical O 1 0.9992247819900513
phenotypes O 1 0.9494089484214783
ectopia B-Disease 1 0.9953561425209045
pupillae I-Disease 1 0.992321789264679
( O 0 0.0073318094946444035
displaced B-Disease 0 0.02239544875919819
pupils I-Disease 0 0.01141079980880022
) O 0 0.0014844989636912942
and O 0 0.0020155436359345913
congenital B-Disease 1 0.9999992847442627
nystagmus I-Disease 1 0.999931812286377
( O 0 0.026941603049635887
searching B-Disease 0 0.004635597579181194
gaze I-Disease 0 0.13305312395095825
) O 0 0.000603612104896456
, O 0 0.00039649190148338675
and O 0 0.0002976100950036198
two O 0 0.0003181171778123826
in O 0 0.00048792993766255677
association O 0 0.0013323783641681075
with O 0 0.000978320138528943
more O 0 0.0016761553706601262
recognizable O 0 0.10140766948461533
aniridia B-Disease 1 0.9790018796920776
phenotypes O 0 0.16493500769138336
. O 0 0.009115492925047874

Strikingly O 0 0.013815139420330524
, O 0 0.0031166719272732735
all O 0 0.0012587533565238118
four O 0 0.0012258411152288318
mutations O 0 0.0014000087976455688
are O 0 0.0006253704777918756
located O 0 0.0012984235072508454
within O 0 0.0008963147993199527
the O 0 0.001695085666142404
PAX6 O 1 0.9932540059089661
paired O 0 0.004180197138339281
domain O 0 0.001620327471755445
and O 0 0.0008751990972086787
affect O 0 0.0010888894321396947
amino O 0 0.0011361576616764069
acids O 0 0.0009344398276880383
which O 0 0.00046890275552868843
are O 0 0.000407962390454486
highly O 0 0.0007574238697998226
conserved O 0 0.0011402294039726257
in O 0 0.0007443288341164589
all O 0 0.0007310722721740603
known O 0 0.0018214171286672354
paired O 0 0.0045347921550273895
domain O 0 0.004910433664917946
proteins O 0 0.005442650057375431
. O 0 0.006087611895054579

Our O 0 0.005644871387630701
results O 0 0.0030092857778072357
support O 0 0.0019824006594717503
the O 0 0.001228144858032465
hypothesis O 0 0.0015620950143784285
that O 0 0.0005454141064547002
the O 0 0.0005859379889443517
under O 0 0.0009193684672936797
- O 0 0.001369384117424488
representation O 0 0.0008963259169831872
of O 0 0.0008251340477727354
missense O 0 0.08580979704856873
mutations O 0 0.002028106013312936
is O 0 0.0006795059889554977
caused O 0 0.0024538973812013865
by O 0 0.0009729419834911823
ascertainment O 1 0.9994093179702759
bias O 0 0.023998796939849854
and O 0 0.0006302194087766111
suggest O 0 0.0007809381349943578
that O 0 0.00039662871859036386
a O 0 0.0006775996298529208
substantial O 0 0.0015362948179244995
burden O 0 0.14346061646938324
of O 0 0.03925555944442749
PAX6 B-Disease 1 0.9999995231628418
- I-Disease 1 0.9998862743377686
related I-Disease 1 0.9685856103897095
disease I-Disease 1 0.9999814033508301
remains O 0 0.06525404006242752
to O 0 0.0010284088784828782
be O 0 0.0010857580928131938
uncovered O 0 0.005780754145234823
. O 0 0.0030447025783360004
. O 0 0.006674761418253183

The O 0 0.006993002258241177
chromosomal O 0 0.009299779310822487
order O 0 0.0024112090468406677
of O 0 0.00206121988594532
genes O 0 0.002150483662262559
controlling O 0 0.005721695721149445
the O 0 0.002259397879242897
major O 0 0.26551029086112976
histocompatibility O 1 0.9999794960021973
complex O 0 0.10440152883529663
, O 0 0.003441479289904237
properdin O 1 0.9329199194908142
factor O 0 0.014532710425555706
B O 0 0.15803518891334534
, O 0 0.0013580175582319498
and O 0 0.001577226910740137
deficiency B-Disease 1 0.9979603290557861
of I-Disease 0 0.0020982588175684214
the I-Disease 0 0.00312879029661417
second I-Disease 0 0.012737367302179337
component I-Disease 0 0.00994454137980938
of I-Disease 0 0.004734348505735397
complement I-Disease 0 0.01599065586924553
. O 0 0.007448182441294193

The O 0 0.005101791117340326
relationship O 0 0.0037192164454609156
of O 0 0.001977224601432681
the O 0 0.0021173330023884773
genes O 0 0.002058575162664056
coding O 0 0.0036064786836504936
for O 0 0.001170270494185388
HLA O 1 0.6623716950416565
to O 0 0.000675385061185807
those O 0 0.0005357644404284656
coding O 0 0.0015538920415565372
for O 0 0.0009042114834301174
properdin O 0 0.0380268320441246
Factor O 0 0.002913443837314844
B O 0 0.014505604282021523
allotypes O 0 0.03706427663564682
and O 0 0.0008999474812299013
for O 0 0.0009927299106493592
deficiency B-Disease 1 0.9974724650382996
of I-Disease 0 0.001085376483388245
the I-Disease 0 0.0015324046835303307
second I-Disease 0 0.003043408738449216
component I-Disease 0 0.002184453420341015
of I-Disease 0 0.0010196627117693424
complement I-Disease 0 0.015870120376348495
( O 0 0.002016346203163266
C2 O 1 0.9032623171806335
) O 0 0.0005911415792070329
was O 0 0.0005961844581179321
studied O 0 0.0006532057886943221
in O 0 0.000467988895252347
families O 0 0.0007915451424196362
of O 0 0.0030431728810071945
patients O 1 0.9993828535079956
with O 1 0.9230549335479736
connective O 1 0.9999998807907104
tissue O 1 0.9999986886978149
disorders O 1 0.9999997615814209
. O 1 0.50733482837677

Patients O 0 0.047634296119213104
were O 0 0.002572646364569664
selected O 0 0.002224440686404705
because O 0 0.001035888446494937
they O 0 0.0006878150743432343
were O 0 0.0009433184750378132
heterozygous O 0 0.0029119718819856644
or O 0 0.002005387796089053
homozygous O 0 0.01418381743133068
for O 0 0.025616008788347244
C2 B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999998807907104
. O 0 0.22685353457927704

12 O 0 0.006497026886790991
families O 0 0.0038224165327847004
with O 0 0.001909821410663426
15 O 0 0.0028762808069586754
matings O 0 0.00970926508307457
informative O 0 0.00872283149510622
for O 0 0.02402229607105255
C2 B-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999995231628418
were O 0 0.006768055725842714
found O 0 0.008091934956610203
. O 0 0.009614317677915096

Of O 0 0.007559745106846094
57 O 0 0.009540067985653877
informative O 0 0.007059241645038128
meioses O 0 0.012190824374556541
, O 0 0.0013501844368875027
two O 0 0.000718012684956193
crossovers O 0 0.001663782401010394
were O 0 0.0007900763885118067
noted O 0 0.0011079489486292005
between O 0 0.0009907956700772047
the O 0 0.005570875946432352
C2 B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999997615814209
gene O 0 0.005456655286252499
and O 0 0.0012137989979237318
the O 0 0.02937478758394718
HLA O 1 0.9999986886978149
- O 1 0.9838730692863464
B O 0 0.2054920196533203
gene O 0 0.0011504703434184194
, O 0 0.0007029668195173144
with O 0 0.0006334169302135706
a O 0 0.0013176565989851952
recombinant O 0 0.005059290677309036
fraction O 0 0.003114148275926709
of O 0 0.0027334976475685835
0 O 0 0.006968971341848373
. O 0 0.006903452333062887

035 O 1 0.8625431060791016
. O 0 0.060715533792972565

A O 0 0.008314733393490314
lod O 0 0.019603414461016655
score O 0 0.0026241701561957598
of O 0 0.0013378404546529055
13 O 0 0.0013604684500023723
was O 0 0.0011609104694798589
calculated O 0 0.0014609845820814371
for O 0 0.0008775622700341046
linkage O 0 0.020379498600959778
between O 0 0.03277043625712395
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9945424795150757
HLA O 1 0.9999998807907104
- O 1 0.9961691498756409
B O 0 0.07517487555742264
at O 0 0.0009333098423667252
a O 0 0.0008130565984174609
maximum O 0 0.0010596395004540682
likelihood O 0 0.0012349701719358563
value O 0 0.0007797055877745152
of O 0 0.0008812908199615777
the O 0 0.0014555659145116806
recombinant O 0 0.00495183514431119
fraction O 0 0.003561523975804448
of O 0 0.003211380448192358
0 O 0 0.007005550432950258
. O 0 0.006771655287593603

04 O 0 0.48866403102874756
. O 0 0.059869397431612015

18 O 0 0.006604586727917194
families O 0 0.0034008133225142956
with O 0 0.0016017946181818843
21 O 0 0.0024933016393333673
informative O 0 0.0033490797504782677
matings O 0 0.004417107440531254
for O 0 0.001091593992896378
both O 0 0.001192141673527658
properdin O 0 0.059784166514873505
Factor O 0 0.005132769700139761
B O 0 0.038737423717975616
allotype O 0 0.4389066994190216
and O 0 0.0034299299586564302
HLA O 1 0.9999639987945557
- O 1 0.5490682721138
B O 0 0.016561711207032204
were O 0 0.002197213238105178
found O 0 0.004172455053776503
. O 0 0.007353402674198151

Of O 0 0.007233996409922838
72 O 0 0.009884362109005451
informative O 0 0.006879022344946861
meioses O 0 0.017441309988498688
, O 0 0.001383221591822803
three O 0 0.0011452989419922233
recombinants O 0 0.009820317849516869
were O 0 0.0008839996298775077
found O 0 0.0009256979101337492
, O 0 0.0008883101399987936
giving O 0 0.0012800375698134303
a O 0 0.0018013004446402192
recombinant O 0 0.005834509152919054
fraction O 0 0.003632921725511551
of O 0 0.003591794753447175
0 O 0 0.008060184307396412
. O 0 0.007901947945356369

042 O 1 0.592646062374115
. O 0 0.05687996372580528

A O 0 0.009957635775208473
lod O 0 0.017934653908014297
score O 0 0.0038054196629673243
of O 0 0.001862926408648491
16 O 0 0.0023828570265322924
between O 0 0.002387876156717539
HLA O 1 0.9999814033508301
- O 1 0.8146406412124634
B O 0 0.13944198191165924
and O 0 0.001093817874789238
Factor O 0 0.0022176795173436403
B O 0 0.0038860654458403587
allotypes O 0 0.003943843767046928
was O 0 0.0010816770372912288
calculated O 0 0.0011312863789498806
at O 0 0.0007670880295336246
a O 0 0.0008076067315414548
maximum O 0 0.0010902694193646312
likelihood O 0 0.0012145621003583074
value O 0 0.0007595396018587053
of O 0 0.0007812823168933392
the O 0 0.0013680955162271857
recombinant O 0 0.006402692291885614
fraction O 0 0.003527946537360549
of O 0 0.0038809743709862232
0 O 0 0.008622751571238041
. O 0 0.00758384121581912

04 O 1 0.6805081367492676
. O 0 0.04596906900405884

A O 0 0.009198472835123539
crossover O 0 0.008017581887543201
was O 0 0.003376496722921729
shown O 0 0.001422819565050304
to O 0 0.0007184232817962766
have O 0 0.000550868280697614
occurred O 0 0.0007768301875330508
between O 0 0.0004908209666609764
genes O 0 0.0007042787619866431
for O 0 0.0006041839951649308
Factor O 0 0.0018009963678196073
B O 0 0.008057069964706898
and O 0 0.0015434538945555687
HLA O 1 0.999724805355072
- O 0 0.1275806725025177
D O 0 0.027099572122097015
, O 0 0.0006289833108894527
in O 0 0.0006594304577447474
which O 0 0.0011176408734172583
HLA O 1 0.9987874627113342
- O 0 0.39453279972076416
D O 1 0.7654986381530762
segregared O 0 0.196100652217865
with O 0 0.002314558019861579
HLA O 1 0.9998645782470703
- O 0 0.10695813596248627
A O 0 0.004303493071347475
and O 0 0.003668324090540409
B O 0 0.02278248779475689
. O 0 0.009053702466189861

These O 0 0.003555198898538947
studies O 0 0.0027799333911389112
suggest O 0 0.002102130325511098
that O 0 0.0007956491317600012
the O 0 0.0008433223119936883
genes O 0 0.0010342568857595325
for O 0 0.0008833066676743329
Factor O 0 0.009662482887506485
B O 1 0.832582950592041
and O 0 0.04467054083943367
C2 B-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.9999963045120239
are O 0 0.0007737342966720462
located O 0 0.0011696211295202374
outside O 0 0.0008095287485048175
those O 0 0.0005711300182156265
for O 0 0.0007772067328915
HLA O 1 0.9439460635185242
, O 0 0.0006110175745561719
that O 0 0.0003767202724702656
the O 0 0.00044774331036023796
order O 0 0.0005361739313229918
of O 0 0.0007656270754523575
genese O 0 0.47055014967918396
is O 0 0.0014224402839317918
HLA O 1 0.9977366924285889
- O 0 0.00497449841350317
A O 0 0.0013683222932741046
, O 0 0.000898318481631577
- O 0 0.0029295189306139946
B O 0 0.00247199391014874
, O 0 0.0009598464821465313
- O 0 0.0027187063824385405
D O 0 0.005767219699919224
, O 0 0.00090288050705567
Factor O 0 0.0021605961956083775
B O 0 0.026899881660938263
allotype O 1 0.8179187774658203
, O 0 0.015852894634008408
C2 B-Disease 1 0.9999984502792358
deficiency I-Disease 1 0.9999912977218628
, O 0 0.0010400786995887756
that O 0 0.0005918374517932534
the O 0 0.0008150377543643117
genes O 0 0.0013796173734590411
coding O 0 0.005904873833060265
for O 0 0.0034379728604108095
C2 B-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.9999996423721313
and O 0 0.002757829613983631
Factor O 0 0.008766221813857555
B O 0 0.014959094114601612
allotypes O 0 0.0031785573810338974
are O 0 0.0003709714219439775
approximately O 0 0.0007511925650760531
3 O 0 0.0007942280499264598
- O 0 0.0012659704079851508
- O 0 0.001205299748107791
5 O 0 0.0008284271461889148
centimorgans O 0 0.0019706133753061295
from O 0 0.0006058551371097565
the O 0 0.0010120527585968375
HLA O 1 0.9973210692405701
- O 0 0.012318943627178669
A O 0 0.001992160687223077
and O 0 0.0022393602412194014
HLA O 1 0.9999822378158569
- O 1 0.7319983839988708
B O 0 0.060909900814294815
loci O 0 0.0018466874025762081
, O 0 0.0006289116572588682
and O 0 0.0005070089246146381
that O 0 0.00040840625297278166
the O 0 0.0005579465650953352
apparent O 0 0.0014577452093362808
lack O 0 0.0011454663472250104
of O 0 0.00113481970038265
recombinants O 0 0.4662272334098816
between O 0 0.0009199107880704105
the O 0 0.0013066690880805254
Factor O 0 0.033550553023815155
B O 1 0.7109526991844177
gene O 0 0.006352135445922613
and O 0 0.01599714159965515
C2 B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999997615814209
gene O 0 0.003538748249411583
suggests O 0 0.0012858172412961721
that O 0 0.0004457636969164014
these O 0 0.0002874010242521763
two O 0 0.00041892522131092846
genes O 0 0.0007536191842518747
lie O 0 0.001250488101504743
in O 0 0.0006320952670648694
close O 0 0.0011146309552714229
proximity O 0 0.0016593440668657422
to O 0 0.0010116015328094363
one O 0 0.0018990563694387674
another O 0 0.004479060415178537
. O 0 0.00626907916739583

Distribution O 0 0.007431003265082836
of O 0 0.004671949427574873
emerin O 1 0.8719915747642517
and O 0 0.0032689033541828394
lamins O 1 0.9541798233985901
in O 0 0.0016724603483453393
the O 0 0.001961733214557171
heart O 1 0.8668943643569946
and O 0 0.0018506593769416213
implications O 0 0.04798771068453789
for O 0 0.017156757414340973
Emery B-Disease 1 0.9999440908432007
- I-Disease 1 0.999991774559021
Dreifuss I-Disease 1 0.9999997615814209
muscular I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
. O 1 0.531223714351654

Emerin O 0 0.12142015248537064
is O 0 0.004458155017346144
a O 0 0.0028391783125698566
nuclear O 0 0.002744031138718128
membrane O 0 0.0022866942454129457
protein O 0 0.0011506725568324327
which O 0 0.000554483849555254
is O 0 0.000624660518951714
missing O 0 0.001050120685249567
or O 0 0.0009429684723727405
defective O 0 0.07419140636920929
in O 0 0.0023750190157443285
Emery B-Disease 1 0.9989344477653503
- I-Disease 1 0.9999765157699585
Dreifuss I-Disease 1 0.9999998807907104
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9993453621864319
EDMD B-Disease 1 0.9999935626983643
) O 0 0.011462144553661346
. O 0 0.008325976319611073

It O 0 0.003076757537201047
is O 0 0.0018565022619441152
one O 0 0.0010588725563138723
member O 0 0.0011608607601374388
of O 0 0.0007502417429350317
a O 0 0.0010665527079254389
family O 0 0.0016301559517160058
of O 0 0.01004291046410799
lamina O 1 0.9999948740005493
- O 1 0.8178333044052124
associated O 0 0.001712669851258397
proteins O 0 0.0008661939646117389
which O 0 0.0005488471360877156
includes O 0 0.0010061421198770404
LAP1 O 0 0.2914986312389374
, O 0 0.001530831796117127
LAP2 O 0 0.18038511276245117
and O 0 0.0023691875394433737
lamin O 1 0.9469050168991089
B O 0 0.37419795989990234
receptor O 0 0.012033496052026749
( O 0 0.007502537686377764
LBR O 1 0.969670832157135
) O 0 0.007462748326361179
. O 0 0.009570814669132233

A O 0 0.0069572399370372295
panel O 0 0.004533625673502684
of O 0 0.002557649975642562
16 O 0 0.004169337917119265
monoclonal O 1 0.6201577186584473
antibodies O 0 0.22585834562778473
( O 0 0.003121901536360383
mAbs O 0 0.11220449209213257
) O 0 0.000820755201857537
has O 0 0.0005097168614156544
been O 0 0.0005463858251459897
mapped O 0 0.0010939361527562141
to O 0 0.0004124814295209944
six O 0 0.00042506062891334295
specific O 0 0.00037716657971031964
sites O 0 0.0004529197176452726
throughout O 0 0.0004946904955431819
the O 0 0.0007216387311927974
emerin O 0 0.0038086494896560907
molecule O 0 0.0014816131442785263
using O 0 0.0011621779995039105
phage O 0 0.16128909587860107
- O 0 0.004225191194564104
displayed O 0 0.002122329780831933
peptide O 0 0.0021389001049101353
libraries O 0 0.0008908826275728643
and O 0 0.0005614488036371768
has O 0 0.0005243463674560189
been O 0 0.00047274804092012346
used O 0 0.0005067211459390819
to O 0 0.0006240460788831115
localize O 0 0.0046829953789711
emerin O 0 0.008937772363424301
in O 0 0.0011565639870241284
human O 0 0.002483100863173604
and O 0 0.0034935856238007545
rabbit O 1 0.7889477610588074
heart O 1 0.8706640005111694
. O 0 0.01172376424074173

Several O 0 0.006578095257282257
mAbs O 0 0.1507566124200821
against O 0 0.0039040350820869207
different O 0 0.002039759187027812
emerin O 0 0.10089283436536789
epitopes O 0 0.010880347341299057
did O 0 0.0011826824629679322
not O 0 0.0007082116790115833
recognize O 0 0.0012914077378809452
intercalated O 0 0.09416015446186066
discs O 0 0.0025798229034990072
in O 0 0.0008716285228729248
the O 0 0.0012540502939373255
heart O 1 0.7378040552139282
, O 0 0.0007285250467248261
though O 0 0.000530088203959167
they O 0 0.0004052816075272858
recognized O 0 0.0009525542845949531
cardiomyocyte O 0 0.012059970758855343
nuclei O 0 0.0013575790217146277
strongly O 0 0.0008220674353651702
, O 0 0.00044377840822562575
both O 0 0.0004217553941998631
at O 0 0.0006477318238466978
the O 0 0.0006788761238567531
rim O 0 0.002663597697392106
and O 0 0.0008182820165529847
in O 0 0.0012239557690918446
intranuclear O 0 0.41084033250808716
spots O 0 0.004357826430350542
or O 0 0.0027333847247064114
channels O 0 0.006395140662789345
. O 0 0.007623572833836079

A O 0 0.04688332974910736
polyclonal O 1 0.9922707080841064
rabbit O 1 0.9370430707931519
antiserum O 1 0.8163710832595825
against O 0 0.006554461549967527
emerin O 0 0.42148342728614807
did O 0 0.0017188346246257424
recognize O 0 0.0014288313686847687
both O 0 0.0008417154313065112
nuclear O 0 0.0014806389808654785
membrane O 0 0.0015814858488738537
and O 0 0.0007501391810365021
intercalated O 0 0.061681002378463745
discs O 0 0.0016936676111072302
but O 0 0.0005051844054833055
, O 0 0.0005296513554640114
after O 0 0.0007469092961400747
affinity O 0 0.0010414052521809936
purification O 0 0.003194020828232169
against O 0 0.0010237946407869458
a O 0 0.0011604815954342484
pure O 0 0.008333251811563969
- O 0 0.12638811767101288
emerin O 0 0.03561178967356682
band O 0 0.001228134729899466
on O 0 0.0006145190563984215
a O 0 0.0008441257523372769
western O 0 0.0011503213318064809
blot O 0 0.02932543307542801
, O 0 0.001083726529031992
it O 0 0.0009208385017700493
stained O 0 0.01483819168061018
only O 0 0.0011090438347309828
the O 0 0.001995326019823551
nuclear O 0 0.005596311297267675
membrane O 0 0.008610345423221588
. O 0 0.00751103600487113

These O 0 0.0034772506915032864
results O 0 0.002397166332229972
would O 0 0.0010770813096314669
not O 0 0.0006010737852193415
be O 0 0.0005546765169128776
expected O 0 0.0007206937880255282
if O 0 0.0006241442169994116
immunostaining O 0 0.0026741856709122658
at O 0 0.0011043724371120334
intercalated O 0 0.022435544058680534
discs O 0 0.0020828023552894592
were O 0 0.0006908712675794959
due O 0 0.0006606907700188458
to O 0 0.0004232209757901728
a O 0 0.0005702608032152057
product O 0 0.0006672773160971701
of O 0 0.0006723729893565178
the O 0 0.00112075952347368
emerin O 1 0.7030690312385559
gene O 0 0.001017704140394926
and O 0 0.00047888304106891155
, O 0 0.0005021991091780365
therefore O 0 0.0005390103324316442
, O 0 0.00046844527241773903
cast O 0 0.0006528859375976026
some O 0 0.0004405083891469985
doubt O 0 0.0007538289646618068
upon O 0 0.0006697479984723032
the O 0 0.0007315329858101904
hypothesis O 0 0.00295572099275887
that O 0 0.0012903750175610185
cardiac B-Disease 1 0.999914288520813
defects I-Disease 1 0.9997701048851013
in O 0 0.02355598285794258
EDMD B-Disease 1 0.9999690055847168
are O 0 0.0006971096736378968
caused O 0 0.0031070790719240904
by O 0 0.0008271328406408429
absence O 0 0.0049504064954817295
of O 0 0.004660522099584341
emerin O 1 0.996250331401825
from O 0 0.005620979238301516
intercalated O 1 0.9862879514694214
discs O 0 0.09908126294612885
. O 0 0.009180666878819466

Although O 0 0.009059937670826912
emerin O 0 0.36013898253440857
was O 0 0.004936338402330875
abundant O 0 0.0031993601005524397
in O 0 0.001223909785039723
the O 0 0.0013260190607979894
membranes O 0 0.0029294758569449186
of O 0 0.0019367665518075228
cardiomyocyte O 1 0.9710573554039001
nuclei O 0 0.0028187285643070936
, O 0 0.0006651873118244112
it O 0 0.00042631776886992157
was O 0 0.0007314753602258861
absent O 0 0.0008726207306608558
from O 0 0.0005636984715238214
many O 0 0.0007279227138496935
non O 0 0.012029800564050674
- O 1 0.8699912428855896
myocyte O 1 0.9987648725509644
cells O 0 0.002398859476670623
in O 0 0.001510776812210679
the O 0 0.003219014033675194
heart O 1 0.8207109570503235
. O 0 0.00804456789046526

This O 0 0.004073204938322306
distribution O 0 0.0032491800375282764
of O 0 0.002682897262275219
emerin O 1 0.9302362203598022
was O 0 0.002586673479527235
similar O 0 0.0008511680644005537
to O 0 0.0004599896492436528
that O 0 0.0004077635530848056
of O 0 0.0007276792312040925
lamin O 0 0.47002166509628296
A O 0 0.0012743358965963125
, O 0 0.0005821544327773154
a O 0 0.000714099733158946
candidate O 0 0.0010943030938506126
gene O 0 0.000720798154361546
for O 0 0.0004903074586763978
an O 0 0.0011007299181073904
autosomal O 0 0.20565757155418396
form O 0 0.0030213729478418827
of O 0 0.08991475403308868
EDMD B-Disease 1 0.999987006187439
. O 0 0.014341626316308975

In O 0 0.006072379648685455
contrast O 0 0.006778204347938299
, O 0 0.0048696119338274
lamin O 1 0.9989274144172668
B1 O 1 0.9998480081558228
was O 0 0.006672561634331942
absent O 0 0.0038483927492052317
from O 0 0.0011166007025167346
cardiomyocyte O 0 0.11273354291915894
nuclei O 0 0.0021984358318150043
, O 0 0.0009245480760000646
showing O 0 0.0020384835079312325
that O 0 0.0014116235543042421
lamin O 1 0.9992011189460754
B1 O 1 0.9994969367980957
is O 0 0.0009271808085031807
not O 0 0.00046641906374134123
essential O 0 0.0008922239649109542
for O 0 0.0006777223316021264
localization O 0 0.002407916123047471
of O 0 0.001236294163390994
emerin O 0 0.011732375249266624
to O 0 0.0016611692262813449
the O 0 0.0030986021738499403
nuclear O 0 0.00948367454111576
lamina O 1 0.9669467210769653
. O 0 0.009205576963722706

Lamin O 1 0.9998400211334229
B1 O 1 0.9997149109840393
is O 0 0.004116566386073828
also O 0 0.00219904026016593
almost O 0 0.0023727966472506523
completely O 0 0.004391383845359087
absent O 0 0.010535093024373055
from O 0 0.0042879413813352585
skeletal O 1 0.9997157454490662
muscle O 1 0.9968421459197998
nuclei O 0 0.18507617712020874
. O 0 0.011837231926620007

In O 0 0.007208720315247774
EDMD B-Disease 1 0.9054049849510193
, O 0 0.0020666569471359253
the O 0 0.001334988628514111
additional O 0 0.0011931026820093393
absence O 0 0.002694085706025362
of O 0 0.00922549981623888
lamin O 1 0.9999926090240479
B1 O 1 0.9999974966049194
from O 0 0.0118810273706913
heart O 1 0.9991078972816467
and O 0 0.1586192101240158
skeletal O 1 0.9999939203262329
muscle O 1 0.9993976354598999
nuclei O 0 0.2199048101902008
which O 0 0.0007631736807525158
already O 0 0.0014569306513294578
lack O 0 0.007417295128107071
emerin O 1 0.7760624289512634
may O 0 0.0006751234759576619
offer O 0 0.0005315555608831346
an O 0 0.0004652529605664313
alternative O 0 0.0007204420980997384
explanation O 0 0.0008905797149054706
of O 0 0.0006820076960138977
why O 0 0.0009046191116794944
these O 0 0.0005320578347891569
tissues O 0 0.0017468209844082594
are O 0 0.0007288330816663802
particularly O 0 0.0016159680671989918
affected O 0 0.0029854977037757635
. O 0 0.0028380826115608215
. O 0 0.005648420192301273

Genetic O 0 0.011747722513973713
mapping O 0 0.008458015508949757
of O 0 0.003911796025931835
the O 0 0.005535770673304796
copper B-Disease 1 0.989401638507843
toxicosis I-Disease 1 0.9999247789382935
locus O 0 0.43219637870788574
in O 0 0.0031953672878444195
Bedlington O 1 0.9802740812301636
terriers O 0 0.044099725782871246
to O 0 0.001066202181391418
dog O 0 0.0026963595300912857
chromosome O 0 0.0014351214049383998
10 O 0 0.0006853672675788403
, O 0 0.0005791299627162516
in O 0 0.000598363927565515
a O 0 0.0008593868114985526
region O 0 0.0013688839972019196
syntenic O 0 0.007304537575691938
to O 0 0.0010469990083947778
human O 0 0.002081106184050441
chromosome O 0 0.005203482694923878
region O 0 0.00524043058976531
2p13 O 1 0.9199331402778625
- O 1 0.6872996091842651
p16 O 0 0.36789923906326294
. O 0 0.011117331683635712

Abnormal O 1 0.9999403953552246
hepatic B-Disease 1 0.9999973773956299
copper I-Disease 1 0.9998155236244202
accumulation I-Disease 1 0.997225284576416
is O 0 0.012828796170651913
recognized O 0 0.00797979161143303
as O 0 0.0031610229052603245
an O 0 0.4105933606624603
inherited B-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999998807907104
in O 1 0.8085970878601074
man O 1 0.9940788745880127
, O 0 0.0618712417781353
mouse O 0 0.283465176820755
, O 0 0.0022926409728825092
rat O 1 0.6513583064079285
and O 0 0.002503911964595318
dog O 0 0.0172918438911438
. O 0 0.006458044517785311

The O 0 0.008820454590022564
major O 0 0.056973058730363846
cause O 1 0.7705571055412292
of O 1 0.8091326951980591
hepatic B-Disease 1 0.9999998807907104
copper I-Disease 1 0.9999918937683105
accumulation I-Disease 1 0.999550998210907
in O 0 0.023015692830085754
man O 0 0.31049472093582153
is O 0 0.0011562491999939084
a O 0 0.002033483237028122
dysfunctional O 1 0.9730592966079712
ATP7B O 1 0.9965085387229919
gene O 0 0.0027731074951589108
, O 0 0.0015589224640280008
causing O 1 0.7089256048202515
Wilson B-Disease 1 0.9992831349372864
disease I-Disease 1 0.9999997615814209
( O 1 0.9956364035606384
WD B-Disease 1 0.9999765157699585
) O 0 0.006246584467589855
. O 0 0.006634283345192671

Mutations O 0 0.008919958956539631
in O 0 0.0032958555966615677
the O 0 0.0030721668154001236
ATP7B O 1 0.9699317216873169
genes O 0 0.002067193854600191
have O 0 0.0007110711303539574
also O 0 0.000710975204128772
been O 0 0.0008396143093705177
demonstrated O 0 0.0016533572925254703
in O 0 0.0013279503909870982
mouse O 0 0.005960698239505291
and O 0 0.0031327696051448584
rat O 0 0.39607590436935425
. O 0 0.0073373266495764256

The O 0 0.013127273879945278
ATP7B O 1 0.9724437594413757
gene O 0 0.005607283674180508
has O 0 0.0018603142816573381
been O 0 0.001226596301421523
excluded O 0 0.0016383046749979258
in O 0 0.0007576462812721729
the O 0 0.0010017667664214969
much O 0 0.0014549603220075369
rarer O 0 0.1483294516801834
human O 0 0.06357774138450623
copper B-Disease 1 0.9999407529830933
overload I-Disease 1 0.999997615814209
disease O 1 0.9999996423721313
non B-Disease 1 0.9989463686943054
- I-Disease 1 0.9996925592422485
Indian I-Disease 1 0.8846255540847778
childhood I-Disease 1 0.9999816417694092
cirrhosis I-Disease 1 0.9999996423721313
, O 0 0.17615318298339844
indicating O 0 0.374960720539093
genetic O 0 0.0991029292345047
heterogeneity O 1 0.6241329908370972
. O 0 0.01163946371525526

By O 0 0.006186929531395435
investigating O 0 0.00685538025572896
the O 0 0.004079474601894617
common O 0 0.34079867601394653
autosomal O 1 0.9999799728393555
recessive O 1 0.9999974966049194
copper B-Disease 1 0.9999988079071045
toxicosis I-Disease 1 1.0
( O 1 0.986156165599823
CT B-Disease 1 0.9995335340499878
) O 0 0.0015782928094267845
in O 0 0.0011354824528098106
Bedlington O 1 0.9363501071929932
terriers O 0 0.044642459601163864
, O 0 0.0006548763485625386
we O 0 0.0004425927472766489
have O 0 0.0003245169064030051
identified O 0 0.000535241502802819
a O 0 0.0005603890749625862
new O 0 0.0006739749223925173
locus O 0 0.005969460587948561
involved O 0 0.0022283706348389387
in O 0 0.03446878120303154
progressive O 1 0.9999929666519165
liver B-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
. O 1 0.6381386518478394

We O 0 0.005817259196192026
examined O 0 0.005967415403574705
whether O 0 0.002814097562804818
the O 0 0.0030920517165213823
WD B-Disease 1 0.9987843632698059
gene O 0 0.004208975471556187
ATP7B O 1 0.7038072347640991
was O 0 0.0026685248594731092
also O 0 0.000953635317273438
causative O 0 0.019115766510367393
for O 0 0.0007578564691357315
CT B-Disease 0 0.0589466392993927
by O 0 0.0005271732807159424
investigating O 0 0.0011367752449586987
the O 0 0.001126631861552596
chromosomal O 0 0.07296363264322281
co O 0 0.12971889972686768
- O 0 0.03362501412630081
localization O 0 0.0033025259617716074
of O 0 0.001297497539781034
ATP7B O 1 0.8635526299476624
and O 0 0.000997508643195033
C04107 O 0 0.004623011685907841
, O 0 0.0007822269108146429
using O 0 0.0009296776261180639
fluorescence O 0 0.002372725633904338
in O 0 0.0012725276174023747
situ O 0 0.009321282617747784
hybridization O 0 0.005468735005706549
( O 0 0.0031454944983124733
FISH O 0 0.005937611684203148
) O 0 0.0061719068326056
. O 0 0.009465782903134823

C04107 O 0 0.03139294683933258
is O 0 0.00431510154157877
an O 0 0.003004634054377675
anonymous O 0 0.0062727490440011024
microsatellite O 0 0.06442157924175262
marker O 0 0.010869740508496761
closely O 0 0.003978252876549959
linked O 0 0.006432636175304651
to O 0 0.004220056347548962
CT B-Disease 1 0.914236307144165
. O 0 0.009681712836027145

However O 0 0.009216534905135632
, O 0 0.007378666196018457
BAC O 1 0.9738681316375732
clones O 0 0.045485977083444595
containing O 0 0.00596967525780201
ATP7B O 1 0.758041501045227
and O 0 0.0018649084959179163
C04107 O 0 0.016907714307308197
mapped O 0 0.0028835118282586336
to O 0 0.0009458735585212708
the O 0 0.0014147518668323755
canine O 0 0.48267069458961487
chromosome O 0 0.003302374854683876
regions O 0 0.0013793775578960776
CFA22q11 O 0 0.2059529423713684
and O 0 0.0009872358059510589
CFA10q26 O 0 0.06676438450813293
, O 0 0.000883523840457201
respectively O 0 0.0012865037424489856
, O 0 0.0008946585585363209
demonstrating O 0 0.002667233580723405
that O 0 0.001238008146174252
WD B-Disease 1 0.9103032350540161
cannot O 0 0.0013716990360990167
be O 0 0.001216409495100379
homologous O 0 0.00469603156670928
to O 0 0.0028918362222611904
CT B-Disease 0 0.24467317759990692
. O 0 0.008636744692921638

The O 0 0.010214206762611866
copper O 1 0.6233025193214417
transport O 0 0.04429185017943382
genes O 0 0.005497712641954422
CTR1 O 1 0.9470370411872864
and O 0 0.0018135986756533384
CTR2 O 1 0.6918399930000305
were O 0 0.0009696502238512039
also O 0 0.0007302367012016475
excluded O 0 0.0011942526325583458
as O 0 0.0006945652421563864
candidate O 0 0.0010028367396444082
genes O 0 0.0007184798596426845
for O 0 0.0006152219721116126
CT B-Disease 0 0.11970119923353195
since O 0 0.0006075137061998248
they O 0 0.0004001679481007159
both O 0 0.0005879614618606865
mapped O 0 0.0021276879124343395
to O 0 0.001261334284208715
canine O 0 0.2617429196834564
chromosome O 0 0.00775558827444911
region O 0 0.00698119169101119
CFA11q22 O 0 0.2503488063812256
. O 0 0.008824862539768219

2 O 0 0.03234153240919113
- O 0 0.034562136977910995
22 O 0 0.02757316455245018
. O 0 0.02327478490769863

5 O 0 0.05196300148963928
. O 0 0.036328352987766266

A O 0 0.007612534333020449
transcribed O 0 0.006339282263070345
sequence O 0 0.0027992865070700645
identified O 0 0.0017593145603314042
from O 0 0.0009215481695719063
the O 0 0.0013896628515794873
C04107 O 0 0.4867289960384369
- O 0 0.15350911021232605
containing O 0 0.006575047504156828
BAC O 1 0.9574554562568665
was O 0 0.0017226991476491094
found O 0 0.0005944774020463228
to O 0 0.00041831901762634516
be O 0 0.00038088520523160696
homologous O 0 0.001032997970469296
to O 0 0.00041127490112558007
a O 0 0.000688569329213351
gene O 0 0.0007047100807540119
expressed O 0 0.0006332880002446473
from O 0 0.0005986436735838652
human O 0 0.0011612987145781517
chromosome O 0 0.004777833353728056
2p13 O 1 0.7066296339035034
- O 0 0.2506081461906433
p16 O 0 0.040327850729227066
, O 0 0.0009186535025946796
a O 0 0.0010639765532687306
region O 0 0.0014420051593333483
devoid O 0 0.002759479684755206
of O 0 0.0013856500154361129
any O 0 0.0016744846943765879
positional O 0 0.007219980005174875
candidate O 0 0.005896247923374176
genes O 0 0.00620603421702981
. O 0 0.007091639097779989

Molecular O 0 0.007880381308495998
analysis O 0 0.00289082620292902
of O 0 0.002245585434138775
the O 0 0.0022692158818244934
APC B-Disease 0 0.23436316847801208
gene O 0 0.0017962816637009382
in O 0 0.0009679620270617306
205 O 0 0.0027541914023458958
families O 0 0.0011834397446364164
: O 0 0.001166119589470327
extended O 0 0.0021520222071558237
genotype O 0 0.009172183461487293
- O 0 0.010606326162815094
phenotype O 0 0.004096912685781717
correlations O 0 0.0026847352273762226
in O 0 0.0011105404701083899
FAP B-Disease 1 0.9955476522445679
and O 0 0.0007339779986068606
evidence O 0 0.0007364176562987268
for O 0 0.00047436796012334526
the O 0 0.0006210467545315623
role O 0 0.0010954326717182994
of O 0 0.0012022965820506215
APC B-Disease 1 0.9373205304145813
amino O 0 0.0028878587763756514
acid O 0 0.02248327247798443
changes O 0 0.002684694714844227
in O 0 0.1300082802772522
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
predisposition O 1 0.9999889135360718
. O 0 0.05053979903459549

BACKGROUND O 0 0.027235940098762512
/ O 0 0.14413370192050934
AIMS O 0 0.009038412012159824
The O 0 0.0028410758823156357
development O 0 0.01470330823212862
of O 1 0.8975958824157715
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
and O 0 0.015006366185843945
a O 0 0.002146016573533416
variable O 0 0.0016211554175242782
range O 0 0.0011923800921067595
of O 0 0.001397716929204762
extracolonic O 1 0.7705503702163696
manifestations O 1 0.913536787033081
in O 0 0.19529207050800323
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.999995231628418
FAP B-Disease 1 1.0
) O 0 0.005099457688629627
is O 0 0.000774483778513968
the O 0 0.0006969917449168861
result O 0 0.0006436089752241969
of O 0 0.0007525373948737979
the O 0 0.0014858579961583018
dominant O 0 0.015128319151699543
inheritance O 0 0.48307278752326965
of O 1 0.9783546924591064
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9994052648544312
APC B-Disease 1 0.9999580383300781
) O 0 0.007575612980872393
gene O 0 0.007425627205520868
mutations O 0 0.009471646510064602
. O 0 0.008587409742176533

In O 0 0.0042426567524671555
this O 0 0.00180117879062891
study O 0 0.0018101722234860063
, O 0 0.0010567563585937023
direct O 0 0.000983924139291048
mutation O 0 0.0010360348969697952
analysis O 0 0.0007059509516693652
of O 0 0.0007510156719945371
the O 0 0.001227955799549818
APC B-Disease 1 0.9125376343727112
gene O 0 0.0010193174239248037
was O 0 0.0008352609002031386
performed O 0 0.0007316246046684682
to O 0 0.0005007037543691695
determine O 0 0.0011116131208837032
genotype O 0 0.0039013996720314026
- O 0 0.002467615529894829
phenotype O 0 0.0020643509924411774
correlations O 0 0.0015738169895485044
for O 0 0.0006453059613704681
nine O 0 0.0012744839768856764
extracolonic O 0 0.030431978404521942
manifestations O 0 0.004083516076207161
and O 0 0.0006931788520887494
to O 0 0.0005287046660669148
investigate O 0 0.00131151860114187
the O 0 0.0009123124764300883
incidence O 0 0.31426891684532166
of O 0 0.0028828966896981
APC B-Disease 1 0.9935362339019775
mutations O 0 0.007080530747771263
in O 0 0.003637755988165736
non O 1 0.9966211318969727
- O 1 0.9999977350234985
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.11200959980487823

METHODS O 0 0.011582553386688232
The O 0 0.0065884762443602085
APC B-Disease 0 0.20830601453781128
gene O 0 0.0026289154775440693
was O 0 0.001817188924178481
analysed O 0 0.002362016821280122
in O 0 0.0010002929484471679
190 O 0 0.0020936450455337763
unrelated O 0 0.002932195784524083
FAP B-Disease 1 0.9705058336257935
and O 0 0.0014727083034813404
15 O 0 0.0032420610077679157
non O 1 0.9640213251113892
- O 1 0.9999942779541016
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9995025396347046
using O 0 0.006065925117582083
denaturing O 1 0.9988440275192261
gradient O 1 0.7827282547950745
gel O 1 0.9374024271965027
electrophoresis O 0 0.013609461486339569
, O 0 0.00102437031455338
the O 0 0.0009428113698959351
protein O 0 0.0012451433576643467
truncation O 0 0.003183936234563589
test O 0 0.0012493357062339783
, O 0 0.0009715012274682522
and O 0 0.00114770932123065
direct O 0 0.0027679509948939085
sequencing O 0 0.0077033997513353825
. O 0 0.00616246135905385

RESULTS O 0 0.009423007257282734
Chain O 0 0.010038379579782486
terminating O 0 0.010371504351496696
signals O 0 0.00234246370382607
were O 0 0.0009979534661397338
only O 0 0.0006721807876601815
identified O 0 0.0011700328905135393
in O 0 0.0006989876856096089
patients O 0 0.002985923085361719
belonging O 0 0.0013455848675221205
to O 0 0.0007430613623000681
the O 0 0.0018218125915154815
FAP B-Disease 1 0.9999569654464722
group O 0 0.003315811976790428
( O 0 0.003433540230616927
105 O 0 0.007357302121818066
patients O 0 0.022771989926695824
) O 0 0.003923259675502777
. O 0 0.00554254837334156

Amino O 0 0.01033985149115324
acid O 0 0.007526090834289789
changes O 0 0.0018611717969179153
were O 0 0.0010093325981870294
identified O 0 0.0010510163847357035
in O 0 0.0006187582039274275
four O 0 0.0006214973400346935
patients O 0 0.0037355232052505016
, O 0 0.00042780573130585253
three O 0 0.00037023317418061197
of O 0 0.0005395832122303545
whom O 0 0.0009283052640967071
belonged O 0 0.0011417173082008958
to O 0 0.0005210258532315493
the O 0 0.0009948484366759658
non O 0 0.1431143432855606
- O 1 0.994419276714325
FAP O 1 0.9999959468841553
group O 0 0.23229412734508514
of O 1 0.9941608309745789
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999934434890747
. O 0 0.31801778078079224

Genotype O 1 0.7535346746444702
- O 0 0.3474636971950531
phenotype O 0 0.019367754459381104
correlations O 0 0.005568187218159437
identified O 0 0.0019936594180762768
significant O 0 0.0009155822917819023
differences O 0 0.0008244087221100926
in O 0 0.0005355612374842167
the O 0 0.000726948375813663
nature O 0 0.0010558476205915213
of O 0 0.0009642085060477257
certain O 0 0.0014348630793392658
extracolonic O 1 0.9954186677932739
manifestations O 1 0.9933360815048218
in O 0 0.32652926445007324
FAP B-Disease 1 0.9999996423721313
patients O 1 0.9075900316238403
belonging O 0 0.0029334239661693573
to O 0 0.0010918279876932502
three O 0 0.0018256987677887082
mutation O 0 0.00752996327355504
subgroups O 0 0.012825118377804756
. O 0 0.007446771953254938

CONCLUSIONS O 0 0.016961783170700073
Extended O 0 0.013760524801909924
genotype O 0 0.12000346183776855
- O 0 0.08372414112091064
phenotype O 0 0.006415138486772776
correlations O 0 0.003128800541162491
made O 0 0.001129091251641512
in O 0 0.00065629679011181
this O 0 0.00046999016194604337
study O 0 0.0007588198059238493
may O 0 0.0005563322338275611
have O 0 0.0003096424916293472
the O 0 0.00044705645996145904
potential O 0 0.0005280982586555183
to O 0 0.00033975622500292957
determine O 0 0.00046706796274520457
the O 0 0.00040849673678167164
most O 0 0.00040527735836803913
appropriate O 0 0.0007050432031974196
surveillance O 0 0.0013132503954693675
and O 0 0.0009184193913824856
prophylactic O 1 0.9941500425338745
treatment O 1 0.9720783233642578
regimens O 1 0.9741453528404236
for O 0 0.0010946200927719474
those O 0 0.000788694538641721
patients O 0 0.11980397254228592
with O 0 0.0009031295776367188
mutations O 0 0.00417786929756403
associated O 0 0.0014098623069003224
with O 0 0.0013409933308139443
life O 0 0.0687672570347786
threatening O 1 0.8116318583488464
conditions O 0 0.19814054667949677
. O 0 0.008398495614528656

This O 0 0.004151356406509876
study O 0 0.002962624654173851
also O 0 0.0014811184955760837
provided O 0 0.0014339000917971134
evidence O 0 0.0009391320054419339
for O 0 0.0006362221320159733
the O 0 0.0007597342482767999
pathological O 0 0.01004883460700512
nature O 0 0.0009685672121122479
of O 0 0.0008048375020734966
amino O 0 0.0013073288137093186
acid O 0 0.0018914585234597325
changes O 0 0.0005571950459852815
in O 0 0.0005299283657222986
APC O 0 0.020503249019384384
associated O 0 0.0005962796276435256
with O 0 0.0005491032497957349
both O 0 0.0010362088214606047
FAP B-Disease 1 0.999990701675415
and O 0 0.2160012423992157
non O 1 0.9998838901519775
- O 1 0.9999997615814209
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999898672103882
. O 0 0.027371345087885857
. O 0 0.008527353405952454

Inherited B-Disease 1 0.9999992847442627
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9998984336853027
cancer B-Disease 1 0.9999998807907104
risk O 1 0.998708963394165
of O 1 0.8588622212409973
the O 1 0.9864447712898254
APC O 1 0.9999879598617554
I1307K O 1 0.9990338087081909
polymorphism O 0 0.2633741796016693
. O 0 0.012014219537377357

Germ O 1 0.9985606074333191
- O 0 0.33912599086761475
line O 0 0.005702094174921513
and O 0 0.00221038400195539
somatic O 0 0.013441002927720547
truncating O 0 0.061284035444259644
mutations O 0 0.002153634326532483
of O 0 0.0013483410002663732
the O 0 0.0020816342439502478
APC B-Disease 1 0.851571798324585
gene O 0 0.0009573563002049923
are O 0 0.0003669841098599136
thought O 0 0.0008244094788096845
to O 0 0.000943250663112849
initiate O 0 0.050913259387016296
colorectal B-Disease 1 0.9999984502792358
tumor I-Disease 1 0.9999542236328125
formation O 1 0.9864698052406311
in O 1 0.9733462929725647
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999949932098389
sporadic O 1 0.9999998807907104
colorectal O 1 1.0
carcinogenesis O 1 0.9999998807907104
, O 1 0.903411328792572
respectively O 0 0.48817744851112366
. O 0 0.00974302925169468

Recently O 0 0.00871929433196783
, O 0 0.003653066698461771
an O 0 0.003434494836255908
isoleucine O 1 0.9971736669540405
- O 1 0.9393895864486694
- O 1 0.5632273554801941
> O 0 0.009756348095834255
lysine O 0 0.004249029327183962
polymorphism O 0 0.0031758497934788465
at O 0 0.0015596351586282253
codon O 0 0.004032903350889683
1307 O 0 0.0073420582339167595
( O 0 0.0018555553397163749
I1307K O 0 0.003695701016113162
) O 0 0.0008590331999585032
of O 0 0.0006161218043416739
the O 0 0.0009952593827620149
APC B-Disease 0 0.28609979152679443
gene O 0 0.0009078942821361125
has O 0 0.00045174124534241855
been O 0 0.0004441053024493158
identified O 0 0.0005198303260840476
in O 0 0.0003961235051974654
6 O 0 0.000787349243182689
% O 0 0.0006235859473235905
- O 0 0.001100710011087358
7 O 0 0.0009321272955276072
% O 0 0.0007385119097307324
of O 0 0.00078541663242504
the O 0 0.0014122031861916184
Ashkenazi O 0 0.009978223592042923
Jewish O 0 0.0046195681206882
population O 0 0.004775050096213818
. O 0 0.007865311577916145

To O 0 0.004581482149660587
assess O 0 0.0053651100024580956
the O 0 0.00231371121481061
risk O 0 0.0024901560973376036
of O 0 0.0012383259600028396
this O 0 0.0010329304495826364
common O 0 0.004632045980542898
APC B-Disease 1 0.9977383613586426
allelic O 1 0.9955177903175354
variant O 1 0.9550129175186157
in O 0 0.0750468298792839
colorectal O 1 0.9999998807907104
carcinogenesis O 1 0.9999525547027588
, O 0 0.001376836677081883
we O 0 0.0004914507735520601
have O 0 0.00035988393938168883
analyzed O 0 0.0007966509438119829
a O 0 0.0006504295743070543
large O 0 0.0008954892982728779
cohort O 0 0.003583198878914118
of O 0 0.0012198785552754998
unselected O 1 0.6911932826042175
Ashkenazi O 0 0.06758202612400055
Jewish O 0 0.0020100693218410015
subjects O 0 0.0024921956937760115
with O 0 0.004772472195327282
adenomatous B-Disease 1 0.9999995231628418
polyps I-Disease 1 0.9999825954437256
and O 0 0.08596596121788025
. O 0 0.04624224454164505
or O 1 0.8482484221458435
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
, I-Disease 0 0.02159792371094227
for O 0 0.0033655676525086164
the O 0 0.045452214777469635
APC O 1 0.999239444732666
I1307K O 1 0.8873345851898193
polymorphism O 0 0.0223404373973608
. O 0 0.008817475289106369

The O 0 0.01428957562893629
APC O 1 0.9013598561286926
I1307K O 0 0.12323219329118729
allele O 0 0.006680109538137913
was O 0 0.0027015432715415955
identified O 0 0.0015131724067032337
in O 0 0.0008455410716123879
48 O 0 0.0012318528024479747
( O 0 0.0008185112965293229
10 O 0 0.0005615041591227055
. O 0 0.0004631491319742054
1 O 0 0.0009383077849633992
% O 0 0.0009552594274282455
) O 0 0.0012017091503366828
of O 0 0.002057858044281602
476 O 0 0.2821023762226105
patients O 0 0.23284417390823364
. O 0 0.007394864689558744

Compared O 0 0.0047505805268883705
with O 0 0.0015241345390677452
the O 0 0.0011391241569072008
frequency O 0 0.0008798982598818839
in O 0 0.0004628075403161347
two O 0 0.0003702269750647247
separate O 0 0.0005428784643299878
population O 0 0.0005147439078427851
control O 0 0.0006566547090187669
groups O 0 0.00041315716225653887
, O 0 0.0006136209703981876
the O 0 0.001137154409661889
APC O 1 0.8566141128540039
I1307K O 0 0.13986307382583618
allele O 0 0.0017953141359612346
is O 0 0.0006001804140396416
associated O 0 0.000578445615246892
with O 0 0.0004320680454839021
an O 0 0.0006511840620078146
estimated O 0 0.0011956009548157454
relative O 0 0.0017545191803947091
risk O 0 0.002592958975583315
of O 0 0.002420659177005291
1 O 0 0.006291762460023165
. O 0 0.007569560781121254

5 O 0 0.026016991585493088
- O 0 0.03731818497180939
1 O 0 0.018978774547576904
. O 0 0.01558205857872963

7 O 0 0.01289479248225689
for O 0 0.0077215214259922504
colorectal B-Disease 1 0.9999967813491821
neoplasia I-Disease 1 0.9999555349349976
( O 0 0.007456682622432709
both O 0 0.0029342316556721926
P O 0 0.40541505813598633
= O 0 0.007643334101885557
. O 0 0.0025303601287305355
01 O 0 0.04238232225179672
) O 0 0.005624279845505953
. O 0 0.007628581020981073

Furthermore O 0 0.010051866061985493
, O 0 0.003278252435848117
compared O 0 0.0027721887454390526
with O 0 0.0017131476197391748
noncarriers O 1 0.850479006767273
, O 0 0.0030555222183465958
APC O 1 0.9799937009811401
I1307K O 1 0.5717278122901917
carriers O 0 0.00289706327021122
had O 0 0.0010957145132124424
increased O 0 0.0010119477519765496
numbers O 0 0.0008487029117532074
of O 0 0.001363361719995737
adenomas B-Disease 1 0.9995699524879456
and O 0 0.03563674911856651
colorectal B-Disease 1 0.9999997615814209
cancers I-Disease 1 0.9999210834503174
per O 0 0.008878138847649097
patient O 1 0.9594112038612366
( O 0 0.007754054386168718
P O 0 0.1201528012752533
= O 0 0.0019498069304972887
. O 0 0.0005903459968976676
03 O 0 0.003363104071468115
) O 0 0.000571572280023247
, O 0 0.00043000231380574405
as O 0 0.0004143889818806201
well O 0 0.0004434242728166282
as O 0 0.0005812201998196542
a O 0 0.0008971867500804365
younger O 0 0.00192583620082587
age O 0 0.0022716301027685404
at O 0 0.004554626066237688
diagnosis O 1 0.993874728679657
. O 0 0.008308498188853264

We O 0 0.0054595437832176685
conclude O 0 0.005610738880932331
that O 0 0.001976706786081195
the O 0 0.002536979503929615
APC O 1 0.9295479655265808
I1307K O 1 0.7805362343788147
variant O 0 0.13215766847133636
leads O 0 0.0035710702650249004
to O 0 0.0011390037834644318
increased O 0 0.0162940826267004
adenoma B-Disease 1 0.9999666213989258
formation O 0 0.005520856939256191
and O 0 0.0006373521755449474
directly O 0 0.0006083324551582336
contributes O 0 0.0008952521020546556
to O 0 0.000423132412834093
3 O 0 0.000715838628821075
% O 0 0.0005750705604441464
- O 0 0.0010179930832237005
4 O 0 0.0009581279591657221
% O 0 0.0007224548025988042
of O 0 0.0008127506589516997
all O 0 0.0014208954526111484
Ashkenazi O 1 0.9146286249160767
Jewish O 1 0.9515108466148376
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
. O 0 0.15072475373744965

The O 0 0.007288763299584389
estimated O 0 0.005731517449021339
relative O 0 0.004177619703114033
risk O 0 0.009790655225515366
for O 0 0.0013020068872720003
carriers O 0 0.0038483489770442247
may O 0 0.000998557428829372
justify O 0 0.0017067514127120376
specific O 0 0.0007583780097775161
clinical O 0 0.002306889509782195
screening O 0 0.0012522664619609714
for O 0 0.0004697791882790625
the O 0 0.0005946212913841009
360 O 0 0.0011357306502759457
, O 0 0.0005995127139613032
000 O 0 0.0012246426194906235
Americans O 0 0.0006250752485357225
expected O 0 0.0005391406593844295
to O 0 0.00044884326052851975
harbor O 0 0.0014880073722451925
this O 0 0.0004911231808364391
allele O 0 0.0010806944919750094
, O 0 0.0005504043074324727
and O 0 0.000495288462843746
genetic O 0 0.0007842914783395827
testing O 0 0.0007111255545169115
in O 0 0.00040996650932356715
the O 0 0.0004372697731014341
setting O 0 0.0006847319309599698
of O 0 0.0007559327059425414
long O 0 0.0030993858817964792
- O 0 0.047144532203674316
term O 0 0.002163927536457777
- O 0 0.0017465332057327032
outcome O 0 0.0007759372238069773
studies O 0 0.000787999015301466
may O 0 0.0007293816306628287
impact O 0 0.0015193962026387453
significantly O 0 0.0022852623369544744
on O 0 0.00985678844153881
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
prevention O 1 0.999976634979248
in O 0 0.005214671138674021
this O 0 0.002254793420433998
population O 0 0.004271788522601128
. O 0 0.006506479345262051

Localization O 0 0.015710726380348206
of O 0 0.004829799756407738
human O 0 0.008455048315227032
BRCA1 O 1 0.9253478050231934
and O 0 0.001199794001877308
its O 0 0.0008389976574108005
loss O 0 0.0030457130633294582
in O 0 0.000909870897885412
high O 0 0.005283573642373085
- O 0 0.28255730867385864
grade O 0 0.42766454815864563
, O 0 0.002516151638701558
non B-Disease 1 0.6181846261024475
- I-Disease 1 0.9994578957557678
inherited I-Disease 1 0.9999897480010986
breast I-Disease 1 0.9999986886978149
carcinomas I-Disease 1 0.9999983310699463
. O 0 0.08186253160238266

Although O 0 0.005392256658524275
the O 0 0.0029253948014229536
link O 0 0.0035688315983861685
between O 0 0.0021956658456474543
the O 0 0.015777844935655594
BRCA1 O 1 0.9999924898147583
tumour B-Disease 1 0.9999997615814209
- O 1 0.9996610879898071
suppressor O 1 0.9973942041397095
gene O 0 0.003835198702290654
and O 0 0.0026124673895537853
hereditary B-Disease 1 0.9999938011169434
breast I-Disease 1 1.0
and I-Disease 1 0.9999817609786987
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 1 0.5573307275772095
established O 0 0.025926662608981133
, O 0 0.0006856112158857286
the O 0 0.0005612888489849865
role O 0 0.0007835287251509726
, O 0 0.0003369967744220048
if O 0 0.00026466924464330077
any O 0 0.00024571502581238747
, O 0 0.0003750670875888318
of O 0 0.0005589461652562022
BRCA1 O 1 0.6220897436141968
in O 0 0.0015729250153526664
non B-Disease 1 0.9320219159126282
- I-Disease 1 0.9996309280395508
familial I-Disease 1 0.9999932050704956
cancers I-Disease 1 0.9999773502349854
is O 0 0.026010781526565552
unclear O 0 0.008139119483530521
. O 0 0.007627270650118589

BRCA1 O 1 0.974556028842926
mutations O 0 0.007184149697422981
are O 0 0.0015162266790866852
rare O 0 0.0025022393092513084
in O 0 0.001436208258382976
sporadic B-Disease 0 0.2781662344932556
cancers I-Disease 1 0.9921950101852417
, O 0 0.0012993616983294487
but O 0 0.0007171776960603893
loss O 0 0.006502337753772736
of O 0 0.0027377400547266006
BRCA1 O 1 0.9964531660079956
resulting O 0 0.008103417232632637
from O 0 0.0009005247266031802
reduced O 0 0.0015616124728694558
expression O 0 0.0009669858263805509
or O 0 0.0006794309010729194
incorrect O 0 0.0017132407519966364
subcellular O 0 0.0034556868486106396
localization O 0 0.0023771352134644985
is O 0 0.000759761082008481
postulated O 0 0.0014096254017204046
to O 0 0.0005294554866850376
be O 0 0.0003807481552939862
important O 0 0.0005643632030114532
in O 0 0.0007771000964567065
non B-Disease 0 0.03443806990981102
- I-Disease 1 0.9978571534156799
familial I-Disease 1 0.9999980926513672
breast I-Disease 1 0.9999998807907104
and I-Disease 1 0.9997661709785461
ovarian I-Disease 1 1.0
cancers I-Disease 1 0.9999997615814209
. O 1 0.5270546674728394

Epigenetic O 0 0.20223772525787354
loss O 0 0.25705093145370483
, O 0 0.002389028901234269
however O 0 0.0014354821760207415
, O 0 0.0009943107143044472
has O 0 0.0008153267554007471
not O 0 0.000550209719222039
received O 0 0.0009413622319698334
general O 0 0.0012413172516971827
acceptance O 0 0.0015502888709306717
due O 0 0.00079131661914289
to O 0 0.0005438471562229097
controversy O 0 0.0011112921638414264
regarding O 0 0.0009085533092729747
the O 0 0.0008011616300791502
subcellular O 0 0.003732541110366583
localization O 0 0.0031839620787650347
of O 0 0.0013750218786299229
BRCA1 O 0 0.4988802373409271
proteins O 0 0.0006737533840350807
, O 0 0.0005451355827972293
reports O 0 0.0005961373099125922
of O 0 0.0005413946346379817
which O 0 0.0003864476748276502
have O 0 0.00034164710086770356
ranged O 0 0.000811964157037437
from O 0 0.00041409183177165687
exclusively O 0 0.0006366188172250986
nuclear O 0 0.000636720098555088
, O 0 0.00040646246634423733
to O 0 0.0003511954564601183
conditionally O 0 0.0013646931620314717
nuclear O 0 0.0007147909491322935
, O 0 0.00047574518248438835
to O 0 0.0005191710079088807
the O 0 0.0013617388904094696
ER O 1 0.9990886449813843
/ O 0 0.17272362112998962
golgi O 0 0.041453927755355835
, O 0 0.0009234392200596631
to O 0 0.0009413532097823918
cytoplasmic O 0 0.002978457137942314
invaginations O 0 0.006270392332226038
into O 0 0.0021293782629072666
the O 0 0.0032452032901346684
nucleus O 0 0.009332121349871159
. O 0 0.007645786739885807

In O 0 0.0036264739464968443
an O 0 0.0021649212576448917
attempt O 0 0.002486741403117776
to O 0 0.0009681603987701237
resolve O 0 0.0018485974287614226
this O 0 0.0006195601890794933
issue O 0 0.0008134518866427243
, O 0 0.0006094753625802696
we O 0 0.0006210212595760822
have O 0 0.000654086354188621
comprehensively O 0 0.0037203298415988684
characterized O 0 0.00512338150292635
19 O 0 0.005589215084910393
anti O 1 0.9286456108093262
- O 1 0.993309497833252
BRCA1 O 1 0.9980668425559998
antibodies O 0 0.1238958090543747
. O 0 0.011026516556739807

These O 0 0.005433263257145882
reagents O 0 0.009811878204345703
detect O 0 0.00599440885707736
a O 0 0.0033568846993148327
220 O 0 0.006332778837531805
- O 0 0.18469643592834473
kD O 1 0.7491104602813721
protein O 0 0.0020676562562584877
localized O 0 0.0018448681803420186
in O 0 0.0007203738205134869
discrete O 0 0.001408832729794085
nuclear O 0 0.0013229134492576122
foci O 0 0.0026829128619283438
in O 0 0.0006545340875163674
all O 0 0.0006334980134852231
epithelial O 0 0.1519918292760849
cell O 0 0.001209981506690383
lines O 0 0.0007276806281879544
, O 0 0.0005376157350838184
including O 0 0.0006162742502056062
those O 0 0.0007912841974757612
derived O 0 0.0026231794618070126
from O 0 0.0035974225029349327
breast B-Disease 1 0.9997372031211853
malignancies I-Disease 1 0.9947779178619385
. O 0 0.01393099408596754

Immunohistochemical O 1 0.9379267692565918
staining O 0 0.18044573068618774
of O 0 0.00904104858636856
human O 0 0.20691490173339844
breast O 1 0.9999064207077026
specimens O 0 0.05703851953148842
also O 0 0.002165480749681592
revealed O 0 0.01144180353730917
BRCA1 O 1 0.5461481809616089
nuclear O 0 0.002494476968422532
foci O 0 0.16496992111206055
in O 0 0.0023364850785583258
benign O 1 0.9998551607131958
breast O 1 0.999993085861206
, O 0 0.484073281288147
invasive B-Disease 1 0.9999885559082031
lobular I-Disease 1 0.9999998807907104
cancers I-Disease 1 0.9999771118164062
and O 1 0.5882337093353271
low B-Disease 1 0.9995025396347046
- I-Disease 1 0.999984622001648
grade I-Disease 1 0.9999910593032837
ductal I-Disease 1 0.9999998807907104
carcinomas I-Disease 1 0.9999973773956299
. O 0 0.05450660362839699

Conversely O 0 0.021856674924492836
, O 0 0.004846430383622646
BRCA1 O 0 0.26052623987197876
expression O 0 0.0036052828654646873
was O 0 0.0033674361184239388
reduced O 0 0.002233782084658742
or O 0 0.001079706009477377
undetectable O 0 0.008760642260313034
in O 0 0.0006509452359750867
the O 0 0.0005967867909930646
majority O 0 0.0006217535701580346
of O 0 0.000850993674248457
high O 0 0.21671757102012634
- O 1 0.9941251277923584
grade O 1 0.9969273209571838
, O 0 0.15872927010059357
ductal B-Disease 1 0.9999996423721313
carcinomas I-Disease 1 0.9999943971633911
, O 0 0.001494161318987608
suggesting O 0 0.0014905560528859496
that O 0 0.0004629745671991259
absence O 0 0.0017497818917036057
of O 0 0.0032240282744169235
BRCA1 O 1 0.9981642365455627
may O 0 0.001023150165565312
contribute O 0 0.0008704577921889722
to O 0 0.0004545389674603939
the O 0 0.0006428638007491827
pathogenesis O 0 0.05306507274508476
of O 0 0.0007448001415468752
a O 0 0.0009225400863215327
significant O 0 0.0010122701060026884
percentage O 0 0.0015463517047464848
of O 0 0.002493428299203515
sporadic B-Disease 1 0.9964132905006409
breast I-Disease 1 0.9999994039535522
cancers I-Disease 1 0.9999699592590332
. O 0 0.005727644544094801
. O 0 0.008505631238222122

